,category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,term,ontology,foreground_genes
1017,GO:0007409,0.000643907374527766,0.999907229581983,12,17,axonogenesis,BP,WNT7A;WNT3;SPTBN5;SPTB;FGF8;ARTN;HRAS;GDNF;PIK3CA;BMP7;SPTBN4;NOTCH1
2516,GO:0032990,0.00109845678178251,0.999799022547833,13,20,cell part morphogenesis,BP,WNT7A;WNT3;WNT7B;SPTBN5;SPTB;FGF8;ARTN;HRAS;GDNF;PIK3CA;BMP7;SPTBN4;NOTCH1
3903,GO:0048812,0.00109845678178251,0.999799022547833,13,20,neuron projection morphogenesis,BP,WNT7A;WNT3;WNT7B;SPTBN5;SPTB;FGF8;ARTN;HRAS;GDNF;PIK3CA;BMP7;SPTBN4;NOTCH1
3920,GO:0048858,0.00109845678178251,0.999799022547833,13,20,cell projection morphogenesis,BP,WNT7A;WNT3;WNT7B;SPTBN5;SPTB;FGF8;ARTN;HRAS;GDNF;PIK3CA;BMP7;SPTBN4;NOTCH1
4947,GO:0071396,0.00245082540089832,0.999515834216624,12,19,cellular response to lipid,BP,GJB2;BMP6;WNT3;HEY1;WNT7B;WNT2;FZD7;VDR;WNT5B;CCL20;BMP4;BMP7
3861,GO:0048667,0.00266682838456869,0.99946652877087,12,19,cell morphogenesis involved in neuron differentiation,BP,WNT7A;WNT3;SPTBN5;SPTB;FGF8;ARTN;HRAS;GDNF;PIK3CA;BMP7;SPTBN4;NOTCH1
2742,GO:0035556,0.00267270684079125,0.99895671695969,34,78,intracellular signal transduction,BP,TLE1;WNT7A;PIK3CG;ACTN3;RABIF;BMP6;WNT7B;PMAIP1;AXIN1;MAPK12;SPTBN5;RAB40B;SPTB;RRAS2;FZD7;FGF8;ARTN;AMOT;WNK4;DUSP5;INHBB;CCL20;PKN3;FGF17;HRAS;BMP4;GDNF;RAB38;PIK3CA;BMP7;SPTBN4;NOTCH1;RND3;GUCY1B3
2699,GO:0035116,0.00345198690540622,1,5,5,embryonic hindlimb morphogenesis,BP,WNT7A;WNT3;FGF8;BMP4;NOTCH1
2701,GO:0035137,0.00345198690540622,1,5,5,hindlimb morphogenesis,BP,WNT7A;WNT3;FGF8;BMP4;NOTCH1
1018,GO:0007411,0.0039540333253733,0.999312380825021,10,15,axon guidance,BP,WNT3;SPTBN5;SPTB;FGF8;ARTN;HRAS;GDNF;PIK3CA;BMP7;SPTBN4
5399,GO:0097485,0.0039540333253733,0.999312380825021,10,15,neuron projection guidance,BP,WNT3;SPTBN5;SPTB;FGF8;ARTN;HRAS;GDNF;PIK3CA;BMP7;SPTBN4
1865,GO:0021953,0.00429537168786482,0.999756974111977,6,7,central nervous system neuron differentiation,BP,WNT7A;WNT3;AXIN1;WNT2;FGF8;SPTBN4
2015,GO:0030326,0.00456880550601091,0.999737567597476,6,7,embryonic limb morphogenesis,BP,WNT7A;WNT3;FGF8;BMP4;BMP7;NOTCH1
2697,GO:0035113,0.00456880550601091,0.999737567597476,6,7,embryonic appendage morphogenesis,BP,WNT7A;WNT3;FGF8;BMP4;BMP7;NOTCH1
2592,GO:0033993,0.00479242329993769,0.998676478031744,15,27,response to lipid,BP,WNT7A;GJB2;BMP6;WNT3;HEY1;GJB6;WNT7B;WNT2;FZD7;VDR;WNT5B;CCL20;BMP4;BMP7;NOTCH1
4733,GO:0061564,0.00488346831578317,0.998884560980968,12,20,axon development,BP,WNT7A;WNT3;SPTBN5;SPTB;FGF8;ARTN;HRAS;GDNF;PIK3CA;BMP7;SPTBN4;NOTCH1
23,GO:0000165,0.00528179131708099,0.998209293596698,20,40,MAPK cascade,BP,WNT7A;PIK3CG;BMP6;WNT7B;AXIN1;MAPK12;SPTBN5;SPTB;FZD7;FGF8;ARTN;DUSP5;INHBB;CCL20;FGF17;HRAS;BMP4;GDNF;BMP7;SPTBN4
4516,GO:0060561,0.00652734538857496,1,4,4,apoptotic process involved in morphogenesis,BP,JAG2;VDR;BMP7;NOTCH1
5737,GO:1902742,0.00652734538857496,1,4,4,apoptotic process involved in development,BP,JAG2;VDR;BMP7;NOTCH1
4240,GO:0051693,0.00680288747643109,1,4,4,actin filament capping,BP,SCIN;SPTBN5;SPTB;SPTBN4
3818,GO:0048545,0.00889958043854614,0.998521765928844,8,12,response to steroid hormone,BP,GJB2;BMP6;HEY1;WNT7B;VDR;BMP4;BMP7;NOTCH1
5257,GO:0090100,0.0098162924438806,0.998967502386617,6,8,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,BMP6;CRB2;INHBB;BMP4;BMP7;NOTCH1
100,GO:0001570,0.01043132648155,0.999342492755234,5,6,vasculogenesis,BP,WNT7A;HEY1;WNT7B;AMOT;NOTCH1
51,GO:0000904,0.0106439701471865,0.996927625261884,13,24,cell morphogenesis involved in differentiation,BP,WNT7A;WNT3;SPTBN5;SPTB;FZD7;FGF8;ARTN;HRAS;GDNF;PIK3CA;BMP7;SPTBN4;NOTCH1
2401,GO:0032526,0.0112548321476592,0.998373950017242,7,10,response to retinoic acid,BP,GJB2;BMP6;WNT3;WNT7B;WNT2;FZD7;WNT5B
4942,GO:0071383,0.0117161774836016,0.999236215852183,5,6,cellular response to steroid hormone stimulus,BP,GJB2;HEY1;VDR;BMP4;BMP7
946,GO:0007154,0.012508897720928,0.994343454007486,52,142,cell communication,BP,RHPN1;TLE1;WNT7A;GJB2;PIK3CG;SYT5;ACTN3;CLDN18;RABIF;GJA3;BMP6;WNT3;HEY1;GJB6;WNT7B;JAG2;PMAIP1;KCNG2;AXIN1;MAPK12;WNT2;SPTBN5;RAB40B;SPTB;RRAS2;FZD7;FGF8;VDR;CRB2;ARTN;AMOT;WNT5B;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;FGF17;TSPAN15;HRAS;BMP4;GDNF;RAB38;PIK3CA;BMP7;FSTL3;SPTBN4;TSPAN13;NOTCH1;RND3;GUCY1B3
1010,GO:0007369,0.013162370775028,0.997114184977543,9,15,gastrulation,BP,WNT3;AXIN1;FZD7;FGF8;CRB2;AMOT;DUSP5;BMP4;BMP7
84,GO:0001501,0.0135943859428195,0.996123026365695,12,22,skeletal system development,BP,SCIN;WNT7A;CLDN18;BMP6;WNT7B;JAG2;AXIN1;FGF8;VDR;WNT5B;BMP4;BMP7
1912,GO:0023014,0.0145218789435674,0.994309362960864,20,43,signal transduction by protein phosphorylation,BP,WNT7A;PIK3CG;BMP6;WNT7B;AXIN1;MAPK12;SPTBN5;SPTB;FZD7;FGF8;ARTN;DUSP5;INHBB;CCL20;FGF17;HRAS;BMP4;GDNF;BMP7;SPTBN4
2694,GO:0035107,0.0150090416980156,0.998239669184441,6,8,appendage morphogenesis,BP,WNT7A;WNT3;FGF8;BMP4;BMP7;NOTCH1
2695,GO:0035108,0.0150090416980156,0.998239669184441,6,8,limb morphogenesis,BP,WNT7A;WNT3;FGF8;BMP4;BMP7;NOTCH1
1915,GO:0023052,0.0151735687700787,0.993005475714454,52,143,signaling,BP,RHPN1;TLE1;WNT7A;GJB2;PIK3CG;SYT5;ACTN3;CLDN18;RABIF;GJA3;BMP6;WNT3;HEY1;WNT7B;JAG2;PMAIP1;KCNG2;AXIN1;MAPK12;WNT2;SPTBN5;RAB40B;SPTB;RRAS2;FZD7;FGF8;VDR;CRB2;ARTN;AMOT;WNT5B;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;FGF17;TSPAN15;HRAS;BMP4;KCNK6;GDNF;RAB38;PIK3CA;BMP7;FSTL3;SPTBN4;TSPAN13;NOTCH1;RND3;GUCY1B3
3352,GO:0044700,0.0151735687700787,0.993005475714454,52,143,single organism signaling,BP,RHPN1;TLE1;WNT7A;GJB2;PIK3CG;SYT5;ACTN3;CLDN18;RABIF;GJA3;BMP6;WNT3;HEY1;WNT7B;JAG2;PMAIP1;KCNG2;AXIN1;MAPK12;WNT2;SPTBN5;RAB40B;SPTB;RRAS2;FZD7;FGF8;VDR;CRB2;ARTN;AMOT;WNT5B;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;FGF17;TSPAN15;HRAS;BMP4;KCNK6;GDNF;RAB38;PIK3CA;BMP7;FSTL3;SPTBN4;TSPAN13;NOTCH1;RND3;GUCY1B3
3836,GO:0048598,0.016135565002456,0.994225245756055,16,33,embryonic morphogenesis,BP,WNT7A;WNT3;GJB6;WNT7B;JAG2;AXIN1;WNT2;FZD7;FGF8;CRB2;AMOT;DUSP5;BMP4;GDNF;BMP7;NOTCH1
2163,GO:0031175,0.0179818008812175,0.993930571372567,14,28,neuron projection development,BP,WNT7A;WNT3;WNT7B;CDH1;SPTBN5;SPTB;FGF8;ARTN;HRAS;GDNF;PIK3CA;BMP7;SPTBN4;NOTCH1
3832,GO:0048589,0.0183310346876895,0.99480384767499,11,20,developmental growth,BP,WNT7A;ACTN3;WNT3;WNT7B;WNT2;FZD7;FGF8;BMP4;PIK3CA;SPTBN4;NOTCH1
1887,GO:0022411,0.0195496776613493,0.99703849298355,6,9,cellular component disassembly,BP,SCIN;AXIN1;CDH1;SPTBN5;SPTB;SPTBN4
50,GO:0000902,0.0208886893258597,0.992455200798346,15,31,cell morphogenesis,BP,WNT7A;WNT3;WNT7B;SPTBN5;SPTB;FZD7;FGF8;VDR;ARTN;HRAS;GDNF;PIK3CA;BMP7;SPTBN4;NOTCH1
991,GO:0007267,0.0217788284608981,0.990764336983541,21,47,cell-cell signaling,BP,TLE1;WNT7A;GJB2;SYT5;GJA3;BMP6;WNT3;WNT7B;KCNG2;AXIN1;WNT2;FZD7;FGF8;WNT5B;INHBB;CCL20;FGF17;HRAS;BMP4;GDNF;NOTCH1
1970,GO:0030182,0.0218676762114072,0.990678831755563,21,48,neuron differentiation,BP,WNT7A;BMP6;WNT3;WNT7B;JAG2;AXIN1;WNT2;CDH1;SPTBN5;SPTB;FZD7;FGF8;ARTN;WNT5B;HRAS;BMP4;GDNF;PIK3CA;BMP7;SPTBN4;NOTCH1
1084,GO:0008091,0.0232753971477338,1,3,3,spectrin,CC,SPTBN5;SPTB;SPTBN4
2034,GO:0030506,0.0232756960454968,1,3,3,ankyrin binding,MF,CDH1;SPTB;SPTBN4
2514,GO:0032984,0.0234731740747198,0.997209629093093,5,7,macromolecular complex disassembly,BP,SCIN;AXIN1;SPTBN5;SPTB;SPTBN4
3128,GO:0043241,0.0234731740747198,0.997209629093093,5,7,protein complex disassembly,BP,SCIN;AXIN1;SPTBN5;SPTB;SPTBN4
894,GO:0006935,0.0243247623841158,0.991006942554502,15,31,chemotaxis,BP,PIK3CG;WNT3;SPTBN5;SPTB;FGF8;ARTN;AMOT;CCL20;HRAS;BMP4;GDNF;PIK3CA;BMP7;SPTBN4;NOTCH1
2963,GO:0042330,0.0243247623841158,0.991006942554502,15,31,taxis,BP,PIK3CG;WNT3;SPTBN5;SPTB;FGF8;ARTN;AMOT;CCL20;HRAS;BMP4;GDNF;PIK3CA;BMP7;SPTBN4;NOTCH1
1021,GO:0007420,0.0244659276250824,0.992512146785007,11,21,brain development,BP,WNT7A;WNT3;WNT7B;AXIN1;POU3F1;WNT2;CDH1;FGF8;BMP4;BMP7;NOTCH1
3246,GO:0043902,0.0246646976724273,1,3,3,positive regulation of multi-organism process,BP,BMP6;INHBB;NOTCH1
4716,GO:0061383,0.0256114468952691,1,3,3,trabecula morphogenesis,BP,HEY1;BMP7;NOTCH1
4717,GO:0061384,0.0256114468952691,1,3,3,heart trabecula morphogenesis,BP,HEY1;BMP7;NOTCH1
429,GO:0003206,0.0258315751454261,0.995787156022125,6,9,cardiac chamber morphogenesis,BP,HEY1;WNT2;FGF8;BMP4;BMP7;NOTCH1
2094,GO:0030835,0.0261851638074238,0.998116271643299,4,5,negative regulation of actin filament depolymerization,BP,SCIN;SPTBN5;SPTB;SPTBN4
3129,GO:0043242,0.0261851638074238,0.998116271643299,4,5,negative regulation of protein complex disassembly,BP,SCIN;SPTBN5;SPTB;SPTBN4
5647,GO:1901880,0.0261851638074238,0.998116271643299,4,5,negative regulation of protein depolymerization,BP,SCIN;SPTBN5;SPTB;SPTBN4
1935,GO:0030041,0.0261852019949925,0.998116267922169,4,5,actin filament polymerization,BP,SCIN;SPTBN5;SPTB;SPTBN4
2092,GO:0030833,0.0261852019949925,0.998116267922169,4,5,regulation of actin filament polymerization,BP,SCIN;SPTBN5;SPTB;SPTBN4
2096,GO:0030837,0.0261852019949925,0.998116267922169,4,5,negative regulation of actin filament polymerization,BP,SCIN;SPTBN5;SPTB;SPTBN4
2192,GO:0031333,0.0261852019949925,0.998116267922169,4,5,negative regulation of protein complex assembly,BP,SCIN;SPTBN5;SPTB;SPTBN4
2330,GO:0032272,0.0261852019949925,0.998116267922169,4,5,negative regulation of protein polymerization,BP,SCIN;SPTBN5;SPTB;SPTBN4
2039,GO:0030513,0.0268503679804941,1,3,3,positive regulation of BMP signaling pathway,BP,CRB2;BMP4;NOTCH1
3481,GO:0045606,0.0268503803712213,1,3,3,positive regulation of epidermal cell differentiation,BP,VDR;BMP4;NOTCH1
1235,GO:0009755,0.0269112763011233,1,3,3,hormone-mediated signaling pathway,BP,VDR;BMP4;BMP7
3166,GO:0043401,0.0269112763011233,1,3,3,steroid hormone mediated signaling pathway,BP,VDR;BMP4;BMP7
5051,GO:0072044,0.0269503168191267,1,3,3,collecting duct development,BP,WNT7B;BMP4;NOTCH1
3426,GO:0045165,0.0270090277460586,0.991582019561823,11,21,cell fate commitment,BP,WNT7A;WNT3;WNT7B;JAG2;AXIN1;WNT2;FZD7;FGF8;WNT5B;BMP4;NOTCH1
1708,GO:0017145,0.0271608887349895,1,3,3,stem cell division,BP,WNT7A;FZD7;NOTCH1
3740,GO:0048103,0.0271608887349895,1,3,3,somatic stem cell division,BP,WNT7A;FZD7;NOTCH1
3872,GO:0048704,0.0273548925809847,1,3,3,embryonic skeletal system morphogenesis,BP,AXIN1;BMP4;BMP7
4410,GO:0060272,0.0273548925809847,1,3,3,embryonic skeletal joint morphogenesis,BP,AXIN1;BMP4;BMP7
5173,GO:0072498,0.0273548925809847,1,3,3,embryonic skeletal joint development,BP,AXIN1;BMP4;BMP7
1711,GO:0017156,0.0278434573811987,1,3,3,calcium ion regulated exocytosis,BP,SCIN;SYT5;NOTCH1
3170,GO:0043407,0.0288177203773207,1,3,3,negative regulation of MAP kinase activity,BP,DUSP5;BMP4;BMP7
3858,GO:0048663,0.0290164117628324,0.997834756319395,4,5,neuron fate commitment,BP,JAG2;AXIN1;BMP4;NOTCH1
671,GO:0005794,0.0291907858965559,0.988786418512937,15,32,Golgi apparatus,CC,WNT7A;WNT3;WNT7B;CDH1;RAB39A;SPTB;WNT5B;PKN3;HRAS;RNF144A;RAB38;FSTL3;NOTCH1;RND3;RAB20
4563,GO:0060711,0.0292146539404039,0.997814630268937,4,5,labyrinthine layer development,BP,HEY1;WNT7B;WNT2;BMP7
4245,GO:0051716,0.0292696390340848,0.985453297467795,51,143,cellular response to stimulus,BP,RHPN1;TLE1;WNT7A;GJB2;PIK3CG;ACTN3;CLDN18;RABIF;BMP6;WNT3;HEY1;GJB6;WNT7B;JAG2;PMAIP1;AXIN1;MAPK12;WNT2;CDH1;SPTBN5;RAB40B;SPTB;RRAS2;FZD7;FGF8;VDR;CRB2;ARTN;AMOT;WNT5B;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;FGF17;TSPAN15;HRAS;BMP4;GDNF;RAB38;PIK3CA;BMP7;FSTL3;SPTBN4;TSPAN13;NOTCH1;RND3;GUCY1B3;TF
4807,GO:0070306,0.029847064850843,1,3,3,lens fiber cell differentiation,BP,WNT7A;WNT7B;WNT5B
4808,GO:0070307,0.029847064850843,1,3,3,lens fiber cell development,BP,WNT7A;WNT7B;WNT5B
4450,GO:0060395,0.0300918410632632,0.997724938593308,4,5,SMAD protein signal transduction,BP,BMP6;INHBB;BMP4;BMP7
4911,GO:0071300,0.0303944800306294,0.996091345200685,5,7,cellular response to retinoic acid,BP,WNT3;WNT7B;WNT2;FZD7;WNT5B
3471,GO:0045595,0.0312057055826592,0.986255230558786,20,46,regulation of cell differentiation,BP,SCIN;WNT7A;CLDN18;BMP6;WNT3;HEY1;WNT7B;AXIN1;MAPK12;WNT2;FZD7;FGF8;VDR;CRB2;WNT5B;BMP4;GDNF;BMP7;FSTL3;NOTCH1
425,GO:0003197,0.0312120289215417,0.995953116225837,5,7,endocardial cushion development,BP,HEY1;FGF8;BMP4;BMP7;NOTCH1
3885,GO:0048736,0.0314656122544803,0.994585114317882,6,9,appendage development,BP,WNT7A;WNT3;FGF8;BMP4;BMP7;NOTCH1
4393,GO:0060173,0.0314656122544803,0.994585114317882,6,9,limb development,BP,WNT7A;WNT3;FGF8;BMP4;BMP7;NOTCH1
233,GO:0002088,0.031517389059294,0.995901169824609,5,7,lens development in camera-type eye,BP,WNT7A;WNT7B;WNT2;WNT5B;BMP4
3790,GO:0048471,0.0316110937834957,0.990415785779163,10,19,perinuclear region of cytoplasm,CC,GJB2;SYT5;AXIN1;CDH1;RAB40B;INHBB;PKN3;HRAS;TPD52;TF
2104,GO:0030858,0.0317699298143232,0.995858079549381,5,7,positive regulation of epithelial cell differentiation,BP,BMP6;VDR;BMP4;GDNF;NOTCH1
1020,GO:0007417,0.032372296778581,0.988245196886255,13,27,central nervous system development,BP,WNT7A;WNT3;WNT7B;AXIN1;POU3F1;WNT2;CDH1;FGF8;BMP4;BMP7;DRP2;SPTBN4;NOTCH1
2325,GO:0032259,0.0324443828983922,1,3,3,methylation,BP,RAB3D;PIK3CA;PNMT
448,GO:0003272,0.0327957202080441,0.997442050276234,4,5,endocardial cushion formation,BP,HEY1;FGF8;BMP7;NOTCH1
1921,GO:0030004,0.033728855922745,1,3,3,cellular monovalent inorganic cation homeostasis,BP,RAB39A;RAB38;RAB20
2056,GO:0030641,0.033728855922745,1,3,3,regulation of cellular pH,BP,RAB39A;RAB38;RAB20
3557,GO:0045851,0.033728855922745,1,3,3,pH reduction,BP,RAB39A;RAB38;RAB20
4197,GO:0051452,0.033728855922745,1,3,3,intracellular pH reduction,BP,RAB39A;RAB38;RAB20
4198,GO:0051453,0.033728855922745,1,3,3,regulation of intracellular pH,BP,RAB39A;RAB38;RAB20
5312,GO:0090383,0.033728855922745,1,3,3,phagosome acidification,BP,RAB39A;RAB38;RAB20
3084,GO:0043087,0.0344498638529636,0.988004082804476,12,24,regulation of GTPase activity,BP,RABIF;AXIN1;SPTBN5;SPTB;FGF8;ARTN;AMOT;CCL20;FGF17;HRAS;GDNF;SPTBN4
3846,GO:0048638,0.0349993284594403,0.99103729899464,8,14,regulation of developmental growth,BP,ACTN3;WNT3;WNT2;FGF8;BMP4;PIK3CA;SPTBN4;NOTCH1
1023,GO:0007423,0.0355559488513847,0.986878759295114,13,27,sensory organ development,BP,WNT7A;GJB2;BMP6;GJB6;WNT7B;JAG2;AXIN1;WNT2;FGF8;WNT5B;BMP4;BMP7;NOTCH1
3804,GO:0048518,0.0366572022113701,0.980829602458607,41,111,positive regulation of biological process,BP,MAGEC2;SCIN;TLE1;WNT7A;PIK3CG;ACTN3;BMP6;WNT3;HEY1;WNT7B;JAG2;PMAIP1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;RRAS2;FZD7;FGF8;VDR;CRB2;ARTN;AMOT;WNT5B;DUSP5;INHBB;CCL20;PKP1;FGF17;HRAS;BMP4;RAB3D;GDNF;RNF144A;PIK3CA;BMP7;FSTL3;SPTBN4;NOTCH1;TF
368,GO:0003002,0.0366832758560699,0.988541335365149,10,19,regionalization,BP,WNT7A;WNT3;WNT7B;AXIN1;WNT2;FGF8;CRB2;BMP4;GDNF;NOTCH1
2036,GO:0030509,0.0374193041625852,0.991296168964998,7,12,BMP signaling pathway,BP,BMP6;FGF8;CRB2;BMP4;BMP7;FSTL3;NOTCH1
5000,GO:0071772,0.0374193041625852,0.991296168964998,7,12,response to BMP,BP,BMP6;FGF8;CRB2;BMP4;BMP7;FSTL3;NOTCH1
5001,GO:0071773,0.0374193041625852,0.991296168964998,7,12,cellular response to BMP stimulus,BP,BMP6;FGF8;CRB2;BMP4;BMP7;FSTL3;NOTCH1
5453,GO:0098772,0.0375545518955017,0.984037456939095,17,38,molecular function regulator,MF,WNT7A;RABIF;WNT3;AXIN1;WNT2;SPTBN5;SPTB;FGF8;CRB2;ARTN;WNK4;FGF17;GDNF;PIK3CA;SPTBN4;TSPAN13;NOTCH1
2396,GO:0032501,0.0378642063422612,0.980895690905105,53,152,multicellular organismal process,BP,SLC2A14;SCIN;TLE1;WNT7A;GJB2;PIK3CG;ACTN3;CLDN18;GJA3;BMP6;WNT3;HEY1;GJB6;WNT7B;JAG2;KCNG2;AXIN1;POU3F1;MAPK12;WNT2;CDH1;SPTBN5;SPTB;RRAS2;FZD7;FGF8;VDR;CRB2;ARTN;DSG3;AMOT;WNT5B;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;FGF17;HRAS;BMP4;RAB3D;KCNK6;GDNF;PIK3CA;BMP7;DRP2;FSTL3;TPD52;SPTBN4;NOTCH1;GUCY1B3;TF
4754,GO:0065009,0.0380702273250559,0.980958102158625,28,70,regulation of molecular function,BP,MAGEC2;PIK3CG;RABIF;HEY1;WNT7B;PMAIP1;AXIN1;MAPK12;WNT2;SPTBN5;SPTB;FGF8;VDR;CRB2;ARTN;AMOT;WNK4;DUSP5;CCL20;FGF17;HRAS;BMP4;GDNF;PIK3CA;BMP7;SPTBN4;TSPAN13;NOTCH1
88,GO:0001505,0.0383476640892673,1,3,3,regulation of neurotransmitter levels,BP,WNT7A;SYT5;GDNF
864,GO:0006836,0.0383476640892673,1,3,3,neurotransmitter transport,BP,WNT7A;SYT5;GDNF
5496,GO:0099531,0.0383476640892673,1,3,3,presynaptic process involved in chemical synaptic transmission,BP,WNT7A;SYT5;GDNF
1263,GO:0009952,0.0397569075871659,0.99061035704704,7,12,anterior/posterior pattern specification,BP,WNT3;AXIN1;WNT2;FGF8;CRB2;BMP4;NOTCH1
4367,GO:0060070,0.0419474189022027,0.987376735593822,9,17,canonical Wnt signaling pathway,BP,WNT7A;WNT3;WNT7B;AXIN1;WNT2;FZD7;FGF8;WNT5B;NOTCH1
1013,GO:0007389,0.0423277538357425,0.985347509236496,11,22,pattern specification process,BP,WNT7A;WNT3;WNT7B;AXIN1;WNT2;FGF8;CRB2;BMP4;GDNF;BMP7;NOTCH1
171,GO:0001890,0.0424967088219274,0.991162716724584,6,10,placenta development,BP,GJB2;HEY1;WNT7B;WNT2;VDR;BMP7
3945,GO:0050679,0.0429349103431103,0.989659813552507,7,12,positive regulation of epithelial cell proliferation,BP,WNT7A;BMP6;WNT2;FZD7;HRAS;BMP4;NOTCH1
5426,GO:0098588,0.043722875577351,0.980096964225226,19,44,bounding membrane of organelle,CC,WNT7A;SYT5;WNT3;WNT7B;PMAIP1;SPTBN5;RAB39A;FZD7;WNT5B;PKP1;TSPAN15;HRAS;RAB3D;RNF144A;RAB38;NOTCH1;RND3;RAB20;TF
3593,GO:0045995,0.0443180079148423,0.987513067607485,8,15,regulation of embryonic development,BP,WNT2;FZD7;CRB2;AMOT;BMP4;GDNF;BMP7;NOTCH1
158,GO:0001837,0.044583614965317,0.990603462722727,6,10,epithelial to mesenchymal transition,BP,HEY1;WNT2;FGF8;CRB2;BMP7;NOTCH1
2063,GO:0030666,0.0447015195338188,0.989122651949947,7,12,endocytic vesicle membrane,CC,WNT7A;WNT3;WNT7B;RAB39A;WNT5B;RAB38;RAB20
1956,GO:0030139,0.0451833686262715,0.986179872440281,9,17,endocytic vesicle,CC,WNT7A;WNT3;WNT7B;RAB39A;AMOT;WNT5B;RAB38;RAB20;TF
3212,GO:0043547,0.0453131958216004,0.984103781962769,11,22,positive regulation of GTPase activity,BP,RABIF;AXIN1;SPTBN5;SPTB;FGF8;ARTN;CCL20;FGF17;HRAS;GDNF;SPTBN4
3064,GO:0043009,0.0466680067920652,0.983262082033888,11,23,chordate embryonic development,BP,HEY1;WNT7B;JAG2;AXIN1;WNT2;FGF8;CRB2;AMOT;BMP4;BMP7;NOTCH1
5635,GO:1901701,0.0470175670464886,0.979592470110811,16,37,cellular response to oxygen-containing compound,BP,GJB2;PIK3CG;BMP6;WNT3;GJB6;WNT7B;WNT2;CDH1;FZD7;VDR;WNT5B;INHBB;CCL20;PIK3CA;BMP7;GUCY1B3
3838,GO:0048608,0.0474799687121786,0.981348790955968,13,28,reproductive structure development,BP,WNT7A;GJB2;BMP6;HEY1;WNT7B;WNT2;FGF8;VDR;INHBB;BMP4;BMP7;FSTL3;NOTCH1
4729,GO:0061458,0.0474799687121786,0.981348790955968,13,28,reproductive system development,BP,WNT7A;GJB2;BMP6;HEY1;WNT7B;WNT2;FGF8;VDR;INHBB;BMP4;BMP7;FSTL3;NOTCH1
2943,GO:0042221,0.0475683808676925,0.974672293712704,34,90,response to chemical,BP,WNT7A;GJB2;PIK3CG;CLDN18;BMP6;WNT3;HEY1;GJB6;WNT7B;PMAIP1;WNT2;CDH1;SPTBN5;SPTB;FZD7;FGF8;VDR;CRB2;ARTN;AMOT;WNT5B;INHBB;CCL20;FGF17;HRAS;BMP4;GDNF;PIK3CA;BMP7;FSTL3;SPTBN4;NOTCH1;GUCY1B3;TF
3870,GO:0048699,0.047703221537994,0.977144725335161,21,51,generation of neurons,BP,WNT7A;BMP6;WNT3;WNT7B;JAG2;AXIN1;WNT2;CDH1;SPTBN5;SPTB;FZD7;FGF8;ARTN;WNT5B;HRAS;BMP4;GDNF;PIK3CA;BMP7;SPTBN4;NOTCH1
4111,GO:0051179,0.0479344059363824,0.97445182218641,48,136,localization,BP,SLC2A14;SCIN;WNT7A;GJB2;PIK3CG;SYT5;CLDN18;RABIF;GJA3;BMP6;WNT3;JAG2;PMAIP1;KCNG2;CDH1;SPTBN5;RAB40B;RAB39A;SPTB;RRAS2;FZD7;FGF8;VDR;CRB2;ARTN;AMOT;WNT5B;WNK4;INHBB;CCL20;PKN3;PKP1;TSPAN15;HRAS;BMP4;RAB3D;KCNK6;CLDN15;GDNF;RAB38;PIK3CA;BMP7;TPD52;SPTBN4;TSPAN13;NOTCH1;RAB20;TF
1030,GO:0007498,0.0480028270083082,0.989669547134759,6,10,mesoderm development,BP,WNT3;AXIN1;FGF8;CRB2;BMP4;BMP7
955,GO:0007165,0.0480799131247478,0.974275765143368,47,132,signal transduction,BP,RHPN1;TLE1;WNT7A;PIK3CG;ACTN3;CLDN18;RABIF;BMP6;WNT3;HEY1;WNT7B;JAG2;PMAIP1;AXIN1;MAPK12;WNT2;SPTBN5;RAB40B;SPTB;RRAS2;FZD7;FGF8;VDR;CRB2;ARTN;AMOT;WNT5B;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;FGF17;TSPAN15;HRAS;BMP4;GDNF;RAB38;PIK3CA;BMP7;FSTL3;SPTBN4;TSPAN13;NOTCH1;RND3;GUCY1B3
428,GO:0003205,0.0484245464275359,0.989552876413026,6,10,cardiac chamber development,BP,HEY1;WNT2;FGF8;BMP4;BMP7;NOTCH1
1598,GO:0016202,0.0485623550811813,0.989514681377234,6,10,regulation of striated muscle tissue development,BP,ACTN3;WNT2;FZD7;FGF8;BMP4;NOTCH1
3843,GO:0048634,0.0485623550811813,0.989514681377234,6,10,regulation of muscle organ development,BP,ACTN3;WNT2;FZD7;FGF8;BMP4;NOTCH1
5643,GO:1901861,0.0485623550811813,0.989514681377234,6,10,regulation of muscle tissue development,BP,ACTN3;WNT2;FZD7;FGF8;BMP4;NOTCH1
1086,GO:0008104,0.0487547612131548,0.975926249813194,23,57,protein localization,BP,SCIN;WNT7A;CLDN18;RABIF;BMP6;PMAIP1;KCNG2;CDH1;RAB40B;RAB39A;FZD7;AMOT;WNK4;INHBB;TSPAN15;BMP4;RAB3D;RAB38;BMP7;SPTBN4;NOTCH1;RAB20;TF
1586,GO:0016055,0.0492286801743237,0.983294542768634,10,20,Wnt signaling pathway,BP,TLE1;WNT7A;WNT3;WNT7B;AXIN1;WNT2;FZD7;FGF8;WNT5B;NOTCH1
5513,GO:0198738,0.0492286801743237,0.983294542768634,10,20,cell-cell signaling by wnt,BP,TLE1;WNT7A;WNT3;WNT7B;AXIN1;WNT2;FZD7;FGF8;WNT5B;NOTCH1
1244,GO:0009887,0.0497314898906134,0.976822998951518,19,45,animal organ morphogenesis,BP,TLE1;WNT7A;BMP6;HEY1;GJB6;WNT7B;JAG2;AXIN1;WNT2;FZD7;FGF8;VDR;CRB2;WNK4;HRAS;BMP4;GDNF;BMP7;NOTCH1
1874,GO:0022008,0.0500787390957806,0.975495192606177,22,54,neurogenesis,BP,WNT7A;BMP6;WNT3;WNT7B;JAG2;AXIN1;POU3F1;WNT2;CDH1;SPTBN5;SPTB;FZD7;FGF8;ARTN;WNT5B;HRAS;BMP4;GDNF;PIK3CA;BMP7;SPTBN4;NOTCH1
3847,GO:0048639,0.0502817522998675,0.9890352734806,6,10,positive regulation of developmental growth,BP,ACTN3;WNT3;WNT2;FGF8;SPTBN4;NOTCH1
559,GO:0005109,0.0510459598907973,0.98882050984972,6,10,frizzled binding,MF,WNT7A;WNT3;WNT7B;WNT2;FZD7;WNT5B
2117,GO:0030900,0.051288527379094,0.985041515976238,8,15,forebrain development,BP,WNT7A;WNT7B;AXIN1;POU3F1;CDH1;FGF8;BMP4;NOTCH1
3328,GO:0044431,0.0516088634165955,0.982312999029149,10,20,Golgi apparatus part,CC,WNT7A;WNT3;WNT7B;CDH1;RAB39A;WNT5B;HRAS;RAB38;NOTCH1;RND3
1257,GO:0009913,0.0516977712823054,0.986253062347817,7,13,epidermal cell differentiation,BP,JAG2;POU3F1;VDR;DSG3;PKP1;BMP4;NOTCH1
3985,GO:0050794,0.0525332381956003,0.973764118269522,58,170,regulation of cellular process,BP,MAGEC2;RHPN1;SCIN;TLE1;WNT7A;PIK3CG;SYT5;ACTN3;CLDN18;RABIF;BMP6;WNT3;HEY1;GJB6;WNT7B;JAG2;PMAIP1;KCNG2;AXIN1;POU3F1;MAPK12;WNT2;CDH1;SPTBN5;RAB40B;SPTB;RRAS2;FZD7;FGF8;VDR;CRB2;ARTN;AMOT;WNT5B;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;FGF17;TSPAN15;HRAS;BMP4;RAB3D;GDNF;RNF144A;RAB38;PIK3CA;BMP7;FSTL3;SPTBN4;TSPAN13;NOTCH1;RND3;RAB20;GUCY1B3;TF
3940,GO:0050673,0.053212861063225,0.984342786753753,8,15,epithelial cell proliferation,BP,WNT7A;BMP6;WNT2;FZD7;VDR;HRAS;BMP4;NOTCH1
3944,GO:0050678,0.053212861063225,0.984342786753753,8,15,regulation of epithelial cell proliferation,BP,WNT7A;BMP6;WNT2;FZD7;VDR;HRAS;BMP4;NOTCH1
121,GO:0001704,0.0562500861279798,0.984712149827914,7,13,formation of primary germ layer,BP,WNT3;AXIN1;FZD7;CRB2;DUSP5;BMP4;BMP7
5934,GO:1905114,0.0563199024877066,0.979034211923316,11,23,cell surface receptor signaling pathway involved in cell-cell signaling,BP,TLE1;WNT7A;WNT3;WNT7B;AXIN1;WNT2;FZD7;FGF8;WNT5B;BMP4;NOTCH1
1516,GO:0015031,0.0563910914057038,0.975482821384132,15,34,protein transport,BP,RABIF;BMP6;KCNG2;CDH1;RAB40B;RAB39A;FZD7;INHBB;BMP4;RAB3D;RAB38;BMP7;NOTCH1;RAB20;TF
611,GO:0005509,0.0578696770100159,0.979306443237569,10,21,calcium ion binding,MF,SCIN;SYT5;ACTN3;RHBDL3;JAG2;CDH1;CRB2;DSG3;TPD52;NOTCH1
4178,GO:0051345,0.0580016210175354,0.976370131140886,13,28,positive regulation of hydrolase activity,BP,RABIF;PMAIP1;AXIN1;MAPK12;SPTBN5;SPTB;FGF8;ARTN;CCL20;FGF17;HRAS;GDNF;SPTBN4
4880,GO:0070887,0.0582949678196502,0.969290987675575,27,70,cellular response to chemical stimulus,BP,WNT7A;GJB2;PIK3CG;CLDN18;BMP6;WNT3;HEY1;GJB6;WNT7B;PMAIP1;WNT2;CDH1;FZD7;FGF8;VDR;CRB2;WNT5B;INHBB;CCL20;FGF17;BMP4;PIK3CA;BMP7;FSTL3;NOTCH1;GUCY1B3;TF
4914,GO:0071310,0.0597287407686043,0.969256754303554,24,61,cellular response to organic substance,BP,WNT7A;GJB2;PIK3CG;CLDN18;BMP6;WNT3;HEY1;GJB6;WNT7B;WNT2;CDH1;FZD7;FGF8;VDR;CRB2;WNT5B;INHBB;CCL20;FGF17;BMP4;PIK3CA;BMP7;FSTL3;NOTCH1
4454,GO:0060411,0.0606469458418862,0.988454110088294,5,8,cardiac septum morphogenesis,BP,HEY1;FGF8;BMP4;BMP7;NOTCH1
5750,GO:1902904,0.060853999695825,0.991359900306771,4,6,negative regulation of supramolecular fiber organization,BP,SCIN;SPTBN5;SPTB;SPTBN4
1936,GO:0030042,0.0608552145614351,0.991359662680711,4,6,actin filament depolymerization,BP,SCIN;SPTBN5;SPTB;SPTBN4
2093,GO:0030834,0.0608552145614351,0.991359662680711,4,6,regulation of actin filament depolymerization,BP,SCIN;SPTBN5;SPTB;SPTBN4
3131,GO:0043244,0.0608552145614351,0.991359662680711,4,6,regulation of protein complex disassembly,BP,SCIN;SPTBN5;SPTB;SPTBN4
3237,GO:0043624,0.0608552145614351,0.991359662680711,4,6,cellular protein complex disassembly,BP,SCIN;SPTBN5;SPTB;SPTBN4
4153,GO:0051261,0.0608552145614351,0.991359662680711,4,6,protein depolymerization,BP,SCIN;SPTBN5;SPTB;SPTBN4
5646,GO:1901879,0.0608552145614351,0.991359662680711,4,6,regulation of protein depolymerization,BP,SCIN;SPTBN5;SPTB;SPTBN4
4312,GO:0055024,0.0616093194038591,0.988210135583753,5,8,regulation of cardiac muscle tissue development,BP,WNT2;FZD7;FGF8;BMP4;NOTCH1
552,GO:0005085,0.0618982874370343,0.98110594284485,8,15,guanyl-nucleotide exchange factor activity,MF,RABIF;SPTBN5;SPTB;FGF8;ARTN;FGF17;GDNF;SPTBN4
3270,GO:0044093,0.0622727120428902,0.968989263203728,21,51,positive regulation of molecular function,BP,MAGEC2;PIK3CG;RABIF;WNT7B;PMAIP1;AXIN1;MAPK12;WNT2;SPTBN5;SPTB;FGF8;VDR;ARTN;DUSP5;CCL20;FGF17;HRAS;BMP4;GDNF;PIK3CA;SPTBN4
2102,GO:0030856,0.0622873472683025,0.988037406141273,5,8,regulation of epithelial cell differentiation,BP,BMP6;VDR;BMP4;GDNF;NOTCH1
3280,GO:0044249,0.0630912943689041,0.966411752905081,27,70,cellular biosynthetic process,BP,TLE1;WNT7A;PIK3CG;MBOAT2;BMP6;HEY1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;CRB2;INHBB;CCL20;FGF17;HRAS;BMP4;GDNF;PIK3CA;BMP7;FSTL3;NOTCH1;PNMT;GUCY1B3
3860,GO:0048666,0.0631861440857283,0.972640599418072,14,32,neuron development,BP,WNT7A;WNT3;WNT7B;CDH1;SPTBN5;SPTB;FGF8;ARTN;HRAS;GDNF;PIK3CA;BMP7;SPTBN4;NOTCH1
1337,GO:0010604,0.0633150149785727,0.965823992716537,29,76,positive regulation of macromolecule metabolic process,BP,MAGEC2;TLE1;WNT7A;PIK3CG;BMP6;WNT3;HEY1;WNT7B;PMAIP1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;DUSP5;INHBB;CCL20;PKP1;HRAS;BMP4;GDNF;RNF144A;PIK3CA;BMP7;FSTL3;NOTCH1
1238,GO:0009792,0.0641059170906076,0.975165283135635,11,24,embryo development ending in birth or egg hatching,BP,HEY1;WNT7B;JAG2;AXIN1;WNT2;FGF8;CRB2;AMOT;BMP4;BMP7;NOTCH1
1375,GO:0010721,0.064557587704046,0.98745404536823,5,8,negative regulation of cell development,BP,WNT7A;CLDN18;WNT3;BMP7;NOTCH1
4710,GO:0061351,0.0649716621364993,0.987346819129144,5,8,neural precursor cell proliferation,BP,WNT7A;WNT2;FGF8;ARTN;NOTCH1
1267,GO:0009967,0.0655148487747564,0.967503980298524,20,49,positive regulation of signal transduction,BP,WNT7A;PIK3CG;BMP6;WNT3;WNT7B;JAG2;PMAIP1;AXIN1;WNT2;FZD7;FGF8;CRB2;DUSP5;INHBB;CCL20;HRAS;BMP4;PIK3CA;BMP7;NOTCH1
1355,GO:0010647,0.0655148487747564,0.967503980298524,20,49,positive regulation of cell communication,BP,WNT7A;PIK3CG;BMP6;WNT3;WNT7B;JAG2;PMAIP1;AXIN1;WNT2;FZD7;FGF8;CRB2;DUSP5;INHBB;CCL20;HRAS;BMP4;PIK3CA;BMP7;NOTCH1
1916,GO:0023056,0.0655148487747564,0.967503980298524,20,49,positive regulation of signaling,BP,WNT7A;PIK3CG;BMP6;WNT3;WNT7B;JAG2;PMAIP1;AXIN1;WNT2;FZD7;FGF8;CRB2;DUSP5;INHBB;CCL20;HRAS;BMP4;PIK3CA;BMP7;NOTCH1
3752,GO:0048193,0.0661228653831977,0.990310916507605,4,6,Golgi vesicle transport,BP,RABIF;SPTBN5;SPTB;SPTBN4
2329,GO:0032271,0.066211075182665,0.990293044855267,4,6,regulation of protein polymerization,BP,SCIN;SPTBN5;SPTB;SPTBN4
565,GO:0005125,0.0666877577836485,0.981042595065139,7,13,cytokine activity,MF,WNT7A;BMP6;WNT2;INHBB;CCL20;BMP4;BMP7
1475,GO:0014070,0.0667953674083081,0.971790325944595,13,29,response to organic cyclic compound,BP,WNT7A;GJB2;PIK3CG;BMP6;HEY1;WNT7B;PMAIP1;CDH1;FGF8;VDR;BMP4;BMP7;NOTCH1
2037,GO:0030510,0.06720808726749,0.990090345640432,4,6,regulation of BMP signaling pathway,BP,CRB2;BMP4;FSTL3;NOTCH1
869,GO:0006873,0.0676705190366433,0.980687727534619,7,13,cellular ion homeostasis,BP,PIK3CG;BMP6;RAB39A;VDR;RAB38;RAB20;TF
1920,GO:0030003,0.0676705190366433,0.980687727534619,7,13,cellular cation homeostasis,BP,PIK3CG;BMP6;RAB39A;VDR;RAB38;RAB20;TF
105,GO:0001649,0.0681584476999571,0.98051096007469,7,13,osteoblast differentiation,BP,BMP6;WNT3;WNT7B;RRAS2;BMP4;BMP7;NOTCH1
1350,GO:0010639,0.0682257836124986,0.982606692400862,6,11,negative regulation of organelle organization,BP,SCIN;SPTBN5;SPTB;BMP4;BMP7;SPTBN4
3873,GO:0048705,0.0683780605378778,0.986455180271835,5,8,skeletal system morphogenesis,BP,WNT7A;BMP6;AXIN1;BMP4;BMP7
1448,GO:0012506,0.0689347011549097,0.971893570261142,12,26,vesicle membrane,CC,WNT7A;SYT5;WNT3;WNT7B;RAB39A;WNT5B;PKP1;RAB3D;RNF144A;RAB38;RAB20;TF
2059,GO:0030659,0.0689347011549097,0.971893570261142,12,26,cytoplasmic vesicle membrane,CC,WNT7A;SYT5;WNT3;WNT7B;RAB39A;WNT5B;PKP1;RAB3D;RNF144A;RAB38;RAB20;TF
1410,GO:0010862,0.0692605513081907,0.989669036829455,4,6,positive regulation of pathway-restricted SMAD protein phosphorylation,BP,BMP6;INHBB;BMP4;BMP7
4446,GO:0060389,0.0692605513081907,0.989669036829455,4,6,pathway-restricted SMAD protein phosphorylation,BP,BMP6;INHBB;BMP4;BMP7
4449,GO:0060393,0.0692605513081907,0.989669036829455,4,6,regulation of pathway-restricted SMAD protein phosphorylation,BP,BMP6;INHBB;BMP4;BMP7
3801,GO:0048513,0.0702464080201829,0.960546510590215,35,96,animal organ development,BP,SCIN;TLE1;WNT7A;GJB2;ACTN3;CLDN18;BMP6;WNT3;HEY1;GJB6;WNT7B;JAG2;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;CRB2;ARTN;DSG3;WNT5B;WNK4;INHBB;PKP1;HRAS;BMP4;GDNF;PIK3CA;BMP7;FSTL3;TPD52;NOTCH1
769,GO:0006357,0.0710240893256404,0.966811233794218,16,38,regulation of transcription from RNA polymerase II promoter,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;POU3F1;WNT2;FGF8;VDR;CRB2;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
3473,GO:0045597,0.0711328433299032,0.968533611439214,14,32,positive regulation of cell differentiation,BP,SCIN;BMP6;WNT3;WNT7B;MAPK12;WNT2;FGF8;VDR;CRB2;WNT5B;BMP4;GDNF;BMP7;NOTCH1
3972,GO:0050768,0.0721363669371404,0.98906969308555,4,6,negative regulation of neurogenesis,BP,WNT7A;WNT3;BMP7;NOTCH1
3881,GO:0048729,0.0721859074387715,0.965412129336952,17,41,tissue morphogenesis,BP,WNT7A;WNT3;HEY1;WNT7B;JAG2;AXIN1;WNT2;FZD7;FGF8;VDR;CRB2;ARTN;WNK4;BMP4;GDNF;BMP7;NOTCH1
4426,GO:0060322,0.0723678436170749,0.971258316246903,11,24,head development,BP,WNT7A;WNT3;WNT7B;AXIN1;POU3F1;WNT2;CDH1;FGF8;BMP4;BMP7;NOTCH1
572,GO:0005160,0.0726063049143473,0.988970762314413,4,6,transforming growth factor beta receptor binding,MF,BMP6;INHBB;BMP4;BMP7
1149,GO:0008593,0.0733948199780268,0.988804143525394,4,6,regulation of Notch signaling pathway,BP,HEY1;JAG2;BMP7;NOTCH1
427,GO:0003203,0.0735601695984829,0.988769105426886,4,6,endocardial cushion morphogenesis,BP,HEY1;FGF8;BMP7;NOTCH1
3982,GO:0050790,0.0740908700902496,0.960684039164506,24,61,regulation of catalytic activity,BP,MAGEC2;PIK3CG;RABIF;WNT7B;PMAIP1;AXIN1;MAPK12;SPTBN5;SPTB;FGF8;VDR;CRB2;ARTN;AMOT;DUSP5;CCL20;FGF17;HRAS;BMP4;GDNF;PIK3CA;BMP7;SPTBN4;NOTCH1
1557,GO:0015833,0.0741435946263204,0.965971177510107,15,35,peptide transport,BP,RABIF;BMP6;KCNG2;CDH1;RAB40B;RAB39A;FZD7;INHBB;BMP4;RAB3D;RAB38;BMP7;NOTCH1;RAB20;TF
3053,GO:0042886,0.0741435946263204,0.965971177510107,15,35,amide transport,BP,RABIF;BMP6;KCNG2;CDH1;RAB40B;RAB39A;FZD7;INHBB;BMP4;RAB3D;RAB38;BMP7;NOTCH1;RAB20;TF
6061,GO:2000209,0.0751254607148689,0.993284714616645,3,4,regulation of anoikis,BP,TLE1;PIK3CA;NOTCH1
6133,GO:2000811,0.0751254607148689,0.993284714616645,3,4,negative regulation of anoikis,BP,TLE1;PIK3CA;NOTCH1
3561,GO:0045862,0.0752577428103672,0.988407416759735,4,6,positive regulation of proteolysis,BP,PMAIP1;AXIN1;MAPK12;RNF144A
4423,GO:0060317,0.0752660487561608,0.988405638287634,4,6,cardiac epithelial to mesenchymal transition,BP,HEY1;WNT2;FGF8;NOTCH1
1083,GO:0008083,0.0759476316662917,0.973179655973245,9,18,growth factor activity,MF,BMP6;JAG2;FGF8;ARTN;INHBB;FGF17;BMP4;GDNF;BMP7
1028,GO:0007492,0.0763588435197352,0.988170905593989,4,6,endoderm development,BP,FGF8;DUSP5;BMP4;NOTCH1
81,GO:0001191,0.0769197549201888,0.993047074943063,3,4,transcriptional repressor activity, RNA polymerase II transcription factor binding,MF,TLE1;POU3F1;NOTCH1
877,GO:0006888,0.0774285349196308,0.992979158858426,3,4,ER to Golgi vesicle-mediated transport,BP,SPTBN5;SPTB;SPTBN4
3356,GO:0044707,0.0778560386254368,0.956344102220631,50,146,single-multicellular organism process,BP,SLC2A14;SCIN;TLE1;WNT7A;GJB2;PIK3CG;ACTN3;CLDN18;BMP6;WNT3;HEY1;GJB6;WNT7B;JAG2;AXIN1;POU3F1;MAPK12;WNT2;CDH1;SPTBN5;SPTB;RRAS2;FZD7;FGF8;VDR;CRB2;ARTN;DSG3;AMOT;WNT5B;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;FGF17;HRAS;BMP4;RAB3D;KCNK6;GDNF;PIK3CA;BMP7;DRP2;FSTL3;TPD52;SPTBN4;NOTCH1;TF
3912,GO:0048844,0.0783554438974891,0.98773824415474,4,6,artery morphogenesis,BP,HEY1;FGF8;BMP4;NOTCH1
4591,GO:0060840,0.0783554438974891,0.98773824415474,4,6,artery development,BP,HEY1;FGF8;BMP4;NOTCH1
1851,GO:0021871,0.0786464634168593,0.987674773440134,4,6,forebrain regionalization,BP,WNT7B;AXIN1;FGF8;BMP4
5709,GO:1902531,0.0795829578696896,0.959193356833331,20,50,regulation of intracellular signal transduction,BP,TLE1;WNT7A;PIK3CG;ACTN3;BMP6;WNT7B;PMAIP1;AXIN1;FZD7;FGF8;AMOT;DUSP5;INHBB;CCL20;FGF17;HRAS;BMP4;PIK3CA;BMP7;NOTCH1
3276,GO:0044238,0.0809231409964611,0.953613260366816,45,129,primary metabolic process,BP,MAGEC2;GLDC;TLE1;WNT7A;PIK3CG;ACTN3;RHBDL3;MBOAT2;BMP6;HEY1;WNT7B;JAG2;PMAIP1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;SPTBN5;RAB40B;SPTB;FZD7;FGF8;VDR;CRB2;ARTN;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;FGF17;TSPAN15;HRAS;BMP4;RAB3D;GDNF;RNF144A;PIK3CA;BMP7;FSTL3;SPTBN4;NOTCH1;GUCY1B3
3513,GO:0045684,0.0811504523103758,0.992475223979399,3,4,positive regulation of epidermis development,BP,VDR;BMP4;NOTCH1
4082,GO:0051094,0.081724448612675,0.959246834781655,18,44,positive regulation of developmental process,BP,SCIN;WNT7A;ACTN3;BMP6;WNT3;WNT7B;MAPK12;WNT2;FGF8;VDR;CRB2;AMOT;WNT5B;BMP4;GDNF;BMP7;SPTBN4;NOTCH1
3874,GO:0048706,0.0822009827282408,0.992330737481666,3,4,embryonic skeletal system development,BP,AXIN1;BMP4;BMP7
3479,GO:0045604,0.082266469683663,0.992321698019614,3,4,regulation of epidermal cell differentiation,BP,VDR;BMP4;NOTCH1
1256,GO:0009912,0.0823457799439222,1,2,2,auditory receptor cell fate commitment,BP,JAG2;NOTCH1
4380,GO:0060120,0.0823457799439222,1,2,2,inner ear receptor cell fate commitment,BP,JAG2;NOTCH1
3484,GO:0045616,0.0823457888077483,1,2,2,regulation of keratinocyte differentiation,BP,VDR;NOTCH1
3485,GO:0045618,0.0823457888077483,1,2,2,positive regulation of keratinocyte differentiation,BP,VDR;NOTCH1
5044,GO:0072017,0.0824370396151738,1,2,2,distal tubule development,BP,WNK4;NOTCH1
2561,GO:0033280,0.0825445526059901,1,2,2,response to vitamin D,BP,VDR;BMP7
5694,GO:1902337,0.0825445526059901,1,2,2,regulation of apoptotic process involved in morphogenesis,BP,VDR;BMP7
5904,GO:1904748,0.0825445526059901,1,2,2,regulation of apoptotic process involved in development,BP,VDR;BMP7
1310,GO:0010470,0.0827574337077905,1,2,2,regulation of gastrulation,BP,FZD7;CRB2
1792,GO:0019842,0.0827867843264952,1,2,2,vitamin binding,MF,GLDC;VDR
4546,GO:0060669,0.0828709338000959,1,2,2,embryonic placenta morphogenesis,BP,WNT7B;BMP7
4562,GO:0060710,0.0828709338000959,1,2,2,chorio-allantoic fusion,BP,WNT7B;BMP7
4565,GO:0060713,0.0828709338000959,1,2,2,labyrinthine layer morphogenesis,BP,WNT7B;BMP7
1611,GO:0016307,0.0829618551552531,1,2,2,phosphatidylinositol phosphate kinase activity,MF,PIK3CG;PIK3CA
2679,GO:0035005,0.0829618551552531,1,2,2,1-phosphatidylinositol-4-phosphate 3-kinase activity,MF,PIK3CG;PIK3CA
4175,GO:0051336,0.0833519129478598,0.960934164585776,15,35,regulation of hydrolase activity,BP,RABIF;PMAIP1;AXIN1;MAPK12;SPTBN5;SPTB;FGF8;CRB2;ARTN;AMOT;CCL20;FGF17;HRAS;GDNF;SPTBN4
3048,GO:0042787,0.0837903969733754,1,2,2,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,BP,AXIN1;RNF144A
3896,GO:0048771,0.0839432833319409,0.986501650652349,4,6,tissue remodeling,BP,CLDN18;FGF8;VDR;RAB3D
2596,GO:0034103,0.0839448926322713,1,2,2,regulation of tissue remodeling,BP,CLDN18;VDR
3573,GO:0045927,0.0840317618111535,0.977206504794578,6,11,positive regulation of growth,BP,ACTN3;WNT3;WNT2;FGF8;SPTBN4;NOTCH1
3090,GO:0043124,0.0844148933907105,1,2,2,negative regulation of I-kappaB kinase/NF-kappaB signaling,BP,TLE1;BMP7
2580,GO:0033612,0.0845338847275136,0.992006365108299,3,4,receptor serine/threonine kinase binding,MF,BMP6;BMP4;BMP7
4861,GO:0070696,0.0845338847275136,0.992006365108299,3,4,transmembrane receptor protein serine/threonine kinase binding,MF,BMP6;BMP4;BMP7
4862,GO:0070700,0.0845338847275136,0.992006365108299,3,4,BMP receptor binding,MF,BMP6;BMP4;BMP7
1979,GO:0030216,0.0846980893011769,0.980144332418459,5,9,keratinocyte differentiation,BP,POU3F1;VDR;DSG3;PKP1;NOTCH1
2917,GO:0042074,0.085287551397726,0.991900542593563,3,4,cell migration involved in gastrulation,BP,FGF8;CRB2;AMOT
4327,GO:0055082,0.0854534501512644,0.968332403831398,9,19,cellular chemical homeostasis,BP,PIK3CG;BMP6;GJB6;RAB39A;VDR;RAB38;PIK3CA;RAB20;TF
251,GO:0002244,0.0856298386391589,0.991852316291725,3,4,hematopoietic progenitor cell differentiation,BP,BMP4;FSTL3;NOTCH1
80,GO:0001190,0.0859257057062163,1,2,2,transcriptional activator activity, RNA polymerase II transcription factor binding,MF,POU3F1;NOTCH1
5464,GO:0098811,0.0859257057062163,1,2,2,transcriptional repressor activity, RNA polymerase II activating transcription factor binding,MF,POU3F1;NOTCH1
2402,GO:0032535,0.0861991442793007,0.972739918313593,7,14,regulation of cellular component size,BP,SCIN;WNT7A;WNT3;WNT7B;SPTBN5;SPTB;SPTBN4
1499,GO:0014855,0.0862240560946968,1,2,2,striated muscle cell proliferation,BP,WNT2;NOTCH1
4349,GO:0060038,0.0862240560946968,1,2,2,cardiac muscle cell proliferation,BP,WNT2;NOTCH1
4353,GO:0060043,0.0862240560946968,1,2,2,regulation of cardiac muscle cell proliferation,BP,WNT2;NOTCH1
4354,GO:0060045,0.0862240560946968,1,2,2,positive regulation of cardiac muscle cell proliferation,BP,WNT2;NOTCH1
2515,GO:0032989,0.086811435870952,0.958775122349533,15,36,cellular component morphogenesis,BP,WNT7A;WNT3;WNT7B;SPTBN5;SPTB;FZD7;FGF8;VDR;ARTN;HRAS;GDNF;PIK3CA;BMP7;SPTBN4;NOTCH1
3181,GO:0043457,0.0868428339279616,1,2,2,regulation of cellular respiration,BP,ACTN3;PIK3CA
3452,GO:0045333,0.0868428339279616,1,2,2,cellular respiration,BP,ACTN3;PIK3CA
14,GO:0000122,0.0876231278721344,0.972164416685651,7,14,negative regulation of transcription from RNA polymerase II promoter,BP,TLE1;BMP6;HEY1;AXIN1;VDR;BMP4;NOTCH1
3472,GO:0045596,0.0878668421628575,0.967221216043433,9,19,negative regulation of cell differentiation,BP,WNT7A;CLDN18;WNT3;AXIN1;FZD7;BMP4;BMP7;FSTL3;NOTCH1
4992,GO:0071704,0.0883991099750569,0.949003522647175,47,136,organic substance metabolic process,BP,MAGEC2;GLDC;TLE1;WNT7A;PIK3CG;ACTN3;RHBDL3;MBOAT2;BMP6;WNT3;HEY1;WNT7B;JAG2;PMAIP1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;SPTBN5;RAB40B;SPTB;FZD7;FGF8;VDR;CRB2;ARTN;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;FGF17;TSPAN15;HRAS;BMP4;RAB3D;GDNF;RNF144A;PIK3CA;BMP7;FSTL3;SPTBN4;NOTCH1;PNMT;GUCY1B3
1354,GO:0010646,0.0885452019181001,0.949867838467736,29,78,regulation of cell communication,BP,TLE1;WNT7A;PIK3CG;ACTN3;BMP6;WNT3;HEY1;WNT7B;JAG2;PMAIP1;KCNG2;AXIN1;WNT2;FZD7;FGF8;CRB2;AMOT;WNT5B;DUSP5;INHBB;CCL20;FGF17;HRAS;BMP4;GDNF;PIK3CA;BMP7;FSTL3;NOTCH1
414,GO:0003177,0.0888516061232193,0.991393337718771,3,4,pulmonary valve development,BP,HEY1;BMP4;NOTCH1
419,GO:0003184,0.0888516061232193,0.991393337718771,3,4,pulmonary valve morphogenesis,BP,HEY1;BMP4;NOTCH1
5943,GO:1905314,0.0888516061232193,0.991393337718771,3,4,semi-lunar valve development,BP,HEY1;BMP4;NOTCH1
873,GO:0006879,0.0893189256165811,1,2,2,cellular iron ion homeostasis,BP,BMP6;TF
1282,GO:0010039,0.0893189256165811,1,2,2,response to iron ion,BP,BMP6;TF
4907,GO:0071281,0.0893189256165811,1,2,2,cellular response to iron ion,BP,BMP6;TF
3037,GO:0042733,0.0894521123355243,0.991306782998148,3,4,embryonic digit morphogenesis,BP,WNT7A;BMP4;NOTCH1
4728,GO:0061448,0.0894734611223927,0.966476830948444,9,19,connective tissue development,BP,SCIN;WNT7A;BMP6;WNT7B;WNT5B;BMP4;PIK3CA;BMP7;NOTCH1
3477,GO:0045601,0.0895434761684899,0.99129358656241,3,4,regulation of endothelial cell differentiation,BP,BMP6;BMP4;NOTCH1
3478,GO:0045603,0.0895434761684899,0.99129358656241,3,4,positive regulation of endothelial cell differentiation,BP,BMP6;BMP4;NOTCH1
2101,GO:0030855,0.0900426653298967,0.955936345216189,16,39,epithelial cell differentiation,BP,WNT7A;BMP6;HEY1;WNT7B;JAG2;POU3F1;FZD7;FGF8;VDR;DSG3;WNT5B;PKP1;BMP4;GDNF;BMP7;NOTCH1
2345,GO:0032330,0.0901160167356986,0.991210724035015,3,4,regulation of chondrocyte differentiation,BP,SCIN;BMP6;BMP4
1266,GO:0009966,0.0902567410932369,0.949045577283867,28,75,regulation of signal transduction,BP,TLE1;WNT7A;PIK3CG;ACTN3;BMP6;WNT3;HEY1;WNT7B;JAG2;PMAIP1;AXIN1;WNT2;FZD7;FGF8;CRB2;AMOT;WNT5B;DUSP5;INHBB;CCL20;FGF17;HRAS;BMP4;GDNF;PIK3CA;BMP7;FSTL3;NOTCH1
431,GO:0003208,0.0902778232238395,1,2,2,cardiac ventricle morphogenesis,BP,HEY1;NOTCH1
4695,GO:0061314,0.0902778232238395,1,2,2,Notch signaling involved in heart development,BP,HEY1;NOTCH1
3462,GO:0045445,0.0903397771828742,0.991178262046674,3,4,myoblast differentiation,BP,MAPK12;BMP4;NOTCH1
771,GO:0006366,0.0903619917967728,0.95575235700747,16,39,transcription from RNA polymerase II promoter,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;POU3F1;WNT2;FGF8;VDR;CRB2;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
2529,GO:0033036,0.0903815966486349,0.950894520980046,23,60,macromolecule localization,BP,SCIN;WNT7A;CLDN18;RABIF;BMP6;PMAIP1;KCNG2;CDH1;RAB40B;RAB39A;FZD7;AMOT;WNK4;INHBB;TSPAN15;BMP4;RAB3D;RAB38;BMP7;SPTBN4;NOTCH1;RAB20;TF
3528,GO:0045746,0.0904820934717323,1,2,2,negative regulation of Notch signaling pathway,BP,HEY1;BMP7
2798,GO:0035904,0.0904859282207853,0.991157035686836,3,4,aorta development,BP,HEY1;FGF8;NOTCH1
2800,GO:0035909,0.0904859282207853,0.991157035686836,3,4,aorta morphogenesis,BP,HEY1;FGF8;NOTCH1
5786,GO:1903305,0.0910968637392936,0.991068104799634,3,4,regulation of regulated secretory pathway,BP,SYT5;RAB3D;NOTCH1
3171,GO:0043408,0.0911372913440013,0.958796287241323,13,30,regulation of MAPK cascade,BP,WNT7A;PIK3CG;BMP6;WNT7B;AXIN1;FZD7;FGF8;DUSP5;INHBB;CCL20;HRAS;BMP4;BMP7
3808,GO:0048522,0.0920618363012495,0.946296735776548,36,100,positive regulation of cellular process,BP,MAGEC2;SCIN;WNT7A;PIK3CG;ACTN3;BMP6;WNT3;HEY1;WNT7B;JAG2;PMAIP1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;RRAS2;FZD7;FGF8;VDR;CRB2;WNT5B;DUSP5;INHBB;CCL20;FGF17;HRAS;BMP4;RAB3D;GDNF;RNF144A;PIK3CA;BMP7;FSTL3;NOTCH1;TF
5614,GO:1901576,0.0921485352347537,0.948144621529984,27,72,organic substance biosynthetic process,BP,TLE1;WNT7A;PIK3CG;MBOAT2;BMP6;HEY1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;CRB2;INHBB;CCL20;FGF17;HRAS;BMP4;GDNF;PIK3CA;BMP7;FSTL3;NOTCH1;PNMT;GUCY1B3
3244,GO:0043900,0.0923839383933783,0.990879690909126,3,4,regulation of multi-organism process,BP,BMP6;INHBB;NOTCH1
3202,GO:0043523,0.0924686077140519,0.984543570749297,4,6,regulation of neuron apoptotic process,BP,FGF8;HRAS;GDNF;PIK3CA
3203,GO:0043524,0.0924686077140519,0.984543570749297,4,6,negative regulation of neuron apoptotic process,BP,FGF8;HRAS;GDNF;PIK3CA
4187,GO:0051402,0.0924686077140519,0.984543570749297,4,6,neuron apoptotic process,BP,FGF8;HRAS;GDNF;PIK3CA
426,GO:0003198,0.0927193784148782,0.990830350215254,3,4,epithelial to mesenchymal transition involved in endocardial cushion formation,BP,HEY1;FGF8;NOTCH1
701,GO:0005921,0.093550179947914,0.990707726508261,3,4,gap junction,CC,GJB2;GJA3;GJB6
702,GO:0005922,0.093550179947914,0.990707726508261,3,4,connexin complex,CC,GJB2;GJA3;GJB6
3076,GO:0043065,0.0936849296712218,0.969681912606023,7,14,positive regulation of apoptotic process,BP,SCIN;PMAIP1;VDR;INHBB;BMP4;BMP7;NOTCH1
1604,GO:0016247,0.0937693531229861,1,2,2,channel regulator activity,MF,WNK4;TSPAN13
5490,GO:0099106,0.0937693531229861,1,2,2,ion channel regulator activity,MF,WNK4;TSPAN13
5256,GO:0090092,0.0938496092773876,0.969613742981124,7,14,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,BMP6;CRB2;INHBB;BMP4;BMP7;FSTL3;NOTCH1
401,GO:0003156,0.0940086356473919,0.97361015609388,6,11,regulation of animal organ formation,BP,WNT2;FGF8;BMP4;GDNF;BMP7;NOTCH1
1713,GO:0017158,0.0943121493849491,1,2,2,regulation of calcium ion-dependent exocytosis,BP,SYT5;NOTCH1
2201,GO:0031396,0.0943784283305635,1,2,2,regulation of protein ubiquitination,BP,MAGEC2;AXIN1
2202,GO:0031398,0.0943784283305635,1,2,2,positive regulation of protein ubiquitination,BP,MAGEC2;AXIN1
4192,GO:0051438,0.0943784283305635,1,2,2,regulation of ubiquitin-protein transferase activity,BP,MAGEC2;AXIN1
4193,GO:0051443,0.0943784283305635,1,2,2,positive regulation of ubiquitin-protein transferase activity,BP,MAGEC2;AXIN1
5793,GO:1903320,0.0943784283305635,1,2,2,regulation of protein modification by small protein conjugation or removal,BP,MAGEC2;AXIN1
5794,GO:1903322,0.0943784283305635,1,2,2,positive regulation of protein modification by small protein conjugation or removal,BP,MAGEC2;AXIN1
3082,GO:0043085,0.0944904393728923,0.950205697165824,20,50,positive regulation of catalytic activity,BP,MAGEC2;PIK3CG;RABIF;WNT7B;PMAIP1;AXIN1;MAPK12;SPTBN5;SPTB;FGF8;VDR;ARTN;DUSP5;CCL20;FGF17;HRAS;BMP4;GDNF;PIK3CA;SPTBN4
3176,GO:0043414,0.094517732836748,1,2,2,macromolecule methylation,BP,RAB3D;PIK3CA
4902,GO:0071241,0.0945369424692414,0.97699430002401,5,9,cellular response to inorganic substance,BP,BMP6;CDH1;FSTL3;GUCY1B3;TF
3884,GO:0048732,0.0945787841135536,0.959792996456965,11,25,gland development,BP,WNT3;WNT7B;WNT2;CDH1;FGF8;VDR;BMP4;PIK3CA;BMP7;FSTL3;NOTCH1
1016,GO:0007405,0.0946324725249027,1,2,2,neuroblast proliferation,BP,ARTN;NOTCH1
274,GO:0002320,0.0947215965555851,1,2,2,lymphoid progenitor cell differentiation,BP,BMP4;NOTCH1
413,GO:0003176,0.0947215965555851,1,2,2,aortic valve development,BP,BMP4;NOTCH1
416,GO:0003180,0.0947215965555851,1,2,2,aortic valve morphogenesis,BP,BMP4;NOTCH1
4620,GO:0060976,0.0947215965555851,1,2,2,coronary vasculature development,BP,BMP4;NOTCH1
6046,GO:2000136,0.0947215965555851,1,2,2,regulation of cell proliferation involved in heart morphogenesis,BP,BMP4;NOTCH1
5634,GO:1901700,0.0947903735039357,0.950586521292975,19,48,response to oxygen-containing compound,BP,WNT7A;GJB2;PIK3CG;CLDN18;BMP6;WNT3;GJB6;WNT7B;WNT2;CDH1;FZD7;VDR;WNT5B;INHBB;CCL20;PIK3CA;BMP7;NOTCH1;GUCY1B3
2952,GO:0042306,0.0948459577578657,0.976893231622172,5,9,regulation of protein import into nucleus,BP,BMP6;CDH1;FZD7;BMP4;BMP7
3671,GO:0046822,0.0948459577578657,0.976893231622172,5,9,regulation of nucleocytoplasmic transport,BP,BMP6;CDH1;FZD7;BMP4;BMP7
5822,GO:1903533,0.0948459577578657,0.976893231622172,5,9,regulation of protein targeting,BP,BMP6;CDH1;FZD7;BMP4;BMP7
5893,GO:1904589,0.0948459577578657,0.976893231622172,5,9,regulation of protein import,BP,BMP6;CDH1;FZD7;BMP4;BMP7
3553,GO:0045839,0.094928701692473,1,2,2,negative regulation of mitotic nuclear division,BP,BMP4;BMP7
4479,GO:0060442,0.094928701692473,1,2,2,branching involved in prostate gland morphogenesis,BP,BMP4;BMP7
4555,GO:0060687,0.094928701692473,1,2,2,regulation of branching involved in prostate gland morphogenesis,BP,BMP4;BMP7
4471,GO:0060433,0.0950619840203671,1,2,2,bronchus development,BP,WNT7B;BMP4
4475,GO:0060438,0.0950619840203671,1,2,2,trachea development,BP,WNT7B;BMP4
4476,GO:0060439,0.0950619840203671,1,2,2,trachea morphogenesis,BP,WNT7B;BMP4
5131,GO:0072205,0.0950619840203671,1,2,2,metanephric collecting duct development,BP,WNT7B;BMP4
5311,GO:0090382,0.095122097577417,0.990474086425522,3,4,phagosome maturation,BP,RAB39A;RAB38;RAB20
2066,GO:0030670,0.0951221401365096,0.990474080070986,3,4,phagocytic vesicle membrane,CC,RAB39A;RAB38;RAB20
1300,GO:0010453,0.0951505327175249,1,2,2,regulation of cell fate commitment,BP,FZD7;BMP4
4583,GO:0060795,0.0951505327175249,1,2,2,cell fate commitment involved in formation of primary germ layer,BP,FZD7;BMP4
3555,GO:0045843,0.0952871177204509,0.990449435409523,3,4,negative regulation of striated muscle tissue development,BP,FZD7;FGF8;BMP4
3844,GO:0048635,0.0952871177204509,0.990449435409523,3,4,negative regulation of muscle organ development,BP,FZD7;FGF8;BMP4
5644,GO:1901862,0.0952871177204509,0.990449435409523,3,4,negative regulation of muscle tissue development,BP,FZD7;FGF8;BMP4
124,GO:0001707,0.0954207241464328,0.976704904650803,5,9,mesoderm formation,BP,WNT3;AXIN1;CRB2;BMP4;BMP7
3777,GO:0048332,0.0954207241464328,0.976704904650803,5,9,mesoderm morphogenesis,BP,WNT3;AXIN1;CRB2;BMP4;BMP7
3464,GO:0045453,0.0955388527659486,1,2,2,bone resorption,BP,CLDN18;RAB3D
3679,GO:0046849,0.0955388527659486,1,2,2,bone remodeling,BP,CLDN18;RAB3D
1091,GO:0008152,0.0956087313051379,0.944456497528485,48,140,metabolic process,BP,MAGEC2;GLDC;TLE1;WNT7A;PIK3CG;ACTN3;RHBDL3;MBOAT2;BMP6;WNT3;HEY1;WNT7B;JAG2;PMAIP1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;SPTBN5;RAB40B;RAB39A;SPTB;FZD7;FGF8;VDR;CRB2;ARTN;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;FGF17;TSPAN15;HRAS;BMP4;RAB3D;GDNF;RNF144A;PIK3CA;BMP7;FSTL3;SPTBN4;NOTCH1;PNMT;GUCY1B3
6169,GO:2001235,0.0956807585426419,1,2,2,positive regulation of apoptotic signaling pathway,BP,PMAIP1;INHBB
1463,GO:0014045,0.0956882264157955,1,2,2,establishment of endothelial blood-brain barrier,BP,WNT7A;WNT7B
1875,GO:0022009,0.0956882264157955,1,2,2,central nervous system vasculogenesis,BP,WNT7A;WNT7B
2403,GO:0032536,0.0956882264157955,1,2,2,regulation of cell projection size,BP,WNT7A;WNT7B
4599,GO:0060856,0.0956882264157955,1,2,2,establishment of blood-brain barrier,BP,WNT7A;WNT7B
1497,GO:0014834,0.0957769393984017,1,2,2,skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration,BP,WNT7A;FZD7
3167,GO:0043403,0.0957769393984017,1,2,2,skeletal muscle tissue regeneration,BP,WNT7A;FZD7
4348,GO:0060037,0.0957787003448401,0.990375863111979,3,4,pharyngeal system development,BP,FGF8;BMP4;BMP7
884,GO:0006906,0.0958424430875941,0.990366307898131,3,4,vesicle fusion,BP,SYT5;RAB39A;RAB20
3767,GO:0048284,0.0958424430875941,0.990366307898131,3,4,organelle fusion,BP,SYT5;RAB39A;RAB20
5271,GO:0090174,0.0958424430875941,0.990366307898131,3,4,organelle membrane fusion,BP,SYT5;RAB39A;RAB20
4287,GO:0051962,0.0963189912666104,0.968586980991102,7,14,positive regulation of nervous system development,BP,WNT7A;BMP6;WNT3;WNT2;BMP4;BMP7;NOTCH1
2945,GO:0042246,0.0965625732499426,0.990258116070676,3,4,tissue regeneration,BP,WNT7A;FZD7;NOTCH1
3132,GO:0043254,0.0970862371735036,0.976156693461298,5,9,regulation of protein complex assembly,BP,SCIN;PMAIP1;SPTBN5;SPTB;SPTBN4
3981,GO:0050789,0.0974601273678601,0.94779651290579,59,177,regulation of biological process,BP,MAGEC2;RHPN1;SCIN;TLE1;WNT7A;PIK3CG;SYT5;ACTN3;CLDN18;RABIF;BMP6;WNT3;HEY1;GJB6;WNT7B;JAG2;PMAIP1;KCNG2;AXIN1;POU3F1;MAPK12;WNT2;CDH1;SPTBN5;RAB40B;SPTB;RRAS2;FZD7;FGF8;VDR;CRB2;ARTN;AMOT;WNT5B;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;FGF17;TSPAN15;HRAS;BMP4;RAB3D;KCNK6;GDNF;RNF144A;RAB38;PIK3CA;BMP7;FSTL3;SPTBN4;TSPAN13;NOTCH1;RND3;RAB20;GUCY1B3;TF
756,GO:0006261,0.0974645227463541,1,2,2,DNA-dependent DNA replication,BP,BMP6;BMP4
965,GO:0007184,0.0974645227463541,1,2,2,SMAD protein import into nucleus,BP,BMP6;BMP4
4447,GO:0060390,0.0974645227463541,1,2,2,regulation of SMAD protein import into nucleus,BP,BMP6;BMP4
4448,GO:0060391,0.0974645227463541,1,2,2,positive regulation of SMAD protein import into nucleus,BP,BMP6;BMP4
5310,GO:0090329,0.0974645227463541,1,2,2,regulation of DNA-dependent DNA replication,BP,BMP6;BMP4
6036,GO:2000105,0.0974645227463541,1,2,2,positive regulation of DNA-dependent DNA replication,BP,BMP6;BMP4
4970,GO:0071542,0.0976823474061777,0.990088998874404,3,4,dopaminergic neuron differentiation,BP,WNT3;WNT2;FGF8
675,GO:0005802,0.0981254739324229,1,2,2,trans-Golgi network,CC,CDH1;RAB38
5455,GO:0098791,0.0981254739324229,1,2,2,Golgi subcompartment,CC,CDH1;RAB38
4498,GO:0060502,0.0987590370109737,1,2,2,epithelial cell proliferation involved in lung morphogenesis,BP,WNT2;BMP4
2486,GO:0032879,0.0988867820496064,0.943075269254877,29,79,regulation of localization,BP,SCIN;WNT7A;PIK3CG;SYT5;CLDN18;BMP6;WNT3;JAG2;PMAIP1;KCNG2;CDH1;RRAS2;FZD7;AMOT;WNT5B;WNK4;INHBB;CCL20;HRAS;BMP4;RAB3D;KCNK6;GDNF;BMP7;SPTBN4;TSPAN13;NOTCH1;RAB20;TF
5462,GO:0098805,0.0994012403668997,0.949488343597404,17,42,whole membrane,CC,WNT7A;SYT5;WNT3;WNT7B;PMAIP1;CDH1;RAB39A;FZD7;CRB2;WNT5B;PKP1;TSPAN15;RAB3D;RNF144A;RAB38;RAB20;TF
3821,GO:0048562,0.099792342692237,0.967128455271931,7,14,embryonic organ morphogenesis,BP,GJB6;AXIN1;FGF8;CRB2;BMP4;BMP7;NOTCH1
5313,GO:0090385,0.100765713060795,1,2,2,phagosome-lysosome fusion,BP,RAB39A;RAB20
4138,GO:0051239,0.100906648256179,0.942051497894361,28,76,regulation of multicellular organismal process,BP,SCIN;WNT7A;PIK3CG;ACTN3;CLDN18;BMP6;WNT3;HEY1;WNT7B;KCNG2;WNT2;FZD7;FGF8;VDR;CRB2;AMOT;WNK4;INHBB;CCL20;HRAS;BMP4;KCNK6;GDNF;PIK3CA;BMP7;FSTL3;SPTBN4;NOTCH1
1284,GO:0010092,0.100956638950008,0.982510652305235,4,6,specification of animal organ identity,BP,WNT2;FGF8;BMP4;GDNF
5925,GO:1904954,0.101372435660407,1,2,2,canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,WNT3;WNT2
6007,GO:1990909,0.101372435660407,1,2,2,Wnt signalosome,CC,WNT3;WNT2
3325,GO:0044428,0.101467385572557,0.952795467370647,13,31,nuclear part,CC,MAGEC2;TLE1;HEY1;POU3F1;MAPK12;RAB40B;VDR;AMOT;DUSP5;PKP1;FSTL3;SPTBN4;NOTCH1
874,GO:0006885,0.101672915234023,0.98947760705933,3,4,regulation of pH,BP,RAB39A;RAB38;RAB20
2270,GO:0031960,0.101789404695076,0.974588796810091,5,9,response to corticosteroid,BP,GJB2;BMP6;HEY1;WNT7B;NOTCH1
3506,GO:0045667,0.102025967154944,0.974509166720341,5,9,regulation of osteoblast differentiation,BP,BMP6;WNT7B;BMP4;BMP7;NOTCH1
3995,GO:0050808,0.10257649183849,0.974323570159358,5,9,synapse organization,BP,WNT7A;WNT7B;CDH1;GDNF;DRP2
451,GO:0003279,0.103102920530766,0.974145727843332,5,9,cardiac septum development,BP,HEY1;FGF8;BMP4;BMP7;NOTCH1
4128,GO:0051216,0.103285141993656,0.965645121742849,7,14,cartilage development,BP,SCIN;WNT7A;BMP6;WNT7B;WNT5B;BMP4;BMP7
4140,GO:0051241,0.103384113497546,0.950300759619151,14,34,negative regulation of multicellular organismal process,BP,WNT7A;PIK3CG;CLDN18;WNT3;FZD7;FGF8;AMOT;WNK4;INHBB;BMP4;BMP7;FSTL3;SPTBN4;NOTCH1
6123,GO:2000736,0.104893903447766,1,2,2,regulation of stem cell differentiation,BP,GDNF;NOTCH1
1126,GO:0008344,0.104894451434614,1,2,2,adult locomotory behavior,BP,GDNF;SPTBN4
2045,GO:0030534,0.104894451434614,1,2,2,adult behavior,BP,GDNF;SPTBN4
2145,GO:0031090,0.105641506335956,0.943924651841699,19,48,organelle membrane,CC,WNT7A;SYT5;WNT3;WNT7B;PMAIP1;SPTBN5;RAB39A;FZD7;WNT5B;PKP1;TSPAN15;HRAS;RAB3D;RNF144A;RAB38;NOTCH1;RND3;RAB20;TF
5718,GO:1902582,0.10595989419475,0.960889877425803,8,17,single-organism intracellular transport,BP,WNT7A;PIK3CG;SYT5;BMP6;CDH1;FZD7;BMP4;BMP7
1958,GO:0030154,0.106526700418864,0.936475947824282,37,105,cell differentiation,BP,SLC2A14;SCIN;WNT7A;CLDN18;BMP6;WNT3;HEY1;WNT7B;JAG2;AXIN1;POU3F1;MAPK12;WNT2;CDH1;SPTBN5;SPTB;RRAS2;FZD7;FGF8;VDR;CRB2;ARTN;DSG3;AMOT;WNT5B;INHBB;PKP1;HRAS;BMP4;GDNF;RAB38;PIK3CA;BMP7;FSTL3;TPD52;SPTBN4;NOTCH1
1215,GO:0009605,0.106606155305891,0.941179659517508,22,57,response to external stimulus,BP,GJB2;PIK3CG;BMP6;WNT3;GJB6;PMAIP1;SPTBN5;SPTB;FGF8;VDR;ARTN;AMOT;INHBB;CCL20;HRAS;BMP4;GDNF;RAB38;PIK3CA;BMP7;SPTBN4;NOTCH1
1307,GO:0010467,0.107455015353122,0.939401125667582,24,64,gene expression,BP,TLE1;WNT7A;RHBDL3;BMP6;WNT3;HEY1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;CRB2;PKP1;TSPAN15;HRAS;BMP4;GDNF;PIK3CA;BMP7;FSTL3;NOTCH1
1250,GO:0009893,0.107534469670976,0.937058072218105,30,82,positive regulation of metabolic process,BP,MAGEC2;TLE1;WNT7A;PIK3CG;ACTN3;BMP6;WNT3;HEY1;WNT7B;PMAIP1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;DUSP5;INHBB;CCL20;PKP1;HRAS;BMP4;GDNF;RNF144A;PIK3CA;BMP7;FSTL3;NOTCH1
993,GO:0007269,0.107798498214806,1,2,2,neurotransmitter secretion,BP,WNT7A;SYT5
2852,GO:0036465,0.107798498214806,1,2,2,synaptic vesicle recycling,BP,WNT7A;SYT5
5507,GO:0099643,0.107798498214806,1,2,2,signal release from synapse,BP,WNT7A;SYT5
1164,GO:0009058,0.108966849867703,0.937083169571551,27,73,biosynthetic process,BP,TLE1;WNT7A;PIK3CG;MBOAT2;BMP6;HEY1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;CRB2;INHBB;CCL20;FGF17;HRAS;BMP4;GDNF;PIK3CA;BMP7;FSTL3;NOTCH1;PNMT;GUCY1B3
5440,GO:0098657,0.109492445605582,1,2,2,import into cell,BP,GDNF;TF
2072,GO:0030742,0.110214911274736,1,2,2,GTP-dependent protein binding,MF,RAB3D;RAB38
1159,GO:0008654,0.110366674698667,0.971655332959401,5,9,phospholipid biosynthetic process,BP,PIK3CG;MBOAT2;FGF8;FGF17;PIK3CA
1077,GO:0008064,0.110536682679106,0.976783392215531,4,7,regulation of actin polymerization or depolymerization,BP,SCIN;SPTBN5;SPTB;SPTBN4
1092,GO:0008154,0.110536682679106,0.976783392215531,4,7,actin polymerization or depolymerization,BP,SCIN;SPTBN5;SPTB;SPTBN4
2091,GO:0030832,0.110536682679106,0.976783392215531,4,7,regulation of actin filament length,BP,SCIN;SPTBN5;SPTB;SPTBN4
1109,GO:0008219,0.110716049043469,0.938414942242162,22,58,cell death,BP,SCIN;TLE1;WNT7A;PIK3CG;ACTN3;BMP6;GJB6;JAG2;PMAIP1;AXIN1;RRAS2;FGF8;VDR;DSG3;INHBB;PKP1;HRAS;BMP4;GDNF;PIK3CA;BMP7;NOTCH1
3358,GO:0044710,0.11087309740957,0.935817466203026,27,73,single-organism metabolic process,BP,GLDC;WNT7A;PIK3CG;ACTN3;MBOAT2;BMP6;WNT7B;PMAIP1;AXIN1;MAPK12;SPTBN5;SPTB;FZD7;FGF8;VDR;ARTN;DUSP5;INHBB;CCL20;FGF17;HRAS;BMP4;GDNF;PIK3CA;BMP7;SPTBN4;GUCY1B3
2698,GO:0035115,0.110900590711065,1,2,2,embryonic forelimb morphogenesis,BP,WNT7A;WNT3
2700,GO:0035136,0.110900590711065,1,2,2,forelimb morphogenesis,BP,WNT7A;WNT3
3564,GO:0045893,0.110974679158504,0.944563120879016,15,37,positive regulation of transcription, DNA-templated,BP,WNT7A;BMP6;HEY1;AXIN1;POU3F1;WNT2;CDH1;FZD7;VDR;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
5732,GO:1902680,0.110974679158504,0.944563120879016,15,37,positive regulation of RNA biosynthetic process,BP,WNT7A;BMP6;HEY1;AXIN1;POU3F1;WNT2;CDH1;FZD7;VDR;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
5810,GO:1903508,0.110974679158504,0.944563120879016,15,37,positive regulation of nucleic acid-templated transcription,BP,WNT7A;BMP6;HEY1;AXIN1;POU3F1;WNT2;CDH1;FZD7;VDR;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
4205,GO:0051494,0.11115616943611,0.976600628270782,4,7,negative regulation of cytoskeleton organization,BP,SCIN;SPTBN5;SPTB;SPTBN4
369,GO:0003006,0.111875216128754,0.946917790249622,13,31,developmental process involved in reproduction,BP,WNT7A;GJB2;BMP6;HEY1;WNT7B;WNT2;FGF8;VDR;INHBB;BMP4;BMP7;FSTL3;NOTCH1
3431,GO:0045184,0.11219168693383,0.940550192007536,18,46,establishment of protein localization,BP,RABIF;BMP6;PMAIP1;KCNG2;CDH1;RAB40B;RAB39A;FZD7;INHBB;TSPAN15;BMP4;RAB3D;RAB38;BMP7;SPTBN4;NOTCH1;RAB20;TF
86,GO:0001503,0.112461481768676,0.9578321914164,8,17,ossification,BP,BMP6;WNT3;WNT7B;RRAS2;BMP4;BMP7;FSTL3;NOTCH1
5422,GO:0098542,0.11312181396814,0.987648900376381,3,4,defense response to other organism,BP,PMAIP1;CCL20;HRAS
107,GO:0001654,0.113663995824466,0.957260600246048,8,17,eye development,BP,WNT7A;BMP6;WNT7B;AXIN1;WNT2;WNT5B;BMP4;BMP7
768,GO:0006355,0.11433593822521,0.938309921539916,19,49,regulation of transcription, DNA-templated,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;CRB2;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
398,GO:0003148,0.114539936676365,1,2,2,outflow tract septum morphogenesis,BP,FGF8;BMP4
553,GO:0005088,0.114572885838394,0.960740116707997,7,14,Ras guanyl-nucleotide exchange factor activity,MF,SPTBN5;SPTB;FGF8;ARTN;FGF17;GDNF;SPTBN4
1323,GO:0010556,0.114769956406704,0.936468500545487,21,55,regulation of macromolecule biosynthetic process,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;CRB2;INHBB;CCL20;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
1783,GO:0019725,0.114861353284692,0.953498646445574,9,20,cellular homeostasis,BP,PIK3CG;BMP6;GJB6;RAB39A;VDR;RAB38;PIK3CA;RAB20;TF
1850,GO:0021846,0.115198052239543,1,2,2,cell proliferation in forebrain,BP,WNT7A;FGF8
3829,GO:0048584,0.11537547147807,0.93607812308115,21,55,positive regulation of response to stimulus,BP,WNT7A;PIK3CG;BMP6;WNT3;WNT7B;JAG2;PMAIP1;AXIN1;WNT2;FZD7;FGF8;CRB2;ARTN;DUSP5;INHBB;CCL20;HRAS;BMP4;PIK3CA;BMP7;NOTCH1
1324,GO:0010557,0.115392386386386,0.940679493587653,16,40,positive regulation of macromolecule biosynthetic process,BP,WNT7A;BMP6;HEY1;AXIN1;POU3F1;WNT2;CDH1;FZD7;VDR;CCL20;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
3353,GO:0044702,0.115569365995578,0.939451187758318,17,43,single organism reproductive process,BP,SLC2A14;WNT7A;GJB2;BMP6;WNT3;HEY1;WNT7B;JAG2;WNT2;FGF8;VDR;INHBB;BMP4;BMP7;FSTL3;SPTBN4;NOTCH1
1343,GO:0010628,0.115649644306474,0.937479007474415,19,49,positive regulation of gene expression,BP,TLE1;WNT7A;BMP6;WNT3;HEY1;AXIN1;POU3F1;WNT2;CDH1;FZD7;FGF8;VDR;PKP1;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
5192,GO:0072594,0.116993845963268,0.963191423803469,6,12,establishment of protein localization to organelle,BP,BMP6;PMAIP1;CDH1;FZD7;BMP4;BMP7
3463,GO:0045446,0.117762948827094,0.9628726264771,6,12,endothelial cell differentiation,BP,WNT7A;BMP6;HEY1;WNT7B;BMP4;NOTCH1
1770,GO:0019438,0.117940565652148,0.934419993489239,21,55,aromatic compound biosynthetic process,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;CRB2;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1;PNMT;GUCY1B3
3894,GO:0048762,0.11927251895234,0.954570171093472,8,17,mesenchymal cell differentiation,BP,HEY1;WNT2;FGF8;CRB2;BMP4;GDNF;BMP7;NOTCH1
3221,GO:0043565,0.119641895857957,0.974050620865218,4,7,sequence-specific DNA binding,MF,HEY1;POU3F1;VDR;NOTCH1
3825,GO:0048568,0.119962677899451,0.948117470334301,10,23,embryonic organ development,BP,HEY1;GJB6;WNT7B;AXIN1;WNT2;FGF8;CRB2;BMP4;BMP7;NOTCH1
220,GO:0002062,0.120168449000712,0.968188889956173,5,9,chondrocyte differentiation,BP,SCIN;WNT7A;BMP6;WNT5B;BMP4
3828,GO:0048583,0.120322004743979,0.928667304641037,29,80,regulation of response to stimulus,BP,TLE1;WNT7A;PIK3CG;ACTN3;BMP6;WNT3;HEY1;WNT7B;JAG2;PMAIP1;AXIN1;WNT2;FZD7;FGF8;CRB2;ARTN;AMOT;WNT5B;DUSP5;INHBB;CCL20;FGF17;HRAS;BMP4;GDNF;PIK3CA;BMP7;FSTL3;NOTCH1
119,GO:0001701,0.120324461368131,0.957021367758191,7,15,in utero embryonic development,BP,HEY1;WNT7B;JAG2;WNT2;AMOT;BMP7;NOTCH1
172,GO:0001892,0.120749013898933,0.97371158754463,4,7,embryonic placenta development,BP,HEY1;WNT7B;WNT2;BMP7
952,GO:0007162,0.120898687488556,0.97366564153792,4,7,negative regulation of cell adhesion,BP,CDH1;FZD7;BMP4;NOTCH1
996,GO:0007275,0.122187733932609,0.925846618126399,44,129,multicellular organism development,BP,SLC2A14;SCIN;TLE1;WNT7A;GJB2;PIK3CG;ACTN3;CLDN18;BMP6;WNT3;HEY1;GJB6;WNT7B;JAG2;AXIN1;POU3F1;MAPK12;WNT2;CDH1;SPTBN5;SPTB;FZD7;FGF8;VDR;CRB2;ARTN;DSG3;AMOT;WNT5B;WNK4;DUSP5;INHBB;PKP1;FGF17;HRAS;BMP4;GDNF;PIK3CA;BMP7;DRP2;FSTL3;TPD52;SPTBN4;NOTCH1
370,GO:0003007,0.122256360579654,0.960994976558682,6,12,heart morphogenesis,BP,HEY1;WNT2;FGF8;BMP4;BMP7;NOTCH1
5842,GO:1903707,0.122914898774113,0.973044136299871,4,7,negative regulation of hemopoiesis,BP,CLDN18;BMP4;FSTL3;NOTCH1
3852,GO:0048645,0.124251413299771,0.966709784088061,5,9,animal organ formation,BP,WNT2;FGF8;BMP4;GDNF;BMP7
1914,GO:0023051,0.12551901047411,0.925116897788911,29,80,regulation of signaling,BP,TLE1;WNT7A;PIK3CG;ACTN3;BMP6;WNT3;HEY1;WNT7B;JAG2;PMAIP1;KCNG2;AXIN1;WNT2;FZD7;FGF8;CRB2;AMOT;WNT5B;DUSP5;INHBB;CCL20;FGF17;HRAS;BMP4;GDNF;PIK3CA;BMP7;FSTL3;NOTCH1
4887,GO:0070997,0.125674787351408,0.966189356245787,5,9,neuron death,BP,RRAS2;FGF8;HRAS;GDNF;PIK3CA
5584,GO:1901214,0.125674787351408,0.966189356245787,5,9,regulation of neuron death,BP,RRAS2;FGF8;HRAS;GDNF;PIK3CA
4286,GO:0051961,0.126461628526606,0.971939237933215,4,7,negative regulation of nervous system development,BP,WNT7A;WNT3;BMP7;NOTCH1
3556,GO:0045844,0.127612501503464,0.971577546682451,4,7,positive regulation of striated muscle tissue development,BP,ACTN3;WNT2;BMP4;NOTCH1
3845,GO:0048636,0.127612501503464,0.971577546682451,4,7,positive regulation of muscle organ development,BP,ACTN3;WNT2;BMP4;NOTCH1
5645,GO:1901863,0.127612501503464,0.971577546682451,4,7,positive regulation of muscle tissue development,BP,ACTN3;WNT2;BMP4;NOTCH1
4132,GO:0051223,0.127809079244052,0.953541664547173,7,15,regulation of protein transport,BP,BMP6;KCNG2;CDH1;FZD7;INHBB;BMP4;BMP7
5716,GO:1902580,0.127993898968734,0.939073863295998,12,29,single-organism cellular localization,BP,WNT7A;PIK3CG;SYT5;BMP6;PMAIP1;CDH1;RAB40B;FZD7;TSPAN15;BMP4;BMP7;SPTBN4
3099,GO:0043170,0.128480607227654,0.921276382285912,42,122,macromolecule metabolic process,BP,MAGEC2;TLE1;WNT7A;PIK3CG;RHBDL3;BMP6;WNT3;HEY1;WNT7B;JAG2;PMAIP1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;SPTBN5;RAB40B;SPTB;FZD7;FGF8;VDR;CRB2;ARTN;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;FGF17;TSPAN15;HRAS;BMP4;RAB3D;GDNF;RNF144A;PIK3CA;BMP7;FSTL3;SPTBN4;NOTCH1
3984,GO:0050793,0.129657966576169,0.924577427514402,24,65,regulation of developmental process,BP,SCIN;WNT7A;ACTN3;CLDN18;BMP6;WNT3;HEY1;WNT7B;AXIN1;MAPK12;WNT2;FZD7;FGF8;VDR;CRB2;AMOT;WNT5B;BMP4;GDNF;PIK3CA;BMP7;FSTL3;SPTBN4;NOTCH1
3584,GO:0045944,0.129933994536574,0.937947646817075,12,29,positive regulation of transcription from RNA polymerase II promoter,BP,WNT7A;BMP6;HEY1;POU3F1;WNT2;VDR;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
5070,GO:0072089,0.130295593284396,0.970728326149742,4,7,stem cell proliferation,BP,WNT3;WNT7B;ARTN;NOTCH1
1863,GO:0021915,0.131034842890684,0.970492878832519,4,7,neural tube development,BP,FGF8;BMP4;BMP7;NOTCH1
4081,GO:0051093,0.131053377843176,0.93952810541856,11,26,negative regulation of developmental process,BP,WNT7A;CLDN18;WNT3;AXIN1;FZD7;FGF8;AMOT;BMP4;BMP7;FSTL3;NOTCH1
1446,GO:0012501,0.131203778580528,0.925579972995079,21,56,programmed cell death,BP,SCIN;TLE1;WNT7A;PIK3CG;ACTN3;BMP6;GJB6;JAG2;PMAIP1;AXIN1;FGF8;VDR;DSG3;INHBB;PKP1;HRAS;BMP4;GDNF;PIK3CA;BMP7;NOTCH1
2160,GO:0031128,0.131730440613174,0.963947799994885,5,9,developmental induction,BP,WNT3;WNT2;FGF8;BMP4;GDNF
4185,GO:0051384,0.131968843904611,0.97019449946377,4,7,response to glucocorticoid,BP,GJB2;BMP6;HEY1;WNT7B
4147,GO:0051252,0.132353801385471,0.92564586992559,20,53,regulation of RNA metabolic process,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;CRB2;PKP1;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
3096,GO:0043167,0.132793699867362,0.918679952713242,34,97,ion binding,MF,GLDC;SCIN;PIK3CG;SYT5;ACTN3;RHBDL3;RABIF;JAG2;MAPK12;CDH1;RAB40B;RAB39A;RRAS2;FZD7;VDR;CRB2;DSG3;WNK4;PKN3;HRAS;BMP4;RAB3D;RNF144A;RAB38;PIK3CA;BMP7;DRP2;TPD52;SPTBN4;NOTCH1;RND3;RAB20;GUCY1B3;TF
655,GO:0005768,0.132844389230047,0.944205886094714,9,20,endosome,CC,SYT5;CDH1;RAB40B;FZD7;TSPAN15;RNF144A;RAB38;RAB20;TF
3883,GO:0048731,0.133973570949361,0.917416666723057,42,123,system development,BP,SCIN;TLE1;WNT7A;GJB2;PIK3CG;ACTN3;CLDN18;BMP6;WNT3;HEY1;GJB6;WNT7B;JAG2;AXIN1;POU3F1;MAPK12;WNT2;CDH1;SPTBN5;SPTB;FZD7;FGF8;VDR;CRB2;ARTN;DSG3;AMOT;WNT5B;WNK4;INHBB;PKP1;FGF17;HRAS;BMP4;GDNF;PIK3CA;BMP7;DRP2;FSTL3;TPD52;SPTBN4;NOTCH1
4149,GO:0051254,0.135401413671218,0.929395695057839,15,38,positive regulation of RNA metabolic process,BP,WNT7A;BMP6;HEY1;AXIN1;POU3F1;WNT2;CDH1;FZD7;VDR;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
5808,GO:1903506,0.136012173964099,0.924164788049763,19,50,regulation of nucleic acid-templated transcription,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;CRB2;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
6163,GO:2001141,0.136012173964099,0.924164788049763,19,50,regulation of RNA biosynthetic process,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;CRB2;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
3098,GO:0043169,0.136760036902425,0.924503270638277,18,48,cation binding,MF,GLDC;SCIN;SYT5;ACTN3;RHBDL3;RABIF;JAG2;MAPK12;CDH1;VDR;CRB2;DSG3;RNF144A;DRP2;TPD52;NOTCH1;GUCY1B3;TF
1952,GO:0030111,0.137375176515976,0.948992856545799,7,15,regulation of Wnt signaling pathway,BP,TLE1;WNT7A;WNT3;AXIN1;WNT2;WNT5B;NOTCH1
765,GO:0006351,0.137966308424134,0.922880503849885,19,50,transcription, DNA-templated,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;CRB2;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
3683,GO:0046872,0.138825120201634,0.924292696206508,17,45,metal ion binding,MF,SCIN;SYT5;ACTN3;RHBDL3;RABIF;JAG2;MAPK12;CDH1;VDR;CRB2;DSG3;RNF144A;DRP2;TPD52;NOTCH1;GUCY1B3;TF
3285,GO:0044260,0.139558118076197,0.913391552139844,39,113,cellular macromolecule metabolic process,BP,MAGEC2;TLE1;WNT7A;PIK3CG;BMP6;HEY1;WNT7B;JAG2;PMAIP1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;SPTBN5;RAB40B;SPTB;FZD7;FGF8;VDR;CRB2;ARTN;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;FGF17;HRAS;BMP4;RAB3D;GDNF;RNF144A;PIK3CA;BMP7;FSTL3;SPTBN4;NOTCH1
2186,GO:0031326,0.139683008433731,0.919924143097763,21,56,regulation of cellular biosynthetic process,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;CRB2;INHBB;CCL20;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
4515,GO:0060560,0.139792543750434,0.967655681511609,4,7,developmental growth involved in morphogenesis,BP,WNT3;WNT7B;BMP4;NOTCH1
890,GO:0006915,0.140210390513173,0.921400893821143,19,50,apoptotic process,BP,SCIN;TLE1;WNT7A;PIK3CG;ACTN3;BMP6;GJB6;JAG2;PMAIP1;AXIN1;FGF8;VDR;INHBB;HRAS;BMP4;GDNF;PIK3CA;BMP7;NOTCH1
3275,GO:0044237,0.141177817266302,0.912703169424322,45,133,cellular metabolic process,BP,MAGEC2;GLDC;TLE1;WNT7A;PIK3CG;ACTN3;MBOAT2;BMP6;HEY1;WNT7B;JAG2;PMAIP1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;SPTBN5;RAB40B;RAB39A;SPTB;FZD7;FGF8;VDR;CRB2;ARTN;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;FGF17;HRAS;BMP4;RAB3D;GDNF;RNF144A;PIK3CA;BMP7;FSTL3;SPTBN4;NOTCH1;PNMT;GUCY1B3
4752,GO:0065007,0.142428221315967,0.920294222024048,60,183,biological regulation,BP,MAGEC2;RHPN1;SCIN;TLE1;WNT7A;PIK3CG;SYT5;ACTN3;CLDN18;RABIF;BMP6;WNT3;HEY1;GJB6;WNT7B;JAG2;PMAIP1;KCNG2;AXIN1;POU3F1;MAPK12;WNT2;CDH1;SPTBN5;RAB40B;RAB39A;SPTB;RRAS2;FZD7;FGF8;VDR;CRB2;ARTN;AMOT;WNT5B;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;FGF17;TSPAN15;HRAS;BMP4;RAB3D;KCNK6;GDNF;RNF144A;RAB38;PIK3CA;BMP7;FSTL3;SPTBN4;TSPAN13;NOTCH1;RND3;RAB20;GUCY1B3;TF
4635,GO:0061025,0.143417448905575,0.966455678541301,4,7,membrane fusion,BP,SYT5;RABIF;RAB39A;RAB20
2548,GO:0033157,0.144094718077985,0.956748269175544,5,10,regulation of intracellular protein transport,BP,BMP6;CDH1;FZD7;BMP4;BMP7
2188,GO:0031328,0.144244104993416,0.922349637223612,16,41,positive regulation of cellular biosynthetic process,BP,WNT7A;BMP6;HEY1;AXIN1;POU3F1;WNT2;CDH1;FZD7;VDR;CCL20;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
3988,GO:0050801,0.144818756772812,0.940765198719629,8,18,ion homeostasis,BP,PIK3CG;BMP6;RAB39A;VDR;WNK4;RAB38;RAB20;TF
852,GO:0006807,0.145592540309507,0.912429920322505,26,72,nitrogen compound metabolic process,BP,GLDC;TLE1;WNT7A;ACTN3;MBOAT2;BMP6;HEY1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;CRB2;PKP1;HRAS;BMP4;GDNF;PIK3CA;BMP7;FSTL3;NOTCH1;PNMT;GUCY1B3
1610,GO:0016303,0.145806741522627,0.965656571143425,4,7,1-phosphatidylinositol-3-kinase activity,MF,PIK3CG;FGF8;FGF17;PIK3CA
2833,GO:0036092,0.145806741522627,0.965656571143425,4,7,phosphatidylinositol-3-phosphate biosynthetic process,BP,PIK3CG;FGF8;FGF17;PIK3CA
4296,GO:0052742,0.145806741522627,0.965656571143425,4,7,phosphatidylinositol kinase activity,MF,PIK3CG;FGF8;FGF17;PIK3CA
806,GO:0006606,0.146056184076014,0.955942616099146,5,10,protein import into nucleus,BP,BMP6;CDH1;FZD7;BMP4;BMP7
888,GO:0006913,0.146056184076014,0.955942616099146,5,10,nucleocytoplasmic transport,BP,BMP6;CDH1;FZD7;BMP4;BMP7
1698,GO:0017038,0.146056184076014,0.955942616099146,5,10,protein import,BP,BMP6;CDH1;FZD7;BMP4;BMP7
3365,GO:0044744,0.146056184076014,0.955942616099146,5,10,protein targeting to nucleus,BP,BMP6;CDH1;FZD7;BMP4;BMP7
4105,GO:0051169,0.146056184076014,0.955942616099146,5,10,nuclear transport,BP,BMP6;CDH1;FZD7;BMP4;BMP7
4106,GO:0051170,0.146056184076014,0.955942616099146,5,10,nuclear import,BP,BMP6;CDH1;FZD7;BMP4;BMP7
5721,GO:1902593,0.146056184076014,0.955942616099146,5,10,single-organism nuclear import,BP,BMP6;CDH1;FZD7;BMP4;BMP7
4139,GO:0051240,0.146668495897194,0.917114714671968,19,50,positive regulation of multicellular organismal process,BP,SCIN;WNT7A;ACTN3;BMP6;WNT3;WNT7B;WNT2;FGF8;VDR;CRB2;AMOT;INHBB;CCL20;HRAS;BMP4;GDNF;BMP7;SPTBN4;NOTCH1
3700,GO:0046903,0.147169670845686,0.920465503623702,16,41,secretion,BP,SCIN;WNT7A;PIK3CG;SYT5;BMP6;KCNG2;RAB40B;VDR;WNK4;INHBB;PKP1;RAB3D;GDNF;TPD52;NOTCH1;TF
3578,GO:0045934,0.147280757366657,0.93238464359493,10,24,negative regulation of nucleobase-containing compound metabolic process,BP,TLE1;ACTN3;BMP6;HEY1;AXIN1;VDR;PKP1;BMP4;BMP7;NOTCH1
1618,GO:0016331,0.148885810553686,0.943372556543218,7,15,morphogenesis of embryonic epithelium,BP,WNT7B;JAG2;WNT2;FGF8;BMP4;GDNF;BMP7
1271,GO:0009987,0.150174491321036,0.936833917333073,69,216,cellular process,BP,MAGEC2;SLC2A14;GLDC;RHPN1;SCIN;TLE1;WNT7A;GJB2;PIK3CG;SYT5;ACTN3;CLDN18;RABIF;MBOAT2;GJA3;BMP6;WNT3;HEY1;GJB6;WNT7B;JAG2;PMAIP1;KCNG2;AXIN1;POU3F1;MAPK12;WNT2;CDH1;SPTBN5;RAB40B;RAB39A;SPTB;RRAS2;FZD7;FGF8;VDR;CRB2;ARTN;DSG3;AMOT;WNT5B;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;FGF17;TSPAN15;HRAS;BMP4;RAB3D;KCNK6;GDNF;RNF144A;RAB38;PIK3CA;BMP7;DRP2;FSTL3;TPD52;SPTBN4;TSPAN13;NOTCH1;RND3;PNMT;RAB20;GUCY1B3;TF
854,GO:0006810,0.150188481195035,0.905994788775868,36,104,transport,BP,SLC2A14;SCIN;WNT7A;GJB2;PIK3CG;SYT5;RABIF;GJA3;BMP6;PMAIP1;KCNG2;CDH1;SPTBN5;RAB40B;RAB39A;SPTB;FZD7;VDR;WNK4;INHBB;PKP1;HRAS;BMP4;RAB3D;KCNK6;CLDN15;GDNF;RAB38;PIK3CA;BMP7;TPD52;SPTBN4;TSPAN13;NOTCH1;RAB20;TF
4464,GO:0060425,0.150580437315986,0.964040712920548,4,7,lung morphogenesis,BP,WNT7B;WNT2;FGF8;BMP4
4993,GO:0071705,0.150851485052612,0.918081915706702,16,41,nitrogen compound transport,BP,RABIF;BMP6;KCNG2;CDH1;RAB40B;RAB39A;FZD7;INHBB;BMP4;RAB3D;GDNF;RAB38;BMP7;NOTCH1;RAB20;TF
642,GO:0005654,0.150902269565402,0.930307132054223,10,24,nucleoplasm,CC,TLE1;HEY1;POU3F1;MAPK12;VDR;DUSP5;PKP1;FSTL3;SPTBN4;NOTCH1
69,GO:0001076,0.150974932644748,0.97331085004813,3,5,transcription factor activity, RNA polymerase II transcription factor binding,MF,TLE1;POU3F1;NOTCH1
3143,GO:0043276,0.151583533207316,0.97314809785528,3,5,anoikis,BP,TLE1;PIK3CA;NOTCH1
4556,GO:0060688,0.15248956756679,0.963387325698067,4,7,regulation of morphogenesis of a branching structure,BP,WNT2;BMP4;GDNF;BMP7
2397,GO:0032502,0.1525927358926,0.904786488694284,46,137,developmental process,BP,SLC2A14;SCIN;TLE1;WNT7A;GJB2;PIK3CG;ACTN3;CLDN18;BMP6;WNT3;HEY1;GJB6;WNT7B;JAG2;AXIN1;POU3F1;MAPK12;WNT2;CDH1;SPTBN5;SPTB;RRAS2;FZD7;FGF8;VDR;CRB2;ARTN;DSG3;AMOT;WNT5B;WNK4;DUSP5;INHBB;PKP1;FGF17;HRAS;BMP4;GDNF;RAB38;PIK3CA;BMP7;DRP2;FSTL3;TPD52;SPTBN4;NOTCH1
3371,GO:0044767,0.1525927358926,0.904786488694284,46,137,single-organism developmental process,BP,SLC2A14;SCIN;TLE1;WNT7A;GJB2;PIK3CG;ACTN3;CLDN18;BMP6;WNT3;HEY1;GJB6;WNT7B;JAG2;AXIN1;POU3F1;MAPK12;WNT2;CDH1;SPTBN5;SPTB;RRAS2;FZD7;FGF8;VDR;CRB2;ARTN;DSG3;AMOT;WNT5B;WNK4;DUSP5;INHBB;PKP1;FGF17;HRAS;BMP4;GDNF;RAB38;PIK3CA;BMP7;DRP2;FSTL3;TPD52;SPTBN4;NOTCH1
2277,GO:0031981,0.152729461087695,0.926386468639934,11,27,nuclear lumen,CC,MAGEC2;TLE1;HEY1;POU3F1;MAPK12;VDR;DUSP5;PKP1;FSTL3;SPTBN4;NOTCH1
1997,GO:0030278,0.152829565939061,0.953125290971525,5,10,regulation of ossification,BP,BMP6;WNT7B;BMP4;BMP7;NOTCH1
1264,GO:0009953,0.154134290239907,0.962821161734851,4,7,dorsal/ventral pattern formation,BP,WNT7A;WNT3;FGF8;BMP4
1236,GO:0009790,0.15479567157691,0.913834774569319,17,45,embryo development,BP,WNT7A;WNT3;HEY1;GJB6;WNT7B;JAG2;AXIN1;WNT2;FZD7;FGF8;CRB2;AMOT;DUSP5;BMP4;GDNF;BMP7;NOTCH1
837,GO:0006725,0.15508719057254,0.906980562024849,24,66,cellular aromatic compound metabolic process,BP,TLE1;WNT7A;ACTN3;BMP6;HEY1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;CRB2;PKP1;HRAS;BMP4;GDNF;PIK3CA;BMP7;FSTL3;NOTCH1;PNMT;GUCY1B3
3367,GO:0044763,0.155544090879433,0.914598208553614,62,191,single-organism cellular process,BP,SLC2A14;GLDC;SCIN;TLE1;WNT7A;GJB2;PIK3CG;SYT5;ACTN3;CLDN18;MBOAT2;GJA3;BMP6;WNT3;HEY1;GJB6;WNT7B;JAG2;PMAIP1;KCNG2;AXIN1;POU3F1;MAPK12;WNT2;CDH1;SPTBN5;RAB40B;RAB39A;SPTB;RRAS2;FZD7;FGF8;VDR;CRB2;ARTN;DSG3;AMOT;WNT5B;DUSP5;INHBB;CCL20;PKN3;PKP1;FGF17;TSPAN15;HRAS;BMP4;RAB3D;KCNK6;GDNF;RAB38;PIK3CA;BMP7;DRP2;FSTL3;TPD52;SPTBN4;NOTCH1;RND3;RAB20;GUCY1B3;TF
2637,GO:0034504,0.155944931060973,0.94435198073206,6,13,protein localization to nucleus,BP,CLDN18;BMP6;CDH1;FZD7;BMP4;BMP7
5532,GO:1900180,0.155944931060973,0.94435198073206,6,13,regulation of protein localization to nucleus,BP,CLDN18;BMP6;CDH1;FZD7;BMP4;BMP7
2185,GO:0031325,0.155968066972996,0.904619809504909,27,75,positive regulation of cellular metabolic process,BP,MAGEC2;WNT7A;PIK3CG;ACTN3;BMP6;HEY1;WNT7B;PMAIP1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;DUSP5;INHBB;CCL20;HRAS;BMP4;GDNF;RNF144A;PIK3CA;BMP7;FSTL3;NOTCH1
1279,GO:0010033,0.156666085724116,0.905233315419151,25,69,response to organic substance,BP,WNT7A;GJB2;PIK3CG;CLDN18;BMP6;WNT3;HEY1;GJB6;WNT7B;PMAIP1;WNT2;CDH1;FZD7;FGF8;VDR;CRB2;WNT5B;INHBB;CCL20;FGF17;BMP4;PIK3CA;BMP7;FSTL3;NOTCH1
1754,GO:0019219,0.156828772224776,0.907245000085747,22,60,regulation of nucleobase-containing compound metabolic process,BP,TLE1;WNT7A;ACTN3;BMP6;HEY1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;CRB2;PKP1;HRAS;BMP4;GDNF;PIK3CA;BMP7;FSTL3;NOTCH1
4107,GO:0051171,0.156828772224776,0.907245000085747,22,60,regulation of nitrogen compound metabolic process,BP,TLE1;WNT7A;ACTN3;BMP6;HEY1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;CRB2;PKP1;HRAS;BMP4;GDNF;PIK3CA;BMP7;FSTL3;NOTCH1
639,GO:0005634,0.157098956424128,0.908855958035994,20,54,nucleus,CC,MAGEC2;SLC2A14;TJP3;GLDC;TLE1;HEY1;PMAIP1;AXIN1;POU3F1;MAPK12;RAB40B;VDR;AMOT;DUSP5;PKN3;PKP1;HRAS;FSTL3;SPTBN4;NOTCH1
3592,GO:0045992,0.157232302205697,0.971619361163999,3,5,negative regulation of embryonic development,BP,FZD7;BMP4;BMP7
1589,GO:0016070,0.157445846447029,0.908618682130876,20,54,RNA metabolic process,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;CRB2;PKP1;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
4467,GO:0060429,0.158795424342077,0.907694484329003,20,54,epithelium development,BP,WNT7A;BMP6;WNT3;HEY1;WNT7B;JAG2;POU3F1;WNT2;FZD7;FGF8;VDR;CRB2;DSG3;WNT5B;WNK4;PKP1;BMP4;GDNF;BMP7;NOTCH1
2953,GO:0042307,0.159295359270232,0.971052885339655,3,5,positive regulation of protein import into nucleus,BP,BMP6;CDH1;BMP4
5895,GO:1904591,0.159295359270232,0.971052885339655,3,5,positive regulation of protein import,BP,BMP6;CDH1;BMP4
5208,GO:0080090,0.159400265292607,0.900467089390183,31,88,regulation of primary metabolic process,BP,MAGEC2;TLE1;WNT7A;PIK3CG;ACTN3;BMP6;HEY1;WNT7B;PMAIP1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;CRB2;DUSP5;INHBB;CCL20;PKP1;HRAS;BMP4;GDNF;RNF144A;PIK3CA;BMP7;FSTL3;SPTBN4;NOTCH1
2533,GO:0033077,0.159403395938473,0.971023100679967,3,5,T cell differentiation in thymus,BP,JAG2;FZD7;BMP4
626,GO:0005546,0.159948535688428,0.970872629103388,3,5,phosphatidylinositol-4,5-bisphosphate binding,MF,SCIN;SYT5;FZD7
2113,GO:0030879,0.160072225821715,0.950052923953748,5,10,mammary gland development,BP,WNT3;WNT7B;WNT2;VDR;BMP4
3504,GO:0045665,0.160658310614838,0.970676259558139,3,5,negative regulation of neuron differentiation,BP,WNT3;BMP7;NOTCH1
4068,GO:0051049,0.161355945513035,0.905936347306525,20,54,regulation of transport,BP,SCIN;PIK3CG;SYT5;BMP6;PMAIP1;KCNG2;CDH1;FZD7;WNK4;INHBB;BMP4;RAB3D;KCNK6;GDNF;BMP7;SPTBN4;TSPAN13;NOTCH1;RAB20;TF
6040,GO:2000112,0.162130939412697,0.906468932091951,19,51,regulation of cellular macromolecule biosynthetic process,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;CRB2;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
2460,GO:0032774,0.16217005301897,0.906442217381389,19,51,RNA biosynthetic process,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;CRB2;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
5409,GO:0097659,0.16217005301897,0.906442217381389,19,51,nucleic acid-templated transcription,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;CRB2;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
5714,GO:1902578,0.162461775914792,0.899414920396051,28,79,single-organism localization,BP,SLC2A14;SCIN;WNT7A;PIK3CG;SYT5;BMP6;PMAIP1;KCNG2;CDH1;RAB40B;RAB39A;FZD7;VDR;WNK4;INHBB;PKP1;TSPAN15;BMP4;RAB3D;KCNK6;GDNF;PIK3CA;BMP7;TPD52;SPTBN4;NOTCH1;RAB20;TF
1304,GO:0010463,0.162536062256301,0.970154273564812,3,5,mesenchymal cell proliferation,BP,WNT2;BMP4;BMP7
1245,GO:0009888,0.163004840943071,0.899507231641511,27,76,tissue development,BP,SCIN;WNT7A;GJB2;ACTN3;BMP6;WNT3;HEY1;WNT7B;JAG2;AXIN1;POU3F1;WNT2;FZD7;FGF8;VDR;CRB2;ARTN;DSG3;WNT5B;WNK4;DUSP5;PKP1;BMP4;GDNF;PIK3CA;BMP7;NOTCH1
1720,GO:0018130,0.163561625049231,0.904416970911935,20,54,heterocycle biosynthetic process,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;CRB2;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1;GUCY1B3
2653,GO:0034654,0.163561625049231,0.904416970911935,20,54,nucleobase-containing compound biosynthetic process,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;CRB2;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1;GUCY1B3
3291,GO:0044271,0.163561625049231,0.904416970911935,20,54,cellular nitrogen compound biosynthetic process,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;CRB2;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1;GUCY1B3
479,GO:0003674,0.163596202050319,0.953683099485036,72,228,molecular_function,MF,MAGEC2;SLC2A14;TJP3;GLDC;RHPN1;SCIN;TLE1;WNT7A;GJB2;PIK3CG;SYT5;ACTN3;CLDN18;RHBDL3;RABIF;MBOAT2;GJA3;BMP6;WNT3;HEY1;WNT7B;JAG2;PMAIP1;KCNG2;AXIN1;POU3F1;MAPK12;WNT2;CDH1;SPTBN5;RAB40B;RAB39A;SPTB;RRAS2;FZD7;FGF8;VDR;CRB2;ARTN;DSG3;AMOT;WNT5B;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;FGF17;TSPAN15;HRAS;BMP4;RAB3D;KCNK6;CLDN15;GDNF;RNF144A;RAB38;PIK3CA;BMP7;DRP2;FSTL3;TPD52;SPTBN4;TSPAN13;NOTCH1;RND3;PNMT;MB21D2;RAB20;GUCY1B3;TF
4030,GO:0050896,0.164338260283174,0.898712085513384,52,157,response to stimulus,BP,RHPN1;TLE1;WNT7A;GJB2;PIK3CG;ACTN3;CLDN18;RABIF;BMP6;WNT3;HEY1;GJB6;WNT7B;JAG2;PMAIP1;AXIN1;MAPK12;WNT2;CDH1;SPTBN5;RAB40B;SPTB;RRAS2;FZD7;FGF8;VDR;CRB2;ARTN;AMOT;WNT5B;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;FGF17;TSPAN15;HRAS;BMP4;RAB3D;GDNF;RAB38;PIK3CA;BMP7;FSTL3;SPTBN4;TSPAN13;NOTCH1;RND3;GUCY1B3;TF
3924,GO:0048869,0.164341295814782,0.895599845836797,37,108,cellular developmental process,BP,SLC2A14;SCIN;WNT7A;CLDN18;BMP6;WNT3;HEY1;WNT7B;JAG2;AXIN1;POU3F1;MAPK12;WNT2;CDH1;SPTBN5;SPTB;RRAS2;FZD7;FGF8;VDR;CRB2;ARTN;DSG3;AMOT;WNT5B;INHBB;PKP1;HRAS;BMP4;GDNF;RAB38;PIK3CA;BMP7;FSTL3;TPD52;SPTBN4;NOTCH1
1204,GO:0009306,0.164782878279916,0.948021798587851,5,10,protein secretion,BP,BMP6;KCNG2;RAB40B;INHBB;NOTCH1
784,GO:0006468,0.164942058209722,0.900779695294898,23,63,protein phosphorylation,BP,WNT7A;PIK3CG;BMP6;WNT7B;AXIN1;MAPK12;SPTBN5;SPTB;FZD7;FGF8;ARTN;WNK4;DUSP5;INHBB;CCL20;PKN3;FGF17;HRAS;BMP4;GDNF;PIK3CA;BMP7;SPTBN4
5674,GO:1902106,0.165576253145125,0.96930152930952,3,5,negative regulation of leukocyte differentiation,BP,CLDN18;BMP4;FSTL3
4092,GO:0051129,0.165992065834267,0.933365838819625,7,16,negative regulation of cellular component organization,BP,SCIN;WNT3;SPTBN5;SPTB;BMP4;BMP7;SPTBN4
3612,GO:0046330,0.166084885568725,0.947455868046919,5,10,positive regulation of JNK cascade,BP,WNT7A;WNT7B;AXIN1;FZD7;HRAS
1311,GO:0010498,0.166134117245336,0.969144032271268,3,5,proteasomal protein catabolic process,BP,PMAIP1;AXIN1;RNF144A
4224,GO:0051603,0.166134117245336,0.969144032271268,3,5,proteolysis involved in cellular protein catabolic process,BP,PMAIP1;AXIN1;RNF144A
3172,GO:0043409,0.166220713445786,0.969119555919888,3,5,negative regulation of MAPK cascade,BP,DUSP5;BMP4;BMP7
140,GO:0001759,0.167058697893692,0.958267615932553,4,7,organ induction,BP,WNT2;FGF8;BMP4;GDNF
5595,GO:1901362,0.167116823315375,0.900966170336726,21,57,organic cyclic compound biosynthetic process,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;CRB2;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1;PNMT;GUCY1B3
5944,GO:1905330,0.167283503262277,0.946933146836098,5,10,regulation of morphogenesis of an epithelium,BP,WNT2;FZD7;BMP4;GDNF;BMP7
2843,GO:0036294,0.167825630725736,0.96866454728705,3,5,cellular response to decreased oxygen levels,BP,PMAIP1;BMP7;NOTCH1
4958,GO:0071453,0.167825630725736,0.96866454728705,3,5,cellular response to oxygen levels,BP,PMAIP1;BMP7;NOTCH1
4959,GO:0071456,0.167825630725736,0.96866454728705,3,5,cellular response to hypoxia,BP,PMAIP1;BMP7;NOTCH1
403,GO:0003158,0.168242135566348,0.938425849564846,6,13,endothelium development,BP,WNT7A;BMP6;HEY1;WNT7B;BMP4;NOTCH1
174,GO:0001894,0.168310258305326,0.968526636425534,3,5,tissue homeostasis,BP,CLDN18;RAB3D;TF
3973,GO:0050769,0.168718683174078,0.938192669275696,6,13,positive regulation of neurogenesis,BP,BMP6;WNT3;WNT2;BMP4;BMP7;NOTCH1
4313,GO:0055025,0.168817516251678,0.968382030094771,3,5,positive regulation of cardiac muscle tissue development,BP,WNT2;BMP4;NOTCH1
2482,GO:0032870,0.169966158642533,0.926195495397276,8,19,cellular response to hormone stimulus,BP,GJB2;HEY1;VDR;INHBB;BMP4;PIK3CA;BMP7;NOTCH1
1015,GO:0007399,0.172109614540678,0.894126658867503,25,70,nervous system development,BP,WNT7A;BMP6;WNT3;WNT7B;JAG2;AXIN1;POU3F1;WNT2;CDH1;SPTBN5;SPTB;FZD7;FGF8;CRB2;ARTN;WNT5B;FGF17;HRAS;BMP4;GDNF;PIK3CA;BMP7;DRP2;SPTBN4;NOTCH1
5254,GO:0090087,0.172697883871309,0.929826132456845,7,16,regulation of peptide transport,BP,BMP6;KCNG2;CDH1;FZD7;INHBB;BMP4;BMP7
4949,GO:0071407,0.172915575957738,0.929710370621939,7,16,cellular response to organic cyclic compound,BP,GJB2;PIK3CG;HEY1;CDH1;VDR;BMP4;BMP7
1225,GO:0009653,0.173290751871589,0.891051183668771,29,83,anatomical structure morphogenesis,BP,TLE1;WNT7A;PIK3CG;BMP6;WNT3;HEY1;GJB6;WNT7B;JAG2;AXIN1;WNT2;SPTBN5;SPTB;FZD7;FGF8;VDR;CRB2;ARTN;AMOT;WNK4;DUSP5;HRAS;BMP4;GDNF;PIK3CA;BMP7;TPD52;SPTBN4;NOTCH1
3399,GO:0045055,0.173334345230926,0.929487532274204,7,16,regulated exocytosis,BP,SCIN;PIK3CG;SYT5;PKP1;RAB3D;NOTCH1;TF
4148,GO:0051253,0.173974867027151,0.919649943603934,9,22,negative regulation of RNA metabolic process,BP,TLE1;BMP6;HEY1;AXIN1;VDR;PKP1;BMP4;BMP7;NOTCH1
2326,GO:0032268,0.175588282940701,0.896054081657637,20,54,regulation of cellular protein metabolic process,BP,MAGEC2;WNT7A;PIK3CG;BMP6;WNT7B;PMAIP1;AXIN1;MAPK12;FZD7;FGF8;CRB2;DUSP5;INHBB;CCL20;HRAS;BMP4;RNF144A;PIK3CA;BMP7;SPTBN4
109,GO:0001656,0.175611704193758,0.943255628953541,5,10,metanephros development,BP,WNT7B;FGF8;BMP4;GDNF;BMP7
5029,GO:0071901,0.176009193668703,0.966303786039242,3,5,negative regulation of protein serine/threonine kinase activity,BP,DUSP5;BMP4;BMP7
2901,GO:0040019,0.176907709507694,0.966040452304219,3,5,positive regulation of embryonic development,BP,WNT2;AMOT;GDNF
2099,GO:0030850,0.177214154600134,0.965950453718099,3,5,prostate gland development,BP,BMP4;BMP7;NOTCH1
4501,GO:0060512,0.177214154600134,0.965950453718099,3,5,prostate gland morphogenesis,BP,BMP4;BMP7;NOTCH1
4567,GO:0060740,0.177214154600134,0.965950453718099,3,5,prostate gland epithelium morphogenesis,BP,BMP4;BMP7;NOTCH1
3454,GO:0045335,0.177413998134404,0.965891711331414,3,5,phagocytic vesicle,CC,RAB39A;RAB38;RAB20
4779,GO:0070201,0.177880125069335,0.92174705499871,8,19,regulation of establishment of protein localization,BP,BMP6;PMAIP1;KCNG2;CDH1;FZD7;INHBB;BMP4;BMP7
1308,GO:0010468,0.178266848316858,0.892008085423837,22,61,regulation of gene expression,BP,TLE1;WNT7A;BMP6;WNT3;HEY1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;CRB2;PKP1;HRAS;BMP4;GDNF;PIK3CA;BMP7;FSTL3;NOTCH1
1432,GO:0010942,0.17859631389099,0.926670736483201,7,16,positive regulation of cell death,BP,SCIN;PMAIP1;VDR;INHBB;BMP4;BMP7;NOTCH1
3079,GO:0043068,0.17859631389099,0.926670736483201,7,16,positive regulation of programmed cell death,BP,SCIN;PMAIP1;VDR;INHBB;BMP4;BMP7;NOTCH1
3909,GO:0048839,0.179728281548964,0.932733231820926,6,13,inner ear development,BP,GJB2;GJB6;JAG2;FGF8;BMP4;NOTCH1
2328,GO:0032270,0.180532034396044,0.895032977927408,18,48,positive regulation of cellular protein metabolic process,BP,MAGEC2;WNT7A;PIK3CG;BMP6;WNT7B;PMAIP1;AXIN1;MAPK12;FZD7;FGF8;DUSP5;INHBB;CCL20;HRAS;BMP4;RNF144A;PIK3CA;BMP7
1252,GO:0009895,0.182725262816205,0.948349680574613,4,8,negative regulation of catabolic process,BP,PIK3CG;ACTN3;PKP1;PIK3CA
1810,GO:0019932,0.182779307320402,0.964299532751965,3,5,second-messenger-mediated signaling,BP,ACTN3;CCL20;GUCY1B3
4408,GO:0060255,0.18302315230769,0.883124437671027,31,89,regulation of macromolecule metabolic process,BP,MAGEC2;TLE1;WNT7A;PIK3CG;BMP6;WNT3;HEY1;WNT7B;PMAIP1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;CRB2;DUSP5;INHBB;CCL20;PKP1;HRAS;BMP4;GDNF;RNF144A;PIK3CA;BMP7;FSTL3;SPTBN4;NOTCH1
3330,GO:0044433,0.183730515081499,0.899660668008351,14,36,cytoplasmic vesicle part,CC,WNT7A;SYT5;WNT3;WNT7B;RAB39A;FZD7;WNT5B;PKP1;TSPAN15;RAB3D;RNF144A;RAB38;RAB20;TF
4108,GO:0051172,0.183744127225952,0.910056602144199,10,25,negative regulation of nitrogen compound metabolic process,BP,TLE1;ACTN3;BMP6;HEY1;AXIN1;VDR;PKP1;BMP4;BMP7;NOTCH1
3380,GO:0044801,0.184219741962865,0.963867127426455,3,5,single-organism membrane fusion,BP,SYT5;RAB39A;RAB20
4466,GO:0060428,0.184694241694111,0.963724228477616,3,5,lung epithelium development,BP,WNT7B;WNT2;BMP4
1612,GO:0016310,0.184797553134766,0.885662460757029,24,67,phosphorylation,BP,WNT7A;PIK3CG;ACTN3;BMP6;WNT7B;AXIN1;MAPK12;SPTBN5;SPTB;FZD7;FGF8;ARTN;WNK4;DUSP5;INHBB;CCL20;PKN3;FGF17;HRAS;BMP4;GDNF;PIK3CA;BMP7;SPTBN4
3122,GO:0043231,0.185221519701449,0.880121518539011,37,109,intracellular membrane-bounded organelle,CC,MAGEC2;SLC2A14;TJP3;GLDC;TLE1;WNT7A;GJB2;PIK3CG;MBOAT2;WNT3;HEY1;WNT7B;PMAIP1;AXIN1;POU3F1;MAPK12;CDH1;RAB40B;RAB39A;SPTB;RRAS2;VDR;AMOT;WNT5B;DUSP5;PKN3;PKP1;HRAS;RAB3D;RNF144A;RAB38;FSTL3;TPD52;SPTBN4;NOTCH1;RND3;RAB20
5327,GO:0090596,0.186310918700694,0.929403419453467,6,13,sensory organ morphogenesis,BP,GJB6;AXIN1;WNT2;FGF8;BMP4;BMP7
2275,GO:0031974,0.189888703954358,0.88969457336096,17,46,membrane-enclosed lumen,CC,MAGEC2;GLDC;TLE1;WNT7A;WNT3;HEY1;WNT7B;POU3F1;MAPK12;VDR;WNT5B;DUSP5;PKP1;FSTL3;SPTBN4;NOTCH1;TF
3124,GO:0043233,0.189888703954358,0.88969457336096,17,46,organelle lumen,CC,MAGEC2;GLDC;TLE1;WNT7A;WNT3;HEY1;WNT7B;POU3F1;MAPK12;VDR;WNT5B;DUSP5;PKP1;FSTL3;SPTBN4;NOTCH1;TF
4756,GO:0070013,0.189888703954358,0.88969457336096,17,46,intracellular organelle lumen,CC,MAGEC2;GLDC;TLE1;WNT7A;WNT3;HEY1;WNT7B;POU3F1;MAPK12;VDR;WNT5B;DUSP5;PKP1;FSTL3;SPTBN4;NOTCH1;TF
5317,GO:0090407,0.190467338804545,0.927275870394589,6,13,organophosphate biosynthetic process,BP,PIK3CG;MBOAT2;FGF8;FGF17;PIK3CA;GUCY1B3
4903,GO:0071248,0.191448428728973,0.944765910854883,4,8,cellular response to metal ion,BP,BMP6;CDH1;FSTL3;TF
1596,GO:0016192,0.194164181381156,0.885221253996872,18,49,vesicle-mediated transport,BP,SCIN;WNT7A;PIK3CG;SYT5;RABIF;SPTBN5;RAB40B;RAB39A;SPTB;PKP1;HRAS;RAB3D;RAB38;PIK3CA;SPTBN4;NOTCH1;RAB20;TF
4150,GO:0051258,0.195290908265023,0.943160173051741,4,8,protein polymerization,BP,SCIN;SPTBN5;SPTB;SPTBN4
113,GO:0001664,0.195683980971138,0.917311956837322,7,16,G-protein coupled receptor binding,MF,WNT7A;WNT3;WNT7B;WNT2;FZD7;WNT5B;CCL20
5210,GO:0080135,0.195750249720024,0.917275039325515,7,16,regulation of cellular response to stress,BP,WNT7A;WNT7B;PMAIP1;AXIN1;FZD7;HRAS;BMP7
3083,GO:0043086,0.195782926723733,0.917256833608475,7,16,negative regulation of catalytic activity,BP,CRB2;AMOT;DUSP5;HRAS;BMP4;BMP7;NOTCH1
3338,GO:0044446,0.196084553637887,0.872054974982136,36,106,intracellular organelle part,CC,MAGEC2;GLDC;SCIN;TLE1;WNT7A;SYT5;ACTN3;MBOAT2;WNT3;HEY1;WNT7B;PMAIP1;POU3F1;MAPK12;CDH1;SPTBN5;RAB40B;RAB39A;SPTB;FZD7;VDR;AMOT;WNT5B;DUSP5;PKP1;TSPAN15;HRAS;RAB3D;RNF144A;RAB38;FSTL3;SPTBN4;NOTCH1;RND3;RAB20;TF
556,GO:0005102,0.198050179885044,0.878747231889734,21,58,receptor binding,MF,WNT7A;PIK3CG;ACTN3;BMP6;WNT3;WNT7B;JAG2;WNT2;FZD7;FGF8;VDR;ARTN;WNT5B;INHBB;CCL20;FGF17;BMP4;GDNF;BMP7;NOTCH1;TF
1788,GO:0019827,0.199154806783723,0.941528828478092,4,8,stem cell population maintenance,BP,WNT7A;FZD7;BMP7;NOTCH1
5446,GO:0098727,0.199154806783723,0.941528828478092,4,8,maintenance of cell number,BP,WNT7A;FZD7;BMP7;NOTCH1
224,GO:0002067,0.199270500438833,0.941479725335958,4,8,glandular epithelial cell differentiation,BP,BMP6;FGF8;BMP4;NOTCH1
1883,GO:0022407,0.200154021718633,0.929199540594007,5,11,regulation of cell-cell adhesion,BP,CDH1;BMP4;PIK3CA;BMP7;FSTL3
467,GO:0003344,0.200772023143557,0.976668091791459,2,3,pericardium morphogenesis,BP,BMP7;NOTCH1
582,GO:0005200,0.200848829838317,0.976652855056296,2,3,structural constituent of cytoskeleton,MF,SPTB;SPTBN4
2517,GO:0032991,0.200976244140804,0.874340556345164,23,66,macromolecular complex,CC,GLDC;SCIN;GJB2;PIK3CG;GJA3;WNT3;GJB6;KCNG2;AXIN1;POU3F1;WNT2;CDH1;SPTB;VDR;CRB2;AMOT;PKP1;KCNK6;RNF144A;PIK3CA;NOTCH1;GUCY1B3;TF
1393,GO:0010812,0.201076723258408,0.976607618532293,2,3,negative regulation of cell-substrate adhesion,BP,FZD7;NOTCH1
5408,GO:0097651,0.201369808721786,0.97654938088584,2,3,phosphatidylinositol 3-kinase complex, class I,CC,PIK3CG;PIK3CA
3369,GO:0044765,0.202387652795414,0.871850430141217,25,71,single-organism transport,BP,SLC2A14;SCIN;WNT7A;PIK3CG;SYT5;BMP6;KCNG2;CDH1;RAB40B;RAB39A;FZD7;VDR;WNK4;INHBB;PKP1;BMP4;RAB3D;KCNK6;GDNF;PIK3CA;BMP7;TPD52;NOTCH1;RAB20;TF
3283,GO:0044257,0.202834873995197,0.939959607772398,4,8,cellular protein catabolic process,BP,MAGEC2;PMAIP1;AXIN1;RNF144A
1387,GO:0010799,0.202837271009493,0.976256762605731,2,3,regulation of peptidyl-threonine phosphorylation,BP,AXIN1;BMP7
1388,GO:0010800,0.202837271009493,0.976256762605731,2,3,positive regulation of peptidyl-threonine phosphorylation,BP,AXIN1;BMP7
562,GO:0005112,0.202983363768192,0.976227537456381,2,3,Notch binding,MF,JAG2;NOTCH1
2,GO:0000003,0.203010304081313,0.880469529000753,17,46,reproduction,BP,SLC2A14;WNT7A;GJB2;BMP6;WNT3;HEY1;WNT7B;JAG2;WNT2;FGF8;VDR;INHBB;BMP4;BMP7;FSTL3;SPTBN4;NOTCH1
1889,GO:0022414,0.203010304081313,0.880469529000753,17,46,reproductive process,BP,SLC2A14;WNT7A;GJB2;BMP6;WNT3;HEY1;WNT7B;JAG2;WNT2;FGF8;VDR;INHBB;BMP4;BMP7;FSTL3;SPTBN4;NOTCH1
984,GO:0007257,0.203020574895606,0.976220090840304,2,3,activation of JUN kinase activity,BP,WNT7B;AXIN1
4141,GO:0051246,0.203236581010696,0.876114617180792,20,55,regulation of protein metabolic process,BP,MAGEC2;WNT7A;PIK3CG;BMP6;WNT7B;PMAIP1;AXIN1;MAPK12;FZD7;FGF8;CRB2;DUSP5;INHBB;CCL20;HRAS;BMP4;RNF144A;PIK3CA;BMP7;SPTBN4
5841,GO:1903706,0.203528309673475,0.927538209354952,5,11,regulation of hemopoiesis,BP,SCIN;CLDN18;BMP4;FSTL3;NOTCH1
125,GO:0001708,0.203572729420183,0.976109465466948,2,3,cell fate specification,BP,FZD7;NOTCH1
5710,GO:1902532,0.2039145756874,0.927347217145145,5,11,negative regulation of intracellular signal transduction,BP,TLE1;ACTN3;DUSP5;BMP4;BMP7
1683,GO:0016829,0.204052580541889,0.976013129400668,2,3,lyase activity,MF,GLDC;GUCY1B3
4102,GO:0051154,0.204557189560466,0.975911625352076,2,3,negative regulation of striated muscle cell differentiation,BP,FZD7;NOTCH1
6023,GO:2000027,0.204842379756183,0.906082805265039,8,19,regulation of organ morphogenesis,BP,WNT2;FZD7;FGF8;VDR;BMP4;GDNF;BMP7;NOTCH1
1248,GO:0009891,0.205300266494466,0.880568903306455,16,43,positive regulation of biosynthetic process,BP,WNT7A;BMP6;HEY1;AXIN1;POU3F1;WNT2;CDH1;FZD7;VDR;CCL20;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
1716,GO:0018105,0.205337424541036,0.926642238152072,5,11,peptidyl-serine phosphorylation,BP,AXIN1;MAPK12;PKN3;PIK3CA;SPTBN4
1726,GO:0018209,0.205337424541036,0.926642238152072,5,11,peptidyl-serine modification,BP,AXIN1;MAPK12;PKN3;PIK3CA;SPTBN4
2895,GO:0040011,0.20551578716986,0.873106099266419,21,59,locomotion,BP,WNT7A;PIK3CG;WNT3;JAG2;SPTBN5;SPTB;RRAS2;FGF8;CRB2;ARTN;AMOT;WNT5B;CCL20;PKN3;HRAS;BMP4;GDNF;PIK3CA;BMP7;SPTBN4;NOTCH1
3508,GO:0045669,0.205639726189299,0.938753460996353,4,8,positive regulation of osteoblast differentiation,BP,BMP6;WNT7B;BMP4;BMP7
5093,GO:0072132,0.205963944137573,0.938613476194294,4,8,mesenchyme morphogenesis,BP,HEY1;FGF8;BMP7;NOTCH1
214,GO:0002028,0.206202968563218,0.975579162487797,2,3,regulation of sodium ion transport,BP,WNK4;SPTBN4
858,GO:0006814,0.206202968563218,0.975579162487797,2,3,sodium ion transport,BP,WNK4;SPTBN4
3544,GO:0045822,0.20628226563667,0.975563089277976,2,3,negative regulation of heart contraction,BP,PIK3CG;SPTBN4
5817,GO:1903523,0.20628226563667,0.975563089277976,2,3,negative regulation of blood circulation,BP,PIK3CG;SPTBN4
745,GO:0006139,0.206669867980977,0.870284814967448,23,65,nucleobase-containing compound metabolic process,BP,TLE1;WNT7A;ACTN3;BMP6;HEY1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;CRB2;PKP1;HRAS;BMP4;GDNF;PIK3CA;BMP7;FSTL3;NOTCH1;GUCY1B3
3259,GO:0044060,0.207403962131597,0.975335189115126,2,3,regulation of endocrine process,BP,BMP6;INHBB
4624,GO:0060986,0.207403962131597,0.975335189115126,2,3,endocrine hormone secretion,BP,BMP6;INHBB
5772,GO:1903052,0.208142262617362,0.975184637987287,2,3,positive regulation of proteolysis involved in cellular protein catabolic process,BP,AXIN1;RNF144A
75,GO:0001104,0.208268023807242,0.975158949968008,2,3,RNA polymerase II transcription cofactor activity,MF,TLE1;POU3F1
643,GO:0005667,0.208479653763168,0.975115693891562,2,3,transcription factor complex,CC,POU3F1;VDR
3919,GO:0048856,0.209079027067752,0.862485282061224,44,133,anatomical structure development,BP,SLC2A14;SCIN;TLE1;WNT7A;GJB2;PIK3CG;ACTN3;CLDN18;BMP6;WNT3;HEY1;GJB6;WNT7B;JAG2;AXIN1;POU3F1;MAPK12;WNT2;CDH1;SPTBN5;SPTB;FZD7;FGF8;VDR;CRB2;ARTN;DSG3;AMOT;WNT5B;WNK4;DUSP5;INHBB;PKP1;FGF17;HRAS;BMP4;GDNF;PIK3CA;BMP7;DRP2;FSTL3;TPD52;SPTBN4;NOTCH1
1228,GO:0009719,0.209116959568436,0.874276597892465,18,50,response to endogenous stimulus,BP,WNT7A;GJB2;PIK3CG;BMP6;HEY1;WNT7B;WNT2;CDH1;FGF8;VDR;CRB2;INHBB;FGF17;BMP4;PIK3CA;BMP7;FSTL3;NOTCH1
4491,GO:0060485,0.209272991595712,0.903435012814112,8,19,mesenchyme development,BP,HEY1;WNT2;FGF8;CRB2;BMP4;GDNF;BMP7;NOTCH1
2040,GO:0030514,0.209397506011406,0.974927676020881,2,3,negative regulation of BMP signaling pathway,BP,FSTL3;NOTCH1
5873,GO:1904019,0.209440012805968,0.974918952406517,2,3,epithelial cell apoptotic process,BP,PIK3CG;JAG2
2558,GO:0033273,0.209725240671428,0.974860378146275,2,3,response to vitamin,BP,VDR;BMP7
4142,GO:0051247,0.21002292410893,0.873894262345635,18,49,positive regulation of protein metabolic process,BP,MAGEC2;WNT7A;PIK3CG;BMP6;WNT7B;PMAIP1;AXIN1;MAPK12;FZD7;FGF8;DUSP5;INHBB;CCL20;HRAS;BMP4;RNF144A;PIK3CA;BMP7
16,GO:0000139,0.210313406846957,0.936724257739623,4,8,Golgi membrane,CC,RAB39A;HRAS;NOTCH1;RND3
3310,GO:0044346,0.210325074626192,0.974736984557635,2,3,fibroblast apoptotic process,BP,PIK3CG;PIK3CA
6069,GO:2000269,0.210325074626192,0.974736984557635,2,3,regulation of fibroblast apoptotic process,BP,PIK3CG;PIK3CA
6070,GO:2000270,0.210325074626192,0.974736984557635,2,3,negative regulation of fibroblast apoptotic process,BP,PIK3CG;PIK3CA
3706,GO:0046916,0.210743740317895,0.974650689310084,2,3,cellular transition metal ion homeostasis,BP,BMP6;TF
766,GO:0006352,0.211239613627909,0.974548298855155,2,3,DNA-templated transcription, initiation,BP,VDR;NOTCH1
772,GO:0006367,0.211239613627909,0.974548298855155,2,3,transcription initiation from RNA polymerase II promoter,BP,VDR;NOTCH1
2400,GO:0032507,0.211256799491051,0.97454474670647,2,3,maintenance of protein location in cell,BP,SCIN;SPTBN4
3432,GO:0045185,0.211256799491051,0.97454474670647,2,3,maintenance of protein location,BP,SCIN;SPTBN4
4235,GO:0051651,0.211256799491051,0.97454474670647,2,3,maintenance of location in cell,BP,SCIN;SPTBN4
4965,GO:0071495,0.21167486119927,0.873990733941259,17,47,cellular response to endogenous stimulus,BP,WNT7A;GJB2;PIK3CG;BMP6;HEY1;WNT2;CDH1;FGF8;VDR;CRB2;INHBB;FGF17;BMP4;PIK3CA;BMP7;FSTL3;NOTCH1
2010,GO:0030316,0.211693365264854,0.974454433673466,2,3,osteoclast differentiation,BP,CLDN18;FSTL3
3509,GO:0045670,0.211693365264854,0.974454433673466,2,3,regulation of osteoclast differentiation,BP,CLDN18;FSTL3
3510,GO:0045671,0.211693365264854,0.974454433673466,2,3,negative regulation of osteoclast differentiation,BP,CLDN18;FSTL3
3661,GO:0046697,0.21185697606555,0.974420547996296,2,3,decidualization,BP,GJB2;VDR
5533,GO:1900181,0.212020665341068,0.974386624642039,2,3,negative regulation of protein localization to nucleus,BP,CLDN18;BMP7
1573,GO:0015980,0.212490412342502,0.974289154145702,2,3,energy derivation by oxidation of organic compounds,BP,ACTN3;PIK3CA
3184,GO:0043467,0.212490412342502,0.974289154145702,2,3,regulation of generation of precursor metabolites and energy,BP,ACTN3;PIK3CA
3288,GO:0044265,0.212652360777668,0.922982231612341,5,11,cellular macromolecule catabolic process,BP,MAGEC2;PMAIP1;AXIN1;PKP1;RNF144A
4589,GO:0060837,0.214235301422142,0.973925550576729,2,3,blood vessel endothelial cell differentiation,BP,HEY1;NOTCH1
4593,GO:0060842,0.214235301422142,0.973925550576729,2,3,arterial endothelial cell differentiation,BP,HEY1;NOTCH1
421,GO:0003188,0.214623237317976,0.973844380338453,2,3,heart valve formation,BP,HEY1;NOTCH1
422,GO:0003190,0.214623237317976,0.973844380338453,2,3,atrioventricular valve formation,BP,HEY1;NOTCH1
5821,GO:1903532,0.21474847233448,0.934776254915309,4,8,positive regulation of secretion by cell,BP,BMP6;INHBB;RAB3D;GDNF
4321,GO:0055072,0.214939755567882,0.973778063903736,2,3,iron ion homeostasis,BP,BMP6;TF
1617,GO:0016328,0.215754781849137,0.93433122451459,4,8,lateral plasma membrane,CC,GJB2;AXIN1;CDH1;CLDN15
2565,GO:0033365,0.215931752343172,0.904284909145778,7,17,protein localization to organelle,BP,CLDN18;BMP6;PMAIP1;CDH1;FZD7;BMP4;BMP7
3019,GO:0042592,0.216015705639196,0.874590740629371,15,41,homeostatic process,BP,PIK3CG;CLDN18;BMP6;GJB6;WNT7B;PMAIP1;RAB39A;VDR;WNK4;BMP4;RAB3D;RAB38;PIK3CA;RAB20;TF
1581,GO:0016050,0.216640528643897,0.933938584779246,4,8,vesicle organization,BP,SYT5;RAB39A;RAB38;RAB20
1145,GO:0008544,0.217021385734704,0.903645269114369,7,17,epidermis development,BP,JAG2;POU3F1;VDR;DSG3;PKP1;BMP4;NOTCH1
5031,GO:0071944,0.217492290645635,0.856625934082283,46,140,cell periphery,CC,SLC2A14;TJP3;GLDC;SCIN;WNT7A;GJB2;PIK3CG;SYT5;CLDN18;GJA3;WNT3;GJB6;WNT7B;JAG2;KCNG2;AXIN1;WNT2;CDH1;SPTBN5;RAB40B;RAB39A;SPTB;RRAS2;FZD7;FGF8;CRB2;DSG3;AMOT;WNT5B;INHBB;PKP1;TSPAN15;HRAS;RAB3D;KCNK6;CLDN15;RNF144A;RAB38;PIK3CA;DRP2;SPTBN4;TSPAN13;NOTCH1;RAB20;GUCY1B3;TF
3563,GO:0045892,0.218099273893206,0.896896738610845,8,20,negative regulation of transcription, DNA-templated,BP,TLE1;BMP6;HEY1;AXIN1;VDR;BMP4;BMP7;NOTCH1
5731,GO:1902679,0.218099273893206,0.896896738610845,8,20,negative regulation of RNA biosynthetic process,BP,TLE1;BMP6;HEY1;AXIN1;VDR;BMP4;BMP7;NOTCH1
5809,GO:1903507,0.218099273893206,0.896896738610845,8,20,negative regulation of nucleic acid-templated transcription,BP,TLE1;BMP6;HEY1;AXIN1;VDR;BMP4;BMP7;NOTCH1
4553,GO:0060685,0.218207368356215,0.973088740224707,2,3,regulation of prostatic bud formation,BP,BMP4;BMP7
4554,GO:0060686,0.218207368356215,0.973088740224707,2,3,negative regulation of prostatic bud formation,BP,BMP4;BMP7
5945,GO:1905331,0.218207368356215,0.973088740224707,2,3,negative regulation of morphogenesis of an epithelium,BP,BMP4;BMP7
1247,GO:0009890,0.218480110803027,0.891576062529268,9,23,negative regulation of biosynthetic process,BP,TLE1;BMP6;HEY1;AXIN1;VDR;INHBB;BMP4;BMP7;NOTCH1
1325,GO:0010558,0.218480110803027,0.891576062529268,9,23,negative regulation of macromolecule biosynthetic process,BP,TLE1;BMP6;HEY1;AXIN1;VDR;INHBB;BMP4;BMP7;NOTCH1
2187,GO:0031327,0.218480110803027,0.891576062529268,9,23,negative regulation of cellular biosynthetic process,BP,TLE1;BMP6;HEY1;AXIN1;VDR;INHBB;BMP4;BMP7;NOTCH1
4254,GO:0051784,0.218667849500803,0.972990909356207,2,3,negative regulation of nuclear division,BP,BMP4;BMP7
5305,GO:0090304,0.219071319091316,0.863093674122455,21,59,nucleic acid metabolic process,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;CRB2;PKP1;HRAS;BMP4;GDNF;PIK3CA;BMP7;FSTL3;NOTCH1
821,GO:0006661,0.219078940481446,0.932853188332934,4,8,phosphatidylinositol biosynthetic process,BP,PIK3CG;FGF8;FGF17;PIK3CA
3394,GO:0045017,0.219078940481446,0.932853188332934,4,8,glycerolipid biosynthetic process,BP,PIK3CG;FGF8;FGF17;PIK3CA
3628,GO:0046474,0.219078940481446,0.932853188332934,4,8,glycerophospholipid biosynthetic process,BP,PIK3CG;FGF8;FGF17;PIK3CA
5711,GO:1902533,0.219571004858626,0.877301639088618,13,34,positive regulation of intracellular signal transduction,BP,WNT7A;PIK3CG;WNT7B;PMAIP1;AXIN1;FZD7;FGF8;DUSP5;CCL20;HRAS;BMP4;PIK3CA;NOTCH1
4307,GO:0055017,0.219636587032255,0.972784540839797,2,3,cardiac muscle tissue growth,BP,WNT2;NOTCH1
4310,GO:0055021,0.219636587032255,0.972784540839797,2,3,regulation of cardiac muscle tissue growth,BP,WNT2;NOTCH1
4311,GO:0055023,0.219636587032255,0.972784540839797,2,3,positive regulation of cardiac muscle tissue growth,BP,WNT2;NOTCH1
2184,GO:0031324,0.220361035676426,0.871508442788369,15,41,negative regulation of cellular metabolic process,BP,TLE1;PIK3CG;ACTN3;BMP6;HEY1;AXIN1;VDR;CRB2;DUSP5;INHBB;PKP1;BMP4;PIK3CA;BMP7;NOTCH1
3501,GO:0045661,0.220436334678339,0.972613602855469,2,3,regulation of myoblast differentiation,BP,BMP4;NOTCH1
3502,GO:0045662,0.220436334678339,0.972613602855469,2,3,negative regulation of myoblast differentiation,BP,BMP4;NOTCH1
3695,GO:0046887,0.221036294486805,0.97248502937637,2,3,positive regulation of hormone secretion,BP,BMP6;INHBB
3702,GO:0046907,0.221119781980899,0.881807637909662,11,29,intracellular transport,BP,WNT7A;PIK3CG;SYT5;BMP6;CDH1;SPTBN5;SPTB;FZD7;BMP4;BMP7;SPTBN4
4038,GO:0050922,0.221490713254085,0.972387452829761,2,3,negative regulation of chemotaxis,BP,WNT3;NOTCH1
2119,GO:0030902,0.221591197135211,0.972365853631673,2,3,hindbrain development,BP,WNT7A;BMP7
1280,GO:0010035,0.222511824569871,0.908099389067187,6,14,response to inorganic substance,BP,BMP6;CDH1;BMP7;FSTL3;GUCY1B3;TF
5090,GO:0072125,0.222732953735131,0.972119859064391,2,3,negative regulation of glomerular mesangial cell proliferation,BP,BMP4;BMP7
5278,GO:0090185,0.222732953735131,0.972119859064391,2,3,negative regulation of kidney development,BP,BMP4;BMP7
5286,GO:0090194,0.222732953735131,0.972119859064391,2,3,negative regulation of glomerulus development,BP,BMP4;BMP7
5637,GO:1901723,0.222732953735131,0.972119859064391,2,3,negative regulation of cell proliferation involved in kidney development,BP,BMP4;BMP7
5583,GO:1901213,0.222774687573514,0.972110847473994,2,3,regulation of transcription from RNA polymerase II promoter involved in heart development,BP,BMP4;NOTCH1
4566,GO:0060716,0.222908608184726,0.972081920496283,2,3,labyrinthine layer blood vessel development,BP,HEY1;WNT2
1246,GO:0009889,0.223019228657674,0.860149532766647,21,59,regulation of biosynthetic process,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;CRB2;INHBB;CCL20;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
2280,GO:0031984,0.223418347190196,0.971971683982564,2,3,organelle subcompartment,CC,CDH1;RAB38
1305,GO:0010464,0.223490368854154,0.971956091614375,2,3,regulation of mesenchymal cell proliferation,BP,WNT2;BMP4
4437,GO:0060348,0.224044660825046,0.930622520412693,4,8,bone development,BP,CLDN18;BMP6;FGF8;BMP4
4918,GO:0071322,0.224566648578458,0.971722582753197,2,3,cellular response to carbohydrate stimulus,BP,GJB6;PIK3CA
4919,GO:0071326,0.224566648578458,0.971722582753197,2,3,cellular response to monosaccharide stimulus,BP,GJB6;PIK3CA
4920,GO:0071331,0.224566648578458,0.971722582753197,2,3,cellular response to hexose stimulus,BP,GJB6;PIK3CA
4921,GO:0071333,0.224566648578458,0.971722582753197,2,3,cellular response to glucose stimulus,BP,GJB6;PIK3CA
1929,GO:0030030,0.225117182188605,0.870384693742496,14,38,cell projection organization,BP,WNT7A;WNT3;WNT7B;CDH1;SPTBN5;SPTB;FGF8;ARTN;HRAS;GDNF;PIK3CA;BMP7;SPTBN4;NOTCH1
4066,GO:0051047,0.225242214372705,0.916543822229365,5,11,positive regulation of secretion,BP,SCIN;BMP6;INHBB;RAB3D;GDNF
2614,GO:0034260,0.225835507351428,0.971446089514149,2,3,negative regulation of GTPase activity,BP,AMOT;HRAS
1884,GO:0022408,0.225889100427751,0.971434382543113,2,3,negative regulation of cell-cell adhesion,BP,CDH1;BMP4
166,GO:0001845,0.226238933583438,0.971357907233773,2,3,phagolysosome assembly,BP,RAB39A;RAB20
928,GO:0007040,0.226238933583438,0.971357907233773,2,3,lysosome organization,BP,RAB39A;RAB20
5211,GO:0080171,0.226238933583438,0.971357907233773,2,3,lytic vacuole organization,BP,RAB39A;RAB20
782,GO:0006464,0.226465780357985,0.852151205231786,27,78,cellular protein modification process,BP,MAGEC2;WNT7A;PIK3CG;BMP6;WNT7B;AXIN1;MAPK12;SPTBN5;RAB40B;SPTB;FZD7;FGF8;ARTN;WNK4;DUSP5;INHBB;CCL20;PKN3;FGF17;HRAS;BMP4;RAB3D;GDNF;RNF144A;PIK3CA;BMP7;SPTBN4
2839,GO:0036211,0.226465780357985,0.852151205231786,27,78,protein modification process,BP,MAGEC2;WNT7A;PIK3CG;BMP6;WNT7B;AXIN1;MAPK12;SPTBN5;RAB40B;SPTB;FZD7;FGF8;ARTN;WNK4;DUSP5;INHBB;CCL20;PKN3;FGF17;HRAS;BMP4;RAB3D;GDNF;RNF144A;PIK3CA;BMP7;SPTBN4
3928,GO:0048878,0.226869109969887,0.877934555260706,11,29,chemical homeostasis,BP,PIK3CG;BMP6;GJB6;WNT7B;RAB39A;VDR;WNK4;RAB38;PIK3CA;RAB20;TF
2118,GO:0030901,0.227067798969767,0.971176317579955,2,3,midbrain development,BP,WNT3;WNT2
5921,GO:1904948,0.227067798969767,0.971176317579955,2,3,midbrain dopaminergic neuron differentiation,BP,WNT3;WNT2
5924,GO:1904953,0.227067798969767,0.971176317579955,2,3,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,WNT3;WNT2
1866,GO:0021954,0.227185781638595,0.971150424441158,2,3,central nervous system neuron development,BP,FGF8;SPTBN4
1366,GO:0010676,0.227266590257596,0.971132683221096,2,3,positive regulation of cellular carbohydrate metabolic process,BP,ACTN3;PMAIP1
1423,GO:0010907,0.227266590257596,0.971132683221096,2,3,positive regulation of glucose metabolic process,BP,ACTN3;PMAIP1
198,GO:0001958,0.228704880335077,0.970816026731347,2,3,endochondral ossification,BP,BMP6;BMP4
2830,GO:0036075,0.228704880335077,0.970816026731347,2,3,replacement ossification,BP,BMP6;BMP4
2485,GO:0032874,0.228900589386987,0.914640119014758,5,11,positive regulation of stress-activated MAPK cascade,BP,WNT7A;WNT7B;AXIN1;FZD7;HRAS
4806,GO:0070304,0.228900589386987,0.914640119014758,5,11,positive regulation of stress-activated protein kinase signaling cascade,BP,WNT7A;WNT7B;AXIN1;FZD7;HRAS
819,GO:0006644,0.229113817802124,0.914528707321094,5,11,phospholipid metabolic process,BP,PIK3CG;MBOAT2;FGF8;FGF17;PIK3CA
820,GO:0006650,0.229113817802124,0.914528707321094,5,11,glycerophospholipid metabolic process,BP,PIK3CG;MBOAT2;FGF8;FGF17;PIK3CA
1852,GO:0021872,0.229273908556586,0.970690285274926,2,3,forebrain generation of neurons,BP,AXIN1;FGF8
1854,GO:0021879,0.229273908556586,0.970690285274926,2,3,forebrain neuron differentiation,BP,AXIN1;FGF8
1918,GO:0023061,0.229762133929084,0.914189655461577,5,11,signal release,BP,WNT7A;SYT5;BMP6;KCNG2;INHBB
983,GO:0007254,0.229949803297138,0.914091423183255,5,11,JNK cascade,BP,WNT7A;WNT7B;AXIN1;FZD7;HRAS
3610,GO:0046328,0.229949803297138,0.914091423183255,5,11,regulation of JNK cascade,BP,WNT7A;WNT7B;AXIN1;FZD7;HRAS
1773,GO:0019538,0.229963331693369,0.846953178390529,32,94,protein metabolic process,BP,MAGEC2;WNT7A;PIK3CG;RHBDL3;BMP6;WNT7B;JAG2;PMAIP1;AXIN1;MAPK12;SPTBN5;RAB40B;SPTB;FZD7;FGF8;CRB2;ARTN;WNK4;DUSP5;INHBB;CCL20;PKN3;FGF17;TSPAN15;HRAS;BMP4;RAB3D;GDNF;RNF144A;PIK3CA;BMP7;SPTBN4
1278,GO:0010008,0.230370970844545,0.913870829380053,5,11,endosome membrane,CC,SYT5;FZD7;TSPAN15;RNF144A;TF
3334,GO:0044440,0.230370970844545,0.913870829380053,5,11,endosomal part,CC,SYT5;FZD7;TSPAN15;RNF144A;TF
2183,GO:0031323,0.230593051617884,0.846828410932926,31,91,regulation of cellular metabolic process,BP,MAGEC2;TLE1;WNT7A;PIK3CG;ACTN3;BMP6;HEY1;WNT7B;PMAIP1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;CRB2;DUSP5;INHBB;CCL20;PKP1;HRAS;BMP4;GDNF;RNF144A;PIK3CA;BMP7;FSTL3;SPTBN4;NOTCH1
6167,GO:2001233,0.230773494374134,0.927556446467651,4,8,regulation of apoptotic signaling pathway,BP,PMAIP1;INHBB;BMP4;GDNF
588,GO:0005243,0.230873909459537,0.970335314910497,2,3,gap junction channel activity,MF,GJB2;GJA3
1901,GO:0022829,0.230873909459537,0.970335314910497,2,3,wide pore channel activity,MF,GJB2;GJA3
4314,GO:0055026,0.231300916633406,0.970240228981824,2,3,negative regulation of cardiac muscle tissue development,BP,FZD7;FGF8
850,GO:0006796,0.231925561012451,0.848625527412182,26,75,phosphate-containing compound metabolic process,BP,WNT7A;PIK3CG;ACTN3;MBOAT2;BMP6;WNT7B;AXIN1;MAPK12;SPTBN5;SPTB;FZD7;FGF8;ARTN;WNK4;DUSP5;INHBB;CCL20;PKN3;FGF17;HRAS;BMP4;GDNF;PIK3CA;BMP7;SPTBN4;GUCY1B3
1044,GO:0007586,0.232665856828392,0.969935289351957,2,3,digestion,BP,VDR;WNK4
1890,GO:0022600,0.232665856828392,0.969935289351957,2,3,digestive system process,BP,VDR;WNK4
209,GO:0002009,0.234200360074143,0.869544686803568,12,32,morphogenesis of an epithelium,BP,WNT7A;WNT7B;JAG2;WNT2;FZD7;FGF8;VDR;WNK4;BMP4;GDNF;BMP7;NOTCH1
5060,GO:0072073,0.235330165603093,0.892710413105839,7,17,kidney epithelium development,BP,WNT7B;FGF8;WNK4;BMP4;GDNF;BMP7;NOTCH1
3629,GO:0046483,0.235333084214224,0.848527687833869,23,66,heterocycle metabolic process,BP,TLE1;WNT7A;ACTN3;BMP6;HEY1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;CRB2;PKP1;HRAS;BMP4;GDNF;PIK3CA;BMP7;FSTL3;NOTCH1;GUCY1B3
3579,GO:0045935,0.235475940301234,0.858555059654834,16,44,positive regulation of nucleobase-containing compound metabolic process,BP,WNT7A;ACTN3;BMP6;HEY1;AXIN1;POU3F1;WNT2;CDH1;FZD7;VDR;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
4109,GO:0051173,0.235475940301234,0.858555059654834,16,44,positive regulation of nitrogen compound metabolic process,BP,WNT7A;ACTN3;BMP6;HEY1;AXIN1;POU3F1;WNT2;CDH1;FZD7;VDR;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
4647,GO:0061046,0.235476068791304,0.969302684018616,2,3,regulation of branching involved in lung morphogenesis,BP,WNT2;BMP4
4648,GO:0061047,0.235476068791304,0.969302684018616,2,3,positive regulation of branching involved in lung morphogenesis,BP,WNT2;BMP4
4511,GO:0060541,0.235486587081415,0.892615477678616,7,17,respiratory system development,BP,WNT7B;AXIN1;WNT2;FGF8;BMP4;FSTL3;NOTCH1
4699,GO:0061326,0.235743231966272,0.900593971935545,6,14,renal tubule development,BP,WNT7B;FGF8;WNK4;BMP4;GDNF;NOTCH1
5039,GO:0072009,0.235743231966272,0.900593971935545,6,14,nephron epithelium development,BP,WNT7B;FGF8;WNK4;BMP4;GDNF;NOTCH1
5067,GO:0072080,0.235743231966272,0.900593971935545,6,14,nephron tubule development,BP,WNT7B;FGF8;WNK4;BMP4;GDNF;NOTCH1
5493,GO:0099504,0.235809791285165,0.96922713192419,2,3,synaptic vesicle cycle,BP,WNT7A;SYT5
4943,GO:0071384,0.236400459757584,0.969093186317807,2,3,cellular response to corticosteroid stimulus,BP,GJB2;HEY1
4944,GO:0071385,0.236400459757584,0.969093186317807,2,3,cellular response to glucocorticoid stimulus,BP,GJB2;HEY1
2713,GO:0035264,0.236588460385237,0.96905049369399,2,3,multicellular organism growth,BP,PIK3CA;SPTBN4
2898,GO:0040014,0.236588460385237,0.96905049369399,2,3,regulation of multicellular organism growth,BP,PIK3CA;SPTBN4
73,GO:0001101,0.236817857340023,0.891806470383757,7,17,response to acid chemical,BP,GJB2;BMP6;WNT3;WNT7B;WNT2;FZD7;WNT5B
4233,GO:0051649,0.236920433514455,0.864636485601234,13,35,establishment of localization in cell,BP,WNT7A;PIK3CG;SYT5;BMP6;PMAIP1;CDH1;SPTBN5;SPTB;FZD7;BMP4;GDNF;BMP7;SPTBN4
5593,GO:1901360,0.237202470146949,0.846163142100097,24,69,organic cyclic compound metabolic process,BP,TLE1;WNT7A;ACTN3;BMP6;HEY1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;CRB2;PKP1;HRAS;BMP4;GDNF;PIK3CA;BMP7;FSTL3;NOTCH1;PNMT;GUCY1B3
5585,GO:1901215,0.237260194255644,0.924553507352925,4,8,negative regulation of neuron death,BP,FGF8;HRAS;GDNF;PIK3CA
4326,GO:0055080,0.237432404235166,0.89143239016031,7,17,cation homeostasis,BP,PIK3CG;BMP6;RAB39A;VDR;RAB38;RAB20;TF
5452,GO:0098771,0.237432404235166,0.89143239016031,7,17,inorganic ion homeostasis,BP,PIK3CG;BMP6;RAB39A;VDR;RAB38;RAB20;TF
2458,GO:0032768,0.237507754525666,0.968841317197419,2,3,regulation of monooxygenase activity,BP,VDR;GDNF
1431,GO:0010941,0.237552337052797,0.855133393907751,17,47,regulation of cell death,BP,SCIN;TLE1;WNT7A;PIK3CG;ACTN3;BMP6;PMAIP1;RRAS2;FGF8;VDR;INHBB;HRAS;BMP4;GDNF;PIK3CA;BMP7;NOTCH1
3140,GO:0043269,0.238037933715212,0.891063414462372,7,17,regulation of ion transport,BP,PIK3CG;KCNG2;WNK4;KCNK6;GDNF;SPTBN4;TSPAN13
4135,GO:0051234,0.238876019332532,0.838817576202987,37,111,establishment of localization,BP,SLC2A14;SCIN;WNT7A;GJB2;PIK3CG;SYT5;RABIF;GJA3;BMP6;PMAIP1;KCNG2;CDH1;SPTBN5;RAB40B;RAB39A;SPTB;FZD7;VDR;WNK4;INHBB;PKP1;TSPAN15;HRAS;BMP4;RAB3D;KCNK6;CLDN15;GDNF;RAB38;PIK3CA;BMP7;TPD52;SPTBN4;TSPAN13;NOTCH1;RAB20;TF
3848,GO:0048640,0.239064862070669,0.968485434661042,2,3,negative regulation of developmental growth,BP,WNT3;BMP4
4991,GO:0071702,0.239748315102724,0.853507233842891,17,47,organic substance transport,BP,SLC2A14;RABIF;BMP6;KCNG2;CDH1;RAB40B;RAB39A;FZD7;INHBB;BMP4;RAB3D;GDNF;RAB38;BMP7;NOTCH1;RAB20;TF
3056,GO:0042981,0.239861983823101,0.855338360256839,16,44,regulation of apoptotic process,BP,SCIN;TLE1;WNT7A;PIK3CG;ACTN3;BMP6;PMAIP1;FGF8;VDR;INHBB;HRAS;BMP4;GDNF;PIK3CA;BMP7;NOTCH1
3974,GO:0050770,0.239936893004263,0.968285261141507,2,3,regulation of axonogenesis,BP,WNT7A;WNT3
3289,GO:0044267,0.241086397702439,0.839055389219556,30,88,cellular protein metabolic process,BP,MAGEC2;WNT7A;PIK3CG;BMP6;WNT7B;JAG2;PMAIP1;AXIN1;MAPK12;SPTBN5;RAB40B;SPTB;FZD7;FGF8;CRB2;ARTN;WNK4;DUSP5;INHBB;CCL20;PKN3;FGF17;HRAS;BMP4;RAB3D;GDNF;RNF144A;PIK3CA;BMP7;SPTBN4
1945,GO:0030073,0.241413726460786,0.967944833187371,2,3,insulin secretion,BP,KCNG2;INHBB
3987,GO:0050796,0.241413726460786,0.967944833187371,2,3,regulation of insulin secretion,BP,KCNG2;INHBB
5297,GO:0090276,0.241413726460786,0.967944833187371,2,3,regulation of peptide hormone secretion,BP,KCNG2;INHBB
2190,GO:0031330,0.241613847975652,0.936988251271534,3,6,negative regulation of cellular catabolic process,BP,PIK3CG;PKP1;PIK3CA
3797,GO:0048489,0.241972607477754,0.96781553723596,2,3,synaptic vesicle transport,BP,WNT7A;SYT5
5398,GO:0097480,0.241972607477754,0.96781553723596,2,3,establishment of synaptic vesicle localization,BP,WNT7A;SYT5
5481,GO:0099003,0.241972607477754,0.96781553723596,2,3,vesicle-mediated transport in synapse,BP,WNT7A;SYT5
962,GO:0007178,0.242044952501852,0.881880640784328,8,20,transmembrane receptor protein serine/threonine kinase signaling pathway,BP,BMP6;FGF8;CRB2;INHBB;BMP4;BMP7;FSTL3;NOTCH1
1165,GO:0009059,0.242468202947468,0.845247557617938,21,60,macromolecule biosynthetic process,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;CRB2;INHBB;CCL20;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
781,GO:0006461,0.243253437093856,0.875507383609507,9,23,protein complex assembly,BP,SCIN;TLE1;PMAIP1;KCNG2;AXIN1;SPTBN5;SPTB;HRAS;SPTBN4
4751,GO:0065003,0.243253437093856,0.875507383609507,9,23,macromolecular complex assembly,BP,SCIN;TLE1;PMAIP1;KCNG2;AXIN1;SPTBN5;SPTB;HRAS;SPTBN4
4797,GO:0070271,0.243253437093856,0.875507383609507,9,23,protein complex biogenesis,BP,SCIN;TLE1;PMAIP1;KCNG2;AXIN1;SPTBN5;SPTB;HRAS;SPTBN4
5264,GO:0090132,0.243548183515176,0.887688269840199,7,17,epithelium migration,BP,WNT7A;FGF8;AMOT;PKN3;BMP4;PIK3CA;NOTCH1
997,GO:0007276,0.24442389153947,0.887148979746428,7,17,gamete generation,BP,SLC2A14;WNT3;JAG2;INHBB;BMP4;FSTL3;NOTCH1
1892,GO:0022603,0.244541924234263,0.859210906989254,13,35,regulation of anatomical structure morphogenesis,BP,WNT7A;WNT3;HEY1;WNT2;FZD7;FGF8;VDR;CRB2;AMOT;BMP4;GDNF;BMP7;NOTCH1
1436,GO:0010952,0.244772213152989,0.967163987427695,2,3,positive regulation of peptidase activity,BP,PMAIP1;MAPK12
1820,GO:0021532,0.244795288364954,0.967158590334523,2,3,neural tube patterning,BP,FGF8;BMP4
3159,GO:0043331,0.245452589575215,0.967004668881185,2,3,response to dsRNA,BP,PMAIP1;BMP4
2702,GO:0035148,0.245919351663615,0.905590961127773,5,11,tube formation,BP,FGF8;BMP4;GDNF;BMP7;NOTCH1
3381,GO:0044802,0.246475026748944,0.873373349345951,9,23,single-organism membrane organization,BP,SYT5;PMAIP1;CDH1;RAB40B;RAB39A;TSPAN15;GDNF;SPTBN4;RAB20
4231,GO:0051641,0.246775959799424,0.84465332063533,19,54,cellular localization,BP,SCIN;WNT7A;PIK3CG;SYT5;CLDN18;BMP6;PMAIP1;CDH1;SPTBN5;RAB40B;SPTB;FZD7;AMOT;TSPAN15;BMP4;GDNF;RAB38;BMP7;SPTBN4
3065,GO:0043010,0.248254686939514,0.893324316262544,6,14,camera-type eye development,BP,WNT7A;WNT7B;WNT2;WNT5B;BMP4;BMP7
2992,GO:0042487,0.248317208273025,0.966329691271029,2,3,regulation of odontogenesis of dentin-containing tooth,BP,FGF8;BMP4
1959,GO:0030155,0.248994638452988,0.870715240780899,9,24,regulation of cell adhesion,BP,PIK3CG;JAG2;CDH1;FZD7;BMP4;PIK3CA;BMP7;FSTL3;NOTCH1
1814,GO:0019953,0.249063742167635,0.877369205272316,8,20,sexual reproduction,BP,SLC2A14;WNT3;JAG2;INHBB;BMP4;FSTL3;SPTBN4;NOTCH1
4625,GO:0060993,0.249221621539809,0.892755541242554,6,14,kidney morphogenesis,BP,WNT7B;FGF8;WNK4;BMP4;GDNF;BMP7
464,GO:0003337,0.249936182718224,0.965945217560885,2,3,mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,BMP4;GDNF
5150,GO:0072283,0.249936182718224,0.965945217560885,2,3,metanephric renal vesicle morphogenesis,BP,BMP4;GDNF
956,GO:0007166,0.250035748141338,0.833077696363074,28,82,cell surface receptor signaling pathway,BP,TLE1;WNT7A;CLDN18;BMP6;WNT3;HEY1;WNT7B;JAG2;PMAIP1;AXIN1;MAPK12;WNT2;FZD7;FGF8;CRB2;WNT5B;INHBB;CCL20;FGF17;TSPAN15;HRAS;BMP4;GDNF;PIK3CA;BMP7;FSTL3;TSPAN13;NOTCH1
2717,GO:0035282,0.250412641322371,0.933381804641343,3,6,segmentation,BP,CRB2;BMP4;NOTCH1
1980,GO:0030217,0.250584902716404,0.933310352299927,3,6,T cell differentiation,BP,JAG2;FZD7;BMP4
2681,GO:0035019,0.251314063974503,0.965616287324137,2,3,somatic stem cell population maintenance,BP,WNT7A;BMP7
4357,GO:0060054,0.251623819553864,0.965542125021488,2,3,positive regulation of epithelial cell proliferation involved in wound healing,BP,WNT7A;FZD7
3511,GO:0045682,0.252220988186331,0.932630099145584,3,6,regulation of epidermis development,BP,VDR;BMP4;NOTCH1
2106,GO:0030863,0.25292074486565,0.912734673930931,4,9,cortical cytoskeleton,CC,CDH1;SPTBN5;SPTB;SPTBN4
2107,GO:0030864,0.25292074486565,0.912734673930931,4,9,cortical actin cytoskeleton,CC,CDH1;SPTBN5;SPTB;SPTBN4
2692,GO:0035091,0.253229419635287,0.932209351149443,3,6,phosphatidylinositol binding,MF,SCIN;SYT5;FZD7
5657,GO:1901981,0.253229419635287,0.932209351149443,3,6,phosphatidylinositol phosphate binding,MF,SCIN;SYT5;FZD7
5754,GO:1902936,0.253229419635287,0.932209351149443,3,6,phosphatidylinositol bisphosphate binding,MF,SCIN;SYT5;FZD7
722,GO:0006006,0.254019362394058,0.931878984466688,3,6,glucose metabolic process,BP,ACTN3;PMAIP1;PIK3CA
2000,GO:0030282,0.254745586824333,0.93157466206652,3,6,bone mineralization,BP,BMP6;BMP4;BMP7
2032,GO:0030500,0.254745586824333,0.93157466206652,3,6,regulation of bone mineralization,BP,BMP6;BMP4;BMP7
2033,GO:0030501,0.254745586824333,0.93157466206652,3,6,positive regulation of bone mineralization,BP,BMP6;BMP4;BMP7
2893,GO:0040007,0.254856733405317,0.858637554707756,11,29,growth,BP,WNT7A;ACTN3;WNT3;WNT7B;WNT2;FZD7;FGF8;BMP4;PIK3CA;SPTBN4;NOTCH1
3673,GO:0046824,0.25495625410984,0.93148627426384,3,6,positive regulation of nucleocytoplasmic transport,BP,BMP6;CDH1;BMP4
1249,GO:0009892,0.256616122358978,0.842525244435763,16,45,negative regulation of metabolic process,BP,TLE1;PIK3CG;ACTN3;BMP6;HEY1;AXIN1;VDR;CRB2;DUSP5;INHBB;PKP1;HRAS;BMP4;PIK3CA;BMP7;NOTCH1
3174,GO:0043412,0.256665128461051,0.828484745270861,27,79,macromolecule modification,BP,MAGEC2;WNT7A;PIK3CG;BMP6;WNT7B;AXIN1;MAPK12;SPTBN5;RAB40B;SPTB;FZD7;FGF8;ARTN;WNK4;DUSP5;INHBB;CCL20;PKN3;FGF17;HRAS;BMP4;RAB3D;GDNF;RNF144A;PIK3CA;BMP7;SPTBN4
68,GO:0001071,0.25714285061429,0.910590421732413,4,9,nucleic acid binding transcription factor activity,MF,HEY1;POU3F1;VDR;NOTCH1
485,GO:0003700,0.25714285061429,0.910590421732413,4,9,transcription factor activity, sequence-specific DNA binding,MF,HEY1;POU3F1;VDR;NOTCH1
4065,GO:0051046,0.257331262863576,0.866107596628827,9,23,regulation of secretion,BP,SCIN;SYT5;BMP6;KCNG2;WNK4;INHBB;RAB3D;GDNF;NOTCH1
1969,GO:0030178,0.257866461750553,0.910220928532686,4,9,negative regulation of Wnt signaling pathway,BP,TLE1;AXIN1;WNT5B;NOTCH1
4101,GO:0051153,0.258362238879453,0.930050496917415,3,6,regulation of striated muscle cell differentiation,BP,FZD7;BMP4;NOTCH1
4405,GO:0060249,0.259140579176773,0.929720603368811,3,6,anatomical structure homeostasis,BP,CLDN18;RAB3D;TF
4455,GO:0060412,0.259281867378783,0.929660648093724,3,6,ventricular septum morphogenesis,BP,HEY1;BMP4;NOTCH1
1229,GO:0009725,0.259719361908891,0.858636577833546,10,27,response to hormone,BP,GJB2;BMP6;HEY1;WNT7B;VDR;INHBB;BMP4;PIK3CA;BMP7;NOTCH1
4693,GO:0061311,0.259727649145907,0.929471338031417,3,6,cell surface receptor signaling pathway involved in heart development,BP,HEY1;BMP4;NOTCH1
849,GO:0006793,0.2597826403143,0.826741459185423,26,76,phosphorus metabolic process,BP,WNT7A;PIK3CG;ACTN3;MBOAT2;BMP6;WNT7B;AXIN1;MAPK12;SPTBN5;SPTB;FZD7;FGF8;ARTN;WNK4;DUSP5;INHBB;CCL20;PKN3;FGF17;HRAS;BMP4;GDNF;PIK3CA;BMP7;SPTBN4;GUCY1B3
5592,GO:1901343,0.259907784312493,0.909175430089945,4,9,negative regulation of vasculature development,BP,AMOT;BMP4;BMP7;NOTCH1
3279,GO:0044248,0.260261533171725,0.863101002803721,9,24,cellular catabolic process,BP,MAGEC2;GLDC;PIK3CG;PMAIP1;AXIN1;RAB39A;PKP1;RNF144A;PIK3CA
5281,GO:0090189,0.261512667338073,0.963132487727434,2,3,regulation of branching involved in ureteric bud morphogenesis,BP,BMP4;GDNF
4641,GO:0061035,0.262435529311798,0.928316690574595,3,6,regulation of cartilage development,BP,SCIN;BMP6;BMP4
3173,GO:0043410,0.264562864667503,0.856124078021826,10,26,positive regulation of MAPK cascade,BP,WNT7A;PIK3CG;WNT7B;AXIN1;FZD7;FGF8;DUSP5;CCL20;HRAS;BMP4
2648,GO:0034641,0.264628052042748,0.825611680621884,23,67,cellular nitrogen compound metabolic process,BP,TLE1;WNT7A;ACTN3;BMP6;HEY1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;CRB2;PKP1;HRAS;BMP4;GDNF;PIK3CA;BMP7;FSTL3;NOTCH1;GUCY1B3
2366,GO:0032386,0.265940259459434,0.891555655498856,5,12,regulation of intracellular transport,BP,BMP6;CDH1;FZD7;BMP4;BMP7
2487,GO:0032880,0.266029099334007,0.854224074773622,10,27,regulation of protein localization,BP,WNT7A;CLDN18;BMP6;PMAIP1;KCNG2;CDH1;FZD7;INHBB;BMP4;BMP7
2475,GO:0032835,0.26763646728058,0.926076370814151,3,6,glomerulus development,BP,BMP4;BMP7;NOTCH1
4722,GO:0061437,0.26763646728058,0.926076370814151,3,6,renal system vasculature development,BP,BMP4;BMP7;NOTCH1
4725,GO:0061440,0.26763646728058,0.926076370814151,3,6,kidney vasculature development,BP,BMP4;BMP7;NOTCH1
5041,GO:0072012,0.26763646728058,0.926076370814151,3,6,glomerulus vasculature development,BP,BMP4;BMP7;NOTCH1
5085,GO:0072109,0.26763646728058,0.926076370814151,3,6,glomerular mesangium development,BP,BMP4;BMP7;NOTCH1
3833,GO:0048592,0.268692261929446,0.904623235176382,4,9,eye morphogenesis,BP,AXIN1;WNT2;BMP4;BMP7
516,GO:0004674,0.27087449902564,0.888700893787374,5,12,protein serine/threonine kinase activity,MF,PIK3CG;MAPK12;WNK4;PKN3;PIK3CA
696,GO:0005911,0.270994149740565,0.846424826110727,11,30,cell-cell junction,CC,TJP3;GJB2;CLDN18;GJA3;GJB6;CDH1;DSG3;AMOT;WNK4;PKP1;CLDN15
4315,GO:0055037,0.271212780764634,0.924518570171821,3,6,recycling endosome,CC,SYT5;FZD7;TF
3730,GO:0048018,0.272598954467674,0.923910973973026,3,6,receptor agonist activity,MF,WNT7A;WNT3;WNT2
4402,GO:0060231,0.272950512066629,0.923756539776418,3,6,mesenchymal to epithelial transition,BP,FZD7;BMP4;GDNF
1216,GO:0009607,0.273331343785318,0.868903509043266,7,17,response to biotic stimulus,BP,GJB2;BMP6;GJB6;PMAIP1;CCL20;HRAS;NOTCH1
3112,GO:0043207,0.273331343785318,0.868903509043266,7,17,response to external biotic stimulus,BP,GJB2;BMP6;GJB6;PMAIP1;CCL20;HRAS;NOTCH1
4244,GO:0051707,0.273331343785318,0.868903509043266,7,17,response to other organism,BP,GJB2;BMP6;GJB6;PMAIP1;CCL20;HRAS;NOTCH1
3926,GO:0048871,0.273386140459271,0.887237570284951,5,12,multicellular organismal homeostasis,BP,CLDN18;BMP6;RAB3D;PIK3CA;TF
5204,GO:0072676,0.273794054722749,0.923385426787103,3,6,lymphocyte migration,BP,PIK3CG;ARTN;CCL20
3646,GO:0046620,0.273804332264131,0.923380900378792,3,6,regulation of organ growth,BP,WNT2;FGF8;NOTCH1
3647,GO:0046622,0.273804332264131,0.923380900378792,3,6,positive regulation of organ growth,BP,WNT2;FGF8;NOTCH1
805,GO:0006605,0.274242093312359,0.886737309075885,5,12,protein targeting,BP,BMP6;CDH1;FZD7;BMP4;BMP7
3078,GO:0043067,0.274474093806426,0.828991842011068,16,45,regulation of programmed cell death,BP,SCIN;TLE1;WNT7A;PIK3CG;ACTN3;BMP6;PMAIP1;FGF8;VDR;INHBB;HRAS;BMP4;GDNF;PIK3CA;BMP7;NOTCH1
999,GO:0007283,0.275140114516167,0.901227080810358,4,9,spermatogenesis,BP,SLC2A14;JAG2;FSTL3;NOTCH1
3753,GO:0048232,0.275140114516167,0.901227080810358,4,9,male gamete generation,BP,SLC2A14;JAG2;FSTL3;NOTCH1
1447,GO:0012505,0.275517133662617,0.815039309800358,25,73,endomembrane system,CC,WNT7A;SYT5;MBOAT2;WNT3;WNT7B;CDH1;RAB40B;RAB39A;SPTB;RRAS2;FZD7;WNT5B;PKN3;PKP1;TSPAN15;HRAS;RAB3D;RNF144A;RAB38;FSTL3;TPD52;NOTCH1;RND3;RAB20;TF
1712,GO:0017157,0.276059785520754,0.922384734905916,3,6,regulation of exocytosis,BP,SYT5;RAB3D;NOTCH1
975,GO:0007219,0.276790154550449,0.900350526100631,4,9,Notch signaling pathway,BP,HEY1;JAG2;BMP7;NOTCH1
222,GO:0002065,0.277107458462565,0.885056845271065,5,12,columnar/cuboidal epithelial cell differentiation,BP,BMP6;JAG2;FGF8;BMP4;NOTCH1
2645,GO:0034622,0.277586173518966,0.884775220038044,5,12,cellular macromolecular complex assembly,BP,SCIN;AXIN1;SPTBN5;SPTB;SPTBN4
3236,GO:0043623,0.277586173518966,0.884775220038044,5,12,cellular protein complex assembly,BP,SCIN;AXIN1;SPTBN5;SPTB;SPTBN4
1963,GO:0030163,0.278112137594526,0.899646051432105,4,9,protein catabolic process,BP,MAGEC2;PMAIP1;AXIN1;RNF144A
5423,GO:0098552,0.278261641351606,0.884377422184891,5,12,side of membrane,CC,CDH1;SPTB;FGF8;AMOT;TF
3505,GO:0045666,0.280180307686806,0.898540022427814,4,9,positive regulation of neuron differentiation,BP,BMP6;WNT3;BMP4;BMP7
4678,GO:0061180,0.281110189489129,0.898041176637951,4,9,mammary gland epithelium development,BP,WNT3;WNT7B;WNT2;VDR
3534,GO:0045778,0.281235650764828,0.897973797498167,4,9,positive regulation of ossification,BP,BMP6;WNT7B;BMP4;BMP7
3210,GO:0043542,0.281363054581844,0.882544560057843,5,12,endothelial cell migration,BP,WNT7A;AMOT;BMP4;PIK3CA;NOTCH1
5946,GO:1905332,0.282192396184861,0.9196476745941,3,6,positive regulation of morphogenesis of an epithelium,BP,WNT2;BMP4;GDNF
4519,GO:0060571,0.282203661593712,0.919642608339057,3,6,morphogenesis of an epithelial fold,BP,WNT2;BMP4;BMP7
4520,GO:0060572,0.282203661593712,0.919642608339057,3,6,morphogenesis of an epithelial bud,BP,WNT2;BMP4;BMP7
1894,GO:0022607,0.28254048583297,0.816736638121698,19,55,cellular component assembly,BP,SCIN;TLE1;WNT7A;GJB2;ACTN3;PMAIP1;KCNG2;AXIN1;CDH1;SPTBN5;RAB39A;SPTB;PKP1;HRAS;RAB38;BMP7;SPTBN4;NOTCH1;RAB20
1022,GO:0007422,0.283058266846249,0.919257866477749,3,6,peripheral nervous system development,BP,POU3F1;ARTN;GDNF
3264,GO:0044087,0.283146972945844,0.847259619375199,9,24,regulation of cellular component biogenesis,BP,SCIN;WNT7A;PMAIP1;SPTBN5;SPTB;HRAS;BMP7;SPTBN4;NOTCH1
3704,GO:0046914,0.283309989353901,0.881388621811717,5,12,transition metal ion binding,MF,RABIF;VDR;RNF144A;DRP2;TF
557,GO:0005104,0.284222234966301,0.957286207373466,2,3,fibroblast growth factor receptor binding,MF,FGF8;FGF17
912,GO:0006979,0.285580196665847,0.895629697182222,4,9,response to oxidative stress,BP,GJB2;FGF8;BMP7;GUCY1B3
1757,GO:0019222,0.285844262914596,0.802166840594942,32,96,regulation of metabolic process,BP,MAGEC2;TLE1;WNT7A;PIK3CG;ACTN3;BMP6;WNT3;HEY1;WNT7B;PMAIP1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;CRB2;DUSP5;INHBB;CCL20;PKP1;HRAS;BMP4;GDNF;RNF144A;PIK3CA;BMP7;FSTL3;SPTBN4;NOTCH1
2398,GO:0032504,0.287821959666466,0.843962192967768,9,24,multicellular organism reproduction,BP,SLC2A14;GJB2;WNT3;JAG2;VDR;INHBB;BMP4;FSTL3;NOTCH1
3839,GO:0048609,0.287821959666466,0.843962192967768,9,24,multicellular organismal reproductive process,BP,SLC2A14;GJB2;WNT3;JAG2;VDR;INHBB;BMP4;FSTL3;NOTCH1
924,GO:0007030,0.288388682603517,1,1,1,Golgi organization,BP,SPTBN5
1799,GO:0019894,0.288388682603517,1,1,1,kinesin binding,MF,SPTBN5
2288,GO:0032029,0.288388682603517,1,1,1,myosin tail binding,MF,SPTBN5
2289,GO:0032036,0.288388682603517,1,1,1,myosin heavy chain binding,MF,SPTBN5
2635,GO:0034452,0.288388682603517,1,1,1,dynactin binding,MF,SPTBN5
3235,GO:0043621,0.288388682603517,1,1,1,protein self-association,MF,SPTBN5
3467,GO:0045505,0.288388682603517,1,1,1,dynein intermediate chain binding,MF,SPTBN5
4392,GO:0060170,0.288388682603517,1,1,1,ciliary membrane,CC,SPTBN5
5388,GO:0097381,0.288388682603517,1,1,1,photoreceptor disc membrane,CC,SPTBN5
218,GO:0002052,0.28839045848013,1,1,1,positive regulation of neuroblast proliferation,BP,NOTCH1
240,GO:0002193,0.28839045848013,1,1,1,MAML1-RBP-Jkappa- ICN1 complex,CC,NOTCH1
276,GO:0002328,0.28839045848013,1,1,1,pro-B cell differentiation,BP,NOTCH1
294,GO:0002437,0.28839045848013,1,1,1,inflammatory response to antigenic stimulus,BP,NOTCH1
405,GO:0003160,0.28839045848013,1,1,1,endocardium morphogenesis,BP,NOTCH1
406,GO:0003161,0.28839045848013,1,1,1,cardiac conduction system development,BP,NOTCH1
407,GO:0003162,0.28839045848013,1,1,1,atrioventricular node development,BP,NOTCH1
408,GO:0003169,0.28839045848013,1,1,1,coronary vein morphogenesis,BP,NOTCH1
430,GO:0003207,0.28839045848013,1,1,1,cardiac chamber formation,BP,NOTCH1
433,GO:0003211,0.28839045848013,1,1,1,cardiac ventricle formation,BP,NOTCH1
435,GO:0003214,0.28839045848013,1,1,1,cardiac left ventricle morphogenesis,BP,NOTCH1
436,GO:0003215,0.28839045848013,1,1,1,cardiac right ventricle morphogenesis,BP,NOTCH1
437,GO:0003219,0.28839045848013,1,1,1,cardiac right ventricle formation,BP,NOTCH1
438,GO:0003222,0.28839045848013,1,1,1,ventricular trabecula myocardium morphogenesis,BP,NOTCH1
440,GO:0003229,0.28839045848013,1,1,1,ventricular cardiac muscle tissue development,BP,NOTCH1
443,GO:0003241,0.28839045848013,1,1,1,growth involved in heart morphogenesis,BP,NOTCH1
444,GO:0003256,0.28839045848013,1,1,1,regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,NOTCH1
445,GO:0003264,0.28839045848013,1,1,1,regulation of cardioblast proliferation,BP,NOTCH1
446,GO:0003266,0.28839045848013,1,1,1,regulation of secondary heart field cardioblast proliferation,BP,NOTCH1
447,GO:0003270,0.28839045848013,1,1,1,Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation,BP,NOTCH1
449,GO:0003273,0.28839045848013,1,1,1,cell migration involved in endocardial cushion formation,BP,NOTCH1
977,GO:0007221,0.28839045848013,1,1,1,positive regulation of transcription of Notch receptor target,BP,NOTCH1
1026,GO:0007440,0.28839045848013,1,1,1,foregut morphogenesis,BP,NOTCH1
1277,GO:0010002,0.28839045848013,1,1,1,cardioblast differentiation,BP,NOTCH1
1336,GO:0010596,0.28839045848013,1,1,1,negative regulation of endothelial cell migration,BP,NOTCH1
1347,GO:0010633,0.28839045848013,1,1,1,negative regulation of epithelial cell migration,BP,NOTCH1
1404,GO:0010830,0.28839045848013,1,1,1,regulation of myotube differentiation,BP,NOTCH1
1405,GO:0010832,0.28839045848013,1,1,1,negative regulation of myotube differentiation,BP,NOTCH1
1452,GO:0014009,0.28839045848013,1,1,1,glial cell proliferation,BP,NOTCH1
1454,GO:0014014,0.28839045848013,1,1,1,negative regulation of gliogenesis,BP,NOTCH1
1512,GO:0014902,0.28839045848013,1,1,1,myotube differentiation,BP,NOTCH1
1819,GO:0021515,0.28839045848013,1,1,1,cell differentiation in spinal cord,BP,NOTCH1
1998,GO:0030279,0.28839045848013,1,1,1,negative regulation of ossification,BP,NOTCH1
2360,GO:0032354,0.28839045848013,1,1,1,response to follicle-stimulating hormone,BP,NOTCH1
2394,GO:0032495,0.28839045848013,1,1,1,response to muramyl dipeptide,BP,NOTCH1
2772,GO:0035767,0.28839045848013,1,1,1,endothelial cell chemotaxis,BP,NOTCH1
2802,GO:0035914,0.28839045848013,1,1,1,skeletal muscle cell differentiation,BP,NOTCH1
3209,GO:0043537,0.28839045848013,1,1,1,negative regulation of blood vessel endothelial cell migration,BP,NOTCH1
3247,GO:0043903,0.28839045848013,1,1,1,regulation of symbiosis, encompassing mutualism through parasitism,BP,NOTCH1
3403,GO:0045069,0.28839045848013,1,1,1,regulation of viral genome replication,BP,NOTCH1
3404,GO:0045070,0.28839045848013,1,1,1,positive regulation of viral genome replication,BP,NOTCH1
3507,GO:0045668,0.28839045848013,1,1,1,negative regulation of osteoblast differentiation,BP,NOTCH1
3515,GO:0045686,0.28839045848013,1,1,1,negative regulation of glial cell differentiation,BP,NOTCH1
3569,GO:0045920,0.28839045848013,1,1,1,negative regulation of exocytosis,BP,NOTCH1
3585,GO:0045955,0.28839045848013,1,1,1,negative regulation of calcium ion-dependent exocytosis,BP,NOTCH1
3636,GO:0046532,0.28839045848013,1,1,1,regulation of photoreceptor cell differentiation,BP,NOTCH1
3637,GO:0046533,0.28839045848013,1,1,1,negative regulation of photoreceptor cell differentiation,BP,NOTCH1
3810,GO:0048524,0.28839045848013,1,1,1,positive regulation of viral process,BP,NOTCH1
3879,GO:0048713,0.28839045848013,1,1,1,regulation of oligodendrocyte differentiation,BP,NOTCH1
3880,GO:0048715,0.28839045848013,1,1,1,negative regulation of oligodendrocyte differentiation,BP,NOTCH1
3983,GO:0050792,0.28839045848013,1,1,1,regulation of viral process,BP,NOTCH1
4305,GO:0055010,0.28839045848013,1,1,1,ventricular cardiac muscle tissue morphogenesis,BP,NOTCH1
4406,GO:0060251,0.28839045848013,1,1,1,regulation of glial cell proliferation,BP,NOTCH1
4407,GO:0060253,0.28839045848013,1,1,1,negative regulation of glial cell proliferation,BP,NOTCH1
4445,GO:0060379,0.28839045848013,1,1,1,cardiac muscle cell myoblast differentiation,BP,NOTCH1
4503,GO:0060525,0.28839045848013,1,1,1,prostate glandular acinus development,BP,NOTCH1
4504,GO:0060528,0.28839045848013,1,1,1,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,BP,NOTCH1
4568,GO:0060742,0.28839045848013,1,1,1,epithelial cell differentiation involved in prostate gland development,BP,NOTCH1
4579,GO:0060767,0.28839045848013,1,1,1,epithelial cell proliferation involved in prostate gland development,BP,NOTCH1
4580,GO:0060768,0.28839045848013,1,1,1,regulation of epithelial cell proliferation involved in prostate gland development,BP,NOTCH1
4594,GO:0060843,0.28839045848013,1,1,1,venous endothelial cell differentiation,BP,NOTCH1
4611,GO:0060947,0.28839045848013,1,1,1,cardiac vascular smooth muscle cell differentiation,BP,NOTCH1
4612,GO:0060948,0.28839045848013,1,1,1,cardiac vascular smooth muscle cell development,BP,NOTCH1
4619,GO:0060973,0.28839045848013,1,1,1,cell migration involved in heart development,BP,NOTCH1
4621,GO:0060977,0.28839045848013,1,1,1,coronary vasculature morphogenesis,BP,NOTCH1
4622,GO:0060979,0.28839045848013,1,1,1,vasculogenesis involved in coronary vascular morphogenesis,BP,NOTCH1
4623,GO:0060982,0.28839045848013,1,1,1,coronary artery morphogenesis,BP,NOTCH1
4719,GO:0061418,0.28839045848013,1,1,1,regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,NOTCH1
4720,GO:0061419,0.28839045848013,1,1,1,positive regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,NOTCH1
4936,GO:0071372,0.28839045848013,1,1,1,cellular response to follicle-stimulating hormone stimulus,BP,NOTCH1
5194,GO:0072602,0.28839045848013,1,1,1,interleukin-4 secretion,BP,NOTCH1
5249,GO:0090049,0.28839045848013,1,1,1,regulation of cell migration involved in sprouting angiogenesis,BP,NOTCH1
5250,GO:0090051,0.28839045848013,1,1,1,negative regulation of cell migration involved in sprouting angiogenesis,BP,NOTCH1
5348,GO:0097084,0.28839045848013,1,1,1,vascular smooth muscle cell development,BP,NOTCH1
5582,GO:1901201,0.28839045848013,1,1,1,regulation of extracellular matrix assembly,BP,NOTCH1
5603,GO:1901532,0.28839045848013,1,1,1,regulation of hematopoietic progenitor cell differentiation,BP,NOTCH1
5604,GO:1901533,0.28839045848013,1,1,1,negative regulation of hematopoietic progenitor cell differentiation,BP,NOTCH1
5687,GO:1902263,0.28839045848013,1,1,1,apoptotic process involved in embryonic digit morphogenesis,BP,NOTCH1
5736,GO:1902692,0.28839045848013,1,1,1,regulation of neuroblast proliferation,BP,NOTCH1
5787,GO:1903306,0.28839045848013,1,1,1,negative regulation of regulated secretory pathway,BP,NOTCH1
5839,GO:1903671,0.28839045848013,1,1,1,negative regulation of sprouting angiogenesis,BP,NOTCH1
5868,GO:1903900,0.28839045848013,1,1,1,regulation of viral life cycle,BP,NOTCH1
5869,GO:1903902,0.28839045848013,1,1,1,positive regulation of viral life cycle,BP,NOTCH1
5951,GO:1905456,0.28839045848013,1,1,1,regulation of lymphoid progenitor cell differentiation,BP,NOTCH1
5952,GO:1905457,0.28839045848013,1,1,1,negative regulation of lymphoid progenitor cell differentiation,BP,NOTCH1
6054,GO:2000179,0.28839045848013,1,1,1,positive regulation of neural precursor cell proliferation,BP,NOTCH1
6124,GO:2000737,0.28839045848013,1,1,1,negative regulation of stem cell differentiation,BP,NOTCH1
6144,GO:2000973,0.28839045848013,1,1,1,regulation of pro-B cell differentiation,BP,NOTCH1
6145,GO:2000974,0.28839045848013,1,1,1,negative regulation of pro-B cell differentiation,BP,NOTCH1
6151,GO:2001026,0.28839045848013,1,1,1,regulation of endothelial cell chemotaxis,BP,NOTCH1
6152,GO:2001027,0.28839045848013,1,1,1,negative regulation of endothelial cell chemotaxis,BP,NOTCH1
1482,GO:0014731,0.288391027864068,1,1,1,spectrin-associated cytoskeleton,CC,SPTB
2173,GO:0031235,0.288391027864068,1,1,1,intrinsic component of the cytoplasmic side of the plasma membrane,CC,SPTB
3111,GO:0043204,0.288391768996781,1,1,1,perikaryon,CC,DRP2
469,GO:0003365,0.288391877355469,1,1,1,establishment of cell polarity involved in ameboidal cell migration,BP,AMOT
1095,GO:0008180,0.288391877355469,1,1,1,COP9 signalosome,CC,AMOT
2727,GO:0035329,0.288391877355469,1,1,1,hippo signaling,BP,AMOT
3205,GO:0043532,0.288391877355469,1,1,1,angiostatin binding,MF,AMOT
2228,GO:0031624,0.288392202127719,1,1,1,ubiquitin conjugating enzyme binding,MF,RNF144A
3314,GO:0044390,0.288392202127719,1,1,1,ubiquitin-like protein conjugating enzyme binding,MF,RNF144A
4741,GO:0061630,0.288392202127719,1,1,1,ubiquitin protein ligase activity,MF,RNF144A
4745,GO:0061659,0.288392202127719,1,1,1,ubiquitin-like protein ligase activity,MF,RNF144A
1457,GO:0014028,0.288392224333758,1,1,1,notochord formation,BP,CRB2
1789,GO:0019828,0.288392224333758,1,1,1,aspartic-type endopeptidase inhibitor activity,MF,CRB2
1923,GO:0030011,0.288392224333758,1,1,1,maintenance of cell polarity,BP,CRB2
2691,GO:0035090,0.288392224333758,1,1,1,maintenance of apical/basal cell polarity,BP,CRB2
3439,GO:0045199,0.288392224333758,1,1,1,maintenance of epithelial cell apical/basal polarity,BP,CRB2
4333,GO:0055111,0.288392224333758,1,1,1,ingression involved in gastrulation with mouth forming second,BP,CRB2
920,GO:0007016,0.288392242268344,1,1,1,cytoskeletal anchoring at plasma membrane,BP,SPTBN4
1064,GO:0007628,0.288392242268344,1,1,1,adult walking behavior,BP,SPTBN4
1302,GO:0010459,0.288392242268344,1,1,1,negative regulation of heart rate,BP,SPTBN4
1626,GO:0016363,0.288392242268344,1,1,1,nuclear matrix,CC,SPTBN4
1658,GO:0016605,0.288392242268344,1,1,1,PML body,CC,SPTBN4
1864,GO:0021952,0.288392242268344,1,1,1,central nervous system projection neuron axonogenesis,BP,SPTBN4
1867,GO:0021955,0.288392242268344,1,1,1,central nervous system neuron axonogenesis,BP,SPTBN4
2556,GO:0033268,0.288392242268344,1,1,1,node of Ranvier,CC,SPTBN4
2557,GO:0033270,0.288392242268344,1,1,1,paranode region of axon,CC,SPTBN4
2631,GO:0034399,0.288392242268344,1,1,1,nuclear periphery,CC,SPTBN4
2900,GO:0040018,0.288392242268344,1,1,1,positive regulation of multicellular organism growth,BP,SPTBN4
3008,GO:0042551,0.288392242268344,1,1,1,neuron maturation,BP,SPTBN4
3103,GO:0043194,0.288392242268344,1,1,1,axon initial segment,CC,SPTBN4
3110,GO:0043203,0.288392242268344,1,1,1,axon hillock,CC,SPTBN4
3424,GO:0045161,0.288392242268344,1,1,1,neuronal ion channel clustering,BP,SPTBN4
3425,GO:0045162,0.288392242268344,1,1,1,clustering of voltage-gated sodium channels,BP,SPTBN4
4875,GO:0070852,0.288392242268344,1,1,1,cell body fiber,CC,SPTBN4
5330,GO:0090659,0.288392242268344,1,1,1,walking behavior,BP,SPTBN4
617,GO:0005521,0.288392273582907,1,1,1,lamin binding,MF,PKP1
687,GO:0005882,0.288392273582907,1,1,1,intermediate filament,CC,PKP1
1750,GO:0019215,0.288392273582907,1,1,1,intermediate filament binding,MF,PKP1
1999,GO:0030280,0.288392273582907,1,1,1,structural constituent of epidermis,MF,PKP1
3412,GO:0045103,0.288392273582907,1,1,1,intermediate filament-based process,BP,PKP1
3413,GO:0045104,0.288392273582907,1,1,1,intermediate filament cytoskeleton organization,BP,PKP1
3414,GO:0045109,0.288392273582907,1,1,1,intermediate filament organization,BP,PKP1
3415,GO:0045110,0.288392273582907,1,1,1,intermediate filament bundle assembly,BP,PKP1
3416,GO:0045111,0.288392273582907,1,1,1,intermediate filament cytoskeleton,CC,PKP1
5510,GO:0101003,0.288392273582907,1,1,1,ficolin-1-rich granule membrane,CC,PKP1
320,GO:0002675,0.288392281403641,1,1,1,positive regulation of acute inflammatory response,BP,PIK3CG
321,GO:0002679,0.288392281403641,1,1,1,respiratory burst involved in defense response,BP,PIK3CG
710,GO:0005944,0.288392281403641,1,1,1,phosphatidylinositol 3-kinase complex, class IB,CC,PIK3CG
1420,GO:0010896,0.288392281403641,1,1,1,regulation of triglyceride catabolic process,BP,PIK3CG
1421,GO:0010897,0.288392281403641,1,1,1,negative regulation of triglyceride catabolic process,BP,PIK3CG
1769,GO:0019433,0.288392281403641,1,1,1,triglyceride catabolic process,BP,PIK3CG
2324,GO:0032252,0.288392281403641,1,1,1,secretory granule localization,BP,PIK3CG
2770,GO:0035747,0.288392281403641,1,1,1,natural killer cell chemotaxis,BP,PIK3CG
3419,GO:0045123,0.288392281403641,1,1,1,cellular extravasation,BP,PIK3CG
3518,GO:0045730,0.288392281403641,1,1,1,respiratory burst,BP,PIK3CG
3625,GO:0046461,0.288392281403641,1,1,1,neutral lipid catabolic process,BP,PIK3CG
3626,GO:0046464,0.288392281403641,1,1,1,acylglycerol catabolic process,BP,PIK3CG
3634,GO:0046503,0.288392281403641,1,1,1,glycerolipid catabolic process,BP,PIK3CG
5203,GO:0072672,0.288392281403641,1,1,1,neutrophil extravasation,BP,PIK3CG
5291,GO:0090207,0.288392281403641,1,1,1,regulation of triglyceride metabolic process,BP,PIK3CG
5292,GO:0090209,0.288392281403641,1,1,1,negative regulation of triglyceride metabolic process,BP,PIK3CG
5380,GO:0097284,0.288392281403641,1,1,1,hepatocyte apoptotic process,BP,PIK3CG
2995,GO:0042492,0.288392334533887,1,1,1,gamma-delta T cell differentiation,BP,JAG2
3402,GO:0045061,0.288392334533887,1,1,1,thymic T cell selection,BP,JAG2
3649,GO:0046629,0.288392334533887,1,1,1,gamma-delta T cell activation,BP,JAG2
5979,GO:1990134,0.288392334533887,1,1,1,epithelial cell apoptotic process involved in palatal shelf morphogenesis,BP,JAG2
692,GO:0005901,0.288392357231702,1,1,1,caveola,CC,CDH1
1291,GO:0010226,0.288392357231702,1,1,1,response to lithium ion,BP,CDH1
1656,GO:0016600,0.288392357231702,1,1,1,flotillin complex,CC,CDH1
2756,GO:0035635,0.288392357231702,1,1,1,entry of bacterium into host cell,BP,CDH1
4909,GO:0071285,0.288392357231702,1,1,1,cellular response to lithium ion,BP,CDH1
4983,GO:0071680,0.288392357231702,1,1,1,response to indole-3-methanol,BP,CDH1
4984,GO:0071681,0.288392357231702,1,1,1,cellular response to indole-3-methanol,BP,CDH1
486,GO:0003707,0.288392365455983,1,1,1,steroid hormone receptor activity,MF,VDR
541,GO:0004879,0.288392365455983,1,1,1,RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,MF,VDR
606,GO:0005496,0.288392365455983,1,1,1,steroid binding,MF,VDR
607,GO:0005499,0.288392365455983,1,1,1,vitamin D binding,MF,VDR
847,GO:0006775,0.288392365455983,1,1,1,fat-soluble vitamin metabolic process,BP,VDR
1136,GO:0008434,0.288392365455983,1,1,1,calcitriol receptor activity,MF,VDR
1174,GO:0009110,0.288392365455983,1,1,1,vitamin biosynthetic process,BP,VDR
1443,GO:0010979,0.288392365455983,1,1,1,regulation of vitamin D 24-hydroxylase activity,BP,VDR
1444,GO:0010980,0.288392365455983,1,1,1,positive regulation of vitamin D 24-hydroxylase activity,BP,VDR
2043,GO:0030522,0.288392365455983,1,1,1,intracellular receptor signaling pathway,BP,VDR
2057,GO:0030656,0.288392365455983,1,1,1,regulation of vitamin metabolic process,BP,VDR
2291,GO:0032052,0.288392365455983,1,1,1,bile acid binding,MF,VDR
2598,GO:0034105,0.288392365455983,1,1,1,positive regulation of tissue remodeling,BP,VDR
2712,GO:0035257,0.288392365455983,1,1,1,nuclear hormone receptor binding,MF,VDR
2884,GO:0038181,0.288392365455983,1,1,1,bile acid receptor activity,MF,VDR
2885,GO:0038183,0.288392365455983,1,1,1,bile acid signaling pathway,BP,VDR
2886,GO:0038186,0.288392365455983,1,1,1,lithocholic acid receptor activity,MF,VDR
2968,GO:0042359,0.288392365455983,1,1,1,vitamin D metabolic process,BP,VDR
2969,GO:0042362,0.288392365455983,1,1,1,fat-soluble vitamin biosynthetic process,BP,VDR
2970,GO:0042368,0.288392365455983,1,1,1,vitamin D biosynthetic process,BP,VDR
3055,GO:0042974,0.288392365455983,1,1,1,retinoic acid receptor binding,MF,VDR
3378,GO:0044798,0.288392365455983,1,1,1,nuclear transcription factor complex,CC,VDR
3714,GO:0046965,0.288392365455983,1,1,1,retinoid X receptor binding,MF,VDR
4029,GO:0050892,0.288392365455983,1,1,1,intestinal absorption,BP,VDR
4358,GO:0060056,0.288392365455983,1,1,1,mammary gland involution,BP,VDR
4359,GO:0060057,0.288392365455983,1,1,1,apoptotic process involved in mammary gland involution,BP,VDR
4360,GO:0060058,0.288392365455983,1,1,1,positive regulation of apoptotic process involved in mammary gland involution,BP,VDR
4513,GO:0060556,0.288392365455983,1,1,1,regulation of vitamin D biosynthetic process,BP,VDR
4514,GO:0060558,0.288392365455983,1,1,1,regulation of calcidiol 1-monooxygenase activity,BP,VDR
4843,GO:0070561,0.288392365455983,1,1,1,vitamin D receptor signaling pathway,BP,VDR
4849,GO:0070644,0.288392365455983,1,1,1,vitamin D response element binding,MF,VDR
4912,GO:0071305,0.288392365455983,1,1,1,cellular response to vitamin D,BP,VDR
5325,GO:0090575,0.288392365455983,1,1,1,RNA polymerase II transcription factor complex,CC,VDR
5421,GO:0098531,0.288392365455983,1,1,1,transcription factor activity, direct ligand regulated sequence-specific DNA binding,MF,VDR
5672,GO:1902098,0.288392365455983,1,1,1,calcitriol binding,MF,VDR
5680,GO:1902121,0.288392365455983,1,1,1,lithocholic acid binding,MF,VDR
5688,GO:1902271,0.288392365455983,1,1,1,D3 vitamins binding,MF,VDR
5696,GO:1902339,0.288392365455983,1,1,1,positive regulation of apoptotic process involved in morphogenesis,BP,VDR
5753,GO:1902930,0.288392365455983,1,1,1,regulation of alcohol biosynthetic process,BP,VDR
5814,GO:1903519,0.288392365455983,1,1,1,regulation of mammary gland involution,BP,VDR
5815,GO:1903521,0.288392365455983,1,1,1,positive regulation of mammary gland involution,BP,VDR
5903,GO:1904747,0.288392365455983,1,1,1,positive regulation of apoptotic process involved in development,BP,VDR
388,GO:0003096,0.288710576356639,1,1,1,renal sodium ion transport,BP,WNK4
1099,GO:0008200,0.288710576356639,1,1,1,ion channel inhibitor activity,MF,WNK4
1383,GO:0010766,0.288710576356639,1,1,1,negative regulation of sodium ion transport,BP,WNK4
1605,GO:0016248,0.288710576356639,1,1,1,channel inhibitor activity,MF,WNK4
1703,GO:0017081,0.288710576356639,1,1,1,chloride channel regulator activity,MF,WNK4
1795,GO:0019869,0.288710576356639,1,1,1,chloride channel inhibitor activity,MF,WNK4
1960,GO:0030157,0.288710576356639,1,1,1,pancreatic juice secretion,BP,WNK4
4486,GO:0060457,0.288710576356639,1,1,1,negative regulation of digestive system process,BP,WNK4
4801,GO:0070294,0.288710576356639,1,1,1,renal sodium ion absorption,BP,WNK4
5102,GO:0072156,0.288710576356639,1,1,1,distal tubule morphogenesis,BP,WNK4
5279,GO:0090186,0.288710576356639,1,1,1,regulation of pancreatic juice secretion,BP,WNK4
5280,GO:0090188,0.288710576356639,1,1,1,negative regulation of pancreatic juice secretion,BP,WNK4
39,GO:0000303,0.289083273642784,1,1,1,response to superoxide,BP,BMP7
40,GO:0000305,0.289083273642784,1,1,1,response to oxygen radical,BP,BMP7
163,GO:0001842,0.289083273642784,1,1,1,neural fold formation,BP,BMP7
1360,GO:0010658,0.289083273642784,1,1,1,striated muscle cell apoptotic process,BP,BMP7
1362,GO:0010662,0.289083273642784,1,1,1,regulation of striated muscle cell apoptotic process,BP,BMP7
1363,GO:0010664,0.289083273642784,1,1,1,negative regulation of striated muscle cell apoptotic process,BP,BMP7
1768,GO:0019430,0.289083273642784,1,1,1,removal of superoxide radicals,BP,BMP7
1817,GO:0021502,0.289083273642784,1,1,1,neural fold elevation formation,BP,BMP7
2299,GO:0032088,0.289083273642784,1,1,1,negative regulation of NF-kappaB transcription factor activity,BP,BMP7
2601,GO:0034114,0.289083273642784,1,1,1,regulation of heterotypic cell-cell adhesion,BP,BMP7
2602,GO:0034116,0.289083273642784,1,1,1,positive regulation of heterotypic cell-cell adhesion,BP,BMP7
2835,GO:0036118,0.289083273642784,1,1,1,hyaluranon cable assembly,BP,BMP7
2965,GO:0042345,0.289083273642784,1,1,1,regulation of NF-kappaB import into nucleus,BP,BMP7
2966,GO:0042347,0.289083273642784,1,1,1,negative regulation of NF-kappaB import into nucleus,BP,BMP7
2967,GO:0042348,0.289083273642784,1,1,1,NF-kappaB import into nucleus,BP,BMP7
3060,GO:0042992,0.289083273642784,1,1,1,negative regulation of transcription factor import into nucleus,BP,BMP7
4834,GO:0070486,0.289083273642784,1,1,1,leukocyte aggregation,BP,BMP7
4835,GO:0070487,0.289083273642784,1,1,1,monocyte aggregation,BP,BMP7
4956,GO:0071450,0.289083273642784,1,1,1,cellular response to oxygen radical,BP,BMP7
4957,GO:0071451,0.289083273642784,1,1,1,cellular response to superoxide,BP,BMP7
5048,GO:0072038,0.289083273642784,1,1,1,mesenchymal stem cell maintenance involved in nephron morphogenesis,BP,BMP7
5049,GO:0072039,0.289083273642784,1,1,1,regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,BMP7
5050,GO:0072040,0.289083273642784,1,1,1,negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,BMP7
5063,GO:0072076,0.289083273642784,1,1,1,nephrogenic mesenchyme development,BP,BMP7
5092,GO:0072131,0.289083273642784,1,1,1,kidney mesenchyme morphogenesis,BP,BMP7
5094,GO:0072133,0.289083273642784,1,1,1,metanephric mesenchyme morphogenesis,BP,BMP7
5095,GO:0072134,0.289083273642784,1,1,1,nephrogenic mesenchyme morphogenesis,BP,BMP7
5096,GO:0072135,0.289083273642784,1,1,1,kidney mesenchymal cell proliferation,BP,BMP7
5097,GO:0072136,0.289083273642784,1,1,1,metanephric mesenchymal cell proliferation involved in metanephros development,BP,BMP7
5308,GO:0090322,0.289083273642784,1,1,1,regulation of superoxide metabolic process,BP,BMP7
5359,GO:0097152,0.289083273642784,1,1,1,mesenchymal cell apoptotic process,BP,BMP7
5514,GO:1900006,0.289083273642784,1,1,1,positive regulation of dendrite development,BP,BMP7
5525,GO:1900104,0.289083273642784,1,1,1,regulation of hyaluranon cable assembly,BP,BMP7
5526,GO:1900106,0.289083273642784,1,1,1,positive regulation of hyaluranon cable assembly,BP,BMP7
5578,GO:1901145,0.289083273642784,1,1,1,mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,BMP7
5695,GO:1902338,0.289083273642784,1,1,1,negative regulation of apoptotic process involved in morphogenesis,BP,BMP7
5703,GO:1902455,0.289083273642784,1,1,1,negative regulation of stem cell population maintenance,BP,BMP7
5867,GO:1903867,0.289083273642784,1,1,1,extraembryonic membrane development,BP,BMP7
5897,GO:1904672,0.289083273642784,1,1,1,regulation of somatic stem cell population maintenance,BP,BMP7
5898,GO:1904673,0.289083273642784,1,1,1,negative regulation of somatic stem cell population maintenance,BP,BMP7
5902,GO:1904746,0.289083273642784,1,1,1,negative regulation of apoptotic process involved in development,BP,BMP7
5933,GO:1905069,0.289083273642784,1,1,1,allantois development,BP,BMP7
6024,GO:2000036,0.289083273642784,1,1,1,regulation of stem cell population maintenance,BP,BMP7
6044,GO:2000121,0.289083273642784,1,1,1,regulation of removal of superoxide radicals,BP,BMP7
6155,GO:2001053,0.289083273642784,1,1,1,regulation of mesenchymal cell apoptotic process,BP,BMP7
6156,GO:2001054,0.289083273642784,1,1,1,negative regulation of mesenchymal cell apoptotic process,BP,BMP7
1619,GO:0016332,0.289528554513781,1,1,1,establishment or maintenance of polarity of embryonic epithelium,BP,WNT7B
2362,GO:0032364,0.289528554513781,1,1,1,oxygen homeostasis,BP,WNT7B
2566,GO:0033483,0.289528554513781,1,1,1,gas homeostasis,BP,WNT7B
4490,GO:0060482,0.289528554513781,1,1,1,lobar bronchus development,BP,WNT7B
4505,GO:0060534,0.289528554513781,1,1,1,trachea cartilage development,BP,WNT7B
4506,GO:0060535,0.289528554513781,1,1,1,trachea cartilage morphogenesis,BP,WNT7B
4507,GO:0060536,0.289528554513781,1,1,1,cartilage morphogenesis,BP,WNT7B
5055,GO:0072053,0.289528554513781,1,1,1,renal inner medulla development,BP,WNT7B
5056,GO:0072054,0.289528554513781,1,1,1,renal outer medulla development,BP,WNT7B
5057,GO:0072060,0.289528554513781,1,1,1,outer medullary collecting duct development,BP,WNT7B
5058,GO:0072061,0.289528554513781,1,1,1,inner medullary collecting duct development,BP,WNT7B
5141,GO:0072236,0.289528554513781,1,1,1,metanephric loop of Henle development,BP,WNT7B
3503,GO:0045664,0.289591009788798,0.865791078105584,6,15,regulation of neuron differentiation,BP,WNT7A;BMP6;WNT3;BMP4;BMP7;NOTCH1
4634,GO:0061024,0.289640022472776,0.828909725342435,12,33,membrane organization,BP,SYT5;RABIF;PMAIP1;CDH1;RAB40B;RAB39A;TSPAN15;GDNF;RAB38;SPTBN4;RAB20;TF
893,GO:0006928,0.289783293948673,0.806530019980605,22,65,movement of cell or subcellular component,BP,WNT7A;PIK3CG;ACTN3;WNT3;JAG2;SPTBN5;SPTB;RRAS2;FGF8;CRB2;ARTN;AMOT;WNT5B;CCL20;PKN3;HRAS;BMP4;GDNF;PIK3CA;BMP7;SPTBN4;NOTCH1
122,GO:0001705,0.289824135056174,1,1,1,ectoderm formation,BP,FZD7
128,GO:0001712,0.289824135056174,1,1,1,ectodermal cell fate commitment,BP,FZD7
129,GO:0001715,0.289824135056174,1,1,1,ectodermal cell fate specification,BP,FZD7
1014,GO:0007398,0.289824135056174,1,1,1,ectoderm development,BP,FZD7
1275,GO:0009996,0.289824135056174,1,1,1,negative regulation of cell fate specification,BP,FZD7
1301,GO:0010454,0.289824135056174,1,1,1,negative regulation of cell fate commitment,BP,FZD7
1364,GO:0010668,0.289824135056174,1,1,1,ectodermal cell differentiation,BP,FZD7
2734,GO:0035411,0.289824135056174,1,1,1,catenin import into nucleus,BP,FZD7
2735,GO:0035412,0.289824135056174,1,1,1,regulation of catenin import into nucleus,BP,FZD7
3028,GO:0042659,0.289824135056174,1,1,1,regulation of cell fate specification,BP,FZD7
3029,GO:0042665,0.289824135056174,1,1,1,regulation of ectodermal cell fate specification,BP,FZD7
3030,GO:0042666,0.289824135056174,1,1,1,negative regulation of ectodermal cell fate specification,BP,FZD7
6081,GO:2000383,0.289824135056174,1,1,1,regulation of ectoderm development,BP,FZD7
6082,GO:2000384,0.289824135056174,1,1,1,negative regulation of ectoderm development,BP,FZD7
6099,GO:2000542,0.289824135056174,1,1,1,negative regulation of gastrulation,BP,FZD7
566,GO:0005126,0.289925007137253,0.877430340979968,5,12,cytokine receptor binding,MF,BMP6;INHBB;CCL20;BMP4;BMP7
504,GO:0004375,0.289926014437171,1,1,1,glycine dehydrogenase (decarboxylating) activity,MF,GLDC
712,GO:0005960,0.289926014437171,1,1,1,glycine cleavage complex,CC,GLDC
800,GO:0006520,0.289926014437171,1,1,1,cellular amino acid metabolic process,BP,GLDC
801,GO:0006544,0.289926014437171,1,1,1,glycine metabolic process,BP,GLDC
802,GO:0006546,0.289926014437171,1,1,1,glycine catabolic process,BP,GLDC
1161,GO:0009055,0.289926014437171,1,1,1,electron carrier activity,MF,GLDC
1168,GO:0009063,0.289926014437171,1,1,1,cellular amino acid catabolic process,BP,GLDC
1169,GO:0009069,0.289926014437171,1,1,1,serine family amino acid metabolic process,BP,GLDC
1170,GO:0009071,0.289926014437171,1,1,1,serine family amino acid catabolic process,BP,GLDC
1654,GO:0016594,0.289926014437171,1,1,1,glycine binding,MF,GLDC
1662,GO:0016638,0.289926014437171,1,1,1,oxidoreductase activity, acting on the CH-NH2 group of donors,MF,GLDC
1663,GO:0016642,0.289926014437171,1,1,1,oxidoreductase activity, acting on the CH-NH2 group of donors, disulfide as acceptor,MF,GLDC
1772,GO:0019464,0.289926014437171,1,1,1,glycine decarboxylation via glycine cleavage system,BP,GLDC
1966,GO:0030170,0.289926014437171,1,1,1,pyridoxal phosphate binding,MF,GLDC
3631,GO:0046487,0.289926014437171,1,1,1,glyoxylate metabolic process,BP,GLDC
3734,GO:0048037,0.289926014437171,1,1,1,cofactor binding,MF,GLDC
4799,GO:0070279,0.289926014437171,1,1,1,vitamin B6 binding,MF,GLDC
5615,GO:1901605,0.289926014437171,1,1,1,alpha-amino acid metabolic process,BP,GLDC
5616,GO:1901606,0.289926014437171,1,1,1,alpha-amino acid catabolic process,BP,GLDC
5983,GO:1990204,0.289926014437171,1,1,1,oxidoreductase complex,CC,GLDC
495,GO:0003841,0.290005509993989,1,1,1,1-acylglycerol-3-phosphate O-acyltransferase activity,MF,MBOAT2
1130,GO:0008374,0.290005509993989,1,1,1,O-acyltransferase activity,MF,MBOAT2
1628,GO:0016411,0.290005509993989,1,1,1,acylglycerol O-acyltransferase activity,MF,MBOAT2
2836,GO:0036151,0.290005509993989,1,1,1,phosphatidylcholine acyl-chain remodeling,BP,MBOAT2
2837,GO:0036152,0.290005509993989,1,1,1,phosphatidylethanolamine acyl-chain remodeling,BP,MBOAT2
2938,GO:0042171,0.290005509993989,1,1,1,lysophosphatidic acid acyltransferase activity,MF,MBOAT2
3627,GO:0046470,0.290005509993989,1,1,1,phosphatidylcholine metabolic process,BP,MBOAT2
3717,GO:0047144,0.290005509993989,1,1,1,2-acylglycerol-3-phosphate O-acyltransferase activity,MF,MBOAT2
4978,GO:0071617,0.290005509993989,1,1,1,lysophospholipid acyltransferase activity,MF,MBOAT2
1896,GO:0022612,0.290196499680184,0.877266869211779,5,12,gland morphogenesis,BP,FGF8;VDR;BMP4;BMP7;NOTCH1
3788,GO:0048468,0.290200939189383,0.805041462693384,23,68,cell development,BP,WNT7A;CLDN18;BMP6;WNT3;WNT7B;AXIN1;POU3F1;WNT2;CDH1;SPTBN5;SPTB;FZD7;FGF8;ARTN;WNT5B;INHBB;HRAS;BMP4;GDNF;PIK3CA;BMP7;SPTBN4;NOTCH1
3249,GO:0043933,0.290249509062646,0.842241786502814,9,24,macromolecular complex subunit organization,BP,SCIN;TLE1;PMAIP1;KCNG2;AXIN1;SPTBN5;SPTB;HRAS;SPTBN4
5010,GO:0071822,0.290249509062646,0.842241786502814,9,24,protein complex subunit organization,BP,SCIN;TLE1;PMAIP1;KCNG2;AXIN1;SPTBN5;SPTB;HRAS;SPTBN4
760,GO:0006304,0.290534100319796,1,1,1,DNA modification,BP,PIK3CA
761,GO:0006305,0.290534100319796,1,1,1,DNA alkylation,BP,PIK3CA
762,GO:0006306,0.290534100319796,1,1,1,DNA methylation,BP,PIK3CA
2862,GO:0038028,0.290534100319796,1,1,1,insulin receptor signaling pathway via phosphatidylinositol 3-kinase,BP,PIK3CA
3253,GO:0044028,0.290534100319796,1,1,1,DNA hypomethylation,BP,PIK3CA
3254,GO:0044029,0.290534100319796,1,1,1,hypomethylation of CpG island,BP,PIK3CA
3255,GO:0044030,0.290534100319796,1,1,1,regulation of DNA methylation,BP,PIK3CA
3363,GO:0044728,0.290534100319796,1,1,1,DNA methylation or demethylation,BP,PIK3CA
4536,GO:0060612,0.290534100319796,1,1,1,adipose tissue development,BP,PIK3CA
4969,GO:0071514,0.290534100319796,1,1,1,genetic imprinting,BP,PIK3CA
6111,GO:2000653,0.290534100319796,1,1,1,regulation of genetic imprinting,BP,PIK3CA
4587,GO:0060828,0.291099768395366,0.876722413807993,5,12,regulation of canonical Wnt signaling pathway,BP,WNT7A;AXIN1;WNT2;WNT5B;NOTCH1
855,GO:0006811,0.291941962592039,0.835715203078348,10,27,ion transport,BP,PIK3CG;KCNG2;VDR;WNK4;KCNK6;CLDN15;GDNF;SPTBN4;TSPAN13;TF
3853,GO:0048646,0.292205353609873,0.81490330699344,16,46,anatomical structure formation involved in morphogenesis,BP,WNT7A;PIK3CG;WNT3;HEY1;AXIN1;WNT2;FZD7;FGF8;CRB2;AMOT;DUSP5;BMP4;GDNF;PIK3CA;BMP7;NOTCH1
856,GO:0006812,0.29222207185216,0.840839720035096,9,24,cation transport,BP,PIK3CG;KCNG2;VDR;WNK4;KCNK6;GDNF;SPTBN4;TSPAN13;TF
3574,GO:0045930,0.292588103367636,0.914912523687821,3,6,negative regulation of mitotic cell cycle,BP,HRAS;BMP4;BMP7
940,GO:0007088,0.292931792936461,0.914753919935582,3,6,regulation of mitotic nuclear division,BP,FGF8;BMP4;BMP7
1240,GO:0009799,0.293382077671436,0.891367173066336,4,9,specification of symmetry,BP,AXIN1;FGF8;BMP4;NOTCH1
134,GO:0001743,0.293399399048751,1,1,1,optic placode formation,BP,AXIN1
767,GO:0006354,0.293399399048751,1,1,1,DNA-templated transcription, elongation,BP,AXIN1
773,GO:0006368,0.293399399048751,1,1,1,transcription elongation from RNA polymerase II promoter,BP,AXIN1
1848,GO:0021797,0.293399399048751,1,1,1,forebrain anterior/posterior pattern specification,BP,AXIN1
1853,GO:0021877,0.293399399048751,1,1,1,forebrain neuron fate commitment,BP,AXIN1
1855,GO:0021881,0.293399399048751,1,1,1,Wnt-activated signaling pathway involved in forebrain neuron fate commitment,BP,AXIN1
1860,GO:0021898,0.293399399048751,1,1,1,commitment of multipotent stem cells to neuronal lineage in forebrain,BP,AXIN1
1873,GO:0021999,0.293399399048751,1,1,1,neural plate anterior/posterior regionalization,BP,AXIN1
1961,GO:0030159,0.293399399048751,1,1,1,receptor signaling complex scaffold activity,MF,AXIN1
2111,GO:0030877,0.293399399048751,1,1,1,beta-catenin destruction complex,CC,AXIN1
2121,GO:0030910,0.293399399048751,1,1,1,olfactory placode formation,BP,AXIN1
2462,GO:0032784,0.293399399048751,1,1,1,regulation of DNA-templated transcription, elongation,BP,AXIN1
2463,GO:0032785,0.293399399048751,1,1,1,negative regulation of DNA-templated transcription, elongation,BP,AXIN1
2506,GO:0032947,0.293399399048751,1,1,1,protein complex scaffold,MF,AXIN1
2610,GO:0034243,0.293399399048751,1,1,1,regulation of transcription elongation from RNA polymerase II promoter,BP,AXIN1
2611,GO:0034244,0.293399399048751,1,1,1,negative regulation of transcription elongation from RNA polymerase II promoter,BP,AXIN1
3774,GO:0048318,0.293399399048751,1,1,1,axial mesoderm development,BP,AXIN1
3775,GO:0048319,0.293399399048751,1,1,1,axial mesoderm morphogenesis,BP,AXIN1
3776,GO:0048320,0.293399399048751,1,1,1,axial mesoderm formation,BP,AXIN1
4582,GO:0060788,0.293399399048751,1,1,1,ectodermal placode formation,BP,AXIN1
4586,GO:0060823,0.293399399048751,1,1,1,canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,AXIN1
4603,GO:0060896,0.293399399048751,1,1,1,neural plate pattern specification,BP,AXIN1
4604,GO:0060897,0.293399399048751,1,1,1,neural plate regionalization,BP,AXIN1
4757,GO:0070016,0.293399399048751,1,1,1,armadillo repeat domain binding,MF,AXIN1
4827,GO:0070411,0.293399399048751,1,1,1,I-SMAD binding,MF,AXIN1
4987,GO:0071696,0.293399399048751,1,1,1,ectodermal placode development,BP,AXIN1
4988,GO:0071697,0.293399399048751,1,1,1,ectodermal placode morphogenesis,BP,AXIN1
4989,GO:0071698,0.293399399048751,1,1,1,olfactory placode development,BP,AXIN1
4990,GO:0071699,0.293399399048751,1,1,1,olfactory placode morphogenesis,BP,AXIN1
5911,GO:1904885,0.293399399048751,1,1,1,beta-catenin destruction complex assembly,BP,AXIN1
5912,GO:1904886,0.293399399048751,1,1,1,beta-catenin destruction complex disassembly,BP,AXIN1
6030,GO:2000058,0.293399399048751,1,1,1,regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,BP,AXIN1
6031,GO:2000060,0.293399399048751,1,1,1,positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,BP,AXIN1
520,GO:0004697,0.29347406461679,1,1,1,protein kinase C activity,MF,PKN3
2597,GO:0034104,0.29393129002871,1,1,1,negative regulation of tissue remodeling,BP,CLDN18
2828,GO:0036035,0.29393129002871,1,1,1,osteoclast development,BP,CLDN18
3420,GO:0045124,0.29393129002871,1,1,1,regulation of bone resorption,BP,CLDN18
3535,GO:0045779,0.29393129002871,1,1,1,negative regulation of bone resorption,BP,CLDN18
3680,GO:0046850,0.29393129002871,1,1,1,regulation of bone remodeling,BP,CLDN18
3681,GO:0046851,0.29393129002871,1,1,1,negative regulation of bone remodeling,BP,CLDN18
5012,GO:0071847,0.29393129002871,1,1,1,TNFSF11-mediated signaling pathway,BP,CLDN18
5758,GO:1903010,0.29393129002871,1,1,1,regulation of bone development,BP,CLDN18
5759,GO:1903011,0.29393129002871,1,1,1,negative regulation of bone development,BP,CLDN18
6164,GO:2001204,0.29393129002871,1,1,1,regulation of osteoclast development,BP,CLDN18
6165,GO:2001205,0.29393129002871,1,1,1,negative regulation of osteoclast development,BP,CLDN18
1374,GO:0010720,0.294182093885521,0.862841228199598,6,15,positive regulation of cell development,BP,BMP6;WNT3;WNT2;BMP4;BMP7;NOTCH1
1531,GO:0015267,0.294287050232608,0.890868332616046,4,9,channel activity,MF,GJB2;GJA3;KCNG2;KCNK6
1899,GO:0022803,0.294287050232608,0.890868332616046,4,9,passive transmembrane transporter activity,MF,GJB2;GJA3;KCNG2;KCNK6
5908,GO:1904837,0.294860952605578,1,1,1,beta-catenin-TCF complex assembly,BP,TLE1
755,GO:0006260,0.294866158460179,0.913858799655983,3,6,DNA replication,BP,BMP6;HRAS;BMP4
757,GO:0006275,0.294866158460179,0.913858799655983,3,6,regulation of DNA replication,BP,BMP6;HRAS;BMP4
3523,GO:0045740,0.294866158460179,0.913858799655983,3,6,positive regulation of DNA replication,BP,BMP6;HRAS;BMP4
987,GO:0007263,0.295201992263057,1,1,1,nitric oxide mediated signal transduction,BP,GUCY1B3
1811,GO:0019934,0.295201992263057,1,1,1,cGMP-mediated signaling,BP,GUCY1B3
1812,GO:0019935,0.295201992263057,1,1,1,cyclic-nucleotide-mediated signaling,BP,GUCY1B3
2866,GO:0038060,0.295201992263057,1,1,1,nitric oxide-cGMP-mediated signaling pathway,BP,GUCY1B3
4997,GO:0071731,0.295201992263057,1,1,1,response to nitric oxide,BP,GUCY1B3
4998,GO:0071732,0.295201992263057,1,1,1,cellular response to nitric oxide,BP,GUCY1B3
5681,GO:1902170,0.295201992263057,1,1,1,cellular response to reactive nitrogen species,BP,GUCY1B3
3630,GO:0046486,0.29560118362065,0.873995905555907,5,12,glycerolipid metabolic process,BP,PIK3CG;MBOAT2;FGF8;FGF17;PIK3CA
2071,GO:0030728,0.296018088240778,1,1,1,ovulation,BP,INHBB
2332,GO:0032274,0.296018088240778,1,1,1,gonadotropin secretion,BP,INHBB
2333,GO:0032276,0.296018088240778,1,1,1,regulation of gonadotropin secretion,BP,INHBB
2334,GO:0032277,0.296018088240778,1,1,1,negative regulation of gonadotropin secretion,BP,INHBB
2335,GO:0032278,0.296018088240778,1,1,1,positive regulation of gonadotropin secretion,BP,INHBB
2417,GO:0032605,0.296018088240778,1,1,1,hepatocyte growth factor production,BP,INHBB
2430,GO:0032646,0.296018088240778,1,1,1,regulation of hepatocyte growth factor production,BP,INHBB
2441,GO:0032686,0.296018088240778,1,1,1,negative regulation of hepatocyte growth factor production,BP,INHBB
3302,GO:0044320,0.296018088240778,1,1,1,cellular response to leptin stimulus,BP,INHBB
3656,GO:0046676,0.296018088240778,1,1,1,negative regulation of insulin secretion,BP,INHBB
3667,GO:0046789,0.296018088240778,1,1,1,host cell surface receptor binding,MF,INHBB
3669,GO:0046812,0.296018088240778,1,1,1,host cell surface binding,MF,INHBB
3688,GO:0046880,0.296018088240778,1,1,1,regulation of follicle-stimulating hormone secretion,BP,INHBB
3689,GO:0046881,0.296018088240778,1,1,1,positive regulation of follicle-stimulating hormone secretion,BP,INHBB
3690,GO:0046882,0.296018088240778,1,1,1,negative regulation of follicle-stimulating hormone secretion,BP,INHBB
3692,GO:0046884,0.296018088240778,1,1,1,follicle-stimulating hormone secretion,BP,INHBB
3747,GO:0048175,0.296018088240778,1,1,1,hepatocyte growth factor biosynthetic process,BP,INHBB
3748,GO:0048176,0.296018088240778,1,1,1,regulation of hepatocyte growth factor biosynthetic process,BP,INHBB
3749,GO:0048178,0.296018088240778,1,1,1,negative regulation of hepatocyte growth factor biosynthetic process,BP,INHBB
4411,GO:0060278,0.296018088240778,1,1,1,regulation of ovulation,BP,INHBB
4412,GO:0060279,0.296018088240778,1,1,1,positive regulation of ovulation,BP,INHBB
5298,GO:0090278,0.296018088240778,1,1,1,negative regulation of peptide hormone secretion,BP,INHBB
2012,GO:0030323,0.296181786782955,0.861549481036835,6,15,respiratory tube development,BP,WNT7B;WNT2;FGF8;BMP4;FSTL3;NOTCH1
2013,GO:0030324,0.296181786782955,0.861549481036835,6,15,lung development,BP,WNT7B;WNT2;FGF8;BMP4;FSTL3;NOTCH1
5036,GO:0072006,0.296974857707357,0.851532097497603,7,18,nephron development,BP,WNT7B;FGF8;WNK4;BMP4;GDNF;BMP7;NOTCH1
362,GO:0002831,0.297478416983652,1,1,1,regulation of response to biotic stimulus,BP,BMP6
363,GO:0002833,0.297478416983652,1,1,1,positive regulation of response to biotic stimulus,BP,BMP6
2240,GO:0031664,0.297478416983652,1,1,1,regulation of lipopolysaccharide-mediated signaling pathway,BP,BMP6
2241,GO:0031666,0.297478416983652,1,1,1,positive regulation of lipopolysaccharide-mediated signaling pathway,BP,BMP6
2287,GO:0032026,0.297478416983652,1,1,1,response to magnesium ion,BP,BMP6
2347,GO:0032332,0.297478416983652,1,1,1,positive regulation of chondrocyte differentiation,BP,BMP6
2804,GO:0035929,0.297478416983652,1,1,1,steroid hormone secretion,BP,BMP6
2805,GO:0035930,0.297478416983652,1,1,1,corticosteroid hormone secretion,BP,BMP6
2806,GO:0035931,0.297478416983652,1,1,1,mineralocorticoid secretion,BP,BMP6
2807,GO:0035932,0.297478416983652,1,1,1,aldosterone secretion,BP,BMP6
4526,GO:0060586,0.297478416983652,1,1,1,multicellular organismal iron ion homeostasis,BP,BMP6
6136,GO:2000831,0.297478416983652,1,1,1,regulation of steroid hormone secretion,BP,BMP6
6137,GO:2000833,0.297478416983652,1,1,1,positive regulation of steroid hormone secretion,BP,BMP6
6138,GO:2000846,0.297478416983652,1,1,1,regulation of corticosteroid hormone secretion,BP,BMP6
6139,GO:2000848,0.297478416983652,1,1,1,positive regulation of corticosteroid hormone secretion,BP,BMP6
6140,GO:2000855,0.297478416983652,1,1,1,regulation of mineralocorticoid secretion,BP,BMP6
6141,GO:2000857,0.297478416983652,1,1,1,positive regulation of mineralocorticoid secretion,BP,BMP6
6142,GO:2000858,0.297478416983652,1,1,1,regulation of aldosterone secretion,BP,BMP6
6143,GO:2000860,0.297478416983652,1,1,1,positive regulation of aldosterone secretion,BP,BMP6
2361,GO:0032355,0.297810910910053,0.912488093184297,3,6,response to estradiol,BP,WNT7A;GJB2;BMP7
2149,GO:0031098,0.298406259401217,0.872285724225322,5,12,stress-activated protein kinase signaling cascade,BP,WNT7A;WNT7B;AXIN1;FZD7;HRAS
2483,GO:0032872,0.298406259401217,0.872285724225322,5,12,regulation of stress-activated MAPK cascade,BP,WNT7A;WNT7B;AXIN1;FZD7;HRAS
4188,GO:0051403,0.298406259401217,0.872285724225322,5,12,stress-activated MAPK cascade,BP,WNT7A;WNT7B;AXIN1;FZD7;HRAS
4804,GO:0070302,0.298406259401217,0.872285724225322,5,12,regulation of stress-activated protein kinase signaling cascade,BP,WNT7A;WNT7B;AXIN1;FZD7;HRAS
155,GO:0001822,0.298971419964387,0.836014558165929,9,24,kidney development,BP,BMP6;WNT7B;FGF8;WNK4;BMP4;GDNF;BMP7;FSTL3;NOTCH1
2207,GO:0031410,0.299006893785077,0.802064380315709,20,58,cytoplasmic vesicle,CC,WNT7A;SYT5;WNT3;WNT7B;AXIN1;CDH1;RAB40B;RAB39A;FZD7;AMOT;WNT5B;PKP1;TSPAN15;RAB3D;RNF144A;RAB38;FSTL3;NOTCH1;RAB20;TF
5411,GO:0097708,0.299006893785077,0.802064380315709,20,58,intracellular vesicle,CC,WNT7A;SYT5;WNT3;WNT7B;AXIN1;CDH1;RAB40B;RAB39A;FZD7;AMOT;WNT5B;PKP1;TSPAN15;RAB3D;RNF144A;RAB38;FSTL3;NOTCH1;RAB20;TF
1968,GO:0030177,0.299161468404184,0.88816565325577,4,9,positive regulation of Wnt signaling pathway,BP,WNT7A;WNT3;AXIN1;WNT2
1962,GO:0030162,0.299775616246343,0.871447753808381,5,12,regulation of proteolysis,BP,PMAIP1;AXIN1;MAPK12;CRB2;RNF144A
76,GO:0001105,0.300694071626718,1,1,1,RNA polymerase II transcription coactivator activity,MF,POU3F1
236,GO:0002102,0.300856296944682,1,1,1,podosome,CC,SCIN
625,GO:0005545,0.300856296944682,1,1,1,1-phosphatidylinositol binding,MF,SCIN
2097,GO:0030838,0.300856296944682,1,1,1,positive regulation of actin filament polymerization,BP,SCIN
3057,GO:0042989,0.300856296944682,1,1,1,sequestering of actin monomers,BP,SCIN
3393,GO:0045010,0.300856296944682,1,1,1,actin nucleation,BP,SCIN
3499,GO:0045652,0.300856296944682,1,1,1,regulation of megakaryocyte differentiation,BP,SCIN
3500,GO:0045654,0.300856296944682,1,1,1,positive regulation of megakaryocyte differentiation,BP,SCIN
4058,GO:0051014,0.300856296944682,1,1,1,actin filament severing,BP,SCIN
4089,GO:0051125,0.300856296944682,1,1,1,regulation of actin nucleation,BP,SCIN
4090,GO:0051127,0.300856296944682,1,1,1,positive regulation of actin nucleation,BP,SCIN
2988,GO:0042475,0.301382537776752,0.886925312120795,4,9,odontogenesis of dentin-containing tooth,BP,JAG2;FGF8;BMP4;BMP7
230,GO:0002082,0.301683026080401,1,1,1,regulation of oxidative phosphorylation,BP,ACTN3
372,GO:0003009,0.301683026080401,1,1,1,skeletal muscle contraction,BP,ACTN3
734,GO:0006089,0.301683026080401,1,1,1,lactate metabolic process,BP,ACTN3
740,GO:0006110,0.301683026080401,1,1,1,regulation of glycolytic process,BP,ACTN3
743,GO:0006113,0.301683026080401,1,1,1,fermentation,BP,ACTN3
744,GO:0006119,0.301683026080401,1,1,1,oxidative phosphorylation,BP,ACTN3
1166,GO:0009060,0.301683026080401,1,1,1,aerobic respiration,BP,ACTN3
1367,GO:0010677,0.301683026080401,1,1,1,negative regulation of cellular carbohydrate metabolic process,BP,ACTN3
1481,GO:0014728,0.301683026080401,1,1,1,regulation of the force of skeletal muscle contraction,BP,ACTN3
1483,GO:0014732,0.301683026080401,1,1,1,skeletal muscle atrophy,BP,ACTN3
1484,GO:0014733,0.301683026080401,1,1,1,regulation of skeletal muscle adaptation,BP,ACTN3
1490,GO:0014819,0.301683026080401,1,1,1,regulation of skeletal muscle contraction,BP,ACTN3
1498,GO:0014854,0.301683026080401,1,1,1,response to inactivity,BP,ACTN3
1500,GO:0014862,0.301683026080401,1,1,1,regulation of skeletal muscle contraction by chemo-mechanical energy conversion,BP,ACTN3
1502,GO:0014870,0.301683026080401,1,1,1,response to muscle inactivity,BP,ACTN3
1503,GO:0014874,0.301683026080401,1,1,1,response to stimulus involved in regulation of muscle adaptation,BP,ACTN3
1504,GO:0014877,0.301683026080401,1,1,1,response to muscle inactivity involved in regulation of muscle adaptation,BP,ACTN3
1505,GO:0014883,0.301683026080401,1,1,1,transition between fast and slow fiber,BP,ACTN3
1506,GO:0014888,0.301683026080401,1,1,1,striated muscle adaptation,BP,ACTN3
1507,GO:0014889,0.301683026080401,1,1,1,muscle atrophy,BP,ACTN3
1508,GO:0014891,0.301683026080401,1,1,1,striated muscle atrophy,BP,ACTN3
1509,GO:0014894,0.301683026080401,1,1,1,response to denervation involved in regulation of muscle adaptation,BP,ACTN3
1775,GO:0019659,0.301683026080401,1,1,1,glucose catabolic process to lactate,BP,ACTN3
1776,GO:0019660,0.301683026080401,1,1,1,glycolytic fermentation,BP,ACTN3
1777,GO:0019661,0.301683026080401,1,1,1,glucose catabolic process to lactate via pyruvate,BP,ACTN3
2552,GO:0033173,0.301683026080401,1,1,1,calcineurin-NFAT signaling cascade,BP,ACTN3
3183,GO:0043465,0.301683026080401,1,1,1,regulation of fermentation,BP,ACTN3
3185,GO:0043470,0.301683026080401,1,1,1,regulation of carbohydrate catabolic process,BP,ACTN3
3196,GO:0043501,0.301683026080401,1,1,1,skeletal muscle adaptation,BP,ACTN3
3543,GO:0045820,0.301683026080401,1,1,1,negative regulation of glycolytic process,BP,ACTN3
3567,GO:0045912,0.301683026080401,1,1,1,negative regulation of carbohydrate metabolic process,BP,ACTN3
4022,GO:0050879,0.301683026080401,1,1,1,multicellular organismal movement,BP,ACTN3
4024,GO:0050881,0.301683026080401,1,1,1,musculoskeletal movement,BP,ACTN3
4118,GO:0051193,0.301683026080401,1,1,1,regulation of cofactor metabolic process,BP,ACTN3
4119,GO:0051194,0.301683026080401,1,1,1,positive regulation of cofactor metabolic process,BP,ACTN3
4120,GO:0051195,0.301683026080401,1,1,1,negative regulation of cofactor metabolic process,BP,ACTN3
4121,GO:0051196,0.301683026080401,1,1,1,regulation of coenzyme metabolic process,BP,ACTN3
4122,GO:0051197,0.301683026080401,1,1,1,positive regulation of coenzyme metabolic process,BP,ACTN3
4123,GO:0051198,0.301683026080401,1,1,1,negative regulation of coenzyme metabolic process,BP,ACTN3
4878,GO:0070884,0.301683026080401,1,1,1,regulation of calcineurin-NFAT signaling cascade,BP,ACTN3
4879,GO:0070885,0.301683026080401,1,1,1,negative regulation of calcineurin-NFAT signaling cascade,BP,ACTN3
5309,GO:0090324,0.301683026080401,1,1,1,negative regulation of oxidative phosphorylation,BP,ACTN3
5413,GO:0097720,0.301683026080401,1,1,1,calcineurin-mediated signaling,BP,ACTN3
5734,GO:1902688,0.301683026080401,1,1,1,regulation of NAD metabolic process,BP,ACTN3
5735,GO:1902690,0.301683026080401,1,1,1,positive regulation of NAD metabolic process,BP,ACTN3
5833,GO:1903578,0.301683026080401,1,1,1,regulation of ATP metabolic process,BP,ACTN3
5834,GO:1903579,0.301683026080401,1,1,1,negative regulation of ATP metabolic process,BP,ACTN3
5835,GO:1903580,0.301683026080401,1,1,1,positive regulation of ATP metabolic process,BP,ACTN3
5844,GO:1903715,0.301683026080401,1,1,1,regulation of aerobic respiration,BP,ACTN3
5874,GO:1904023,0.301683026080401,1,1,1,regulation of glucose catabolic process to lactate via pyruvate,BP,ACTN3
5875,GO:1904025,0.301683026080401,1,1,1,positive regulation of glucose catabolic process to lactate via pyruvate,BP,ACTN3
439,GO:0003228,0.301702789329042,1,1,1,atrial cardiac muscle tissue development,BP,WNT2
4304,GO:0055009,0.301702789329042,1,1,1,atrial cardiac muscle tissue morphogenesis,BP,WNT2
4497,GO:0060501,0.301702789329042,1,1,1,positive regulation of epithelial cell proliferation involved in lung morphogenesis,BP,WNT2
6129,GO:2000794,0.301702789329042,1,1,1,regulation of epithelial cell proliferation involved in lung morphogenesis,BP,WNT2
354,GO:0002790,0.302370422162547,0.869854280257951,5,12,peptide secretion,BP,BMP6;KCNG2;RAB40B;INHBB;NOTCH1
630,GO:0005578,0.302498982451994,0.857441207645362,6,15,proteinaceous extracellular matrix,CC,WNT7A;WNT3;WNT7B;WNT2;WNT5B;BMP4
3991,GO:0050804,0.302660715805341,0.910209452799542,3,6,modulation of synaptic transmission,BP,WNT7A;HRAS;GDNF
609,GO:0005506,0.303121143840493,1,1,1,iron ion binding,MF,TF
1097,GO:0008198,0.303121143840493,1,1,1,ferrous iron binding,MF,TF
1098,GO:0008199,0.303121143840493,1,1,1,ferric iron binding,MF,TF
1259,GO:0009925,0.303121143840493,1,1,1,basal plasma membrane,CC,TF
1521,GO:0015091,0.303121143840493,1,1,1,ferric iron transmembrane transporter activity,MF,TF
1543,GO:0015682,0.303121143840493,1,1,1,ferric iron transport,BP,TF
1544,GO:0015684,0.303121143840493,1,1,1,ferrous iron transport,BP,TF
2171,GO:0031232,0.303121143840493,1,1,1,extrinsic component of external side of plasma membrane,CC,TF
2574,GO:0033572,0.303121143840493,1,1,1,transferrin transport,BP,TF
3762,GO:0048260,0.303121143840493,1,1,1,positive regulation of receptor-mediated endocytosis,BP,TF
4847,GO:0070627,0.303121143840493,1,1,1,ferrous iron import,BP,TF
5177,GO:0072510,0.303121143840493,1,1,1,trivalent inorganic cation transmembrane transporter activity,MF,TF
5179,GO:0072512,0.303121143840493,1,1,1,trivalent inorganic cation transport,BP,TF
5381,GO:0097286,0.303121143840493,1,1,1,iron ion import,BP,TF
5395,GO:0097459,0.303121143840493,1,1,1,iron ion import into cell,BP,TF
5396,GO:0097460,0.303121143840493,1,1,1,ferrous iron import into cell,BP,TF
5441,GO:0098659,0.303121143840493,1,1,1,inorganic cation import into cell,BP,TF
5502,GO:0099587,0.303121143840493,1,1,1,inorganic ion import into cell,BP,TF
5993,GO:1990459,0.303121143840493,1,1,1,transferrin receptor binding,MF,TF
5995,GO:1990712,0.303121143840493,1,1,1,HFE-transferrin receptor complex,CC,TF
5045,GO:0072028,0.303213644461105,0.869334878899217,5,12,nephron morphogenesis,BP,FGF8;WNK4;BMP4;GDNF;BMP7
2500,GO:0032940,0.305073036470477,0.813687545850396,13,36,secretion by cell,BP,SCIN;WNT7A;PIK3CG;SYT5;BMP6;KCNG2;RAB40B;INHBB;PKP1;RAB3D;GDNF;NOTCH1;TF
4034,GO:0050918,0.306082566776217,0.908585825224818,3,6,positive chemotaxis,BP,FGF8;ARTN;BMP4
5720,GO:1902589,0.306151823298752,0.80916705906642,14,40,single-organism organelle organization,BP,SCIN;SYT5;PMAIP1;AXIN1;SPTBN5;RAB39A;SPTB;AMOT;PKP1;HRAS;SPTBN4;NOTCH1;RND3;RAB20
384,GO:0003085,0.306498712527239,1,1,1,negative regulation of systemic arterial blood pressure,BP,KCNK6
4369,GO:0060075,0.306498712527239,1,1,1,regulation of resting membrane potential,BP,KCNK6
5262,GO:0090130,0.307001749060966,0.844700221082156,7,18,tissue migration,BP,WNT7A;FGF8;AMOT;PKN3;BMP4;PIK3CA;NOTCH1
3321,GO:0044422,0.309159070766847,0.781738543128497,36,110,organelle part,CC,MAGEC2;GLDC;SCIN;TLE1;WNT7A;SYT5;ACTN3;MBOAT2;WNT3;HEY1;WNT7B;PMAIP1;POU3F1;MAPK12;CDH1;SPTBN5;RAB40B;RAB39A;SPTB;FZD7;VDR;AMOT;WNT5B;DUSP5;PKP1;TSPAN15;HRAS;RAB3D;RNF144A;RAB38;FSTL3;SPTBN4;NOTCH1;RND3;RAB20;TF
141,GO:0001763,0.309317686846946,0.843107820856106,7,18,morphogenesis of a branching structure,BP,WNT2;FGF8;VDR;BMP4;GDNF;BMP7;NOTCH1
3892,GO:0048754,0.309317686846946,0.843107820856106,7,18,branching morphogenesis of an epithelial tube,BP,WNT2;FGF8;VDR;BMP4;GDNF;BMP7;NOTCH1
4667,GO:0061138,0.309317686846946,0.843107820856106,7,18,morphogenesis of a branching epithelium,BP,WNT2;FGF8;VDR;BMP4;GDNF;BMP7;NOTCH1
28,GO:0000188,0.309374600072107,1,1,1,inactivation of MAPK activity,BP,DUSP5
1089,GO:0008138,0.309374600072107,1,1,1,protein tyrosine/serine/threonine phosphatase activity,MF,DUSP5
1696,GO:0017017,0.309374600072107,1,1,1,MAP kinase tyrosine/serine/threonine phosphatase activity,MF,DUSP5
2568,GO:0033549,0.309374600072107,1,1,1,MAP kinase phosphatase activity,MF,DUSP5
2811,GO:0035970,0.309374600072107,1,1,1,peptidyl-threonine dephosphorylation,BP,DUSP5
250,GO:0002237,0.310678710208908,0.864702842399438,5,12,response to molecule of bacterial origin,BP,GJB2;BMP6;GJB6;CCL20;NOTCH1
2395,GO:0032496,0.310678710208908,0.864702842399438,5,12,response to lipopolysaccharide,BP,GJB2;BMP6;GJB6;CCL20;NOTCH1
1239,GO:0009798,0.311309242248882,0.881314024781184,4,9,axis specification,BP,WNT7A;WNT3;BMP4;NOTCH1
880,GO:0006892,0.311889240491561,1,1,1,post-Golgi vesicle-mediated transport,BP,RABIF
6170,GO:2001236,0.312015134090849,0.905739614516312,3,6,regulation of extrinsic apoptotic signaling pathway,BP,PMAIP1;BMP4;GDNF
366,GO:0002931,0.314401317545087,1,1,1,response to ischemia,BP,GJB2
670,GO:0005793,0.314401317545087,1,1,1,endoplasmic reticulum-Golgi intermediate compartment,CC,GJB2
2411,GO:0032570,0.314401317545087,1,1,1,response to progesterone,BP,GJB2
3366,GO:0044752,0.314401317545087,1,1,1,response to human chorionic gonadotropin,BP,GJB2
3657,GO:0046677,0.314401317545087,1,1,1,response to antibiotic,BP,GJB2
4972,GO:0071549,0.314401317545087,1,1,1,cellular response to dexamethasone stimulus,BP,GJB2
5389,GO:0097386,0.314401317545087,1,1,1,glial cell projection,CC,GJB2
5393,GO:0097449,0.314401317545087,1,1,1,astrocyte projection,CC,GJB2
61,GO:0000983,0.315168150035266,1,1,1,transcription factor activity, RNA polymerase II core promoter sequence-specific,MF,HEY1
484,GO:0003696,0.315168150035266,1,1,1,satellite DNA binding,MF,HEY1
2799,GO:0035907,0.315168150035266,1,1,1,dorsal aorta development,BP,HEY1
2801,GO:0035912,0.315168150035266,1,1,1,dorsal aorta morphogenesis,BP,HEY1
2808,GO:0035939,0.315168150035266,1,1,1,microsatellite binding,MF,HEY1
2845,GO:0036304,0.315168150035266,1,1,1,umbilical cord morphogenesis,BP,HEY1
3164,GO:0043392,0.315168150035266,1,1,1,negative regulation of DNA binding,BP,HEY1
4435,GO:0060343,0.315168150035266,1,1,1,trabecula formation,BP,HEY1
4436,GO:0060347,0.315168150035266,1,1,1,heart trabecula formation,BP,HEY1
4636,GO:0061027,0.315168150035266,1,1,1,umbilical cord development,BP,HEY1
6115,GO:2000678,0.315168150035266,1,1,1,negative regulation of transcription regulatory region DNA binding,BP,HEY1
6134,GO:2000820,0.315168150035266,1,1,1,negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,HEY1
6166,GO:2001212,0.315168150035266,1,1,1,regulation of vasculogenesis,BP,HEY1
601,GO:0005355,0.317777264077315,1,1,1,glucose transmembrane transporter activity,MF,SLC2A14
1526,GO:0015145,0.317777264077315,1,1,1,monosaccharide transmembrane transporter activity,MF,SLC2A14
1527,GO:0015149,0.317777264077315,1,1,1,hexose transmembrane transporter activity,MF,SLC2A14
2607,GO:0034219,0.317777264077315,1,1,1,carbohydrate transmembrane transport,BP,SLC2A14
2737,GO:0035428,0.317777264077315,1,1,1,hexose transmembrane transport,BP,SLC2A14
4317,GO:0055056,0.317777264077315,1,1,1,D-glucose transmembrane transporter activity,MF,SLC2A14
5896,GO:1904659,0.317777264077315,1,1,1,glucose transmembrane transport,BP,SLC2A14
5972,GO:1905950,0.317777264077315,1,1,1,monosaccharide transmembrane transport,BP,SLC2A14
3097,GO:0043168,0.318481806398178,0.783159269297766,22,65,anion binding,MF,GLDC;SCIN;PIK3CG;SYT5;MAPK12;RAB40B;RAB39A;RRAS2;FZD7;VDR;WNK4;PKN3;HRAS;BMP4;RAB3D;RAB38;PIK3CA;BMP7;SPTBN4;RND3;RAB20;GUCY1B3
689,GO:0005886,0.318760870438572,0.774515645901758,44,137,plasma membrane,CC,SLC2A14;TJP3;GLDC;WNT7A;GJB2;PIK3CG;SYT5;CLDN18;GJA3;WNT3;GJB6;WNT7B;JAG2;KCNG2;AXIN1;WNT2;CDH1;SPTBN5;RAB40B;RAB39A;SPTB;RRAS2;FZD7;FGF8;CRB2;DSG3;AMOT;WNT5B;PKP1;TSPAN15;HRAS;RAB3D;KCNK6;CLDN15;RNF144A;RAB38;PIK3CA;DRP2;SPTBN4;TSPAN13;NOTCH1;RAB20;GUCY1B3;TF
2650,GO:0034645,0.319036466173515,0.78719813462703,19,56,cellular macromolecule biosynthetic process,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;CRB2;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
5613,GO:1901575,0.319906479886671,0.826212016468356,8,22,organic substance catabolic process,BP,MAGEC2;GLDC;PIK3CG;ACTN3;PMAIP1;AXIN1;PKP1;RNF144A
1117,GO:0008284,0.32026805710892,0.814776832156783,10,27,positive regulation of cell proliferation,BP,WNT7A;BMP6;WNT2;FZD7;FGF8;FGF17;HRAS;BMP4;GDNF;NOTCH1
4223,GO:0051602,0.321983580133834,1,1,1,response to electrical stimulus,BP,GJB6
6041,GO:2000113,0.32282266120302,0.824094202741427,8,22,negative regulation of cellular macromolecule biosynthetic process,BP,TLE1;BMP6;HEY1;AXIN1;VDR;BMP4;BMP7;NOTCH1
613,GO:0005515,0.323079557303915,0.78520564050915,58,183,protein binding,MF,MAGEC2;TJP3;GLDC;RHPN1;SCIN;TLE1;WNT7A;PIK3CG;SYT5;ACTN3;CLDN18;RABIF;BMP6;WNT3;HEY1;WNT7B;JAG2;PMAIP1;AXIN1;MAPK12;WNT2;CDH1;SPTBN5;RAB39A;SPTB;RRAS2;FZD7;FGF8;VDR;CRB2;ARTN;AMOT;WNT5B;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;FGF17;TSPAN15;HRAS;BMP4;RAB3D;CLDN15;GDNF;RNF144A;RAB38;PIK3CA;BMP7;FSTL3;TPD52;SPTBN4;NOTCH1;RND3;MB21D2;GUCY1B3;TF
2203,GO:0031399,0.323116705680377,0.790395491732779,16,46,regulation of protein modification process,BP,MAGEC2;WNT7A;PIK3CG;BMP6;WNT7B;AXIN1;FZD7;FGF8;DUSP5;INHBB;CCL20;HRAS;BMP4;PIK3CA;BMP7;SPTBN4
306,GO:0002520,0.323958769606207,0.816649989473381,9,25,immune system development,BP,SCIN;CLDN18;JAG2;FZD7;ARTN;BMP4;FSTL3;TPD52;NOTCH1
3813,GO:0048534,0.323958769606207,0.816649989473381,9,25,hematopoietic or lymphoid organ development,BP,SCIN;CLDN18;JAG2;FZD7;ARTN;BMP4;FSTL3;TPD52;NOTCH1
165,GO:0001844,0.32521934074896,1,1,1,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,PMAIP1
891,GO:0006919,0.32521934074896,1,1,1,activation of cysteine-type endopeptidase activity involved in apoptotic process,BP,PMAIP1
916,GO:0007006,0.32521934074896,1,1,1,mitochondrial membrane organization,BP,PMAIP1
1399,GO:0010822,0.32521934074896,1,1,1,positive regulation of mitochondrion organization,BP,PMAIP1
1424,GO:0010917,0.32521934074896,1,1,1,negative regulation of mitochondrial membrane potential,BP,PMAIP1
2391,GO:0032459,0.32521934074896,1,1,1,regulation of protein oligomerization,BP,PMAIP1
2392,GO:0032461,0.32521934074896,1,1,1,positive regulation of protein oligomerization,BP,PMAIP1
2778,GO:0035794,0.32521934074896,1,1,1,positive regulation of mitochondrial membrane permeability,BP,PMAIP1
3200,GO:0043516,0.32521934074896,1,1,1,regulation of DNA damage response, signal transduction by p53 class mediator,BP,PMAIP1
3201,GO:0043517,0.32521934074896,1,1,1,positive regulation of DNA damage response, signal transduction by p53 class mediator,BP,PMAIP1
3552,GO:0045837,0.32521934074896,1,1,1,negative regulation of membrane potential,BP,PMAIP1
3699,GO:0046902,0.32521934074896,1,1,1,regulation of mitochondrial membrane permeability,BP,PMAIP1
4124,GO:0051204,0.32521934074896,1,1,1,protein insertion into mitochondrial membrane,BP,PMAIP1
4227,GO:0051607,0.32521934074896,1,1,1,defense response to virus,BP,PMAIP1
4261,GO:0051881,0.32521934074896,1,1,1,regulation of mitochondrial membrane potential,BP,PMAIP1
4760,GO:0070059,0.32521934074896,1,1,1,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,PMAIP1
5288,GO:0090200,0.32521934074896,1,1,1,positive regulation of release of cytochrome c from mitochondria,BP,PMAIP1
5324,GO:0090559,0.32521934074896,1,1,1,regulation of membrane permeability,BP,PMAIP1
5386,GO:0097345,0.32521934074896,1,1,1,mitochondrial outer membrane permeabilization,BP,PMAIP1
5556,GO:1900739,0.32521934074896,1,1,1,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,PMAIP1
5557,GO:1900740,0.32521934074896,1,1,1,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,PMAIP1
5567,GO:1901028,0.32521934074896,1,1,1,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,PMAIP1
5568,GO:1901030,0.32521934074896,1,1,1,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,PMAIP1
5640,GO:1901798,0.32521934074896,1,1,1,positive regulation of signal transduction by p53 class mediator,BP,PMAIP1
5669,GO:1902041,0.32521934074896,1,1,1,regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,PMAIP1
5670,GO:1902043,0.32521934074896,1,1,1,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,PMAIP1
5676,GO:1902108,0.32521934074896,1,1,1,regulation of mitochondrial membrane permeability involved in apoptotic process,BP,PMAIP1
5677,GO:1902110,0.32521934074896,1,1,1,positive regulation of mitochondrial membrane permeability involved in apoptotic process,BP,PMAIP1
5685,GO:1902235,0.32521934074896,1,1,1,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,PMAIP1
5686,GO:1902237,0.32521934074896,1,1,1,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,PMAIP1
5733,GO:1902686,0.32521934074896,1,1,1,mitochondrial outer membrane permeabilization involved in programmed cell death,BP,PMAIP1
5851,GO:1903747,0.32521934074896,1,1,1,regulation of establishment of protein localization to mitochondrion,BP,PMAIP1
5852,GO:1903749,0.32521934074896,1,1,1,positive regulation of establishment of protein localization to mitochondrion,BP,PMAIP1
5961,GO:1905710,0.32521934074896,1,1,1,positive regulation of membrane permeability,BP,PMAIP1
6172,GO:2001238,0.32521934074896,1,1,1,positive regulation of extrinsic apoptotic signaling pathway,BP,PMAIP1
6177,GO:2001244,0.32521934074896,1,1,1,positive regulation of intrinsic apoptotic signaling pathway,BP,PMAIP1
6022,GO:2000026,0.325408359463907,0.783830390176607,18,53,regulation of multicellular organismal development,BP,SCIN;WNT7A;ACTN3;CLDN18;BMP6;WNT3;HEY1;WNT2;FZD7;FGF8;VDR;CRB2;AMOT;BMP4;GDNF;BMP7;FSTL3;NOTCH1
992,GO:0007268,0.325968523416979,0.872824244531833,4,9,chemical synaptic transmission,BP,WNT7A;SYT5;HRAS;GDNF
5478,GO:0098916,0.325968523416979,0.872824244531833,4,9,anterograde trans-synaptic signaling,BP,WNT7A;SYT5;HRAS;GDNF
5497,GO:0099536,0.325968523416979,0.872824244531833,4,9,synaptic signaling,BP,WNT7A;SYT5;HRAS;GDNF
5498,GO:0099537,0.325968523416979,0.872824244531833,4,9,trans-synaptic signaling,BP,WNT7A;SYT5;HRAS;GDNF
591,GO:0005246,0.326119143625473,1,1,1,calcium channel regulator activity,MF,TSPAN13
790,GO:0006479,0.326766125371367,1,1,1,protein methylation,BP,RAB3D
1107,GO:0008213,0.326766125371367,1,1,1,protein alkylation,BP,RAB3D
1719,GO:0018125,0.326766125371367,1,1,1,peptidyl-cysteine methylation,BP,RAB3D
1723,GO:0018198,0.326766125371367,1,1,1,peptidyl-cysteine modification,BP,RAB3D
3017,GO:0042588,0.326766125371367,1,1,1,zymogen granule,CC,RAB3D
624,GO:0005544,0.328144734622933,1,1,1,calcium-dependent phospholipid binding,MF,SYT5
1591,GO:0016079,0.328144734622933,1,1,1,synaptic vesicle exocytosis,BP,SYT5
1996,GO:0030276,0.328144734622933,1,1,1,clathrin binding,MF,SYT5
2137,GO:0031045,0.328144734622933,1,1,1,dense core granule,CC,SYT5
3796,GO:0048488,0.328144734622933,1,1,1,synaptic vesicle endocytosis,BP,SYT5
3898,GO:0048791,0.328144734622933,1,1,1,calcium ion-regulated exocytosis of neurotransmitter,BP,SYT5
5997,GO:1990769,0.328144734622933,1,1,1,proximal neuron projection,CC,SYT5
3058,GO:0042990,0.328147790788285,0.926136667505838,2,4,regulation of transcription factor import into nucleus,BP,CDH1;BMP7
3059,GO:0042991,0.328147790788285,0.926136667505838,2,4,transcription factor import into nucleus,BP,CDH1;BMP7
708,GO:0005942,0.328787576870324,0.925880955382419,2,4,phosphatidylinositol 3-kinase complex,CC,PIK3CG;PIK3CA
3815,GO:0048537,0.329157754880592,1,1,1,mucosal-associated lymphoid tissue development,BP,ARTN
3817,GO:0048541,0.329157754880592,1,1,1,Peyer's patch development,BP,ARTN
4670,GO:0061146,0.329157754880592,1,1,1,Peyer's patch morphogenesis,BP,ARTN
5338,GO:0097021,0.329157754880592,1,1,1,lymphocyte migration into lymphoid organs,BP,ARTN
3336,GO:0044444,0.329300621957579,0.767086636234199,47,147,cytoplasmic part,CC,MAGEC2;GLDC;RHPN1;SCIN;TLE1;WNT7A;GJB2;PIK3CG;SYT5;ACTN3;RABIF;MBOAT2;WNT3;GJB6;WNT7B;PMAIP1;AXIN1;MAPK12;CDH1;SPTBN5;RAB40B;RAB39A;SPTB;RRAS2;FZD7;DSG3;AMOT;WNT5B;WNK4;INHBB;PKN3;PKP1;TSPAN15;HRAS;RAB3D;RNF144A;RAB38;PIK3CA;FSTL3;TPD52;SPTBN4;NOTCH1;RND3;PNMT;RAB20;GUCY1B3;TF
127,GO:0001710,0.329439166948814,1,1,1,mesodermal cell fate commitment,BP,BMP4
217,GO:0002043,0.329439166948814,1,1,1,blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,BMP4
234,GO:0002089,0.329439166948814,1,1,1,lens morphogenesis in camera-type eye,BP,BMP4
391,GO:0003128,0.329439166948814,1,1,1,heart field specification,BP,BMP4
396,GO:0003139,0.329439166948814,1,1,1,secondary heart field specification,BP,BMP4
399,GO:0003149,0.329439166948814,1,1,1,membranous septum morphogenesis,BP,BMP4
964,GO:0007182,0.329439166948814,1,1,1,common-partner SMAD protein phosphorylation,BP,BMP4
1031,GO:0007500,0.329439166948814,1,1,1,mesodermal cell fate determination,BP,BMP4
1285,GO:0010159,0.329439166948814,1,1,1,specification of animal organ position,BP,BMP4
1629,GO:0016441,0.329439166948814,1,1,1,posttranscriptional gene silencing,BP,BMP4
1633,GO:0016458,0.329439166948814,1,1,1,gene silencing,BP,BMP4
1984,GO:0030224,0.329439166948814,1,1,1,monocyte differentiation,BP,BMP4
2138,GO:0031047,0.329439166948814,1,1,1,gene silencing by RNA,BP,BMP4
2139,GO:0031050,0.329439166948814,1,1,1,dsRNA fragmentation,BP,BMP4
2346,GO:0032331,0.329439166948814,1,1,1,negative regulation of chondrocyte differentiation,BP,BMP4
2536,GO:0033081,0.329439166948814,1,1,1,regulation of T cell differentiation in thymus,BP,BMP4
2537,GO:0033083,0.329439166948814,1,1,1,regulation of immature T cell proliferation,BP,BMP4
2538,GO:0033084,0.329439166948814,1,1,1,regulation of immature T cell proliferation in thymus,BP,BMP4
2539,GO:0033085,0.329439166948814,1,1,1,negative regulation of T cell differentiation in thymus,BP,BMP4
2540,GO:0033087,0.329439166948814,1,1,1,negative regulation of immature T cell proliferation,BP,BMP4
2541,GO:0033088,0.329439166948814,1,1,1,negative regulation of immature T cell proliferation in thymus,BP,BMP4
2705,GO:0035194,0.329439166948814,1,1,1,posttranscriptional gene silencing by RNA,BP,BMP4
2706,GO:0035195,0.329439166948814,1,1,1,gene silencing by miRNA,BP,BMP4
2707,GO:0035196,0.329439166948814,1,1,1,production of miRNAs involved in gene silencing by miRNA,BP,BMP4
2788,GO:0035844,0.329439166948814,1,1,1,cloaca development,BP,BMP4
2814,GO:0035989,0.329439166948814,1,1,1,tendon development,BP,BMP4
2815,GO:0035990,0.329439166948814,1,1,1,tendon cell differentiation,BP,BMP4
2816,GO:0035992,0.329439166948814,1,1,1,tendon formation,BP,BMP4
2817,GO:0035993,0.329439166948814,1,1,1,deltoid tuberosity development,BP,BMP4
2903,GO:0040029,0.329439166948814,1,1,1,regulation of gene expression, epigenetic,BP,BMP4
3469,GO:0045580,0.329439166948814,1,1,1,regulation of T cell differentiation,BP,BMP4
3470,GO:0045581,0.329439166948814,1,1,1,negative regulation of T cell differentiation,BP,BMP4
3487,GO:0045620,0.329439166948814,1,1,1,negative regulation of lymphocyte differentiation,BP,BMP4
3783,GO:0048389,0.329439166948814,1,1,1,intermediate mesoderm development,BP,BMP4
3784,GO:0048390,0.329439166948814,1,1,1,intermediate mesoderm morphogenesis,BP,BMP4
3785,GO:0048391,0.329439166948814,1,1,1,intermediate mesoderm formation,BP,BMP4
3786,GO:0048392,0.329439166948814,1,1,1,intermediate mesodermal cell differentiation,BP,BMP4
3871,GO:0048701,0.329439166948814,1,1,1,embryonic cranial skeleton morphogenesis,BP,BMP4
4308,GO:0055018,0.329439166948814,1,1,1,regulation of cardiac muscle fiber development,BP,BMP4
4309,GO:0055020,0.329439166948814,1,1,1,positive regulation of cardiac muscle fiber development,BP,BMP4
4388,GO:0060147,0.329439166948814,1,1,1,regulation of posttranscriptional gene silencing,BP,BMP4
4389,GO:0060148,0.329439166948814,1,1,1,positive regulation of posttranscriptional gene silencing,BP,BMP4
4398,GO:0060197,0.329439166948814,1,1,1,cloacal septation,BP,BMP4
4403,GO:0060235,0.329439166948814,1,1,1,lens induction in camera-type eye,BP,BMP4
4441,GO:0060363,0.329439166948814,1,1,1,cranial suture morphogenesis,BP,BMP4
4477,GO:0060440,0.329439166948814,1,1,1,trachea formation,BP,BMP4
4499,GO:0060503,0.329439166948814,1,1,1,bud dilation involved in lung branching,BP,BMP4
4550,GO:0060677,0.329439166948814,1,1,1,ureteric bud elongation,BP,BMP4
4551,GO:0060681,0.329439166948814,1,1,1,branch elongation involved in ureteric bud branching,BP,BMP4
4608,GO:0060914,0.329439166948814,1,1,1,heart formation,BP,BMP4
4615,GO:0060964,0.329439166948814,1,1,1,regulation of gene silencing by miRNA,BP,BMP4
4616,GO:0060966,0.329439166948814,1,1,1,regulation of gene silencing by RNA,BP,BMP4
4617,GO:0060968,0.329439166948814,1,1,1,regulation of gene silencing,BP,BMP4
4626,GO:0060994,0.329439166948814,1,1,1,regulation of transcription from RNA polymerase II promoter involved in kidney development,BP,BMP4
4629,GO:0061004,0.329439166948814,1,1,1,pattern specification involved in kidney development,BP,BMP4
4643,GO:0061037,0.329439166948814,1,1,1,negative regulation of cartilage development,BP,BMP4
4671,GO:0061149,0.329439166948814,1,1,1,BMP signaling pathway involved in ureter morphogenesis,BP,BMP4
4672,GO:0061150,0.329439166948814,1,1,1,renal system segmentation,BP,BMP4
4673,GO:0061151,0.329439166948814,1,1,1,BMP signaling pathway involved in renal system segmentation,BP,BMP4
4675,GO:0061155,0.329439166948814,1,1,1,pulmonary artery endothelial tube morphogenesis,BP,BMP4
4684,GO:0061216,0.329439166948814,1,1,1,regulation of transcription from RNA polymerase II promoter involved in mesonephros development,BP,BMP4
4686,GO:0061218,0.329439166948814,1,1,1,negative regulation of mesonephros development,BP,BMP4
4687,GO:0061227,0.329439166948814,1,1,1,pattern specification involved in mesonephros development,BP,BMP4
4697,GO:0061323,0.329439166948814,1,1,1,cell proliferation involved in heart morphogenesis,BP,BMP4
4698,GO:0061325,0.329439166948814,1,1,1,cell proliferation involved in outflow tract morphogenesis,BP,BMP4
4723,GO:0061438,0.329439166948814,1,1,1,renal system vasculature morphogenesis,BP,BMP4
4724,GO:0061439,0.329439166948814,1,1,1,kidney vasculature morphogenesis,BP,BMP4
4740,GO:0061626,0.329439166948814,1,1,1,pharyngeal arch artery morphogenesis,BP,BMP4
4782,GO:0070229,0.329439166948814,1,1,1,negative regulation of lymphocyte apoptotic process,BP,BMP4
4786,GO:0070233,0.329439166948814,1,1,1,negative regulation of T cell apoptotic process,BP,BMP4
4790,GO:0070244,0.329439166948814,1,1,1,negative regulation of thymocyte apoptotic process,BP,BMP4
4882,GO:0070918,0.329439166948814,1,1,1,production of small RNA involved in gene silencing by RNA,BP,BMP4
4883,GO:0070920,0.329439166948814,1,1,1,regulation of production of small RNA involved in gene silencing by RNA,BP,BMP4
5026,GO:0071893,0.329439166948814,1,1,1,BMP signaling pathway involved in nephric duct formation,BP,BMP4
5043,GO:0072015,0.329439166948814,1,1,1,glomerular visceral epithelial cell development,BP,BMP4
5052,GO:0072048,0.329439166948814,1,1,1,renal system pattern specification,BP,BMP4
5053,GO:0072049,0.329439166948814,1,1,1,comma-shaped body morphogenesis,BP,BMP4
5072,GO:0072095,0.329439166948814,1,1,1,regulation of branch elongation involved in ureteric bud branching,BP,BMP4
5073,GO:0072096,0.329439166948814,1,1,1,negative regulation of branch elongation involved in ureteric bud branching,BP,BMP4
5074,GO:0072097,0.329439166948814,1,1,1,negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway,BP,BMP4
5075,GO:0072098,0.329439166948814,1,1,1,anterior/posterior pattern specification involved in kidney development,BP,BMP4
5076,GO:0072099,0.329439166948814,1,1,1,anterior/posterior pattern specification involved in ureteric bud development,BP,BMP4
5077,GO:0072100,0.329439166948814,1,1,1,specification of ureteric bud anterior/posterior symmetry,BP,BMP4
5078,GO:0072101,0.329439166948814,1,1,1,specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway,BP,BMP4
5079,GO:0072102,0.329439166948814,1,1,1,glomerulus morphogenesis,BP,BMP4
5080,GO:0072103,0.329439166948814,1,1,1,glomerulus vasculature morphogenesis,BP,BMP4
5081,GO:0072104,0.329439166948814,1,1,1,glomerular capillary formation,BP,BMP4
5117,GO:0072179,0.329439166948814,1,1,1,nephric duct formation,BP,BMP4
5119,GO:0072189,0.329439166948814,1,1,1,ureter development,BP,BMP4
5120,GO:0072190,0.329439166948814,1,1,1,ureter urothelium development,BP,BMP4
5121,GO:0072191,0.329439166948814,1,1,1,ureter smooth muscle development,BP,BMP4
5122,GO:0072192,0.329439166948814,1,1,1,ureter epithelial cell differentiation,BP,BMP4
5123,GO:0072193,0.329439166948814,1,1,1,ureter smooth muscle cell differentiation,BP,BMP4
5124,GO:0072197,0.329439166948814,1,1,1,ureter morphogenesis,BP,BMP4
5125,GO:0072198,0.329439166948814,1,1,1,mesenchymal cell proliferation involved in ureter development,BP,BMP4
5126,GO:0072199,0.329439166948814,1,1,1,regulation of mesenchymal cell proliferation involved in ureter development,BP,BMP4
5127,GO:0072200,0.329439166948814,1,1,1,negative regulation of mesenchymal cell proliferation involved in ureter development,BP,BMP4
5149,GO:0072278,0.329439166948814,1,1,1,metanephric comma-shaped body morphogenesis,BP,BMP4
5157,GO:0072310,0.329439166948814,1,1,1,glomerular epithelial cell development,BP,BMP4
5283,GO:0090191,0.329439166948814,1,1,1,negative regulation of branching involved in ureteric bud morphogenesis,BP,BMP4
5350,GO:0097094,0.329439166948814,1,1,1,craniofacial suture morphogenesis,BP,BMP4
5654,GO:1901963,0.329439166948814,1,1,1,regulation of cell proliferation involved in outflow tract morphogenesis,BP,BMP4
5655,GO:1901964,0.329439166948814,1,1,1,positive regulation of cell proliferation involved in outflow tract morphogenesis,BP,BMP4
5778,GO:1903131,0.329439166948814,1,1,1,mononuclear cell differentiation,BP,BMP4
5856,GO:1903798,0.329439166948814,1,1,1,regulation of production of miRNAs involved in gene silencing by miRNA,BP,BMP4
5857,GO:1903800,0.329439166948814,1,1,1,positive regulation of production of miRNAs involved in gene silencing by miRNA,BP,BMP4
5913,GO:1904888,0.329439166948814,1,1,1,cranial skeletal system development,BP,BMP4
6010,GO:2000004,0.329439166948814,1,1,1,regulation of metanephric S-shaped body morphogenesis,BP,BMP4
6011,GO:2000005,0.329439166948814,1,1,1,negative regulation of metanephric S-shaped body morphogenesis,BP,BMP4
6012,GO:2000006,0.329439166948814,1,1,1,regulation of metanephric comma-shaped body morphogenesis,BP,BMP4
6013,GO:2000007,0.329439166948814,1,1,1,negative regulation of metanephric comma-shaped body morphogenesis,BP,BMP4
6047,GO:2000137,0.329439166948814,1,1,1,negative regulation of cell proliferation involved in heart morphogenesis,BP,BMP4
6048,GO:2000138,0.329439166948814,1,1,1,positive regulation of cell proliferation involved in heart morphogenesis,BP,BMP4
6107,GO:2000637,0.329439166948814,1,1,1,positive regulation of gene silencing by miRNA,BP,BMP4
522,GO:0004707,0.330058292537703,1,1,1,MAP kinase activity,MF,MAPK12
909,GO:0006975,0.330058292537703,1,1,1,DNA damage induced protein phosphorylation,BP,MAPK12
2726,GO:0035315,0.330082505925984,0.925361986931602,2,4,hair cell differentiation,BP,JAG2;NOTCH1
2994,GO:0042491,0.330082505925984,0.925361986931602,2,4,auditory receptor cell differentiation,BP,JAG2;NOTCH1
138,GO:0001756,0.33008271566756,0.925361902720906,2,4,somitogenesis,BP,CRB2;NOTCH1
5664,GO:1901998,0.330114577714243,1,1,1,toxin transport,BP,RAB40B
6009,GO:1990967,0.330114577714243,1,1,1,multi-organism toxin transport,BP,RAB40B
1643,GO:0016525,0.330507114439805,0.925191406409562,2,4,negative regulation of angiogenesis,BP,AMOT;NOTCH1
1087,GO:0008105,0.331409159135629,1,1,1,asymmetric protein localization,BP,WNT7A
1480,GO:0014719,0.331409159135629,1,1,1,skeletal muscle satellite cell activation,BP,WNT7A
1821,GO:0021533,0.331409159135629,1,1,1,cell differentiation in hindbrain,BP,WNT7A
1832,GO:0021681,0.331409159135629,1,1,1,cerebellar granular layer development,BP,WNT7A
1833,GO:0021683,0.331409159135629,1,1,1,cerebellar granular layer morphogenesis,BP,WNT7A
1834,GO:0021684,0.331409159135629,1,1,1,cerebellar granular layer formation,BP,WNT7A
1844,GO:0021707,0.331409159135629,1,1,1,cerebellar granule cell differentiation,BP,WNT7A
2161,GO:0031133,0.331409159135629,1,1,1,regulation of axon diameter,BP,WNT7A
2764,GO:0035659,0.331409159135629,1,1,1,Wnt signaling pathway involved in wound healing, spreading of epidermal cells,BP,WNT7A
4290,GO:0051965,0.331409159135629,1,1,1,positive regulation of synapse assembly,BP,WNT7A
4364,GO:0060066,0.331409159135629,1,1,1,oviduct development,BP,WNT7A
4628,GO:0060997,0.331409159135629,1,1,1,dendritic spine morphogenesis,BP,WNT7A
5466,GO:0098815,0.331409159135629,1,1,1,modulation of excitatory postsynaptic potential,BP,WNT7A
5914,GO:1904889,0.331409159135629,1,1,1,regulation of excitatory synapse assembly,BP,WNT7A
5915,GO:1904891,0.331409159135629,1,1,1,positive regulation of excitatory synapse assembly,BP,WNT7A
5947,GO:1905383,0.331409159135629,1,1,1,protein localization to presynapse,BP,WNT7A
5948,GO:1905384,0.331409159135629,1,1,1,regulation of protein localization to presynapse,BP,WNT7A
5949,GO:1905386,0.331409159135629,1,1,1,positive regulation of protein localization to presynapse,BP,WNT7A
6089,GO:2000463,0.331409159135629,1,1,1,positive regulation of excitatory postsynaptic potential,BP,WNT7A
5374,GO:0097197,0.331718733311037,1,1,1,tetraspanin-enriched microdomain,CC,TSPAN15
2035,GO:0030507,0.332560810979476,0.924363498093262,2,4,spectrin binding,MF,SPTBN5;SPTBN4
120,GO:0001702,0.332562464825345,0.924362829461909,2,4,gastrulation with mouth forming second,BP,CRB2;AMOT
1068,GO:0008013,0.332623603187449,0.924338109742306,2,4,beta-catenin binding,MF,AXIN1;CDH1
1940,GO:0030054,0.33292011871805,0.775512026968468,19,57,cell junction,CC,TJP3;SCIN;GJB2;SYT5;ACTN3;CLDN18;GJA3;GJB6;CDH1;RRAS2;DSG3;AMOT;WNK4;PKP1;CLDN15;DRP2;SPTBN4;NOTCH1;RND3
1479,GO:0014706,0.333442285384374,0.824449900008916,7,19,striated muscle tissue development,BP,ACTN3;WNT2;FZD7;FGF8;BMP4;BMP7;NOTCH1
620,GO:0005525,0.333516350963366,0.810646422916621,9,24,GTP binding,MF,RAB40B;RAB39A;RRAS2;HRAS;RAB3D;RAB38;RND3;RAB20;GUCY1B3
1734,GO:0019001,0.333516350963366,0.810646422916621,9,24,guanyl nucleotide binding,MF,RAB40B;RAB39A;RRAS2;HRAS;RAB3D;RAB38;RND3;RAB20;GUCY1B3
2405,GO:0032549,0.333516350963366,0.810646422916621,9,24,ribonucleoside binding,MF,RAB40B;RAB39A;RRAS2;HRAS;RAB3D;RAB38;RND3;RAB20;GUCY1B3
2406,GO:0032550,0.333516350963366,0.810646422916621,9,24,purine ribonucleoside binding,MF,RAB40B;RAB39A;RRAS2;HRAS;RAB3D;RAB38;RND3;RAB20;GUCY1B3
2410,GO:0032561,0.333516350963366,0.810646422916621,9,24,guanyl ribonucleotide binding,MF,RAB40B;RAB39A;RRAS2;HRAS;RAB3D;RAB38;RND3;RAB20;GUCY1B3
5101,GO:0072148,0.335228914891976,0.923280797066706,2,4,epithelial cell fate commitment,BP,JAG2;NOTCH1
5797,GO:1903364,0.335973060719515,0.922977391340442,2,4,positive regulation of cellular protein catabolic process,BP,AXIN1;RNF144A
3736,GO:0048048,0.336043244457802,0.922948743418632,2,4,embryonic eye morphogenesis,BP,AXIN1;BMP7
1372,GO:0010717,0.336278920873859,0.922852503094925,2,4,regulation of epithelial to mesenchymal transition,BP,CRB2;NOTCH1
1373,GO:0010718,0.336278920873859,0.922852503094925,2,4,positive regulation of epithelial to mesenchymal transition,BP,CRB2;NOTCH1
1919,GO:0030001,0.337183593813553,0.813544875295029,8,22,metal ion transport,BP,PIK3CG;KCNG2;VDR;WNK4;KCNK6;SPTBN4;TSPAN13;TF
1042,GO:0007584,0.337271625430511,0.922446433122899,2,4,response to nutrient,BP,VDR;BMP7
1262,GO:0009950,0.33751435372703,1,1,1,dorsal/ventral axis specification,BP,WNT3
1385,GO:0010770,0.33751435372703,1,1,1,positive regulation of cell morphogenesis involved in differentiation,BP,WNT3
3306,GO:0044338,0.33751435372703,1,1,1,canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation,BP,WNT3
3307,GO:0044339,0.33751435372703,1,1,1,canonical Wnt signaling pathway involved in osteoblast differentiation,BP,WNT3
3308,GO:0044340,0.33751435372703,1,1,1,canonical Wnt signaling pathway involved in regulation of cell proliferation,BP,WNT3
3862,GO:0048668,0.33751435372703,1,1,1,collateral sprouting,BP,WNT3
3863,GO:0048669,0.33751435372703,1,1,1,collateral sprouting in absence of injury,BP,WNT3
3864,GO:0048670,0.33751435372703,1,1,1,regulation of collateral sprouting,BP,WNT3
3865,GO:0048672,0.33751435372703,1,1,1,positive regulation of collateral sprouting,BP,WNT3
3868,GO:0048696,0.33751435372703,1,1,1,regulation of collateral sprouting in absence of injury,BP,WNT3
3869,GO:0048697,0.33751435372703,1,1,1,positive regulation of collateral sprouting in absence of injury,BP,WNT3
3976,GO:0050772,0.33751435372703,1,1,1,positive regulation of axonogenesis,BP,WNT3
4361,GO:0060061,0.33751435372703,1,1,1,Spemann organizer formation,BP,WNT3
4362,GO:0060064,0.33751435372703,1,1,1,Spemann organizer formation at the anterior end of the primitive streak,BP,WNT3
5172,GO:0072497,0.33751435372703,1,1,1,mesenchymal stem cell differentiation,BP,WNT3
5953,GO:1905474,0.33751435372703,1,1,1,canonical Wnt signaling pathway involved in stem cell proliferation,BP,WNT3
3339,GO:0044448,0.337717278880009,0.861251983337227,4,10,cell cortex part,CC,CDH1;SPTBN5;SPTB;SPTBN4
1885,GO:0022409,0.337864777322328,0.88499991683686,3,7,positive regulation of cell-cell adhesion,BP,PIK3CA;BMP7;FSTL3
3886,GO:0048738,0.337983333951053,0.831298177438068,6,16,cardiac muscle tissue development,BP,WNT2;FZD7;FGF8;BMP4;BMP7;NOTCH1
3449,GO:0045296,0.338963462461319,0.9217518021917,2,4,cadherin binding,MF,CDH1;MB21D2
4334,GO:0055114,0.339504177037217,0.884105939885636,3,7,oxidation-reduction process,BP,GLDC;ACTN3;PIK3CA
3716,GO:0046983,0.339812984461598,0.798912872838122,10,28,protein dimerization activity,MF,GLDC;SYT5;ACTN3;BMP6;HEY1;AXIN1;INHBB;GDNF;TPD52;NOTCH1
2388,GO:0032438,0.340044019312717,1,1,1,melanosome organization,BP,RAB38
2564,GO:0033363,0.340044019312717,1,1,1,secretory granule organization,BP,RAB38
2760,GO:0035646,0.340044019312717,1,1,1,endosome to melanosome transport,BP,RAB38
2761,GO:0035650,0.340044019312717,1,1,1,AP-1 adaptor complex binding,MF,RAB38
2762,GO:0035651,0.340044019312717,1,1,1,AP-3 adaptor complex binding,MF,RAB38
2851,GO:0036461,0.340044019312717,1,1,1,BLOC-2 complex binding,MF,RAB38
3187,GO:0043476,0.340044019312717,1,1,1,pigment accumulation,BP,RAB38
3188,GO:0043482,0.340044019312717,1,1,1,cellular pigment accumulation,BP,RAB38
3190,GO:0043485,0.340044019312717,1,1,1,endosome to pigment granule transport,BP,RAB38
3891,GO:0048753,0.340044019312717,1,1,1,pigment granule organization,BP,RAB38
3893,GO:0048757,0.340044019312717,1,1,1,pigment granule maturation,BP,RAB38
4390,GO:0060155,0.340044019312717,1,1,1,platelet dense granule organization,BP,RAB38
5785,GO:1903232,0.340044019312717,1,1,1,melanosome assembly,BP,RAB38
736,GO:0006091,0.340237305126323,0.921226642494391,2,4,generation of precursor metabolites and energy,BP,ACTN3;PIK3CA
4133,GO:0051224,0.340630709978942,0.921064082266573,2,4,negative regulation of protein transport,BP,INHBB;BMP7
2206,GO:0031406,0.341667396620501,0.920634864008362,2,4,carboxylic acid binding,MF,GLDC;VDR
3100,GO:0043177,0.341667396620501,0.920634864008362,2,4,organic acid binding,MF,GLDC;VDR
350,GO:0002762,0.342430848679971,0.920317988446721,2,4,negative regulation of myeloid leukocyte differentiation,BP,CLDN18;FSTL3
62,GO:0000988,0.342947481669598,0.858007940975284,4,10,transcription factor activity, protein binding,MF,TLE1;HEY1;POU3F1;NOTCH1
4324,GO:0055076,0.343185510775529,0.920004106628659,2,4,transition metal ion homeostasis,BP,BMP6;TF
2662,GO:0034698,0.343825841444021,0.919737267084558,2,4,response to gonadotropin,BP,GJB2;NOTCH1
558,GO:0005105,0.345263529728345,1,1,1,type 1 fibroblast growth factor receptor binding,MF,FGF17
798,GO:0006511,0.345311025047684,0.919116551379195,2,4,ubiquitin-dependent protein catabolic process,BP,AXIN1;RNF144A
1813,GO:0019941,0.345311025047684,0.919116551379195,2,4,modification-dependent protein catabolic process,BP,AXIN1;RNF144A
3095,GO:0043161,0.345311025047684,0.919116551379195,2,4,proteasome-mediated ubiquitin-dependent protein catabolic process,BP,AXIN1;RNF144A
3239,GO:0043632,0.345311025047684,0.919116551379195,2,4,modification-dependent macromolecule catabolic process,BP,AXIN1;RNF144A
5771,GO:1903050,0.345311025047684,0.919116551379195,2,4,regulation of proteolysis involved in cellular protein catabolic process,BP,AXIN1;RNF144A
1116,GO:0008283,0.345404467861446,0.765426632618818,19,56,cell proliferation,BP,SCIN;WNT7A;PIK3CG;BMP6;WNT3;GJB6;WNT7B;JAG2;WNT2;FZD7;FGF8;VDR;ARTN;FGF17;HRAS;BMP4;GDNF;BMP7;NOTCH1
173,GO:0001893,0.345474233116915,0.919048186183453,2,4,maternal placenta development,BP,GJB2;VDR
4136,GO:0051235,0.346346630939727,0.918682234451832,2,4,maintenance of location,BP,SCIN;SPTBN4
511,GO:0004603,0.347084018027369,1,1,1,phenylethanolamine N-methyltransferase activity,MF,PNMT
1093,GO:0008168,0.347084018027369,1,1,1,methyltransferase activity,MF,PNMT
1094,GO:0008170,0.347084018027369,1,1,1,N-methyltransferase activity,MF,PNMT
1160,GO:0008757,0.347084018027369,1,1,1,S-adenosylmethionine-dependent methyltransferase activity,MF,PNMT
1227,GO:0009713,0.347084018027369,1,1,1,catechol-containing compound biosynthetic process,BP,PNMT
1667,GO:0016741,0.347084018027369,1,1,1,transferase activity, transferring one-carbon groups,MF,PNMT
2974,GO:0042414,0.347084018027369,1,1,1,epinephrine metabolic process,BP,PNMT
2976,GO:0042418,0.347084018027369,1,1,1,epinephrine biosynthetic process,BP,PNMT
2977,GO:0042423,0.347084018027369,1,1,1,catecholamine biosynthetic process,BP,PNMT
97,GO:0001562,0.34719597776418,1,1,1,response to protozoan,BP,HRAS
1333,GO:0010586,0.34719597776418,1,1,1,miRNA metabolic process,BP,HRAS
2219,GO:0031529,0.34719597776418,1,1,1,ruffle organization,BP,HRAS
2655,GO:0034660,0.34719597776418,1,1,1,ncRNA metabolic process,BP,HRAS
2796,GO:0035900,0.34719597776418,1,1,1,response to isolation stress,BP,HRAS
2918,GO:0042088,0.34719597776418,1,1,1,T-helper 1 type immune response,BP,HRAS
3052,GO:0042832,0.34719597776418,1,1,1,defense response to protozoan,BP,HRAS
3745,GO:0048168,0.34719597776418,1,1,1,regulation of neuronal synaptic plasticity,BP,HRAS
3746,GO:0048169,0.34719597776418,1,1,1,regulation of long-term neuronal synaptic plasticity,BP,HRAS
5362,GO:0097178,0.34719597776418,1,1,1,ruffle assembly,BP,HRAS
5517,GO:1900027,0.34719597776418,1,1,1,regulation of ruffle assembly,BP,HRAS
5518,GO:1900029,0.34719597776418,1,1,1,positive regulation of ruffle assembly,BP,HRAS
6067,GO:2000249,0.34719597776418,1,1,1,regulation of actin cytoskeleton reorganization,BP,HRAS
6068,GO:2000251,0.34719597776418,1,1,1,positive regulation of actin cytoskeleton reorganization,BP,HRAS
6105,GO:2000628,0.34719597776418,1,1,1,regulation of miRNA metabolic process,BP,HRAS
6106,GO:2000630,0.34719597776418,1,1,1,positive regulation of miRNA metabolic process,BP,HRAS
3971,GO:0050767,0.34734643981233,0.814365481028567,7,19,regulation of neurogenesis,BP,WNT7A;BMP6;WNT3;WNT2;BMP4;BMP7;NOTCH1
2993,GO:0042490,0.347630258988579,0.879627559375421,3,7,mechanoreceptor differentiation,BP,JAG2;BMP4;NOTCH1
4377,GO:0060113,0.347630258988579,0.879627559375421,3,7,inner ear receptor cell differentiation,BP,JAG2;BMP4;NOTCH1
2643,GO:0034614,0.347863052963866,0.91804404721287,2,4,cellular response to reactive oxygen species,BP,BMP7;GUCY1B3
2743,GO:0035567,0.347999312790903,0.917986572622651,2,4,non-canonical Wnt signaling pathway,BP,WNT7A;FZD7
1034,GO:0007519,0.348303475976949,0.917858199020585,2,4,skeletal muscle tissue development,BP,ACTN3;NOTCH1
210,GO:0002011,0.348896768142136,0.878922478801496,3,7,morphogenesis of an epithelial sheet,BP,WNT7A;BMP7;NOTCH1
4026,GO:0050886,0.349229535210593,0.917466694662012,2,4,endocrine process,BP,BMP6;INHBB
981,GO:0007249,0.349844534328954,0.917206148741803,2,4,I-kappaB kinase/NF-kappaB signaling,BP,TLE1;BMP7
3088,GO:0043122,0.349844534328954,0.917206148741803,2,4,regulation of I-kappaB kinase/NF-kappaB signaling,BP,TLE1;BMP7
1441,GO:0010976,0.350009718681509,0.917136093600287,2,4,positive regulation of neuron projection development,BP,WNT3;BMP7
5306,GO:0090316,0.350076339778969,0.878264071961694,3,7,positive regulation of intracellular protein transport,BP,BMP6;CDH1;BMP4
160,GO:0001839,0.350173603474231,1,1,1,neural plate morphogenesis,BP,FGF8
161,GO:0001840,0.350173603474231,1,1,1,neural plate development,BP,FGF8
1075,GO:0008045,0.350173603474231,1,1,1,motor neuron axon guidance,BP,FGF8
1081,GO:0008078,0.350173603474231,1,1,1,mesodermal cell migration,BP,FGF8
1825,GO:0021544,0.350173603474231,1,1,1,subpallium development,BP,FGF8
1849,GO:0021798,0.350173603474231,1,1,1,forebrain dorsal/ventral pattern formation,BP,FGF8
1861,GO:0021903,0.350173603474231,1,1,1,rostrocaudal neural tube patterning,BP,FGF8
1913,GO:0023019,0.350173603474231,1,1,1,signal transduction involved in regulation of gene expression,BP,FGF8
2123,GO:0030917,0.350173603474231,1,1,1,midbrain-hindbrain boundary development,BP,FGF8
2573,GO:0033563,0.350173603474231,1,1,1,dorsal/ventral axon guidance,BP,FGF8
3782,GO:0048382,0.350173603474231,1,1,1,mesendoderm development,BP,FGF8
5265,GO:0090133,0.350173603474231,1,1,1,mesendoderm migration,BP,FGF8
5266,GO:0090134,0.350173603474231,1,1,1,cell migration involved in mesendoderm migration,BP,FGF8
1054,GO:0007605,0.350419714929129,0.878072095731284,3,7,sensory perception of sound,BP,GJB2;GJB6;SPTBN4
4047,GO:0050954,0.350419714929129,0.878072095731284,3,7,sensory perception of mechanical stimulus,BP,GJB2;GJB6;SPTBN4
4097,GO:0051148,0.350804254545457,0.877856937411265,3,7,negative regulation of muscle cell differentiation,BP,FZD7;BMP4;NOTCH1
1542,GO:0015672,0.350818276646925,0.853066783749347,4,10,monovalent inorganic cation transport,BP,KCNG2;WNK4;KCNK6;SPTBN4
2639,GO:0034599,0.351065006807858,0.877710940035751,3,7,cellular response to oxidative stress,BP,GJB2;BMP7;GUCY1B3
4547,GO:0060674,0.351196584894893,0.916631813390804,2,4,placenta blood vessel development,BP,HEY1;WNT2
5061,GO:0072074,0.351523138470363,0.916492780363563,2,4,kidney mesenchyme development,BP,BMP4;BMP7
5781,GO:1903169,0.351923628626457,0.916322099712291,2,4,regulation of calcium ion transmembrane transport,BP,PIK3CG;TSPAN13
4459,GO:0060419,0.352515110122314,0.916069682777027,2,4,heart growth,BP,WNT2;NOTCH1
4460,GO:0060420,0.352515110122314,0.916069682777027,2,4,regulation of heart growth,BP,WNT2;NOTCH1
4461,GO:0060421,0.352515110122314,0.916069682777027,2,4,positive regulation of heart growth,BP,WNT2;NOTCH1
225,GO:0002068,0.352583541758757,0.916040453161306,2,4,glandular epithelial cell development,BP,BMP6;BMP4
462,GO:0003309,0.352583541758757,0.916040453161306,2,4,type B pancreatic cell differentiation,BP,BMP6;BMP4
463,GO:0003323,0.352583541758757,0.916040453161306,2,4,type B pancreatic cell development,BP,BMP6;BMP4
2794,GO:0035883,0.352583541758757,0.916040453161306,2,4,enteroendocrine cell differentiation,BP,BMP6;BMP4
1697,GO:0017022,0.353012329737795,0.915857178810978,2,4,myosin binding,MF,SPTBN5;RAB3D
5617,GO:1901615,0.353256267163996,0.851521761022835,4,10,organic hydroxy compound metabolic process,BP,ACTN3;BMP6;VDR;PNMT
4642,GO:0061036,0.353624834646014,0.915595009557137,2,4,positive regulation of cartilage development,BP,BMP6;BMP4
115,GO:0001667,0.354670101724877,0.793334431791137,9,25,ameboidal-type cell migration,BP,WNT7A;FGF8;CRB2;AMOT;PKN3;BMP4;GDNF;PIK3CA;NOTCH1
6135,GO:2000826,0.354740906938032,0.915116179500307,2,4,regulation of heart morphogenesis,BP,BMP4;NOTCH1
3067,GO:0043025,0.355569719691182,0.875175835595824,3,7,neuronal cell body,CC,SYT5;DRP2;SPTBN4
2875,GO:0038093,0.355625943489456,0.914735441699533,2,4,Fc receptor signaling pathway,BP,HRAS;PIK3CA
2877,GO:0038095,0.355625943489456,0.914735441699533,2,4,Fc-epsilon receptor signaling pathway,BP,HRAS;PIK3CA
1067,GO:0008009,0.3558843434208,1,1,1,chemokine activity,MF,CCL20
2253,GO:0031731,0.3558843434208,1,1,1,CCR6 chemokine receptor binding,MF,CCL20
2420,GO:0032610,0.3558843434208,1,1,1,interleukin-1 alpha production,BP,CCL20
2432,GO:0032650,0.3558843434208,1,1,1,regulation of interleukin-1 alpha production,BP,CCL20
2450,GO:0032730,0.3558843434208,1,1,1,positive regulation of interleukin-1 alpha production,BP,CCL20
2747,GO:0035584,0.3558843434208,1,1,1,calcium-mediated signaling using intracellular calcium source,BP,CCL20
2944,GO:0042222,0.3558843434208,1,1,1,interleukin-1 biosynthetic process,BP,CCL20
2971,GO:0042379,0.3558843434208,1,1,1,chemokine receptor binding,MF,CCL20
3455,GO:0045360,0.3558843434208,1,1,1,regulation of interleukin-1 biosynthetic process,BP,CCL20
3456,GO:0045362,0.3558843434208,1,1,1,positive regulation of interleukin-1 biosynthetic process,BP,CCL20
3731,GO:0048020,0.3558843434208,1,1,1,CCR chemokine receptor binding,MF,CCL20
3960,GO:0050719,0.3558843434208,1,1,1,interleukin-1 alpha biosynthetic process,BP,CCL20
3961,GO:0050721,0.3558843434208,1,1,1,regulation of interleukin-1 alpha biosynthetic process,BP,CCL20
3962,GO:0050726,0.3558843434208,1,1,1,positive regulation of interleukin-1 alpha biosynthetic process,BP,CCL20
4250,GO:0051770,0.3558843434208,1,1,1,positive regulation of nitric-oxide synthase biosynthetic process,BP,CCL20
4825,GO:0070391,0.3558843434208,1,1,1,response to lipoteichoic acid,BP,CCL20
4898,GO:0071223,0.3558843434208,1,1,1,cellular response to lipoteichoic acid,BP,CCL20
5206,GO:0072679,0.3558843434208,1,1,1,thymocyte migration,BP,CCL20
718,GO:0005996,0.356231651199513,0.874801267341525,3,7,monosaccharide metabolic process,BP,ACTN3;PMAIP1;PIK3CA
1761,GO:0019318,0.356231651199513,0.874801267341525,3,7,hexose metabolic process,BP,ACTN3;PMAIP1;PIK3CA
150,GO:0001816,0.356444818279658,0.831670921849007,5,13,cytokine production,BP,PIK3CG;INHBB;CCL20;HRAS;NOTCH1
4899,GO:0071229,0.356654641177132,0.831527176609167,5,13,cellular response to acid chemical,BP,WNT3;WNT7B;WNT2;FZD7;WNT5B
5086,GO:0072110,0.356799757346716,0.914229066793658,2,4,glomerular mesangial cell proliferation,BP,BMP4;BMP7
5089,GO:0072124,0.356799757346716,0.914229066793658,2,4,regulation of glomerular mesangial cell proliferation,BP,BMP4;BMP7
5284,GO:0090192,0.356799757346716,0.914229066793658,2,4,regulation of glomerulus development,BP,BMP4;BMP7
5636,GO:1901722,0.356799757346716,0.914229066793658,2,4,regulation of cell proliferation involved in kidney development,BP,BMP4;BMP7
6064,GO:2000241,0.357198537878281,0.849008889035255,4,10,regulation of reproductive process,BP,INHBB;BMP4;BMP7;NOTCH1
2670,GO:0034762,0.357367058567453,0.848901069874643,4,10,regulation of transmembrane transport,BP,PIK3CG;KCNG2;KCNK6;TSPAN13
2673,GO:0034765,0.357367058567453,0.848901069874643,4,10,regulation of ion transmembrane transport,BP,PIK3CG;KCNG2;KCNK6;TSPAN13
1365,GO:0010675,0.357528737251688,0.913913781593021,2,4,regulation of cellular carbohydrate metabolic process,BP,ACTN3;PMAIP1
1422,GO:0010906,0.357528737251688,0.913913781593021,2,4,regulation of glucose metabolic process,BP,ACTN3;PMAIP1
3263,GO:0044085,0.357774384275625,0.754731742815107,19,57,cellular component biogenesis,BP,SCIN;TLE1;WNT7A;GJB2;ACTN3;PMAIP1;KCNG2;AXIN1;CDH1;SPTBN5;RAB39A;SPTB;PKP1;HRAS;RAB38;BMP7;SPTBN4;NOTCH1;RAB20
186,GO:0001935,0.357865160491041,0.873874653135225,3,7,endothelial cell proliferation,BP,BMP6;WNT2;BMP4
187,GO:0001936,0.357865160491041,0.873874653135225,3,7,regulation of endothelial cell proliferation,BP,BMP6;WNT2;BMP4
188,GO:0001938,0.357865160491041,0.873874653135225,3,7,positive regulation of endothelial cell proliferation,BP,BMP6;WNT2;BMP4
4243,GO:0051704,0.357923209505677,0.759046541021361,17,50,multi-organism process,BP,SLC2A14;GJB2;BMP6;WNT3;GJB6;JAG2;PMAIP1;CDH1;RAB40B;VDR;INHBB;CCL20;HRAS;BMP4;FSTL3;SPTBN4;NOTCH1
1345,GO:0010631,0.357965435894888,0.817142441713002,6,16,epithelial cell migration,BP,WNT7A;AMOT;PKN3;BMP4;PIK3CA;NOTCH1
5495,GO:0099513,0.358214008342107,0.848358694761402,4,10,polymeric cytoskeletal fiber,CC,ACTN3;AMOT;PKP1;RAB3D
193,GO:0001947,0.35831579526551,0.913572681126365,2,4,heart looping,BP,FGF8;NOTCH1
4714,GO:0061371,0.35831579526551,0.913572681126365,2,4,determination of heart left/right asymmetry,BP,FGF8;NOTCH1
442,GO:0003231,0.358511119576054,0.873507343087043,3,7,cardiac ventricle development,BP,HEY1;BMP4;NOTCH1
452,GO:0003281,0.358511119576054,0.873507343087043,3,7,ventricular septum development,BP,HEY1;BMP4;NOTCH1
5205,GO:0072678,0.358785440663285,0.913368798280508,2,4,T cell migration,BP,PIK3CG;CCL20
623,GO:0005543,0.358972243635457,0.84787242541675,4,10,phospholipid binding,MF,SCIN;SYT5;FZD7;SPTBN4
5632,GO:1901698,0.359170803255857,0.782848608774486,10,29,response to nitrogen compound,BP,GJB2;PIK3CG;PMAIP1;CDH1;INHBB;BMP4;PIK3CA;BMP7;NOTCH1;GUCY1B3
3834,GO:0048593,0.359484501940682,0.872952900319512,3,7,camera-type eye morphogenesis,BP,WNT2;BMP4;BMP7
3269,GO:0044092,0.360088355634826,0.796306457197009,8,22,negative regulation of molecular function,BP,HEY1;CRB2;AMOT;DUSP5;HRAS;BMP4;BMP7;NOTCH1
87,GO:0001504,0.360359997740837,1,1,1,neurotransmitter uptake,BP,GDNF
202,GO:0001963,0.360359997740837,1,1,1,synaptic transmission, dopaminergic,BP,GDNF
1464,GO:0014046,0.360359997740837,1,1,1,dopamine secretion,BP,GDNF
1468,GO:0014059,0.360359997740837,1,1,1,regulation of dopamine secretion,BP,GDNF
1565,GO:0015872,0.360359997740837,1,1,1,dopamine transport,BP,GDNF
1847,GO:0021784,0.360359997740837,1,1,1,postganglionic parasympathetic fiber development,BP,GDNF
2029,GO:0030432,0.360359997740837,1,1,1,peristalsis,BP,GDNF
2315,GO:0032225,0.360359997740837,1,1,1,regulation of synaptic transmission, dopaminergic,BP,GDNF
2577,GO:0033603,0.360359997740837,1,1,1,positive regulation of dopamine secretion,BP,GDNF
2579,GO:0033605,0.360359997740837,1,1,1,positive regulation of catecholamine secretion,BP,GDNF
3193,GO:0043489,0.360359997740837,1,1,1,RNA stabilization,BP,GDNF
3760,GO:0048255,0.360359997740837,1,1,1,mRNA stabilization,BP,GDNF
3792,GO:0048483,0.360359997740837,1,1,1,autonomic nervous system development,BP,GDNF
3793,GO:0048484,0.360359997740837,1,1,1,enteric nervous system development,BP,GDNF
3794,GO:0048485,0.360359997740837,1,1,1,sympathetic nervous system development,BP,GDNF
3795,GO:0048486,0.360359997740837,1,1,1,parasympathetic nervous system development,BP,GDNF
4216,GO:0051580,0.360359997740837,1,1,1,regulation of neurotransmitter uptake,BP,GDNF
4217,GO:0051583,0.360359997740837,1,1,1,dopamine uptake involved in synaptic transmission,BP,GDNF
4218,GO:0051584,0.360359997740837,1,1,1,regulation of dopamine uptake involved in synaptic transmission,BP,GDNF
4219,GO:0051588,0.360359997740837,1,1,1,regulation of neurotransmitter transport,BP,GDNF
4277,GO:0051934,0.360359997740837,1,1,1,catecholamine uptake involved in synaptic transmission,BP,GDNF
4279,GO:0051940,0.360359997740837,1,1,1,regulation of catecholamine uptake involved in synaptic transmission,BP,GDNF
4282,GO:0051954,0.360359997740837,1,1,1,positive regulation of amine transport,BP,GDNF
4549,GO:0060676,0.360359997740837,1,1,1,ureteric bud formation,BP,GDNF
5082,GO:0072106,0.360359997740837,1,1,1,regulation of ureteric bud formation,BP,GDNF
5083,GO:0072107,0.360359997740837,1,1,1,positive regulation of ureteric bud formation,BP,GDNF
5111,GO:0072172,0.360359997740837,1,1,1,mesonephric tubule formation,BP,GDNF
5318,GO:0090493,0.360359997740837,1,1,1,catecholamine uptake,BP,GDNF
5319,GO:0090494,0.360359997740837,1,1,1,dopamine uptake,BP,GDNF
5463,GO:0098810,0.360359997740837,1,1,1,neurotransmitter reuptake,BP,GDNF
5942,GO:1905278,0.360359997740837,1,1,1,positive regulation of epithelial tube formation,BP,GDNF
876,GO:0006887,0.360624736443689,0.795896680933119,8,22,exocytosis,BP,SCIN;PIK3CG;SYT5;RAB40B;PKP1;RAB3D;NOTCH1;TF
409,GO:0003170,0.36123707755017,0.871951740727525,3,7,heart valve development,BP,HEY1;BMP4;NOTCH1
415,GO:0003179,0.36123707755017,0.871951740727525,3,7,heart valve morphogenesis,BP,HEY1;BMP4;NOTCH1
3568,GO:0045913,0.361536020504731,0.912169529921411,2,4,positive regulation of carbohydrate metabolic process,BP,ACTN3;PMAIP1
3297,GO:0044297,0.362259172870257,0.845756742685158,4,10,cell body,CC,GJB2;SYT5;DRP2;SPTBN4
592,GO:0005249,0.362352179849132,0.911811972622853,2,4,voltage-gated potassium channel activity,MF,KCNG2;KCNK6
599,GO:0005267,0.362352179849132,0.911811972622853,2,4,potassium channel activity,MF,KCNG2;KCNK6
1080,GO:0008076,0.362352179849132,0.911811972622853,2,4,voltage-gated potassium channel complex,CC,KCNG2;KCNK6
1518,GO:0015077,0.362352179849132,0.911811972622853,2,4,monovalent inorganic cation transmembrane transporter activity,MF,KCNG2;KCNK6
1519,GO:0015079,0.362352179849132,0.911811972622853,2,4,potassium ion transmembrane transporter activity,MF,KCNG2;KCNK6
2666,GO:0034705,0.362352179849132,0.911811972622853,2,4,potassium channel complex,CC,KCNG2;KCNK6
4341,GO:0060021,0.362380790067237,0.911799424361061,2,4,palate development,BP,WNT7A;JAG2
1063,GO:0007626,0.362498532231659,0.911747773259551,2,4,locomotory behavior,BP,GDNF;SPTBN4
871,GO:0006875,0.362518170400379,0.84558950129656,4,10,cellular metal ion homeostasis,BP,PIK3CG;BMP6;VDR;TF
953,GO:0007163,0.362755757866881,0.845436016326585,4,10,establishment or maintenance of cell polarity,BP,WNT7A;WNT7B;CRB2;AMOT
2196,GO:0031346,0.363124685628983,0.870869288358955,3,7,positive regulation of cell projection organization,BP,WNT3;HRAS;BMP7
4776,GO:0070169,0.363671709494208,0.870554790023936,3,7,positive regulation of biomineral tissue development,BP,BMP6;BMP4;BMP7
3529,GO:0045747,0.363887947689549,0.91113703308502,2,4,positive regulation of Notch signaling pathway,BP,JAG2;NOTCH1
1114,GO:0008270,0.363908028325045,0.84469070111267,4,10,zinc ion binding,MF,RABIF;VDR;RNF144A;DRP2
1344,GO:0010629,0.364251461588129,0.778811923485467,10,29,negative regulation of gene expression,BP,TLE1;BMP6;HEY1;AXIN1;VDR;PKP1;HRAS;BMP4;BMP7;NOTCH1
2908,GO:0042035,0.364761689732571,0.910751801031611,2,4,regulation of cytokine biosynthetic process,BP,INHBB;CCL20
2919,GO:0042089,0.364761689732571,0.910751801031611,2,4,cytokine biosynthetic process,BP,INHBB;CCL20
2925,GO:0042107,0.364761689732571,0.910751801031611,2,4,cytokine metabolic process,BP,INHBB;CCL20
1152,GO:0008610,0.364881229476486,0.801370327942259,7,19,lipid biosynthetic process,BP,PIK3CG;MBOAT2;BMP6;FGF8;VDR;FGF17;PIK3CA
221,GO:0002064,0.365186034912207,0.811923864776692,6,16,epithelial cell development,BP,WNT7A;BMP6;WNT7B;WNT5B;BMP4;NOTCH1
3351,GO:0044699,0.365193716417684,0.781059302621498,66,211,single-organism process,BP,SLC2A14;GLDC;RHPN1;SCIN;TLE1;WNT7A;GJB2;PIK3CG;SYT5;ACTN3;CLDN18;RABIF;MBOAT2;GJA3;BMP6;WNT3;HEY1;GJB6;WNT7B;JAG2;PMAIP1;KCNG2;AXIN1;POU3F1;MAPK12;WNT2;CDH1;SPTBN5;RAB40B;RAB39A;SPTB;RRAS2;FZD7;FGF8;VDR;CRB2;ARTN;DSG3;AMOT;WNT5B;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;FGF17;TSPAN15;HRAS;BMP4;RAB3D;KCNK6;GDNF;RAB38;PIK3CA;BMP7;DRP2;FSTL3;TPD52;SPTBN4;TSPAN13;NOTCH1;RND3;RAB20;GUCY1B3;TF
3168,GO:0043405,0.365304387759674,0.801052888463085,7,19,regulation of MAP kinase activity,BP,PIK3CG;WNT7B;AXIN1;DUSP5;HRAS;BMP4;BMP7
1647,GO:0016567,0.366060001150053,0.843294615224616,4,10,protein ubiquitination,BP,MAGEC2;AXIN1;RAB40B;RNF144A
2389,GO:0032446,0.366060001150053,0.843294615224616,4,10,protein modification by small protein conjugation,BP,MAGEC2;AXIN1;RAB40B;RNF144A
3225,GO:0043583,0.366156154418642,0.811218531471638,6,16,ear development,BP,GJB2;GJB6;JAG2;FGF8;BMP4;NOTCH1
2880,GO:0038128,0.366313111332944,0.910065560756169,2,4,ERBB2 signaling pathway,BP,HRAS;PIK3CA
926,GO:0007033,0.366993121230209,0.909763875312632,2,4,vacuole organization,BP,RAB39A;RAB20
3952,GO:0050708,0.367352736285309,0.868429028309957,3,7,regulation of protein secretion,BP,BMP6;KCNG2;INHBB
3758,GO:0048247,0.367815475771317,0.909398307664656,2,4,lymphocyte chemotaxis,BP,PIK3CG;CCL20
2049,GO:0030545,0.367973326938057,0.868069020208042,3,7,receptor regulator activity,MF,WNT7A;WNT3;WNT2
2050,GO:0030546,0.367973326938057,0.868069020208042,3,7,receptor activator activity,MF,WNT7A;WNT3;WNT2
2193,GO:0031334,0.368717736872547,0.90899629649118,2,4,positive regulation of protein complex assembly,BP,SCIN;PMAIP1
2718,GO:0035295,0.368817741047864,0.765539890488015,12,35,tube development,BP,WNT7A;CLDN18;WNT7B;WNT2;FGF8;VDR;WNK4;BMP4;GDNF;BMP7;FSTL3;NOTCH1
1384,GO:0010769,0.36894392692125,0.908895363930165,2,4,regulation of cell morphogenesis involved in differentiation,BP,WNT7A;WNT3
1538,GO:0015629,0.369518220454524,0.796207273290252,7,20,actin cytoskeleton,CC,SCIN;ACTN3;CDH1;SPTBN5;SPTB;AMOT;SPTBN4
1946,GO:0030097,0.369645996352427,0.787597571926075,8,23,hemopoiesis,BP,SCIN;CLDN18;JAG2;FZD7;BMP4;FSTL3;TPD52;NOTCH1
1907,GO:0022857,0.369936393160341,0.808460584249466,6,16,transmembrane transporter activity,MF,SLC2A14;GJB2;GJA3;KCNG2;KCNK6;TF
4232,GO:0051648,0.370121380576293,0.866819300583749,3,7,vesicle localization,BP,WNT7A;PIK3CG;SYT5
657,GO:0005770,0.370987201002129,0.907980840922403,2,4,late endosome,CC,TSPAN15;TF
5397,GO:0097479,0.371083431154131,0.90793764803592,2,4,synaptic vesicle localization,BP,WNT7A;SYT5
2961,GO:0042326,0.371124695475016,0.839987587900803,4,10,negative regulation of phosphorylation,BP,ACTN3;DUSP5;BMP4;BMP7
5819,GO:1903530,0.371172354021481,0.796632265621844,7,19,regulation of secretion by cell,BP,SYT5;BMP6;KCNG2;INHBB;RAB3D;GDNF;NOTCH1
2569,GO:0033554,0.371220657412891,0.763570235002959,12,35,cellular response to stress,BP,WNT7A;GJB2;WNT7B;PMAIP1;AXIN1;MAPK12;FZD7;INHBB;HRAS;BMP7;NOTCH1;GUCY1B3
2931,GO:0042127,0.371728417806916,0.749885228380398,16,47,regulation of cell proliferation,BP,SCIN;WNT7A;BMP6;WNT3;GJB6;JAG2;WNT2;FZD7;FGF8;VDR;FGF17;HRAS;BMP4;GDNF;BMP7;NOTCH1
1254,GO:0009897,0.372271099771919,0.86556297640846,3,7,external side of plasma membrane,CC,FGF8;AMOT;TF
1261,GO:0009948,0.372745380588422,0.907189940980563,2,4,anterior/posterior axis specification,BP,WNT3;BMP4
2130,GO:0031012,0.373875750548096,0.794583937884623,7,19,extracellular matrix,CC,WNT7A;WNT3;WNT7B;WNT2;WNT5B;BMP4;BMP7
915,GO:0007005,0.374886565350484,0.906221764534691,2,4,mitochondrion organization,BP,PMAIP1;RAB38
42,GO:0000323,0.375341545638122,0.837211271466693,4,10,lytic vacuole,CC,PIK3CG;RAB39A;RAB3D;RAB38
652,GO:0005764,0.375341545638122,0.837211271466693,4,10,lysosome,CC,PIK3CG;RAB39A;RAB3D;RAB38
2205,GO:0031401,0.375408350347576,0.749550248730545,15,44,positive regulation of protein modification process,BP,MAGEC2;WNT7A;PIK3CG;BMP6;WNT7B;AXIN1;FZD7;FGF8;DUSP5;INHBB;CCL20;HRAS;BMP4;PIK3CA;BMP7
882,GO:0006898,0.376196747036533,0.905626634286369,2,4,receptor-mediated endocytosis,BP,SYT5;TF
4316,GO:0055038,0.376247968940081,0.905603325685077,2,4,recycling endosome membrane,CC,SYT5;FZD7
149,GO:0001786,0.37686597884719,0.905321851063806,2,4,phosphatidylserine binding,MF,SCIN;SYT5
672,GO:0005796,0.377916665847493,0.835505586492392,4,10,Golgi lumen,CC,WNT7A;WNT3;WNT7B;WNT5B
2497,GO:0032924,0.378937359336041,0.904375084659921,2,4,activin receptor signaling pathway,BP,INHBB;FSTL3
4753,GO:0065008,0.379525733689871,0.725413297767129,27,83,regulation of biological quality,BP,SCIN;WNT7A;PIK3CG;SYT5;CLDN18;BMP6;WNT3;GJB6;WNT7B;PMAIP1;KCNG2;SPTBN5;RAB39A;SPTB;VDR;WNK4;INHBB;HRAS;BMP4;RAB3D;KCNK6;GDNF;RAB38;PIK3CA;SPTBN4;RAB20;TF
5064,GO:0072077,0.379749539566764,0.904002450549309,2,4,renal vesicle morphogenesis,BP,BMP4;GDNF
5068,GO:0072087,0.379749539566764,0.904002450549309,2,4,renal vesicle development,BP,BMP4;GDNF
4502,GO:0060513,0.379765130060667,0.903995289733639,2,4,prostatic bud formation,BP,BMP4;BMP7
4532,GO:0060601,0.379765130060667,0.903995289733639,2,4,lateral sprouting from an epithelium,BP,BMP4;BMP7
5296,GO:0090263,0.380383659159232,0.860770894008472,3,7,positive regulation of canonical Wnt signaling pathway,BP,WNT7A;AXIN1;WNT2
4177,GO:0051341,0.380606322290691,0.903608489484198,2,4,regulation of oxidoreductase activity,BP,VDR;GDNF
4182,GO:0051353,0.380606322290691,0.903608489484198,2,4,positive regulation of oxidoreductase activity,BP,VDR;GDNF
4319,GO:0055067,0.380629400123043,0.860624472310261,3,7,monovalent inorganic cation homeostasis,BP,RAB39A;RAB38;RAB20
2678,GO:0035004,0.382410510172092,0.832510303625627,4,10,phosphatidylinositol 3-kinase activity,MF,PIK3CG;FGF8;FGF17;PIK3CA
3632,GO:0046488,0.382410510172092,0.832510303625627,4,10,phosphatidylinositol metabolic process,BP,PIK3CG;FGF8;FGF17;PIK3CA
3676,GO:0046834,0.382410510172092,0.832510303625627,4,10,lipid phosphorylation,BP,PIK3CG;FGF8;FGF17;PIK3CA
3682,GO:0046854,0.382410510172092,0.832510303625627,4,10,phosphatidylinositol phosphorylation,BP,PIK3CG;FGF8;FGF17;PIK3CA
3707,GO:0046934,0.382410510172092,0.832510303625627,4,10,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,MF,PIK3CG;FGF8;FGF17;PIK3CA
4297,GO:0052813,0.382410510172092,0.832510303625627,4,10,phosphatidylinositol bisphosphate kinase activity,MF,PIK3CG;FGF8;FGF17;PIK3CA
1090,GO:0008150,0.383321876351231,0.827153545767666,71,228,biological_process,BP,MAGEC2;SLC2A14;GLDC;RHPN1;SCIN;TLE1;WNT7A;GJB2;PIK3CG;SYT5;ACTN3;CLDN18;RHBDL3;RABIF;MBOAT2;GJA3;BMP6;WNT3;HEY1;GJB6;WNT7B;JAG2;PMAIP1;KCNG2;AXIN1;POU3F1;MAPK12;WNT2;CDH1;SPTBN5;RAB40B;RAB39A;SPTB;RRAS2;FZD7;FGF8;VDR;CRB2;ARTN;DSG3;AMOT;WNT5B;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;FGF17;TSPAN15;HRAS;BMP4;RAB3D;KCNK6;CLDN15;GDNF;RNF144A;RAB38;PIK3CA;BMP7;DRP2;FSTL3;TPD52;SPTBN4;TSPAN13;NOTCH1;RND3;PNMT;RAB20;GUCY1B3;TF
1944,GO:0030072,0.38461247386229,0.901754610174248,2,4,peptide hormone secretion,BP,KCNG2;INHBB
785,GO:0006469,0.384985275458456,0.858016700558099,3,7,negative regulation of protein kinase activity,BP,DUSP5;BMP4;BMP7
2585,GO:0033673,0.384985275458456,0.858016700558099,3,7,negative regulation of kinase activity,BP,DUSP5;BMP4;BMP7
4181,GO:0051348,0.384985275458456,0.858016700558099,3,7,negative regulation of transferase activity,BP,DUSP5;BMP4;BMP7
1781,GO:0019722,0.385694527703974,0.901250537599625,2,4,calcium-mediated signaling,BP,ACTN3;CCL20
1339,GO:0010608,0.386311360721813,0.9009625489056,2,4,posttranscriptional regulation of gene expression,BP,BMP4;GDNF
167,GO:0001882,0.386854416433709,0.767954166409962,9,25,nucleoside binding,MF,RAB40B;RAB39A;RRAS2;HRAS;RAB3D;RAB38;RND3;RAB20;GUCY1B3
168,GO:0001883,0.386854416433709,0.767954166409962,9,25,purine nucleoside binding,MF,RAB40B;RAB39A;RRAS2;HRAS;RAB3D;RAB38;RND3;RAB20;GUCY1B3
2789,GO:0035850,0.387246580463923,0.856653641339312,3,7,epithelial cell differentiation involved in kidney development,BP,BMP4;GDNF;NOTCH1
4151,GO:0051259,0.387760185155474,0.828913498664675,4,10,protein oligomerization,BP,PMAIP1;KCNG2;SPTBN5;HRAS
1822,GO:0021536,0.387958800638293,0.856223017967442,3,7,diencephalon development,BP,CDH1;FGF8;BMP4
1869,GO:0021983,0.387958800638293,0.856223017967442,3,7,pituitary gland development,BP,CDH1;FGF8;BMP4
1220,GO:0009617,0.388466254411075,0.809168337386209,5,13,response to bacterium,BP,GJB2;BMP6;GJB6;CCL20;NOTCH1
1024,GO:0007431,0.389297818122743,0.899561652405197,2,4,salivary gland development,BP,FGF8;BMP7
1025,GO:0007435,0.389297818122743,0.899561652405197,2,4,salivary gland morphogenesis,BP,FGF8;BMP7
2716,GO:0035272,0.389297818122743,0.899561652405197,2,4,exocrine system development,BP,FGF8;BMP7
4482,GO:0060445,0.389297818122743,0.899561652405197,2,4,branching involved in salivary gland morphogenesis,BP,FGF8;BMP7
2989,GO:0042476,0.389826708455273,0.827515014528155,4,10,odontogenesis,BP,JAG2;FGF8;BMP4;BMP7
4700,GO:0061333,0.391409269403093,0.826440615040712,4,10,renal tubule morphogenesis,BP,FGF8;WNK4;BMP4;GDNF
5065,GO:0072078,0.391409269403093,0.826440615040712,4,10,nephron tubule morphogenesis,BP,FGF8;WNK4;BMP4;GDNF
3354,GO:0044703,0.391509941560581,0.7567567735825,10,29,multi-organism reproductive process,BP,SLC2A14;GJB2;WNT3;JAG2;VDR;INHBB;BMP4;FSTL3;SPTBN4;NOTCH1
465,GO:0003338,0.393043621876981,0.853130276787704,3,7,metanephros morphogenesis,BP,WNT7B;BMP4;GDNF
4508,GO:0060537,0.393596592710283,0.777639501498107,7,20,muscle tissue development,BP,ACTN3;WNT2;FZD7;FGF8;BMP4;BMP7;NOTCH1
4438,GO:0060349,0.393784721284199,0.89743635641328,2,4,bone morphogenesis,BP,BMP6;BMP4
4439,GO:0060350,0.393784721284199,0.89743635641328,2,4,endochondral bone morphogenesis,BP,BMP6;BMP4
5369,GO:0097190,0.394578225339071,0.804742939237135,5,13,apoptotic signaling pathway,BP,PMAIP1;INHBB;HRAS;BMP4;GDNF
307,GO:0002521,0.394778506927294,0.78769793715407,6,17,leukocyte differentiation,BP,CLDN18;JAG2;FZD7;BMP4;FSTL3;TPD52
4685,GO:0061217,0.395706092664174,0.8965186766372,2,4,regulation of mesonephros development,BP,BMP4;GDNF
4478,GO:0060441,0.397460362478736,0.895676814450615,2,4,epithelial tube branching involved in lung morphogenesis,BP,WNT2;BMP4
2047,GO:0030539,0.397515648167092,0.895650221143823,2,4,male genitalia development,BP,BMP6;FGF8
2960,GO:0042325,0.397593239677192,0.727352223990773,16,48,regulation of phosphorylation,BP,WNT7A;PIK3CG;ACTN3;BMP6;WNT7B;AXIN1;FZD7;FGF8;DUSP5;INHBB;CCL20;HRAS;BMP4;PIK3CA;BMP7;SPTBN4
108,GO:0001655,0.399458285917681,0.756532938067732,9,26,urogenital system development,BP,BMP6;WNT7B;FGF8;WNK4;BMP4;GDNF;BMP7;FSTL3;NOTCH1
5035,GO:0072001,0.399458285917681,0.756532938067732,9,26,renal system development,BP,BMP6;WNT7B;FGF8;WNK4;BMP4;GDNF;BMP7;FSTL3;NOTCH1
637,GO:0005622,0.400104290334224,0.726287563560787,60,191,intracellular,CC,MAGEC2;SLC2A14;TJP3;GLDC;RHPN1;SCIN;TLE1;WNT7A;GJB2;PIK3CG;SYT5;ACTN3;RABIF;MBOAT2;BMP6;WNT3;HEY1;GJB6;WNT7B;PMAIP1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;SPTBN5;RAB40B;RAB39A;SPTB;RRAS2;FZD7;FGF8;VDR;ARTN;DSG3;AMOT;WNT5B;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;FGF17;TSPAN15;HRAS;RAB3D;GDNF;RNF144A;RAB38;PIK3CA;FSTL3;TPD52;SPTBN4;NOTCH1;RND3;PNMT;RAB20;GUCY1B3;TF
497,GO:0003924,0.401110321380648,0.764158937275712,8,22,GTPase activity,MF,RAB40B;RAB39A;RRAS2;HRAS;RAB3D;RAB38;RND3;RAB20
1162,GO:0009056,0.401863393085819,0.747262430935048,10,30,catabolic process,BP,MAGEC2;GLDC;PIK3CG;ACTN3;PMAIP1;AXIN1;RAB39A;PKP1;RNF144A;PIK3CA
2927,GO:0042110,0.402504996510697,0.795887233975322,5,14,T cell activation,BP,PIK3CG;JAG2;FZD7;BMP4;PIK3CA
665,GO:0005783,0.40332219734485,0.753364655823966,9,26,endoplasmic reticulum,CC,WNT7A;MBOAT2;WNT3;WNT7B;RRAS2;WNT5B;RAB38;TPD52;NOTCH1
5114,GO:0072175,0.404393538766638,0.817512768753712,4,10,epithelial tube formation,BP,FGF8;BMP4;GDNF;BMP7
3125,GO:0043234,0.404720596718472,0.723551475912326,15,46,protein complex,CC,SCIN;GJB2;GJA3;WNT3;GJB6;AXIN1;POU3F1;WNT2;CDH1;SPTB;VDR;CRB2;AMOT;NOTCH1;GUCY1B3
4285,GO:0051960,0.405125765705176,0.768540558786144,7,20,regulation of nervous system development,BP,WNT7A;BMP6;WNT3;WNT2;BMP4;BMP7;NOTCH1
92,GO:0001525,0.405154921523046,0.759417870211411,8,23,angiogenesis,BP,WNT7A;PIK3CG;HEY1;FGF8;AMOT;BMP4;PIK3CA;NOTCH1
1338,GO:0010605,0.408224869222737,0.727802682085768,13,39,negative regulation of macromolecule metabolic process,BP,TLE1;BMP6;HEY1;AXIN1;VDR;CRB2;DUSP5;INHBB;PKP1;HRAS;BMP4;BMP7;NOTCH1
638,GO:0005623,0.410192538821484,0.789633013257242,70,225,cell,CC,MAGEC2;SLC2A14;TJP3;GLDC;RHPN1;SCIN;TLE1;WNT7A;GJB2;PIK3CG;SYT5;ACTN3;CLDN18;RABIF;MBOAT2;GJA3;BMP6;WNT3;HEY1;GJB6;WNT7B;JAG2;PMAIP1;KCNG2;AXIN1;POU3F1;MAPK12;WNT2;CDH1;SPTBN5;RAB40B;RAB39A;SPTB;RRAS2;FZD7;FGF8;VDR;CRB2;ARTN;DSG3;AMOT;WNT5B;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;FGF17;TSPAN15;HRAS;RAB3D;KCNK6;CLDN15;GDNF;RNF144A;RAB38;PIK3CA;DRP2;FSTL3;TMEM206;TPD52;SPTBN4;TSPAN13;NOTCH1;RND3;PNMT;RAB20;GUCY1B3;TF
3347,GO:0044464,0.410192538821484,0.789633013257242,70,225,cell part,CC,MAGEC2;SLC2A14;TJP3;GLDC;RHPN1;SCIN;TLE1;WNT7A;GJB2;PIK3CG;SYT5;ACTN3;CLDN18;RABIF;MBOAT2;GJA3;BMP6;WNT3;HEY1;GJB6;WNT7B;JAG2;PMAIP1;KCNG2;AXIN1;POU3F1;MAPK12;WNT2;CDH1;SPTBN5;RAB40B;RAB39A;SPTB;RRAS2;FZD7;FGF8;VDR;CRB2;ARTN;DSG3;AMOT;WNT5B;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;FGF17;TSPAN15;HRAS;RAB3D;KCNK6;CLDN15;GDNF;RNF144A;RAB38;PIK3CA;DRP2;FSTL3;TMEM206;TPD52;SPTBN4;TSPAN13;NOTCH1;RND3;PNMT;RAB20;GUCY1B3;TF
707,GO:0005938,0.41044931892449,0.789937353041032,5,14,cell cortex,CC,SCIN;CDH1;SPTBN5;SPTB;SPTBN4
5500,GO:0099568,0.41044931892449,0.789937353041032,5,14,cytoplasmic region,CC,SCIN;CDH1;SPTBN5;SPTB;SPTBN4
680,GO:0005829,0.410768220148359,0.700509909969064,24,75,cytosol,CC,MAGEC2;RHPN1;TLE1;GJB2;PIK3CG;ACTN3;RABIF;GJB6;PMAIP1;AXIN1;MAPK12;SPTBN5;RAB39A;SPTB;DSG3;AMOT;WNK4;HRAS;RAB38;PIK3CA;SPTBN4;NOTCH1;PNMT;GUCY1B3
183,GO:0001932,0.411515957249676,0.718113428991274,15,45,regulation of protein phosphorylation,BP,WNT7A;PIK3CG;BMP6;WNT7B;AXIN1;FZD7;FGF8;DUSP5;INHBB;CCL20;HRAS;BMP4;PIK3CA;BMP7;SPTBN4
3805,GO:0048519,0.412758273501495,0.692128550367296,33,104,negative regulation of biological process,BP,SCIN;TLE1;WNT7A;PIK3CG;ACTN3;CLDN18;BMP6;WNT3;HEY1;GJB6;AXIN1;MAPK12;CDH1;SPTBN5;SPTB;FZD7;FGF8;VDR;CRB2;AMOT;WNT5B;WNK4;DUSP5;INHBB;PKP1;HRAS;BMP4;GDNF;PIK3CA;BMP7;FSTL3;SPTBN4;NOTCH1
2278,GO:0031982,0.414068706788665,0.691828868414106,31,97,vesicle,CC,SCIN;WNT7A;SYT5;ACTN3;BMP6;WNT3;WNT7B;KCNG2;AXIN1;CDH1;SPTBN5;RAB40B;RAB39A;RRAS2;FZD7;CRB2;DSG3;AMOT;WNT5B;PKP1;TSPAN15;RAB3D;RNF144A;RAB38;BMP7;FSTL3;SPTBN4;NOTCH1;RND3;RAB20;TF
5707,GO:1902494,0.414714259103295,0.805811474815744,4,11,catalytic complex,CC,GLDC;PIK3CG;RNF144A;PIK3CA
4415,GO:0060284,0.415486084082198,0.750987929085007,8,23,regulation of cell development,BP,WNT7A;CLDN18;BMP6;WNT3;WNT2;BMP4;BMP7;NOTCH1
1163,GO:0009057,0.419618254627894,0.782981105751995,5,14,macromolecule catabolic process,BP,MAGEC2;PMAIP1;AXIN1;PKP1;RNF144A
1437,GO:0010959,0.424066915852179,0.79902306647617,4,11,regulation of metal ion transport,BP,PIK3CG;WNK4;SPTBN4;TSPAN13
3150,GO:0043296,0.425194553402955,0.76397364639549,6,17,apical junction complex,CC,TJP3;CLDN18;CDH1;AMOT;WNK4;CLDN15
4822,GO:0070374,0.426165230284786,0.802086250260733,4,10,positive regulation of ERK1 and ERK2 cascade,BP,FGF8;CCL20;HRAS;BMP4
1948,GO:0030099,0.426676170144365,0.797110164835888,4,11,myeloid cell differentiation,BP,SCIN;CLDN18;BMP4;FSTL3
323,GO:0002683,0.427221830130382,0.796709075273201,4,11,negative regulation of immune system process,BP,CLDN18;BMP4;FSTL3;NOTCH1
3118,GO:0043227,0.428215803673663,0.682268616825271,49,156,membrane-bounded organelle,CC,MAGEC2;SLC2A14;TJP3;GLDC;SCIN;TLE1;WNT7A;GJB2;PIK3CG;SYT5;ACTN3;MBOAT2;BMP6;WNT3;HEY1;WNT7B;PMAIP1;KCNG2;AXIN1;POU3F1;MAPK12;CDH1;SPTBN5;RAB40B;RAB39A;SPTB;RRAS2;FZD7;VDR;CRB2;DSG3;AMOT;WNT5B;DUSP5;PKN3;PKP1;TSPAN15;HRAS;RAB3D;RNF144A;RAB38;BMP7;FSTL3;TPD52;SPTBN4;NOTCH1;RND3;RAB20;TF
797,GO:0006508,0.429443085100877,0.760580211479334,6,17,proteolysis,BP,RHBDL3;PMAIP1;AXIN1;MAPK12;CRB2;RNF144A
5923,GO:1904951,0.430071086354299,0.79460878236252,4,11,positive regulation of establishment of protein localization,BP,BMP6;PMAIP1;CDH1;BMP4
2642,GO:0034613,0.435013545194575,0.703857557488087,13,40,cellular protein localization,BP,SCIN;CLDN18;BMP6;PMAIP1;CDH1;RAB40B;FZD7;AMOT;TSPAN15;BMP4;RAB38;BMP7;SPTBN4
4864,GO:0070727,0.435013545194575,0.703857557488087,13,40,cellular macromolecule localization,BP,SCIN;CLDN18;BMP6;PMAIP1;CDH1;RAB40B;FZD7;AMOT;TSPAN15;BMP4;RAB38;BMP7;SPTBN4
3493,GO:0045637,0.436125112092568,0.818120167047671,3,8,regulation of myeloid cell differentiation,BP,SCIN;CLDN18;FSTL3
481,GO:0003677,0.436555666338403,0.789791489490584,4,11,DNA binding,MF,HEY1;POU3F1;VDR;NOTCH1
4096,GO:0051147,0.437293474393857,0.789240090851016,4,11,regulation of muscle cell differentiation,BP,MAPK12;FZD7;BMP4;NOTCH1
5255,GO:0090090,0.438292089515818,0.816624431818074,3,8,negative regulation of canonical Wnt signaling pathway,BP,AXIN1;WNT5B;NOTCH1
2544,GO:0033135,0.439905407561433,0.815506804063692,3,8,regulation of peptidyl-serine phosphorylation,BP,AXIN1;PIK3CA;SPTBN4
1120,GO:0008289,0.440075805839209,0.767112420704812,5,14,lipid binding,MF,SCIN;SYT5;FZD7;VDR;SPTBN4
3169,GO:0043406,0.440766212257015,0.766568422294199,5,14,positive regulation of MAP kinase activity,BP,PIK3CG;WNT7B;AXIN1;DUSP5;HRAS
1088,GO:0008134,0.441388372317719,0.814476422086082,3,8,transcription factor binding,MF,TLE1;HEY1;VDR
5534,GO:1900182,0.441606032690064,0.814324942240889,3,8,positive regulation of protein localization to nucleus,BP,BMP6;CDH1;BMP4
4131,GO:0051222,0.443161855585018,0.813240331575132,3,8,positive regulation of protein transport,BP,BMP6;CDH1;BMP4
2368,GO:0032388,0.443441283295612,0.813045191485938,3,8,positive regulation of intracellular transport,BP,BMP6;CDH1;BMP4
2715,GO:0035270,0.443649086232741,0.764290880810247,5,14,endocrine system development,BP,BMP6;CDH1;FGF8;BMP4;FSTL3
1281,GO:0010038,0.444214938682502,0.784034432457074,4,11,response to metal ion,BP,BMP6;CDH1;FSTL3;TF
4518,GO:0060563,0.444549973953393,0.812269900698679,3,8,neuroepithelial cell differentiation,BP,JAG2;FGF8;NOTCH1
4871,GO:0070838,0.445154896202706,0.783322883537181,4,11,divalent metal ion transport,BP,PIK3CG;VDR;TSPAN13;TF
5178,GO:0072511,0.445154896202706,0.783322883537181,4,11,divalent inorganic cation transport,BP,PIK3CG;VDR;TSPAN13;TF
314,GO:0002573,0.446037284983426,0.811227259610768,3,8,myeloid leukocyte differentiation,BP,CLDN18;BMP4;FSTL3
4851,GO:0070647,0.446476572790436,0.78232050432506,4,11,protein modification by small protein conjugation or removal,BP,MAGEC2;AXIN1;RAB40B;RNF144A
4298,GO:0055001,0.44991807432091,0.80849273459959,3,8,muscle cell development,BP,AXIN1;BMP4;NOTCH1
5673,GO:1902105,0.450565429195579,0.808034613223523,3,8,regulation of leukocyte differentiation,BP,CLDN18;BMP4;FSTL3
1036,GO:0007548,0.451414984761488,0.75810719342602,5,14,sex differentiation,BP,WNT7A;BMP6;FGF8;INHBB;FSTL3
4652,GO:0061053,0.451449437151826,0.852267989399747,2,5,somite development,BP,CRB2;NOTCH1
6055,GO:2000181,0.451852502918013,0.852023815351964,2,5,negative regulation of blood vessel morphogenesis,BP,AMOT;NOTCH1
5165,GO:0072358,0.452451536186596,0.692583803862786,12,37,cardiovascular system development,BP,WNT7A;PIK3CG;HEY1;WNT7B;WNT2;FGF8;CRB2;AMOT;BMP4;PIK3CA;BMP7;NOTCH1
2194,GO:0031344,0.452770008775228,0.777517413567562,4,11,regulation of cell projection organization,BP,WNT7A;WNT3;HRAS;BMP7
988,GO:0007264,0.454369829369482,0.740271424245348,6,17,small GTPase mediated signal transduction,BP,RABIF;RRAS2;AMOT;HRAS;RAB38;RND3
93,GO:0001533,0.454512735027163,0.85040641276875,2,5,cornified envelope,CC,DSG3;PKP1
2208,GO:0031424,0.454512735027163,0.85040641276875,2,5,keratinization,BP,DSG3;PKP1
4796,GO:0070268,0.454512735027163,0.85040641276875,2,5,cornification,BP,DSG3;PKP1
688,GO:0005884,0.455529490475264,0.849785539850552,2,5,actin filament,CC,ACTN3;AMOT
3519,GO:0045732,0.45654826236647,0.849161937815003,2,5,positive regulation of protein catabolic process,BP,AXIN1;RNF144A
4350,GO:0060039,0.456795418840753,0.849010424188922,2,5,pericardium development,BP,BMP7;NOTCH1
5618,GO:1901617,0.457228181812412,0.803286518584568,3,8,organic hydroxy compound biosynthetic process,BP,BMP6;VDR;PNMT
1255,GO:0009898,0.457597376094869,0.848518193360524,2,5,cytoplasmic side of plasma membrane,CC,CDH1;SPTB
5424,GO:0098562,0.457597376094869,0.848518193360524,2,5,cytoplasmic side of membrane,CC,CDH1;SPTB
260,GO:0002275,0.457691466480859,0.802954122931629,3,8,myeloid cell activation involved in immune response,BP,PIK3CG;PKP1;RAB3D
297,GO:0002444,0.457691466480859,0.802954122931629,3,8,myeloid leukocyte mediated immunity,BP,PIK3CG;PKP1;RAB3D
3152,GO:0043299,0.457691466480859,0.802954122931629,3,8,leukocyte degranulation,BP,PIK3CG;PKP1;RAB3D
3206,GO:0043534,0.459674779168964,0.847238770816831,2,5,blood vessel endothelial cell migration,BP,AMOT;NOTCH1
5860,GO:1903828,0.460091701075873,0.846981242635588,2,5,negative regulation of cellular protein localization,BP,CLDN18;BMP7
4303,GO:0055008,0.460460020264802,0.846753525207974,2,5,cardiac muscle tissue morphogenesis,BP,WNT2;NOTCH1
4457,GO:0060415,0.460460020264802,0.846753525207974,2,5,muscle tissue morphogenesis,BP,WNT2;NOTCH1
5922,GO:1904950,0.460958943545507,0.846444745000925,2,5,negative regulation of establishment of protein localization,BP,INHBB;BMP7
1717,GO:0018107,0.461326363714751,0.846217119004506,2,5,peptidyl-threonine phosphorylation,BP,AXIN1;BMP7
1727,GO:0018210,0.461326363714751,0.846217119004506,2,5,peptidyl-threonine modification,BP,AXIN1;BMP7
659,GO:0005773,0.461425041049876,0.770830325545796,4,11,vacuole,CC,PIK3CG;RAB39A;RAB3D;RAB38
432,GO:0003209,0.461802616447953,0.845921775208373,2,5,cardiac atrium morphogenesis,BP,WNT2;NOTCH1
441,GO:0003230,0.461802616447953,0.845921775208373,2,5,cardiac atrium development,BP,WNT2;NOTCH1
1909,GO:0022891,0.462497154609423,0.76999536149176,4,11,substrate-specific transmembrane transporter activity,MF,SLC2A14;KCNG2;KCNK6;TF
1910,GO:0022892,0.462497154609423,0.76999536149176,4,11,substrate-specific transporter activity,MF,SLC2A14;KCNG2;KCNK6;TF
2166,GO:0031214,0.463374292785208,0.798852947556607,3,8,biomineral tissue development,BP,BMP6;BMP4;BMP7
4774,GO:0070167,0.463374292785208,0.798852947556607,3,8,regulation of biomineral tissue development,BP,BMP6;BMP4;BMP7
355,GO:0002791,0.464561412267515,0.797990632157488,3,8,regulation of peptide secretion,BP,BMP6;KCNG2;INHBB
666,GO:0005788,0.464598855148121,0.768354296574099,4,11,endoplasmic reticulum lumen,CC,WNT7A;WNT3;WNT7B;WNT5B
1223,GO:0009636,0.464844946072337,0.844027269505377,2,5,response to toxic substance,BP,CDH1;BMP7
3494,GO:0045638,0.465158650323349,0.843831148857111,2,5,negative regulation of myeloid cell differentiation,BP,CLDN18;FSTL3
170,GO:0001889,0.465189361314829,0.843811941280956,2,5,liver development,BP,PIK3CA;NOTCH1
4631,GO:0061008,0.465189361314829,0.843811941280956,2,5,hepaticobiliary system development,BP,PIK3CA;NOTCH1
98,GO:0001568,0.465664322533953,0.685635894949501,11,34,blood vessel development,BP,WNT7A;PIK3CG;HEY1;WNT7B;WNT2;FGF8;AMOT;BMP4;PIK3CA;BMP7;NOTCH1
5796,GO:1903362,0.465732073172371,0.843472284140773,2,5,regulation of cellular protein catabolic process,BP,AXIN1;RNF144A
1440,GO:0010975,0.465761997267251,0.797116560670435,3,8,regulation of neuron projection development,BP,WNT7A;WNT3;BMP7
3461,GO:0045444,0.466249933247447,0.796760756367017,3,8,fat cell differentiation,BP,AXIN1;WNT5B;INHBB
1268,GO:0009968,0.46670458980129,0.684700075680141,11,34,negative regulation of signal transduction,BP,TLE1;ACTN3;HEY1;AXIN1;WNT5B;DUSP5;BMP4;GDNF;BMP7;FSTL3;NOTCH1
3359,GO:0044711,0.467316964843232,0.697583174593994,9,27,single-organism biosynthetic process,BP,PIK3CG;MBOAT2;BMP6;FGF8;VDR;FGF17;BMP4;PIK3CA;GUCY1B3
3198,GO:0043506,0.467947710678433,0.842081121629514,2,5,regulation of JUN kinase activity,BP,WNT7B;AXIN1
3199,GO:0043507,0.467947710678433,0.842081121629514,2,5,positive regulation of JUN kinase activity,BP,WNT7B;AXIN1
4517,GO:0060562,0.468268114058645,0.704778616538395,8,24,epithelial tube morphogenesis,BP,WNT2;FGF8;VDR;WNK4;BMP4;GDNF;BMP7;NOTCH1
215,GO:0002040,0.468597734722839,0.841671607078813,2,5,sprouting angiogenesis,BP,BMP4;NOTCH1
27,GO:0000187,0.468841300574069,0.79486560751264,3,8,activation of MAPK activity,BP,WNT7B;AXIN1;DUSP5
185,GO:0001934,0.469613646461033,0.668980622650164,14,43,positive regulation of protein phosphorylation,BP,WNT7A;PIK3CG;BMP6;WNT7B;AXIN1;FZD7;FGF8;DUSP5;INHBB;CCL20;HRAS;BMP4;PIK3CA;BMP7
2962,GO:0042327,0.469613646461033,0.668980622650164,14,43,positive regulation of phosphorylation,BP,WNT7A;PIK3CG;BMP6;WNT7B;AXIN1;FZD7;FGF8;DUSP5;INHBB;CCL20;HRAS;BMP4;PIK3CA;BMP7
59,GO:0000981,0.469952111537782,0.840816341618231,2,5,RNA polymerase II transcription factor activity, sequence-specific DNA binding,MF,HEY1;VDR
5069,GO:0072088,0.470108565777303,0.7640253075022,4,11,nephron epithelium morphogenesis,BP,FGF8;WNK4;BMP4;GDNF
410,GO:0003171,0.470980986570564,0.840164806517631,2,5,atrioventricular valve development,BP,HEY1;NOTCH1
417,GO:0003181,0.470980986570564,0.840164806517631,2,5,atrioventricular valve morphogenesis,BP,HEY1;NOTCH1
1009,GO:0007368,0.471160053631057,0.793161938190681,3,8,determination of left/right symmetry,BP,AXIN1;FGF8;NOTCH1
1241,GO:0009855,0.471160053631057,0.793161938190681,3,8,determination of bilateral symmetry,BP,AXIN1;FGF8;NOTCH1
3809,GO:0048523,0.471792616972692,0.638392269853287,31,99,negative regulation of cellular process,BP,SCIN;TLE1;WNT7A;PIK3CG;ACTN3;CLDN18;BMP6;WNT3;HEY1;GJB6;AXIN1;MAPK12;CDH1;SPTBN5;SPTB;FZD7;FGF8;VDR;CRB2;WNT5B;DUSP5;INHBB;PKP1;HRAS;BMP4;GDNF;PIK3CA;BMP7;FSTL3;SPTBN4;NOTCH1
3228,GO:0043588,0.47193054725285,0.738463750816558,5,15,skin development,BP,POU3F1;VDR;DSG3;PKP1;NOTCH1
3823,GO:0048565,0.472499450988031,0.79217442903588,3,8,digestive tract development,BP,CLDN18;BMP4;NOTCH1
4338,GO:0055123,0.472499450988031,0.79217442903588,3,8,digestive system development,BP,CLDN18;BMP4;NOTCH1
5303,GO:0090288,0.473299147838822,0.838691060085392,2,5,negative regulation of cellular response to growth factor stimulus,BP,FSTL3;NOTCH1
2894,GO:0040008,0.473539833198235,0.700144226915762,8,24,regulation of growth,BP,ACTN3;WNT3;WNT2;FGF8;BMP4;PIK3CA;SPTBN4;NOTCH1
5276,GO:0090183,0.474042765432325,0.791033474654622,3,8,regulation of kidney development,BP,BMP4;GDNF;BMP7
162,GO:0001841,0.474134841725405,0.838157811065109,2,5,neural tube formation,BP,BMP4;BMP7
1456,GO:0014020,0.474134841725405,0.838157811065109,2,5,primary neural tube formation,BP,BMP4;BMP7
2199,GO:0031349,0.47417933290881,0.838129392364321,2,5,positive regulation of defense response,BP,PIK3CG;HRAS
1033,GO:0007517,0.474625295112623,0.70894283837767,7,21,muscle organ development,BP,ACTN3;MAPK12;WNT2;FZD7;FGF8;BMP4;NOTCH1
2923,GO:0042098,0.47467830300282,0.83781047288494,2,5,T cell proliferation,BP,PIK3CG;BMP4
902,GO:0006952,0.474768764568856,0.708817856426057,7,21,defense response,BP,PIK3CG;BMP6;PMAIP1;INHBB;CCL20;HRAS;NOTCH1
110,GO:0001657,0.474947065784426,0.76019145586383,4,11,ureteric bud development,BP,FGF8;BMP4;GDNF;BMP7
5106,GO:0072163,0.474947065784426,0.76019145586383,4,11,mesonephric epithelium development,BP,FGF8;BMP4;GDNF;BMP7
5107,GO:0072164,0.474947065784426,0.76019145586383,4,11,mesonephric tubule development,BP,FGF8;BMP4;GDNF;BMP7
4094,GO:0051145,0.475850759320984,0.789692611800643,3,8,smooth muscle cell differentiation,BP,HEY1;BMP4;NOTCH1
5251,GO:0090066,0.476262103931946,0.707515639844784,7,21,regulation of anatomical structure size,BP,SCIN;WNT7A;WNT3;WNT7B;SPTBN5;SPTB;SPTBN4
5591,GO:1901342,0.476434222447304,0.7347074978558,5,15,regulation of vasculature development,BP,HEY1;AMOT;BMP4;BMP7;NOTCH1
2150,GO:0031099,0.476578727163891,0.789151436170249,3,8,regeneration,BP,WNT7A;FZD7;NOTCH1
4271,GO:0051924,0.477015190130366,0.836311873090521,2,5,regulation of calcium ion transport,BP,PIK3CG;TSPAN13
159,GO:0001838,0.477102211345965,0.788761815462048,3,8,embryonic epithelial tube formation,BP,BMP4;GDNF;BMP7
5258,GO:0090101,0.477590352372051,0.835941775135732,2,5,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,FSTL3;NOTCH1
2132,GO:0031018,0.477741455381564,0.83584446275863,2,5,endocrine pancreas development,BP,BMP6;BMP4
3946,GO:0050680,0.479192965159603,0.834907918195277,2,5,negative regulation of epithelial cell proliferation,BP,VDR;BMP4
4328,GO:0055085,0.479284726816936,0.70487254056034,7,21,transmembrane transport,BP,SLC2A14;GJB2;PIK3CG;GJA3;KCNG2;KCNK6;TSPAN13
5087,GO:0072111,0.479601903289968,0.834643488758919,2,5,cell proliferation involved in kidney development,BP,BMP4;BMP7
514,GO:0004672,0.479791069841099,0.704428814416077,7,21,protein kinase activity,MF,PIK3CG;MAPK12;FGF8;WNK4;PKN3;FGF17;PIK3CA
4630,GO:0061005,0.479869241268915,0.786695961676091,3,8,cell differentiation involved in kidney development,BP,BMP4;GDNF;NOTCH1
4845,GO:0070588,0.480439710365409,0.834100952732636,2,5,calcium ion transmembrane transport,BP,PIK3CG;TSPAN13
2305,GO:0032103,0.481010712304261,0.78584060129395,3,8,positive regulation of response to external stimulus,BP,PIK3CG;BMP6;ARTN
2507,GO:0032956,0.48140262265977,0.730535340267932,5,15,regulation of actin cytoskeleton organization,BP,SCIN;SPTBN5;SPTB;HRAS;SPTBN4
739,GO:0006109,0.48223872638541,0.832932377621677,2,5,regulation of carbohydrate metabolic process,BP,ACTN3;PMAIP1
397,GO:0003143,0.48232791534314,0.832874315980977,2,5,embryonic heart tube morphogenesis,BP,FGF8;NOTCH1
2684,GO:0035050,0.48232791534314,0.832874315980977,2,5,embryonic heart tube development,BP,FGF8;NOTCH1
1019,GO:0007416,0.482384995348788,0.832837150793129,2,5,synapse assembly,BP,WNT7A;CDH1
1624,GO:0016358,0.48263137023685,0.832676677592589,2,5,dendrite development,BP,WNT7A;BMP7
1908,GO:0022890,0.483001147787528,0.784344665656761,3,8,inorganic cation transmembrane transporter activity,MF,KCNG2;KCNK6;TF
3684,GO:0046873,0.483001147787528,0.784344665656761,3,8,metal ion transmembrane transporter activity,MF,KCNG2;KCNK6;TF
5937,GO:1905207,0.483494298042457,0.832113892549894,2,5,regulation of cardiocyte differentiation,BP,FZD7;BMP4
6120,GO:2000725,0.483494298042457,0.832113892549894,2,5,regulation of cardiac muscle cell differentiation,BP,FZD7;BMP4
169,GO:0001885,0.484142091500934,0.831690669090643,2,5,endothelial cell development,BP,WNT7A;WNT7B
4637,GO:0061028,0.484142091500934,0.831690669090643,2,5,establishment of endothelial barrier,BP,WNT7A;WNT7B
4225,GO:0051604,0.484514708640486,0.831446937032894,2,5,protein maturation,BP,RHBDL3;TSPAN15
875,GO:0006886,0.486111702067146,0.726553386841927,5,15,intracellular protein transport,BP,BMP6;CDH1;FZD7;BMP4;BMP7
4895,GO:0071216,0.486919720270876,0.829868695644466,2,5,cellular response to biotic stimulus,BP,BMP6;CCL20
4896,GO:0071219,0.486919720270876,0.829868695644466,2,5,cellular response to molecule of bacterial origin,BP,BMP6;CCL20
4897,GO:0071222,0.486919720270876,0.829868695644466,2,5,cellular response to lipopolysaccharide,BP,BMP6;CCL20
589,GO:0005244,0.490106808234546,0.827763564533179,2,5,voltage-gated ion channel activity,MF,KCNG2;KCNK6
597,GO:0005261,0.490106808234546,0.827763564533179,2,5,cation channel activity,MF,KCNG2;KCNK6
1902,GO:0022832,0.490106808234546,0.827763564533179,2,5,voltage-gated channel activity,MF,KCNG2;KCNK6
1904,GO:0022836,0.490106808234546,0.827763564533179,2,5,gated channel activity,MF,KCNG2;KCNK6
1906,GO:0022843,0.490106808234546,0.827763564533179,2,5,voltage-gated cation channel activity,MF,KCNG2;KCNK6
4434,GO:0060341,0.490386242885986,0.683768224283792,8,25,regulation of cellular localization,BP,CLDN18;BMP6;PMAIP1;CDH1;FZD7;BMP4;GDNF;BMP7
4069,GO:0051050,0.490399910010193,0.675728428650834,9,28,positive regulation of transport,BP,SCIN;BMP6;PMAIP1;CDH1;INHBB;BMP4;RAB3D;GDNF;TF
1801,GO:0019898,0.490850803957043,0.743155937634962,4,12,extrinsic component of membrane,CC,PIK3CG;CDH1;PIK3CA;TF
2054,GO:0030593,0.492034078875706,0.826482969545022,2,5,neutrophil chemotaxis,BP,PIK3CG;CCL20
4979,GO:0071621,0.492034078875706,0.826482969545022,2,5,granulocyte chemotaxis,BP,PIK3CG;CCL20
5401,GO:0097530,0.492034078875706,0.826482969545022,2,5,granulocyte migration,BP,PIK3CG;CCL20
5986,GO:1990266,0.492034078875706,0.826482969545022,2,5,neutrophil migration,BP,PIK3CG;CCL20
4293,GO:0052547,0.49324852782933,0.7765538936353,3,8,regulation of peptidase activity,BP,PMAIP1;MAPK12;CRB2
3802,GO:0048514,0.493529227596395,0.672877536473483,9,28,blood vessel morphogenesis,BP,WNT7A;PIK3CG;HEY1;WNT7B;FGF8;AMOT;BMP4;PIK3CA;NOTCH1
2369,GO:0032391,0.494437181263256,0.917654942410332,1,2,photoreceptor connecting cilium,CC,SPTBN5
2792,GO:0035869,0.494437181263256,0.917654942410332,1,2,ciliary transition zone,CC,SPTBN5
3635,GO:0046530,0.494438447904204,0.917654433357766,1,2,photoreceptor cell differentiation,BP,NOTCH1
434,GO:0003213,0.494438866616416,0.917654265080286,1,2,cardiac right atrium morphogenesis,BP,NOTCH1
5071,GO:0072091,0.494438938531902,0.91765423617794,1,2,regulation of stem cell proliferation,BP,NOTCH1
6110,GO:2000648,0.494438938531902,0.91765423617794,1,2,positive regulation of stem cell proliferation,BP,NOTCH1
2120,GO:0030903,0.494440126107438,0.917653758898286,1,2,notochord development,BP,CRB2
3827,GO:0048570,0.494440126107438,0.917653758898286,1,2,notochord morphogenesis,BP,CRB2
1395,GO:0010818,0.494440166812404,0.917653742539163,1,2,T cell chemotaxis,BP,PIK3CG
3965,GO:0050729,0.494440166812404,0.917653742539163,1,2,positive regulation of inflammatory response,BP,PIK3CG
815,GO:0006638,0.494440263757112,0.917653703577565,1,2,neutral lipid metabolic process,BP,PIK3CG
816,GO:0006639,0.494440263757112,0.917653703577565,1,2,acylglycerol metabolic process,BP,PIK3CG
817,GO:0006641,0.494440263757112,0.917653703577565,1,2,triglyceride metabolic process,BP,PIK3CG
194,GO:0001948,0.494440338418157,0.917653673571649,1,2,glycoprotein binding,MF,CDH1
1623,GO:0016342,0.494498237615702,0.91763040183852,1,2,catenin complex,CC,CDH1
3389,GO:0044853,0.494498237615702,0.91763040183852,1,2,plasma membrane raft,CC,CDH1
3448,GO:0045295,0.494498237615702,0.91763040183852,1,2,gamma-catenin binding,MF,CDH1
216,GO:0002042,0.494535135949897,0.917615568673169,1,2,cell migration involved in sprouting angiogenesis,BP,NOTCH1
3913,GO:0048845,0.494535135949897,0.917615568673169,1,2,venous blood vessel morphogenesis,BP,NOTCH1
4592,GO:0060841,0.494535135949897,0.917615568673169,1,2,venous blood vessel development,BP,NOTCH1
5865,GO:1903847,0.494535135949897,0.917615568673169,1,2,regulation of aorta morphogenesis,BP,NOTCH1
5866,GO:1903849,0.494535135949897,0.917615568673169,1,2,positive regulation of aorta morphogenesis,BP,NOTCH1
5957,GO:1905651,0.494535135949897,0.917615568673169,1,2,regulation of artery morphogenesis,BP,NOTCH1
5958,GO:1905653,0.494535135949897,0.917615568673169,1,2,positive regulation of artery morphogenesis,BP,NOTCH1
3685,GO:0046875,0.49453643590053,0.917615046057408,1,2,ephrin receptor binding,MF,PIK3CG
1408,GO:0010839,0.494536495839357,0.917615021960299,1,2,negative regulation of keratinocyte proliferation,BP,VDR
4570,GO:0060745,0.495275339393656,0.917317607698461,1,2,mammary gland branching involved in pregnancy,BP,VDR
131,GO:0001736,0.495461429102459,0.9172425797479,1,2,establishment of planar polarity,BP,FZD7
954,GO:0007164,0.495461429102459,0.9172425797479,1,2,establishment of tissue polarity,BP,FZD7
2864,GO:0038031,0.495461429102459,0.9172425797479,1,2,non-canonical Wnt signaling pathway via JNK cascade,BP,FZD7
4368,GO:0060071,0.495461429102459,0.9172425797479,1,2,Wnt signaling pathway, planar cell polarity pathway,BP,FZD7
5272,GO:0090175,0.495461429102459,0.9172425797479,1,2,regulation of establishment of planar polarity,BP,FZD7
5773,GO:1903053,0.495499759799986,0.917227119544291,1,2,regulation of extracellular matrix organization,BP,NOTCH1
1898,GO:0022617,0.495501111263869,0.917226574411136,1,2,extracellular matrix disassembly,BP,CDH1
1047,GO:0007595,0.495501117117617,0.917226572049936,1,2,lactation,BP,VDR
4071,GO:0051052,0.495538130446524,0.743534157291605,4,11,regulation of DNA metabolic process,BP,BMP6;HRAS;BMP4;PIK3CA
1823,GO:0021537,0.495563588989347,0.824122819841278,2,5,telencephalon development,BP,FGF8;BMP4
1669,GO:0016747,0.495590907558872,0.917190348050663,1,2,transferase activity, transferring acyl groups other than amino-acyl groups,MF,MBOAT2
5361,GO:0097164,0.495799646614993,0.917106093540194,1,2,ammonium ion metabolic process,BP,MBOAT2
709,GO:0005943,0.495967810251987,0.917038172669851,1,2,phosphatidylinositol 3-kinase complex, class IA,CC,PIK3CA
3220,GO:0043560,0.495967810251987,0.917038172669851,1,2,insulin receptor substrate binding,MF,PIK3CA
5140,GO:0072234,0.496041737422742,0.917008301229315,1,2,metanephric nephron tubule development,BP,WNT7B
5143,GO:0072243,0.496041737422742,0.917008301229315,1,2,metanephric nephron epithelium development,BP,WNT7B
1758,GO:0019226,0.496232361870146,0.916931241337495,1,2,transmission of nerve impulse,BP,SPTBN4
4098,GO:0051149,0.496741232248657,0.823331024569599,2,5,positive regulation of muscle cell differentiation,BP,MAPK12;BMP4
5859,GO:1903827,0.497288481478566,0.687250758026928,7,22,regulation of cellular protein localization,BP,CLDN18;BMP6;PMAIP1;CDH1;FZD7;BMP4;BMP7
2819,GO:0036003,0.497328819153548,0.916487015859888,1,2,positive regulation of transcription from RNA polymerase II promoter in response to stress,BP,NOTCH1
3232,GO:0043618,0.497328819153548,0.916487015859888,1,2,regulation of transcription from RNA polymerase II promoter in response to stress,BP,NOTCH1
3234,GO:0043620,0.497328819153548,0.916487015859888,1,2,regulation of DNA-templated transcription in response to stress,BP,NOTCH1
636,GO:0005615,0.497363692939314,0.643237232953628,14,43,extracellular space,CC,WNT7A;BMP6;WNT3;WNT7B;WNT2;ARTN;WNT5B;INHBB;CCL20;FGF17;BMP4;BMP7;FSTL3;TF
252,GO:0002250,0.497611260588114,0.822744663472255,2,5,adaptive immune response,BP,PIK3CG;HRAS
5451,GO:0098754,0.497820167696867,0.916287403553421,1,2,detoxification,BP,BMP7
5473,GO:0098869,0.497820167696867,0.916287403553421,1,2,cellular oxidant detoxification,BP,BMP7
5569,GO:1901031,0.497820167696867,0.916287403553421,1,2,regulation of response to reactive oxygen species,BP,BMP7
5996,GO:1990748,0.497820167696867,0.916287403553421,1,2,cellular detoxification,BP,BMP7
4872,GO:0070848,0.497950224688728,0.661994731457669,10,31,response to growth factor,BP,WNT7A;BMP6;WNT2;FGF8;CRB2;FGF17;BMP4;BMP7;FSTL3;NOTCH1
4933,GO:0071363,0.497950224688728,0.661994731457669,10,31,cellular response to growth factor stimulus,BP,WNT7A;BMP6;WNT2;FGF8;CRB2;FGF17;BMP4;BMP7;FSTL3;NOTCH1
656,GO:0005769,0.4982289879304,0.77271293623062,3,8,early endosome,CC,RAB38;RAB20;TF
1655,GO:0016597,0.498417841814836,0.916044140938477,1,2,amino acid binding,MF,GLDC
231,GO:0002085,0.498752160707627,0.915907849792764,1,2,inhibition of neuroepithelial cell differentiation,BP,NOTCH1
1012,GO:0007386,0.498752160707627,0.915907849792764,1,2,compartment pattern specification,BP,NOTCH1
1487,GO:0014807,0.498752160707627,0.915907849792764,1,2,regulation of somitogenesis,BP,NOTCH1
2103,GO:0030857,0.498752160707627,0.915907849792764,1,2,negative regulation of epithelial cell differentiation,BP,NOTCH1
2904,GO:0040034,0.498752160707627,0.915907849792764,1,2,regulation of development, heterochronic,BP,NOTCH1
3480,GO:0045605,0.498752160707627,0.915907849792764,1,2,negative regulation of epidermal cell differentiation,BP,NOTCH1
3482,GO:0045607,0.498752160707627,0.915907849792764,1,2,regulation of auditory receptor cell differentiation,BP,NOTCH1
3483,GO:0045608,0.498752160707627,0.915907849792764,1,2,negative regulation of auditory receptor cell differentiation,BP,NOTCH1
3489,GO:0045631,0.498752160707627,0.915907849792764,1,2,regulation of mechanoreceptor differentiation,BP,NOTCH1
3490,GO:0045632,0.498752160707627,0.915907849792764,1,2,negative regulation of mechanoreceptor differentiation,BP,NOTCH1
3512,GO:0045683,0.498752160707627,0.915907849792764,1,2,negative regulation of epidermis development,BP,NOTCH1
3798,GO:0048505,0.498752160707627,0.915907849792764,1,2,regulation of timing of cell differentiation,BP,NOTCH1
4618,GO:0060972,0.498752160707627,0.915907849792764,1,2,left/right pattern formation,BP,NOTCH1
4886,GO:0070986,0.498752160707627,0.915907849792764,1,2,left/right axis specification,BP,NOTCH1
6146,GO:2000980,0.498752160707627,0.915907849792764,1,2,regulation of inner ear receptor cell differentiation,BP,NOTCH1
6147,GO:2000981,0.498752160707627,0.915907849792764,1,2,negative regulation of inner ear receptor cell differentiation,BP,NOTCH1
976,GO:0007220,0.498753487484917,0.915907308595864,1,2,Notch receptor processing,BP,JAG2
77,GO:0001106,0.499053950384593,0.915784685177311,1,2,RNA polymerase II transcription corepressor activity,MF,TLE1
423,GO:0003192,0.499415250061778,0.915637065555711,1,2,mitral valve formation,BP,NOTCH1
2425,GO:0032633,0.499415250061778,0.915637065555711,1,2,interleukin-4 production,BP,NOTCH1
3401,GO:0045058,0.49941657509971,0.915636523835007,1,2,T cell selection,BP,JAG2
506,GO:0004383,0.499504418746366,0.915600604852229,1,2,guanylate cyclase activity,MF,GUCY1B3
1079,GO:0008074,0.499504418746366,0.915600604852229,1,2,guanylate cyclase complex, soluble,CC,GUCY1B3
1269,GO:0009975,0.499504418746366,0.915600604852229,1,2,cyclase activity,MF,GUCY1B3
1684,GO:0016849,0.499504418746366,0.915600604852229,1,2,phosphorus-oxygen lyase activity,MF,GUCY1B3
3337,GO:0044445,0.499504418746366,0.915600604852229,1,2,cytosolic part,CC,GUCY1B3
5059,GO:0072070,0.499557039118232,0.915579083358588,1,2,loop of Henle development,BP,WNT7B
3876,GO:0048709,0.49974184460685,0.915503467907847,1,2,oligodendrocyte differentiation,BP,NOTCH1
94,GO:0001541,0.49987921276672,0.915447230905312,1,2,ovarian follicle development,BP,INHBB
1891,GO:0022602,0.49987921276672,0.915447230905312,1,2,ovulation cycle process,BP,INHBB
5370,GO:0097191,0.500029006973556,0.771315905329152,3,8,extrinsic apoptotic signaling pathway,BP,PMAIP1;BMP4;GDNF
4073,GO:0051054,0.500114703314729,0.771249277099797,3,8,positive regulation of DNA metabolic process,BP,BMP6;HRAS;BMP4
5333,GO:0097009,0.500268171766198,0.91528785133696,1,2,energy homeostasis,BP,PIK3CA
3956,GO:0050714,0.500920669640867,0.915020005485177,1,2,positive regulation of protein secretion,BP,BMP6
1709,GO:0017147,0.501080850938209,0.914954160346112,1,2,Wnt-protein binding,MF,FZD7
1964,GO:0030165,0.501080850938209,0.914954160346112,1,2,PDZ domain binding,MF,FZD7
3051,GO:0042813,0.501080850938209,0.914954160346112,1,2,Wnt-activated receptor activity,MF,FZD7
1816,GO:0020037,0.501123848222857,0.914936479441935,1,2,heme binding,MF,GUCY1B3
3701,GO:0046906,0.501123848222857,0.914936479441935,1,2,tetrapyrrole binding,MF,GUCY1B3
5938,GO:1905208,0.501452232438811,0.914801358489122,1,2,negative regulation of cardiocyte differentiation,BP,FZD7
6121,GO:2000726,0.501452232438811,0.914801358489122,1,2,negative regulation of cardiac muscle cell differentiation,BP,FZD7
1418,GO:0010893,0.501745173300933,0.914680692828477,1,2,positive regulation of steroid biosynthetic process,BP,BMP6
2352,GO:0032346,0.501745173300933,0.914680692828477,1,2,positive regulation of aldosterone metabolic process,BP,BMP6
2355,GO:0032349,0.501745173300933,0.914680692828477,1,2,positive regulation of aldosterone biosynthetic process,BP,BMP6
2358,GO:0032352,0.501745173300933,0.914680692828477,1,2,positive regulation of hormone metabolic process,BP,BMP6
3583,GO:0045940,0.501745173300933,0.914680692828477,1,2,positive regulation of steroid metabolic process,BP,BMP6
3694,GO:0046886,0.501745173300933,0.914680692828477,1,2,positive regulation of hormone biosynthetic process,BP,BMP6
5245,GO:0090031,0.501745173300933,0.914680692828477,1,2,positive regulation of steroid hormone biosynthetic process,BP,BMP6
5148,GO:0072273,0.501854047891967,0.819868181370145,2,5,metanephric nephron morphogenesis,BP,BMP4;GDNF
4935,GO:0071371,0.502167341793453,0.914506583211935,1,2,cellular response to gonadotropin stimulus,BP,NOTCH1
3658,GO:0046683,0.50216862229123,0.914506054728451,1,2,response to organophosphorus,BP,PIK3CG
4220,GO:0051591,0.50216862229123,0.914506054728451,1,2,response to cAMP,BP,PIK3CG
4917,GO:0071320,0.50216862229123,0.914506054728451,1,2,cellular response to cAMP,BP,PIK3CG
5130,GO:0072203,0.502654003208933,0.914305562233356,1,2,cell proliferation involved in metanephros development,BP,BMP7
402,GO:0003157,0.502724598167454,0.914276374291195,1,2,endocardium development,BP,NOTCH1
468,GO:0003348,0.502724598167454,0.914276374291195,1,2,cardiac endothelial cell differentiation,BP,NOTCH1
4613,GO:0060956,0.502724598167454,0.914276374291195,1,2,endocardial cell differentiation,BP,NOTCH1
844,GO:0006766,0.502725936221193,0.914275820995924,1,2,vitamin metabolic process,BP,VDR
1652,GO:0016579,0.502766051850765,0.91425923170163,1,2,protein deubiquitination,BP,AXIN1
4850,GO:0070646,0.502766051850765,0.91425923170163,1,2,protein modification by small protein removal,BP,AXIN1
3819,GO:0048546,0.502779474831399,0.81923699959787,2,5,digestive tract morphogenesis,BP,BMP4;NOTCH1
5129,GO:0072202,0.50279458361872,0.819226683500249,2,5,cell differentiation involved in metanephros development,BP,BMP4;GDNF
5450,GO:0098751,0.503328622749708,0.914026347090999,1,2,bone cell development,BP,CLDN18
2641,GO:0034612,0.503694318884278,0.81861170311851,2,5,response to tumor necrosis factor,BP,CLDN18;CCL20
4929,GO:0071356,0.503694318884278,0.81861170311851,2,5,cellular response to tumor necrosis factor,BP,CLDN18;CCL20
2795,GO:0035886,0.503840866539127,0.913813904726076,1,2,vascular smooth muscle cell differentiation,BP,NOTCH1
1939,GO:0030049,0.503926585220301,0.913778318218785,1,2,muscle filament sliding,BP,ACTN3
2559,GO:0033275,0.503926585220301,0.913778318218785,1,2,actin-myosin filament sliding,BP,ACTN3
219,GO:0002053,0.503933506673309,0.913775444288857,1,2,positive regulation of mesenchymal cell proliferation,BP,WNT2
2560,GO:0033278,0.503933506673309,0.913775444288857,1,2,cell proliferation in midbrain,BP,WNT2
723,GO:0006007,0.50396850559486,0.913760910970321,1,2,glucose catabolic process,BP,ACTN3
735,GO:0006090,0.50396850559486,0.913760910970321,1,2,pyruvate metabolic process,BP,ACTN3
738,GO:0006096,0.50396850559486,0.913760910970321,1,2,glycolytic process,BP,ACTN3
749,GO:0006165,0.50396850559486,0.913760910970321,1,2,nucleoside diphosphate phosphorylation,BP,ACTN3
839,GO:0006733,0.50396850559486,0.913760910970321,1,2,oxidoreduction coenzyme metabolic process,BP,ACTN3
840,GO:0006734,0.50396850559486,0.913760910970321,1,2,NADH metabolic process,BP,ACTN3
843,GO:0006757,0.50396850559486,0.913760910970321,1,2,ATP generation from ADP,BP,ACTN3
1178,GO:0009123,0.50396850559486,0.913760910970321,1,2,nucleoside monophosphate metabolic process,BP,ACTN3
1179,GO:0009126,0.50396850559486,0.913760910970321,1,2,purine nucleoside monophosphate metabolic process,BP,ACTN3
1180,GO:0009132,0.50396850559486,0.913760910970321,1,2,nucleoside diphosphate metabolic process,BP,ACTN3
1181,GO:0009135,0.50396850559486,0.913760910970321,1,2,purine nucleoside diphosphate metabolic process,BP,ACTN3
1187,GO:0009161,0.50396850559486,0.913760910970321,1,2,ribonucleoside monophosphate metabolic process,BP,ACTN3
1190,GO:0009167,0.50396850559486,0.913760910970321,1,2,purine ribonucleoside monophosphate metabolic process,BP,ACTN3
1191,GO:0009179,0.50396850559486,0.913760910970321,1,2,purine ribonucleoside diphosphate metabolic process,BP,ACTN3
1192,GO:0009185,0.50396850559486,0.913760910970321,1,2,ribonucleoside diphosphate metabolic process,BP,ACTN3
1764,GO:0019362,0.50396850559486,0.913760910970321,1,2,pyridine nucleotide metabolic process,BP,ACTN3
1778,GO:0019674,0.50396850559486,0.913760910970321,1,2,NAD metabolic process,BP,ACTN3
3594,GO:0046031,0.50396850559486,0.913760910970321,1,2,ADP metabolic process,BP,ACTN3
3595,GO:0046034,0.50396850559486,0.913760910970321,1,2,ATP metabolic process,BP,ACTN3
3633,GO:0046496,0.50396850559486,0.913760910970321,1,2,nicotinamide nucleotide metabolic process,BP,ACTN3
3709,GO:0046939,0.50396850559486,0.913760910970321,1,2,nucleotide phosphorylation,BP,ACTN3
5183,GO:0072524,0.50396850559486,0.913760910970321,1,2,pyridine-containing compound metabolic process,BP,ACTN3
2387,GO:0032436,0.504032472528854,0.913734344161367,1,2,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,RNF144A
5641,GO:1901800,0.504032472528854,0.913734344161367,1,2,positive regulation of proteasomal protein catabolic process,BP,RNF144A
2465,GO:0032794,0.504032581076134,0.91373429907445,1,2,GTPase activating protein binding,MF,CDH1
5383,GO:0097306,0.504032581076134,0.91373429907445,1,2,cellular response to alcohol,BP,CDH1
4819,GO:0070371,0.504110143676807,0.736434080968237,4,11,ERK1 and ERK2 cascade,BP,FGF8;CCL20;HRAS;BMP4
4820,GO:0070372,0.504110143676807,0.736434080968237,4,11,regulation of ERK1 and ERK2 cascade,BP,FGF8;CCL20;HRAS;BMP4
3298,GO:0044304,0.504389915111075,0.91358578340748,1,2,main axon,CC,SPTBN4
318,GO:0002673,0.504389942479786,0.913585772025487,1,2,regulation of acute inflammatory response,BP,PIK3CG
3590,GO:0045988,0.504389942479786,0.913585772025487,1,2,negative regulation of striated muscle contraction,BP,PIK3CG
4336,GO:0055118,0.504389942479786,0.913585772025487,1,2,negative regulation of cardiac muscle contraction,BP,PIK3CG
377,GO:0003016,0.504389979635664,0.91358575657324,1,2,respiratory system process,BP,JAG2
5459,GO:0098797,0.504480680089714,0.731783301021096,4,12,plasma membrane protein complex,CC,GJB2;GJA3;GJB6;CDH1
5547,GO:1900407,0.504516107979477,0.913533291440675,1,2,regulation of cellular response to oxidative stress,BP,BMP7
4234,GO:0051650,0.504573311034133,0.81800966091155,2,5,establishment of vesicle localization,BP,WNT7A;SYT5
2044,GO:0030529,0.50473892555349,0.913440551368164,1,2,intracellular ribonucleoprotein complex,CC,PKP1
5697,GO:1902369,0.50473892555349,0.913440551368164,1,2,negative regulation of RNA catabolic process,BP,PKP1
5698,GO:1902373,0.50473892555349,0.913440551368164,1,2,negative regulation of mRNA catabolic process,BP,PKP1
5790,GO:1903312,0.50473892555349,0.913440551368164,1,2,negative regulation of mRNA metabolic process,BP,PKP1
5978,GO:1990124,0.50473892555349,0.913440551368164,1,2,messenger ribonucleoprotein complex,CC,PKP1
6006,GO:1990904,0.50473892555349,0.913440551368164,1,2,ribonucleoprotein complex,CC,PKP1
2909,GO:0042036,0.504802452639427,0.913414097439511,1,2,negative regulation of cytokine biosynthetic process,BP,INHBB
5184,GO:0072562,0.505557910911864,0.91309906757085,1,2,blood microparticle,CC,TF
175,GO:0001895,0.505570544352007,0.913093792422403,1,2,retina homeostasis,BP,TF
694,GO:0005903,0.50584162508761,0.91298054639921,1,2,brush border,CC,SCIN
5372,GO:0097193,0.506332836493882,0.816800829808189,2,5,intrinsic apoptotic signaling pathway,BP,PMAIP1;HRAS
2758,GO:0035639,0.506488185887306,0.634065124719941,14,44,purine ribonucleoside triphosphate binding,MF,PIK3CG;MAPK12;RAB40B;RAB39A;RRAS2;WNK4;PKN3;HRAS;RAB3D;RAB38;PIK3CA;RND3;RAB20;GUCY1B3
5135,GO:0072215,0.506624207422044,0.816600175752491,2,5,regulation of metanephros development,BP,BMP4;GDNF
1947,GO:0030098,0.507017689326839,0.729639103238127,4,12,lymphocyte differentiation,BP,JAG2;FZD7;BMP4;TPD52
3226,GO:0043584,0.507777299273013,0.912168838300424,1,2,nose development,BP,AXIN1
3840,GO:0048630,0.508152539809554,0.912010860469165,1,2,skeletal muscle tissue growth,BP,ACTN3
3841,GO:0048631,0.508152539809554,0.912010860469165,1,2,regulation of skeletal muscle tissue growth,BP,ACTN3
3842,GO:0048633,0.508152539809554,0.912010860469165,1,2,positive regulation of skeletal muscle tissue growth,BP,ACTN3
3849,GO:0048641,0.508152539809554,0.912010860469165,1,2,regulation of skeletal muscle tissue development,BP,ACTN3
3850,GO:0048643,0.508152539809554,0.912010860469165,1,2,positive regulation of skeletal muscle tissue development,BP,ACTN3
1982,GO:0030219,0.508219436717271,0.911982675256478,1,2,megakaryocyte differentiation,BP,SCIN
20,GO:0000151,0.508430259580253,0.911893808451359,1,2,ubiquitin ligase complex,CC,RNF144A
5432,GO:0098602,0.508612149661544,0.657917255020928,9,29,single organism cell adhesion,BP,PIK3CG;WNT7B;CDH1;FZD7;PKP1;BMP4;PIK3CA;BMP7;FSTL3
400,GO:0003151,0.509025600109652,0.814941276717161,2,5,outflow tract morphogenesis,BP,FGF8;BMP4
1638,GO:0016477,0.509402687536479,0.624346988679407,16,51,cell migration,BP,WNT7A;PIK3CG;JAG2;RRAS2;FGF8;CRB2;ARTN;AMOT;WNT5B;CCL20;PKN3;HRAS;BMP4;GDNF;PIK3CA;NOTCH1
2583,GO:0033628,0.509439667453284,0.911467428989658,1,2,regulation of cell adhesion mediated by integrin,BP,PIK3CG
501,GO:0004175,0.509439859786206,0.911467347606648,1,2,endopeptidase activity,MF,RHBDL3
502,GO:0004252,0.509439859786206,0.911467347606648,1,2,serine-type endopeptidase activity,MF,RHBDL3
1112,GO:0008236,0.509439859786206,0.911467347606648,1,2,serine-type peptidase activity,MF,RHBDL3
1714,GO:0017171,0.509439859786206,0.911467347606648,1,2,serine hydrolase activity,MF,RHBDL3
1739,GO:0019079,0.509717302318612,0.911349895820862,1,2,viral genome replication,BP,NOTCH1
288,GO:0002407,0.509718563570543,0.911349361631013,1,2,dendritic cell chemotaxis,BP,PIK3CG
2847,GO:0036336,0.509718563570543,0.911349361631013,1,2,dendritic cell migration,BP,PIK3CG
2245,GO:0031670,0.509718621725025,0.911349337000246,1,2,cellular response to nutrient,BP,VDR
4910,GO:0071295,0.509718621725025,0.911349337000246,1,2,cellular response to vitamin,BP,VDR
3830,GO:0048585,0.509936723771667,0.639084032512944,12,38,negative regulation of response to stimulus,BP,TLE1;ACTN3;WNT3;HEY1;AXIN1;WNT5B;DUSP5;BMP4;GDNF;BMP7;FSTL3;NOTCH1
4800,GO:0070293,0.509938786603959,0.911256053132847,1,2,renal absorption,BP,WNK4
2367,GO:0032387,0.510196649191578,0.911146707304871,1,2,negative regulation of intracellular transport,BP,BMP7
2954,GO:0042308,0.510196649191578,0.911146707304871,1,2,negative regulation of protein import into nucleus,BP,BMP7
3177,GO:0043433,0.510196649191578,0.911146707304871,1,2,negative regulation of sequence-specific DNA binding transcription factor activity,BP,BMP7
3672,GO:0046823,0.510196649191578,0.911146707304871,1,2,negative regulation of nucleocytoplasmic transport,BP,BMP7
5307,GO:0090317,0.510196649191578,0.911146707304871,1,2,negative regulation of intracellular protein transport,BP,BMP7
5894,GO:1904590,0.510196649191578,0.911146707304871,1,2,negative regulation of protein import,BP,BMP7
2239,GO:0031663,0.510391162352686,0.911064160712998,1,2,lipopolysaccharide-mediated signaling pathway,BP,BMP6
3077,GO:0043066,0.510657003475121,0.650184008575459,10,31,negative regulation of apoptotic process,BP,TLE1;WNT7A;PIK3CG;FGF8;HRAS;BMP4;GDNF;PIK3CA;BMP7;NOTCH1
3080,GO:0043069,0.510657003475121,0.650184008575459,10,31,negative regulation of programmed cell death,BP,TLE1;WNT7A;PIK3CG;FGF8;HRAS;BMP4;GDNF;PIK3CA;BMP7;NOTCH1
1328,GO:0010562,0.510738991188804,0.626578153769397,15,47,positive regulation of phosphorus metabolic process,BP,WNT7A;PIK3CG;ACTN3;BMP6;WNT7B;AXIN1;FZD7;FGF8;DUSP5;INHBB;CCL20;HRAS;BMP4;PIK3CA;BMP7
3581,GO:0045937,0.510738991188804,0.626578153769397,15,47,positive regulation of phosphate metabolic process,BP,WNT7A;PIK3CG;ACTN3;BMP6;WNT7B;AXIN1;FZD7;FGF8;DUSP5;INHBB;CCL20;HRAS;BMP4;PIK3CA;BMP7
2286,GO:0032008,0.511200444839871,0.910720130556019,1,2,positive regulation of TOR signaling,BP,PIK3CA
5164,GO:0072341,0.511491799608244,0.813227979787219,2,5,modified amino acid binding,MF,SCIN;SYT5
730,GO:0006066,0.511516928784893,0.910585332210947,1,2,alcohol metabolic process,BP,VDR
3601,GO:0046165,0.511516928784893,0.910585332210947,1,2,alcohol biosynthetic process,BP,VDR
651,GO:0005759,0.512574174411578,0.910133965367264,1,2,mitochondrial matrix,CC,GLDC
1462,GO:0014044,0.512641452777577,0.910105187120149,1,2,Schwann cell development,BP,POU3F1
1876,GO:0022011,0.512641452777577,0.910105187120149,1,2,myelination in peripheral nervous system,BP,POU3F1
2338,GO:0032292,0.512641452777577,0.910105187120149,1,2,peripheral nervous system axon ensheathment,BP,POU3F1
587,GO:0005242,0.512727445224455,0.910068394301765,1,2,inward rectifier potassium channel activity,MF,KCNK6
1533,GO:0015276,0.512727445224455,0.910068394301765,1,2,ligand-gated ion channel activity,MF,KCNK6
1903,GO:0022834,0.512727445224455,0.910068394301765,1,2,ligand-gated channel activity,MF,KCNK6
5489,GO:0099094,0.512727445224455,0.910068394301765,1,2,ligand-gated cation channel activity,MF,KCNK6
1722,GO:0018193,0.51315535116312,0.654775084841658,9,28,peptidyl-amino acid modification,BP,AXIN1;MAPK12;FGF8;PKN3;FGF17;RAB3D;PIK3CA;BMP7;SPTBN4
116,GO:0001669,0.513251937086505,0.909843750217356,1,2,acrosomal vesicle,CC,NOTCH1
5376,GO:0097223,0.513251937086505,0.909843750217356,1,2,sperm part,CC,NOTCH1
2562,GO:0033293,0.513253247066264,0.909843188637827,1,2,monocarboxylic acid binding,MF,VDR
2553,GO:0033209,0.513550853430788,0.909715541554624,1,2,tumor necrosis factor-mediated signaling pathway,BP,CLDN18
703,GO:0005923,0.514095741117362,0.702328636016208,5,15,bicellular tight junction,CC,TJP3;CLDN18;AMOT;WNK4;CLDN15
4769,GO:0070160,0.514095741117362,0.702328636016208,5,15,occluding junction,CC,TJP3;CLDN18;AMOT;WNK4;CLDN15
4086,GO:0051101,0.514299292753733,0.909393951866696,1,2,regulation of DNA binding,BP,HEY1
6114,GO:2000677,0.514299292753733,0.909393951866696,1,2,regulation of transcription regulatory region DNA binding,BP,HEY1
1561,GO:0015850,0.514474723472681,0.811142597848264,2,5,organic hydroxy compound transport,BP,BMP6;GDNF
1032,GO:0007507,0.514764447833805,0.671385911700193,7,22,heart development,BP,HEY1;WNT2;FZD7;FGF8;BMP4;BMP7;NOTCH1
2216,GO:0031503,0.514772059883784,0.909190388612859,1,2,protein complex localization,BP,BMP7
4006,GO:0050848,0.515697971667476,0.908790756790422,1,2,regulation of calcium-mediated signaling,BP,ACTN3
4007,GO:0050849,0.515697971667476,0.908790756790422,1,2,negative regulation of calcium-mediated signaling,BP,ACTN3
528,GO:0004721,0.516480488336942,0.908452028195298,1,2,phosphoprotein phosphatase activity,MF,DUSP5
529,GO:0004725,0.516480488336942,0.908452028195298,1,2,protein tyrosine phosphatase activity,MF,DUSP5
2728,GO:0035335,0.516480488336942,0.908452028195298,1,2,peptidyl-tyrosine dephosphorylation,BP,DUSP5
2213,GO:0031490,0.516822779281846,0.908303575477886,1,2,chromatin DNA binding,MF,NOTCH1
3532,GO:0045776,0.517051753478995,0.908204171655276,1,2,negative regulation of blood pressure,BP,KCNK6
2499,GO:0032926,0.517687217717231,0.907927891957183,1,2,negative regulation of activin receptor signaling pathway,BP,FSTL3
3751,GO:0048185,0.517687217717231,0.907927891957183,1,2,activin binding,MF,FSTL3
851,GO:0006801,0.517896078088309,0.907836955069117,1,2,superoxide metabolic process,BP,BMP7
1358,GO:0010656,0.517896078088309,0.907836955069117,1,2,negative regulation of muscle cell apoptotic process,BP,BMP7
1359,GO:0010657,0.517896078088309,0.907836955069117,1,2,muscle cell apoptotic process,BP,BMP7
1361,GO:0010660,0.517896078088309,0.907836955069117,1,2,regulation of muscle cell apoptotic process,BP,BMP7
6002,GO:1990837,0.518326624789253,0.907649292113555,1,2,sequence-specific double-stranded DNA binding,MF,HEY1
905,GO:0006959,0.518485166151417,0.907580118940008,1,2,humoral immune response,BP,NOTCH1
261,GO:0002279,0.518486405049557,0.907579578248939,1,2,mast cell activation involved in immune response,BP,PIK3CG
299,GO:0002448,0.518486405049557,0.907579578248939,1,2,mast cell mediated immunity,BP,PIK3CG
2380,GO:0032418,0.518486405049557,0.907579578248939,1,2,lysosome localization,BP,PIK3CG
3023,GO:0042629,0.518486405049557,0.907579578248939,1,2,mast cell granule,CC,PIK3CG
3153,GO:0043303,0.518486405049557,0.907579578248939,1,2,mast cell degranulation,BP,PIK3CG
3468,GO:0045576,0.518486405049557,0.907579578248939,1,2,mast cell activation,BP,PIK3CG
2834,GO:0036094,0.518495586274656,0.615627227537769,16,51,small molecule binding,MF,GLDC;PIK3CG;MAPK12;RAB40B;RAB39A;RRAS2;VDR;WNK4;PKN3;HRAS;RAB3D;RAB38;PIK3CA;RND3;RAB20;GUCY1B3
283,GO:0002376,0.518834773645335,0.612200292567804,17,55,immune system process,BP,SCIN;PIK3CG;CLDN18;BMP6;JAG2;PMAIP1;FZD7;ARTN;CCL20;PKP1;HRAS;BMP4;RAB3D;PIK3CA;FSTL3;TPD52;NOTCH1
1525,GO:0015144,0.518984574246185,0.907361977274928,1,2,carbohydrate transmembrane transporter activity,MF,SLC2A14
4088,GO:0051119,0.518984574246185,0.907361977274928,1,2,sugar transmembrane transporter activity,MF,SLC2A14
5601,GO:1901476,0.518984574246185,0.907361977274928,1,2,carbohydrate transporter activity,MF,SLC2A14
5209,GO:0080134,0.519287816989986,0.657287222278596,8,25,regulation of response to stress,BP,WNT7A;PIK3CG;WNT7B;PMAIP1;AXIN1;FZD7;HRAS;BMP7
861,GO:0006821,0.51933003496725,0.90721086208293,1,2,chloride transport,BP,WNK4
1547,GO:0015698,0.51933003496725,0.90721086208293,1,2,inorganic anion transport,BP,WNK4
1153,GO:0008625,0.520704283365921,0.906607955660215,1,2,extrinsic apoptotic signaling pathway via death domain receptors,BP,PMAIP1
5967,GO:1905897,0.520704283365921,0.906607955660215,1,2,regulation of response to endoplasmic reticulum stress,BP,PMAIP1
5968,GO:1905898,0.520704283365921,0.906607955660215,1,2,positive regulation of response to endoplasmic reticulum stress,BP,PMAIP1
4125,GO:0051205,0.522004638163935,0.90603485789581,1,2,protein insertion into membrane,BP,PMAIP1
3303,GO:0044321,0.522619298891963,0.905763075746765,1,2,response to leptin,BP,INHBB
1493,GO:0014823,0.523613886084224,0.905322094097875,1,2,response to activity,BP,BMP6
2365,GO:0032370,0.523613886084224,0.905322094097875,1,2,positive regulation of lipid transport,BP,BMP6
5975,GO:1905954,0.523613886084224,0.905322094097875,1,2,positive regulation of lipid localization,BP,BMP6
3887,GO:0048739,0.523713137112149,0.905278005871817,1,2,cardiac muscle fiber development,BP,BMP4
3889,GO:0048747,0.523713137112149,0.905278005871817,1,2,muscle fiber development,BP,BMP4
4781,GO:0070228,0.523713397940298,0.905277889989878,1,2,regulation of lymphocyte apoptotic process,BP,BMP4
4785,GO:0070232,0.523713397940298,0.905277889989878,1,2,regulation of T cell apoptotic process,BP,BMP4
4788,GO:0070242,0.523713397940298,0.905277889989878,1,2,thymocyte apoptotic process,BP,BMP4
4789,GO:0070243,0.523713397940298,0.905277889989878,1,2,regulation of thymocyte apoptotic process,BP,BMP4
5128,GO:0072201,0.523713397940298,0.905277889989878,1,2,negative regulation of mesenchymal cell proliferation,BP,BMP4
4462,GO:0060423,0.523713917872088,0.905277658991855,1,2,foregut regionalization,BP,WNT2
4463,GO:0060424,0.523713917872088,0.905277658991855,1,2,lung field specification,BP,WNT2
4469,GO:0060431,0.523713917872088,0.905277658991855,1,2,primary lung bud formation,BP,WNT2
4494,GO:0060492,0.523713917872088,0.905277658991855,1,2,lung induction,BP,WNT2
4655,GO:0061072,0.523713917872088,0.905277658991855,1,2,iris morphogenesis,BP,WNT2
1862,GO:0021904,0.52373021371318,0.90527041878256,1,2,dorsal/ventral neural tube patterning,BP,BMP4
5115,GO:0072176,0.523804141574188,0.905237567729163,1,2,nephric duct development,BP,BMP4
5116,GO:0072178,0.523804141574188,0.905237567729163,1,2,nephric duct morphogenesis,BP,BMP4
2709,GO:0035239,0.523907349046998,0.652973023860405,8,25,tube morphogenesis,BP,WNT2;FGF8;VDR;WNK4;BMP4;GDNF;BMP7;NOTCH1
2935,GO:0042149,0.524080121841795,0.905114858186882,1,2,cellular response to glucose starvation,BP,PMAIP1
3370,GO:0044766,0.524195128163185,0.905063688643028,1,2,multi-organism transport,BP,RAB40B
5715,GO:1902579,0.524195128163185,0.905063688643028,1,2,multi-organism localization,BP,RAB40B
2534,GO:0033079,0.524500578289498,0.904927687828778,1,2,immature T cell proliferation,BP,BMP4
2535,GO:0033080,0.524500578289498,0.904927687828778,1,2,immature T cell proliferation in thymus,BP,BMP4
5104,GO:0072161,0.524500578289498,0.904927687828778,1,2,mesenchymal cell differentiation involved in kidney development,BP,BMP4
6148,GO:2001012,0.524500578289498,0.904927687828778,1,2,mesenchymal cell differentiation involved in renal system development,BP,BMP4
2736,GO:0035418,0.525118155985583,0.904652279977989,1,2,protein localization to synapse,BP,WNT7A
5484,GO:0099054,0.525118155985583,0.904652279977989,1,2,presynapse assembly,BP,WNT7A
5704,GO:1902473,0.525118155985583,0.904652279977989,1,2,regulation of protein localization to synapse,BP,WNT7A
5705,GO:1902474,0.525118155985583,0.904652279977989,1,2,positive regulation of protein localization to synapse,BP,WNT7A
5909,GO:1904861,0.525118155985583,0.904652279977989,1,2,excitatory synapse assembly,BP,WNT7A
3904,GO:0048813,0.525118215518946,0.904652253401214,1,2,dendrite morphogenesis,BP,WNT7A
4627,GO:0060996,0.525118247098973,0.904652239303313,1,2,dendritic spine development,BP,WNT7A
5345,GO:0097061,0.525118266438125,0.904652230669959,1,2,dendritic spine organization,BP,WNT7A
5302,GO:0090287,0.525289839304222,0.713938353183628,4,12,regulation of cellular response to growth factor stimulus,BP,CRB2;BMP4;FSTL3;NOTCH1
2990,GO:0042481,0.525836454583982,0.803066471020382,2,5,regulation of odontogenesis,BP,FGF8;BMP4
2159,GO:0031122,0.526282722536853,0.904131362877069,1,2,cytoplasmic microtubule organization,BP,AXIN1
1710,GO:0017148,0.526437468014927,0.904061988580976,1,2,negative regulation of translation,BP,BMP4
2613,GO:0034249,0.526437468014927,0.904061988580976,1,2,negative regulation of cellular amide metabolic process,BP,BMP4
3195,GO:0043500,0.526477472379152,0.904044048180331,1,2,muscle adaptation,BP,ACTN3
3197,GO:0043502,0.526477472379152,0.904044048180331,1,2,regulation of muscle adaptation,BP,ACTN3
3586,GO:0045980,0.526477472379152,0.904044048180331,1,2,negative regulation of nucleotide metabolic process,BP,ACTN3
3728,GO:0048016,0.526477472379152,0.904044048180331,1,2,inositol phosphate-mediated signaling,BP,ACTN3
5552,GO:1900543,0.526477472379152,0.904044048180331,1,2,negative regulation of purine nucleotide metabolic process,BP,ACTN3
5427,GO:0098589,0.526599133440568,0.743333801936147,3,9,membrane region,CC,CDH1;CRB2;TF
2912,GO:0042056,0.527571940065065,0.801814078816483,2,5,chemoattractant activity,MF,FGF8;BMP4
126,GO:0001709,0.527779107118327,0.90345897905007,1,2,cell fate determination,BP,BMP4
63,GO:0000989,0.528328937305639,0.741891835859715,3,9,transcription factor activity, transcription factor binding,MF,TLE1;POU3F1;NOTCH1
5984,GO:1990234,0.528488952837092,0.741758216860171,3,9,transferase complex,CC,PIK3CG;RNF144A;PIK3CA
865,GO:0006839,0.528563289851561,0.90310524360813,1,2,mitochondrial transport,BP,PMAIP1
602,GO:0005381,0.529110664227027,0.902857768877153,1,2,iron ion transmembrane transporter activity,MF,TF
3705,GO:0046915,0.529110664227027,0.902857768877153,1,2,transition metal ion transmembrane transporter activity,MF,TF
3360,GO:0044712,0.529158703808432,0.741198526403321,3,9,single-organism catabolic process,BP,GLDC;PIK3CG;ACTN3
1826,GO:0021549,0.529171981286129,0.902830017920488,1,2,cerebellum development,BP,WNT7A
1827,GO:0021575,0.529171981286129,0.902830017920488,1,2,hindbrain morphogenesis,BP,WNT7A
1828,GO:0021587,0.529171981286129,0.902830017920488,1,2,cerebellum morphogenesis,BP,WNT7A
1839,GO:0021695,0.529171981286129,0.902830017920488,1,2,cerebellar cortex development,BP,WNT7A
1840,GO:0021696,0.529171981286129,0.902830017920488,1,2,cerebellar cortex morphogenesis,BP,WNT7A
1841,GO:0021697,0.529171981286129,0.902830017920488,1,2,cerebellar cortex formation,BP,WNT7A
1877,GO:0022037,0.529171981286129,0.902830017920488,1,2,metencephalon development,BP,WNT7A
392,GO:0003129,0.529371663712605,0.902739605192883,1,2,heart induction,BP,BMP4
393,GO:0003130,0.529371663712605,0.902739605192883,1,2,BMP signaling pathway involved in heart induction,BP,BMP4
394,GO:0003133,0.529371663712605,0.902739605192883,1,2,endodermal-mesodermal cell signaling,BP,BMP4
395,GO:0003134,0.529371663712605,0.902739605192883,1,2,endodermal-mesodermal cell signaling involved in heart induction,BP,BMP4
1868,GO:0021978,0.529371663712605,0.902739605192883,1,2,telencephalon regionalization,BP,BMP4
2891,GO:0039706,0.529371663712605,0.902739605192883,1,2,co-receptor binding,MF,BMP4
4682,GO:0061209,0.529371663712605,0.902739605192883,1,2,cell proliferation involved in mesonephros development,BP,BMP4
5098,GO:0072138,0.529371663712605,0.902739605192883,1,2,mesenchymal cell proliferation involved in ureteric bud development,BP,BMP4
1386,GO:0010771,0.529471532798749,0.902694363131364,1,2,negative regulation of cell morphogenesis involved in differentiation,BP,WNT3
1442,GO:0010977,0.529471532798749,0.902694363131364,1,2,negative regulation of neuron projection development,BP,WNT3
2041,GO:0030516,0.529471532798749,0.902694363131364,1,2,regulation of axon extension,BP,WNT3
2042,GO:0030517,0.529471532798749,0.902694363131364,1,2,negative regulation of axon extension,BP,WNT3
3866,GO:0048675,0.529471532798749,0.902694363131364,1,2,axon extension,BP,WNT3
3910,GO:0048841,0.529471532798749,0.902694363131364,1,2,regulation of axon extension involved in axon guidance,BP,WNT3
3911,GO:0048843,0.529471532798749,0.902694363131364,1,2,negative regulation of axon extension involved in axon guidance,BP,WNT3
3914,GO:0048846,0.529471532798749,0.902694363131364,1,2,axon extension involved in axon guidance,BP,WNT3
3975,GO:0050771,0.529471532798749,0.902694363131364,1,2,negative regulation of axonogenesis,BP,WNT3
4718,GO:0061387,0.529471532798749,0.902694363131364,1,2,regulation of extent of cell growth,BP,WNT3
5691,GO:1902284,0.529471532798749,0.902694363131364,1,2,neuron projection extension involved in neuron projection guidance,BP,WNT3
5729,GO:1902667,0.529471532798749,0.902694363131364,1,2,regulation of axon guidance,BP,WNT3
5730,GO:1902668,0.529471532798749,0.902694363131364,1,2,negative regulation of axon guidance,BP,WNT3
654,GO:0005766,0.529648371915413,0.902614214827193,1,2,primary lysosome,CC,RAB3D
2744,GO:0035577,0.529648371915413,0.902614214827193,1,2,azurophil granule membrane,CC,RAB3D
3015,GO:0042582,0.529648371915413,0.902614214827193,1,2,azurophil granule,CC,RAB3D
157,GO:0001836,0.529802644820018,0.902544254701831,1,2,release of cytochrome c from mitochondria,BP,PMAIP1
256,GO:0002260,0.529802644820018,0.902544254701831,1,2,lymphocyte homeostasis,BP,PMAIP1
1156,GO:0008637,0.529802644820018,0.902544254701831,1,2,apoptotic mitochondrial changes,BP,PMAIP1
1398,GO:0010821,0.529802644820018,0.902544254701831,1,2,regulation of mitochondrion organization,BP,PMAIP1
3070,GO:0043029,0.529802644820018,0.902544254701831,1,2,T cell homeostasis,BP,PMAIP1
4844,GO:0070585,0.529802644820018,0.902544254701831,1,2,protein localization to mitochondrion,BP,PMAIP1
5197,GO:0072655,0.529802644820018,0.902544254701831,1,2,establishment of protein localization to mitochondrion,BP,PMAIP1
5287,GO:0090199,0.529802644820018,0.902544254701831,1,2,regulation of release of cytochrome c from mitochondria,BP,PMAIP1
5639,GO:1901796,0.529802644820018,0.902544254701831,1,2,regulation of signal transduction by p53 class mediator,BP,PMAIP1
6175,GO:2001242,0.529802644820018,0.902544254701831,1,2,regulation of intrinsic apoptotic signaling pathway,BP,PMAIP1
4696,GO:0061318,0.530998242220928,0.902000823478772,1,2,renal filtration cell differentiation,BP,BMP4
5040,GO:0072010,0.530998242220928,0.902000823478772,1,2,glomerular epithelium development,BP,BMP4
5054,GO:0072050,0.530998242220928,0.902000823478772,1,2,S-shaped body morphogenesis,BP,BMP4
5088,GO:0072112,0.530998242220928,0.902000823478772,1,2,glomerular visceral epithelial cell differentiation,BP,BMP4
5137,GO:0072217,0.530998242220928,0.902000823478772,1,2,negative regulation of metanephros development,BP,BMP4
5151,GO:0072284,0.530998242220928,0.902000823478772,1,2,metanephric S-shaped body morphogenesis,BP,BMP4
5158,GO:0072311,0.530998242220928,0.902000823478772,1,2,glomerular epithelial cell differentiation,BP,BMP4
3272,GO:0044232,0.531275383003529,0.901874539295274,1,2,organelle membrane contact site,CC,RAB38
3273,GO:0044233,0.531275383003529,0.901874539295274,1,2,ER-mitochondrion membrane contact site,CC,RAB38
4694,GO:0061312,0.531523508590516,0.901761375241007,1,2,BMP signaling pathway involved in heart development,BP,BMP4
950,GO:0007159,0.531589028452357,0.739161830326449,3,9,leukocyte cell-cell adhesion,BP,BMP4;PIK3CA;BMP7
5788,GO:1903307,0.531741532828849,0.901661860728526,1,2,positive regulation of regulated secretory pathway,BP,RAB3D
2331,GO:0032273,0.532881538916606,0.901140314040622,1,2,positive regulation of protein polymerization,BP,SCIN
3888,GO:0048745,0.532983598249517,0.901093523638572,1,2,smooth muscle tissue development,BP,BMP4
4676,GO:0061156,0.532983598249517,0.901093523638572,1,2,pulmonary artery morphogenesis,BP,BMP4
4170,GO:0051301,0.53333069252839,0.706883552847539,4,12,cell division,BP,WNT7A;FZD7;FGF8;NOTCH1
19,GO:0000149,0.533697478302962,0.900765781266217,1,2,SNARE binding,MF,SYT5
1808,GO:0019905,0.533697478302962,0.900765781266217,1,2,syntaxin binding,MF,SYT5
4644,GO:0061038,0.534361258596425,0.900460324285562,1,2,uterus morphogenesis,BP,WNT7A
3993,GO:0050806,0.534469391513298,0.900410498507974,1,2,positive regulation of synaptic transmission,BP,WNT7A
4371,GO:0060078,0.534469391513298,0.900410498507974,1,2,regulation of postsynaptic membrane potential,BP,WNT7A
4372,GO:0060079,0.534469391513298,0.900410498507974,1,2,excitatory postsynaptic potential,BP,WNT7A
1574,GO:0016020,0.534918875225063,0.584579222329849,51,166,membrane,CC,SLC2A14;TJP3;GLDC;WNT7A;GJB2;PIK3CG;SYT5;CLDN18;RHBDL3;RABIF;MBOAT2;GJA3;WNT3;GJB6;WNT7B;JAG2;PMAIP1;KCNG2;AXIN1;WNT2;CDH1;SPTBN5;RAB40B;RAB39A;SPTB;RRAS2;FZD7;FGF8;CRB2;DSG3;AMOT;WNT5B;WNK4;PKP1;TSPAN15;HRAS;RAB3D;KCNK6;CLDN15;RNF144A;RAB38;PIK3CA;DRP2;TMEM206;SPTBN4;TSPAN13;NOTCH1;RND3;RAB20;GUCY1B3;TF
5438,GO:0098655,0.535919328374037,0.704593150296957,4,12,cation transmembrane transport,BP,PIK3CG;KCNG2;KCNK6;TSPAN13
5442,GO:0098660,0.535919328374037,0.704593150296957,4,12,inorganic ion transmembrane transport,BP,PIK3CG;KCNG2;KCNK6;TSPAN13
5444,GO:0098662,0.535919328374037,0.704593150296957,4,12,inorganic cation transmembrane transport,BP,PIK3CG;KCNG2;KCNK6;TSPAN13
3603,GO:0046189,0.536294972017038,0.899566528581559,1,2,phenol-containing compound biosynthetic process,BP,PNMT
6171,GO:2001237,0.53636157187871,0.795393467295928,2,5,negative regulation of extrinsic apoptotic signaling pathway,BP,BMP4;GDNF
245,GO:0002220,0.536391172875073,0.899521909112432,1,2,innate immune response activating cell surface receptor signaling pathway,BP,HRAS
247,GO:0002223,0.536391172875073,0.899521909112432,1,2,stimulatory C-type lectin receptor signaling pathway,BP,HRAS
2504,GO:0032945,0.536459048265552,0.899490418650426,1,2,negative regulation of mononuclear cell proliferation,BP,BMP4
2932,GO:0042129,0.536459048265552,0.899490418650426,1,2,regulation of T cell proliferation,BP,BMP4
2933,GO:0042130,0.536459048265552,0.899490418650426,1,2,negative regulation of T cell proliferation,BP,BMP4
3939,GO:0050672,0.536459048265552,0.899490418650426,1,2,negative regulation of lymphocyte proliferation,BP,BMP4
4016,GO:0050868,0.536459048265552,0.899490418650426,1,2,negative regulation of T cell activation,BP,BMP4
4855,GO:0070664,0.536459048265552,0.899490418650426,1,2,negative regulation of leukocyte proliferation,BP,BMP4
5767,GO:1903038,0.536459048265552,0.899490418650426,1,2,negative regulation of leukocyte cell-cell adhesion,BP,BMP4
3726,GO:0048013,0.536463152953315,0.899488514066987,1,2,ephrin receptor signaling pathway,BP,HRAS
804,GO:0006584,0.536487117247622,0.899477394054821,1,2,catecholamine metabolic process,BP,PNMT
1226,GO:0009712,0.536487117247622,0.899477394054821,1,2,catechol-containing compound metabolic process,BP,PNMT
594,GO:0005251,0.536568545193512,0.899439602742469,1,2,delayed rectifier potassium channel activity,MF,KCNG2
371,GO:0003008,0.537916350746358,0.593640293428282,17,55,system process,BP,GJB2;PIK3CG;ACTN3;GJA3;BMP6;GJB6;JAG2;KCNG2;VDR;WNK4;INHBB;BMP4;KCNK6;GDNF;PIK3CA;SPTBN4;GUCY1B3
1927,GO:0030027,0.538007841195828,0.733739060351919,3,9,lamellipodium,CC,CDH1;AMOT;PIK3CA
1434,GO:0010950,0.538049785147563,0.898750317535617,1,2,positive regulation of endopeptidase activity,BP,PMAIP1
3146,GO:0043280,0.538049785147563,0.898750317535617,1,2,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,PMAIP1
6157,GO:2001056,0.538049785147563,0.898750317535617,1,2,positive regulation of cysteine-type endopeptidase activity,BP,PMAIP1
3486,GO:0045619,0.538114761122509,0.898720001790946,1,2,regulation of lymphocyte differentiation,BP,BMP4
1293,GO:0010256,0.538144032229555,0.662086031338693,6,19,endomembrane system organization,BP,CDH1;SPTBN5;RAB40B;TSPAN15;RAB38;SPTBN4
1856,GO:0021884,0.538497849913302,0.89854112832673,1,2,forebrain neuron development,BP,FGF8
3917,GO:0048853,0.538497849913302,0.89854112832673,1,2,forebrain morphogenesis,BP,FGF8
1824,GO:0021543,0.538550854246939,0.898516360951757,1,2,pallium development,BP,FGF8
3761,GO:0048259,0.538842455822855,0.898380024166466,1,2,regulation of receptor-mediated endocytosis,BP,TF
1993,GO:0030258,0.540168979908499,0.700812641219025,4,12,lipid modification,BP,PIK3CG;FGF8;FGF17;PIK3CA
5163,GO:0072332,0.540554428264197,0.897576867065741,1,2,intrinsic apoptotic signaling pathway by p53 class mediator,BP,PMAIP1
404,GO:0003159,0.540582268312469,0.897563767462647,1,2,morphogenesis of an endothelium,BP,BMP4
4674,GO:0061154,0.540582268312469,0.897563767462647,1,2,endothelial tube morphogenesis,BP,BMP4
2551,GO:0033162,0.541014585028588,0.897360189825697,1,2,melanosome membrane,CC,RAB38
3392,GO:0045009,0.541014585028588,0.897360189825697,1,2,chitosome,CC,RAB38
85,GO:0001502,0.542305334060785,0.896750593058148,1,2,cartilage condensation,BP,WNT7A
5449,GO:0098743,0.542305334060785,0.896750593058148,1,2,cell aggregation,BP,WNT7A
4931,GO:0071359,0.54243165299804,0.896690791097753,1,2,cellular response to dsRNA,BP,BMP4
2452,GO:0032732,0.542569505947267,0.896625499380215,1,2,positive regulation of interleukin-1 production,BP,CCL20
6084,GO:2000403,0.542569505947267,0.896625499380215,1,2,positive regulation of lymphocyte migration,BP,CCL20
6085,GO:2000404,0.542569505947267,0.896625499380215,1,2,regulation of T cell migration,BP,CCL20
6086,GO:2000406,0.542569505947267,0.896625499380215,1,2,positive regulation of T cell migration,BP,CCL20
2899,GO:0040017,0.542572819548336,0.635307733404898,8,25,positive regulation of locomotion,BP,WNT7A;RRAS2;ARTN;WNT5B;CCL20;HRAS;BMP4;NOTCH1
859,GO:0006816,0.543161447254894,0.729339014424824,3,9,calcium ion transport,BP,PIK3CG;VDR;TSPAN13
1774,GO:0019637,0.543808077476545,0.644266021745361,7,22,organophosphate metabolic process,BP,PIK3CG;ACTN3;MBOAT2;FGF8;FGF17;PIK3CA;GUCY1B3
4383,GO:0060128,0.543982027055891,0.895954716171019,1,2,corticotropin hormone secreting cell differentiation,BP,FGF8
1606,GO:0016264,0.544243770733205,0.895830064172612,1,2,gap junction assembly,BP,GJB2
5963,GO:1905867,0.544243770733205,0.895830064172612,1,2,epididymis development,BP,GJB2
259,GO:0002274,0.544304638951728,0.728357365598211,3,9,myeloid leukocyte activation,BP,PIK3CG;PKP1;RAB3D
713,GO:0005975,0.545088330901098,0.727683233049237,3,9,carbohydrate metabolic process,BP,ACTN3;PMAIP1;PIK3CA
3361,GO:0044723,0.545088330901098,0.727683233049237,3,9,single-organism carbohydrate metabolic process,BP,ACTN3;PMAIP1;PIK3CA
5199,GO:0072657,0.545694168390965,0.655005781260562,6,19,protein localization to membrane,BP,PMAIP1;CDH1;RAB40B;TSPAN15;RAB38;SPTBN4
5941,GO:1905276,0.545760469272294,0.895105568473689,1,2,regulation of epithelial tube formation,BP,GDNF
189,GO:0001941,0.545812646944887,0.895080577738921,1,2,postsynaptic membrane organization,BP,GDNF
466,GO:0003339,0.546473107249652,0.894763863761564,1,2,regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,GDNF
5084,GO:0072108,0.546473107249652,0.894763863761564,1,2,positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,GDNF
6116,GO:2000696,0.546473107249652,0.894763863761564,1,2,regulation of epithelial cell differentiation involved in kidney development,BP,GDNF
6117,GO:2000698,0.546473107249652,0.894763863761564,1,2,positive regulation of epithelial cell differentiation involved in kidney development,BP,GDNF
3922,GO:0048863,0.546545262996999,0.695092232671562,4,12,stem cell differentiation,BP,WNT7A;WNT3;GDNF;NOTCH1
2142,GO:0031069,0.546802877254103,0.894605461053121,1,2,hair follicle morphogenesis,BP,NOTCH1
3882,GO:0048730,0.546802877254103,0.894605461053121,1,2,epidermis morphogenesis,BP,NOTCH1
3258,GO:0044058,0.547007753427043,0.894506960748891,1,2,regulation of digestive system process,BP,WNK4
4252,GO:0051781,0.547087471527457,0.89446861536056,1,2,positive regulation of cell division,BP,FGF8
3925,GO:0048870,0.548432971516327,0.586013797791567,16,52,cell motility,BP,WNT7A;PIK3CG;JAG2;RRAS2;FGF8;CRB2;ARTN;AMOT;WNT5B;CCL20;PKN3;HRAS;BMP4;GDNF;PIK3CA;NOTCH1
4239,GO:0051674,0.548432971516327,0.586013797791567,16,52,localization of cell,BP,WNT7A;PIK3CG;JAG2;RRAS2;FGF8;CRB2;ARTN;AMOT;WNT5B;CCL20;PKN3;HRAS;BMP4;GDNF;PIK3CA;NOTCH1
686,GO:0005881,0.54874988564711,0.893666601276789,1,2,cytoplasmic microtubule,CC,RAB3D
3238,GO:0043627,0.549858673605745,0.893129153207211,1,2,response to estrogen,BP,WNT7A
311,GO:0002548,0.551084018830064,0.892532846938295,1,2,monocyte chemotaxis,BP,CCL20
4982,GO:0071674,0.551084018830064,0.892532846938295,1,2,mononuclear cell migration,BP,CCL20
605,GO:0005488,0.551354214753467,0.608973118046131,64,208,binding,MF,MAGEC2;TJP3;GLDC;RHPN1;SCIN;TLE1;WNT7A;PIK3CG;SYT5;ACTN3;CLDN18;RHBDL3;RABIF;BMP6;WNT3;HEY1;WNT7B;JAG2;PMAIP1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;SPTBN5;RAB40B;RAB39A;SPTB;RRAS2;FZD7;FGF8;VDR;CRB2;ARTN;DSG3;AMOT;WNT5B;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;FGF17;TSPAN15;HRAS;BMP4;RAB3D;CLDN15;GDNF;RNF144A;RAB38;PIK3CA;BMP7;DRP2;FSTL3;TPD52;SPTBN4;NOTCH1;RND3;MB21D2;RAB20;GUCY1B3;TF
4190,GO:0051427,0.551639956988828,0.892261483146939,1,2,hormone receptor binding,MF,VDR
5304,GO:0090303,0.552867338554119,0.891660556463441,1,2,positive regulation of wound healing,BP,HRAS
5765,GO:1903036,0.552867338554119,0.891660556463441,1,2,positive regulation of response to wounding,BP,HRAS
4552,GO:0060684,0.552895006480498,0.891646981317545,1,2,epithelial-mesenchymal cell signaling,BP,BMP4
2459,GO:0032770,0.554387336146235,0.890912881709889,1,2,positive regulation of monooxygenase activity,BP,GDNF
3191,GO:0043487,0.554387336146235,0.890912881709889,1,2,regulation of RNA stability,BP,GDNF
3192,GO:0043488,0.554387336146235,0.890912881709889,1,2,regulation of mRNA stability,BP,GDNF
994,GO:0007270,0.554708772939939,0.890754274091916,1,2,neuron-neuron synaptic transmission,BP,GDNF
1041,GO:0007569,0.555581588630009,0.890322722643923,1,2,cell aging,BP,HRAS
1297,GO:0010332,0.555581588630009,0.890322722643923,1,2,response to gamma radiation,BP,HRAS
4962,GO:0071480,0.555581588630009,0.890322722643923,1,2,cellular response to gamma radiation,BP,HRAS
5314,GO:0090398,0.555581588630009,0.890322722643923,1,2,cellular senescence,BP,HRAS
1258,GO:0009914,0.556301658031607,0.717931240290609,3,9,hormone transport,BP,BMP6;KCNG2;INHBB
3687,GO:0046879,0.556301658031607,0.717931240290609,3,9,hormone secretion,BP,BMP6;KCNG2;INHBB
3691,GO:0046883,0.556301658031607,0.717931240290609,3,9,regulation of hormone secretion,BP,BMP6;KCNG2;INHBB
296,GO:0002443,0.556539587178013,0.717722148869562,3,9,leukocyte mediated immunity,BP,PIK3CG;PKP1;RAB3D
948,GO:0007156,0.556765956777465,0.767246023413297,2,6,homophilic cell adhesion via plasma membrane adhesion molecules,BP,CDH1;DSG3
5633,GO:1901699,0.557945349082172,0.629103175935307,7,23,cellular response to nitrogen compound,BP,GJB2;PIK3CG;CDH1;INHBB;BMP4;PIK3CA;GUCY1B3
629,GO:0005576,0.558703201392676,0.554366636990649,30,97,extracellular region,CC,SCIN;WNT7A;ACTN3;BMP6;WNT3;WNT7B;KCNG2;WNT2;CDH1;SPTBN5;RRAS2;FGF8;CRB2;ARTN;DSG3;WNT5B;INHBB;CCL20;PKP1;FGF17;TSPAN15;BMP4;RAB3D;GDNF;BMP7;FSTL3;SPTBN4;NOTCH1;RND3;TF
2973,GO:0042391,0.559041761742759,0.715517736159035,3,9,regulation of membrane potential,BP,WNT7A;PMAIP1;KCNK6
1134,GO:0008406,0.559145175797739,0.715426411581254,3,9,gonad development,BP,FGF8;INHBB;FSTL3
3423,GO:0045137,0.559145175797739,0.715426411581254,3,9,development of primary sexual characteristics,BP,FGF8;INHBB;FSTL3
5596,GO:1901363,0.559336919044504,0.567469131577489,19,62,heterocyclic compound binding,MF,GLDC;PIK3CG;HEY1;POU3F1;MAPK12;RAB40B;RAB39A;RRAS2;VDR;WNK4;PKN3;HRAS;RAB3D;RAB38;PIK3CA;NOTCH1;RND3;RAB20;GUCY1B3
584,GO:0005215,0.560365382513929,0.641047407168817,6,19,transporter activity,MF,SLC2A14;GJB2;GJA3;KCNG2;KCNK6;TF
254,GO:0002252,0.560573931854772,0.656990662459475,5,16,immune effector process,BP,PIK3CG;PMAIP1;PKP1;RAB3D;PIK3CA
1334,GO:0010594,0.560880185456045,0.713891655592943,3,9,regulation of endothelial cell migration,BP,WNT7A;BMP4;NOTCH1
1637,GO:0016462,0.561758216453496,0.616753118609952,8,25,pyrophosphatase activity,MF,RAB40B;RAB39A;RRAS2;HRAS;RAB3D;RAB38;RND3;RAB20
1681,GO:0016817,0.561758216453496,0.616753118609952,8,25,hydrolase activity, acting on acid anhydrides,MF,RAB40B;RAB39A;RRAS2;HRAS;RAB3D;RAB38;RND3;RAB20
1682,GO:0016818,0.561758216453496,0.616753118609952,8,25,hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,MF,RAB40B;RAB39A;RRAS2;HRAS;RAB3D;RAB38;RND3;RAB20
1704,GO:0017111,0.561758216453496,0.616753118609952,8,25,nucleoside-triphosphatase activity,MF,RAB40B;RAB39A;RRAS2;HRAS;RAB3D;RAB38;RND3;RAB20
1943,GO:0030057,0.562754162613234,0.762382189220405,2,6,desmosome,CC,DSG3;PKP1
191,GO:0001944,0.562805841910336,0.592256719667579,11,36,vasculature development,BP,WNT7A;PIK3CG;HEY1;WNT7B;WNT2;FGF8;AMOT;BMP4;PIK3CA;BMP7;NOTCH1
4248,GO:0051767,0.563384919768358,0.886407047164542,1,2,nitric-oxide synthase biosynthetic process,BP,CCL20
4249,GO:0051769,0.563384919768358,0.886407047164542,1,2,regulation of nitric-oxide synthase biosynthetic process,BP,CCL20
4765,GO:0070098,0.563384919768358,0.886407047164542,1,2,chemokine-mediated signaling pathway,BP,CCL20
4841,GO:0070555,0.563384919768358,0.886407047164542,1,2,response to interleukin-1,BP,CCL20
4927,GO:0071347,0.563384919768358,0.886407047164542,1,2,cellular response to interleukin-1,BP,CCL20
184,GO:0001933,0.563451526996711,0.71160813021067,3,9,negative regulation of protein phosphorylation,BP,DUSP5;BMP4;BMP7
2204,GO:0031400,0.563451526996711,0.71160813021067,3,9,negative regulation of protein modification process,BP,DUSP5;BMP4;BMP7
5282,GO:0090190,0.563887155741616,0.886151451731587,1,2,positive regulation of branching involved in ureteric bud morphogenesis,BP,GDNF
539,GO:0004871,0.564285706427624,0.612920174858359,8,26,signal transducer activity,MF,WNT7A;WNT3;AXIN1;MAPK12;WNT2;FZD7;VDR;PKP1
3039,GO:0042742,0.564345706042022,0.88591770710354,1,2,defense response to bacterium,BP,CCL20
3327,GO:0044430,0.565196885059842,0.602657982712826,9,30,cytoskeletal part,CC,SCIN;ACTN3;CDH1;SPTBN5;SPTB;AMOT;PKP1;RAB3D;SPTBN4
3418,GO:0045121,0.565804766563943,0.759879300061712,2,6,membrane raft,CC,CDH1;CRB2
5469,GO:0098857,0.565804766563943,0.759879300061712,2,6,membrane microdomain,CC,CDH1;CRB2
1492,GO:0014821,0.566431953433227,0.88484963536526,1,2,phasic smooth muscle contraction,BP,GDNF
1546,GO:0015696,0.566431953433227,0.88484963536526,1,2,ammonium transport,BP,GDNF
4253,GO:0051783,0.566869960177215,0.708555663731963,3,9,regulation of nuclear division,BP,FGF8;BMP4;BMP7
3851,GO:0048644,0.567509859060178,0.75847290738004,2,6,muscle organ morphogenesis,BP,WNT2;NOTCH1
4179,GO:0051346,0.567741843733501,0.707774062362456,3,9,negative regulation of hydrolase activity,BP,CRB2;AMOT;HRAS
156,GO:0001823,0.568138583911397,0.675283833320383,4,12,mesonephros development,BP,FGF8;BMP4;GDNF;BMP7
1124,GO:0008324,0.569363087967978,0.706317376770576,3,9,cation transmembrane transporter activity,MF,KCNG2;KCNK6;TF
349,GO:0002761,0.569453127900334,0.75686352488562,2,6,regulation of myeloid leukocyte differentiation,BP,CLDN18;FSTL3
6149,GO:2001020,0.570370440835456,0.882812518135217,1,2,regulation of response to DNA damage stimulus,BP,PMAIP1
6150,GO:2001022,0.570370440835456,0.882812518135217,1,2,positive regulation of response to DNA damage stimulus,BP,PMAIP1
2940,GO:0042176,0.571771181480102,0.75493460016725,2,6,regulation of protein catabolic process,BP,AXIN1;RNF144A
4385,GO:0060135,0.572014265467792,0.754731743509872,2,6,maternal process involved in female pregnancy,BP,GJB2;VDR
1755,GO:0019220,0.572535008074718,0.561952628895811,16,52,regulation of phosphate metabolic process,BP,WNT7A;PIK3CG;ACTN3;BMP6;WNT7B;AXIN1;FZD7;FGF8;DUSP5;INHBB;CCL20;HRAS;BMP4;PIK3CA;BMP7;SPTBN4
4110,GO:0051174,0.572535008074718,0.561952628895811,16,52,regulation of phosphorus metabolic process,BP,WNT7A;PIK3CG;ACTN3;BMP6;WNT7B;AXIN1;FZD7;FGF8;DUSP5;INHBB;CCL20;HRAS;BMP4;PIK3CA;BMP7;SPTBN4
4039,GO:0050926,0.57289034753867,0.881494745415053,1,2,regulation of positive chemotaxis,BP,ARTN
4040,GO:0050927,0.57289034753867,0.881494745415053,1,2,positive regulation of positive chemotaxis,BP,ARTN
4041,GO:0050930,0.57289034753867,0.881494745415053,1,2,induction of positive chemotaxis,BP,ARTN
4484,GO:0060449,0.573070400031097,0.881400154562653,1,2,bud elongation involved in lung branching,BP,BMP4
4528,GO:0060592,0.573070400031097,0.881400154562653,1,2,mammary gland formation,BP,BMP4
3320,GO:0044421,0.57335688173929,0.541759151831937,27,88,extracellular region part,CC,SCIN;WNT7A;ACTN3;BMP6;WNT3;WNT7B;KCNG2;WNT2;CDH1;SPTBN5;RRAS2;CRB2;ARTN;DSG3;WNT5B;INHBB;CCL20;PKP1;FGF17;TSPAN15;BMP4;RAB3D;BMP7;FSTL3;SPTBN4;RND3;TF
5066,GO:0072079,0.57360280664984,0.881120114549538,1,2,nephron tubule formation,BP,GDNF
2518,GO:0033002,0.574547770728065,0.701629820823694,3,9,muscle cell proliferation,BP,WNT2;BMP4;NOTCH1
647,GO:0005739,0.574727014725315,0.643439389339274,5,16,mitochondrion,CC,GLDC;PMAIP1;MAPK12;RAB3D;RAB38
938,GO:0007067,0.57630071289958,0.700034859371025,3,9,mitotic nuclear division,BP,FGF8;BMP4;BMP7
1615,GO:0016324,0.576968737361372,0.66300558947481,4,13,apical plasma membrane,CC,GJB6;CRB2;NOTCH1;TF
3294,GO:0044282,0.577216682104211,0.750363753853475,2,6,small molecule catabolic process,BP,GLDC;ACTN3
1040,GO:0007568,0.577335569220838,0.699090858677803,3,9,aging,BP,GJB2;GJB6;HRAS
4394,GO:0060174,0.578236891575951,0.878661079130779,1,2,limb bud formation,BP,WNT3
732,GO:0006081,0.578559277893683,0.74922823250107,2,6,cellular aldehyde metabolic process,BP,GLDC;BMP6
5861,GO:1903829,0.57883301407194,0.661226941077951,4,13,positive regulation of cellular protein localization,BP,BMP6;PMAIP1;CDH1;BMP4
5749,GO:1902903,0.579329852408302,0.660752041836068,4,13,regulation of supramolecular fiber organization,BP,SCIN;SPTBN5;SPTB;SPTBN4
1251,GO:0009894,0.579471532416556,0.620446310752678,6,20,regulation of catabolic process,BP,PIK3CG;ACTN3;AXIN1;PKP1;RNF144A;PIK3CA
118,GO:0001678,0.579604624447801,0.748341751195764,2,6,cellular glucose homeostasis,BP,GJB6;PIK3CA
5881,GO:1904062,0.579751464514851,0.748217060893855,2,6,regulation of cation transmembrane transport,BP,PIK3CG;TSPAN13
3474,GO:0045598,0.579850308845334,0.748133103455667,2,6,regulation of fat cell differentiation,BP,AXIN1;WNT5B
5458,GO:0098796,0.579861226059802,0.660243721080966,4,13,membrane protein complex,CC,GJB2;GJA3;GJB6;CDH1
1800,GO:0019897,0.580242763852789,0.747799572685434,2,6,extrinsic component of plasma membrane,CC,CDH1;TF
1957,GO:0030141,0.580817116957425,0.621138529306922,6,19,secretory granule,CC,SYT5;PKP1;RAB3D;FSTL3;NOTCH1;TF
4008,GO:0050851,0.582486844341148,0.745886789945614,2,6,antigen receptor-mediated signaling pathway,BP,HRAS;PIK3CA
4009,GO:0050852,0.582486844341148,0.745886789945614,2,6,T cell receptor signaling pathway,BP,HRAS;PIK3CA
4509,GO:0060538,0.582887298175347,0.745544444798102,2,6,skeletal muscle organ development,BP,ACTN3;NOTCH1
1753,GO:0019218,0.582973724536779,0.745470519248935,2,6,regulation of steroid metabolic process,BP,BMP6;VDR
3996,GO:0050810,0.582973724536779,0.745470519248935,2,6,regulation of steroid biosynthetic process,BP,BMP6;VDR
55,GO:0000975,0.583103084826439,0.745359843062081,2,6,regulatory region DNA binding,MF,VDR;NOTCH1
67,GO:0001067,0.583103084826439,0.745359843062081,2,6,regulatory region nucleic acid binding,MF,VDR;NOTCH1
3271,GO:0044212,0.583103084826439,0.745359843062081,2,6,transcription regulatory region DNA binding,MF,VDR;NOTCH1
561,GO:0005111,0.583194512672666,0.875987023656827,1,2,type 2 fibroblast growth factor receptor binding,MF,FGF17
646,GO:0005737,0.583286505947026,0.535216087373518,50,164,cytoplasm,CC,MAGEC2;GLDC;RHPN1;SCIN;TLE1;WNT7A;GJB2;PIK3CG;SYT5;ACTN3;RABIF;MBOAT2;BMP6;WNT3;HEY1;GJB6;WNT7B;PMAIP1;AXIN1;MAPK12;WNT2;CDH1;SPTBN5;RAB40B;RAB39A;SPTB;RRAS2;FZD7;DSG3;AMOT;WNT5B;WNK4;INHBB;PKN3;PKP1;TSPAN15;HRAS;RAB3D;RNF144A;RAB38;PIK3CA;FSTL3;TPD52;SPTBN4;NOTCH1;RND3;PNMT;RAB20;GUCY1B3;TF
1620,GO:0016337,0.583399687861576,0.592693948674376,8,27,single organismal cell-cell adhesion,BP,PIK3CG;WNT7B;CDH1;PKP1;BMP4;PIK3CA;BMP7;FSTL3
4301,GO:0055006,0.583867691034436,0.744705017526007,2,6,cardiac cell development,BP,BMP4;NOTCH1
2197,GO:0031347,0.584275602522386,0.744355214411023,2,6,regulation of defense response,BP,PIK3CG;HRAS
4011,GO:0050863,0.584611829420212,0.744066643882253,2,6,regulation of T cell activation,BP,BMP4;PIK3CA
5766,GO:1903037,0.584611829420212,0.744066643882253,2,6,regulation of leukocyte cell-cell adhesion,BP,BMP4;PIK3CA
581,GO:0005198,0.58610455923254,0.601357882578445,7,23,structural molecule activity,MF,ACTN3;CLDN18;AXIN1;SPTB;PKP1;CLDN15;SPTBN4
2112,GO:0030878,0.586335638501262,0.874269211405195,1,2,thyroid gland development,BP,FGF8
2122,GO:0030916,0.586335638501262,0.874269211405195,1,2,otic vesicle formation,BP,FGF8
4975,GO:0071599,0.586335638501262,0.874269211405195,1,2,otic vesicle development,BP,FGF8
4976,GO:0071600,0.586335638501262,0.874269211405195,1,2,otic vesicle morphogenesis,BP,FGF8
4078,GO:0051090,0.586421611532832,0.742509639973084,2,6,regulation of sequence-specific DNA binding transcription factor activity,BP,WNT2;BMP7
38,GO:0000302,0.586870144986005,0.742122777634513,2,6,response to reactive oxygen species,BP,BMP7;GUCY1B3
881,GO:0006897,0.587846941109147,0.599609785484829,7,23,endocytosis,BP,PIK3CG;SYT5;RAB39A;HRAS;PIK3CA;RAB20;TF
262,GO:0002283,0.588173935152084,0.740996041828333,2,6,neutrophil activation involved in immune response,BP,PKP1;RAB3D
298,GO:0002446,0.588173935152084,0.740996041828333,2,6,neutrophil mediated immunity,BP,PKP1;RAB3D
2840,GO:0036230,0.588173935152084,0.740996041828333,2,6,granulocyte activation,BP,PKP1;RAB3D
2930,GO:0042119,0.588173935152084,0.740996041828333,2,6,neutrophil activation,BP,PKP1;RAB3D
3154,GO:0043312,0.588173935152084,0.740996041828333,2,6,neutrophil degranulation,BP,PKP1;RAB3D
223,GO:0002066,0.588200397074386,0.740973139321788,2,6,columnar/cuboidal epithelial cell development,BP,BMP6;BMP4
2530,GO:0033043,0.588260669127394,0.579571014234598,9,30,regulation of organelle organization,BP,SCIN;PMAIP1;SPTBN5;SPTB;FGF8;HRAS;BMP4;BMP7;SPTBN4
111,GO:0001658,0.588643519033929,0.688657975095955,3,9,branching involved in ureteric bud morphogenesis,BP,FGF8;BMP4;GDNF
4548,GO:0060675,0.588643519033929,0.688657975095955,3,9,ureteric bud morphogenesis,BP,FGF8;BMP4;GDNF
5110,GO:0072171,0.588643519033929,0.688657975095955,3,9,mesonephric tubule morphogenesis,BP,FGF8;BMP4;GDNF
3266,GO:0044089,0.589635146414573,0.62886754484285,5,16,positive regulation of cellular component biogenesis,BP,SCIN;WNT7A;PMAIP1;HRAS;BMP7
2897,GO:0040013,0.589698669574232,0.739674182009678,2,6,negative regulation of locomotion,BP,WNT3;NOTCH1
4156,GO:0051271,0.589698669574232,0.739674182009678,2,6,negative regulation of cellular component movement,BP,WNT3;NOTCH1
870,GO:0006874,0.590148157499904,0.739283637736906,2,6,cellular calcium ion homeostasis,BP,PIK3CG;VDR
4322,GO:0055074,0.590148157499904,0.739283637736906,2,6,calcium ion homeostasis,BP,PIK3CG;VDR
5174,GO:0072503,0.590148157499904,0.739283637736906,2,6,cellular divalent inorganic cation homeostasis,BP,PIK3CG;VDR
5175,GO:0072507,0.590148157499904,0.739283637736906,2,6,divalent inorganic cation homeostasis,BP,PIK3CG;VDR
903,GO:0006954,0.590296458629694,0.650174445693042,4,13,inflammatory response,BP,PIK3CG;BMP6;CCL20;NOTCH1
480,GO:0003676,0.590696097290896,0.64978551510698,4,13,nucleic acid binding,MF,HEY1;POU3F1;VDR;NOTCH1
24,GO:0000166,0.590697619905794,0.550036037770092,14,46,nucleotide binding,MF,PIK3CG;MAPK12;RAB40B;RAB39A;RRAS2;WNK4;PKN3;HRAS;RAB3D;RAB38;PIK3CA;RND3;RAB20;GUCY1B3
1702,GO:0017076,0.590697619905794,0.550036037770092,14,46,purine nucleotide binding,MF,PIK3CG;MAPK12;RAB40B;RAB39A;RRAS2;WNK4;PKN3;HRAS;RAB3D;RAB38;PIK3CA;RND3;RAB20;GUCY1B3
2407,GO:0032553,0.590697619905794,0.550036037770092,14,46,ribonucleotide binding,MF,PIK3CG;MAPK12;RAB40B;RAB39A;RRAS2;WNK4;PKN3;HRAS;RAB3D;RAB38;PIK3CA;RND3;RAB20;GUCY1B3
2408,GO:0032555,0.590697619905794,0.550036037770092,14,46,purine ribonucleotide binding,MF,PIK3CG;MAPK12;RAB40B;RAB39A;RRAS2;WNK4;PKN3;HRAS;RAB3D;RAB38;PIK3CA;RND3;RAB20;GUCY1B3
5587,GO:1901265,0.590697619905794,0.550036037770092,14,46,nucleoside phosphate binding,MF,PIK3CG;MAPK12;RAB40B;RAB39A;RRAS2;WNK4;PKN3;HRAS;RAB3D;RAB38;PIK3CA;RND3;RAB20;GUCY1B3
5008,GO:0071804,0.591581264759801,0.738035828900546,2,6,cellular potassium ion transport,BP,KCNG2;KCNK6
5009,GO:0071805,0.591581264759801,0.738035828900546,2,6,potassium ion transmembrane transport,BP,KCNG2;KCNK6
2664,GO:0034703,0.591643197848955,0.737981813170618,2,6,cation channel complex,CC,KCNG2;KCNK6
4538,GO:0060627,0.592153512974216,0.626375269129543,5,16,regulation of vesicle-mediated transport,BP,SYT5;RAB3D;NOTCH1;RAB20;TF
5456,GO:0098793,0.592433567720064,0.685112388694999,3,9,presynapse,CC,WNT7A;SYT5;RAB40B
1356,GO:0010648,0.592844304758857,0.556177525769351,12,40,negative regulation of cell communication,BP,TLE1;ACTN3;HEY1;AXIN1;WNT5B;DUSP5;INHBB;BMP4;GDNF;BMP7;FSTL3;NOTCH1
1917,GO:0023057,0.592844304758857,0.556177525769351,12,40,negative regulation of signaling,BP,TLE1;ACTN3;HEY1;AXIN1;WNT5B;DUSP5;INHBB;BMP4;GDNF;BMP7;FSTL3;NOTCH1
4237,GO:0051656,0.593285914299436,0.684311602971869,3,9,establishment of organelle localization,BP,WNT7A;PIK3CG;SYT5
3050,GO:0042803,0.595466694799764,0.623082716584275,5,16,protein homodimerization activity,MF,ACTN3;AXIN1;INHBB;GDNF;TPD52
2714,GO:0035265,0.596151268321358,0.681610333115151,3,9,organ growth,BP,WNT2;FGF8;NOTCH1
1230,GO:0009743,0.597005069890069,0.733276799898148,2,6,response to carbohydrate,BP,GJB6;PIK3CA
1232,GO:0009746,0.597005069890069,0.733276799898148,2,6,response to hexose,BP,GJB6;PIK3CA
1233,GO:0009749,0.597005069890069,0.733276799898148,2,6,response to glucose,BP,GJB6;PIK3CA
2615,GO:0034284,0.597005069890069,0.733276799898148,2,6,response to monosaccharide,BP,GJB6;PIK3CA
4480,GO:0060443,0.600434310219933,0.730237796915366,2,6,mammary gland morphogenesis,BP,VDR;BMP4
1050,GO:0007600,0.601394493629262,0.639281795500366,4,13,sensory perception,BP,GJB2;GJA3;GJB6;SPTBN4
1218,GO:0009612,0.60390985706848,0.727133728777385,2,6,response to mechanical stimulus,BP,BMP6;INHBB
4966,GO:0071496,0.603910461275669,0.636785615666275,4,13,cellular response to external stimulus,BP,BMP6;PMAIP1;VDR;INHBB
493,GO:0003779,0.604805252851723,0.611106612264652,5,17,actin binding,MF,SCIN;ACTN3;SPTBN5;SPTB;SPTBN4
585,GO:0005216,0.605533498044798,0.725675275964032,2,6,ion channel activity,MF,KCNG2;KCNK6
1905,GO:0022838,0.605533498044798,0.725675275964032,2,6,substrate-specific channel activity,MF,KCNG2;KCNK6
153,GO:0001819,0.606299253898162,0.72498557211859,2,6,positive regulation of cytokine production,BP,CCL20;HRAS
1242,GO:0009880,0.606326163403541,0.724961313487002,2,6,embryonic pattern specification,BP,WNT7A;BMP7
5134,GO:0072210,0.608070258631164,0.723385884014653,2,6,metanephric nephron development,BP,BMP4;GDNF
2189,GO:0031329,0.608309933868018,0.607548954780275,5,17,regulation of cellular catabolic process,BP,PIK3CG;AXIN1;PKP1;RNF144A;PIK3CA
2512,GO:0032970,0.608337737571422,0.6075206597997,5,17,regulation of actin filament-based process,BP,SCIN;SPTBN5;SPTB;HRAS;SPTBN4
1329,GO:0010563,0.608721599396384,0.631984410065783,4,13,negative regulation of phosphorus metabolic process,BP,ACTN3;DUSP5;BMP4;BMP7
3580,GO:0045936,0.608721599396384,0.631984410065783,4,13,negative regulation of phosphate metabolic process,BP,ACTN3;DUSP5;BMP4;BMP7
2131,GO:0031016,0.609404679894305,0.722176314114697,2,6,pancreas development,BP,BMP6;BMP4
4512,GO:0060548,0.612316397359997,0.547877064481736,10,33,negative regulation of cell death,BP,TLE1;WNT7A;PIK3CG;FGF8;HRAS;BMP4;GDNF;PIK3CA;BMP7;NOTCH1
5382,GO:0097305,0.615578072961252,0.716532775372683,2,6,response to alcohol,BP,CLDN18;CDH1
1843,GO:0021700,0.619036155284192,0.713336842040237,2,6,developmental maturation,BP,RAB38;SPTBN4
5428,GO:0098590,0.619751879857258,0.565404959445404,7,24,plasma membrane region,CC,GJB6;CDH1;SPTBN5;CRB2;DRP2;NOTCH1;TF
899,GO:0006941,0.620672179544216,0.651778140655126,3,10,striated muscle contraction,BP,PIK3CG;ACTN3;PIK3CA
2896,GO:0040012,0.621019858700035,0.532015005382101,11,37,regulation of locomotion,BP,WNT7A;WNT3;JAG2;RRAS2;ARTN;AMOT;WNT5B;CCL20;HRAS;BMP4;NOTCH1
2373,GO:0032403,0.624510796011565,0.56041417834831,7,24,protein complex binding,MF,SCIN;ACTN3;SPTB;PKP1;RAB38;FSTL3;MB21D2
1072,GO:0008021,0.624945174547773,0.707817345828938,2,6,synaptic vesicle,CC,SYT5;RAB40B
5492,GO:0099503,0.627675245142149,0.558615631672348,7,23,secretory vesicle,CC,SYT5;RAB40B;PKP1;RAB3D;FSTL3;NOTCH1;TF
2985,GO:0042471,0.629725311107188,0.703297657151812,2,6,ear morphogenesis,BP,GJB6;FGF8
3257,GO:0044057,0.62993376960289,0.544659075412389,8,27,regulation of system process,BP,PIK3CG;ACTN3;BMP6;KCNG2;WNK4;INHBB;KCNK6;SPTBN4
919,GO:0007015,0.630736612012049,0.606021528220696,4,14,actin filament organization,BP,SCIN;SPTBN5;SPTB;SPTBN4
3121,GO:0043230,0.632099969873433,0.494077407905455,18,61,extracellular organelle,CC,SCIN;WNT7A;ACTN3;WNT3;WNT7B;KCNG2;CDH1;SPTBN5;RRAS2;CRB2;DSG3;WNT5B;PKP1;TSPAN15;RAB3D;SPTBN4;RND3;TF
4761,GO:0070062,0.632099969873433,0.494077407905455,18,61,extracellular exosome,CC,SCIN;WNT7A;ACTN3;WNT3;WNT7B;KCNG2;CDH1;SPTBN5;RRAS2;CRB2;DSG3;WNT5B;PKP1;TSPAN15;RAB3D;SPTBN4;RND3;TF
5832,GO:1903561,0.632099969873433,0.494077407905455,18,61,extracellular vesicle,CC,SCIN;WNT7A;ACTN3;WNT3;WNT7B;KCNG2;CDH1;SPTBN5;RRAS2;CRB2;DSG3;WNT5B;PKP1;TSPAN15;RAB3D;SPTBN4;RND3;TF
2243,GO:0031668,0.632644743134447,0.6396835362895,3,10,cellular response to extracellular stimulus,BP,PMAIP1;VDR;INHBB
2244,GO:0031669,0.632644743134447,0.6396835362895,3,10,cellular response to nutrient levels,BP,PMAIP1;VDR;INHBB
4770,GO:0070161,0.633113448150696,0.540106127055422,8,28,anchoring junction,CC,ACTN3;CDH1;RRAS2;DSG3;PKP1;SPTBN4;NOTCH1;RND3
6168,GO:2001234,0.633820444584408,0.699386214768106,2,6,negative regulation of apoptotic signaling pathway,BP,BMP4;GDNF
5360,GO:0097159,0.634973136129843,0.488882341082954,19,64,organic cyclic compound binding,MF,GLDC;PIK3CG;HEY1;POU3F1;MAPK12;RAB40B;RAB39A;RRAS2;VDR;WNK4;PKN3;HRAS;RAB3D;RAB38;PIK3CA;NOTCH1;RND3;RAB20;GUCY1B3
2303,GO:0032101,0.635358454332428,0.579483128715079,5,17,regulation of response to external stimulus,BP,PIK3CG;BMP6;WNT3;ARTN;NOTCH1
1144,GO:0008543,0.635944975166995,0.697342491453503,2,6,fibroblast growth factor receptor signaling pathway,BP,FGF8;FGF17
3309,GO:0044344,0.635944975166995,0.697342491453503,2,6,cellular response to fibroblast growth factor stimulus,BP,FGF8;FGF17
5002,GO:0071774,0.635944975166995,0.697342491453503,2,6,response to fibroblast growth factor,BP,FGF8;FGF17
525,GO:0004713,0.636198341645837,0.697098096969682,2,6,protein tyrosine kinase activity,MF,FGF8;FGF17
151,GO:0001817,0.636376068319576,0.635859374197915,3,10,regulation of cytokine production,BP,INHBB;CCL20;HRAS
5392,GO:0097435,0.63964136544756,0.55676970070665,6,21,supramolecular fiber organization,BP,SCIN;AXIN1;SPTBN5;SPTB;PKP1;SPTBN4
4874,GO:0070851,0.63975450974134,0.69365281825224,2,6,growth factor receptor binding,MF,FGF8;FGF17
376,GO:0003015,0.641440166049424,0.573020495360688,5,17,heart process,BP,PIK3CG;KCNG2;KCNK6;PIK3CA;SPTBN4
4355,GO:0060047,0.641440166049424,0.573020495360688,5,17,heart contraction,BP,PIK3CG;KCNG2;KCNK6;PIK3CA;SPTBN4
2600,GO:0034113,0.641863109555462,0.79915097960441,1,3,heterotypic cell-cell adhesion,BP,BMP7
2689,GO:0035088,0.64186344821909,0.799150705445816,1,3,establishment or maintenance of apical/basal cell polarity,BP,CRB2
3437,GO:0045197,0.64186344821909,0.799150705445816,1,3,establishment or maintenance of epithelial cell apical/basal polarity,BP,CRB2
4688,GO:0061245,0.64186344821909,0.799150705445816,1,3,establishment or maintenance of bipolar cell polarity,BP,CRB2
3061,GO:0042993,0.641916582355889,0.799107688008615,1,3,positive regulation of transcription factor import into nucleus,BP,CDH1
2634,GO:0034446,0.642614124975794,0.798542270008624,1,3,substrate adhesion-dependent cell spreading,BP,FZD7
2863,GO:0038030,0.642738600393936,0.798441237641088,1,3,non-canonical Wnt signaling pathway via MAPK cascade,BP,FZD7
292,GO:0002431,0.643002845319561,0.798226624134174,1,3,Fc receptor mediated stimulatory signaling pathway,BP,PIK3CA
293,GO:0002433,0.643002845319561,0.798226624134174,1,3,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,BP,PIK3CA
2876,GO:0038094,0.643002845319561,0.798226624134174,1,3,Fc-gamma receptor signaling pathway,BP,PIK3CA
2878,GO:0038096,0.643002845319561,0.798226624134174,1,3,Fc-gamma receptor signaling pathway involved in phagocytosis,BP,PIK3CA
5109,GO:0072170,0.643151145356583,0.798106097818394,1,3,metanephric tubule development,BP,WNT7B
5358,GO:0097150,0.644529318113422,0.796983255174909,1,3,neuronal stem cell population maintenance,BP,NOTCH1
5838,GO:1903670,0.644581837554318,0.796940366551053,1,3,regulation of sprouting angiogenesis,BP,NOTCH1
3429,GO:0045177,0.644857528790876,0.591140185365142,4,14,apical part of cell,CC,GJB6;CRB2;NOTCH1;TF
130,GO:0001726,0.644906661756568,0.796674945029221,1,3,ruffle,CC,AMOT
555,GO:0005096,0.645169714787349,0.796459793183035,1,3,GTPase activator activity,MF,AXIN1
3034,GO:0042698,0.645757439648413,0.795978427437046,1,3,ovulation cycle,BP,INHBB
29,GO:0000209,0.645974595616259,0.795800337280441,1,3,protein polyubiquitination,BP,RNF144A
3475,GO:0045599,0.647479531606465,0.794562679907099,1,3,negative regulation of fat cell differentiation,BP,AXIN1
5602,GO:1901522,0.647724958253585,0.794360267130676,1,3,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,BP,NOTCH1
1517,GO:0015075,0.647784421290271,0.62400189909337,3,10,ion transmembrane transporter activity,MF,KCNG2;KCNK6;TF
2306,GO:0032147,0.647788508840422,0.566213195224638,5,17,activation of protein kinase activity,BP,WNT7B;AXIN1;DUSP5;BMP4;PIK3CA
5062,GO:0072075,0.647851715516837,0.79425566233793,1,3,metanephric mesenchyme development,BP,BMP7
3409,GO:0045087,0.648045869148001,0.623727199815001,3,10,innate immune response,BP,PIK3CG;CCL20;HRAS
1123,GO:0008307,0.648172589072144,0.793990672961502,1,3,structural constituent of muscle,MF,ACTN3
838,GO:0006732,0.648202698779806,0.793965793058205,1,3,coenzyme metabolic process,BP,ACTN3
4116,GO:0051186,0.648202698779806,0.793965793058205,1,3,cofactor metabolic process,BP,ACTN3
1182,GO:0009141,0.648208111650375,0.793961320099842,1,3,nucleoside triphosphate metabolic process,BP,ACTN3
1183,GO:0009144,0.648208111650375,0.793961320099842,1,3,purine nucleoside triphosphate metabolic process,BP,ACTN3
1195,GO:0009199,0.648208111650375,0.793961320099842,1,3,ribonucleoside triphosphate metabolic process,BP,ACTN3
1196,GO:0009205,0.648208111650375,0.793961320099842,1,3,purine ribonucleoside triphosphate metabolic process,BP,ACTN3
3304,GO:0044325,0.648265622227993,0.793913791027064,1,3,ion channel binding,MF,ACTN3
3495,GO:0045639,0.648302269076649,0.793883499952132,1,3,positive regulation of myeloid cell differentiation,BP,SCIN
5166,GO:0072359,0.648481905838189,0.492081454819124,13,45,circulatory system development,BP,WNT7A;PIK3CG;HEY1;WNT7B;WNT2;FZD7;FGF8;CRB2;AMOT;BMP4;PIK3CA;BMP7;NOTCH1
1642,GO:0016491,0.648491251783646,0.793727235807691,1,3,oxidoreductase activity,MF,GLDC
2162,GO:0031143,0.648610035612601,0.793628967884059,1,3,pseudopodium,CC,ACTN3
3835,GO:0048596,0.648764939967316,0.793500761029082,1,3,embryonic camera-type eye morphogenesis,BP,BMP7
135,GO:0001750,0.648890671872533,0.793396651329669,1,3,photoreceptor outer segment,CC,SPTBN5
5414,GO:0097730,0.648890671872533,0.793396651329669,1,3,non-motile cilium,CC,SPTBN5
5415,GO:0097731,0.648890671872533,0.793396651329669,1,3,9+0 non-motile cilium,CC,SPTBN5
5416,GO:0097733,0.648890671872533,0.793396651329669,1,3,photoreceptor cell cilium,CC,SPTBN5
1313,GO:0010507,0.649315525733201,0.793044544893725,1,3,negative regulation of autophagy,BP,PIK3CA
1603,GO:0016242,0.649315525733201,0.793044544893725,1,3,negative regulation of macroautophagy,BP,PIK3CA
776,GO:0006401,0.649689673515989,0.79273405912961,1,3,RNA catabolic process,BP,PKP1
777,GO:0006402,0.649689673515989,0.79273405912961,1,3,mRNA catabolic process,BP,PKP1
1590,GO:0016071,0.649689673515989,0.79273405912961,1,3,mRNA metabolic process,BP,PKP1
4632,GO:0061013,0.649689673515989,0.79273405912961,1,3,regulation of mRNA catabolic process,BP,PKP1
5789,GO:1903311,0.649689673515989,0.79273405912961,1,3,regulation of mRNA metabolic process,BP,PKP1
3277,GO:0044242,0.650267228301865,0.792254034117507,1,3,cellular lipid catabolic process,BP,PIK3CG
5743,GO:1902882,0.65060959273472,0.791969057565459,1,3,regulation of response to oxidative stress,BP,BMP7
411,GO:0003174,0.650802675912993,0.791808199350567,1,3,mitral valve development,BP,NOTCH1
418,GO:0003183,0.650802675912993,0.791808199350567,1,3,mitral valve morphogenesis,BP,NOTCH1
1585,GO:0016054,0.651027140061615,0.791621070449156,1,3,organic acid catabolic process,BP,GLDC
3619,GO:0046395,0.651027140061615,0.791621070449156,1,3,carboxylic acid catabolic process,BP,GLDC
1818,GO:0021510,0.651260701169348,0.791426212498109,1,3,spinal cord development,BP,NOTCH1
2803,GO:0035924,0.651260701169348,0.791426212498109,1,3,cellular response to vascular endothelial growth factor stimulus,BP,NOTCH1
4731,GO:0061515,0.651457035113629,0.791262298186513,1,3,myeloid cell development,BP,CLDN18
3322,GO:0044424,0.651479378848681,0.473285199415275,55,182,intracellular part,CC,MAGEC2;SLC2A14;TJP3;GLDC;RHPN1;SCIN;TLE1;WNT7A;GJB2;PIK3CG;SYT5;ACTN3;RABIF;MBOAT2;BMP6;WNT3;HEY1;GJB6;WNT7B;PMAIP1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;SPTBN5;RAB40B;RAB39A;SPTB;RRAS2;FZD7;VDR;DSG3;AMOT;WNT5B;WNK4;DUSP5;INHBB;PKN3;PKP1;TSPAN15;HRAS;RAB3D;RNF144A;RAB38;PIK3CA;FSTL3;TPD52;SPTBN4;NOTCH1;RND3;PNMT;RAB20;GUCY1B3;TF
5608,GO:1901565,0.651896206612653,0.790895265316088,1,3,organonitrogen compound catabolic process,BP,GLDC
4755,GO:0070011,0.652098412626389,0.790726097251723,1,3,peptidase activity, acting on L-amino acid peptides,MF,RHBDL3
2582,GO:0033627,0.652189681232791,0.79064970430232,1,3,cell adhesion mediated by integrin,BP,PIK3CG
5212,GO:0085029,0.652295667418554,0.790560964054577,1,3,extracellular matrix assembly,BP,NOTCH1
3936,GO:0050663,0.65229585853508,0.790560804008617,1,3,cytokine secretion,BP,NOTCH1
4838,GO:0070527,0.652754182151826,0.790176705077089,1,3,platelet aggregation,BP,PIK3CG
357,GO:0002793,0.65302688788823,0.789947891224293,1,3,positive regulation of peptide secretion,BP,BMP6
4036,GO:0050920,0.653250670206403,0.618230590626259,3,10,regulation of chemotaxis,BP,WNT3;ARTN;NOTCH1
3652,GO:0046649,0.653323304834903,0.541995185751785,6,21,lymphocyte activation,BP,PIK3CG;JAG2;FZD7;BMP4;PIK3CA;TPD52
3697,GO:0046889,0.653351644380156,0.789675138758395,1,3,positive regulation of lipid biosynthetic process,BP,BMP6
3614,GO:0046332,0.6539945260818,0.789134350939037,1,3,SMAD binding,MF,AXIN1
1668,GO:0016746,0.654369019566919,0.788818806599925,1,3,transferase activity, transferring acyl groups,MF,MBOAT2
1273,GO:0009991,0.654549875038602,0.580728573922074,4,14,response to extracellular stimulus,BP,PMAIP1;VDR;INHBB;BMP7
2242,GO:0031667,0.654549875038602,0.580728573922074,4,14,response to nutrient levels,BP,PMAIP1;VDR;INHBB;BMP7
123,GO:0001706,0.654738106461436,0.788507440454924,1,3,endoderm formation,BP,DUSP5
3207,GO:0043535,0.654815682313386,0.788441948840349,1,3,regulation of blood vessel endothelial cell migration,BP,NOTCH1
4052,GO:0050995,0.655199259082153,0.788117879315193,1,3,negative regulation of lipid catabolic process,BP,PIK3CG
1476,GO:0014074,0.655336807166888,0.7880015712898,1,3,response to purine-containing compound,BP,PIK3CG
3655,GO:0046661,0.655926049173198,0.615384312007962,3,10,male sex differentiation,BP,BMP6;FGF8;FSTL3
356,GO:0002792,0.656053040024597,0.787395093902839,1,3,negative regulation of peptide secretion,BP,INHBB
3953,GO:0050709,0.656053040024597,0.787395093902839,1,3,negative regulation of protein secretion,BP,INHBB
1004,GO:0007346,0.656399992998233,0.582340768649027,4,13,regulation of mitotic cell cycle,BP,FGF8;HRAS;BMP4;BMP7
2555,GO:0033267,0.656565235855743,0.786960516335472,1,3,axon part,CC,SPTBN4
1677,GO:0016791,0.657145180540275,0.786467578137744,1,3,phosphatase activity,MF,DUSP5
4318,GO:0055065,0.658980658599501,0.575914247332558,4,14,metal ion homeostasis,BP,PIK3CG;BMP6;VDR;TF
2386,GO:0032434,0.659142585858531,0.784762665639442,1,3,regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,RNF144A
4666,GO:0061136,0.659142585858531,0.784762665639442,1,3,regulation of proteasomal protein catabolic process,BP,RNF144A
2620,GO:0034332,0.659425361921604,0.66352583822186,2,7,adherens junction organization,BP,ACTN3;CDH1
695,GO:0005905,0.659772497313541,0.784222681759244,1,3,clathrin-coated pit,CC,TF
1292,GO:0010243,0.659848778450992,0.521011624559799,7,25,response to organonitrogen compound,BP,GJB2;PIK3CG;CDH1;INHBB;PIK3CA;BMP7;NOTCH1
1583,GO:0016052,0.65998739088939,0.784038212044305,1,3,carbohydrate catabolic process,BP,ACTN3
1763,GO:0019320,0.65998739088939,0.784038212044305,1,3,hexose catabolic process,BP,ACTN3
3362,GO:0044724,0.65998739088939,0.784038212044305,1,3,single-organism carbohydrate catabolic process,BP,ACTN3
3616,GO:0046365,0.65998739088939,0.784038212044305,1,3,monosaccharide catabolic process,BP,ACTN3
4867,GO:0070820,0.660078986357818,0.783959544879116,1,3,tertiary granule,CC,PKP1
3977,GO:0050773,0.660586569123641,0.783523177326343,1,3,regulation of dendrite development,BP,BMP7
114,GO:0001666,0.660919200499276,0.610033791215938,3,10,response to hypoxia,BP,PMAIP1;BMP7;NOTCH1
2061,GO:0030662,0.661428988818838,0.782797348241446,1,3,coated vesicle membrane,CC,TF
2062,GO:0030665,0.661428988818838,0.782797348241446,1,3,clathrin-coated vesicle membrane,CC,TF
3778,GO:0048333,0.66226058227749,0.782078879034004,1,3,mesodermal cell differentiation,BP,BMP4
488,GO:0003713,0.662416173272018,0.781944235899253,1,3,transcription coactivator activity,MF,POU3F1
1461,GO:0014037,0.662531183720194,0.78184466561501,1,3,Schwann cell differentiation,BP,POU3F1
985,GO:0007259,0.662584580910018,0.781798424235345,1,3,JAK-STAT cascade,BP,NOTCH1
3620,GO:0046425,0.662584580910018,0.781798424235345,1,3,regulation of JAK-STAT cascade,BP,NOTCH1
3621,GO:0046427,0.662584580910018,0.781798424235345,1,3,positive regulation of JAK-STAT cascade,BP,NOTCH1
5410,GO:0097696,0.662584580910018,0.781798424235345,1,3,STAT cascade,BP,NOTCH1
5916,GO:1904892,0.662584580910018,0.781798424235345,1,3,regulation of STAT cascade,BP,NOTCH1
5917,GO:1904894,0.662584580910018,0.781798424235345,1,3,positive regulation of STAT cascade,BP,NOTCH1
5485,GO:0099068,0.663299375874614,0.781178639104049,1,3,postsynapse assembly,BP,WNT7A
483,GO:0003690,0.663669878000336,0.78085681129019,1,3,double-stranded DNA binding,MF,HEY1
786,GO:0006470,0.663888548984028,0.7806666842312,1,3,protein dephosphorylation,BP,DUSP5
4746,GO:0061695,0.664058248288161,0.658690432146524,2,7,transferase complex, transferring phosphorus-containing groups,CC,PIK3CG;PIK3CA
2019,GO:0030335,0.664108460394217,0.517720394530753,7,24,positive regulation of cell migration,BP,WNT7A;RRAS2;WNT5B;CCL20;HRAS;BMP4;NOTCH1
4157,GO:0051272,0.664108460394217,0.517720394530753,7,24,positive regulation of cellular component movement,BP,WNT7A;RRAS2;WNT5B;CCL20;HRAS;BMP4;NOTCH1
6051,GO:2000147,0.664108460394217,0.517720394530753,7,24,positive regulation of cell motility,BP,WNT7A;RRAS2;WNT5B;CCL20;HRAS;BMP4;NOTCH1
1043,GO:0007585,0.664548160211223,0.780092346896018,1,3,respiratory gaseous exchange,BP,JAG2
4266,GO:0051896,0.66470753997064,0.779953384870614,1,3,regulation of protein kinase B signaling,BP,PIK3CG
4267,GO:0051897,0.66470753997064,0.779953384870614,1,3,positive regulation of protein kinase B signaling,BP,PIK3CG
37,GO:0000287,0.664972802165168,0.779721943370084,1,3,magnesium ion binding,MF,MAPK12
2591,GO:0033762,0.665095288454785,0.779615005884603,1,3,response to glucagon,BP,GJB2
4938,GO:0071377,0.665095288454785,0.779615005884603,1,3,cellular response to glucagon stimulus,BP,GJB2
4230,GO:0051640,0.666324827542521,0.604184192419845,3,10,organelle localization,BP,WNT7A;PIK3CG;SYT5
1985,GO:0030225,0.666345178510213,0.778521316343143,1,3,macrophage differentiation,BP,BMP4
2195,GO:0031345,0.6663597884283,0.778508505653877,1,3,negative regulation of cell projection organization,BP,WNT3
3576,GO:0045932,0.666571083526157,0.778323162952922,1,3,negative regulation of muscle contraction,BP,PIK3CG
3476,GO:0045600,0.666882340277825,0.778049901662694,1,3,positive regulation of fat cell differentiation,BP,WNT5B
5980,GO:1990138,0.66706306109192,0.777891113188421,1,3,neuron projection extension,BP,WNT3
775,GO:0006396,0.667446546048209,0.777553855137038,1,3,RNA processing,BP,BMP4
1746,GO:0019209,0.667761508585494,0.777276540946118,1,3,kinase activator activity,MF,PIK3CA
2003,GO:0030295,0.667761508585494,0.777276540946118,1,3,protein kinase activator activity,MF,PIK3CA
649,GO:0005741,0.667916734484547,0.777139763812439,1,3,mitochondrial outer membrane,CC,PMAIP1
1794,GO:0019867,0.667916734484547,0.777139763812439,1,3,outer membrane,CC,PMAIP1
2273,GO:0031968,0.667916734484547,0.777139763812439,1,3,organelle outer membrane,CC,PMAIP1
5623,GO:1901652,0.668299203974341,0.541399384890511,5,18,response to peptide,BP,GJB2;INHBB;PIK3CA;BMP7;NOTCH1
43,GO:0000578,0.668431389613546,0.776685775490124,1,3,embryonic axis specification,BP,WNT7A
2363,GO:0032368,0.668627725870494,0.776512380173147,1,3,regulation of lipid transport,BP,BMP6
5973,GO:1905952,0.668627725870494,0.776512380173147,1,3,regulation of lipid localization,BP,BMP6
4780,GO:0070227,0.66869723200971,0.776450968604115,1,3,lymphocyte apoptotic process,BP,BMP4
4784,GO:0070231,0.66869723200971,0.776450968604115,1,3,T cell apoptotic process,BP,BMP4
2545,GO:0033138,0.669241290982317,0.653220098701009,2,7,positive regulation of peptidyl-serine phosphorylation,BP,AXIN1;PIK3CA
487,GO:0003712,0.669635467404617,0.652801421419304,2,7,transcription cofactor activity,MF,TLE1;POU3F1
4363,GO:0060065,0.669840553980432,0.77543877456014,1,3,uterus development,BP,WNT7A
2212,GO:0031489,0.669929570553331,0.775359807122186,1,3,myosin V binding,MF,RAB3D
3194,GO:0043491,0.669939814183843,0.652477899266356,2,7,protein kinase B signaling,BP,PIK3CG;PIK3CA
778,GO:0006412,0.670599892635923,0.774764412845239,1,3,translation,BP,BMP4
779,GO:0006417,0.670599892635923,0.774764412845239,1,3,regulation of translation,BP,BMP4
2612,GO:0034248,0.670599892635923,0.774764412845239,1,3,regulation of cellular amide metabolic process,BP,BMP4
3074,GO:0043043,0.670599892635923,0.774764412845239,1,3,peptide biosynthetic process,BP,BMP4
3230,GO:0043604,0.670599892635923,0.774764412845239,1,3,amide biosynthetic process,BP,BMP4
1981,GO:0030218,0.670790205714541,0.774595132610415,1,3,erythrocyte differentiation,BP,BMP4
2595,GO:0034101,0.670790205714541,0.774595132610415,1,3,erythrocyte homeostasis,BP,BMP4
4059,GO:0051015,0.67089012022035,0.651466269319066,2,7,actin filament binding,MF,SCIN;SPTB
291,GO:0002429,0.670938550119728,0.651414655305499,2,7,immune response-activating cell surface receptor signaling pathway,BP,HRAS;PIK3CA
353,GO:0002768,0.670938550119728,0.651414655305499,2,7,immune response-regulating cell surface receptor signaling pathway,BP,HRAS;PIK3CA
4,GO:0000041,0.671285439392103,0.77415413205109,1,3,transition metal ion transport,BP,TF
862,GO:0006826,0.671285439392103,0.77415413205109,1,3,iron ion transport,BP,TF
1733,GO:0018958,0.671353841860523,0.774093163662283,1,3,phenol-containing compound metabolic process,BP,PNMT
5037,GO:0072007,0.671393888233343,0.774057463196733,1,3,mesangial cell differentiation,BP,NOTCH1
5038,GO:0072008,0.671393888233343,0.774057463196733,1,3,glomerular mesangial cell differentiation,BP,NOTCH1
5099,GO:0072143,0.671393888233343,0.774057463196733,1,3,mesangial cell development,BP,NOTCH1
5100,GO:0072144,0.671393888233343,0.774057463196733,1,3,glomerular mesangial cell development,BP,NOTCH1
5884,GO:1904238,0.671393888233343,0.774057463196733,1,3,pericyte cell differentiation,BP,NOTCH1
66,GO:0001047,0.671663642219684,0.773816860380992,1,3,core promoter binding,MF,NOTCH1
244,GO:0002218,0.671718208164704,0.773768165079216,1,3,activation of innate immune response,BP,HRAS
348,GO:0002758,0.671718208164704,0.773768165079216,1,3,innate immune response-activating signal transduction,BP,HRAS
4099,GO:0051150,0.671723040801319,0.773763851953503,1,3,regulation of smooth muscle cell differentiation,BP,BMP4
331,GO:0002695,0.671766461682932,0.773725095750758,1,3,negative regulation of leukocyte activation,BP,BMP4
4145,GO:0051250,0.671766461682932,0.773725095750758,1,3,negative regulation of lymphocyte activation,BP,BMP4
3430,GO:0045178,0.672359238878552,0.773195443931496,1,3,basal part of cell,CC,TF
6038,GO:2000107,0.6725125050262,0.773058330376974,1,3,negative regulation of leukocyte apoptotic process,BP,BMP4
2567,GO:0033500,0.672603016162544,0.649637274165335,2,7,carbohydrate homeostasis,BP,GJB6;PIK3CA
3020,GO:0042593,0.672603016162544,0.649637274165335,2,7,glucose homeostasis,BP,GJB6;PIK3CA
4971,GO:0071548,0.672636045784488,0.772947758916839,1,3,response to dexamethasone,BP,GJB2
3918,GO:0048854,0.672822882512284,0.772780450499139,1,3,brain morphogenesis,BP,FGF8
2608,GO:0034220,0.673195771256401,0.560231147904296,4,14,ion transmembrane transport,BP,PIK3CG;KCNG2;KCNK6;TSPAN13
1222,GO:0009628,0.673711509619283,0.507040349866774,7,24,response to abiotic stimulus,BP,BMP6;GJB6;PMAIP1;INHBB;HRAS;BMP7;NOTCH1
3062,GO:0042995,0.674197792329098,0.473089079240544,11,39,cell projection,CC,SCIN;GJB2;SYT5;ACTN3;CDH1;SPTBN5;AMOT;PIK3CA;DRP2;FSTL3;SPTBN4
3737,GO:0048066,0.674576665546765,0.771204924610519,1,3,developmental pigmentation,BP,RAB38
4042,GO:0050931,0.674576665546765,0.771204924610519,1,3,pigment cell differentiation,BP,RAB38
1369,GO:0010712,0.675071559634851,0.770758675653973,1,3,regulation of collagen metabolic process,BP,BMP4
1370,GO:0010714,0.675071559634851,0.770758675653973,1,3,positive regulation of collagen metabolic process,BP,BMP4
2508,GO:0032963,0.675071559634851,0.770758675653973,1,3,collagen metabolic process,BP,BMP4
2509,GO:0032964,0.675071559634851,0.770758675653973,1,3,collagen biosynthetic process,BP,BMP4
2510,GO:0032965,0.675071559634851,0.770758675653973,1,3,regulation of collagen biosynthetic process,BP,BMP4
2511,GO:0032967,0.675071559634851,0.770758675653973,1,3,positive regulation of collagen biosynthetic process,BP,BMP4
3274,GO:0044236,0.675071559634851,0.770758675653973,1,3,multicellular organism metabolic process,BP,BMP4
3278,GO:0044246,0.675071559634851,0.770758675653973,1,3,regulation of multicellular organismal metabolic process,BP,BMP4
3281,GO:0044253,0.675071559634851,0.770758675653973,1,3,positive regulation of multicellular organismal metabolic process,BP,BMP4
3284,GO:0044259,0.675071559634851,0.770758675653973,1,3,multicellular organismal macromolecule metabolic process,BP,BMP4
2725,GO:0035313,0.675368867507089,0.770490239518587,1,3,wound healing, spreading of epidermal cells,BP,WNT7A
3329,GO:0044432,0.675431035878841,0.51753727593463,6,21,endoplasmic reticulum part,CC,WNT7A;MBOAT2;WNT3;WNT7B;WNT5B;NOTCH1
3536,GO:0045785,0.676032725616828,0.588393266960194,3,11,positive regulation of cell adhesion,BP,PIK3CA;BMP7;FSTL3
6083,GO:2000401,0.676086784699525,0.769840948586161,1,3,regulation of lymphocyte migration,BP,CCL20
5499,GO:0099565,0.676209627509659,0.769729693558913,1,3,chemical synaptic transmission, postsynaptic,BP,WNT7A
3570,GO:0045921,0.676896856052358,0.769106454926514,1,3,positive regulation of exocytosis,BP,RAB3D
1870,GO:0021984,0.677225534830447,0.768807877910072,1,3,adenohypophysis development,BP,FGF8
4384,GO:0060129,0.677225534830447,0.768807877910072,1,3,thyroid-stimulating hormone-secreting cell differentiation,BP,FGF8
4660,GO:0061101,0.677225534830447,0.768807877910072,1,3,neuroendocrine cell differentiation,BP,FGF8
4103,GO:0051155,0.677744994689205,0.768335327885813,1,3,positive regulation of striated muscle cell differentiation,BP,BMP4
5939,GO:1905209,0.677744994689205,0.768335327885813,1,3,positive regulation of cardiocyte differentiation,BP,BMP4
6122,GO:2000727,0.677744994689205,0.768335327885813,1,3,positive regulation of cardiac muscle cell differentiation,BP,BMP4
3744,GO:0048167,0.67777388424741,0.768309023279322,1,3,regulation of synaptic plasticity,BP,HRAS
3391,GO:0044877,0.677799776832855,0.501038259338334,7,25,macromolecular complex binding,MF,SCIN;ACTN3;SPTB;PKP1;RAB38;FSTL3;MB21D2
1471,GO:0014065,0.678211780677961,0.554608900086935,4,14,phosphatidylinositol 3-kinase signaling,BP,PIK3CG;FGF8;FGF17;PIK3CA
3727,GO:0048015,0.678211780677961,0.554608900086935,4,14,phosphatidylinositol-mediated signaling,BP,PIK3CG;FGF8;FGF17;PIK3CA
3729,GO:0048017,0.678211780677961,0.554608900086935,4,14,inositol lipid-mediated signaling,BP,PIK3CG;FGF8;FGF17;PIK3CA
521,GO:0004702,0.678413590801756,0.767725908865994,1,3,signal transducer, downstream of receptor, with serine/threonine kinase activity,MF,MAPK12
829,GO:0006694,0.678640934294684,0.643132481680122,2,7,steroid biosynthetic process,BP,BMP6;VDR
1101,GO:0008202,0.678640934294684,0.643132481680122,2,7,steroid metabolic process,BP,BMP6;VDR
5387,GO:0097367,0.678674702715197,0.445937881300797,17,58,carbohydrate derivative binding,MF,PIK3CG;MAPK12;CDH1;RAB40B;RAB39A;RRAS2;WNK4;PKN3;HRAS;BMP4;RAB3D;RAB38;PIK3CA;BMP7;RND3;RAB20;GUCY1B3
1406,GO:0010837,0.678759058316698,0.767410487908144,1,3,regulation of keratinocyte proliferation,BP,VDR
3231,GO:0043616,0.678759058316698,0.767410487908144,1,3,keratinocyte proliferation,BP,VDR
2926,GO:0042108,0.678891227150325,0.767289718509456,1,3,positive regulation of cytokine biosynthetic process,BP,CCL20
4904,GO:0071260,0.678896023508946,0.767285334834921,1,3,cellular response to mechanical stimulus,BP,BMP6
26,GO:0000186,0.679196209833857,0.767010837816889,1,3,activation of MAPKK activity,BP,BMP4
4288,GO:0051963,0.680958890902343,0.765393464053467,1,3,regulation of synapse assembly,BP,WNT7A
4171,GO:0051302,0.681652327884542,0.764754586235195,1,3,regulation of cell division,BP,FGF8
2256,GO:0031902,0.682158115835322,0.764287661891846,1,3,late endosome membrane,CC,TSPAN15
3286,GO:0044262,0.682193730373947,0.639262492080914,2,7,cellular carbohydrate metabolic process,BP,ACTN3;PMAIP1
640,GO:0005635,0.682630008459521,0.763851318272954,1,3,nuclear envelope,CC,RAB40B
857,GO:0006813,0.682781563836197,0.638619108384874,2,7,potassium ion transport,BP,KCNG2;KCNK6
1073,GO:0008022,0.683219269124234,0.763305483640611,1,3,protein C-terminus binding,MF,HRAS
4152,GO:0051260,0.684607342876612,0.636615200879028,2,7,protein homooligomerization,BP,KCNG2;SPTBN5
2501,GO:0032941,0.685194149186785,0.761468298214322,1,3,secretion by tissue,BP,WNK4
751,GO:0006182,0.685339564374392,0.761332542270901,1,3,cGMP biosynthetic process,BP,GUCY1B3
2422,GO:0032612,0.685531490073496,0.761153264258599,1,3,interleukin-1 production,BP,CCL20
2434,GO:0032652,0.685531490073496,0.761153264258599,1,3,regulation of interleukin-1 production,BP,CCL20
1001,GO:0007292,0.686098395261754,0.760623045327719,1,3,female gamete generation,BP,INHBB
1274,GO:0009994,0.686098395261754,0.760623045327719,1,3,oocyte differentiation,BP,INHBB
3791,GO:0048477,0.686098395261754,0.760623045327719,1,3,oogenesis,BP,INHBB
3837,GO:0048599,0.686098395261754,0.760623045327719,1,3,oocyte development,BP,INHBB
1922,GO:0030010,0.686905442511156,0.634080800956259,2,7,establishment of cell polarity,BP,WNT7A;AMOT
2067,GO:0030672,0.687123618251292,0.759661610886595,1,3,synaptic vesicle membrane,CC,SYT5
5491,GO:0099501,0.687123618251292,0.759661610886595,1,3,exocytic vesicle membrane,CC,SYT5
1046,GO:0007589,0.6873150594628,0.633627643203206,2,7,body fluid secretion,BP,VDR;WNK4
5189,GO:0072583,0.687572338094855,0.7592397709529,1,3,clathrin-dependent endocytosis,BP,SYT5
2685,GO:0035051,0.687778392923332,0.575160264782014,3,11,cardiocyte differentiation,BP,FZD7;BMP4;NOTCH1
2854,GO:0036477,0.68783090475352,0.575100439781702,3,11,somatodendritic compartment,CC,SYT5;DRP2;SPTBN4
3723,GO:0048010,0.688414635502436,0.632409049031071,2,7,vascular endothelial growth factor receptor signaling pathway,BP,MAPK12;PIK3CA
2663,GO:0034702,0.68906305516571,0.631688981115425,2,7,ion channel complex,CC,KCNG2;KCNK6
5708,GO:1902495,0.68906305516571,0.631688981115425,2,7,transmembrane transporter complex,CC,KCNG2;KCNK6
5988,GO:1990351,0.68906305516571,0.631688981115425,2,7,transporter complex,CC,KCNG2;KCNK6
99,GO:0001569,0.692875806492279,0.754205600414294,1,3,branching involved in blood vessel morphogenesis,BP,FGF8
2498,GO:0032925,0.693543370226841,0.753565551012647,1,3,regulation of activin receptor signaling pathway,BP,FSTL3
3554,GO:0045840,0.693568817710663,0.75354112388566,1,3,positive regulation of mitotic nuclear division,BP,FGF8
5400,GO:0097529,0.695297332844697,0.624709930099094,2,7,myeloid leukocyte migration,BP,PIK3CG;CCL20
3789,GO:0048469,0.69536262348887,0.751813952726744,1,3,cell maturation,BP,SPTBN4
1578,GO:0016043,0.695581562607208,0.408055554781393,36,122,cellular component organization,BP,SCIN;TLE1;WNT7A;GJB2;SYT5;ACTN3;RABIF;WNT3;WNT7B;PMAIP1;KCNG2;AXIN1;CDH1;SPTBN5;RAB40B;RAB39A;SPTB;FZD7;FGF8;VDR;ARTN;AMOT;PKP1;TSPAN15;HRAS;BMP4;GDNF;RAB38;PIK3CA;BMP7;DRP2;SPTBN4;NOTCH1;RND3;RAB20;TF
5011,GO:0071840,0.695581562607208,0.408055554781393,36,122,cellular component organization or biogenesis,BP,SCIN;TLE1;WNT7A;GJB2;SYT5;ACTN3;RABIF;WNT3;WNT7B;PMAIP1;KCNG2;AXIN1;CDH1;SPTBN5;RAB40B;RAB39A;SPTB;FZD7;FGF8;VDR;ARTN;AMOT;PKP1;TSPAN15;HRAS;BMP4;GDNF;RAB38;PIK3CA;BMP7;DRP2;SPTBN4;NOTCH1;RND3;RAB20;TF
4683,GO:0061213,0.695606736399184,0.751578098889883,1,3,positive regulation of mesonephros development,BP,GDNF
1219,GO:0009615,0.696018642722207,0.751179687579472,1,3,response to virus,BP,PMAIP1
3741,GO:0048144,0.696051760783366,0.623858444554359,2,7,fibroblast proliferation,BP,WNT7B;WNT2
302,GO:0002460,0.696671917053955,0.750546678155087,1,3,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,HRAS
471,GO:0003401,0.697391192658207,0.749848096215786,1,3,axis elongation,BP,BMP4
4533,GO:0060602,0.697391192658207,0.749848096215786,1,3,branch elongation of an epithelium,BP,BMP4
885,GO:0006909,0.698856621212081,0.562405295778726,3,11,phagocytosis,BP,RAB39A;PIK3CA;RAB20
532,GO:0004857,0.69904853008357,0.620461189659095,2,7,enzyme inhibitor activity,MF,CRB2;NOTCH1
4067,GO:0051048,0.699078456204989,0.562147104657696,3,11,negative regulation of secretion,BP,WNK4;INHBB;NOTCH1
4165,GO:0051291,0.699186833352914,0.748096677436094,1,3,protein heterooligomerization,BP,HRAS
580,GO:0005179,0.699943503938335,0.747355444807686,1,3,hormone activity,MF,INHBB
883,GO:0006904,0.700450864296469,0.746857369412956,1,3,vesicle docking involved in exocytosis,BP,RAB40B
3766,GO:0048278,0.700450864296469,0.746857369412956,1,3,vesicle docking,BP,RAB40B
1237,GO:0009791,0.700634418097702,0.746676963397982,1,3,post-embryonic development,BP,BMP4
5277,GO:0090184,0.700675703764626,0.618606492521787,2,7,positive regulation of kidney development,BP,BMP4;GDNF
3900,GO:0048806,0.701666816883405,0.617473298486727,2,7,genitalia development,BP,BMP6;FGF8
1675,GO:0016787,0.702680903447415,0.4472513059921,10,35,hydrolase activity,MF,RHBDL3;RAB40B;RAB39A;RRAS2;DUSP5;HRAS;RAB3D;RAB38;RND3;RAB20
1458,GO:0014031,0.703463776112269,0.615411950827375,2,7,mesenchymal cell development,BP,GDNF;NOTCH1
258,GO:0002263,0.70371497740438,0.556725305506777,3,11,cell activation involved in immune response,BP,PIK3CG;PKP1;RAB3D
280,GO:0002366,0.70371497740438,0.556725305506777,3,11,leukocyte activation involved in immune response,BP,PIK3CG;PKP1;RAB3D
3451,GO:0045321,0.704793241744495,0.459313583628719,8,29,leukocyte activation,BP,PIK3CG;JAG2;FZD7;PKP1;BMP4;RAB3D;PIK3CA;TPD52
904,GO:0006955,0.70494931803715,0.459132295042444,8,29,immune response,BP,PIK3CG;BMP6;CCL20;PKP1;HRAS;RAB3D;PIK3CA;NOTCH1
1118,GO:0008285,0.705387903727275,0.469425173444642,7,25,negative regulation of cell proliferation,BP,SCIN;GJB6;VDR;HRAS;BMP4;BMP7;NOTCH1
3643,GO:0046579,0.705474981977751,0.741878543050074,1,3,positive regulation of Ras protein signal transduction,BP,HRAS
4076,GO:0051057,0.705474981977751,0.741878543050074,1,3,positive regulation of small GTPase mediated signal transduction,BP,HRAS
4294,GO:0052548,0.706251681926651,0.612196429034868,2,7,regulation of endopeptidase activity,BP,PMAIP1;CRB2
4143,GO:0051248,0.706426571212549,0.497762717890314,5,18,negative regulation of protein metabolic process,BP,CRB2;DUSP5;INHBB;BMP4;BMP7
3031,GO:0042692,0.706865085147456,0.479731087497181,6,22,muscle cell differentiation,BP,HEY1;AXIN1;MAPK12;FZD7;BMP4;NOTCH1
206,GO:0001974,0.707292461877075,0.740056339935216,1,3,blood vessel remodeling,BP,FGF8
1100,GO:0008201,0.707787281890183,0.610416174970701,2,7,heparin binding,MF,BMP4;BMP7
3345,GO:0044459,0.709792156771462,0.405880710664978,19,67,plasma membrane part,CC,GJB2;GJA3;GJB6;JAG2;KCNG2;AXIN1;CDH1;SPTBN5;SPTB;FGF8;CRB2;AMOT;TSPAN15;KCNK6;CLDN15;DRP2;TSPAN13;NOTCH1;TF
5028,GO:0071900,0.7101566567561,0.463843161040066,7,25,regulation of protein serine/threonine kinase activity,BP,PIK3CG;WNT7B;AXIN1;DUSP5;HRAS;BMP4;BMP7
4823,GO:0070382,0.710715784381089,0.607002981200003,2,7,exocytic vesicle,CC,SYT5;RAB40B
754,GO:0006259,0.711971055242985,0.515511335071242,4,14,DNA metabolic process,BP,BMP6;HRAS;BMP4;PIK3CA
5030,GO:0071902,0.712150141106518,0.490990396126782,5,18,positive regulation of protein serine/threonine kinase activity,BP,PIK3CG;WNT7B;AXIN1;DUSP5;HRAS
917,GO:0007009,0.714211587930962,0.509676167315397,4,15,plasma membrane organization,BP,CDH1;RAB40B;TSPAN15;SPTBN4
5200,GO:0072659,0.714211587930962,0.509676167315397,4,15,protein localization to plasma membrane,BP,CDH1;RAB40B;TSPAN15;SPTBN4
5999,GO:1990778,0.714211587930962,0.509676167315397,4,15,protein localization to cell periphery,BP,CDH1;RAB40B;TSPAN15;SPTBN4
3923,GO:0048864,0.715594936998803,0.601262879552773,2,7,stem cell development,BP,WNT7A;GDNF
5607,GO:1901564,0.716744384459163,0.468048395390882,6,22,organonitrogen compound metabolic process,BP,GLDC;ACTN3;MBOAT2;BMP4;PNMT;GUCY1B3
5574,GO:1901099,0.71697327613624,0.730156551735592,1,3,negative regulation of signal transduction in absence of ligand,BP,GDNF
6173,GO:2001239,0.71697327613624,0.730156551735592,1,3,regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,GDNF
6174,GO:2001240,0.71697327613624,0.730156551735592,1,3,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,GDNF
3715,GO:0046982,0.72013663224273,0.502539737441489,4,15,protein heterodimerization activity,MF,SYT5;BMP6;TPD52;NOTCH1
1472,GO:0014066,0.721885623372003,0.534997755605634,3,11,regulation of phosphatidylinositol 3-kinase signaling,BP,FGF8;FGF17;PIK3CA
4093,GO:0051130,0.72291110738612,0.438028115733489,8,29,positive regulation of cellular component organization,BP,SCIN;WNT7A;WNT3;PMAIP1;FGF8;HRAS;BMP7;TF
2220,GO:0031532,0.723058666153147,0.723761788870569,1,3,actin cytoskeleton reorganization,BP,HRAS
4204,GO:0051493,0.727710279448251,0.470144829211157,5,19,regulation of cytoskeleton organization,BP,SCIN;SPTBN5;SPTB;HRAS;SPTBN4
3293,GO:0044281,0.728123695589286,0.441202147496852,7,26,small molecule metabolic process,BP,GLDC;ACTN3;BMP6;PMAIP1;VDR;PIK3CA;GUCY1B3
5609,GO:1901566,0.729605932751438,0.525526879653488,3,11,organonitrogen compound biosynthetic process,BP,BMP4;PNMT;GUCY1B3
2842,GO:0036293,0.730221880159367,0.524764928004968,3,11,response to decreased oxygen levels,BP,PMAIP1;BMP7;NOTCH1
4654,GO:0061061,0.731933682946714,0.418648808062127,9,33,muscle structure development,BP,ACTN3;HEY1;AXIN1;MAPK12;WNT2;FZD7;FGF8;BMP4;NOTCH1
3126,GO:0043235,0.733618277112453,0.516219100547204,3,12,receptor complex,CC,VDR;NOTCH1;TF
2481,GO:0032869,0.735261245147101,0.56904284655405,2,8,cellular response to insulin stimulus,BP,INHBB;PIK3CA
5394,GO:0097458,0.735477118786268,0.432309409809873,7,26,neuron part,CC,WNT7A;SYT5;SPTBN5;RAB40B;DRP2;FSTL3;SPTBN4
3530,GO:0045765,0.735515435957588,0.568724353909885,2,8,regulation of angiogenesis,BP,AMOT;NOTCH1
494,GO:0003824,0.73598624003391,0.370879618140844,22,77,catalytic activity,MF,GLDC;PIK3CG;RHBDL3;MBOAT2;MAPK12;RAB40B;RAB39A;RRAS2;FGF8;WNK4;DUSP5;PKN3;FGF17;HRAS;RAB3D;RNF144A;RAB38;PIK3CA;RND3;PNMT;RAB20;GUCY1B3
4180,GO:0051347,0.738809817041751,0.418936323039291,8,29,positive regulation of transferase activity,BP,MAGEC2;PIK3CG;WNT7B;AXIN1;DUSP5;HRAS;BMP4;PIK3CA
2327,GO:0032269,0.741475360032353,0.476217927834564,4,15,negative regulation of cellular protein metabolic process,BP,CRB2;DUSP5;BMP4;BMP7
1349,GO:0010638,0.74188244939281,0.475706034877705,4,15,positive regulation of organelle organization,BP,SCIN;PMAIP1;FGF8;HRAS
255,GO:0002253,0.743973064832503,0.558014309978738,2,8,activation of immune response,BP,HRAS;PIK3CA
347,GO:0002757,0.743973064832503,0.558014309978738,2,8,immune response-activating signal transduction,BP,HRAS;PIK3CA
352,GO:0002764,0.743973064832503,0.558014309978738,2,8,immune response-regulating signaling pathway,BP,HRAS;PIK3CA
1666,GO:0016740,0.746487236973096,0.394082038811224,10,37,transferase activity,MF,PIK3CG;MBOAT2;MAPK12;FGF8;WNK4;PKN3;FGF17;RNF144A;PIK3CA;PNMT
1076,GO:0008047,0.746629074210013,0.554605016468743,2,8,enzyme activator activity,MF,AXIN1;PIK3CA
132,GO:0001738,0.746920889966876,0.671573198960757,1,4,morphogenesis of a polarized epithelium,BP,FZD7
4481,GO:0060444,0.74704790833938,0.671417824962648,1,4,branching involved in mammary gland duct morphogenesis,BP,VDR
2174,GO:0031252,0.748619142730171,0.49718950919458,3,12,cell leading edge,CC,CDH1;AMOT;PIK3CA
4176,GO:0051338,0.749525952860327,0.397374182202908,9,33,regulation of transferase activity,BP,MAGEC2;PIK3CG;WNT7B;AXIN1;DUSP5;HRAS;BMP4;PIK3CA;BMP7
1085,GO:0008092,0.749545744433781,0.413882776545934,7,27,cytoskeletal protein binding,MF,SCIN;ACTN3;CDH1;SPTBN5;SPTB;RAB3D;SPTBN4
3698,GO:0046890,0.750692687994535,0.549345500188039,2,8,regulation of lipid biosynthetic process,BP,BMP6;VDR
3442,GO:0045211,0.751127809057643,0.666390830160585,1,4,postsynaptic membrane,CC,DRP2
5132,GO:0072207,0.75121443803359,0.6662833226426,1,4,metanephric epithelium development,BP,WNT7B
3963,GO:0050727,0.751454103030965,0.665985727923152,1,4,regulation of inflammatory response,BP,PIK3CG
1253,GO:0009896,0.751549832630086,0.493403501781758,3,12,positive regulation of catabolic process,BP,ACTN3;AXIN1;RNF144A
2179,GO:0031294,0.751750855717876,0.665616904840262,1,4,lymphocyte costimulation,BP,PIK3CA
2180,GO:0031295,0.751750855717876,0.665616904840262,1,4,T cell costimulation,BP,PIK3CA
4017,GO:0050870,0.751750855717876,0.665616904840262,1,4,positive regulation of T cell activation,BP,PIK3CA
5768,GO:1903039,0.751750855717876,0.665616904840262,1,4,positive regulation of leukocyte cell-cell adhesion,BP,PIK3CA
3326,GO:0044429,0.751935950418467,0.547725746427351,2,8,mitochondrial part,CC,GLDC;PMAIP1
1771,GO:0019439,0.752034892927791,0.6652635305069,1,4,aromatic compound catabolic process,BP,PKP1
2654,GO:0034655,0.752034892927791,0.6652635305069,1,4,nucleobase-containing compound catabolic process,BP,PKP1
3290,GO:0044270,0.752034892927791,0.6652635305069,1,4,cellular nitrogen compound catabolic process,BP,PKP1
3662,GO:0046700,0.752034892927791,0.6652635305069,1,4,heterocycle catabolic process,BP,PKP1
5594,GO:1901361,0.752034892927791,0.6652635305069,1,4,organic cyclic compound catabolic process,BP,PKP1
5433,GO:0098609,0.752053988541836,0.38147594892858,11,41,cell-cell adhesion,BP,PIK3CG;CLDN18;WNT7B;CDH1;DSG3;PKP1;BMP4;CLDN15;PIK3CA;BMP7;FSTL3
900,GO:0006942,0.752085539944419,0.547530519900082,2,8,regulation of striated muscle contraction,BP,PIK3CG;ACTN3
5471,GO:0098862,0.752175984920052,0.665087866966823,1,4,cluster of actin-based cell projections,CC,SCIN
322,GO:0002682,0.752671210214318,0.400970533137237,8,30,regulation of immune system process,BP,SCIN;CLDN18;CCL20;HRAS;BMP4;PIK3CA;FSTL3;NOTCH1
1786,GO:0019752,0.752693390487847,0.546736477448639,2,8,carboxylic acid metabolic process,BP,GLDC;ACTN3
2464,GO:0032787,0.752693390487847,0.546736477448639,2,8,monocarboxylic acid metabolic process,BP,GLDC;ACTN3
6066,GO:2000243,0.75312411315499,0.663905190996307,1,4,positive regulation of reproductive process,BP,INHBB
1147,GO:0008585,0.753124148560812,0.663905146759196,1,4,female gonad development,BP,INHBB
3640,GO:0046545,0.753124148560812,0.663905146759196,1,4,development of primary female sexual characteristics,BP,INHBB
4155,GO:0051270,0.75392722920115,0.385028854548269,10,37,regulation of cellular component movement,BP,WNT7A;WNT3;JAG2;RRAS2;AMOT;WNT5B;CCL20;HRAS;BMP4;NOTCH1
2599,GO:0034109,0.754147579421153,0.662624168141726,1,4,homotypic cell-cell adhesion,BP,PIK3CG
3799,GO:0048511,0.754149723182354,0.662621480120754,1,4,rhythmic process,BP,INHBB
901,GO:0006950,0.754614519137051,0.355762798174077,18,64,response to stress,BP,WNT7A;GJB2;PIK3CG;BMP6;WNT7B;PMAIP1;AXIN1;MAPK12;FZD7;FGF8;WNT5B;INHBB;CCL20;HRAS;PIK3CA;BMP7;NOTCH1;GUCY1B3
489,GO:0003714,0.754790174126189,0.661817533790377,1,4,transcription corepressor activity,MF,TLE1
2229,GO:0031625,0.75491547580704,0.543823481444313,2,8,ubiquitin protein ligase binding,MF,MAGEC2;AXIN1
3313,GO:0044389,0.75491547580704,0.543823481444313,2,8,ubiquitin-like protein ligase binding,MF,MAGEC2;AXIN1
5269,GO:0090150,0.756365653201718,0.45453429299305,4,16,establishment of protein localization to membrane,BP,PMAIP1;CDH1;TSPAN15;SPTBN4
1577,GO:0016042,0.757292513207452,0.658659155743046,1,4,lipid catabolic process,BP,PIK3CG
4051,GO:0050994,0.757292513207452,0.658659155743046,1,4,regulation of lipid catabolic process,BP,PIK3CG
4083,GO:0051098,0.757483126736062,0.540437251509705,2,8,regulation of binding,BP,HEY1;BMP4
6052,GO:2000177,0.757495524495192,0.658401710141391,1,4,regulation of neural precursor cell proliferation,BP,NOTCH1
4701,GO:0061337,0.757636590770517,0.540234170833663,2,8,cardiac conduction,BP,KCNK6;SPTBN4
831,GO:0006700,0.758368529099123,0.65729253918477,1,4,C21-steroid hormone biosynthetic process,BP,BMP6
834,GO:0006705,0.758368529099123,0.65729253918477,1,4,mineralocorticoid biosynthetic process,BP,BMP6
1103,GO:0008207,0.758368529099123,0.65729253918477,1,4,C21-steroid hormone metabolic process,BP,BMP6
1106,GO:0008212,0.758368529099123,0.65729253918477,1,4,mineralocorticoid metabolic process,BP,BMP6
1332,GO:0010566,0.758368529099123,0.65729253918477,1,4,regulation of ketone biosynthetic process,BP,BMP6
2348,GO:0032341,0.758368529099123,0.65729253918477,1,4,aldosterone metabolic process,BP,BMP6
2349,GO:0032342,0.758368529099123,0.65729253918477,1,4,aldosterone biosynthetic process,BP,BMP6
2350,GO:0032344,0.758368529099123,0.65729253918477,1,4,regulation of aldosterone metabolic process,BP,BMP6
2353,GO:0032347,0.758368529099123,0.65729253918477,1,4,regulation of aldosterone biosynthetic process,BP,BMP6
2356,GO:0032350,0.758368529099123,0.65729253918477,1,4,regulation of hormone metabolic process,BP,BMP6
2668,GO:0034754,0.758368529099123,0.65729253918477,1,4,cellular hormone metabolic process,BP,BMP6
2942,GO:0042181,0.758368529099123,0.65729253918477,1,4,ketone biosynthetic process,BP,BMP6
2980,GO:0042445,0.758368529099123,0.65729253918477,1,4,hormone metabolic process,BP,BMP6
2981,GO:0042446,0.758368529099123,0.65729253918477,1,4,hormone biosynthetic process,BP,BMP6
3602,GO:0046184,0.758368529099123,0.65729253918477,1,4,aldehyde biosynthetic process,BP,BMP6
3693,GO:0046885,0.758368529099123,0.65729253918477,1,4,regulation of hormone biosynthetic process,BP,BMP6
5244,GO:0090030,0.758368529099123,0.65729253918477,1,4,regulation of steroid hormone biosynthetic process,BP,BMP6
5843,GO:1903708,0.758568620053703,0.65703784200406,1,4,positive regulation of hemopoiesis,BP,SCIN
2478,GO:0032845,0.758995039199358,0.656494454585492,1,4,negative regulation of homeostatic process,BP,CLDN18
3376,GO:0044782,0.759476537476191,0.65587990331095,1,4,cilium organization,BP,NOTCH1
4409,GO:0060271,0.759476537476191,0.65587990331095,1,4,cilium assembly,BP,NOTCH1
482,GO:0003682,0.759734319407843,0.65555046170677,1,4,chromatin binding,MF,NOTCH1
1846,GO:0021782,0.759972345327648,0.655246003444743,1,4,glial cell development,BP,POU3F1
2020,GO:0030336,0.760404769966013,0.654692239369517,1,4,negative regulation of cell migration,BP,NOTCH1
6050,GO:2000146,0.760404769966013,0.654692239369517,1,4,negative regulation of cell motility,BP,NOTCH1
6065,GO:2000242,0.760651619978985,0.536228393620271,2,8,negative regulation of reproductive process,BP,BMP4;BMP7
4951,GO:0071417,0.760746468636471,0.42693815894078,5,20,cellular response to organonitrogen compound,BP,GJB2;PIK3CG;CDH1;INHBB;PIK3CA
152,GO:0001818,0.760983438621109,0.653949878212584,1,4,negative regulation of cytokine production,BP,INHBB
2677,GO:0034976,0.761103016273923,0.653796286436781,1,4,response to endoplasmic reticulum stress,BP,PMAIP1
1641,GO:0016485,0.761194033941013,0.653679335317048,1,4,protein processing,BP,RHBDL3
1971,GO:0030183,0.763050926888906,0.651285165232091,1,4,B cell differentiation,BP,TPD52
1394,GO:0010817,0.763160256092672,0.478176831740529,3,12,regulation of hormone levels,BP,BMP6;KCNG2;INHBB
315,GO:0002576,0.763502425194469,0.650700657542497,1,4,platelet degranulation,BP,TF
2915,GO:0042060,0.763589314784692,0.387377611961558,8,30,wound healing,BP,WNT7A;PIK3CG;FZD7;WNT5B;CCL20;HRAS;PIK3CA;NOTCH1
1051,GO:0007601,0.763905857061521,0.650177587712337,1,4,visual perception,BP,GJA3
4046,GO:0050953,0.763905857061521,0.650177587712337,1,4,sensory perception of light stimulus,BP,GJA3
5956,GO:1905477,0.763985449590641,0.65007430390735,1,4,positive regulation of protein localization to membrane,BP,PMAIP1
1455,GO:0014015,0.763994951219394,0.650061972111188,1,4,positive regulation of gliogenesis,BP,NOTCH1
3514,GO:0045685,0.763994951219394,0.650061972111188,1,4,regulation of glial cell differentiation,BP,NOTCH1
3516,GO:0045687,0.763994951219394,0.650061972111188,1,4,positive regulation of glial cell differentiation,BP,NOTCH1
3877,GO:0048710,0.763994951219394,0.650061972111188,1,4,regulation of astrocyte differentiation,BP,NOTCH1
3878,GO:0048711,0.763994951219394,0.650061972111188,1,4,positive regulation of astrocyte differentiation,BP,NOTCH1
1933,GO:0030036,0.765210832098429,0.394248374644504,7,27,actin cytoskeleton organization,BP,SCIN;SPTBN5;SPTB;AMOT;HRAS;SPTBN4;RND3
3357,GO:0044708,0.765356238806083,0.529916449756939,2,8,single-organism behavior,BP,GDNF;SPTBN4
2151,GO:0031100,0.765705337562575,0.647835361953567,1,4,animal organ regeneration,BP,NOTCH1
927,GO:0007034,0.765978744978637,0.647478183548952,1,4,vacuolar transport,BP,SPTBN5
929,GO:0007041,0.765978744978637,0.647478183548952,1,4,lysosomal transport,BP,SPTBN5
1111,GO:0008233,0.766609775125197,0.646652484592251,1,4,peptidase activity,MF,RHBDL3
4079,GO:0051091,0.766857865812924,0.646327352642015,1,4,positive regulation of sequence-specific DNA binding transcription factor activity,BP,WNT2
4430,GO:0060326,0.766965029776678,0.4731058948746,3,12,cell chemotaxis,BP,PIK3CG;CCL20;NOTCH1
164,GO:0001843,0.767361218173131,0.645666809700841,1,4,neural tube closure,BP,BMP4
1270,GO:0009986,0.767462690838958,0.382505993121457,8,30,cell surface,CC,WNT7A;FGF8;AMOT;WNT5B;TSPAN15;TMEM206;NOTCH1;TF
3410,GO:0045088,0.767626078952606,0.645318761344443,1,4,regulation of innate immune response,BP,HRAS
3411,GO:0045089,0.767626078952606,0.645318761344443,1,4,positive regulation of innate immune response,BP,HRAS
5512,GO:0120025,0.76771974383791,0.367383865276245,10,38,plasma membrane bounded cell projection,CC,GJB2;SYT5;ACTN3;CDH1;SPTBN5;AMOT;PIK3CA;DRP2;FSTL3;SPTBN4
5626,GO:1901655,0.767754492606884,0.645149897415718,1,4,cellular response to ketone,BP,GJB2
6037,GO:2000106,0.768190553969234,0.644575900506045,1,4,regulation of leukocyte apoptotic process,BP,BMP4
203,GO:0001968,0.76916382283363,0.643291545368475,1,4,fibronectin binding,MF,FSTL3
1893,GO:0022604,0.769193337205102,0.524712053752766,2,8,regulation of cell morphogenesis,BP,WNT7A;WNT3
1335,GO:0010595,0.769330609837079,0.524524915248465,2,8,positive regulation of endothelial cell migration,BP,WNT7A;BMP4
309,GO:0002526,0.769513680013794,0.642828772882231,1,4,acute inflammatory response,BP,PIK3CG
2449,GO:0032729,0.769681743326517,0.64260626208217,1,4,positive regulation of interferon-gamma production,BP,HRAS
3301,GO:0044319,0.770706856718546,0.641246145601596,1,4,wound healing, spreading of cells,BP,WNT7A
5320,GO:0090504,0.770706856718546,0.641246145601596,1,4,epiboly,BP,WNT7A
5321,GO:0090505,0.770706856718546,0.641246145601596,1,4,epiboly involved in wound healing,BP,WNT7A
3558,GO:0045859,0.771396918575264,0.377530809087326,8,30,regulation of protein kinase activity,BP,PIK3CG;WNT7B;AXIN1;DUSP5;HRAS;BMP4;PIK3CA;BMP7
1798,GO:0019887,0.771965702074169,0.639569073962787,1,4,protein kinase regulator activity,MF,PIK3CA
4014,GO:0050866,0.77201869396919,0.639498310461966,1,4,negative regulation of cell activation,BP,BMP4
4085,GO:0051100,0.772111996034169,0.63937368548804,1,4,negative regulation of binding,BP,HEY1
2018,GO:0030334,0.772335162600739,0.368282133711487,9,34,regulation of cell migration,BP,WNT7A;JAG2;RRAS2;AMOT;WNT5B;CCL20;HRAS;BMP4;NOTCH1
6049,GO:2000145,0.772335162600739,0.368282133711487,9,34,regulation of cell motility,BP,WNT7A;JAG2;RRAS2;AMOT;WNT5B;CCL20;HRAS;BMP4;NOTCH1
190,GO:0001942,0.772584169304125,0.638742356170835,1,4,hair follicle development,BP,NOTCH1
1880,GO:0022404,0.772584169304125,0.638742356170835,1,4,molting cycle process,BP,NOTCH1
1881,GO:0022405,0.772584169304125,0.638742356170835,1,4,hair cycle process,BP,NOTCH1
2951,GO:0042303,0.772584169304125,0.638742356170835,1,4,molting cycle,BP,NOTCH1
3024,GO:0042633,0.772584169304125,0.638742356170835,1,4,hair cycle,BP,NOTCH1
549,GO:0005057,0.772684894574597,0.638607540736204,1,4,signal transducer activity, downstream of receptor,MF,MAPK12
4894,GO:0071214,0.772953951357705,0.519561328917442,2,8,cellular response to abiotic stimulus,BP,BMP6;HRAS
2301,GO:0032092,0.773124716106707,0.638018290963157,1,4,positive regulation of protein binding,BP,BMP4
4084,GO:0051099,0.773124716106707,0.638018290963157,1,4,positive regulation of binding,BP,BMP4
4206,GO:0051495,0.773428456293109,0.518907857372119,2,8,positive regulation of cytoskeleton organization,BP,SCIN;HRAS
4884,GO:0070925,0.773680011591114,0.431804123154032,4,16,organelle assembly,BP,RAB39A;RAB38;NOTCH1;RAB20
799,GO:0006518,0.773938371345022,0.636925738574641,1,4,peptide metabolic process,BP,BMP4
1756,GO:0019221,0.774102719307474,0.517977900929616,2,8,cytokine-mediated signaling pathway,BP,CLDN18;CCL20
1609,GO:0016301,0.774200600411946,0.382776993466687,7,27,kinase activity,MF,PIK3CG;MAPK12;FGF8;WNK4;PKN3;FGF17;PIK3CA
1672,GO:0016772,0.774200600411946,0.382776993466687,7,27,transferase activity, transferring phosphorus-containing groups,MF,PIK3CG;MAPK12;FGF8;WNK4;PKN3;FGF17;PIK3CA
1673,GO:0016773,0.774200600411946,0.382776993466687,7,27,phosphotransferase activity, alcohol group as acceptor,MF,PIK3CG;MAPK12;FGF8;WNK4;PKN3;FGF17;PIK3CA
3990,GO:0050803,0.774218872763974,0.636548347149856,1,4,regulation of synapse structure or activity,BP,WNT7A
3994,GO:0050807,0.774218872763974,0.636548347149856,1,4,regulation of synapse organization,BP,WNT7A
653,GO:0005765,0.774355648056565,0.636364188960273,1,4,lysosomal membrane,CC,RAB3D
660,GO:0005774,0.774355648056565,0.636364188960273,1,4,vacuolar membrane,CC,RAB3D
5468,GO:0098852,0.774355648056565,0.636364188960273,1,4,lytic vacuole membrane,CC,RAB3D
3831,GO:0048588,0.775123302237792,0.635328910386462,1,4,developmental cell growth,BP,WNT3
3299,GO:0044306,0.776403021872254,0.633596654921851,1,4,neuron projection terminus,CC,FSTL3
2064,GO:0030667,0.776927971761019,0.51406346684784,2,8,secretory granule membrane,CC,PKP1;RAB3D
2502,GO:0032943,0.77697584431798,0.513996889709692,2,8,mononuclear cell proliferation,BP,PIK3CG;BMP4
3653,GO:0046651,0.77697584431798,0.513996889709692,2,8,lymphocyte proliferation,BP,PIK3CG;BMP4
973,GO:0007204,0.777262380670901,0.632428899589754,1,4,positive regulation of cytosolic calcium ion concentration,BP,PIK3CG
2144,GO:0031076,0.777268263794056,0.632420892663886,1,4,embryonic camera-type eye development,BP,BMP7
3598,GO:0046068,0.777305475456193,0.632370243665435,1,4,cGMP metabolic process,BP,GUCY1B3
1209,GO:0009566,0.777716126660828,0.631810849919697,1,4,fertilization,BP,SPTBN4
3147,GO:0043281,0.779527701092383,0.629333119499677,1,4,regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,PMAIP1
6042,GO:2000116,0.779527701092383,0.629333119499677,1,4,regulation of cysteine-type endopeptidase activity,BP,PMAIP1
697,GO:0005912,0.779751188681355,0.386492491213287,6,24,adherens junction,CC,ACTN3;CDH1;RRAS2;SPTBN4;NOTCH1;RND3
1287,GO:0010171,0.779923744734928,0.628789262884183,1,4,body morphogenesis,BP,WNT3
4427,GO:0060323,0.779923744734928,0.628789262884183,1,4,head morphogenesis,BP,WNT3
5136,GO:0072216,0.780132915515479,0.628501707606061,1,4,positive regulation of metanephros development,BP,GDNF
1346,GO:0010632,0.780577811062384,0.454621507229037,3,12,regulation of epithelial cell migration,BP,WNT7A;BMP4;NOTCH1
4493,GO:0060491,0.780718145304151,0.6276960026093,1,4,regulation of cell projection assembly,BP,HRAS
2532,GO:0033059,0.781814067216371,0.6261825708666,1,4,cellular pigmentation,BP,RAB38
2623,GO:0034341,0.782467614739882,0.625277150882113,1,4,response to interferon-gamma,BP,CCL20
4926,GO:0071346,0.782467614739882,0.625277150882113,1,4,cellular response to interferon-gamma,BP,CCL20
621,GO:0005539,0.782512482064002,0.506240277185474,2,8,glycosaminoglycan binding,MF,BMP4;BMP7
5631,GO:1901681,0.7832077907276,0.505258146097016,2,8,sulfur compound binding,MF,BMP4;BMP7
1070,GO:0008016,0.783875028640921,0.418069735419647,4,16,regulation of heart contraction,BP,PIK3CG;KCNG2;KCNK6;SPTBN4
1433,GO:0010948,0.784115953687084,0.503972625242167,2,8,negative regulation of cell cycle process,BP,BMP4;BMP7
536,GO:0004866,0.784725211037426,0.622132737058404,1,4,endopeptidase inhibitor activity,MF,CRB2
2023,GO:0030414,0.784725211037426,0.622132737058404,1,4,peptidase inhibitor activity,MF,CRB2
4664,GO:0061134,0.784725211037426,0.622132737058404,1,4,peptidase regulator activity,MF,CRB2
4665,GO:0061135,0.784725211037426,0.622132737058404,1,4,endopeptidase regulator activity,MF,CRB2
4031,GO:0050900,0.785453649657525,0.394500406630414,5,20,leukocyte migration,BP,PIK3CG;ARTN;CCL20;HRAS;PIK3CA
2005,GO:0030307,0.786888249403656,0.619095403425611,1,4,positive regulation of cell growth,BP,WNT3
748,GO:0006164,0.787520671651252,0.618202759967433,1,4,purine nucleotide biosynthetic process,BP,GUCY1B3
1185,GO:0009152,0.787520671651252,0.618202759967433,1,4,purine ribonucleotide biosynthetic process,BP,GUCY1B3
1188,GO:0009165,0.787520671651252,0.618202759967433,1,4,nucleotide biosynthetic process,BP,GUCY1B3
1194,GO:0009190,0.787520671651252,0.618202759967433,1,4,cyclic nucleotide biosynthetic process,BP,GUCY1B3
1200,GO:0009260,0.787520671651252,0.618202759967433,1,4,ribonucleotide biosynthetic process,BP,GUCY1B3
3617,GO:0046390,0.787520671651252,0.618202759967433,1,4,ribose phosphate biosynthetic process,BP,GUCY1B3
4295,GO:0052652,0.787520671651252,0.618202759967433,1,4,cyclic purine nucleotide metabolic process,BP,GUCY1B3
5181,GO:0072522,0.787520671651252,0.618202759967433,1,4,purine-containing compound biosynthetic process,BP,GUCY1B3
5589,GO:1901293,0.787520671651252,0.618202759967433,1,4,nucleoside phosphate biosynthetic process,BP,GUCY1B3
2016,GO:0030330,0.788075966602167,0.617417252655944,1,4,DNA damage response, signal transduction by p53 class mediator,BP,PMAIP1
3045,GO:0042770,0.788075966602167,0.617417252655944,1,4,signal transduction in response to DNA damage,BP,PMAIP1
4833,GO:0070482,0.788778938613492,0.443217877854849,3,12,response to oxygen levels,BP,PMAIP1;BMP7;NOTCH1
3769,GO:0048286,0.790404954338608,0.614105012421146,1,4,lung alveolus development,BP,BMP4
684,GO:0005874,0.790679170882666,0.613713133371316,1,4,microtubule,CC,RAB3D
3642,GO:0046578,0.791610793196428,0.612378763517752,1,4,regulation of Ras protein signal transduction,BP,HRAS
2986,GO:0042472,0.792573330804048,0.61099522103803,1,4,inner ear morphogenesis,BP,FGF8
5237,GO:0090002,0.795325940576711,0.430352440067085,3,13,establishment of protein localization to plasma membrane,BP,CDH1;TSPAN15;SPTBN4
914,GO:0006996,0.795336945522155,0.305896360202423,18,66,organelle organization,BP,SCIN;SYT5;PMAIP1;AXIN1;SPTBN5;RAB39A;SPTB;FGF8;AMOT;PKP1;HRAS;BMP4;RAB38;BMP7;SPTBN4;NOTCH1;RND3;RAB20
3465,GO:0045471,0.795836390805525,0.606267539550767,1,4,response to ethanol,BP,CLDN18
941,GO:0007093,0.795848317907685,0.606250152137872,1,4,mitotic cell cycle checkpoint,BP,HRAS
1559,GO:0015844,0.796194179335613,0.605745611933976,1,4,monoamine transport,BP,GDNF
3934,GO:0050432,0.796194179335613,0.605745611933976,1,4,catecholamine secretion,BP,GDNF
3935,GO:0050433,0.796194179335613,0.605745611933976,1,4,regulation of catecholamine secretion,BP,GDNF
4278,GO:0051937,0.796194179335613,0.605745611933976,1,4,catecholamine transport,BP,GDNF
1391,GO:0010810,0.79706303127519,0.478723234900363,2,9,regulation of cell-substrate adhesion,BP,FZD7;NOTCH1
979,GO:0007224,0.797128111960721,0.604379895177086,1,4,smoothened signaling pathway,BP,BMP4
4004,GO:0050839,0.797385289162411,0.427412813779713,3,13,cell adhesion molecule binding,MF,ACTN3;CDH1;MB21D2
1751,GO:0019216,0.799244556382829,0.424747083440099,3,13,regulation of lipid metabolic process,BP,PIK3CG;BMP6;VDR
4937,GO:0071375,0.799292561964655,0.424678107154075,3,13,cellular response to peptide hormone stimulus,BP,GJB2;INHBB;PIK3CA
5624,GO:1901653,0.799292561964655,0.424678107154075,3,13,cellular response to peptide,BP,GJB2;INHBB;PIK3CA
2865,GO:0038034,0.799778056574673,0.600478348793929,1,4,signal transduction in absence of ligand,BP,GDNF
5371,GO:0097192,0.799778056574673,0.600478348793929,1,4,extrinsic apoptotic signaling pathway in absence of ligand,BP,GDNF
1953,GO:0030133,0.800920001148506,0.425946578795214,3,12,transport vesicle,CC,SYT5;RAB40B;RAB3D
934,GO:0007050,0.801133152445872,0.479293962652722,2,8,cell cycle arrest,BP,MAPK12;HRAS
1289,GO:0010212,0.801244042938402,0.598302972211164,1,4,response to ionizing radiation,BP,HRAS
4961,GO:0071479,0.801244042938402,0.598302972211164,1,4,cellular response to ionizing radiation,BP,HRAS
3178,GO:0043434,0.803931842087723,0.387933740976559,4,17,response to peptide hormone,BP,GJB2;INHBB;PIK3CA;BMP7
144,GO:0001775,0.80402356326548,0.326786696487395,9,35,cell activation,BP,WNT7A;PIK3CG;JAG2;FZD7;PKP1;BMP4;RAB3D;PIK3CA;TPD52
3575,GO:0045931,0.805812022081028,0.591445514957665,1,4,positive regulation of mitotic cell cycle,BP,FGF8
1928,GO:0030029,0.807970754951421,0.328235854654971,8,32,actin filament-based process,BP,SCIN;ACTN3;SPTBN5;SPTB;AMOT;HRAS;SPTBN4;RND3
619,GO:0005524,0.808461678747831,0.361391893579262,5,21,ATP binding,MF,PIK3CG;MAPK12;WNK4;PKN3;PIK3CA
4356,GO:0060048,0.808501307857464,0.461623527106889,2,9,cardiac muscle contraction,BP,PIK3CG;PIK3CA
3120,GO:0043229,0.810531069807225,0.276743310839331,44,152,intracellular organelle,CC,MAGEC2;SLC2A14;TJP3;GLDC;SCIN;TLE1;WNT7A;GJB2;PIK3CG;SYT5;ACTN3;MBOAT2;WNT3;HEY1;WNT7B;PMAIP1;AXIN1;POU3F1;MAPK12;CDH1;SPTBN5;RAB40B;RAB39A;SPTB;RRAS2;FZD7;VDR;AMOT;WNT5B;DUSP5;PKN3;PKP1;TSPAN15;HRAS;RAB3D;RNF144A;RAB38;FSTL3;TPD52;SPTBN4;NOTCH1;RND3;RAB20;TF
3927,GO:0048872,0.810954358056279,0.457885871971214,2,9,homeostasis of number of cells,BP,PMAIP1;BMP4
3537,GO:0045786,0.812048000363462,0.378651703677643,4,16,negative regulation of cell cycle,BP,MAPK12;HRAS;BMP4;BMP7
733,GO:0006082,0.812787971872405,0.455075309573631,2,9,organic acid metabolic process,BP,GLDC;ACTN3
3179,GO:0043436,0.812787971872405,0.455075309573631,2,9,oxoacid metabolic process,BP,GLDC;ACTN3
809,GO:0006629,0.813323243521583,0.329970898878669,7,28,lipid metabolic process,BP,PIK3CG;MBOAT2;BMP6;FGF8;VDR;FGF17;PIK3CA
2757,GO:0035637,0.814125556883818,0.45301593612483,2,9,multicellular organismal signaling,BP,KCNK6;SPTBN4
4070,GO:0051051,0.814295370895673,0.373116758882529,4,17,negative regulation of transport,BP,WNK4;INHBB;BMP7;NOTCH1
2304,GO:0032102,0.814826191185116,0.451934130716658,2,9,negative regulation of response to external stimulus,BP,WNT3;NOTCH1
3063,GO:0043005,0.814951018896622,0.372168674529049,4,17,neuron projection,CC,SYT5;DRP2;FSTL3;SPTBN4
3295,GO:0044283,0.815543090014192,0.450824998562135,2,9,small molecule biosynthetic process,BP,BMP6;VDR
540,GO:0004872,0.816413344480719,0.335807876422662,6,25,receptor activity,MF,FZD7;VDR;AMOT;KCNK6;NOTCH1;GUCY1B3
4375,GO:0060089,0.816413344480719,0.335807876422662,6,25,molecular transducer activity,MF,FZD7;VDR;AMOT;KCNK6;NOTCH1;GUCY1B3
1203,GO:0009267,0.819683965233956,0.444374252520344,2,9,cellular response to starvation,BP,PMAIP1;INHBB
3021,GO:0042594,0.819683965233956,0.444374252520344,2,9,response to starvation,BP,PMAIP1;INHBB
3344,GO:0044456,0.822392719551389,0.361315761662333,4,17,synapse part,CC,WNT7A;SYT5;RAB40B;DRP2
2055,GO:0030595,0.822547139912557,0.439869102997134,2,9,leukocyte chemotaxis,BP,PIK3CG;CCL20
35,GO:0000280,0.822915962507043,0.389789873345529,3,13,nuclear division,BP,FGF8;BMP4;BMP7
3768,GO:0048285,0.822915962507043,0.389789873345529,3,13,organelle fission,BP,FGF8;BMP4;BMP7
3572,GO:0045926,0.823587037841277,0.438223623802707,2,9,negative regulation of growth,BP,WNT3;BMP4
5344,GO:0097060,0.824084472648629,0.5456922335188,1,5,synaptic membrane,CC,DRP2
1474,GO:0014069,0.824149852101737,0.545583799618619,1,5,postsynaptic density,CC,DRP2
2336,GO:0032279,0.824149852101737,0.545583799618619,1,5,asymmetric synapse,CC,DRP2
5480,GO:0098984,0.824149852101737,0.545583799618619,1,5,neuron to neuron synapse,CC,DRP2
5501,GO:0099572,0.824149852101737,0.545583799618619,1,5,postsynaptic specialization,CC,DRP2
1805,GO:0019902,0.824221566246528,0.545464827451241,1,5,phosphatase binding,MF,SPTBN4
4792,GO:0070252,0.825906035929693,0.542660666817097,1,5,actin-mediated cell contraction,BP,ACTN3
698,GO:0005913,0.827144048151804,0.54058782973155,1,5,cell-cell adherens junction,CC,CDH1
4075,GO:0051056,0.827572034645433,0.431871756885562,2,9,regulation of small GTPase mediated signal transduction,BP,AMOT;HRAS
4925,GO:0071345,0.827697729325531,0.431670201171377,2,9,cellular response to cytokine stimulus,BP,CLDN18;CCL20
531,GO:0004842,0.82776914347369,0.539537353470334,1,5,ubiquitin-protein transferase activity,MF,RNF144A
1787,GO:0019787,0.82776914347369,0.539537353470334,1,5,ubiquitin-like protein transferase activity,MF,RNF144A
932,GO:0007045,0.828967984350548,0.537515390573632,1,5,cell-substrate adherens junction assembly,BP,ACTN3
2621,GO:0034333,0.828967984350548,0.537515390573632,1,5,adherens junction assembly,BP,ACTN3
3735,GO:0048041,0.828967984350548,0.537515390573632,1,5,focal adhesion assembly,BP,ACTN3
998,GO:0007281,0.82913324896391,0.42936300827658,2,9,germ cell development,BP,INHBB;BMP4
4852,GO:0070661,0.829134178297787,0.429361511474379,2,9,leukocyte proliferation,BP,PIK3CG;BMP4
2586,GO:0033674,0.830206126925568,0.30660127339123,7,28,positive regulation of kinase activity,BP,PIK3CG;WNT7B;AXIN1;DUSP5;HRAS;BMP4;PIK3CA
3559,GO:0045860,0.830206126925568,0.30660127339123,7,28,positive regulation of protein kinase activity,BP,PIK3CG;WNT7B;AXIN1;DUSP5;HRAS;BMP4;PIK3CA
3549,GO:0045834,0.830779104989918,0.534442391414182,1,5,positive regulation of lipid metabolic process,BP,BMP6
3282,GO:0044255,0.831898234617525,0.327908351164419,5,21,cellular lipid metabolic process,BP,PIK3CG;MBOAT2;FGF8;FGF17;PIK3CA
1676,GO:0016788,0.831904708011562,0.532521290009975,1,5,hydrolase activity, acting on ester bonds,MF,DUSP5
3012,GO:0042578,0.831904708011562,0.532521290009975,1,5,phosphoric ester hydrolase activity,MF,DUSP5
1331,GO:0010565,0.832502807857887,0.531496957141611,1,5,regulation of cellular ketone metabolic process,BP,BMP6
2941,GO:0042180,0.832502807857887,0.531496957141611,1,5,cellular ketone metabolic process,BP,BMP6
2284,GO:0032006,0.832917227839939,0.530785755529598,1,5,regulation of TOR signaling,BP,PIK3CA
1949,GO:0030100,0.833013660067719,0.423077109103673,2,9,regulation of endocytosis,BP,RAB20;TF
1453,GO:0014013,0.833234301704049,0.530240810722457,1,5,regulation of gliogenesis,BP,NOTCH1
145,GO:0001776,0.833851128832086,0.529178689802205,1,5,leukocyte homeostasis,BP,PMAIP1
3214,GO:0043549,0.834051171941119,0.292657077891815,8,32,regulation of kinase activity,BP,PIK3CG;WNT7B;AXIN1;DUSP5;HRAS;BMP4;PIK3CA;BMP7
213,GO:0002027,0.834724477050761,0.527670324989997,1,5,regulation of heart rate,BP,SPTBN4
2014,GO:0030325,0.836124884975676,0.525240491619466,1,5,adrenal gland development,BP,FSTL3
908,GO:0006974,0.83859999626537,0.413898573439154,2,9,cellular response to DNA damage stimulus,BP,PMAIP1;MAPK12
4306,GO:0055013,0.838800909073798,0.520558575977951,1,5,cardiac muscle cell development,BP,BMP4
645,GO:0005730,0.839196324266913,0.519862400877598,1,5,nucleolus,CC,MAGEC2
5024,GO:0071887,0.839339148191324,0.519610663993905,1,5,leukocyte apoptotic process,BP,BMP4
2928,GO:0042113,0.839562529448914,0.519216642386974,1,5,B cell activation,BP,TPD52
4534,GO:0060603,0.839919789834434,0.518585717369398,1,5,mammary gland duct morphogenesis,BP,VDR
3049,GO:0042802,0.840044568681831,0.284264200793508,8,32,identical protein binding,MF,TLE1;ACTN3;CLDN18;AXIN1;INHBB;CLDN15;GDNF;TPD52
3229,GO:0043603,0.840269087021553,0.517967955821538,1,5,cellular amide metabolic process,BP,BMP4
868,GO:0006869,0.840478336691129,0.517597453112775,1,5,lipid transport,BP,BMP6
1414,GO:0010876,0.840478336691129,0.517597453112775,1,5,lipid localization,BP,BMP6
374,GO:0003013,0.840480254374921,0.301570519652581,6,25,circulatory system process,BP,PIK3CG;KCNG2;KCNK6;PIK3CA;SPTBN4;GUCY1B3
1069,GO:0008015,0.840480254374921,0.301570519652581,6,25,blood circulation,BP,PIK3CG;KCNG2;KCNK6;PIK3CA;SPTBN4;GUCY1B3
5454,GO:0098773,0.840697398482924,0.517209233338033,1,5,skin epidermis development,BP,NOTCH1
2235,GO:0031647,0.840744253196646,0.517126152076284,1,5,regulation of protein stability,BP,TF
4091,GO:0051128,0.841619500733013,0.255139523231198,14,54,regulation of cellular component organization,BP,SCIN;WNT7A;WNT3;PMAIP1;SPTBN5;SPTB;FGF8;HRAS;BMP4;BMP7;SPTBN4;NOTCH1;RAB20;TF
2419,GO:0032609,0.842230350362101,0.514482665718649,1,5,interferon-gamma production,BP,HRAS
2431,GO:0032649,0.842230350362101,0.514482665718649,1,5,regulation of interferon-gamma production,BP,HRAS
989,GO:0007265,0.842304652593579,0.4077251549798,2,9,Ras protein signal transduction,BP,RRAS2;HRAS
4199,GO:0051480,0.842828797896798,0.513413522776957,1,5,regulation of cytosolic calcium ion concentration,BP,PIK3CG
4095,GO:0051146,0.843426303288823,0.354900998441461,3,14,striated muscle cell differentiation,BP,FZD7;BMP4;NOTCH1
1128,GO:0008361,0.844027574643586,0.511263832770261,1,5,regulation of cell size,BP,WNT3
383,GO:0003073,0.844504309555817,0.510405935106529,1,5,regulation of systemic arterial blood pressure,BP,KCNK6
3331,GO:0044437,0.844884581635787,0.509720394747195,1,5,vacuolar part,CC,RAB3D
2984,GO:0042470,0.845855952507399,0.507964263549123,1,5,melanosome,CC,RAB38
3895,GO:0048770,0.845855952507399,0.507964263549123,1,5,pigment granule,CC,RAB38
3186,GO:0043473,0.845856060222156,0.507964068414441,1,5,pigmentation,BP,RAB38
4255,GO:0051785,0.84706177178329,0.50577425106081,1,5,positive regulation of nuclear division,BP,FGF8
2480,GO:0032868,0.84820327866897,0.392651912078161,2,10,response to insulin,BP,INHBB;PIK3CA
1986,GO:0030234,0.849513531962476,0.318322545905806,4,18,enzyme regulator activity,MF,AXIN1;CRB2;PIK3CA;NOTCH1
327,GO:0002687,0.849995872865186,0.500398315120383,1,5,positive regulation of leukocyte migration,BP,CCL20
3315,GO:0044403,0.850164084387974,0.344050764606857,3,14,symbiosis, encompassing mutualism through parasitism,BP,PMAIP1;CDH1;NOTCH1
3318,GO:0044419,0.850164084387974,0.344050764606857,3,14,interspecies interaction between organisms,BP,PMAIP1;CDH1;NOTCH1
1882,GO:0022406,0.850460929045639,0.499540033415241,1,5,membrane docking,BP,RAB40B
3856,GO:0048661,0.850460954992662,0.499539985481149,1,5,positive regulation of smooth muscle cell proliferation,BP,BMP4
1306,GO:0010466,0.850844894546098,0.498830117833839,1,5,negative regulation of peptidase activity,BP,CRB2
1435,GO:0010951,0.850844894546098,0.498830117833839,1,5,negative regulation of endopeptidase activity,BP,CRB2
3560,GO:0045861,0.850844894546098,0.498830117833839,1,5,negative regulation of proteolysis,BP,CRB2
2024,GO:0030424,0.851067801849658,0.498417446509509,1,5,axon,CC,SPTBN4
3368,GO:0044764,0.851186433210549,0.342387619124555,3,14,multi-organism cellular process,BP,PMAIP1;INHBB;NOTCH1
3587,GO:0045981,0.851639043823389,0.497358091922318,1,5,positive regulation of nucleotide metabolic process,BP,ACTN3
5553,GO:1900544,0.851639043823389,0.497358091922318,1,5,positive regulation of purine nucleotide metabolic process,BP,ACTN3
3323,GO:0044425,0.852736457861496,0.221715367540186,30,110,membrane part,CC,SLC2A14;GJB2;PIK3CG;SYT5;CLDN18;RHBDL3;MBOAT2;GJA3;GJB6;JAG2;KCNG2;AXIN1;CDH1;SPTBN5;SPTB;FZD7;FGF8;CRB2;DSG3;AMOT;TSPAN15;KCNK6;CLDN15;RNF144A;PIK3CA;DRP2;TMEM206;TSPAN13;NOTCH1;TF
4535,GO:0060606,0.85283654843738,0.495128867646577,1,5,tube closure,BP,BMP4
5162,GO:0072331,0.853176102868024,0.494494665615942,1,5,signal transduction by p53 class mediator,BP,PMAIP1
1037,GO:0007565,0.854077452721693,0.382538614268052,2,10,female pregnancy,BP,GJB2;VDR
4302,GO:0055007,0.854791013341574,0.381297304900937,2,10,cardiac muscle cell differentiation,BP,FZD7;BMP4
5486,GO:0099080,0.855137585629889,0.309493840642585,4,18,supramolecular complex,CC,ACTN3;AMOT;PKP1;RAB3D
5487,GO:0099081,0.855137585629889,0.309493840642585,4,18,supramolecular polymer,CC,ACTN3;AMOT;PKP1;RAB3D
5494,GO:0099512,0.855137585629889,0.309493840642585,4,18,supramolecular fiber,CC,ACTN3;AMOT;PKP1;RAB3D
137,GO:0001755,0.855233815722928,0.490631314504122,1,5,neural crest cell migration,BP,GDNF
3978,GO:0050776,0.855750591446833,0.379623569996225,2,10,regulation of immune response,BP,HRAS;PIK3CA
3980,GO:0050778,0.855750591446833,0.379623569996225,2,10,positive regulation of immune response,BP,HRAS;PIK3CA
2191,GO:0031331,0.856039717314141,0.379118258615657,2,10,positive regulation of cellular catabolic process,BP,AXIN1;RNF144A
1965,GO:0030168,0.856837692932431,0.37772118948071,2,10,platelet activation,BP,PIK3CG;PIK3CA
1217,GO:0009611,0.856945551413877,0.259447576741316,8,33,response to wounding,BP,WNT7A;PIK3CG;FZD7;WNT5B;CCL20;HRAS;PIK3CA;NOTCH1
373,GO:0003012,0.85848401778335,0.304184113578473,4,18,muscle system process,BP,PIK3CG;ACTN3;GDNF;PIK3CA
895,GO:0006936,0.85848401778335,0.304184113578473,4,18,muscle contraction,BP,PIK3CG;ACTN3;GDNF;PIK3CA
8,GO:0000075,0.858582940239548,0.484268502692779,1,5,cell cycle checkpoint,BP,HRAS
1558,GO:0015837,0.858926679048088,0.483610121163987,1,5,amine transport,BP,GDNF
4280,GO:0051952,0.858926679048088,0.483610121163987,1,5,regulation of amine transport,BP,GDNF
2168,GO:0031224,0.859426157353636,0.217835295909546,22,83,intrinsic component of membrane,CC,SLC2A14;GJB2;SYT5;CLDN18;RHBDL3;MBOAT2;GJA3;GJB6;JAG2;KCNG2;CDH1;SPTB;FZD7;CRB2;DSG3;TSPAN15;KCNK6;CLDN15;RNF144A;TMEM206;TSPAN13;NOTCH1
375,GO:0003014,0.860651868368938,0.370993566462694,2,10,renal system process,BP,WNK4;BMP4
5820,GO:1903531,0.862048130723033,0.36850982428581,2,10,negative regulation of secretion by cell,BP,INHBB;NOTCH1
1057,GO:0007610,0.863471572407585,0.365965979211993,2,10,behavior,BP,GDNF;SPTBN4
747,GO:0006163,0.864555585824388,0.364020687691398,2,10,purine nucleotide metabolic process,BP,ACTN3;GUCY1B3
842,GO:0006753,0.864555585824388,0.364020687691398,2,10,nucleoside phosphate metabolic process,BP,ACTN3;GUCY1B3
1176,GO:0009117,0.864555585824388,0.364020687691398,2,10,nucleotide metabolic process,BP,ACTN3;GUCY1B3
1184,GO:0009150,0.864555585824388,0.364020687691398,2,10,purine ribonucleotide metabolic process,BP,ACTN3;GUCY1B3
1199,GO:0009259,0.864555585824388,0.364020687691398,2,10,ribonucleotide metabolic process,BP,ACTN3;GUCY1B3
1780,GO:0019693,0.864555585824388,0.364020687691398,2,10,ribose phosphate metabolic process,BP,ACTN3;GUCY1B3
4329,GO:0055086,0.864555585824388,0.364020687691398,2,10,nucleobase-containing small molecule metabolic process,BP,ACTN3;GUCY1B3
5180,GO:0072521,0.864555585824388,0.364020687691398,2,10,purine-containing compound metabolic process,BP,ACTN3;GUCY1B3
667,GO:0005789,0.864686322627619,0.363785603840364,2,10,endoplasmic reticulum membrane,CC,MBOAT2;NOTCH1
1930,GO:0030031,0.865777344786097,0.361819791639513,2,10,cell projection assembly,BP,HRAS;NOTCH1
681,GO:0005856,0.866185823788405,0.239304639644105,9,38,cytoskeleton,CC,SCIN;ACTN3;CDH1;SPTBN5;SPTB;AMOT;PKP1;RAB3D;SPTBN4
2272,GO:0031967,0.866845467702135,0.359888285128778,2,10,organelle envelope,CC,PMAIP1;RAB40B
2276,GO:0031975,0.866845467702135,0.359888285128778,2,10,envelope,CC,PMAIP1;RAB40B
960,GO:0007173,0.866906915444963,0.359776957491073,2,10,epidermal growth factor receptor signaling pathway,BP,HRAS;PIK3CA
2879,GO:0038127,0.866906915444963,0.359776957491073,2,10,ERBB signaling pathway,BP,HRAS;PIK3CA
2503,GO:0032944,0.867199616402057,0.4674545478549,1,5,regulation of mononuclear cell proliferation,BP,BMP4
3937,GO:0050670,0.867199616402057,0.4674545478549,1,5,regulation of lymphocyte proliferation,BP,BMP4
2058,GO:0030658,0.867570538190956,0.466715887571786,1,5,transport vesicle membrane,CC,SYT5
957,GO:0007167,0.870814908988853,0.220615541675808,12,48,enzyme linked receptor protein signaling pathway,BP,BMP6;MAPK12;FGF8;CRB2;INHBB;FGF17;HRAS;BMP4;PIK3CA;BMP7;FSTL3;NOTCH1
5191,GO:0072593,0.872314826722698,0.349887876407167,2,10,reactive oxygen species metabolic process,BP,PMAIP1;BMP7
2053,GO:0030554,0.872959922470291,0.262754796732738,5,23,adenyl nucleotide binding,MF,PIK3CG;MAPK12;WNK4;PKN3;PIK3CA
2409,GO:0032559,0.872959922470291,0.262754796732738,5,23,adenyl ribonucleotide binding,MF,PIK3CG;MAPK12;WNK4;PKN3;PIK3CA
1807,GO:0019904,0.873469169158924,0.302579432042481,3,15,protein domain specific binding,MF,WNT3;AXIN1;FZD7
1888,GO:0022412,0.873829740291282,0.347084646845901,2,10,cellular process involved in reproduction in multicellular organism,BP,INHBB;BMP4
1938,GO:0030048,0.877155464945463,0.435666548012416,1,6,actin filament-based movement,BP,ACTN3
918,GO:0007010,0.877192275916519,0.223173151984366,9,38,cytoskeleton organization,BP,SCIN;AXIN1;SPTBN5;SPTB;AMOT;PKP1;HRAS;SPTBN4;RND3
3117,GO:0043226,0.878794708152135,0.194204064261673,50,174,organelle,CC,MAGEC2;SLC2A14;TJP3;GLDC;SCIN;TLE1;WNT7A;GJB2;PIK3CG;SYT5;ACTN3;MBOAT2;BMP6;WNT3;HEY1;WNT7B;PMAIP1;KCNG2;AXIN1;POU3F1;MAPK12;CDH1;SPTBN5;RAB40B;RAB39A;SPTB;RRAS2;FZD7;VDR;CRB2;DSG3;AMOT;WNT5B;DUSP5;PKN3;PKP1;TSPAN15;HRAS;RAB3D;RNF144A;RAB38;BMP7;DRP2;FSTL3;TPD52;SPTBN4;NOTCH1;RND3;RAB20;TF
2070,GO:0030695,0.880324404208411,0.428985325549683,1,6,GTPase regulator activity,MF,AXIN1
4527,GO:0060589,0.880324404208411,0.428985325549683,1,6,nucleoside-triphosphatase regulator activity,MF,AXIN1
2175,GO:0031253,0.882197264448832,0.42498932506716,1,6,cell projection membrane,CC,SPTBN5
5954,GO:1905475,0.882343905628697,0.424674935411412,1,6,regulation of protein localization to membrane,BP,PMAIP1
3142,GO:0043271,0.882566165274418,0.424198002986742,1,6,negative regulation of ion transport,BP,WNK4
257,GO:0002262,0.884276181216099,0.420511489086599,1,6,myeloid cell homeostasis,BP,BMP4
2279,GO:0031983,0.8845748917072,0.419864389079721,1,6,vesicle lumen,CC,TF
2676,GO:0034774,0.8845748917072,0.419864389079721,1,6,secretory granule lumen,CC,TF
4399,GO:0060205,0.8845748917072,0.419864389079721,1,6,cytoplasmic vesicle lumen,CC,TF
3875,GO:0048708,0.884597633893417,0.419815084029802,1,6,astrocyte differentiation,BP,NOTCH1
4020,GO:0050877,0.884713954890844,0.259421751182401,4,19,neurological system process,BP,GJB2;GJA3;GJB6;SPTBN4
1613,GO:0016311,0.884757723231953,0.419467856466919,1,6,dephosphorylation,BP,DUSP5
5448,GO:0098742,0.88483273450679,0.259219663272289,4,19,cell-cell adhesion via plasma-membrane adhesion molecules,BP,CLDN18;CDH1;DSG3;CLDN15
1744,GO:0019207,0.886498553891783,0.415674542254093,1,6,kinase regulator activity,MF,PIK3CA
1600,GO:0016236,0.887059651378221,0.41444500018264,1,6,macroautophagy,BP,PIK3CA
1602,GO:0016241,0.887059651378221,0.41444500018264,1,6,regulation of macroautophagy,BP,PIK3CA
1575,GO:0016021,0.887118100730576,0.181289250930046,21,81,integral component of membrane,CC,SLC2A14;GJB2;SYT5;CLDN18;RHBDL3;MBOAT2;GJA3;GJB6;JAG2;KCNG2;CDH1;FZD7;CRB2;DSG3;TSPAN15;KCNK6;CLDN15;RNF144A;TMEM206;TSPAN13;NOTCH1
947,GO:0007155,0.887475702505615,0.187195645748326,16,64,cell adhesion,BP,PIK3CG;ACTN3;CLDN18;WNT7B;JAG2;CDH1;FZD7;DSG3;PKP1;BMP4;CLDN15;PIK3CA;BMP7;FSTL3;NOTCH1;RND3
1895,GO:0022610,0.887475702505615,0.187195645748326,16,64,biological adhesion,BP,PIK3CG;ACTN3;CLDN18;WNT7B;JAG2;CDH1;FZD7;DSG3;PKP1;BMP4;CLDN15;PIK3CA;BMP7;FSTL3;NOTCH1;RND3
3009,GO:0042552,0.888785317645608,0.41064215276829,1,6,myelination,BP,POU3F1
4299,GO:0055002,0.88903429614581,0.410090793565244,1,6,striated muscle cell development,BP,BMP4
3542,GO:0045807,0.889627975286969,0.408773342176766,1,6,positive regulation of endocytosis,BP,TF
3165,GO:0043393,0.89016999980588,0.407567109025979,1,6,regulation of protein binding,BP,BMP4
3444,GO:0045216,0.890405936366853,0.272535313478146,3,15,cell-cell junction organization,BP,GJB2;ACTN3;CDH1
5816,GO:1903522,0.891431102430969,0.247887721482952,4,19,regulation of blood circulation,BP,PIK3CG;KCNG2;KCNK6;SPTBN4
889,GO:0006914,0.891863885095798,0.308653648722068,2,11,autophagy,BP,RAB39A;PIK3CA
3355,GO:0044706,0.893410334100913,0.30559010803924,2,11,multi-multicellular organism process,BP,GJB2;VDR
1657,GO:0016604,0.895331341319588,0.395914116018407,1,6,nuclear body,CC,SPTBN4
2939,GO:0042175,0.897768099787914,0.29685898039545,2,11,nuclear outer membrane-endoplasmic reticulum membrane network,CC,MBOAT2;NOTCH1
896,GO:0006937,0.898674852972303,0.295023558962928,2,11,regulation of muscle contraction,BP,PIK3CG;ACTN3
5295,GO:0090257,0.898674852972303,0.295023558962928,2,11,regulation of muscle system process,BP,PIK3CG;ACTN3
4645,GO:0061041,0.898706104128886,0.388125926441906,1,6,regulation of wound healing,BP,HRAS
5763,GO:1903034,0.898706104128886,0.388125926441906,1,6,regulation of response to wounding,BP,HRAS
3742,GO:0048145,0.898722873964957,0.388086881249239,1,6,regulation of fibroblast proliferation,BP,WNT2
3743,GO:0048146,0.898722873964957,0.388086881249239,1,6,positive regulation of fibroblast proliferation,BP,WNT2
1276,GO:0010001,0.899002387903686,0.294358961047384,2,11,glial cell differentiation,BP,POU3F1;NOTCH1
2916,GO:0042063,0.899002387903686,0.294358961047384,2,11,gliogenesis,BP,POU3F1;NOTCH1
746,GO:0006140,0.90021952706845,0.384588256836326,1,6,regulation of nucleotide metabolic process,BP,ACTN3
5551,GO:1900542,0.90021952706845,0.384588256836326,1,6,regulation of purine nucleotide metabolic process,BP,ACTN3
4960,GO:0071478,0.901041133227722,0.38265578984716,1,6,cellular response to radiation,BP,HRAS
1459,GO:0014032,0.902647803630864,0.378852144066089,1,6,neural crest cell development,BP,GDNF
1460,GO:0014033,0.902647803630864,0.378852144066089,1,6,neural crest cell differentiation,BP,GDNF
930,GO:0007043,0.903053036417492,0.37788758035573,1,6,cell-cell junction assembly,BP,GJB2
4037,GO:0050921,0.903210358486222,0.377512540515063,1,6,positive regulation of chemotaxis,BP,ARTN
5770,GO:1903047,0.90403611044719,0.225627609457584,4,19,mitotic cell cycle process,BP,FGF8;HRAS;BMP4;BMP7
1735,GO:0019003,0.904946226296872,0.373353015566861,1,6,GDP binding,MF,HRAS
2594,GO:0034097,0.905638698066819,0.280703733769911,2,11,response to cytokine,BP,CLDN18;CCL20
4144,GO:0051249,0.905883146142145,0.280193661379051,2,11,regulation of lymphocyte activation,BP,BMP4;PIK3CA
4854,GO:0070663,0.906394917066737,0.369851183892498,1,6,regulation of leukocyte proliferation,BP,BMP4
2996,GO:0042493,0.906665647552187,0.278557389885884,2,11,response to drug,BP,CDH1;FGF8
1348,GO:0010634,0.909220328141342,0.273177905527692,2,11,positive regulation of epithelial cell migration,BP,WNT7A;BMP4
3440,GO:0045202,0.90962985589601,0.214210349495987,4,20,synapse,CC,WNT7A;SYT5;RAB40B;DRP2
1621,GO:0016338,0.910053616412492,0.271410616888385,2,11,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,BP,CLDN18;CLDN15
324,GO:0002684,0.913864548836519,0.206419400527216,4,20,positive regulation of immune system process,BP,SCIN;CCL20;HRAS;PIK3CA
1119,GO:0008286,0.914555643058032,0.34173090560609,1,7,insulin receptor signaling pathway,BP,PIK3CA
1994,GO:0030260,0.914908745899427,0.340834731074829,1,7,entry into host cell,BP,CDH1
3317,GO:0044409,0.914908745899427,0.340834731074829,1,7,entry into host,BP,CDH1
4242,GO:0051701,0.914908745899427,0.340834731074829,1,7,interaction with host,BP,CDH1
4258,GO:0051806,0.914908745899427,0.340834731074829,1,7,entry into cell of other organism involved in symbiotic interaction,BP,CDH1
4259,GO:0051828,0.914908745899427,0.340834731074829,1,7,entry into other organism involved in symbiotic interaction,BP,CDH1
931,GO:0007044,0.915023835727987,0.340542239873536,1,7,cell-substrate junction assembly,BP,ACTN3
5872,GO:1904018,0.916388674470612,0.337058746996126,1,7,positive regulation of vasculature development,BP,NOTCH1
706,GO:0005929,0.91697998342027,0.335540946780235,1,7,cilium,CC,SPTBN5
3335,GO:0044441,0.91697998342027,0.335540946780235,1,7,ciliary part,CC,SPTBN5
2258,GO:0031929,0.918808171356049,0.330814813730609,1,7,TOR signaling,BP,PIK3CA
3548,GO:0045833,0.918930772587213,0.33049604120454,1,7,negative regulation of lipid metabolic process,BP,PIK3CG
1614,GO:0016323,0.920623063596218,0.326072040760396,1,7,basolateral plasma membrane,CC,TF
1158,GO:0008645,0.920656323208283,0.325984642363479,1,7,hexose transport,BP,SLC2A14
1552,GO:0015749,0.920656323208283,0.325984642363479,1,7,monosaccharide transport,BP,SLC2A14
1553,GO:0015758,0.920656323208283,0.325984642363479,1,7,glucose transport,BP,SLC2A14
1954,GO:0030135,0.921426105323898,0.323956921843879,1,7,coated vesicle,CC,TF
1955,GO:0030136,0.921426105323898,0.323956921843879,1,7,clathrin-coated vesicle,CC,TF
4335,GO:0055117,0.921829040278792,0.322891751965274,1,7,regulation of cardiac muscle contraction,BP,PIK3CG
3696,GO:0046888,0.922719552451641,0.320528351761876,1,7,negative regulation of hormone secretion,BP,INHBB
1146,GO:0008584,0.922782572928565,0.320360607986384,1,7,male gonad development,BP,FSTL3
3641,GO:0046546,0.922782572928565,0.320360607986384,1,7,development of primary male sexual characteristics,BP,FSTL3
648,GO:0005740,0.92308747707507,0.319548115916219,1,7,mitochondrial envelope,CC,PMAIP1
2271,GO:0031966,0.92308747707507,0.319548115916219,1,7,mitochondrial membrane,CC,PMAIP1
1802,GO:0019899,0.923430804008964,0.154466053820918,8,37,enzyme binding,MF,MAGEC2;GLDC;AXIN1;CRB2;TSPAN15;RNF144A;SPTBN4;NOTCH1
995,GO:0007272,0.92345644931032,0.318562856055882,1,7,ensheathment of neurons,BP,POU3F1
1129,GO:0008366,0.92345644931032,0.318562856055882,1,7,axon ensheathment,BP,POU3F1
860,GO:0006820,0.923630802873291,0.318096501365269,1,7,anion transport,BP,WNK4
543,GO:0004930,0.923822032952155,0.31758442706949,1,7,G-protein coupled receptor activity,MF,FZD7
34,GO:0000278,0.924774295913968,0.185823614476379,4,20,mitotic cell cycle,BP,FGF8;HRAS;BMP4;BMP7
5625,GO:1901654,0.926048292722454,0.311577809447185,1,7,response to ketone,BP,GJB2
3342,GO:0044451,0.926317775134317,0.31084500401026,1,7,nucleoplasm part,CC,SPTBN4
5751,GO:1902905,0.926587017566297,0.310111599485136,1,7,positive regulation of supramolecular fiber organization,BP,SCIN
3141,GO:0043270,0.92888396402983,0.30380318617864,1,7,positive regulation of ion transport,BP,GDNF
1193,GO:0009187,0.929122498355181,0.303142689792242,1,7,cyclic nucleotide metabolic process,BP,GUCY1B3
6079,GO:2000377,0.929190720219302,0.302953596238758,1,7,regulation of reactive oxygen species metabolic process,BP,BMP7
330,GO:0002694,0.929513515628248,0.225387612301362,2,12,regulation of leukocyte activation,BP,BMP4;PIK3CA
704,GO:0005924,0.930906035740406,0.190155742858644,3,17,cell-substrate adherens junction,CC,ACTN3;RRAS2;RND3
705,GO:0005925,0.930906035740406,0.190155742858644,3,17,focal adhesion,CC,ACTN3;RRAS2;RND3
2618,GO:0034330,0.934240891292981,0.183104985146811,3,17,cell junction organization,BP,GJB2;ACTN3;CDH1
3854,GO:0048659,0.934362201094082,0.288367697011584,1,7,smooth muscle cell proliferation,BP,BMP4
3855,GO:0048660,0.934362201094082,0.288367697011584,1,7,regulation of smooth muscle cell proliferation,BP,BMP4
897,GO:0006939,0.934564047750518,0.287788002673206,1,7,smooth muscle contraction,BP,GDNF
5457,GO:0098794,0.939725638061169,0.267283402512293,1,8,postsynapse,CC,DRP2
1736,GO:0019058,0.940168589796562,0.265968613513477,1,8,viral life cycle,BP,NOTCH1
5461,GO:0098802,0.940808135506142,0.264062893824598,1,8,plasma membrane receptor complex,CC,TF
2025,GO:0030425,0.943054550965515,0.25729830235873,1,8,dendrite,CC,DRP2
1576,GO:0016032,0.943658991830216,0.189270504391269,2,13,viral process,BP,PMAIP1;NOTCH1
579,GO:0005178,0.944150513193854,0.253957038327425,1,8,integrin binding,MF,ACTN3
2477,GO:0032844,0.944340089019547,0.253376284596738,1,8,regulation of homeostatic process,BP,CLDN18
1157,GO:0008643,0.944648994269136,0.252428188619743,1,8,carbohydrate transport,BP,SLC2A14
5503,GO:0099600,0.944936712142986,0.186084703157933,2,13,transmembrane receptor activity,MF,FZD7;KCNK6
4247,GO:0051726,0.945038428064573,0.134231954798464,5,25,regulation of cell cycle,BP,MAPK12;FGF8;HRAS;BMP4;BMP7
1330,GO:0010564,0.945447896069494,0.158599497666255,3,17,regulation of cell cycle process,BP,FGF8;BMP4;BMP7
3654,GO:0046660,0.946630633701816,0.246292620112681,1,8,female sex differentiation,BP,INHBB
1941,GO:0030055,0.946928416236094,0.154130949638072,3,18,cell-substrate junction,CC,ACTN3;RRAS2;RND3
2006,GO:0030308,0.948713689463208,0.239740133050394,1,8,negative regulation of cell growth,BP,WNT3
325,GO:0002685,0.948973114914832,0.238916462488811,1,8,regulation of leukocyte migration,BP,CCL20
966,GO:0007186,0.951203177806864,0.144379917718706,3,18,G-protein coupled receptor signaling pathway,BP,PIK3CG;FZD7;CCL20
4146,GO:0051251,0.9521077028996,0.228825272374476,1,8,positive regulation of lymphocyte activation,BP,PIK3CA
1205,GO:0009314,0.955389890015283,0.21796911520993,1,8,response to radiation,BP,HRAS
30,GO:0000226,0.955888443733811,0.216292681108059,1,8,microtubule cytoskeleton organization,BP,AXIN1
921,GO:0007017,0.955888443733811,0.216292681108059,1,8,microtubule-based process,BP,AXIN1
2227,GO:0031589,0.956676910451538,0.130648237657321,3,19,cell-substrate adhesion,BP,ACTN3;FZD7;NOTCH1
2861,GO:0038023,0.959222692729202,0.147088176455259,2,14,signaling receptor activity,MF,FZD7;VDR
4973,GO:0071559,0.959575935262704,0.146121473327993,2,14,response to transforming growth factor beta,BP,WNT7A;WNT2
4974,GO:0071560,0.959575935262704,0.146121473327993,2,14,cellular response to transforming growth factor beta stimulus,BP,WNT7A;WNT2
3119,GO:0043228,0.9603628997424,0.0833823468769873,10,48,non-membrane-bounded organelle,CC,MAGEC2;SCIN;ACTN3;CDH1;SPTBN5;SPTB;AMOT;PKP1;RAB3D;SPTBN4
3123,GO:0043232,0.9603628997424,0.0833823468769873,10,48,intracellular non-membrane-bounded organelle,CC,MAGEC2;SCIN;ACTN3;CDH1;SPTBN5;SPTB;AMOT;PKP1;RAB3D;SPTBN4
2617,GO:0034329,0.961282064071477,0.141416592778922,2,14,cell junction assembly,BP,GJB2;ACTN3
1312,GO:0010506,0.962520155378785,0.189642165191525,1,9,regulation of autophagy,BP,PIK3CA
4013,GO:0050865,0.962905449995525,0.136882955886968,2,14,regulation of cell activation,BP,BMP4;PIK3CA
1597,GO:0016197,0.965057046808031,0.180495722938358,1,9,endosomal transport,BP,RAB38
332,GO:0002696,0.966414243558759,0.175502935549305,1,9,positive regulation of leukocyte activation,BP,PIK3CA
1108,GO:0008217,0.96655058847537,0.174997351067401,1,9,regulation of blood pressure,BP,KCNK6
4021,GO:0050878,0.966976600966465,0.0942102850433023,4,24,regulation of body fluid levels,BP,PIK3CG;VDR;WNK4;PIK3CA
5577,GO:1901137,0.967024659327257,0.173233617937363,1,9,carbohydrate derivative biosynthetic process,BP,GUCY1B3
3346,GO:0044463,0.968088526570817,0.10186906786415,3,20,cell projection part,CC,SPTBN5;FSTL3;SPTBN4
5252,GO:0090068,0.96845937915897,0.167839532233126,1,9,positive regulation of cell cycle process,BP,FGF8
959,GO:0007169,0.975844286292317,0.0669974637287586,5,29,transmembrane receptor protein tyrosine kinase signaling pathway,BP,MAPK12;FGF8;FGF17;HRAS;PIK3CA
2170,GO:0031226,0.977006563027181,0.0602578937067847,6,34,intrinsic component of plasma membrane,CC,JAG2;KCNG2;SPTB;TSPAN15;KCNK6;TSPAN13
4015,GO:0050867,0.977368687866147,0.129832870837872,1,10,positive regulation of cell activation,BP,PIK3CA
933,GO:0007049,0.978170826637593,0.0578556338866264,6,33,cell cycle,BP,JAG2;MAPK12;FGF8;HRAS;BMP4;BMP7
1879,GO:0022402,0.97896018040734,0.0596702985222921,5,29,cell cycle process,BP,MAPK12;FGF8;HRAS;BMP4;BMP7
1975,GO:0030198,0.981114921461431,0.0787741627507323,2,17,extracellular matrix organization,BP,CDH1;NOTCH1
3075,GO:0043062,0.981114921461431,0.0787741627507323,2,17,extracellular structure organization,BP,CDH1;NOTCH1
1718,GO:0018108,0.982888424434448,0.0734849476858433,2,16,peptidyl-tyrosine phosphorylation,BP,FGF8;FGF17
1728,GO:0018212,0.982888424434448,0.0734849476858433,2,16,peptidyl-tyrosine modification,BP,FGF8;FGF17
542,GO:0004888,0.983447627521941,0.10139600058354,1,11,transmembrane signaling receptor activity,MF,FZD7
1539,GO:0015630,0.984107734721164,0.0983433618608807,1,11,microtubule cytoskeleton,CC,RAB3D
1048,GO:0007596,0.984599417425778,0.0669644099396742,2,17,blood coagulation,BP,PIK3CG;PIK3CA
1049,GO:0007599,0.984599417425778,0.0669644099396742,2,17,hemostasis,BP,PIK3CG;PIK3CA
3997,GO:0050817,0.984599417425778,0.0669644099396742,2,17,coagulation,BP,PIK3CG;PIK3CA
690,GO:0005887,0.990744765107555,0.0292125306196636,5,33,integral component of plasma membrane,CC,JAG2;KCNG2;TSPAN15;KCNK6;TSPAN13
951,GO:0007160,0.990801147915341,0.0630399568362787,1,13,cell-matrix adhesion,BP,ACTN3
5575,GO:1901135,0.992369336568622,0.03728770054512,2,19,carbohydrate derivative metabolic process,BP,ACTN3;GUCY1B3
3538,GO:0045787,0.994151776845942,0.0441957449911714,1,13,positive regulation of cell cycle,BP,FGF8
96,GO:0001558,0.994922542234675,0.0390152999851588,1,14,regulation of cell growth,BP,WNT3
1580,GO:0016049,0.994922542234675,0.0390152999851588,1,14,cell growth,BP,WNT3
1804,GO:0019901,0.996176120095388,0.0307350597972602,1,15,protein kinase binding,MF,AXIN1
1803,GO:0019900,0.997562677425163,0.0210955879332434,1,16,kinase binding,MF,AXIN1
4060,GO:0051017,0.999999999999999,0.117007230116796,0,6,actin filament bundle assembly,BP,
4734,GO:0061572,0.999999999999999,0.117007230116796,0,6,actin filament bundle organization,BP,
1,GO:0000002,1,0.707555965307343,0,1,mitochondrial genome maintenance,BP,
3,GO:0000018,1,0.670968878396742,0,1,regulation of DNA recombination,BP,
5,GO:0000045,1,0.683763673758394,0,1,autophagosome assembly,BP,
6,GO:0000060,1,0.326898220362506,0,3,protein import into nucleus, translocation,BP,
7,GO:0000070,1,0.669435136554984,0,1,mitotic sister chromatid segregation,BP,
9,GO:0000077,1,0.314799508098407,0,3,DNA damage checkpoint,BP,
10,GO:0000079,1,0.0906639759551637,0,6,regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
11,GO:0000082,1,0.0925903579721187,0,6,G1/S transition of mitotic cell cycle,BP,
12,GO:0000086,1,0.340411814541922,0,3,G2/M transition of mitotic cell cycle,BP,
13,GO:0000118,1,0.711607679660172,0,1,histone deacetylase complex,CC,
15,GO:0000132,1,0.638176348215889,0,1,establishment of mitotic spindle orientation,BP,
17,GO:0000145,1,0.683763673758394,0,1,exocyst,CC,
18,GO:0000146,1,0.71160840958516,0,1,microfilament motor activity,MF,
21,GO:0000155,1,0.703878036725278,0,1,phosphorelay sensor kinase activity,MF,
22,GO:0000160,1,0.703878036725278,0,1,phosphorelay signal transduction system,BP,
25,GO:0000185,1,0.65849546242005,0,1,activation of MAPKKK activity,BP,
31,GO:0000228,1,0.711607679660172,0,1,nuclear chromosome,CC,
32,GO:0000242,1,0.671686436715183,0,1,pericentriolar material,CC,
33,GO:0000271,1,0.337380714589545,0,3,polysaccharide biosynthetic process,BP,
36,GO:0000281,1,0.711607690438396,0,1,mitotic cytokinesis,BP,
41,GO:0000307,1,0.68226354479179,0,1,cyclin-dependent protein kinase holoenzyme complex,CC,
44,GO:0000785,1,0.483175951029054,0,2,chromatin,CC,
45,GO:0000790,1,0.711607679660172,0,1,nuclear chromatin,CC,
46,GO:0000803,1,0.711607679660172,0,1,sex chromosome,CC,
47,GO:0000805,1,0.711607679660172,0,1,X chromosome,CC,
48,GO:0000806,1,0.711607679660172,0,1,Y chromosome,CC,
49,GO:0000819,1,0.669435136554984,0,1,sister chromatid segregation,BP,
52,GO:0000910,1,0.332197862427689,0,3,cytokinesis,BP,
53,GO:0000922,1,0.442915136134253,0,2,spindle pole,CC,
54,GO:0000930,1,0.476963810816204,0,2,gamma-tubulin complex,CC,
56,GO:0000976,1,0.704630629043406,0,1,transcription regulatory region sequence-specific DNA binding,MF,
57,GO:0000977,1,0.704630629043406,0,1,RNA polymerase II regulatory region sequence-specific DNA binding,MF,
58,GO:0000979,1,0.704630629043406,0,1,RNA polymerase II core promoter sequence-specific DNA binding,MF,
60,GO:0000982,1,0.49293047547578,0,2,transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding,MF,
64,GO:0001012,1,0.704630629043406,0,1,RNA polymerase II regulatory region DNA binding,MF,
65,GO:0001046,1,0.704630629043406,0,1,core promoter sequence-specific DNA binding,MF,
70,GO:0001077,1,0.700771912592825,0,1,transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,MF,
71,GO:0001078,1,0.704630629043406,0,1,transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,MF,
72,GO:0001085,1,0.704630629043406,0,1,RNA polymerase II transcription factor binding,MF,
74,GO:0001102,1,0.704630629043406,0,1,RNA polymerase II activating transcription factor binding,MF,
78,GO:0001134,1,0.710496861605038,0,1,transcription factor activity, transcription factor recruiting,MF,
79,GO:0001135,1,0.710496861605038,0,1,transcription factor activity, RNA polymerase II transcription factor recruiting,MF,
82,GO:0001227,1,0.704630629043406,0,1,transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,MF,
83,GO:0001228,1,0.700771912592825,0,1,transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,MF,
89,GO:0001508,1,0.500046681553418,0,2,action potential,BP,
90,GO:0001516,1,0.454640015942075,0,2,prostaglandin biosynthetic process,BP,
91,GO:0001523,1,0.482464068940171,0,2,retinoid metabolic process,BP,
95,GO:0001556,1,0.631393261474434,0,1,oocyte maturation,BP,
101,GO:0001573,1,0.711609191793077,0,1,ganglioside metabolic process,BP,
102,GO:0001578,1,0.475483776745667,0,2,microtubule bundle formation,BP,
103,GO:0001609,1,0.697657324108981,0,1,G-protein coupled adenosine receptor activity,MF,
104,GO:0001618,1,0.176617621070822,0,5,virus receptor activity,MF,
106,GO:0001653,1,0.711314340107367,0,1,peptide receptor activity,MF,
112,GO:0001659,1,0.697657324108981,0,1,temperature homeostasis,BP,
117,GO:0001676,1,0.476306577864902,0,2,long-chain fatty acid metabolic process,BP,
133,GO:0001741,1,0.711607679660172,0,1,XY body,CC,
136,GO:0001754,1,0.71160840958516,0,1,eye photoreceptor cell differentiation,BP,
139,GO:0001757,1,0.705560336344585,0,1,somite specification,BP,
142,GO:0001764,1,0.49028139434236,0,2,neuron migration,BP,
143,GO:0001771,1,0.710730522233721,0,1,immunological synapse formation,BP,
146,GO:0001779,1,0.489639053392843,0,2,natural killer cell differentiation,BP,
147,GO:0001780,1,0.503635292870167,0,2,neutrophil homeostasis,BP,
148,GO:0001784,1,0.504859652900128,0,2,phosphotyrosine binding,MF,
154,GO:0001821,1,0.679378706287525,0,1,histamine secretion,BP,
176,GO:0001906,1,0.471511044262042,0,2,cell killing,BP,
177,GO:0001909,1,0.696889228938764,0,1,leukocyte mediated cytotoxicity,BP,
178,GO:0001913,1,0.696889228938764,0,1,T cell mediated cytotoxicity,BP,
179,GO:0001917,1,0.71160840958516,0,1,photoreceptor inner segment,CC,
180,GO:0001927,1,0.683763673758394,0,1,exocyst assembly,BP,
181,GO:0001928,1,0.683763673758394,0,1,regulation of exocyst assembly,BP,
182,GO:0001931,1,0.710730522233721,0,1,uropod,CC,
192,GO:0001945,1,0.711472849595939,0,1,lymph vessel development,BP,
195,GO:0001952,1,0.168748071073805,0,5,regulation of cell-matrix adhesion,BP,
196,GO:0001953,1,0.711607815446889,0,1,negative regulation of cell-matrix adhesion,BP,
197,GO:0001954,1,0.491225090785894,0,2,positive regulation of cell-matrix adhesion,BP,
199,GO:0001959,1,0.331829540618339,0,3,regulation of cytokine-mediated signaling pathway,BP,
200,GO:0001960,1,0.690185661474723,0,1,negative regulation of cytokine-mediated signaling pathway,BP,
201,GO:0001961,1,0.331829540618339,0,3,positive regulation of cytokine-mediated signaling pathway,BP,
204,GO:0001972,1,0.685229321173304,0,1,retinoic acid binding,MF,
205,GO:0001973,1,0.697657324108981,0,1,adenosine receptor signaling pathway,BP,
207,GO:0001977,1,0.334465312572382,0,3,renal system process involved in regulation of blood volume,BP,
208,GO:0001990,1,0.679378706287525,0,1,regulation of systemic arterial blood pressure by hormone,BP,
211,GO:0002020,1,0.48674676888633,0,2,protease binding,MF,
212,GO:0002026,1,0.677890918061584,0,1,regulation of the force of heart contraction,BP,
226,GO:0002069,1,0.68226354479179,0,1,columnar/cuboidal epithelial cell maturation,BP,
227,GO:0002070,1,0.68226354479179,0,1,epithelial cell maturation,BP,
228,GO:0002072,1,0.711607822536356,0,1,optic cup morphogenesis involved in camera-type eye development,BP,
229,GO:0002080,1,0.685229321173304,0,1,acrosomal membrane,CC,
232,GO:0002087,1,0.697657324108981,0,1,regulation of respiratory gaseous exchange by neurological system process,BP,
235,GO:0002093,1,0.71160840958516,0,1,auditory receptor cell morphogenesis,BP,
237,GO:0002139,1,0.71160840958516,0,1,stereocilia coupling link,CC,
238,GO:0002140,1,0.71160840958516,0,1,stereocilia tip link,CC,
239,GO:0002159,1,0.697167990491339,0,1,desmosome assembly,BP,
241,GO:0002200,1,0.670968878396742,0,1,somatic diversification of immune receptors,BP,
242,GO:0002204,1,0.670968878396742,0,1,somatic recombination of immunoglobulin genes involved in immune response,BP,
243,GO:0002208,1,0.670968878396742,0,1,somatic diversification of immunoglobulins involved in immune response,BP,
246,GO:0002221,1,0.710679261468123,0,1,pattern recognition receptor signaling pathway,BP,
248,GO:0002224,1,0.710679261468123,0,1,toll-like receptor signaling pathway,BP,
249,GO:0002228,1,0.696889228938764,0,1,natural killer cell mediated immunity,BP,
253,GO:0002251,1,0.674513600005999,0,1,organ or tissue specific immune response,BP,
263,GO:0002285,1,0.22991198026167,0,4,lymphocyte activation involved in immune response,BP,
264,GO:0002286,1,0.490188373555856,0,2,T cell activation involved in immune response,BP,
265,GO:0002287,1,0.704630629043406,0,1,alpha-beta T cell activation involved in immune response,BP,
266,GO:0002292,1,0.704630629043406,0,1,T cell differentiation involved in immune response,BP,
267,GO:0002293,1,0.704630629043406,0,1,alpha-beta T cell differentiation involved in immune response,BP,
268,GO:0002294,1,0.704630629043406,0,1,CD4-positive, alpha-beta T cell differentiation involved in immune response,BP,
269,GO:0002295,1,0.704630629043406,0,1,T-helper cell lineage commitment,BP,
270,GO:0002312,1,0.472509401559609,0,2,B cell activation involved in immune response,BP,
271,GO:0002313,1,0.705560336344585,0,1,mature B cell differentiation involved in immune response,BP,
272,GO:0002315,1,0.705560336344585,0,1,marginal zone B cell differentiation,BP,
273,GO:0002318,1,0.709095041154607,0,1,myeloid progenitor cell differentiation,BP,
275,GO:0002323,1,0.696889228938764,0,1,natural killer cell activation involved in immune response,BP,
277,GO:0002335,1,0.705560336344585,0,1,mature B cell differentiation,BP,
278,GO:0002360,1,0.704630629043406,0,1,T cell lineage commitment,BP,
279,GO:0002363,1,0.704630629043406,0,1,alpha-beta T cell lineage commitment,BP,
281,GO:0002367,1,0.331096908248864,0,3,cytokine production involved in immune response,BP,
282,GO:0002374,1,0.711607822536356,0,1,cytokine secretion involved in immune response,BP,
284,GO:0002377,1,0.670968878396742,0,1,immunoglobulin production,BP,
285,GO:0002381,1,0.670968878396742,0,1,immunoglobulin production involved in immunoglobulin mediated immune response,BP,
286,GO:0002385,1,0.674513600005999,0,1,mucosal immune response,BP,
287,GO:0002386,1,0.674513600005999,0,1,immune response in mucosal-associated lymphoid tissue,BP,
289,GO:0002414,1,0.674513600005999,0,1,immunoglobulin transcytosis in epithelial cells,BP,
290,GO:0002415,1,0.674513600005999,0,1,immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor,BP,
295,GO:0002440,1,0.220825382965369,0,4,production of molecular mediator of immune response,BP,
300,GO:0002449,1,0.466676579436138,0,2,lymphocyte mediated immunity,BP,
301,GO:0002456,1,0.696889228938764,0,1,T cell mediated immunity,BP,
303,GO:0002474,1,0.706386167461074,0,1,antigen processing and presentation of peptide antigen via MHC class I,BP,
304,GO:0002478,1,0.706386167461074,0,1,antigen processing and presentation of exogenous peptide antigen,BP,
305,GO:0002479,1,0.706386167461074,0,1,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,BP,
308,GO:0002523,1,0.709095041154607,0,1,leukocyte migration involved in inflammatory response,BP,
310,GO:0002544,1,0.670588974535174,0,1,chronic inflammatory response,BP,
312,GO:0002551,1,0.677890918061584,0,1,mast cell chemotaxis,BP,
313,GO:0002562,1,0.670968878396742,0,1,somatic diversification of immune receptors via germline recombination within a single locus,BP,
316,GO:0002637,1,0.670968878396742,0,1,regulation of immunoglobulin production,BP,
317,GO:0002639,1,0.670968878396742,0,1,positive regulation of immunoglobulin production,BP,
319,GO:0002674,1,0.697657324108981,0,1,negative regulation of acute inflammatory response,BP,
326,GO:0002686,1,0.697657324108981,0,1,negative regulation of leukocyte migration,BP,
328,GO:0002688,1,0.234055327028265,0,4,regulation of leukocyte chemotaxis,BP,
329,GO:0002690,1,0.331829540618339,0,3,positive regulation of leukocyte chemotaxis,BP,
333,GO:0002697,1,0.476577572228343,0,2,regulation of immune effector process,BP,
334,GO:0002699,1,0.476577572228343,0,2,positive regulation of immune effector process,BP,
335,GO:0002700,1,0.476577572228343,0,2,regulation of production of molecular mediator of immune response,BP,
336,GO:0002702,1,0.476577572228343,0,2,positive regulation of production of molecular mediator of immune response,BP,
337,GO:0002703,1,0.670968878396742,0,1,regulation of leukocyte mediated immunity,BP,
338,GO:0002705,1,0.670968878396742,0,1,positive regulation of leukocyte mediated immunity,BP,
339,GO:0002706,1,0.670968878396742,0,1,regulation of lymphocyte mediated immunity,BP,
340,GO:0002708,1,0.670968878396742,0,1,positive regulation of lymphocyte mediated immunity,BP,
341,GO:0002712,1,0.670968878396742,0,1,regulation of B cell mediated immunity,BP,
342,GO:0002714,1,0.670968878396742,0,1,positive regulation of B cell mediated immunity,BP,
343,GO:0002718,1,0.711607822536356,0,1,regulation of cytokine production involved in immune response,BP,
344,GO:0002720,1,0.711607822536356,0,1,positive regulation of cytokine production involved in immune response,BP,
345,GO:0002739,1,0.711607822536356,0,1,regulation of cytokine secretion involved in immune response,BP,
346,GO:0002741,1,0.711607822536356,0,1,positive regulation of cytokine secretion involved in immune response,BP,
351,GO:0002763,1,0.504767447620671,0,2,positive regulation of myeloid leukocyte differentiation,BP,
358,GO:0002819,1,0.670968878396742,0,1,regulation of adaptive immune response,BP,
359,GO:0002821,1,0.670968878396742,0,1,positive regulation of adaptive immune response,BP,
360,GO:0002822,1,0.670968878396742,0,1,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
361,GO:0002824,1,0.670968878396742,0,1,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
364,GO:0002889,1,0.670968878396742,0,1,regulation of immunoglobulin mediated immune response,BP,
365,GO:0002891,1,0.670968878396742,0,1,positive regulation of immunoglobulin mediated immune response,BP,
367,GO:0002934,1,0.697167990491339,0,1,desmosome organization,BP,
378,GO:0003018,1,0.0296337644744816,0,9,vascular process in circulatory system,BP,
379,GO:0003044,1,0.679378706287525,0,1,regulation of systemic arterial blood pressure mediated by a chemical signal,BP,
380,GO:0003062,1,0.703878036725278,0,1,regulation of heart rate by chemical signal,BP,
381,GO:0003064,1,0.703878036725278,0,1,regulation of heart rate by hormone,BP,
382,GO:0003071,1,0.334465312572382,0,3,renal system process involved in regulation of systemic arterial blood pressure,BP,
385,GO:0003091,1,0.490299181600157,0,2,renal water homeostasis,BP,
386,GO:0003093,1,0.334465312572382,0,3,regulation of glomerular filtration,BP,
387,GO:0003094,1,0.334465312572382,0,3,glomerular filtration,BP,
389,GO:0003100,1,0.679378706287525,0,1,regulation of systemic arterial blood pressure by endothelin,BP,
390,GO:0003104,1,0.481161166557901,0,2,positive regulation of glomerular filtration,BP,
412,GO:0003175,1,0.704630629043406,0,1,tricuspid valve development,BP,
420,GO:0003186,1,0.704630629043406,0,1,tricuspid valve morphogenesis,BP,
424,GO:0003195,1,0.704630629043406,0,1,tricuspid valve formation,BP,
450,GO:0003274,1,0.699990571588227,0,1,endocardial cushion fusion,BP,
453,GO:0003283,1,0.49237865723648,0,2,atrial septum development,BP,
454,GO:0003284,1,0.699990571588227,0,1,septum primum development,BP,
455,GO:0003289,1,0.699990571588227,0,1,atrial septum primum morphogenesis,BP,
456,GO:0003298,1,0.679378706287525,0,1,physiological muscle hypertrophy,BP,
457,GO:0003300,1,0.679378706287525,0,1,cardiac muscle hypertrophy,BP,
458,GO:0003301,1,0.679378706287525,0,1,physiological cardiac muscle hypertrophy,BP,
459,GO:0003306,1,0.49955708558941,0,2,Wnt signaling pathway involved in heart development,BP,
460,GO:0003307,1,0.703191446152061,0,1,regulation of Wnt signaling pathway involved in heart development,BP,
461,GO:0003308,1,0.703191446152061,0,1,negative regulation of Wnt signaling pathway involved in heart development,BP,
470,GO:0003382,1,0.656110163418443,0,1,epithelial cell morphogenesis,BP,
472,GO:0003402,1,0.711607822536356,0,1,planar cell polarity pathway involved in axis elongation,BP,
473,GO:0003408,1,0.711607822536356,0,1,optic cup formation involved in camera-type eye development,BP,
474,GO:0003413,1,0.631393261474434,0,1,chondrocyte differentiation involved in endochondral bone morphogenesis,BP,
475,GO:0003416,1,0.631393261474434,0,1,endochondral bone growth,BP,
476,GO:0003417,1,0.631393261474434,0,1,growth plate cartilage development,BP,
477,GO:0003418,1,0.631393261474434,0,1,growth plate cartilage chondrocyte differentiation,BP,
478,GO:0003419,1,0.631393261474434,0,1,growth plate cartilage chondrocyte proliferation,BP,
490,GO:0003723,1,0.336964215343246,0,3,RNA binding,MF,
491,GO:0003725,1,0.710730522233721,0,1,double-stranded RNA binding,MF,
492,GO:0003774,1,0.358582568008822,0,3,motor activity,MF,
496,GO:0003873,1,0.711537687634486,0,1,6-phosphofructo-2-kinase activity,MF,
498,GO:0004112,1,0.711421550449818,0,1,cyclic-nucleotide phosphodiesterase activity,MF,
499,GO:0004114,1,0.711421550449818,0,1,3',5'-cyclic-nucleotide phosphodiesterase activity,MF,
500,GO:0004115,1,0.711421550449818,0,1,3',5'-cyclic-AMP phosphodiesterase activity,MF,
503,GO:0004331,1,0.711537687634486,0,1,fructose-2,6-bisphosphate 2-phosphatase activity,MF,
505,GO:0004379,1,0.711607661943626,0,1,glycylpeptide N-tetradecanoyltransferase activity,MF,
507,GO:0004407,1,0.711607679660172,0,1,histone deacetylase activity,MF,
508,GO:0004421,1,0.687664047662032,0,1,hydroxymethylglutaryl-CoA synthase activity,MF,
509,GO:0004454,1,0.687957943572463,0,1,ketohexokinase activity,MF,
510,GO:0004467,1,0.711607686616218,0,1,long-chain fatty acid-CoA ligase activity,MF,
512,GO:0004620,1,0.697657324108981,0,1,phospholipase activity,MF,
513,GO:0004629,1,0.697657324108981,0,1,phospholipase C activity,MF,
515,GO:0004673,1,0.703878036725278,0,1,protein histidine kinase activity,MF,
517,GO:0004675,1,0.699990571588227,0,1,transmembrane receptor protein serine/threonine kinase activity,MF,
518,GO:0004690,1,0.711582810605101,0,1,cyclic nucleotide-dependent protein kinase activity,MF,
519,GO:0004691,1,0.711582810605101,0,1,cAMP-dependent protein kinase activity,MF,
523,GO:0004709,1,0.689742136494387,0,1,MAP kinase kinase kinase activity,MF,
524,GO:0004712,1,0.698158470740301,0,1,protein serine/threonine/tyrosine kinase activity,MF,
526,GO:0004714,1,0.503838101621859,0,2,transmembrane receptor protein tyrosine kinase activity,MF,
527,GO:0004716,1,0.710679261468123,0,1,signal transducer, downstream of receptor, with protein tyrosine kinase activity,MF,
530,GO:0004745,1,0.703191446152061,0,1,retinol dehydrogenase activity,MF,
533,GO:0004860,1,0.470013986237748,0,2,protein kinase inhibitor activity,MF,
534,GO:0004861,1,0.68226354479179,0,1,cyclin-dependent protein serine/threonine kinase inhibitor activity,MF,
535,GO:0004862,1,0.690234710370884,0,1,cAMP-dependent protein kinase inhibitor activity,MF,
537,GO:0004867,1,0.685229321173304,0,1,serine-type endopeptidase inhibitor activity,MF,
538,GO:0004869,1,0.445797749620357,0,2,cysteine-type endopeptidase inhibitor activity,MF,
544,GO:0004935,1,0.475084646317265,0,2,adrenergic receptor activity,MF,
545,GO:0004936,1,0.475084646317265,0,2,alpha-adrenergic receptor activity,MF,
546,GO:0004938,1,0.475084646317265,0,2,alpha2-adrenergic receptor activity,MF,
547,GO:0005024,1,0.699990571588227,0,1,transforming growth factor beta-activated receptor activity,MF,
548,GO:0005025,1,0.699990571588227,0,1,transforming growth factor beta receptor activity, type I,MF,
550,GO:0005068,1,0.711607815446889,0,1,transmembrane receptor protein tyrosine kinase adaptor activity,MF,
551,GO:0005080,1,0.482700003015465,0,2,protein kinase C binding,MF,
554,GO:0005092,1,0.342600383863221,0,3,GDP-dissociation inhibitor activity,MF,
560,GO:0005110,1,0.711607822536356,0,1,frizzled-2 binding,MF,
563,GO:0005113,1,0.674696332807623,0,1,patched binding,MF,
564,GO:0005115,1,0.711607822536356,0,1,receptor tyrosine kinase-like orphan receptor binding,MF,
567,GO:0005127,1,0.670968878396742,0,1,ciliary neurotrophic factor receptor binding,MF,
568,GO:0005146,1,0.710496861605038,0,1,leukemia inhibitory factor receptor binding,MF,
569,GO:0005154,1,0.487461673608161,0,2,epidermal growth factor receptor binding,MF,
570,GO:0005158,1,0.711607815446889,0,1,insulin receptor binding,MF,
571,GO:0005159,1,0.711607815446889,0,1,insulin-like growth factor receptor binding,MF,
573,GO:0005161,1,0.496027967738809,0,2,platelet-derived growth factor receptor binding,MF,
574,GO:0005165,1,0.711607815446889,0,1,neurotrophin receptor binding,MF,
575,GO:0005167,1,0.711607815446889,0,1,neurotrophin TRK receptor binding,MF,
576,GO:0005168,1,0.711607815446889,0,1,neurotrophin TRKA receptor binding,MF,
577,GO:0005172,1,0.711422189054973,0,1,vascular endothelial growth factor receptor binding,MF,
578,GO:0005173,1,0.711607721708387,0,1,stem cell factor receptor binding,MF,
583,GO:0005201,1,0.478474823672142,0,2,extracellular matrix structural constituent,MF,
586,GO:0005225,1,0.677010844857903,0,1,volume-sensitive anion channel activity,MF,
590,GO:0005245,1,0.690185661474723,0,1,voltage-gated calcium channel activity,MF,
593,GO:0005250,1,0.711607634773957,0,1,A-type (transient outward) potassium channel activity,MF,
595,GO:0005253,1,0.677010844857903,0,1,anion channel activity,MF,
596,GO:0005254,1,0.677010844857903,0,1,chloride channel activity,MF,
598,GO:0005262,1,0.690185661474723,0,1,calcium channel activity,MF,
600,GO:0005351,1,0.706362630533194,0,1,sugar:proton symporter activity,MF,
603,GO:0005402,1,0.706362630533194,0,1,cation:sugar symporter activity,MF,
604,GO:0005484,1,0.695414751519134,0,1,SNAP receptor activity,MF,
608,GO:0005501,1,0.685229321173304,0,1,retinoid binding,MF,
610,GO:0005507,1,0.710726924865214,0,1,copper ion binding,MF,
612,GO:0005513,1,0.694780337175533,0,1,detection of calcium ion,BP,
614,GO:0005516,1,0.232034160565795,0,4,calmodulin binding,MF,
615,GO:0005518,1,0.351145851209939,0,3,collagen binding,MF,
616,GO:0005520,1,0.487272532726164,0,2,insulin-like growth factor binding,MF,
618,GO:0005522,1,0.711596825427955,0,1,profilin binding,MF,
622,GO:0005540,1,0.673627701183849,0,1,hyaluronic acid binding,MF,
627,GO:0005547,1,0.698158470740301,0,1,phosphatidylinositol-3,4,5-trisphosphate binding,MF,
628,GO:0005575,1,0.300009428411778,73,240,cellular_component,CC,MAGEC2;SLC2A14;TJP3;GLDC;RHPN1;SCIN;TLE1;WNT7A;GJB2;PIK3CG;SYT5;ACTN3;CLDN18;RHBDL3;RABIF;MBOAT2;GJA3;BMP6;WNT3;HEY1;GJB6;WNT7B;JAG2;PMAIP1;KCNG2;AXIN1;POU3F1;MAPK12;WNT2;CDH1;SPTBN5;RAB40B;RAB39A;SPTB;RRAS2;FZD7;FGF8;VDR;CRB2;ARTN;DSG3;AMOT;WNT5B;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;FGF17;TSPAN15;HRAS;BMP4;RAB3D;KCNK6;CLDN15;GDNF;RNF144A;RAB38;PIK3CA;BMP7;DRP2;FSTL3;TMEM206;TPD52;SPTBN4;TSPAN13;NOTCH1;RND3;PNMT;RAB20;GUCY1B3;TF
631,GO:0005604,1,0.505563592135265,0,2,basement membrane,CC,
632,GO:0005605,1,0.505563592135265,0,2,basal lamina,CC,
633,GO:0005606,1,0.71160970801114,0,1,laminin-1 complex,CC,
634,GO:0005608,1,0.71160970801114,0,1,laminin-3 complex,CC,
635,GO:0005610,1,0.711611103298453,0,1,laminin-5 complex,CC,
641,GO:0005641,1,0.670588974535174,0,1,nuclear envelope lumen,CC,
644,GO:0005694,1,0.483175951029054,0,2,chromosome,CC,
650,GO:0005743,1,0.335433693898434,0,3,mitochondrial inner membrane,CC,
658,GO:0005771,1,0.696889228938764,0,1,multivesicular body,CC,
661,GO:0005775,1,0.692648698175897,0,1,vacuolar lumen,CC,
662,GO:0005776,1,0.464378350446325,0,2,autophagosome,CC,
663,GO:0005777,1,0.711607686616218,0,1,peroxisome,CC,
664,GO:0005778,1,0.711607686616218,0,1,peroxisomal membrane,CC,
668,GO:0005790,1,0.677010844857903,0,1,smooth endoplasmic reticulum,CC,
669,GO:0005791,1,0.679378706287525,0,1,rough endoplasmic reticulum,CC,
673,GO:0005798,1,0.711596825427955,0,1,Golgi-associated vesicle,CC,
674,GO:0005801,1,0.487272544640499,0,2,cis-Golgi network,CC,
676,GO:0005811,1,0.711607686616218,0,1,lipid particle,CC,
677,GO:0005813,1,0.0758409328827827,0,7,centrosome,CC,
678,GO:0005815,1,0.0366605456334421,0,9,microtubule organizing center,CC,
679,GO:0005819,1,0.205574466533825,0,4,spindle,CC,
682,GO:0005859,1,0.711608210494458,0,1,muscle myosin complex,CC,
683,GO:0005865,1,0.711607656239832,0,1,striated muscle thin filament,CC,
685,GO:0005876,1,0.448692578745972,0,2,spindle microtubule,CC,
691,GO:0005891,1,0.493428569042605,0,2,voltage-gated calcium channel complex,CC,
693,GO:0005902,1,0.356318770885748,0,3,microvillus,CC,
699,GO:0005915,1,0.699990571588227,0,1,zonula adherens,CC,
700,GO:0005916,1,0.711526480882443,0,1,fascia adherens,CC,
711,GO:0005952,1,0.490299181600157,0,2,cAMP-dependent protein kinase complex,CC,
714,GO:0005976,1,0.337380714589545,0,3,polysaccharide metabolic process,BP,
715,GO:0005977,1,0.698158470740301,0,1,glycogen metabolic process,BP,
716,GO:0005978,1,0.698158470740301,0,1,glycogen biosynthetic process,BP,
717,GO:0005979,1,0.698158470740301,0,1,regulation of glycogen biosynthetic process,BP,
719,GO:0006000,1,0.488644424135502,0,2,fructose metabolic process,BP,
720,GO:0006001,1,0.687957943572463,0,1,fructose catabolic process,BP,
721,GO:0006003,1,0.711537687634486,0,1,fructose 2,6-bisphosphate metabolic process,BP,
724,GO:0006022,1,0.232398870018334,0,4,aminoglycan metabolic process,BP,
725,GO:0006023,1,0.334696153183195,0,3,aminoglycan biosynthetic process,BP,
726,GO:0006024,1,0.334696153183195,0,3,glycosaminoglycan biosynthetic process,BP,
727,GO:0006026,1,0.692648698175897,0,1,aminoglycan catabolic process,BP,
728,GO:0006027,1,0.692648698175897,0,1,glycosaminoglycan catabolic process,BP,
729,GO:0006029,1,0.703191446152061,0,1,proteoglycan metabolic process,BP,
731,GO:0006073,1,0.698158470740301,0,1,cellular glucan metabolic process,BP,
737,GO:0006094,1,0.707555965307343,0,1,gluconeogenesis,BP,
741,GO:0006111,1,0.707555965307343,0,1,regulation of gluconeogenesis,BP,
742,GO:0006112,1,0.698158470740301,0,1,energy reserve metabolic process,BP,
750,GO:0006171,1,0.679378706287525,0,1,cAMP biosynthetic process,BP,
752,GO:0006195,1,0.711421550449818,0,1,purine nucleotide catabolic process,BP,
753,GO:0006198,1,0.711421550449818,0,1,cAMP catabolic process,BP,
758,GO:0006281,1,0.419210308550496,0,2,DNA repair,BP,
759,GO:0006282,1,0.638176348215889,0,1,regulation of DNA repair,BP,
763,GO:0006310,1,0.670968878396742,0,1,DNA recombination,BP,
764,GO:0006325,1,0.239794411893466,0,4,chromatin organization,BP,
770,GO:0006359,1,0.69495645939892,0,1,regulation of transcription from RNA polymerase III promoter,BP,
774,GO:0006383,1,0.69495645939892,0,1,transcription from RNA polymerase III promoter,BP,
780,GO:0006457,1,0.631393261474434,0,1,protein folding,BP,
783,GO:0006465,1,0.690185661474723,0,1,signal peptide processing,BP,
787,GO:0006473,1,0.710496861605038,0,1,protein acetylation,BP,
788,GO:0006475,1,0.710496861605038,0,1,internal protein amino acid acetylation,BP,
789,GO:0006476,1,0.711607679660172,0,1,protein deacetylation,BP,
791,GO:0006486,1,0.695652466100109,0,1,protein glycosylation,BP,
792,GO:0006493,1,0.695652466100109,0,1,protein O-linked glycosylation,BP,
793,GO:0006497,1,0.504931496213516,0,2,protein lipidation,BP,
794,GO:0006498,1,0.711607661943626,0,1,N-terminal protein lipidation,BP,
795,GO:0006499,1,0.711607661943626,0,1,N-terminal protein myristoylation,BP,
796,GO:0006501,1,0.710726924865214,0,1,C-terminal protein lipidation,BP,
803,GO:0006582,1,0.711607822536356,0,1,melanin metabolic process,BP,
807,GO:0006611,1,0.690185661474723,0,1,protein export from nucleus,BP,
808,GO:0006612,1,0.480629777515163,0,2,protein targeting to membrane,BP,
810,GO:0006631,1,0.157194663000517,0,5,fatty acid metabolic process,BP,
811,GO:0006633,1,0.454640015942075,0,2,fatty acid biosynthetic process,BP,
812,GO:0006635,1,0.493131944016563,0,2,fatty acid beta-oxidation,BP,
813,GO:0006636,1,0.454640015942075,0,2,unsaturated fatty acid biosynthetic process,BP,
814,GO:0006637,1,0.711607686616218,0,1,acyl-CoA metabolic process,BP,
818,GO:0006643,1,0.711609191793077,0,1,membrane lipid metabolic process,BP,
822,GO:0006664,1,0.711609191793077,0,1,glycolipid metabolic process,BP,
823,GO:0006665,1,0.711609191793077,0,1,sphingolipid metabolic process,BP,
824,GO:0006672,1,0.711609191793077,0,1,ceramide metabolic process,BP,
825,GO:0006687,1,0.711609191793077,0,1,glycosphingolipid metabolic process,BP,
826,GO:0006690,1,0.454640015942075,0,2,icosanoid metabolic process,BP,
827,GO:0006692,1,0.454640015942075,0,2,prostanoid metabolic process,BP,
828,GO:0006693,1,0.454640015942075,0,2,prostaglandin metabolic process,BP,
830,GO:0006695,1,0.687664047662032,0,1,cholesterol biosynthetic process,BP,
832,GO:0006702,1,0.710436959244465,0,1,androgen biosynthetic process,BP,
833,GO:0006704,1,0.345758439334557,0,3,glucocorticoid biosynthetic process,BP,
835,GO:0006720,1,0.330531029479996,0,3,isoprenoid metabolic process,BP,
836,GO:0006721,1,0.482464068940171,0,2,terpenoid metabolic process,BP,
841,GO:0006735,1,0.711537687634486,0,1,NADH regeneration,BP,
845,GO:0006767,1,0.699990571588227,0,1,water-soluble vitamin metabolic process,BP,
846,GO:0006771,1,0.699990571588227,0,1,riboflavin metabolic process,BP,
848,GO:0006790,1,0.494180193759542,0,2,sulfur compound metabolic process,BP,
853,GO:0006809,1,0.4734145790807,0,2,nitric oxide biosynthetic process,BP,
863,GO:0006835,1,0.697657324108981,0,1,dicarboxylic acid transport,BP,
866,GO:0006862,1,0.66612845920437,0,1,nucleotide transport,BP,
867,GO:0006865,1,0.697657324108981,0,1,amino acid transport,BP,
872,GO:0006878,1,0.710726924865214,0,1,cellular copper ion homeostasis,BP,
878,GO:0006890,1,0.701975889304016,0,1,retrograde vesicle-mediated transport, Golgi to ER,BP,
879,GO:0006891,1,0.701975889304016,0,1,intra-Golgi vesicle-mediated transport,BP,
886,GO:0006910,1,0.674176169736539,0,1,phagocytosis, recognition,BP,
887,GO:0006911,1,0.674176169736539,0,1,phagocytosis, engulfment,BP,
892,GO:0006924,1,0.698158470740301,0,1,activation-induced cell death of T cells,BP,
898,GO:0006940,1,0.223036270928665,0,4,regulation of smooth muscle contraction,BP,
906,GO:0006970,1,0.706809127351861,0,1,response to osmotic stress,BP,
907,GO:0006972,1,0.706809127351861,0,1,hyperosmotic response,BP,
910,GO:0006977,1,0.448309892774536,0,2,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,BP,
911,GO:0006978,1,0.68226354479179,0,1,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
913,GO:0006986,1,0.711607815446889,0,1,response to unfolded protein,BP,
922,GO:0007020,1,0.671686436715183,0,1,microtubule nucleation,BP,
923,GO:0007029,1,0.709685678742096,0,1,endoplasmic reticulum organization,BP,
925,GO:0007032,1,0.696889228938764,0,1,endosome organization,BP,
935,GO:0007051,1,0.669435136554984,0,1,spindle organization,BP,
936,GO:0007052,1,0.669435136554984,0,1,mitotic spindle organization,BP,
937,GO:0007059,1,0.669435136554984,0,1,chromosome segregation,BP,
939,GO:0007080,1,0.669435136554984,0,1,mitotic metaphase plate congression,BP,
942,GO:0007095,1,0.70489454545713,0,1,mitotic G2 DNA damage checkpoint,BP,
943,GO:0007098,1,0.461323785968984,0,2,centrosome cycle,BP,
944,GO:0007126,1,0.242367556374041,0,4,meiotic nuclear division,BP,
945,GO:0007140,1,0.681813936391074,0,1,male meiosis,BP,
949,GO:0007157,1,0.505369503062055,0,2,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,BP,
958,GO:0007168,1,0.448174318882941,0,2,receptor guanylyl cyclase signaling pathway,BP,
961,GO:0007176,1,0.33022401942811,0,3,regulation of epidermal growth factor-activated receptor activity,BP,
963,GO:0007179,1,0.0528101883558517,0,8,transforming growth factor beta receptor signaling pathway,BP,
967,GO:0007187,1,0.157227980833494,0,5,G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,BP,
968,GO:0007188,1,0.157227980833494,0,5,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,BP,
969,GO:0007189,1,0.320789697514815,0,3,adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
970,GO:0007193,1,0.697657324108981,0,1,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,BP,
971,GO:0007200,1,0.325864838090902,0,3,phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
972,GO:0007202,1,0.670757822166244,0,1,activation of phospholipase C activity,BP,
974,GO:0007205,1,0.679378706287525,0,1,protein kinase C-activating G-protein coupled receptor signaling pathway,BP,
978,GO:0007223,1,0.711607822536356,0,1,Wnt signaling pathway, calcium modulating pathway,BP,
980,GO:0007229,1,0.0397748106146122,0,9,integrin-mediated signaling pathway,BP,
982,GO:0007252,1,0.698158470740301,0,1,I-kappaB phosphorylation,BP,
986,GO:0007260,1,0.475830212370733,0,2,tyrosine phosphorylation of STAT protein,BP,
990,GO:0007266,1,0.327412203858665,0,3,Rho protein signal transduction,BP,
1000,GO:0007286,1,0.477535867819087,0,2,spermatid development,BP,
1002,GO:0007338,1,0.314082523784401,0,3,single fertilization,BP,
1003,GO:0007342,1,0.685229321173304,0,1,fusion of sperm to egg plasma membrane,BP,
1005,GO:0007350,1,0.497831450720574,0,2,blastoderm segmentation,BP,
1006,GO:0007351,1,0.497831450720574,0,2,tripartite regional subdivision,BP,
1007,GO:0007354,1,0.700771912592825,0,1,zygotic determination of anterior/posterior axis, embryo,BP,
1008,GO:0007356,1,0.700771912592825,0,1,thorax and anterior abdomen determination,BP,
1011,GO:0007379,1,0.705560336344585,0,1,segment specification,BP,
1027,GO:0007442,1,0.711607822536356,0,1,hindgut morphogenesis,BP,
1029,GO:0007494,1,0.711607822536356,0,1,midgut development,BP,
1035,GO:0007530,1,0.334065691668896,0,3,sex determination,BP,
1038,GO:0007566,1,0.503708276614129,0,2,embryo implantation,BP,
1039,GO:0007567,1,0.679378706287525,0,1,parturition,BP,
1045,GO:0007588,1,0.220758316119638,0,4,excretion,BP,
1052,GO:0007602,1,0.470949439797607,0,2,phototransduction,BP,
1053,GO:0007603,1,0.711607661943626,0,1,phototransduction, visible light,BP,
1055,GO:0007606,1,0.695652466100109,0,1,sensory perception of chemical stimulus,BP,
1056,GO:0007608,1,0.695652466100109,0,1,sensory perception of smell,BP,
1058,GO:0007611,1,0.162065629945992,0,5,learning or memory,BP,
1059,GO:0007612,1,0.471370569604883,0,2,learning,BP,
1060,GO:0007613,1,0.505427387247407,0,2,memory,BP,
1061,GO:0007622,1,0.697657324108981,0,1,rhythmic behavior,BP,
1062,GO:0007623,1,0.697657324108981,0,1,circadian rhythm,BP,
1065,GO:0007631,1,0.697818647628364,0,1,feeding behavior,BP,
1066,GO:0007638,1,0.697818647628364,0,1,mechanosensory behavior,BP,
1071,GO:0008017,1,0.165435058081434,0,5,microtubule binding,MF,
1074,GO:0008037,1,0.339154308848686,0,3,cell recognition,BP,
1078,GO:0008065,1,0.706809127351861,0,1,establishment of blood-nerve barrier,BP,
1082,GO:0008081,1,0.495479863548146,0,2,phosphoric diester hydrolase activity,MF,
1096,GO:0008194,1,0.695652466100109,0,1,UDP-glycosyltransferase activity,MF,
1102,GO:0008203,1,0.687664047662032,0,1,cholesterol metabolic process,BP,
1104,GO:0008209,1,0.710436959244465,0,1,androgen metabolic process,BP,
1105,GO:0008211,1,0.345758439334557,0,3,glucocorticoid metabolic process,BP,
1110,GO:0008227,1,0.475084646317265,0,2,G-protein coupled amine receptor activity,MF,
1113,GO:0008238,1,0.711607633995453,0,1,exopeptidase activity,MF,
1115,GO:0008277,1,0.156572058431646,0,5,regulation of G-protein coupled receptor protein signaling pathway,BP,
1121,GO:0008299,1,0.687664047662032,0,1,isoprenoid biosynthetic process,BP,
1122,GO:0008305,1,0.178106728317616,0,5,integrin complex,CC,
1125,GO:0008333,1,0.330598144768676,0,3,endosome to lysosome transport,BP,
1127,GO:0008360,1,0.225662547977405,0,4,regulation of cell shape,BP,
1131,GO:0008375,1,0.695652466100109,0,1,acetylglucosaminyltransferase activity,MF,
1132,GO:0008378,1,0.695652466100109,0,1,galactosyltransferase activity,MF,
1133,GO:0008380,1,0.497831445740628,0,2,RNA splicing,BP,
1135,GO:0008429,1,0.674176169736539,0,1,phosphatidylethanolamine binding,MF,
1137,GO:0008443,1,0.711537687634486,0,1,phosphofructokinase activity,MF,
1138,GO:0008499,1,0.695652466100109,0,1,UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,MF,
1139,GO:0008506,1,0.706362630533194,0,1,sucrose:proton symporter activity,MF,
1140,GO:0008509,1,0.677010844857903,0,1,anion transmembrane transporter activity,MF,
1141,GO:0008515,1,0.706362630533194,0,1,sucrose transmembrane transporter activity,MF,
1142,GO:0008528,1,0.711314340107367,0,1,G-protein coupled peptide receptor activity,MF,
1143,GO:0008532,1,0.695652466100109,0,1,N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity,MF,
1148,GO:0008589,1,0.453180014882102,0,2,regulation of smoothened signaling pathway,BP,
1150,GO:0008595,1,0.497831450720574,0,2,anterior/posterior axis specification, embryo,BP,
1151,GO:0008603,1,0.690234710370884,0,1,cAMP-dependent protein kinase regulator activity,MF,
1154,GO:0008630,1,0.484631874251242,0,2,intrinsic apoptotic signaling pathway in response to DNA damage,BP,
1155,GO:0008631,1,0.698158470740301,0,1,intrinsic apoptotic signaling pathway in response to oxidative stress,BP,
1167,GO:0009062,1,0.493131944016563,0,2,fatty acid catabolic process,BP,
1171,GO:0009100,1,0.236394734605609,0,4,glycoprotein metabolic process,BP,
1172,GO:0009101,1,0.337970283265086,0,3,glycoprotein biosynthetic process,BP,
1173,GO:0009108,1,0.711607686616218,0,1,coenzyme biosynthetic process,BP,
1175,GO:0009116,1,0.711596825427955,0,1,nucleoside metabolic process,BP,
1177,GO:0009119,1,0.711596825427955,0,1,ribonucleoside metabolic process,BP,
1186,GO:0009154,1,0.711421550449818,0,1,purine ribonucleotide catabolic process,BP,
1189,GO:0009166,1,0.711421550449818,0,1,nucleotide catabolic process,BP,
1197,GO:0009214,1,0.711421550449818,0,1,cyclic nucleotide catabolic process,BP,
1198,GO:0009250,1,0.698158470740301,0,1,glucan biosynthetic process,BP,
1201,GO:0009261,1,0.711421550449818,0,1,ribonucleotide catabolic process,BP,
1202,GO:0009266,1,0.230060145898686,0,4,response to temperature stimulus,BP,
1206,GO:0009408,1,0.331581846299223,0,3,response to heat,BP,
1207,GO:0009411,1,0.337131903553256,0,3,response to UV,BP,
1208,GO:0009416,1,0.156984658676643,0,5,response to light stimulus,BP,
1210,GO:0009581,1,0.327337852673526,0,3,detection of external stimulus,BP,
1211,GO:0009582,1,0.327337852673526,0,3,detection of abiotic stimulus,BP,
1212,GO:0009583,1,0.470949439797607,0,2,detection of light stimulus,BP,
1213,GO:0009584,1,0.711607661943626,0,1,detection of visible light,BP,
1214,GO:0009593,1,0.694780337175533,0,1,detection of chemical stimulus,BP,
1221,GO:0009620,1,0.677890918061584,0,1,response to fungus,BP,
1224,GO:0009651,1,0.706809127351861,0,1,response to salt stress,BP,
1231,GO:0009744,1,0.687957943572463,0,1,response to sucrose,BP,
1234,GO:0009750,1,0.687957943572463,0,1,response to fructose,BP,
1243,GO:0009886,1,0.71160840958516,0,1,post-embryonic animal morphogenesis,BP,
1260,GO:0009946,1,0.638176348215889,0,1,proximal/distal axis specification,BP,
1265,GO:0009954,1,0.449325693925487,0,2,proximal/distal pattern formation,BP,
1272,GO:0009988,1,0.710730522233721,0,1,cell-cell recognition,BP,
1283,GO:0010043,1,0.687957943572463,0,1,response to zinc ion,BP,
1286,GO:0010165,1,0.68226354479179,0,1,response to X-ray,BP,
1288,GO:0010193,1,0.679378706287525,0,1,response to ozone,BP,
1290,GO:0010224,1,0.68226354479179,0,1,response to UV-B,BP,
1294,GO:0010259,1,0.679378706287525,0,1,multicellular organism aging,BP,
1295,GO:0010288,1,0.706809127351861,0,1,response to lead ion,BP,
1296,GO:0010324,1,0.478864571687703,0,2,membrane invagination,BP,
1298,GO:0010385,1,0.700771912592825,0,1,double-stranded methylated DNA binding,MF,
1299,GO:0010389,1,0.70489454545713,0,1,regulation of G2/M transition of mitotic cell cycle,BP,
1303,GO:0010460,1,0.679378706287525,0,1,positive regulation of heart rate,BP,
1309,GO:0010469,1,0.11029118572543,0,6,regulation of receptor activity,BP,
1314,GO:0010508,1,0.156781013971651,0,5,positive regulation of autophagy,BP,
1315,GO:0010511,1,0.698425417725528,0,1,regulation of phosphatidylinositol biosynthetic process,BP,
1316,GO:0010512,1,0.698425417725528,0,1,negative regulation of phosphatidylinositol biosynthetic process,BP,
1317,GO:0010517,1,0.670757822166244,0,1,regulation of phospholipase activity,BP,
1318,GO:0010518,1,0.670757822166244,0,1,positive regulation of phospholipase activity,BP,
1319,GO:0010522,1,0.694780337175533,0,1,regulation of calcium ion transport into cytosol,BP,
1320,GO:0010523,1,0.694780337175533,0,1,negative regulation of calcium ion transport into cytosol,BP,
1321,GO:0010543,1,0.698425417725528,0,1,regulation of platelet activation,BP,
1322,GO:0010544,1,0.698425417725528,0,1,negative regulation of platelet activation,BP,
1326,GO:0010559,1,0.686410749449883,0,1,regulation of glycoprotein biosynthetic process,BP,
1327,GO:0010561,1,0.686410749449883,0,1,negative regulation of glycoprotein biosynthetic process,BP,
1340,GO:0010611,1,0.679378706287525,0,1,regulation of cardiac muscle hypertrophy,BP,
1341,GO:0010613,1,0.679378706287525,0,1,positive regulation of cardiac muscle hypertrophy,BP,
1342,GO:0010623,1,0.711607721708387,0,1,programmed cell death involved in cell development,BP,
1351,GO:0010640,1,0.698425417725528,0,1,regulation of platelet-derived growth factor receptor signaling pathway,BP,
1352,GO:0010642,1,0.698425417725528,0,1,negative regulation of platelet-derived growth factor receptor signaling pathway,BP,
1353,GO:0010644,1,0.694780337175533,0,1,cell communication by electrical coupling,BP,
1357,GO:0010649,1,0.694780337175533,0,1,regulation of cell communication by electrical coupling,BP,
1368,GO:0010700,1,0.475084646317265,0,2,negative regulation of norepinephrine secretion,BP,
1371,GO:0010715,1,0.710120408015064,0,1,regulation of extracellular matrix disassembly,BP,
1376,GO:0010724,1,0.704630629043406,0,1,regulation of definitive erythrocyte differentiation,BP,
1377,GO:0010746,1,0.698158470740301,0,1,regulation of plasma membrane long-chain fatty acid transport,BP,
1378,GO:0010748,1,0.698158470740301,0,1,negative regulation of plasma membrane long-chain fatty acid transport,BP,
1379,GO:0010761,1,0.341390641751761,0,3,fibroblast migration,BP,
1380,GO:0010762,1,0.341390641751761,0,3,regulation of fibroblast migration,BP,
1381,GO:0010763,1,0.698158470740301,0,1,positive regulation of fibroblast migration,BP,
1382,GO:0010765,1,0.698158470740301,0,1,positive regulation of sodium ion transport,BP,
1389,GO:0010803,1,0.690185661474723,0,1,regulation of tumor necrosis factor-mediated signaling pathway,BP,
1390,GO:0010804,1,0.690185661474723,0,1,negative regulation of tumor necrosis factor-mediated signaling pathway,BP,
1392,GO:0010811,1,0.246590021537731,0,4,positive regulation of cell-substrate adhesion,BP,
1396,GO:0010819,1,0.711607822536356,0,1,regulation of T cell chemotaxis,BP,
1397,GO:0010820,1,0.711607822536356,0,1,positive regulation of T cell chemotaxis,BP,
1400,GO:0010823,1,0.698158470740301,0,1,negative regulation of mitochondrion organization,BP,
1401,GO:0010824,1,0.701975889304016,0,1,regulation of centrosome duplication,BP,
1402,GO:0010827,1,0.24870385933891,0,4,regulation of glucose transport,BP,
1403,GO:0010828,1,0.24870385933891,0,4,positive regulation of glucose transport,BP,
1407,GO:0010838,1,0.638176348215889,0,1,positive regulation of keratinocyte proliferation,BP,
1409,GO:0010861,1,0.711597574443894,0,1,thyroid hormone receptor activator activity,MF,
1411,GO:0010863,1,0.670757822166244,0,1,positive regulation of phospholipase C activity,BP,
1412,GO:0010869,1,0.679378706287525,0,1,regulation of receptor biosynthetic process,BP,
1413,GO:0010870,1,0.679378706287525,0,1,positive regulation of receptor biosynthetic process,BP,
1415,GO:0010880,1,0.694780337175533,0,1,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,
1416,GO:0010881,1,0.694780337175533,0,1,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,BP,
1417,GO:0010882,1,0.694780337175533,0,1,regulation of cardiac muscle contraction by calcium ion signaling,BP,
1419,GO:0010894,1,0.345758439334557,0,3,negative regulation of steroid biosynthetic process,BP,
1425,GO:0010921,1,0.491368880883894,0,2,regulation of phosphatase activity,BP,
1426,GO:0010922,1,0.703191446152061,0,1,positive regulation of phosphatase activity,BP,
1427,GO:0010923,1,0.699990571588227,0,1,negative regulation of phosphatase activity,BP,
1428,GO:0010927,1,0.16711849900619,0,5,cellular component assembly involved in morphogenesis,BP,
1429,GO:0010934,1,0.4902815083439,0,2,macrophage cytokine production,BP,
1430,GO:0010935,1,0.711607822536356,0,1,regulation of macrophage cytokine production,BP,
1438,GO:0010962,1,0.698158470740301,0,1,regulation of glucan biosynthetic process,BP,
1439,GO:0010972,1,0.70489454545713,0,1,negative regulation of G2/M transition of mitotic cell cycle,BP,
1445,GO:0010996,1,0.697818647628364,0,1,response to auditory stimulus,BP,
1449,GO:0014002,1,0.49598849767204,0,2,astrocyte development,BP,
1450,GO:0014004,1,0.704172714134509,0,1,microglia differentiation,BP,
1451,GO:0014005,1,0.704172714134509,0,1,microglia development,BP,
1465,GO:0014047,1,0.697657324108981,0,1,glutamate secretion,BP,
1466,GO:0014048,1,0.697657324108981,0,1,regulation of glutamate secretion,BP,
1467,GO:0014050,1,0.697657324108981,0,1,negative regulation of glutamate secretion,BP,
1469,GO:0014060,1,0.475084646317265,0,2,regulation of epinephrine secretion,BP,
1470,GO:0014061,1,0.475084646317265,0,2,regulation of norepinephrine secretion,BP,
1473,GO:0014068,1,0.494837515212774,0,2,positive regulation of phosphatidylinositol 3-kinase signaling,BP,
1477,GO:0014701,1,0.694780337175533,0,1,junctional sarcoplasmic reticulum membrane,CC,
1478,GO:0014704,1,0.505501798260194,0,2,intercalated disc,CC,
1485,GO:0014742,1,0.679378706287525,0,1,positive regulation of muscle hypertrophy,BP,
1486,GO:0014743,1,0.679378706287525,0,1,regulation of muscle hypertrophy,BP,
1488,GO:0014808,1,0.694780337175533,0,1,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,
1489,GO:0014812,1,0.238885791595349,0,4,muscle cell migration,BP,
1491,GO:0014820,1,0.679378706287525,0,1,tonic smooth muscle contraction,BP,
1494,GO:0014824,1,0.679378706287525,0,1,artery smooth muscle contraction,BP,
1495,GO:0014826,1,0.679378706287525,0,1,vein smooth muscle contraction,BP,
1496,GO:0014829,1,0.450759797795871,0,2,vascular smooth muscle contraction,BP,
1501,GO:0014866,1,0.711608210494458,0,1,skeletal myofibril assembly,BP,
1510,GO:0014896,1,0.679378706287525,0,1,muscle hypertrophy,BP,
1511,GO:0014897,1,0.679378706287525,0,1,striated muscle hypertrophy,BP,
1513,GO:0014909,1,0.238885791595349,0,4,smooth muscle cell migration,BP,
1514,GO:0014910,1,0.338157165724105,0,3,regulation of smooth muscle cell migration,BP,
1515,GO:0014911,1,0.491458043499325,0,2,positive regulation of smooth muscle cell migration,BP,
1520,GO:0015085,1,0.690185661474723,0,1,calcium ion transmembrane transporter activity,MF,
1522,GO:0015095,1,0.6624012920059,0,1,magnesium ion transmembrane transporter activity,MF,
1523,GO:0015103,1,0.677010844857903,0,1,inorganic anion transmembrane transporter activity,MF,
1524,GO:0015108,1,0.677010844857903,0,1,chloride transmembrane transporter activity,MF,
1528,GO:0015154,1,0.706362630533194,0,1,disaccharide transmembrane transporter activity,MF,
1529,GO:0015157,1,0.706362630533194,0,1,oligosaccharide transmembrane transporter activity,MF,
1530,GO:0015232,1,0.709021995543303,0,1,heme transporter activity,MF,
1532,GO:0015271,1,0.711607634773957,0,1,outward rectifier potassium channel activity,MF,
1534,GO:0015291,1,0.706362630533194,0,1,secondary active transmembrane transporter activity,MF,
1535,GO:0015293,1,0.706362630533194,0,1,symporter activity,MF,
1536,GO:0015294,1,0.706362630533194,0,1,solute:cation symporter activity,MF,
1537,GO:0015295,1,0.706362630533194,0,1,solute:proton symporter activity,MF,
1540,GO:0015631,1,0.116679476865609,0,6,tubulin binding,MF,
1541,GO:0015645,1,0.711607686616218,0,1,fatty acid ligase activity,MF,
1545,GO:0015693,1,0.6624012920059,0,1,magnesium ion transport,BP,
1548,GO:0015711,1,0.161868530315133,0,5,organic anion transport,BP,
1549,GO:0015718,1,0.335694824697144,0,3,monocarboxylic acid transport,BP,
1550,GO:0015732,1,0.679378706287525,0,1,prostaglandin transport,BP,
1551,GO:0015748,1,0.66612845920437,0,1,organophosphate ester transport,BP,
1554,GO:0015766,1,0.706362630533194,0,1,disaccharide transport,BP,
1555,GO:0015770,1,0.706362630533194,0,1,sucrose transport,BP,
1556,GO:0015772,1,0.706362630533194,0,1,oligosaccharide transport,BP,
1560,GO:0015849,1,0.232925774049865,0,4,organic acid transport,BP,
1562,GO:0015858,1,0.697657324108981,0,1,nucleoside transport,BP,
1563,GO:0015865,1,0.66612845920437,0,1,purine nucleotide transport,BP,
1564,GO:0015868,1,0.66612845920437,0,1,purine ribonucleotide transport,BP,
1566,GO:0015874,1,0.475084646317265,0,2,norepinephrine transport,BP,
1567,GO:0015886,1,0.709021995543303,0,1,heme transport,BP,
1568,GO:0015893,1,0.706809127351861,0,1,drug transport,BP,
1569,GO:0015908,1,0.335694824697144,0,3,fatty acid transport,BP,
1570,GO:0015909,1,0.698158470740301,0,1,long-chain fatty acid transport,BP,
1571,GO:0015911,1,0.698158470740301,0,1,plasma membrane long-chain fatty acid transport,BP,
1572,GO:0015931,1,0.463809028589789,0,2,nucleobase-containing compound transport,BP,
1579,GO:0016048,1,0.697657324108981,0,1,detection of temperature stimulus,BP,
1582,GO:0016051,1,0.237463677435121,0,4,carbohydrate biosynthetic process,BP,
1584,GO:0016053,1,0.454640015942075,0,2,organic acid biosynthetic process,BP,
1587,GO:0016056,1,0.711607661943626,0,1,rhodopsin mediated signaling pathway,BP,
1588,GO:0016064,1,0.670968878396742,0,1,immunoglobulin mediated immune response,BP,
1592,GO:0016101,1,0.482464068940171,0,2,diterpenoid metabolic process,BP,
1593,GO:0016125,1,0.687664047662032,0,1,sterol metabolic process,BP,
1594,GO:0016126,1,0.687664047662032,0,1,sterol biosynthetic process,BP,
1595,GO:0016176,1,0.698425417725528,0,1,superoxide-generating NADPH oxidase activator activity,MF,
1599,GO:0016209,1,0.707555965307343,0,1,antioxidant activity,MF,
1601,GO:0016239,1,0.327371189202178,0,3,positive regulation of macroautophagy,BP,
1607,GO:0016266,1,0.695652466100109,0,1,O-glycan processing,BP,
1608,GO:0016298,1,0.697657324108981,0,1,lipase activity,MF,
1616,GO:0016327,1,0.443076684927583,0,2,apicolateral plasma membrane,CC,
1622,GO:0016339,1,0.504863333230193,0,2,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,BP,
1625,GO:0016361,1,0.699990571588227,0,1,activin receptor activity, type I,MF,
1627,GO:0016410,1,0.711607661943626,0,1,N-acyltransferase activity,MF,
1630,GO:0016444,1,0.670968878396742,0,1,somatic cell DNA recombination,BP,
1631,GO:0016445,1,0.670968878396742,0,1,somatic diversification of immunoglobulins,BP,
1632,GO:0016447,1,0.670968878396742,0,1,somatic recombination of immunoglobulin gene segments,BP,
1634,GO:0016459,1,0.358582568008822,0,3,myosin complex,CC,
1635,GO:0016460,1,0.711608210494458,0,1,myosin II complex,CC,
1636,GO:0016461,1,0.71160840958516,0,1,unconventional myosin complex,CC,
1639,GO:0016480,1,0.69495645939892,0,1,negative regulation of transcription from RNA polymerase III promoter,BP,
1640,GO:0016482,1,0.498072831442934,0,2,cytosolic transport,BP,
1644,GO:0016528,1,0.694780337175533,0,1,sarcoplasm,CC,
1645,GO:0016529,1,0.694780337175533,0,1,sarcoplasmic reticulum,CC,
1646,GO:0016538,1,0.68226354479179,0,1,cyclin-dependent protein serine/threonine kinase regulator activity,MF,
1648,GO:0016569,1,0.342104907353419,0,3,covalent chromatin modification,BP,
1649,GO:0016570,1,0.504767417676463,0,2,histone modification,BP,
1650,GO:0016573,1,0.710496861605038,0,1,histone acetylation,BP,
1651,GO:0016575,1,0.711607679660172,0,1,histone deacetylation,BP,
1653,GO:0016580,1,0.711607679660172,0,1,Sin3 complex,CC,
1659,GO:0016607,1,0.219290155238127,0,4,nuclear speck,CC,
1660,GO:0016614,1,0.703191446152061,0,1,oxidoreductase activity, acting on CH-OH group of donors,MF,
1661,GO:0016616,1,0.703191446152061,0,1,oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,
1664,GO:0016667,1,0.707555965307343,0,1,oxidoreductase activity, acting on a sulfur group of donors,MF,
1665,GO:0016684,1,0.707555965307343,0,1,oxidoreductase activity, acting on peroxide as acceptor,MF,
1670,GO:0016757,1,0.695652466100109,0,1,transferase activity, transferring glycosyl groups,MF,
1671,GO:0016758,1,0.695652466100109,0,1,transferase activity, transferring hexosyl groups,MF,
1674,GO:0016775,1,0.703878036725278,0,1,phosphotransferase activity, nitrogenous group as acceptor,MF,
1678,GO:0016805,1,0.711607633995453,0,1,dipeptidase activity,MF,
1679,GO:0016810,1,0.711607679660172,0,1,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,MF,
1680,GO:0016811,1,0.711607679660172,0,1,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,MF,
1685,GO:0016853,1,0.670588974535174,0,1,isomerase activity,MF,
1686,GO:0016860,1,0.670588974535174,0,1,intramolecular oxidoreductase activity,MF,
1687,GO:0016874,1,0.711607686616218,0,1,ligase activity,MF,
1688,GO:0016877,1,0.711607686616218,0,1,ligase activity, forming carbon-sulfur bonds,MF,
1689,GO:0016878,1,0.711607686616218,0,1,acid-thiol ligase activity,MF,
1690,GO:0016887,1,0.71160840958516,0,1,ATPase activity,MF,
1691,GO:0016936,1,0.656502839512405,0,1,galactoside binding,MF,
1692,GO:0016941,1,0.711314340107367,0,1,natriuretic peptide receptor activity,MF,
1693,GO:0017002,1,0.699990571588227,0,1,activin-activated receptor activity,MF,
1694,GO:0017015,1,0.332451962597946,0,3,regulation of transforming growth factor beta receptor signaling pathway,BP,
1695,GO:0017016,1,0.253399550675947,0,4,Ras GTPase binding,MF,
1699,GO:0017046,1,0.352535584848672,0,3,peptide hormone binding,MF,
1700,GO:0017048,1,0.711607940196285,0,1,Rho GTPase binding,MF,
1701,GO:0017053,1,0.704630629043406,0,1,transcriptional repressor complex,CC,
1705,GO:0017112,1,0.710190747004575,0,1,Rab guanyl-nucleotide exchange factor activity,MF,
1706,GO:0017124,1,0.498258844469823,0,2,SH3 domain binding,MF,
1707,GO:0017137,1,0.504549448689951,0,2,Rab GTPase binding,MF,
1715,GO:0018008,1,0.711607661943626,0,1,N-terminal peptidyl-glycine N-myristoylation,BP,
1721,GO:0018146,1,0.695652466100109,0,1,keratan sulfate biosynthetic process,BP,
1724,GO:0018201,1,0.711607661943626,0,1,peptidyl-glycine modification,BP,
1725,GO:0018205,1,0.710496861605038,0,1,peptidyl-lysine modification,BP,
1729,GO:0018377,1,0.711607661943626,0,1,protein myristoylation,BP,
1730,GO:0018393,1,0.710496861605038,0,1,internal peptidyl-lysine acetylation,BP,
1731,GO:0018394,1,0.710496861605038,0,1,peptidyl-lysine acetylation,BP,
1732,GO:0018410,1,0.710726924865214,0,1,C-terminal protein amino acid modification,BP,
1737,GO:0019062,1,0.690185661474723,0,1,virion attachment to host cell,BP,
1738,GO:0019064,1,0.690185661474723,0,1,fusion of virus membrane with host plasma membrane,BP,
1740,GO:0019107,1,0.711607661943626,0,1,myristoyltransferase activity,MF,
1741,GO:0019199,1,0.351476145833121,0,3,transmembrane receptor protein kinase activity,MF,
1742,GO:0019200,1,0.488644424135502,0,2,carbohydrate kinase activity,MF,
1743,GO:0019203,1,0.711537687634486,0,1,carbohydrate phosphatase activity,MF,
1745,GO:0019208,1,0.703191446152061,0,1,phosphatase regulator activity,MF,
1747,GO:0019210,1,0.470013986237748,0,2,kinase inhibitor activity,MF,
1748,GO:0019211,1,0.703191446152061,0,1,phosphatase activator activity,MF,
1749,GO:0019213,1,0.711607679660172,0,1,deacetylase activity,MF,
1752,GO:0019217,1,0.698158470740301,0,1,regulation of fatty acid metabolic process,BP,
1759,GO:0019229,1,0.223198555003352,0,4,regulation of vasoconstriction,BP,
1760,GO:0019233,1,0.3182012577437,0,3,sensory perception of pain,BP,
1762,GO:0019319,1,0.707555965307343,0,1,hexose biosynthetic process,BP,
1765,GO:0019369,1,0.670588974535174,0,1,arachidonic acid metabolic process,BP,
1766,GO:0019371,1,0.670588974535174,0,1,cyclooxygenase pathway,BP,
1767,GO:0019395,1,0.493131944016563,0,2,fatty acid oxidation,BP,
1779,GO:0019682,1,0.687957943572463,0,1,glyceraldehyde-3-phosphate metabolic process,BP,
1782,GO:0019724,1,0.670968878396742,0,1,B cell mediated immunity,BP,
1784,GO:0019730,1,0.677890918061584,0,1,antimicrobial humoral response,BP,
1785,GO:0019748,1,0.711607822536356,0,1,secondary metabolic process,BP,
1790,GO:0019838,1,0.236100102437866,0,4,growth factor binding,MF,
1791,GO:0019840,1,0.685229321173304,0,1,isoprenoid binding,MF,
1793,GO:0019866,1,0.335433693898434,0,3,organelle inner membrane,CC,
1796,GO:0019882,1,0.491414696351302,0,2,antigen processing and presentation,BP,
1797,GO:0019884,1,0.706386167461074,0,1,antigen processing and presentation of exogenous antigen,BP,
1806,GO:0019903,1,0.248678976183305,0,4,protein phosphatase binding,MF,
1809,GO:0019912,1,0.68226354479179,0,1,cyclin-dependent protein kinase activating kinase activity,MF,
1815,GO:0019955,1,0.699990571588227,0,1,cytokine binding,MF,
1829,GO:0021675,1,0.651377299881628,0,1,nerve development,BP,
1830,GO:0021679,1,0.705560336344585,0,1,cerebellar molecular layer development,BP,
1831,GO:0021680,1,0.705560336344585,0,1,cerebellar Purkinje cell layer development,BP,
1835,GO:0021687,1,0.705560336344585,0,1,cerebellar molecular layer morphogenesis,BP,
1836,GO:0021688,1,0.705560336344585,0,1,cerebellar molecular layer formation,BP,
1837,GO:0021692,1,0.705560336344585,0,1,cerebellar Purkinje cell layer morphogenesis,BP,
1838,GO:0021693,1,0.705560336344585,0,1,cerebellar Purkinje cell layer structural organization,BP,
1842,GO:0021698,1,0.705560336344585,0,1,cerebellar cortex structural organization,BP,
1845,GO:0021772,1,0.711607822536356,0,1,olfactory bulb development,BP,
1857,GO:0021885,1,0.710679261468123,0,1,forebrain cell migration,BP,
1858,GO:0021889,1,0.711607822536356,0,1,olfactory bulb interneuron differentiation,BP,
1859,GO:0021891,1,0.711607822536356,0,1,olfactory bulb interneuron development,BP,
1871,GO:0021987,1,0.711526480882443,0,1,cerebral cortex development,BP,
1872,GO:0021988,1,0.711607822536356,0,1,olfactory lobe development,BP,
1878,GO:0022400,1,0.711607661943626,0,1,regulation of rhodopsin mediated signaling pathway,BP,
1886,GO:0022410,1,0.697657324108981,0,1,circadian sleep/wake cycle process,BP,
1897,GO:0022614,1,0.710730522233721,0,1,membrane to membrane docking,BP,
1900,GO:0022804,1,0.706362630533194,0,1,active transmembrane transporter activity,MF,
1911,GO:0022898,1,0.349938944114777,0,3,regulation of transmembrane transporter activity,BP,
1924,GO:0030016,1,0.078218710329213,0,7,myofibril,CC,
1925,GO:0030017,1,0.114191602112458,0,6,sarcomere,CC,
1926,GO:0030018,1,0.114191602112458,0,6,Z disc,CC,
1931,GO:0030032,1,0.669519565619261,0,1,lamellipodium assembly,BP,
1932,GO:0030035,1,0.711597574443894,0,1,microspike assembly,BP,
1934,GO:0030038,1,0.166707348475165,0,5,contractile actin filament bundle assembly,BP,
1937,GO:0030046,1,0.708023640256459,0,1,parallel actin filament bundle assembly,BP,
1942,GO:0030056,1,0.711607798121381,0,1,hemidesmosome,CC,
1950,GO:0030101,1,0.340005256080466,0,3,natural killer cell activation,BP,
1951,GO:0030104,1,0.345351923081703,0,3,water homeostasis,BP,
1967,GO:0030175,1,0.112186817350724,0,6,filopodium,CC,
1972,GO:0030185,1,0.679378706287525,0,1,nitric oxide transport,BP,
1973,GO:0030193,1,0.325816047488212,0,3,regulation of blood coagulation,BP,
1974,GO:0030195,1,0.325816047488212,0,3,negative regulation of blood coagulation,BP,
1976,GO:0030203,1,0.232398870018334,0,4,glycosaminoglycan metabolic process,BP,
1977,GO:0030212,1,0.486742379985589,0,2,hyaluronan metabolic process,BP,
1978,GO:0030213,1,0.698425417725528,0,1,hyaluronan biosynthetic process,BP,
1983,GO:0030220,1,0.704630629043406,0,1,platelet formation,BP,
1987,GO:0030235,1,0.698158470740301,0,1,nitric-oxide synthase regulator activity,MF,
1988,GO:0030237,1,0.710436959244465,0,1,female sex determination,BP,
1989,GO:0030238,1,0.674696332807623,0,1,male sex determination,BP,
1990,GO:0030239,1,0.16711849900619,0,5,myofibril assembly,BP,
1991,GO:0030241,1,0.711608210494458,0,1,skeletal muscle myosin thick filament assembly,BP,
1992,GO:0030246,1,0.656502839512405,0,1,carbohydrate binding,MF,
1995,GO:0030274,1,0.711597574443894,0,1,LIM domain binding,MF,
2001,GO:0030285,1,0.673712088381978,0,1,integral component of synaptic vesicle membrane,CC,
2002,GO:0030291,1,0.470013986237748,0,2,protein serine/threonine kinase inhibitor activity,MF,
2004,GO:0030296,1,0.690185661474723,0,1,protein tyrosine kinase activator activity,MF,
2007,GO:0030309,1,0.695652466100109,0,1,poly-N-acetyllactosamine metabolic process,BP,
2008,GO:0030311,1,0.695652466100109,0,1,poly-N-acetyllactosamine biosynthetic process,BP,
2009,GO:0030314,1,0.694780337175533,0,1,junctional membrane complex,CC,
2011,GO:0030318,1,0.49506226123454,0,2,melanocyte differentiation,BP,
2017,GO:0030332,1,0.68226354479179,0,1,cyclin binding,MF,
2021,GO:0030374,1,0.48447926847528,0,2,ligand-dependent nuclear receptor transcription coactivator activity,MF,
2022,GO:0030375,1,0.711597574443894,0,1,thyroid hormone receptor coactivator activity,MF,
2026,GO:0030426,1,0.711607657766672,0,1,growth cone,CC,
2027,GO:0030427,1,0.711607657766672,0,1,site of polarized growth,CC,
2028,GO:0030431,1,0.697657324108981,0,1,sleep,BP,
2030,GO:0030485,1,0.664890465759854,0,1,smooth muscle contractile fiber,CC,
2031,GO:0030496,1,0.456796903881282,0,2,midbody,CC,
2038,GO:0030512,1,0.675230251448907,0,1,negative regulation of transforming growth factor beta receptor signaling pathway,BP,
2046,GO:0030538,1,0.638176348215889,0,1,embryonic genitalia morphogenesis,BP,
2048,GO:0030540,1,0.222656363057967,0,4,female genitalia development,BP,
2051,GO:0030551,1,0.490187600432052,0,2,cyclic nucleotide binding,MF,
2052,GO:0030552,1,0.490187600432052,0,2,cAMP binding,MF,
2060,GO:0030660,1,0.711596825427955,0,1,Golgi-associated vesicle membrane,CC,
2065,GO:0030669,1,0.487589411508862,0,2,clathrin-coated endocytic vesicle membrane,CC,
2068,GO:0030673,1,0.697657324108981,0,1,axolemma,CC,
2069,GO:0030674,1,0.711607815446889,0,1,protein binding, bridging,MF,
2073,GO:0030799,1,0.144267872871558,0,5,regulation of cyclic nucleotide metabolic process,BP,
2074,GO:0030800,1,0.679378706287525,0,1,negative regulation of cyclic nucleotide metabolic process,BP,
2075,GO:0030801,1,0.214084094962897,0,4,positive regulation of cyclic nucleotide metabolic process,BP,
2076,GO:0030802,1,0.303211425893755,0,3,regulation of cyclic nucleotide biosynthetic process,BP,
2077,GO:0030803,1,0.679378706287525,0,1,negative regulation of cyclic nucleotide biosynthetic process,BP,
2078,GO:0030804,1,0.448174318882941,0,2,positive regulation of cyclic nucleotide biosynthetic process,BP,
2079,GO:0030808,1,0.303211425893755,0,3,regulation of nucleotide biosynthetic process,BP,
2080,GO:0030809,1,0.679378706287525,0,1,negative regulation of nucleotide biosynthetic process,BP,
2081,GO:0030810,1,0.448174318882941,0,2,positive regulation of nucleotide biosynthetic process,BP,
2082,GO:0030814,1,0.288832816285793,0,3,regulation of cAMP metabolic process,BP,
2083,GO:0030815,1,0.679378706287525,0,1,negative regulation of cAMP metabolic process,BP,
2084,GO:0030816,1,0.677890918061584,0,1,positive regulation of cAMP metabolic process,BP,
2085,GO:0030817,1,0.679378706287525,0,1,regulation of cAMP biosynthetic process,BP,
2086,GO:0030818,1,0.679378706287525,0,1,negative regulation of cAMP biosynthetic process,BP,
2087,GO:0030823,1,0.31772825006806,0,3,regulation of cGMP metabolic process,BP,
2088,GO:0030825,1,0.31772825006806,0,3,positive regulation of cGMP metabolic process,BP,
2089,GO:0030826,1,0.448174318882941,0,2,regulation of cGMP biosynthetic process,BP,
2090,GO:0030828,1,0.448174318882941,0,2,positive regulation of cGMP biosynthetic process,BP,
2095,GO:0030836,1,0.711597574443894,0,1,positive regulation of actin filament depolymerization,BP,
2098,GO:0030849,1,0.711607679660172,0,1,autosome,CC,
2100,GO:0030851,1,0.704630629043406,0,1,granulocyte differentiation,BP,
2105,GO:0030859,1,0.504934176417217,0,2,polarized epithelial cell differentiation,BP,
2108,GO:0030865,1,0.711596825427955,0,1,cortical cytoskeleton organization,BP,
2109,GO:0030866,1,0.711596825427955,0,1,cortical actin cytoskeleton organization,BP,
2110,GO:0030868,1,0.677010844857903,0,1,smooth endoplasmic reticulum membrane,CC,
2114,GO:0030888,1,0.456839004123389,0,2,regulation of B cell proliferation,BP,
2115,GO:0030890,1,0.456839004123389,0,2,positive regulation of B cell proliferation,BP,
2116,GO:0030898,1,0.71160840958516,0,1,actin-dependent ATPase activity,MF,
2124,GO:0030947,1,0.453077216685341,0,2,regulation of vascular endothelial growth factor receptor signaling pathway,BP,
2125,GO:0030949,1,0.453077216685341,0,2,positive regulation of vascular endothelial growth factor receptor signaling pathway,BP,
2126,GO:0030957,1,0.705560336344585,0,1,Tat protein binding,MF,
2127,GO:0030968,1,0.711607815446889,0,1,endoplasmic reticulum unfolded protein response,BP,
2128,GO:0030971,1,0.245831361477521,0,4,receptor tyrosine kinase binding,MF,
2129,GO:0031000,1,0.694780337175533,0,1,response to caffeine,BP,
2133,GO:0031023,1,0.461323785968984,0,2,microtubule organizing center organization,BP,
2134,GO:0031032,1,0.0266209309245803,0,10,actomyosin structure organization,BP,
2135,GO:0031033,1,0.711608210494458,0,1,myosin filament organization,BP,
2136,GO:0031034,1,0.711608210494458,0,1,myosin filament assembly,BP,
2140,GO:0031056,1,0.710496861605038,0,1,regulation of histone modification,BP,
2141,GO:0031058,1,0.710496861605038,0,1,positive regulation of histone modification,BP,
2143,GO:0031072,1,0.697657324108981,0,1,heat shock protein binding,MF,
2146,GO:0031091,1,0.232495592809359,0,4,platelet alpha granule,CC,
2147,GO:0031093,1,0.341204910081565,0,3,platelet alpha granule lumen,CC,
2148,GO:0031094,1,0.685229321173304,0,1,platelet dense tubular network,CC,
2152,GO:0031102,1,0.709095041154607,0,1,neuron projection regeneration,BP,
2153,GO:0031103,1,0.709095041154607,0,1,axon regeneration,BP,
2154,GO:0031109,1,0.448692578745972,0,2,microtubule polymerization or depolymerization,BP,
2155,GO:0031110,1,0.669435136554984,0,1,regulation of microtubule polymerization or depolymerization,BP,
2156,GO:0031112,1,0.669435136554984,0,1,positive regulation of microtubule polymerization or depolymerization,BP,
2157,GO:0031113,1,0.669435136554984,0,1,regulation of microtubule polymerization,BP,
2158,GO:0031116,1,0.669435136554984,0,1,positive regulation of microtubule polymerization,BP,
2164,GO:0031201,1,0.695414751519134,0,1,SNARE complex,CC,
2165,GO:0031210,1,0.685229321173304,0,1,phosphatidylcholine binding,MF,
2167,GO:0031223,1,0.697818647628364,0,1,auditory behavior,BP,
2169,GO:0031225,1,0.710726924865214,0,1,anchored component of membrane,CC,
2172,GO:0031234,1,0.497274102997808,0,2,extrinsic component of cytoplasmic side of plasma membrane,CC,
2176,GO:0031254,1,0.710730522233721,0,1,cell trailing edge,CC,
2177,GO:0031256,1,0.495480310147094,0,2,leading edge membrane,CC,
2178,GO:0031267,1,0.253399550675947,0,4,small GTPase binding,MF,
2181,GO:0031300,1,0.673712088381978,0,1,intrinsic component of organelle membrane,CC,
2182,GO:0031301,1,0.673712088381978,0,1,integral component of organelle membrane,CC,
2198,GO:0031348,1,0.494960755982848,0,2,negative regulation of defense response,BP,
2200,GO:0031365,1,0.711607661943626,0,1,N-terminal protein amino acid modification,BP,
2209,GO:0031432,1,0.711597574443894,0,1,titin binding,MF,
2210,GO:0031434,1,0.689742136494387,0,1,mitogen-activated protein kinase kinase binding,MF,
2211,GO:0031477,1,0.71160840958516,0,1,myosin VII complex,CC,
2214,GO:0031491,1,0.680222067743302,0,1,nucleosome binding,MF,
2215,GO:0031492,1,0.680222067743302,0,1,nucleosomal DNA binding,MF,
2217,GO:0031527,1,0.48088596424501,0,2,filopodium membrane,CC,
2218,GO:0031528,1,0.710730522233721,0,1,microvillus membrane,CC,
2221,GO:0031570,1,0.314799508098407,0,3,DNA integrity checkpoint,BP,
2222,GO:0031571,1,0.448309892774536,0,2,mitotic G1 DNA damage checkpoint,BP,
2223,GO:0031572,1,0.70489454545713,0,1,G2 DNA damage checkpoint,BP,
2224,GO:0031581,1,0.711607798121381,0,1,hemidesmosome assembly,BP,
2225,GO:0031583,1,0.679378706287525,0,1,phospholipase D-activating G-protein coupled receptor signaling pathway,BP,
2226,GO:0031588,1,0.707555965307343,0,1,nucleotide-activated protein kinase complex,CC,
2230,GO:0031638,1,0.690576730624361,0,1,zymogen activation,BP,
2231,GO:0031639,1,0.690576730624361,0,1,plasminogen activation,BP,
2232,GO:0031640,1,0.677890918061584,0,1,killing of cells of other organism,BP,
2233,GO:0031641,1,0.698158470740301,0,1,regulation of myelination,BP,
2234,GO:0031644,1,0.3182012577437,0,3,regulation of neurological system process,BP,
2236,GO:0031648,1,0.703191446152061,0,1,protein destabilization,BP,
2237,GO:0031657,1,0.444588797042141,0,2,regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
2238,GO:0031659,1,0.444588797042141,0,2,positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
2246,GO:0031674,1,0.114191602112458,0,6,I band,CC,
2247,GO:0031683,1,0.697657324108981,0,1,G-protein beta/gamma-subunit complex binding,MF,
2248,GO:0031690,1,0.67531451831299,0,1,adrenergic receptor binding,MF,
2249,GO:0031694,1,0.67531451831299,0,1,alpha-2A adrenergic receptor binding,MF,
2250,GO:0031705,1,0.679378706287525,0,1,bombesin receptor binding,MF,
2251,GO:0031707,1,0.679378706287525,0,1,endothelin A receptor binding,MF,
2252,GO:0031708,1,0.679378706287525,0,1,endothelin B receptor binding,MF,
2254,GO:0031849,1,0.709685678742096,0,1,olfactory receptor binding,MF,
2255,GO:0031901,1,0.673712088381978,0,1,early endosome membrane,CC,
2257,GO:0031903,1,0.711607686616218,0,1,microbody membrane,CC,
2259,GO:0031932,1,0.501332373633352,0,2,TORC2 complex,CC,
2260,GO:0031941,1,0.708023640256459,0,1,filamentous actin,CC,
2261,GO:0031943,1,0.345758439334557,0,3,regulation of glucocorticoid metabolic process,BP,
2262,GO:0031944,1,0.488356881126512,0,2,negative regulation of glucocorticoid metabolic process,BP,
2263,GO:0031945,1,0.710436959244465,0,1,positive regulation of glucocorticoid metabolic process,BP,
2264,GO:0031946,1,0.345758439334557,0,3,regulation of glucocorticoid biosynthetic process,BP,
2265,GO:0031947,1,0.488356881126512,0,2,negative regulation of glucocorticoid biosynthetic process,BP,
2266,GO:0031948,1,0.710436959244465,0,1,positive regulation of glucocorticoid biosynthetic process,BP,
2267,GO:0031952,1,0.698425417725528,0,1,regulation of protein autophosphorylation,BP,
2268,GO:0031954,1,0.698425417725528,0,1,positive regulation of protein autophosphorylation,BP,
2269,GO:0031957,1,0.711607686616218,0,1,very long-chain fatty acid-CoA ligase activity,MF,
2274,GO:0031970,1,0.670588974535174,0,1,organelle envelope lumen,CC,
2281,GO:0031994,1,0.711607798121381,0,1,insulin-like growth factor I binding,MF,
2282,GO:0031998,1,0.698158470740301,0,1,regulation of fatty acid beta-oxidation,BP,
2283,GO:0031999,1,0.698158470740301,0,1,negative regulation of fatty acid beta-oxidation,BP,
2285,GO:0032007,1,0.502669864412949,0,2,negative regulation of TOR signaling,BP,
2290,GO:0032042,1,0.707555965307343,0,1,mitochondrial DNA metabolic process,BP,
2292,GO:0032055,1,0.707555965307343,0,1,negative regulation of translation in response to stress,BP,
2293,GO:0032069,1,0.698158470740301,0,1,regulation of nuclease activity,BP,
2294,GO:0032070,1,0.698158470740301,0,1,regulation of deoxyribonuclease activity,BP,
2295,GO:0032071,1,0.698158470740301,0,1,regulation of endodeoxyribonuclease activity,BP,
2296,GO:0032075,1,0.698158470740301,0,1,positive regulation of nuclease activity,BP,
2297,GO:0032077,1,0.698158470740301,0,1,positive regulation of deoxyribonuclease activity,BP,
2298,GO:0032079,1,0.698158470740301,0,1,positive regulation of endodeoxyribonuclease activity,BP,
2300,GO:0032091,1,0.334667446618018,0,3,negative regulation of protein binding,BP,
2302,GO:0032094,1,0.698158470740301,0,1,response to food,BP,
2307,GO:0032148,1,0.160312700826074,0,5,activation of protein kinase B activity,BP,
2308,GO:0032153,1,0.68651492790583,0,1,cell division site,CC,
2309,GO:0032154,1,0.68651492790583,0,1,cleavage furrow,CC,
2310,GO:0032155,1,0.68651492790583,0,1,cell division site part,CC,
2311,GO:0032182,1,0.711607652756744,0,1,ubiquitin-like protein binding,MF,
2312,GO:0032190,1,0.685229321173304,0,1,acrosin binding,MF,
2313,GO:0032217,1,0.699990571588227,0,1,riboflavin transporter activity,MF,
2314,GO:0032218,1,0.699990571588227,0,1,riboflavin transport,BP,
2316,GO:0032228,1,0.697657324108981,0,1,regulation of synaptic transmission, GABAergic,BP,
2317,GO:0032229,1,0.697657324108981,0,1,negative regulation of synaptic transmission, GABAergic,BP,
2318,GO:0032231,1,0.237661167732212,0,4,regulation of actin filament bundle assembly,BP,
2319,GO:0032233,1,0.335721340138578,0,3,positive regulation of actin filament bundle assembly,BP,
2320,GO:0032239,1,0.697657324108981,0,1,regulation of nucleobase-containing compound transport,BP,
2321,GO:0032241,1,0.697657324108981,0,1,positive regulation of nucleobase-containing compound transport,BP,
2322,GO:0032242,1,0.697657324108981,0,1,regulation of nucleoside transport,BP,
2323,GO:0032244,1,0.697657324108981,0,1,positive regulation of nucleoside transport,BP,
2337,GO:0032287,1,0.698158470740301,0,1,peripheral nervous system myelin maintenance,BP,
2339,GO:0032303,1,0.679378706287525,0,1,regulation of icosanoid secretion,BP,
2340,GO:0032305,1,0.679378706287525,0,1,positive regulation of icosanoid secretion,BP,
2341,GO:0032306,1,0.679378706287525,0,1,regulation of prostaglandin secretion,BP,
2342,GO:0032308,1,0.679378706287525,0,1,positive regulation of prostaglandin secretion,BP,
2343,GO:0032309,1,0.679378706287525,0,1,icosanoid secretion,BP,
2344,GO:0032310,1,0.679378706287525,0,1,prostaglandin secretion,BP,
2351,GO:0032345,1,0.488356881126512,0,2,negative regulation of aldosterone metabolic process,BP,
2354,GO:0032348,1,0.488356881126512,0,2,negative regulation of aldosterone biosynthetic process,BP,
2357,GO:0032351,1,0.488356881126512,0,2,negative regulation of hormone metabolic process,BP,
2359,GO:0032353,1,0.488356881126512,0,2,negative regulation of hormone biosynthetic process,BP,
2364,GO:0032369,1,0.698158470740301,0,1,negative regulation of lipid transport,BP,
2370,GO:0032400,1,0.469152245135803,0,2,melanosome localization,BP,
2371,GO:0032401,1,0.469152245135803,0,2,establishment of melanosome localization,BP,
2372,GO:0032402,1,0.469152245135803,0,2,melanosome transport,BP,
2374,GO:0032409,1,0.349938944114777,0,3,regulation of transporter activity,BP,
2375,GO:0032410,1,0.493551163796482,0,2,negative regulation of transporter activity,BP,
2376,GO:0032411,1,0.711597574443894,0,1,positive regulation of transporter activity,BP,
2377,GO:0032412,1,0.349938944114777,0,3,regulation of ion transmembrane transporter activity,BP,
2378,GO:0032413,1,0.493551163796482,0,2,negative regulation of ion transmembrane transporter activity,BP,
2379,GO:0032414,1,0.711597574443894,0,1,positive regulation of ion transmembrane transporter activity,BP,
2381,GO:0032420,1,0.356309631903489,0,3,stereocilium,CC,
2382,GO:0032421,1,0.356309631903489,0,3,stereocilium bundle,CC,
2383,GO:0032426,1,0.708023640256459,0,1,stereocilium tip,CC,
2384,GO:0032427,1,0.711596825427955,0,1,GBD domain binding,MF,
2385,GO:0032433,1,0.677010844857903,0,1,filopodium tip,CC,
2390,GO:0032456,1,0.479098351444028,0,2,endocytic recycling,BP,
2393,GO:0032479,1,0.711607812592732,0,1,regulation of type I interferon production,BP,
2399,GO:0032506,1,0.711607690438396,0,1,cytokinetic process,BP,
2404,GO:0032542,1,0.707555965307343,0,1,sulfiredoxin activity,MF,
2412,GO:0032571,1,0.690185661474723,0,1,response to vitamin K,BP,
2413,GO:0032585,1,0.696889228938764,0,1,multivesicular body membrane,CC,
2414,GO:0032587,1,0.711422189054973,0,1,ruffle membrane,CC,
2415,GO:0032589,1,0.697657324108981,0,1,neuron projection membrane,CC,
2416,GO:0032602,1,0.500583535837422,0,2,chemokine production,BP,
2418,GO:0032606,1,0.711607812592732,0,1,type I interferon production,BP,
2421,GO:0032611,1,0.711607822536356,0,1,interleukin-1 beta production,BP,
2423,GO:0032613,1,0.705560336344585,0,1,interleukin-10 production,BP,
2424,GO:0032623,1,0.711421550449818,0,1,interleukin-2 production,BP,
2426,GO:0032635,1,0.4902815083439,0,2,interleukin-6 production,BP,
2427,GO:0032637,1,0.711607822536356,0,1,interleukin-8 production,BP,
2428,GO:0032640,1,0.490281503438804,0,2,tumor necrosis factor production,BP,
2429,GO:0032642,1,0.500583535837422,0,2,regulation of chemokine production,BP,
2433,GO:0032651,1,0.711607822536356,0,1,regulation of interleukin-1 beta production,BP,
2435,GO:0032653,1,0.705560336344585,0,1,regulation of interleukin-10 production,BP,
2436,GO:0032663,1,0.711421550449818,0,1,regulation of interleukin-2 production,BP,
2437,GO:0032673,1,0.704630629043406,0,1,regulation of interleukin-4 production,BP,
2438,GO:0032675,1,0.4902815083439,0,2,regulation of interleukin-6 production,BP,
2439,GO:0032677,1,0.711607822536356,0,1,regulation of interleukin-8 production,BP,
2440,GO:0032680,1,0.490281503438804,0,2,regulation of tumor necrosis factor production,BP,
2442,GO:0032689,1,0.690185661474723,0,1,negative regulation of interferon-gamma production,BP,
2443,GO:0032692,1,0.690185661474723,0,1,negative regulation of interleukin-1 production,BP,
2444,GO:0032693,1,0.705560336344585,0,1,negative regulation of interleukin-10 production,BP,
2445,GO:0032713,1,0.704630629043406,0,1,negative regulation of interleukin-4 production,BP,
2446,GO:0032715,1,0.690185661474723,0,1,negative regulation of interleukin-6 production,BP,
2447,GO:0032720,1,0.690185661474723,0,1,negative regulation of tumor necrosis factor production,BP,
2448,GO:0032722,1,0.711607822536356,0,1,positive regulation of chemokine production,BP,
2451,GO:0032731,1,0.711607822536356,0,1,positive regulation of interleukin-1 beta production,BP,
2453,GO:0032743,1,0.711421550449818,0,1,positive regulation of interleukin-2 production,BP,
2454,GO:0032755,1,0.711607822536356,0,1,positive regulation of interleukin-6 production,BP,
2455,GO:0032757,1,0.711607822536356,0,1,positive regulation of interleukin-8 production,BP,
2456,GO:0032760,1,0.711607815446889,0,1,positive regulation of tumor necrosis factor production,BP,
2457,GO:0032762,1,0.677890918061584,0,1,mast cell cytokine production,BP,
2461,GO:0032781,1,0.638176348215889,0,1,positive regulation of ATPase activity,BP,
2466,GO:0032795,1,0.697657324108981,0,1,heterotrimeric G-protein binding,MF,
2467,GO:0032800,1,0.679378706287525,0,1,receptor biosynthetic process,BP,
2468,GO:0032801,1,0.711607832986099,0,1,receptor catabolic process,BP,
2469,GO:0032808,1,0.638176348215889,0,1,lacrimal gland development,BP,
2470,GO:0032811,1,0.475084646317265,0,2,negative regulation of epinephrine secretion,BP,
2471,GO:0032814,1,0.690185661474723,0,1,regulation of natural killer cell activation,BP,
2472,GO:0032816,1,0.690185661474723,0,1,positive regulation of natural killer cell activation,BP,
2473,GO:0032823,1,0.690185661474723,0,1,regulation of natural killer cell differentiation,BP,
2474,GO:0032825,1,0.690185661474723,0,1,positive regulation of natural killer cell differentiation,BP,
2476,GO:0032836,1,0.700771912592825,0,1,glomerular basement membrane development,BP,
2479,GO:0032846,1,0.33391811878667,0,3,positive regulation of homeostatic process,BP,
2484,GO:0032873,1,0.698158470740301,0,1,negative regulation of stress-activated MAPK cascade,BP,
2488,GO:0032881,1,0.486742379985589,0,2,regulation of polysaccharide metabolic process,BP,
2489,GO:0032885,1,0.486742379985589,0,2,regulation of polysaccharide biosynthetic process,BP,
2490,GO:0032886,1,0.327090353459836,0,3,regulation of microtubule-based process,BP,
2491,GO:0032890,1,0.329058383797314,0,3,regulation of organic acid transport,BP,
2492,GO:0032891,1,0.486204882972628,0,2,negative regulation of organic acid transport,BP,
2493,GO:0032892,1,0.679378706287525,0,1,positive regulation of organic acid transport,BP,
2494,GO:0032898,1,0.697657324108981,0,1,neurotrophin production,BP,
2495,GO:0032899,1,0.697657324108981,0,1,regulation of neurotrophin production,BP,
2496,GO:0032900,1,0.697657324108981,0,1,negative regulation of neurotrophin production,BP,
2505,GO:0032946,1,0.290192817274074,0,3,positive regulation of mononuclear cell proliferation,BP,
2513,GO:0032982,1,0.711608210494458,0,1,myosin filament,CC,
2519,GO:0033010,1,0.709095041154607,0,1,paranodal junction,CC,
2520,GO:0033017,1,0.694780337175533,0,1,sarcoplasmic reticulum membrane,CC,
2521,GO:0033018,1,0.694780337175533,0,1,sarcoplasmic reticulum lumen,CC,
2522,GO:0033023,1,0.711607721708387,0,1,mast cell homeostasis,BP,
2523,GO:0033024,1,0.711607721708387,0,1,mast cell apoptotic process,BP,
2524,GO:0033025,1,0.711607721708387,0,1,regulation of mast cell apoptotic process,BP,
2525,GO:0033026,1,0.711607721708387,0,1,negative regulation of mast cell apoptotic process,BP,
2526,GO:0033028,1,0.711607721708387,0,1,myeloid cell apoptotic process,BP,
2527,GO:0033032,1,0.711607721708387,0,1,regulation of myeloid cell apoptotic process,BP,
2528,GO:0033033,1,0.711607721708387,0,1,negative regulation of myeloid cell apoptotic process,BP,
2531,GO:0033044,1,0.710496861605038,0,1,regulation of chromosome organization,BP,
2542,GO:0033093,1,0.47255016617616,0,2,Weibel-Palade body,CC,
2543,GO:0033120,1,0.711607815446889,0,1,positive regulation of RNA splicing,BP,
2546,GO:0033139,1,0.710496861605038,0,1,regulation of peptidyl-serine phosphorylation of STAT protein,BP,
2547,GO:0033141,1,0.710496861605038,0,1,positive regulation of peptidyl-serine phosphorylation of STAT protein,BP,
2549,GO:0033158,1,0.469980442020636,0,2,regulation of protein import into nucleus, translocation,BP,
2550,GO:0033159,1,0.690185661474723,0,1,negative regulation of protein import into nucleus, translocation,BP,
2554,GO:0033218,1,0.23505574762573,0,4,amide binding,MF,
2563,GO:0033327,1,0.674696332807623,0,1,Leydig cell differentiation,BP,
2570,GO:0033558,1,0.711607679660172,0,1,protein deacetylase activity,MF,
2571,GO:0033559,1,0.454640015942075,0,2,unsaturated fatty acid metabolic process,BP,
2572,GO:0033561,1,0.706809127351861,0,1,regulation of water loss via skin,BP,
2575,GO:0033574,1,0.481977097858642,0,2,response to testosterone,BP,
2576,GO:0033598,1,0.711607822536356,0,1,mammary gland epithelial cell proliferation,BP,
2578,GO:0033604,1,0.320789697514815,0,3,negative regulation of catecholamine secretion,BP,
2581,GO:0033613,1,0.704630629043406,0,1,activating transcription factor binding,MF,
2584,GO:0033631,1,0.711422189054973,0,1,cell-cell adhesion mediated by integrin,BP,
2587,GO:0033687,1,0.703191446152061,0,1,osteoblast proliferation,BP,
2588,GO:0033688,1,0.703191446152061,0,1,regulation of osteoblast proliferation,BP,
2589,GO:0033690,1,0.703191446152061,0,1,positive regulation of osteoblast proliferation,BP,
2590,GO:0033692,1,0.484801933609058,0,2,cellular polysaccharide biosynthetic process,BP,
2593,GO:0034059,1,0.685966433896793,0,1,response to anoxia,BP,
2603,GO:0034121,1,0.710679261468123,0,1,regulation of toll-like receptor signaling pathway,BP,
2604,GO:0034122,1,0.710679261468123,0,1,negative regulation of toll-like receptor signaling pathway,BP,
2605,GO:0034198,1,0.68226354479179,0,1,cellular response to amino acid starvation,BP,
2606,GO:0034199,1,0.490299181600157,0,2,activation of protein kinase A activity,BP,
2609,GO:0034236,1,0.690234710370884,0,1,protein kinase A catalytic subunit binding,MF,
2616,GO:0034285,1,0.687957943572463,0,1,response to disaccharide,BP,
2619,GO:0034331,1,0.699990571588227,0,1,cell junction maintenance,BP,
2622,GO:0034340,1,0.711607822536356,0,1,response to type I interferon,BP,
2624,GO:0034349,1,0.486097422926237,0,2,glial cell apoptotic process,BP,
2625,GO:0034350,1,0.486097422926237,0,2,regulation of glial cell apoptotic process,BP,
2626,GO:0034351,1,0.486097422926237,0,2,negative regulation of glial cell apoptotic process,BP,
2627,GO:0034390,1,0.679378706287525,0,1,smooth muscle cell apoptotic process,BP,
2628,GO:0034391,1,0.679378706287525,0,1,regulation of smooth muscle cell apoptotic process,BP,
2629,GO:0034392,1,0.679378706287525,0,1,negative regulation of smooth muscle cell apoptotic process,BP,
2630,GO:0034394,1,0.453189463781812,0,2,protein localization to cell surface,BP,
2632,GO:0034405,1,0.698158470740301,0,1,response to fluid shear stress,BP,
2633,GO:0034440,1,0.493131944016563,0,2,lipid oxidation,BP,
2636,GO:0034453,1,0.699990571588227,0,1,microtubule anchoring,BP,
2638,GO:0034505,1,0.668196837751711,0,1,tooth mineralization,BP,
2640,GO:0034605,1,0.476686157624205,0,2,cellular response to heat,BP,
2644,GO:0034620,1,0.711607815446889,0,1,cellular response to unfolded protein,BP,
2646,GO:0034629,1,0.683763673758394,0,1,cellular protein complex localization,BP,
2647,GO:0034637,1,0.484801933609058,0,2,cellular carbohydrate biosynthetic process,BP,
2649,GO:0034644,1,0.484631874251242,0,2,cellular response to UV,BP,
2651,GO:0034650,1,0.345758439334557,0,3,cortisol metabolic process,BP,
2652,GO:0034651,1,0.345758439334557,0,3,cortisol biosynthetic process,BP,
2656,GO:0034667,1,0.711607657766672,0,1,integrin alpha3-beta1 complex,CC,
2657,GO:0034684,1,0.706386167461074,0,1,integrin alphav-beta5 complex,CC,
2658,GO:0034686,1,0.711609191793077,0,1,integrin alphav-beta8 complex,CC,
2659,GO:0034694,1,0.4734145790807,0,2,response to prostaglandin,BP,
2660,GO:0034695,1,0.698158470740301,0,1,response to prostaglandin E,BP,
2661,GO:0034696,1,0.679378706287525,0,1,response to prostaglandin F,BP,
2665,GO:0034704,1,0.493428569042605,0,2,calcium channel complex,CC,
2667,GO:0034707,1,0.677010844857903,0,1,chloride channel complex,CC,
2669,GO:0034755,1,0.677010844857903,0,1,iron ion transmembrane transport,BP,
2671,GO:0034763,1,0.240419229431657,0,4,negative regulation of transmembrane transport,BP,
2672,GO:0034764,1,0.5000395424614,0,2,positive regulation of transmembrane transport,BP,
2674,GO:0034766,1,0.240419229431657,0,4,negative regulation of ion transmembrane transport,BP,
2675,GO:0034767,1,0.5000395424614,0,2,positive regulation of ion transmembrane transport,BP,
2680,GO:0035014,1,0.504859652900128,0,2,phosphatidylinositol 3-kinase regulator activity,MF,
2682,GO:0035023,1,0.711607657766672,0,1,regulation of Rho protein signal transduction,BP,
2683,GO:0035024,1,0.711607657766672,0,1,negative regulation of Rho protein signal transduction,BP,
2686,GO:0035054,1,0.703191446152061,0,1,embryonic heart tube anterior/posterior pattern specification,BP,
2687,GO:0035065,1,0.710496861605038,0,1,regulation of histone acetylation,BP,
2688,GO:0035066,1,0.710496861605038,0,1,positive regulation of histone acetylation,BP,
2690,GO:0035089,1,0.504934176417217,0,2,establishment of apical/basal cell polarity,BP,
2693,GO:0035094,1,0.679378706287525,0,1,response to nicotine,BP,
2696,GO:0035112,1,0.638176348215889,0,1,genitalia morphogenesis,BP,
2703,GO:0035150,1,0.0296337644744816,0,9,regulation of tube size,BP,
2704,GO:0035162,1,0.50058346462364,0,2,embryonic hemopoiesis,BP,
2708,GO:0035234,1,0.711607721708387,0,1,ectopic germ cell programmed cell death,BP,
2710,GO:0035249,1,0.697657324108981,0,1,synaptic transmission, glutamatergic,BP,
2711,GO:0035250,1,0.695652466100109,0,1,UDP-galactosyltransferase activity,MF,
2719,GO:0035296,1,0.0296337644744816,0,9,regulation of tube diameter,BP,
2720,GO:0035303,1,0.341590592238098,0,3,regulation of dephosphorylation,BP,
2721,GO:0035304,1,0.697657324108981,0,1,regulation of protein dephosphorylation,BP,
2722,GO:0035305,1,0.699990571588227,0,1,negative regulation of dephosphorylation,BP,
2723,GO:0035306,1,0.489724400002346,0,2,positive regulation of dephosphorylation,BP,
2724,GO:0035307,1,0.697657324108981,0,1,positive regulation of protein dephosphorylation,BP,
2729,GO:0035336,1,0.711607686616218,0,1,long-chain fatty-acyl-CoA metabolic process,BP,
2730,GO:0035337,1,0.711607686616218,0,1,fatty-acyl-CoA metabolic process,BP,
2731,GO:0035338,1,0.711607686616218,0,1,long-chain fatty-acyl-CoA biosynthetic process,BP,
2732,GO:0035383,1,0.711607686616218,0,1,thioester metabolic process,BP,
2733,GO:0035384,1,0.711607686616218,0,1,thioester biosynthetic process,BP,
2738,GO:0035455,1,0.690185661474723,0,1,response to interferon-alpha,BP,
2739,GO:0035457,1,0.690185661474723,0,1,cellular response to interferon-alpha,BP,
2740,GO:0035493,1,0.695414751519134,0,1,SNARE complex assembly,BP,
2741,GO:0035502,1,0.700771912592825,0,1,metanephric part of ureteric bud development,BP,
2745,GO:0035579,1,0.33432549489672,0,3,specific granule membrane,CC,
2746,GO:0035580,1,0.696889228938764,0,1,specific granule lumen,CC,
2748,GO:0035586,1,0.697657324108981,0,1,purinergic receptor activity,MF,
2749,GO:0035587,1,0.697657324108981,0,1,purinergic receptor signaling pathway,BP,
2750,GO:0035588,1,0.697657324108981,0,1,G-protein coupled purinergic receptor signaling pathway,BP,
2751,GO:0035591,1,0.711607815446889,0,1,signaling adaptor activity,MF,
2752,GO:0035601,1,0.711607679660172,0,1,protein deacylation,BP,
2753,GO:0035624,1,0.475084646317265,0,2,receptor transactivation,BP,
2754,GO:0035625,1,0.475084646317265,0,2,epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway,BP,
2755,GO:0035630,1,0.703191446152061,0,1,bone mineralization involved in bone maturation,BP,
2759,GO:0035640,1,0.711607657766672,0,1,exploration behavior,BP,
2763,GO:0035655,1,0.486742379985589,0,2,interleukin-18-mediated signaling pathway,BP,
2765,GO:0035690,1,0.23225006638321,0,4,cellular response to drug,BP,
2766,GO:0035701,1,0.690185661474723,0,1,hematopoietic stem cell migration,BP,
2767,GO:0035710,1,0.704630629043406,0,1,CD4-positive, alpha-beta T cell activation,BP,
2768,GO:0035728,1,0.704921978433492,0,1,response to hepatocyte growth factor,BP,
2769,GO:0035729,1,0.704921978433492,0,1,cellular response to hepatocyte growth factor stimulus,BP,
2771,GO:0035754,1,0.690185661474723,0,1,B cell chemotaxis,BP,
2773,GO:0035787,1,0.698425417725528,0,1,cell migration involved in kidney development,BP,
2774,GO:0035788,1,0.698425417725528,0,1,cell migration involved in metanephros development,BP,
2775,GO:0035789,1,0.698425417725528,0,1,metanephric mesenchymal cell migration,BP,
2776,GO:0035791,1,0.698425417725528,0,1,platelet-derived growth factor receptor-beta signaling pathway,BP,
2777,GO:0035793,1,0.698425417725528,0,1,positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
2779,GO:0035801,1,0.700771912592825,0,1,adrenal cortex development,BP,
2780,GO:0035802,1,0.700771912592825,0,1,adrenal cortex formation,BP,
2781,GO:0035809,1,0.482374738024063,0,2,regulation of urine volume,BP,
2782,GO:0035810,1,0.482374738024063,0,2,positive regulation of urine volume,BP,
2783,GO:0035812,1,0.335312388309681,0,3,renal sodium excretion,BP,
2784,GO:0035813,1,0.335312388309681,0,3,regulation of renal sodium excretion,BP,
2785,GO:0035814,1,0.697657324108981,0,1,negative regulation of renal sodium excretion,BP,
2786,GO:0035815,1,0.482374738024063,0,2,positive regulation of renal sodium excretion,BP,
2787,GO:0035821,1,0.677890918061584,0,1,modification of morphology or physiology of other organism,BP,
2790,GO:0035855,1,0.704630629043406,0,1,megakaryocyte development,BP,
2791,GO:0035859,1,0.707555965307343,0,1,Seh1-associated complex,CC,
2793,GO:0035878,1,0.711607798121381,0,1,nail development,BP,
2797,GO:0035902,1,0.70489454545713,0,1,response to immobilization stress,BP,
2809,GO:0035966,1,0.711607815446889,0,1,response to topologically incorrect protein,BP,
2810,GO:0035967,1,0.711607815446889,0,1,cellular response to topologically incorrect protein,BP,
2812,GO:0035987,1,0.501704191455567,0,2,endodermal cell differentiation,BP,
2813,GO:0035988,1,0.685966433896793,0,1,chondrocyte proliferation,BP,
2818,GO:0035994,1,0.679378706287525,0,1,response to muscle stretch,BP,
2820,GO:0036010,1,0.710730522233721,0,1,protein localization to endosome,BP,
2821,GO:0036024,1,0.685229321173304,0,1,protein C inhibitor-TMPRSS7 complex,CC,
2822,GO:0036025,1,0.685229321173304,0,1,protein C inhibitor-TMPRSS11E complex,CC,
2823,GO:0036026,1,0.685229321173304,0,1,protein C inhibitor-PLAT complex,CC,
2824,GO:0036027,1,0.685229321173304,0,1,protein C inhibitor-PLAU complex,CC,
2825,GO:0036028,1,0.685229321173304,0,1,protein C inhibitor-thrombin complex,CC,
2826,GO:0036029,1,0.685229321173304,0,1,protein C inhibitor-KLK3 complex,CC,
2827,GO:0036030,1,0.685229321173304,0,1,protein C inhibitor-plasma kallikrein complex,CC,
2829,GO:0036064,1,0.495967425914134,0,2,ciliary basal body,CC,
2831,GO:0036089,1,0.711607690438396,0,1,cleavage furrow formation,BP,
2832,GO:0036091,1,0.707555965307343,0,1,positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,
2838,GO:0036166,1,0.698425417725528,0,1,phenotypic switching,BP,
2841,GO:0036257,1,0.696889228938764,0,1,multivesicular body organization,BP,
2844,GO:0036296,1,0.68226354479179,0,1,response to increased oxygen levels,BP,
2846,GO:0036312,1,0.711607815446889,0,1,phosphatidylinositol 3-kinase regulatory subunit binding,MF,
2848,GO:0036342,1,0.711607822536356,0,1,post-anal tail morphogenesis,BP,
2849,GO:0036344,1,0.704630629043406,0,1,platelet morphogenesis,BP,
2850,GO:0036379,1,0.711607656239832,0,1,myofilament,CC,
2853,GO:0036473,1,0.698158470740301,0,1,cell death in response to oxidative stress,BP,
2855,GO:0036490,1,0.707555965307343,0,1,regulation of translation in response to endoplasmic reticulum stress,BP,
2856,GO:0036514,1,0.711607822536356,0,1,dopaminergic neuron axon guidance,BP,
2857,GO:0036515,1,0.711607822536356,0,1,serotonergic neuron axon guidance,BP,
2858,GO:0036517,1,0.711607822536356,0,1,chemoattraction of serotonergic neuron axon,BP,
2859,GO:0036518,1,0.711607822536356,0,1,chemorepulsion of dopaminergic neuron axon,BP,
2860,GO:0038001,1,0.698425417725528,0,1,paracrine signaling,BP,
2867,GO:0038061,1,0.698158470740301,0,1,NIK/NF-kappaB signaling,BP,
2868,GO:0038062,1,0.710120408015064,0,1,protein tyrosine kinase collagen receptor activity,MF,
2869,GO:0038063,1,0.710120408015064,0,1,collagen-activated tyrosine kinase receptor signaling pathway,BP,
2870,GO:0038064,1,0.710120408015064,0,1,collagen receptor activity,MF,
2871,GO:0038065,1,0.710120408015064,0,1,collagen-activated signaling pathway,BP,
2872,GO:0038066,1,0.462126340027252,0,2,p38MAPK cascade,BP,
2873,GO:0038083,1,0.710120408015064,0,1,peptidyl-tyrosine autophosphorylation,BP,
2874,GO:0038084,1,0.705560336344585,0,1,vascular endothelial growth factor signaling pathway,BP,
2881,GO:0038132,1,0.711607798121381,0,1,neuregulin binding,MF,
2882,GO:0038166,1,0.711597574443894,0,1,angiotensin-activated signaling pathway,BP,
2883,GO:0038179,1,0.704921978433492,0,1,neurotrophin signaling pathway,BP,
2887,GO:0038201,1,0.501332373633352,0,2,TOR complex,CC,
2888,GO:0038202,1,0.707555965307343,0,1,TORC1 signaling,BP,
2889,GO:0038203,1,0.709721779692915,0,1,TORC2 signaling,BP,
2890,GO:0039663,1,0.690185661474723,0,1,membrane fusion involved in viral entry into host cell,BP,
2892,GO:0040001,1,0.638176348215889,0,1,establishment of mitotic spindle localization,BP,
2902,GO:0040020,1,0.357424161118317,0,3,regulation of meiotic nuclear division,BP,
2905,GO:0040036,1,0.504724794471953,0,2,regulation of fibroblast growth factor receptor signaling pathway,BP,
2906,GO:0040037,1,0.504724794471953,0,2,negative regulation of fibroblast growth factor receptor signaling pathway,BP,
2907,GO:0042033,1,0.711607822536356,0,1,chemokine biosynthetic process,BP,
2910,GO:0042044,1,0.679378706287525,0,1,fluid transport,BP,
2911,GO:0042045,1,0.679378706287525,0,1,epithelial fluid transport,BP,
2913,GO:0042058,1,0.156953327577016,0,5,regulation of epidermal growth factor receptor signaling pathway,BP,
2914,GO:0042059,1,0.689742136494387,0,1,negative regulation of epidermal growth factor receptor signaling pathway,BP,
2920,GO:0042093,1,0.704630629043406,0,1,T-helper cell differentiation,BP,
2921,GO:0042095,1,0.704630629043406,0,1,interferon-gamma biosynthetic process,BP,
2922,GO:0042097,1,0.704630629043406,0,1,interleukin-4 biosynthetic process,BP,
2924,GO:0042100,1,0.456839004123389,0,2,B cell proliferation,BP,
2929,GO:0042116,1,0.711607822536356,0,1,macrophage activation,BP,
2934,GO:0042147,1,0.701975889304016,0,1,retrograde transport, endosome to Golgi,BP,
2936,GO:0042157,1,0.358121979379687,0,3,lipoprotein metabolic process,BP,
2937,GO:0042158,1,0.504931496213516,0,2,lipoprotein biosynthetic process,BP,
2946,GO:0042249,1,0.711607822536356,0,1,establishment of planar polarity of embryonic epithelium,BP,
2947,GO:0042267,1,0.696889228938764,0,1,natural killer cell mediated cytotoxicity,BP,
2948,GO:0042277,1,0.23505574762573,0,4,peptide binding,MF,
2949,GO:0042278,1,0.711596825427955,0,1,purine nucleoside metabolic process,BP,
2950,GO:0042297,1,0.697818647628364,0,1,vocal learning,BP,
2955,GO:0042310,1,0.147175077623414,0,5,vasoconstriction,BP,
2956,GO:0042311,1,0.697657324108981,0,1,vasodilation,BP,
2957,GO:0042313,1,0.679378706287525,0,1,protein kinase C deactivation,BP,
2958,GO:0042321,1,0.697657324108981,0,1,negative regulation of circadian sleep/wake cycle, sleep,BP,
2959,GO:0042323,1,0.697657324108981,0,1,negative regulation of circadian sleep/wake cycle, non-REM sleep,BP,
2964,GO:0042339,1,0.695652466100109,0,1,keratan sulfate metabolic process,BP,
2972,GO:0042383,1,0.711526480882443,0,1,sarcolemma,CC,
2975,GO:0042417,1,0.711314340107367,0,1,dopamine metabolic process,BP,
2978,GO:0042438,1,0.711607822536356,0,1,melanin biosynthetic process,BP,
2979,GO:0042440,1,0.711607822536356,0,1,pigment metabolic process,BP,
2982,GO:0042461,1,0.71160840958516,0,1,photoreceptor cell development,BP,
2983,GO:0042462,1,0.71160840958516,0,1,eye photoreceptor cell development,BP,
2987,GO:0042474,1,0.679378706287525,0,1,middle ear morphogenesis,BP,
2991,GO:0042482,1,0.317338681745175,0,3,positive regulation of odontogenesis,BP,
2997,GO:0042501,1,0.710496861605038,0,1,serine phosphorylation of STAT protein,BP,
2998,GO:0042503,1,0.475830212370733,0,2,tyrosine phosphorylation of Stat3 protein,BP,
2999,GO:0042508,1,0.710496861605038,0,1,tyrosine phosphorylation of Stat1 protein,BP,
3000,GO:0042509,1,0.475830212370733,0,2,regulation of tyrosine phosphorylation of STAT protein,BP,
3001,GO:0042510,1,0.710496861605038,0,1,regulation of tyrosine phosphorylation of Stat1 protein,BP,
3002,GO:0042511,1,0.710496861605038,0,1,positive regulation of tyrosine phosphorylation of Stat1 protein,BP,
3003,GO:0042516,1,0.475830212370733,0,2,regulation of tyrosine phosphorylation of Stat3 protein,BP,
3004,GO:0042517,1,0.475830212370733,0,2,positive regulation of tyrosine phosphorylation of Stat3 protein,BP,
3005,GO:0042531,1,0.475830212370733,0,2,positive regulation of tyrosine phosphorylation of STAT protein,BP,
3006,GO:0042538,1,0.706809127351861,0,1,hyperosmotic salinity response,BP,
3007,GO:0042542,1,0.68651492790583,0,1,response to hydrogen peroxide,BP,
3010,GO:0042554,1,0.679378706287525,0,1,superoxide anion generation,BP,
3011,GO:0042562,1,0.352535584848672,0,3,hormone binding,MF,
3013,GO:0042579,1,0.711607686616218,0,1,microbody,CC,
3014,GO:0042581,1,0.231713108166261,0,4,specific granule,CC,
3016,GO:0042583,1,0.677890918061584,0,1,chromaffin granule,CC,
3018,GO:0042590,1,0.706386167461074,0,1,antigen processing and presentation of exogenous peptide antigen via MHC class I,BP,
3022,GO:0042623,1,0.71160840958516,0,1,ATPase activity, coupled,MF,
3025,GO:0042634,1,0.711607822536356,0,1,regulation of hair cycle,BP,
3026,GO:0042635,1,0.711607822536356,0,1,positive regulation of hair cycle,BP,
3027,GO:0042640,1,0.711607822536356,0,1,anagen,BP,
3032,GO:0042693,1,0.311155478815041,0,3,muscle cell fate commitment,BP,
3033,GO:0042695,1,0.711607822536356,0,1,thelarche,BP,
3035,GO:0042726,1,0.699990571588227,0,1,flavin-containing compound metabolic process,BP,
3036,GO:0042730,1,0.690576730624361,0,1,fibrinolysis,BP,
3038,GO:0042734,1,0.697657324108981,0,1,presynaptic membrane,CC,
3040,GO:0042745,1,0.697657324108981,0,1,circadian sleep/wake cycle,BP,
3041,GO:0042748,1,0.697657324108981,0,1,circadian sleep/wake cycle, non-REM sleep,BP,
3042,GO:0042749,1,0.697657324108981,0,1,regulation of circadian sleep/wake cycle,BP,
3043,GO:0042752,1,0.697657324108981,0,1,regulation of circadian rhythm,BP,
3044,GO:0042754,1,0.697657324108981,0,1,negative regulation of circadian rhythm,BP,
3046,GO:0042771,1,0.68226354479179,0,1,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
3047,GO:0042772,1,0.68226354479179,0,1,DNA damage response, signal transduction resulting in transcription,BP,
3054,GO:0042953,1,0.663076179385611,0,1,lipoprotein transport,BP,
3066,GO:0043015,1,0.505426928191934,0,2,gamma-tubulin binding,MF,
3068,GO:0043027,1,0.690185661474723,0,1,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,MF,
3069,GO:0043028,1,0.690185661474723,0,1,cysteine-type endopeptidase regulator activity involved in apoptotic process,MF,
3071,GO:0043030,1,0.711607822536356,0,1,regulation of macrophage activation,BP,
3072,GO:0043032,1,0.711607822536356,0,1,positive regulation of macrophage activation,BP,
3073,GO:0043034,1,0.692648698175897,0,1,costamere,CC,
3081,GO:0043083,1,0.711611103298453,0,1,synaptic cleft,CC,
3085,GO:0043112,1,0.482574637467434,0,2,receptor metabolic process,BP,
3086,GO:0043113,1,0.711526480882443,0,1,receptor clustering,BP,
3087,GO:0043114,1,0.711314340107367,0,1,regulation of vascular permeability,BP,
3089,GO:0043123,1,0.475118529925922,0,2,positive regulation of I-kappaB kinase/NF-kappaB signaling,BP,
3091,GO:0043125,1,0.711607815446889,0,1,ErbB-3 class receptor binding,MF,
3092,GO:0043130,1,0.711607652756744,0,1,ubiquitin binding,MF,
3093,GO:0043149,1,0.166707348475165,0,5,stress fiber assembly,BP,
3094,GO:0043154,1,0.480976484752435,0,2,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,
3101,GO:0043179,1,0.679378706287525,0,1,rhythmic excitation,BP,
3102,GO:0043184,1,0.711422189054973,0,1,vascular endothelial growth factor receptor 2 binding,MF,
3104,GO:0043195,1,0.484286266994019,0,2,terminal bouton,CC,
3105,GO:0043197,1,0.248805019827528,0,4,dendritic spine,CC,
3106,GO:0043198,1,0.711607733726322,0,1,dendritic shaft,CC,
3107,GO:0043200,1,0.232095530612125,0,4,response to amino acid,BP,
3108,GO:0043201,1,0.707555965307343,0,1,response to leucine,BP,
3109,GO:0043202,1,0.692648698175897,0,1,lysosomal lumen,CC,
3113,GO:0043209,1,0.244450704918828,0,4,myelin sheath,CC,
3114,GO:0043217,1,0.698158470740301,0,1,myelin maintenance,BP,
3115,GO:0043218,1,0.709095041154607,0,1,compact myelin,CC,
3116,GO:0043220,1,0.709095041154607,0,1,Schmidt-Lanterman incisure,CC,
3127,GO:0043236,1,0.711607657766672,0,1,laminin binding,MF,
3130,GO:0043243,1,0.711597574443894,0,1,positive regulation of protein complex disassembly,BP,
3133,GO:0043255,1,0.343201831183977,0,3,regulation of carbohydrate biosynthetic process,BP,
3134,GO:0043256,1,0.505563592135265,0,2,laminin complex,CC,
3135,GO:0043259,1,0.711611103298453,0,1,laminin-10 complex,CC,
3136,GO:0043260,1,0.711611103298453,0,1,laminin-11 complex,CC,
3137,GO:0043266,1,0.240244541529326,0,4,regulation of potassium ion transport,BP,
3138,GO:0043267,1,0.346198368158221,0,3,negative regulation of potassium ion transport,BP,
3139,GO:0043268,1,0.347643442125967,0,3,positive regulation of potassium ion transport,BP,
3144,GO:0043277,1,0.328834324643038,0,3,apoptotic cell clearance,BP,
3145,GO:0043279,1,0.471113927515257,0,2,response to alkaloid,BP,
3148,GO:0043292,1,0.0359629653277321,0,9,contractile fiber,CC,
3149,GO:0043295,1,0.670588974535174,0,1,glutathione binding,MF,
3151,GO:0043297,1,0.462825537860003,0,2,apical junction assembly,BP,
3155,GO:0043316,1,0.696889228938764,0,1,cytotoxic T cell degranulation,BP,
3156,GO:0043320,1,0.696889228938764,0,1,natural killer cell degranulation,BP,
3157,GO:0043325,1,0.698158470740301,0,1,phosphatidylinositol-3,4-bisphosphate binding,MF,
3158,GO:0043330,1,0.683763673758394,0,1,response to exogenous dsRNA,BP,
3160,GO:0043367,1,0.704630629043406,0,1,CD4-positive, alpha-beta T cell differentiation,BP,
3161,GO:0043368,1,0.704630629043406,0,1,positive T cell selection,BP,
3162,GO:0043369,1,0.704630629043406,0,1,CD4-positive or CD8-positive, alpha-beta T cell lineage commitment,BP,
3163,GO:0043373,1,0.704630629043406,0,1,CD4-positive, alpha-beta T cell lineage commitment,BP,
3175,GO:0043413,1,0.695652466100109,0,1,macromolecule glycosylation,BP,
3180,GO:0043455,1,0.711607822536356,0,1,regulation of secondary metabolic process,BP,
3182,GO:0043462,1,0.638176348215889,0,1,regulation of ATPase activity,BP,
3189,GO:0043484,1,0.711607815446889,0,1,regulation of RNA splicing,BP,
3204,GO:0043531,1,0.71160840958516,0,1,ADP binding,MF,
3208,GO:0043536,1,0.486742379985589,0,2,positive regulation of blood vessel endothelial cell migration,BP,
3211,GO:0043543,1,0.504767405059805,0,2,protein acylation,BP,
3213,GO:0043548,1,0.504897609926046,0,2,phosphatidylinositol 3-kinase binding,MF,
3215,GO:0043550,1,0.351397982948657,0,3,regulation of lipid kinase activity,BP,
3216,GO:0043551,1,0.351397982948657,0,3,regulation of phosphatidylinositol 3-kinase activity,BP,
3217,GO:0043552,1,0.698425417725528,0,1,positive regulation of phosphatidylinositol 3-kinase activity,BP,
3218,GO:0043555,1,0.707555965307343,0,1,regulation of translation in response to stress,BP,
3219,GO:0043559,1,0.711607815446889,0,1,insulin binding,MF,
3222,GO:0043567,1,0.703191446152061,0,1,regulation of insulin-like growth factor receptor signaling pathway,BP,
3223,GO:0043569,1,0.703191446152061,0,1,negative regulation of insulin-like growth factor receptor signaling pathway,BP,
3224,GO:0043576,1,0.697657324108981,0,1,regulation of respiratory gaseous exchange,BP,
3227,GO:0043585,1,0.697818647628364,0,1,nose morphogenesis,BP,
3233,GO:0043619,1,0.707555965307343,0,1,regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,
3240,GO:0043679,1,0.325777265935983,0,3,axon terminus,CC,
3241,GO:0043687,1,0.710726924865214,0,1,post-translational protein modification,BP,
3242,GO:0043696,1,0.698425417725528,0,1,dedifferentiation,BP,
3243,GO:0043697,1,0.698425417725528,0,1,cell dedifferentiation,BP,
3245,GO:0043901,1,0.631393261474434,0,1,negative regulation of multi-organism process,BP,
3248,GO:0043931,1,0.703191446152061,0,1,ossification involved in bone maturation,BP,
3250,GO:0043954,1,0.497274080073277,0,2,cellular component maintenance,BP,
3251,GO:0043966,1,0.710496861605038,0,1,histone H3 acetylation,BP,
3252,GO:0043974,1,0.710496861605038,0,1,histone H3-K27 acetylation,BP,
3256,GO:0044042,1,0.698158470740301,0,1,glucan metabolic process,BP,
3260,GO:0044062,1,0.335312388309681,0,3,regulation of excretion,BP,
3261,GO:0044065,1,0.697657324108981,0,1,regulation of respiratory system process,BP,
3262,GO:0044070,1,0.221461102729177,0,4,regulation of anion transport,BP,
3265,GO:0044088,1,0.683763673758394,0,1,regulation of vacuole organization,BP,
3267,GO:0044090,1,0.683763673758394,0,1,positive regulation of vacuole organization,BP,
3268,GO:0044091,1,0.711526480882443,0,1,membrane biogenesis,BP,
3287,GO:0044264,1,0.484801933609058,0,2,cellular polysaccharide metabolic process,BP,
3292,GO:0044272,1,0.494180193759542,0,2,sulfur compound biosynthetic process,BP,
3296,GO:0044291,1,0.357264710251947,0,3,cell-cell contact zone,CC,
3300,GO:0044309,1,0.248805019827528,0,4,neuron spine,CC,
3305,GO:0044331,1,0.505501890588868,0,2,cell-cell adhesion mediated by cadherin,BP,
3311,GO:0044364,1,0.677890918061584,0,1,disruption of cells of other organism,BP,
3312,GO:0044381,1,0.504859652900128,0,2,glucose import in response to insulin stimulus,BP,
3316,GO:0044406,1,0.690185661474723,0,1,adhesion of symbiont to host,BP,
3319,GO:0044420,1,0.505563592135265,0,2,extracellular matrix component,CC,
3324,GO:0044427,1,0.483175951029054,0,2,chromosomal part,CC,
3332,GO:0044438,1,0.711607686616218,0,1,microbody part,CC,
3333,GO:0044439,1,0.711607686616218,0,1,peroxisomal part,CC,
3340,GO:0044449,1,0.0359629653277321,0,9,contractile fiber part,CC,
3341,GO:0044450,1,0.476963810816204,0,2,microtubule organizing center part,CC,
3343,GO:0044454,1,0.711607679660172,0,1,nuclear chromosome part,CC,
3348,GO:0044550,1,0.711607822536356,0,1,secondary metabolite biosynthetic process,BP,
3349,GO:0044557,1,0.697657324108981,0,1,relaxation of smooth muscle,BP,
3350,GO:0044650,1,0.690185661474723,0,1,adhesion of symbiont to host cell,BP,
3364,GO:0044729,1,0.700771912592825,0,1,hemi-methylated DNA-binding,MF,
3372,GO:0044770,1,0.0317700779450563,0,9,cell cycle phase transition,BP,
3373,GO:0044772,1,0.0317700779450563,0,9,mitotic cell cycle phase transition,BP,
3374,GO:0044773,1,0.314799508098407,0,3,mitotic DNA damage checkpoint,BP,
3375,GO:0044774,1,0.314799508098407,0,3,mitotic DNA integrity checkpoint,BP,
3377,GO:0044783,1,0.448309892774536,0,2,G1 DNA damage checkpoint,BP,
3379,GO:0044800,1,0.690185661474723,0,1,multi-organism membrane fusion,BP,
3382,GO:0044803,1,0.690185661474723,0,1,multi-organism membrane organization,BP,
3383,GO:0044818,1,0.70489454545713,0,1,mitotic G2/M transition checkpoint,BP,
3384,GO:0044819,1,0.448309892774536,0,2,mitotic G1/S transition checkpoint,BP,
3385,GO:0044839,1,0.340411814541922,0,3,cell cycle G2/M phase transition,BP,
3386,GO:0044843,1,0.0925903579721187,0,6,cell cycle G1/S phase transition,BP,
3387,GO:0044848,1,0.711607822536356,0,1,biological phase,BP,
3388,GO:0044851,1,0.711607822536356,0,1,hair cycle phase,BP,
3390,GO:0044872,1,0.663076179385611,0,1,lipoprotein localization,BP,
3395,GO:0045022,1,0.710730522233721,0,1,early endosome to late endosome transport,BP,
3396,GO:0045023,1,0.482656081860719,0,2,G0 to G1 transition,BP,
3397,GO:0045026,1,0.685229321173304,0,1,plasma membrane fusion,BP,
3398,GO:0045054,1,0.696889228938764,0,1,constitutive secretory pathway,BP,
3400,GO:0045056,1,0.674513600005999,0,1,transcytosis,BP,
3405,GO:0045072,1,0.704630629043406,0,1,regulation of interferon-gamma biosynthetic process,BP,
3406,GO:0045073,1,0.711607822536356,0,1,regulation of chemokine biosynthetic process,BP,
3407,GO:0045078,1,0.704630629043406,0,1,positive regulation of interferon-gamma biosynthetic process,BP,
3408,GO:0045080,1,0.711607822536356,0,1,positive regulation of chemokine biosynthetic process,BP,
3417,GO:0045117,1,0.679378706287525,0,1,azole transport,BP,
3421,GO:0045125,1,0.670757822166244,0,1,bioactive lipid receptor activity,MF,
3422,GO:0045136,1,0.711607822536356,0,1,development of secondary sexual characteristics,BP,
3427,GO:0045168,1,0.705560336344585,0,1,cell-cell signaling involved in cell fate commitment,BP,
3428,GO:0045171,1,0.470932917534323,0,2,intercellular bridge,CC,
3433,GO:0045187,1,0.697657324108981,0,1,regulation of circadian sleep/wake cycle, sleep,BP,
3434,GO:0045188,1,0.697657324108981,0,1,regulation of circadian sleep/wake cycle, non-REM sleep,BP,
3435,GO:0045190,1,0.670968878396742,0,1,isotype switching,BP,
3436,GO:0045191,1,0.670968878396742,0,1,regulation of isotype switching,BP,
3438,GO:0045198,1,0.504934176417217,0,2,establishment of epithelial cell apical/basal polarity,BP,
3441,GO:0045210,1,0.711607842020405,0,1,FasL biosynthetic process,BP,
3443,GO:0045214,1,0.236474836993802,0,4,sarcomere organization,BP,
3445,GO:0045217,1,0.699990571588227,0,1,cell-cell junction maintenance,BP,
3446,GO:0045218,1,0.699990571588227,0,1,zonula adherens maintenance,BP,
3447,GO:0045294,1,0.495204296200649,0,2,alpha-catenin binding,MF,
3450,GO:0045309,1,0.504859652900128,0,2,protein phosphorylated amino acid binding,MF,
3453,GO:0045334,1,0.487589411508862,0,2,clathrin-coated endocytic vesicle,CC,
3457,GO:0045402,1,0.704630629043406,0,1,regulation of interleukin-4 biosynthetic process,BP,
3458,GO:0045403,1,0.704630629043406,0,1,negative regulation of interleukin-4 biosynthetic process,BP,
3459,GO:0045428,1,0.4734145790807,0,2,regulation of nitric oxide biosynthetic process,BP,
3460,GO:0045429,1,0.4734145790807,0,2,positive regulation of nitric oxide biosynthetic process,BP,
3466,GO:0045494,1,0.710712437150877,0,1,photoreceptor cell maintenance,BP,
3488,GO:0045621,1,0.690185661474723,0,1,positive regulation of lymphocyte differentiation,BP,
3491,GO:0045634,1,0.711607721708387,0,1,regulation of melanocyte differentiation,BP,
3492,GO:0045636,1,0.711607721708387,0,1,positive regulation of melanocyte differentiation,BP,
3496,GO:0045646,1,0.704630629043406,0,1,regulation of erythrocyte differentiation,BP,
3497,GO:0045649,1,0.710496861605038,0,1,regulation of macrophage differentiation,BP,
3498,GO:0045651,1,0.710496861605038,0,1,positive regulation of macrophage differentiation,BP,
3517,GO:0045725,1,0.698158470740301,0,1,positive regulation of glycogen biosynthetic process,BP,
3520,GO:0045736,1,0.68226354479179,0,1,negative regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
3521,GO:0045737,1,0.205736905034085,0,4,positive regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
3522,GO:0045739,1,0.638176348215889,0,1,positive regulation of DNA repair,BP,
3524,GO:0045741,1,0.33022401942811,0,3,positive regulation of epidermal growth factor-activated receptor activity,BP,
3525,GO:0045742,1,0.229280807642413,0,4,positive regulation of epidermal growth factor receptor signaling pathway,BP,
3526,GO:0045744,1,0.711607832986099,0,1,negative regulation of G-protein coupled receptor protein signaling pathway,BP,
3527,GO:0045745,1,0.677890918061584,0,1,positive regulation of G-protein coupled receptor protein signaling pathway,BP,
3531,GO:0045766,1,0.242682464570733,0,4,positive regulation of angiogenesis,BP,
3533,GO:0045777,1,0.697657324108981,0,1,positive regulation of blood pressure,BP,
3539,GO:0045792,1,0.698158470740301,0,1,negative regulation of cell size,BP,
3540,GO:0045793,1,0.679378706287525,0,1,positive regulation of cell size,BP,
3541,GO:0045806,1,0.663076179385611,0,1,negative regulation of endocytosis,BP,
3545,GO:0045823,1,0.314026240310309,0,3,positive regulation of heart contraction,BP,
3546,GO:0045824,1,0.710679261468123,0,1,negative regulation of innate immune response,BP,
3547,GO:0045830,1,0.670968878396742,0,1,positive regulation of isotype switching,BP,
3550,GO:0045835,1,0.710496861605038,0,1,negative regulation of meiotic nuclear division,BP,
3551,GO:0045836,1,0.504724794471953,0,2,positive regulation of meiotic nuclear division,BP,
3562,GO:0045879,1,0.711582810605101,0,1,negative regulation of smoothened signaling pathway,BP,
3565,GO:0045907,1,0.470570888349484,0,2,positive regulation of vasoconstriction,BP,
3566,GO:0045911,1,0.670968878396742,0,1,positive regulation of DNA recombination,BP,
3571,GO:0045922,1,0.698158470740301,0,1,negative regulation of fatty acid metabolic process,BP,
3577,GO:0045933,1,0.314026240310309,0,3,positive regulation of muscle contraction,BP,
3582,GO:0045939,1,0.345758439334557,0,3,negative regulation of steroid metabolic process,BP,
3588,GO:0045986,1,0.470231615006592,0,2,negative regulation of smooth muscle contraction,BP,
3589,GO:0045987,1,0.679378706287525,0,1,positive regulation of smooth muscle contraction,BP,
3591,GO:0045989,1,0.464088604839225,0,2,positive regulation of striated muscle contraction,BP,
3596,GO:0046039,1,0.711596825427955,0,1,GTP metabolic process,BP,
3597,GO:0046058,1,0.204291668476126,0,4,cAMP metabolic process,BP,
3599,GO:0046128,1,0.711596825427955,0,1,purine ribonucleoside metabolic process,BP,
3600,GO:0046148,1,0.711607822536356,0,1,pigment biosynthetic process,BP,
3604,GO:0046209,1,0.4734145790807,0,2,nitric oxide metabolic process,BP,
3605,GO:0046320,1,0.698158470740301,0,1,regulation of fatty acid oxidation,BP,
3606,GO:0046322,1,0.698158470740301,0,1,negative regulation of fatty acid oxidation,BP,
3607,GO:0046323,1,0.174779019952635,0,5,glucose import,BP,
3608,GO:0046324,1,0.24870385933891,0,4,regulation of glucose import,BP,
3609,GO:0046326,1,0.24870385933891,0,4,positive regulation of glucose import,BP,
3611,GO:0046329,1,0.698158470740301,0,1,negative regulation of JNK cascade,BP,
3613,GO:0046331,1,0.705560336344585,0,1,lateral inhibition,BP,
3615,GO:0046364,1,0.707555965307343,0,1,monosaccharide biosynthetic process,BP,
3618,GO:0046394,1,0.454640015942075,0,2,carboxylic acid biosynthetic process,BP,
3622,GO:0046434,1,0.711421550449818,0,1,organophosphate catabolic process,BP,
3623,GO:0046456,1,0.454640015942075,0,2,icosanoid biosynthetic process,BP,
3624,GO:0046457,1,0.454640015942075,0,2,prostanoid biosynthetic process,BP,
3638,GO:0046541,1,0.638176348215889,0,1,saliva secretion,BP,
3639,GO:0046543,1,0.711607822536356,0,1,development of secondary female sexual characteristics,BP,
3644,GO:0046580,1,0.711607657766672,0,1,negative regulation of Ras protein signal transduction,BP,
3645,GO:0046605,1,0.701975889304016,0,1,regulation of centrosome cycle,BP,
3648,GO:0046626,1,0.711607815446889,0,1,regulation of insulin receptor signaling pathway,BP,
3650,GO:0046631,1,0.704630629043406,0,1,alpha-beta T cell activation,BP,
3651,GO:0046632,1,0.704630629043406,0,1,alpha-beta T cell differentiation,BP,
3659,GO:0046685,1,0.68226354479179,0,1,response to arsenic-containing substance,BP,
3660,GO:0046686,1,0.698158470740301,0,1,response to cadmium ion,BP,
3663,GO:0046717,1,0.473073274023053,0,2,acid secretion,BP,
3664,GO:0046718,1,0.120805920148921,0,6,viral entry into host cell,BP,
3665,GO:0046777,1,0.164814494006601,0,5,protein autophosphorylation,BP,
3666,GO:0046785,1,0.448692578745972,0,2,microtubule polymerization,BP,
3668,GO:0046794,1,0.711607661943626,0,1,transport of virus,BP,
3670,GO:0046813,1,0.690185661474723,0,1,receptor-mediated virion attachment to host cell,BP,
3674,GO:0046825,1,0.690185661474723,0,1,regulation of protein export from nucleus,BP,
3675,GO:0046827,1,0.690185661474723,0,1,positive regulation of protein export from nucleus,BP,
3677,GO:0046835,1,0.488644424135502,0,2,carbohydrate phosphorylation,BP,
3678,GO:0046847,1,0.227516368283405,0,4,filopodium assembly,BP,
3686,GO:0046877,1,0.638176348215889,0,1,regulation of saliva secretion,BP,
3703,GO:0046912,1,0.687664047662032,0,1,transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer,MF,
3708,GO:0046935,1,0.504859652900128,0,2,1-phosphatidylinositol-3-kinase regulator activity,MF,
3710,GO:0046942,1,0.232925774049865,0,4,carboxylic acid transport,BP,
3711,GO:0046949,1,0.711607686616218,0,1,fatty-acyl-CoA biosynthetic process,BP,
3712,GO:0046950,1,0.687664047662032,0,1,cellular ketone body metabolic process,BP,
3713,GO:0046951,1,0.687664047662032,0,1,ketone body biosynthetic process,BP,
3718,GO:0047485,1,0.467683694572946,0,2,protein N-terminus binding,MF,
3719,GO:0047676,1,0.711607686616218,0,1,arachidonate-CoA ligase activity,MF,
3720,GO:0048002,1,0.706386167461074,0,1,antigen processing and presentation of peptide antigen,BP,
3721,GO:0048008,1,0.49147724863415,0,2,platelet-derived growth factor receptor signaling pathway,BP,
3722,GO:0048009,1,0.347558114596088,0,3,insulin-like growth factor receptor signaling pathway,BP,
3724,GO:0048011,1,0.704921978433492,0,1,neurotrophin TRK receptor signaling pathway,BP,
3725,GO:0048012,1,0.704921978433492,0,1,hepatocyte growth factor receptor signaling pathway,BP,
3732,GO:0048021,1,0.711607822536356,0,1,regulation of melanin biosynthetic process,BP,
3733,GO:0048022,1,0.711607822536356,0,1,negative regulation of melanin biosynthetic process,BP,
3738,GO:0048070,1,0.711607721708387,0,1,regulation of developmental pigmentation,BP,
3739,GO:0048087,1,0.711607721708387,0,1,positive regulation of developmental pigmentation,BP,
3750,GO:0048179,1,0.699990571588227,0,1,activin receptor complex,CC,
3754,GO:0048237,1,0.679378706287525,0,1,rough endoplasmic reticulum lumen,CC,
3755,GO:0048241,1,0.475084646317265,0,2,epinephrine transport,BP,
3756,GO:0048242,1,0.475084646317265,0,2,epinephrine secretion,BP,
3757,GO:0048243,1,0.475084646317265,0,2,norepinephrine secretion,BP,
3759,GO:0048251,1,0.711608210494458,0,1,elastic fiber assembly,BP,
3763,GO:0048261,1,0.663076179385611,0,1,negative regulation of receptor-mediated endocytosis,BP,
3764,GO:0048262,1,0.699990571588227,0,1,determination of dorsal/ventral asymmetry,BP,
3765,GO:0048263,1,0.699990571588227,0,1,determination of dorsal identity,BP,
3770,GO:0048289,1,0.670968878396742,0,1,isotype switching to IgE isotypes,BP,
3771,GO:0048293,1,0.670968878396742,0,1,regulation of isotype switching to IgE isotypes,BP,
3772,GO:0048295,1,0.670968878396742,0,1,positive regulation of isotype switching to IgE isotypes,BP,
3773,GO:0048306,1,0.694780337175533,0,1,calcium-dependent protein binding,MF,
3779,GO:0048339,1,0.711607822536356,0,1,paraxial mesoderm development,BP,
3780,GO:0048340,1,0.711607822536356,0,1,paraxial mesoderm morphogenesis,BP,
3781,GO:0048341,1,0.711607822536356,0,1,paraxial mesoderm formation,BP,
3787,GO:0048407,1,0.698425417725528,0,1,platelet-derived growth factor binding,MF,
3800,GO:0048512,1,0.697657324108981,0,1,circadian behavior,BP,
3803,GO:0048515,1,0.477535867819087,0,2,spermatid differentiation,BP,
3806,GO:0048520,1,0.697818647628364,0,1,positive regulation of behavior,BP,
3807,GO:0048521,1,0.697657324108981,0,1,negative regulation of behavior,BP,
3811,GO:0048531,1,0.695652466100109,0,1,beta-1,3-galactosyltransferase activity,MF,
3812,GO:0048532,1,0.705560336344585,0,1,anatomical structure arrangement,BP,
3814,GO:0048536,1,0.638176348215889,0,1,spleen development,BP,
3816,GO:0048538,1,0.638176348215889,0,1,thymus development,BP,
3820,GO:0048557,1,0.638176348215889,0,1,embryonic digestive tract morphogenesis,BP,
3822,GO:0048563,1,0.71160840958516,0,1,post-embryonic animal organ morphogenesis,BP,
3824,GO:0048566,1,0.444371329759081,0,2,embryonic digestive tract development,BP,
3826,GO:0048569,1,0.71160840958516,0,1,post-embryonic animal organ development,BP,
3857,GO:0048662,1,0.711314340107367,0,1,negative regulation of smooth muscle cell proliferation,BP,
3859,GO:0048665,1,0.705560336344585,0,1,neuron fate specification,BP,
3867,GO:0048678,1,0.709095041154607,0,1,response to axon injury,BP,
3890,GO:0048752,1,0.638176348215889,0,1,semicircular canal morphogenesis,BP,
3897,GO:0048786,1,0.697657324108981,0,1,presynaptic active zone,CC,
3899,GO:0048799,1,0.703191446152061,0,1,animal organ maturation,BP,
3901,GO:0048807,1,0.638176348215889,0,1,female genitalia morphogenesis,BP,
3902,GO:0048808,1,0.638176348215889,0,1,male genitalia morphogenesis,BP,
3905,GO:0048814,1,0.711607733726322,0,1,regulation of dendrite morphogenesis,BP,
3906,GO:0048818,1,0.711607822536356,0,1,positive regulation of hair follicle maturation,BP,
3907,GO:0048819,1,0.711607822536356,0,1,regulation of hair follicle maturation,BP,
3908,GO:0048820,1,0.711607822536356,0,1,hair follicle maturation,BP,
3915,GO:0048850,1,0.711607822536356,0,1,hypophysis morphogenesis,BP,
3916,GO:0048852,1,0.711607822536356,0,1,diencephalon morphogenesis,BP,
3921,GO:0048861,1,0.710496861605038,0,1,leukemia inhibitory factor signaling pathway,BP,
3929,GO:0050000,1,0.669435136554984,0,1,chromosome localization,BP,
3930,GO:0050220,1,0.670588974535174,0,1,prostaglandin-E synthase activity,MF,
3931,GO:0050308,1,0.711537687634486,0,1,sugar-phosphatase activity,MF,
3932,GO:0050321,1,0.711607652756744,0,1,tau-protein kinase activity,MF,
3933,GO:0050431,1,0.699990571588227,0,1,transforming growth factor beta binding,MF,
3938,GO:0050671,1,0.290192817274074,0,3,positive regulation of lymphocyte proliferation,BP,
3941,GO:0050674,1,0.638176348215889,0,1,urothelial cell proliferation,BP,
3942,GO:0050675,1,0.638176348215889,0,1,regulation of urothelial cell proliferation,BP,
3943,GO:0050677,1,0.638176348215889,0,1,positive regulation of urothelial cell proliferation,BP,
3947,GO:0050701,1,0.4902815083439,0,2,interleukin-1 secretion,BP,
3948,GO:0050702,1,0.711607822536356,0,1,interleukin-1 beta secretion,BP,
3949,GO:0050704,1,0.4902815083439,0,2,regulation of interleukin-1 secretion,BP,
3950,GO:0050706,1,0.711607822536356,0,1,regulation of interleukin-1 beta secretion,BP,
3951,GO:0050707,1,0.4902815083439,0,2,regulation of cytokine secretion,BP,
3954,GO:0050710,1,0.690185661474723,0,1,negative regulation of cytokine secretion,BP,
3955,GO:0050711,1,0.690185661474723,0,1,negative regulation of interleukin-1 secretion,BP,
3957,GO:0050715,1,0.711607822536356,0,1,positive regulation of cytokine secretion,BP,
3958,GO:0050716,1,0.711607822536356,0,1,positive regulation of interleukin-1 secretion,BP,
3959,GO:0050718,1,0.711607822536356,0,1,positive regulation of interleukin-1 beta secretion,BP,
3964,GO:0050728,1,0.494960755982848,0,2,negative regulation of inflammatory response,BP,
3966,GO:0050730,1,0.00984825556808378,0,12,regulation of peptidyl-tyrosine phosphorylation,BP,
3967,GO:0050731,1,0.00984825556808378,0,12,positive regulation of peptidyl-tyrosine phosphorylation,BP,
3968,GO:0050755,1,0.711607822536356,0,1,chemokine metabolic process,BP,
3969,GO:0050764,1,0.322398712051343,0,3,regulation of phagocytosis,BP,
3970,GO:0050766,1,0.322398712051343,0,3,positive regulation of phagocytosis,BP,
3979,GO:0050777,1,0.710679261468123,0,1,negative regulation of immune response,BP,
3986,GO:0050795,1,0.485967251279106,0,2,regulation of behavior,BP,
3989,GO:0050802,1,0.697657324108981,0,1,circadian sleep/wake cycle, sleep,BP,
3992,GO:0050805,1,0.697657324108981,0,1,negative regulation of synaptic transmission,BP,
3998,GO:0050818,1,0.325816047488212,0,3,regulation of coagulation,BP,
3999,GO:0050819,1,0.325816047488212,0,3,negative regulation of coagulation,BP,
4000,GO:0050821,1,0.329174586217092,0,3,protein stabilization,BP,
4001,GO:0050829,1,0.677890918061584,0,1,defense response to Gram-negative bacterium,BP,
4002,GO:0050830,1,0.677890918061584,0,1,defense response to Gram-positive bacterium,BP,
4003,GO:0050832,1,0.677890918061584,0,1,defense response to fungus,BP,
4005,GO:0050840,1,0.711607657766672,0,1,extracellular matrix binding,MF,
4010,GO:0050853,1,0.704921978433492,0,1,B cell receptor signaling pathway,BP,
4012,GO:0050864,1,0.456839004123389,0,2,regulation of B cell activation,BP,
4018,GO:0050871,1,0.456839004123389,0,2,positive regulation of B cell activation,BP,
4019,GO:0050872,1,0.638176348215889,0,1,white fat cell differentiation,BP,
4023,GO:0050880,1,0.0296337644744816,0,9,regulation of blood vessel size,BP,
4025,GO:0050885,1,0.504921695523545,0,2,neuromuscular process controlling balance,BP,
4027,GO:0050890,1,0.11203642139087,0,6,cognition,BP,
4028,GO:0050891,1,0.345351923081703,0,3,multicellular organismal water homeostasis,BP,
4032,GO:0050905,1,0.351133604267599,0,3,neuromuscular process,BP,
4033,GO:0050906,1,0.697657324108981,0,1,detection of stimulus involved in sensory perception,BP,
4035,GO:0050919,1,0.711607822536356,0,1,negative chemotaxis,BP,
4043,GO:0050932,1,0.711607721708387,0,1,regulation of pigment cell differentiation,BP,
4044,GO:0050942,1,0.711607721708387,0,1,positive regulation of pigment cell differentiation,BP,
4045,GO:0050951,1,0.697657324108981,0,1,sensory perception of temperature stimulus,BP,
4048,GO:0050957,1,0.504921695523545,0,2,equilibrioception,BP,
4049,GO:0050961,1,0.697657324108981,0,1,detection of temperature stimulus involved in sensory perception,BP,
4050,GO:0050965,1,0.697657324108981,0,1,detection of temperature stimulus involved in sensory perception of pain,BP,
4053,GO:0050996,1,0.707555965307343,0,1,positive regulation of lipid catabolic process,BP,
4054,GO:0050997,1,0.685229321173304,0,1,quaternary ammonium group binding,MF,
4055,GO:0050999,1,0.698158470740301,0,1,regulation of nitric-oxide synthase activity,BP,
4056,GO:0051000,1,0.698158470740301,0,1,positive regulation of nitric-oxide synthase activity,BP,
4057,GO:0051011,1,0.699990571588227,0,1,microtubule minus-end binding,MF,
4061,GO:0051018,1,0.690234710370884,0,1,protein kinase A binding,MF,
4062,GO:0051020,1,0.253399550675947,0,4,GTPase binding,MF,
4063,GO:0051040,1,0.703191446152061,0,1,regulation of calcium-independent cell-cell adhesion,BP,
4064,GO:0051042,1,0.703191446152061,0,1,negative regulation of calcium-independent cell-cell adhesion,BP,
4072,GO:0051053,1,0.631393261474434,0,1,negative regulation of DNA metabolic process,BP,
4074,GO:0051055,1,0.240205386220189,0,4,negative regulation of lipid biosynthetic process,BP,
4077,GO:0051058,1,0.711607657766672,0,1,negative regulation of small GTPase mediated signal transduction,BP,
4080,GO:0051092,1,0.711607822536356,0,1,positive regulation of NF-kappaB transcription factor activity,BP,
4087,GO:0051117,1,0.683763673758394,0,1,ATPase binding,MF,
4100,GO:0051151,1,0.491458043499325,0,2,negative regulation of smooth muscle cell differentiation,BP,
4104,GO:0051168,1,0.690185661474723,0,1,nuclear export,BP,
4112,GO:0051180,1,0.487599229255244,0,2,vitamin transport,BP,
4113,GO:0051181,1,0.709021995543303,0,1,cofactor transport,BP,
4114,GO:0051183,1,0.487599229255244,0,2,vitamin transporter activity,MF,
4115,GO:0051184,1,0.709021995543303,0,1,cofactor transporter activity,MF,
4117,GO:0051188,1,0.711607686616218,0,1,cofactor biosynthetic process,BP,
4126,GO:0051208,1,0.694780337175533,0,1,sequestering of calcium ion,BP,
4127,GO:0051209,1,0.694780337175533,0,1,release of sequestered calcium ion into cytosol,BP,
4129,GO:0051219,1,0.504859652900128,0,2,phosphoprotein binding,MF,
4130,GO:0051220,1,0.698158470740301,0,1,cytoplasmic sequestering of protein,BP,
4134,GO:0051233,1,0.663076179385611,0,1,spindle midzone,CC,
4137,GO:0051238,1,0.694780337175533,0,1,sequestering of metal ion,BP,
4154,GO:0051262,1,0.711597574443894,0,1,protein tetramerization,BP,
4158,GO:0051276,1,0.15926962475496,0,5,chromosome organization,BP,
4159,GO:0051279,1,0.694780337175533,0,1,regulation of release of sequestered calcium ion into cytosol,BP,
4160,GO:0051280,1,0.694780337175533,0,1,negative regulation of release of sequestered calcium ion into cytosol,BP,
4161,GO:0051282,1,0.694780337175533,0,1,regulation of sequestering of calcium ion,BP,
4162,GO:0051283,1,0.694780337175533,0,1,negative regulation of sequestering of calcium ion,BP,
4163,GO:0051284,1,0.694780337175533,0,1,positive regulation of sequestering of calcium ion,BP,
4164,GO:0051289,1,0.711597574443894,0,1,protein homotetramerization,BP,
4166,GO:0051293,1,0.638176348215889,0,1,establishment of spindle localization,BP,
4167,GO:0051294,1,0.638176348215889,0,1,establishment of spindle orientation,BP,
4168,GO:0051297,1,0.461323785968984,0,2,centrosome organization,BP,
4169,GO:0051298,1,0.701975889304016,0,1,centrosome duplication,BP,
4172,GO:0051303,1,0.669435136554984,0,1,establishment of chromosome localization,BP,
4173,GO:0051310,1,0.669435136554984,0,1,metaphase plate congression,BP,
4174,GO:0051321,1,0.106974608451129,0,6,meiotic cell cycle,BP,
4183,GO:0051373,1,0.711597574443894,0,1,FATZ binding,MF,
4184,GO:0051379,1,0.475084646317265,0,2,epinephrine binding,MF,
4186,GO:0051385,1,0.316069453424921,0,3,response to mineralocorticoid,BP,
4189,GO:0051412,1,0.68226354479179,0,1,response to corticosterone,BP,
4191,GO:0051428,1,0.631393261474434,0,1,peptide hormone receptor binding,MF,
4194,GO:0051445,1,0.15843141299151,0,5,regulation of meiotic cell cycle,BP,
4195,GO:0051446,1,0.504724794471953,0,2,positive regulation of meiotic cell cycle,BP,
4196,GO:0051447,1,0.317348556999183,0,3,negative regulation of meiotic cell cycle,BP,
4200,GO:0051482,1,0.679378706287525,0,1,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,BP,
4201,GO:0051489,1,0.338015371990405,0,3,regulation of filopodium assembly,BP,
4202,GO:0051491,1,0.502995718438404,0,2,positive regulation of filopodium assembly,BP,
4203,GO:0051492,1,0.237661167732212,0,4,regulation of stress fiber assembly,BP,
4207,GO:0051496,1,0.335721340138578,0,3,positive regulation of stress fiber assembly,BP,
4208,GO:0051531,1,0.711607815446889,0,1,NFAT protein import into nucleus,BP,
4209,GO:0051541,1,0.686410749449883,0,1,elastin metabolic process,BP,
4210,GO:0051542,1,0.686410749449883,0,1,elastin biosynthetic process,BP,
4211,GO:0051543,1,0.686410749449883,0,1,regulation of elastin biosynthetic process,BP,
4212,GO:0051545,1,0.686410749449883,0,1,negative regulation of elastin biosynthetic process,BP,
4213,GO:0051546,1,0.437071231541646,0,2,keratinocyte migration,BP,
4214,GO:0051547,1,0.437071231541646,0,2,regulation of keratinocyte migration,BP,
4215,GO:0051549,1,0.437071231541646,0,2,positive regulation of keratinocyte migration,BP,
4221,GO:0051592,1,0.222680878327514,0,4,response to calcium ion,BP,
4222,GO:0051601,1,0.683763673758394,0,1,exocyst localization,BP,
4226,GO:0051606,1,0.22615494243348,0,4,detection of stimulus,BP,
4228,GO:0051608,1,0.679378706287525,0,1,histamine transport,BP,
4229,GO:0051639,1,0.711607656239832,0,1,actin filament network formation,BP,
4236,GO:0051653,1,0.638176348215889,0,1,spindle localization,BP,
4238,GO:0051668,1,0.711526480882443,0,1,localization within membrane,BP,
4241,GO:0051695,1,0.711597574443894,0,1,actin filament uncapping,BP,
4246,GO:0051721,1,0.698158470740301,0,1,protein phosphatase 2A binding,MF,
4251,GO:0051771,1,0.679378706287525,0,1,negative regulation of nitric-oxide synthase biosynthetic process,BP,
4256,GO:0051797,1,0.711607822536356,0,1,regulation of hair follicle development,BP,
4257,GO:0051798,1,0.711607822536356,0,1,positive regulation of hair follicle development,BP,
4260,GO:0051875,1,0.332660862239233,0,3,pigment granule localization,BP,
4262,GO:0051884,1,0.711607822536356,0,1,regulation of timing of anagen,BP,
4263,GO:0051885,1,0.711607822536356,0,1,positive regulation of timing of anagen,BP,
4264,GO:0051893,1,0.491225090785894,0,2,regulation of focal adhesion assembly,BP,
4265,GO:0051894,1,0.491225090785894,0,2,positive regulation of focal adhesion assembly,BP,
4268,GO:0051899,1,0.477309954565902,0,2,membrane depolarization,BP,
4269,GO:0051904,1,0.332660862239233,0,3,pigment granule transport,BP,
4270,GO:0051905,1,0.332660862239233,0,3,establishment of pigment granule localization,BP,
4272,GO:0051926,1,0.694780337175533,0,1,negative regulation of calcium ion transport,BP,
4273,GO:0051928,1,0.698425417725528,0,1,positive regulation of calcium ion transport,BP,
4274,GO:0051930,1,0.3182012577437,0,3,regulation of sensory perception of pain,BP,
4275,GO:0051931,1,0.3182012577437,0,3,regulation of sensory perception,BP,
4276,GO:0051932,1,0.697657324108981,0,1,synaptic transmission, GABAergic,BP,
4281,GO:0051953,1,0.222541652274126,0,4,negative regulation of amine transport,BP,
4283,GO:0051955,1,0.697657324108981,0,1,regulation of amino acid transport,BP,
4284,GO:0051956,1,0.697657324108981,0,1,negative regulation of amino acid transport,BP,
4289,GO:0051964,1,0.711607822536356,0,1,negative regulation of synapse assembly,BP,
4291,GO:0051966,1,0.697657324108981,0,1,regulation of synaptic transmission, glutamatergic,BP,
4292,GO:0051967,1,0.697657324108981,0,1,negative regulation of synaptic transmission, glutamatergic,BP,
4300,GO:0055003,1,0.711607656239832,0,1,cardiac myofibril assembly,BP,
4320,GO:0055070,1,0.710726924865214,0,1,copper ion homeostasis,BP,
4323,GO:0055075,1,0.703878036725278,0,1,potassium ion homeostasis,BP,
4325,GO:0055078,1,0.335312388309681,0,3,sodium ion homeostasis,BP,
4330,GO:0055088,1,0.707555965307343,0,1,lipid homeostasis,BP,
4331,GO:0055090,1,0.707555965307343,0,1,acylglycerol homeostasis,BP,
4332,GO:0055093,1,0.68226354479179,0,1,response to hyperoxia,BP,
4337,GO:0055119,1,0.481387071134835,0,2,relaxation of cardiac muscle,BP,
4339,GO:0055131,1,0.703878036725278,0,1,C3HC4-type RING finger domain binding,MF,
4340,GO:0060019,1,0.453143963704777,0,2,radial glial cell differentiation,BP,
4342,GO:0060024,1,0.679378706287525,0,1,rhythmic synaptic transmission,BP,
4343,GO:0060026,1,0.711607822536356,0,1,convergent extension,BP,
4344,GO:0060027,1,0.711607822536356,0,1,convergent extension involved in gastrulation,BP,
4345,GO:0060028,1,0.711607822536356,0,1,convergent extension involved in axis elongation,BP,
4346,GO:0060029,1,0.711607822536356,0,1,convergent extension involved in organogenesis,BP,
4347,GO:0060031,1,0.711607822536356,0,1,mediolateral intercalation,BP,
4351,GO:0060041,1,0.474647886122905,0,2,retina development in camera-type eye,BP,
4352,GO:0060042,1,0.705560336344585,0,1,retina morphogenesis in camera-type eye,BP,
4365,GO:0060067,1,0.711607822536356,0,1,cervix development,BP,
4366,GO:0060068,1,0.504897614976031,0,2,vagina development,BP,
4370,GO:0060076,1,0.505426931764323,0,2,excitatory synapse,CC,
4373,GO:0060087,1,0.697657324108981,0,1,relaxation of vascular smooth muscle,BP,
4374,GO:0060088,1,0.71160840958516,0,1,auditory receptor cell stereocilium organization,BP,
4376,GO:0060090,1,0.490281503438804,0,2,binding, bridging,MF,
4378,GO:0060117,1,0.71160840958516,0,1,auditory receptor cell development,BP,
4379,GO:0060119,1,0.348511604322686,0,3,inner ear receptor cell development,BP,
4381,GO:0060122,1,0.348511604322686,0,3,inner ear receptor stereocilium organization,BP,
4382,GO:0060126,1,0.710436959244465,0,1,somatotropin secreting cell differentiation,BP,
4386,GO:0060136,1,0.711607686616218,0,1,embryonic process involved in female pregnancy,BP,
4387,GO:0060137,1,0.679378706287525,0,1,maternal process involved in parturition,BP,
4391,GO:0060157,1,0.711607822536356,0,1,urinary bladder development,BP,
4395,GO:0060178,1,0.683763673758394,0,1,regulation of exocyst localization,BP,
4396,GO:0060191,1,0.670757822166244,0,1,regulation of lipase activity,BP,
4397,GO:0060193,1,0.670757822166244,0,1,positive regulation of lipase activity,BP,
4400,GO:0060215,1,0.704630629043406,0,1,primitive hemopoiesis,BP,
4401,GO:0060216,1,0.704630629043406,0,1,definitive hemopoiesis,BP,
4404,GO:0060236,1,0.669435136554984,0,1,regulation of mitotic spindle organization,BP,
4413,GO:0060281,1,0.631393261474434,0,1,regulation of oocyte development,BP,
4414,GO:0060283,1,0.631393261474434,0,1,negative regulation of oocyte development,BP,
4416,GO:0060292,1,0.697657324108981,0,1,long term synaptic depression,BP,
4417,GO:0060297,1,0.679378706287525,0,1,regulation of sarcomere organization,BP,
4418,GO:0060298,1,0.679378706287525,0,1,positive regulation of sarcomere organization,BP,
4419,GO:0060306,1,0.488174884959963,0,2,regulation of membrane repolarization,BP,
4420,GO:0060307,1,0.703878036725278,0,1,regulation of ventricular cardiac muscle cell membrane repolarization,BP,
4421,GO:0060314,1,0.694780337175533,0,1,regulation of ryanodine-sensitive calcium-release channel activity,BP,
4422,GO:0060315,1,0.694780337175533,0,1,negative regulation of ryanodine-sensitive calcium-release channel activity,BP,
4424,GO:0060318,1,0.704630629043406,0,1,definitive erythrocyte differentiation,BP,
4425,GO:0060319,1,0.704630629043406,0,1,primitive erythrocyte differentiation,BP,
4428,GO:0060324,1,0.236607120700597,0,4,face development,BP,
4429,GO:0060325,1,0.334238267392283,0,3,face morphogenesis,BP,
4431,GO:0060337,1,0.711607822536356,0,1,type I interferon signaling pathway,BP,
4432,GO:0060338,1,0.711607822536356,0,1,regulation of type I interferon-mediated signaling pathway,BP,
4433,GO:0060340,1,0.711607822536356,0,1,positive regulation of type I interferon-mediated signaling pathway,BP,
4440,GO:0060351,1,0.631393261474434,0,1,cartilage development involved in endochondral bone morphogenesis,BP,
4442,GO:0060374,1,0.704630629043406,0,1,mast cell differentiation,BP,
4443,GO:0060375,1,0.704630629043406,0,1,regulation of mast cell differentiation,BP,
4444,GO:0060377,1,0.704630629043406,0,1,negative regulation of mast cell differentiation,BP,
4451,GO:0060396,1,0.711607815446889,0,1,growth hormone receptor signaling pathway,BP,
4452,GO:0060401,1,0.475701274247711,0,2,cytosolic calcium ion transport,BP,
4453,GO:0060402,1,0.694780337175533,0,1,calcium ion transport into cytosol,BP,
4456,GO:0060413,1,0.49237865723648,0,2,atrial septum morphogenesis,BP,
4458,GO:0060416,1,0.49596753977048,0,2,response to growth hormone,BP,
4465,GO:0060426,1,0.494948074022282,0,2,lung vasculature development,BP,
4468,GO:0060430,1,0.444371329759081,0,2,lung saccule development,BP,
4470,GO:0060432,1,0.638176348215889,0,1,lung pattern specification process,BP,
4472,GO:0060435,1,0.638176348215889,0,1,bronchiole development,BP,
4473,GO:0060436,1,0.638176348215889,0,1,bronchiole morphogenesis,BP,
4474,GO:0060437,1,0.638176348215889,0,1,lung growth,BP,
4483,GO:0060447,1,0.638176348215889,0,1,bud outgrowth involved in lung branching,BP,
4485,GO:0060452,1,0.464088604839225,0,2,positive regulation of cardiac muscle contraction,BP,
4487,GO:0060462,1,0.710496861605038,0,1,lung lobe development,BP,
4488,GO:0060463,1,0.710496861605038,0,1,lung lobe morphogenesis,BP,
4489,GO:0060479,1,0.638176348215889,0,1,lung cell differentiation,BP,
4492,GO:0060487,1,0.638176348215889,0,1,lung epithelial cell differentiation,BP,
4495,GO:0060495,1,0.638176348215889,0,1,cell-cell signaling involved in lung development,BP,
4496,GO:0060496,1,0.638176348215889,0,1,mesenchymal-epithelial cell signaling involved in lung development,BP,
4500,GO:0060510,1,0.638176348215889,0,1,Type II pneumocyte differentiation,BP,
4510,GO:0060539,1,0.488145739179712,0,2,diaphragm development,BP,
4521,GO:0060574,1,0.68226354479179,0,1,intestinal epithelial cell maturation,BP,
4522,GO:0060575,1,0.68226354479179,0,1,intestinal epithelial cell differentiation,BP,
4523,GO:0060576,1,0.68226354479179,0,1,intestinal epithelial cell development,BP,
4524,GO:0060584,1,0.679378706287525,0,1,regulation of prostaglandin-endoperoxide synthase activity,BP,
4525,GO:0060585,1,0.679378706287525,0,1,positive regulation of prostaglandin-endoperoxide synthase activity,BP,
4529,GO:0060594,1,0.638176348215889,0,1,mammary gland specification,BP,
4530,GO:0060595,1,0.638176348215889,0,1,fibroblast growth factor receptor signaling pathway involved in mammary gland specification,BP,
4531,GO:0060599,1,0.711607822536356,0,1,lateral sprouting involved in mammary gland duct morphogenesis,BP,
4537,GO:0060615,1,0.638176348215889,0,1,mammary gland bud formation,BP,
4539,GO:0060638,1,0.308430727089525,0,3,mesenchymal-epithelial cell signaling,BP,
4540,GO:0060644,1,0.698158470740301,0,1,mammary gland epithelial cell differentiation,BP,
4541,GO:0060648,1,0.638176348215889,0,1,mammary gland bud morphogenesis,BP,
4542,GO:0060661,1,0.638176348215889,0,1,submandibular salivary gland formation,BP,
4543,GO:0060664,1,0.638176348215889,0,1,epithelial cell proliferation involved in salivary gland morphogenesis,BP,
4544,GO:0060665,1,0.638176348215889,0,1,regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling,BP,
4545,GO:0060667,1,0.638176348215889,0,1,branch elongation involved in salivary gland morphogenesis,BP,
4557,GO:0060693,1,0.638176348215889,0,1,regulation of branching involved in salivary gland morphogenesis,BP,
4558,GO:0060706,1,0.495190057262179,0,2,cell differentiation involved in embryonic placenta development,BP,
4559,GO:0060707,1,0.710496861605038,0,1,trophoblast giant cell differentiation,BP,
4560,GO:0060708,1,0.710496861605038,0,1,spongiotrophoblast differentiation,BP,
4561,GO:0060709,1,0.698158470740301,0,1,glycogen cell differentiation involved in embryonic placenta development,BP,
4564,GO:0060712,1,0.495190057262179,0,2,spongiotrophoblast layer development,BP,
4569,GO:0060744,1,0.711607822536356,0,1,mammary gland branching involved in thelarche,BP,
4571,GO:0060748,1,0.710436959244465,0,1,tertiary branching involved in mammary gland duct morphogenesis,BP,
4572,GO:0060749,1,0.710120408015064,0,1,mammary gland alveolus development,BP,
4573,GO:0060750,1,0.711607822536356,0,1,epithelial cell proliferation involved in mammary gland duct elongation,BP,
4574,GO:0060751,1,0.711607822536356,0,1,branch elongation involved in mammary gland duct branching,BP,
4575,GO:0060759,1,0.331829540618339,0,3,regulation of response to cytokine stimulus,BP,
4576,GO:0060760,1,0.331829540618339,0,3,positive regulation of response to cytokine stimulus,BP,
4577,GO:0060761,1,0.690185661474723,0,1,negative regulation of response to cytokine stimulus,BP,
4578,GO:0060762,1,0.711607822536356,0,1,regulation of branching involved in mammary gland duct morphogenesis,BP,
4581,GO:0060775,1,0.711607822536356,0,1,planar cell polarity pathway involved in gastrula mediolateral intercalation,BP,
4584,GO:0060804,1,0.703191446152061,0,1,positive regulation of Wnt signaling pathway by BMP signaling pathway,BP,
4585,GO:0060809,1,0.711607822536356,0,1,mesodermal to mesenchymal transition involved in gastrulation,BP,
4588,GO:0060831,1,0.711582810605101,0,1,smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
4590,GO:0060839,1,0.493030973807366,0,2,endothelial cell fate commitment,BP,
4595,GO:0060844,1,0.705560336344585,0,1,arterial endothelial cell fate commitment,BP,
4596,GO:0060846,1,0.705560336344585,0,1,blood vessel endothelial cell fate commitment,BP,
4597,GO:0060847,1,0.705560336344585,0,1,endothelial cell fate specification,BP,
4598,GO:0060853,1,0.705560336344585,0,1,Notch signaling pathway involved in arterial endothelial cell fate commitment,BP,
4600,GO:0060872,1,0.638176348215889,0,1,semicircular canal development,BP,
4601,GO:0060876,1,0.638176348215889,0,1,semicircular canal formation,BP,
4602,GO:0060879,1,0.638176348215889,0,1,semicircular canal fusion,BP,
4605,GO:0060900,1,0.495725184985998,0,2,embryonic camera-type eye formation,BP,
4606,GO:0060907,1,0.711607822536356,0,1,positive regulation of macrophage cytokine production,BP,
4607,GO:0060911,1,0.489671278313654,0,2,cardiac cell fate commitment,BP,
4609,GO:0060915,1,0.638176348215889,0,1,mesenchymal cell differentiation involved in lung development,BP,
4610,GO:0060923,1,0.489671278313654,0,2,cardiac muscle cell fate commitment,BP,
4614,GO:0060957,1,0.699990571588227,0,1,endocardial cell fate commitment,BP,
4633,GO:0061014,1,0.709721779692915,0,1,positive regulation of mRNA catabolic process,BP,
4638,GO:0061029,1,0.697818647628364,0,1,eyelid development in camera-type eye,BP,
4639,GO:0061032,1,0.700771912592825,0,1,visceral serous pericardium development,BP,
4640,GO:0061033,1,0.638176348215889,0,1,secretion by lung epithelial cell involved in lung growth,BP,
4646,GO:0061045,1,0.230237321358011,0,4,negative regulation of wound healing,BP,
4649,GO:0061049,1,0.679378706287525,0,1,cell growth involved in cardiac muscle cell development,BP,
4650,GO:0061050,1,0.679378706287525,0,1,regulation of cell growth involved in cardiac muscle cell development,BP,
4651,GO:0061051,1,0.679378706287525,0,1,positive regulation of cell growth involved in cardiac muscle cell development,BP,
4653,GO:0061054,1,0.710436959244465,0,1,dermatome development,BP,
4656,GO:0061081,1,0.711607822536356,0,1,positive regulation of myeloid leukocyte cytokine production involved in immune response,BP,
4657,GO:0061082,1,0.331096908248864,0,3,myeloid leukocyte cytokine production,BP,
4658,GO:0061097,1,0.103106712052355,0,6,regulation of protein tyrosine kinase activity,BP,
4659,GO:0061098,1,0.103106712052355,0,6,positive regulation of protein tyrosine kinase activity,BP,
4661,GO:0061107,1,0.685229321173304,0,1,seminal vesicle development,BP,
4662,GO:0061110,1,0.677890918061584,0,1,dense core granule biogenesis,BP,
4663,GO:0061115,1,0.638176348215889,0,1,lung proximal/distal axis specification,BP,
4668,GO:0061140,1,0.638176348215889,0,1,lung secretory cell differentiation,BP,
4669,GO:0061143,1,0.697818647628364,0,1,alveolar primary septum development,BP,
4677,GO:0061162,1,0.504934176417217,0,2,establishment of monopolar cell polarity,BP,
4679,GO:0061183,1,0.710436959244465,0,1,regulation of dermatome development,BP,
4680,GO:0061184,1,0.710436959244465,0,1,positive regulation of dermatome development,BP,
4681,GO:0061205,1,0.49490617279667,0,2,paramesonephric duct development,BP,
4689,GO:0061298,1,0.673993362075014,0,1,retina vasculature development in camera-type eye,BP,
4690,GO:0061299,1,0.673993362075014,0,1,retina vasculature morphogenesis in camera-type eye,BP,
4691,GO:0061302,1,0.489530710302661,0,2,smooth muscle cell-matrix adhesion,BP,
4692,GO:0061303,1,0.455669011724091,0,2,cornea development in camera-type eye,BP,
4702,GO:0061339,1,0.504934176417217,0,2,establishment or maintenance of monopolar cell polarity,BP,
4703,GO:0061341,1,0.711607822536356,0,1,non-canonical Wnt signaling pathway involved in heart development,BP,
4704,GO:0061343,1,0.699990571588227,0,1,cell adhesion involved in heart morphogenesis,BP,
4705,GO:0061346,1,0.711607822536356,0,1,planar cell polarity pathway involved in heart morphogenesis,BP,
4706,GO:0061347,1,0.711607822536356,0,1,planar cell polarity pathway involved in outflow tract morphogenesis,BP,
4707,GO:0061348,1,0.711607822536356,0,1,planar cell polarity pathway involved in ventricular septum morphogenesis,BP,
4708,GO:0061349,1,0.711607822536356,0,1,planar cell polarity pathway involved in cardiac right atrium morphogenesis,BP,
4709,GO:0061350,1,0.711607822536356,0,1,planar cell polarity pathway involved in cardiac muscle tissue morphogenesis,BP,
4711,GO:0061354,1,0.711607822536356,0,1,planar cell polarity pathway involved in pericardium morphogenesis,BP,
4712,GO:0061369,1,0.710436959244465,0,1,negative regulation of testicular blood vessel morphogenesis,BP,
4713,GO:0061370,1,0.710436959244465,0,1,testosterone biosynthetic process,BP,
4715,GO:0061377,1,0.710120408015064,0,1,mammary gland lobule development,BP,
4721,GO:0061436,1,0.706809127351861,0,1,establishment of skin barrier,BP,
4726,GO:0061443,1,0.699990571588227,0,1,endocardial cushion cell differentiation,BP,
4727,GO:0061445,1,0.699990571588227,0,1,endocardial cushion cell fate commitment,BP,
4730,GO:0061462,1,0.71160768531545,0,1,protein localization to lysosome,BP,
4732,GO:0061525,1,0.711607822536356,0,1,hindgut development,BP,
4735,GO:0061614,1,0.490265752601685,0,2,pri-miRNA transcription from RNA polymerase II promoter,BP,
4736,GO:0061615,1,0.711537687634486,0,1,glycolytic process through fructose-6-phosphate,BP,
4737,GO:0061620,1,0.711537687634486,0,1,glycolytic process through glucose-6-phosphate,BP,
4738,GO:0061621,1,0.711537687634486,0,1,canonical glycolysis,BP,
4739,GO:0061624,1,0.687957943572463,0,1,fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate,BP,
4742,GO:0061640,1,0.711607690438396,0,1,cytoskeleton-dependent cytokinesis,BP,
4743,GO:0061642,1,0.711607822536356,0,1,chemoattraction of axon,BP,
4744,GO:0061643,1,0.711607822536356,0,1,chemorepulsion of axon,BP,
4747,GO:0061700,1,0.707555965307343,0,1,GATOR2 complex,CC,
4748,GO:0061718,1,0.711537687634486,0,1,glucose catabolic process to pyruvate,BP,
4749,GO:0061724,1,0.707555965307343,0,1,lipophagy,BP,
4750,GO:0061772,1,0.706809127351861,0,1,drug transport across blood-nerve barrier,BP,
4758,GO:0070050,1,0.710679261468123,0,1,neuron cellular homeostasis,BP,
4759,GO:0070053,1,0.692648698175897,0,1,thrombospondin receptor activity,MF,
4762,GO:0070075,1,0.638176348215889,0,1,tear secretion,BP,
4763,GO:0070080,1,0.711597574443894,0,1,titin Z domain binding,MF,
4764,GO:0070085,1,0.695652466100109,0,1,glycosylation,BP,
4766,GO:0070099,1,0.679378706287525,0,1,regulation of chemokine-mediated signaling pathway,BP,
4767,GO:0070101,1,0.679378706287525,0,1,positive regulation of chemokine-mediated signaling pathway,BP,
4768,GO:0070141,1,0.698158470740301,0,1,response to UV-A,BP,
4771,GO:0070162,1,0.711608192397693,0,1,adiponectin secretion,BP,
4772,GO:0070163,1,0.711608192397693,0,1,regulation of adiponectin secretion,BP,
4773,GO:0070164,1,0.711608192397693,0,1,negative regulation of adiponectin secretion,BP,
4775,GO:0070168,1,0.690185661474723,0,1,negative regulation of biomineral tissue development,BP,
4777,GO:0070170,1,0.668196837751711,0,1,regulation of tooth mineralization,BP,
4778,GO:0070172,1,0.668196837751711,0,1,positive regulation of tooth mineralization,BP,
4783,GO:0070230,1,0.711607822536356,0,1,positive regulation of lymphocyte apoptotic process,BP,
4787,GO:0070234,1,0.711607822536356,0,1,positive regulation of T cell apoptotic process,BP,
4791,GO:0070245,1,0.711607822536356,0,1,positive regulation of thymocyte apoptotic process,BP,
4793,GO:0070254,1,0.697657324108981,0,1,mucus secretion,BP,
4794,GO:0070255,1,0.697657324108981,0,1,regulation of mucus secretion,BP,
4795,GO:0070256,1,0.697657324108981,0,1,negative regulation of mucus secretion,BP,
4798,GO:0070278,1,0.685966433896793,0,1,extracellular matrix constituent secretion,BP,
4802,GO:0070296,1,0.694780337175533,0,1,sarcoplasmic reticulum calcium ion transport,BP,
4803,GO:0070301,1,0.68651492790583,0,1,cellular response to hydrogen peroxide,BP,
4805,GO:0070303,1,0.698158470740301,0,1,negative regulation of stress-activated protein kinase signaling cascade,BP,
4809,GO:0070316,1,0.482656081860719,0,2,regulation of G0 to G1 transition,BP,
4810,GO:0070317,1,0.70489454545713,0,1,negative regulation of G0 to G1 transition,BP,
4811,GO:0070318,1,0.685966433896793,0,1,positive regulation of G0 to G1 transition,BP,
4812,GO:0070328,1,0.707555965307343,0,1,triglyceride homeostasis,BP,
4813,GO:0070341,1,0.638176348215889,0,1,fat cell proliferation,BP,
4814,GO:0070343,1,0.638176348215889,0,1,white fat cell proliferation,BP,
4815,GO:0070344,1,0.638176348215889,0,1,regulation of fat cell proliferation,BP,
4816,GO:0070346,1,0.638176348215889,0,1,positive regulation of fat cell proliferation,BP,
4817,GO:0070350,1,0.638176348215889,0,1,regulation of white fat cell proliferation,BP,
4818,GO:0070352,1,0.638176348215889,0,1,positive regulation of white fat cell proliferation,BP,
4821,GO:0070373,1,0.710496861605038,0,1,negative regulation of ERK1 and ERK2 cascade,BP,
4824,GO:0070384,1,0.638176348215889,0,1,Harderian gland development,BP,
4826,GO:0070405,1,0.685229321173304,0,1,ammonium ion binding,MF,
4828,GO:0070444,1,0.711526480882443,0,1,oligodendrocyte progenitor proliferation,BP,
4829,GO:0070445,1,0.711526480882443,0,1,regulation of oligodendrocyte progenitor proliferation,BP,
4830,GO:0070471,1,0.67531451831299,0,1,uterine smooth muscle contraction,BP,
4831,GO:0070472,1,0.67531451831299,0,1,regulation of uterine smooth muscle contraction,BP,
4832,GO:0070473,1,0.67531451831299,0,1,negative regulation of uterine smooth muscle contraction,BP,
4836,GO:0070507,1,0.327090353459836,0,3,regulation of microtubule cytoskeleton organization,BP,
4837,GO:0070509,1,0.484377549970408,0,2,calcium ion import,BP,
4839,GO:0070528,1,0.496157929997474,0,2,protein kinase C signaling,BP,
4840,GO:0070542,1,0.227410253801009,0,4,response to fatty acid,BP,
4842,GO:0070557,1,0.68226354479179,0,1,PCNA-p21 complex,CC,
4846,GO:0070613,1,0.711582810605101,0,1,regulation of protein processing,BP,
4848,GO:0070633,1,0.679378706287525,0,1,transepithelial transport,BP,
4853,GO:0070662,1,0.711607721708387,0,1,mast cell proliferation,BP,
4856,GO:0070665,1,0.205311896581724,0,4,positive regulation of leukocyte proliferation,BP,
4857,GO:0070666,1,0.711607721708387,0,1,regulation of mast cell proliferation,BP,
4858,GO:0070668,1,0.711607721708387,0,1,positive regulation of mast cell proliferation,BP,
4859,GO:0070672,1,0.711607686616218,0,1,response to interleukin-15,BP,
4860,GO:0070673,1,0.342836584539455,0,3,response to interleukin-18,BP,
4863,GO:0070724,1,0.703191446152061,0,1,BMP receptor complex,CC,
4865,GO:0070728,1,0.707555965307343,0,1,leucine binding,MF,
4866,GO:0070742,1,0.700771912592825,0,1,C2H2 zinc finger domain binding,MF,
4868,GO:0070821,1,0.479350895977682,0,2,tertiary granule membrane,CC,
4869,GO:0070822,1,0.711607679660172,0,1,Sin3-type complex,CC,
4870,GO:0070830,1,0.462825537860003,0,2,bicellular tight junction assembly,BP,
4873,GO:0070849,1,0.698158470740301,0,1,response to epidermal growth factor,BP,
4876,GO:0070873,1,0.698158470740301,0,1,regulation of glycogen metabolic process,BP,
4877,GO:0070875,1,0.698158470740301,0,1,positive regulation of glycogen metabolic process,BP,
4881,GO:0070915,1,0.670757822166244,0,1,lysophosphatidic acid receptor activity,MF,
4885,GO:0070977,1,0.703191446152061,0,1,bone maturation,BP,
4888,GO:0071062,1,0.711422189054973,0,1,alphav-beta3 integrin-vitronectin complex,CC,
4889,GO:0071071,1,0.698425417725528,0,1,regulation of phospholipid biosynthetic process,BP,
4890,GO:0071072,1,0.698425417725528,0,1,negative regulation of phospholipid biosynthetic process,BP,
4891,GO:0071156,1,0.134579873219843,0,5,regulation of cell cycle arrest,BP,
4892,GO:0071157,1,0.433111241514699,0,2,negative regulation of cell cycle arrest,BP,
4893,GO:0071158,1,0.314799508098407,0,3,positive regulation of cell cycle arrest,BP,
4900,GO:0071230,1,0.502669864412949,0,2,cellular response to amino acid stimulus,BP,
4901,GO:0071233,1,0.707555965307343,0,1,cellular response to leucine,BP,
4905,GO:0071276,1,0.698158470740301,0,1,cellular response to cadmium ion,BP,
4906,GO:0071277,1,0.482574630350056,0,2,cellular response to calcium ion,BP,
4908,GO:0071284,1,0.706809127351861,0,1,cellular response to lead ion,BP,
4913,GO:0071307,1,0.690185661474723,0,1,cellular response to vitamin K,BP,
4915,GO:0071312,1,0.694780337175533,0,1,cellular response to alkaloid,BP,
4916,GO:0071313,1,0.694780337175533,0,1,cellular response to caffeine,BP,
4922,GO:0071335,1,0.638176348215889,0,1,hair follicle cell proliferation,BP,
4923,GO:0071336,1,0.638176348215889,0,1,regulation of hair follicle cell proliferation,BP,
4924,GO:0071338,1,0.638176348215889,0,1,positive regulation of hair follicle cell proliferation,BP,
4928,GO:0071351,1,0.486742379985589,0,2,cellular response to interleukin-18,BP,
4930,GO:0071357,1,0.711607822536356,0,1,cellular response to type I interferon,BP,
4932,GO:0071360,1,0.683763673758394,0,1,cellular response to exogenous dsRNA,BP,
4934,GO:0071364,1,0.698158470740301,0,1,cellular response to epidermal growth factor stimulus,BP,
4939,GO:0071378,1,0.711607815446889,0,1,cellular response to growth hormone stimulus,BP,
4940,GO:0071379,1,0.698158470740301,0,1,cellular response to prostaglandin stimulus,BP,
4941,GO:0071380,1,0.698158470740301,0,1,cellular response to prostaglandin E stimulus,BP,
4945,GO:0071389,1,0.679378706287525,0,1,cellular response to mineralocorticoid stimulus,BP,
4946,GO:0071394,1,0.710730522233721,0,1,cellular response to testosterone stimulus,BP,
4948,GO:0071398,1,0.33341193792447,0,3,cellular response to fatty acid,BP,
4950,GO:0071415,1,0.694780337175533,0,1,cellular response to purine-containing compound,BP,
4952,GO:0071425,1,0.344230768249683,0,3,hematopoietic stem cell proliferation,BP,
4953,GO:0071435,1,0.703878036725278,0,1,potassium ion export,BP,
4954,GO:0071437,1,0.711607657766672,0,1,invadopodium,CC,
4955,GO:0071438,1,0.711607657766672,0,1,invadopodium membrane,CC,
4963,GO:0071482,1,0.343680777728465,0,3,cellular response to light stimulus,BP,
4964,GO:0071493,1,0.68226354479179,0,1,cellular response to UV-B,BP,
4967,GO:0071505,1,0.698425417725528,0,1,response to mycophenolic acid,BP,
4968,GO:0071506,1,0.698425417725528,0,1,cellular response to mycophenolic acid,BP,
4977,GO:0071616,1,0.711607686616218,0,1,acyl-CoA biosynthetic process,BP,
4980,GO:0071622,1,0.480863174141598,0,2,regulation of granulocyte chemotaxis,BP,
4981,GO:0071624,1,0.679378706287525,0,1,positive regulation of granulocyte chemotaxis,BP,
4985,GO:0071688,1,0.711608210494458,0,1,striated muscle myosin thick filament assembly,BP,
4986,GO:0071695,1,0.49955708558941,0,2,anatomical structure maturation,BP,
4994,GO:0071706,1,0.490281503438804,0,2,tumor necrosis factor superfamily cytokine production,BP,
4995,GO:0071709,1,0.711526480882443,0,1,membrane assembly,BP,
4996,GO:0071715,1,0.679378706287525,0,1,icosanoid transport,BP,
4999,GO:0071733,1,0.704630629043406,0,1,transcriptional activation by promoter-enhancer looping,BP,
5003,GO:0071782,1,0.709685678742096,0,1,endoplasmic reticulum tubular network,CC,
5004,GO:0071786,1,0.709685678742096,0,1,endoplasmic reticulum tubular network organization,BP,
5005,GO:0071800,1,0.710730522233721,0,1,podosome assembly,BP,
5006,GO:0071801,1,0.710730522233721,0,1,regulation of podosome assembly,BP,
5007,GO:0071803,1,0.710730522233721,0,1,positive regulation of podosome assembly,BP,
5013,GO:0071850,1,0.448309892774536,0,2,mitotic cell cycle arrest,BP,
5014,GO:0071855,1,0.679378706287525,0,1,neuropeptide receptor binding,MF,
5015,GO:0071867,1,0.711421550449818,0,1,response to monoamine,BP,
5016,GO:0071868,1,0.711421550449818,0,1,cellular response to monoamine stimulus,BP,
5017,GO:0071869,1,0.711421550449818,0,1,response to catecholamine,BP,
5018,GO:0071870,1,0.711421550449818,0,1,cellular response to catecholamine stimulus,BP,
5019,GO:0071871,1,0.711421550449818,0,1,response to epinephrine,BP,
5020,GO:0071872,1,0.711421550449818,0,1,cellular response to epinephrine stimulus,BP,
5021,GO:0071875,1,0.320789697514815,0,3,adrenergic receptor signaling pathway,BP,
5022,GO:0071880,1,0.320789697514815,0,3,adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
5023,GO:0071883,1,0.475084646317265,0,2,activation of MAPK activity by adrenergic receptor signaling pathway,BP,
5025,GO:0071889,1,0.698158470740301,0,1,14-3-3 protein binding,MF,
5027,GO:0071897,1,0.325008239258118,0,3,DNA biosynthetic process,BP,
5032,GO:0071963,1,0.669519565619261,0,1,establishment or maintenance of cell polarity regulating cell shape,BP,
5033,GO:0071971,1,0.692648698175897,0,1,extracellular exosome assembly,BP,
5034,GO:0071985,1,0.696889228938764,0,1,multivesicular body sorting pathway,BP,
5042,GO:0072014,1,0.705560336344585,0,1,proximal tubule development,BP,
5046,GO:0072033,1,0.710436959244465,0,1,renal vesicle formation,BP,
5047,GO:0072034,1,0.710436959244465,0,1,renal vesicle induction,BP,
5091,GO:0072126,1,0.698425417725528,0,1,positive regulation of glomerular mesangial cell proliferation,BP,
5103,GO:0072160,1,0.710496861605038,0,1,nephron tubule epithelial cell differentiation,BP,
5105,GO:0072162,1,0.710436959244465,0,1,metanephric mesenchymal cell differentiation,BP,
5108,GO:0072166,1,0.700771912592825,0,1,posterior mesonephric tubule development,BP,
5112,GO:0072173,1,0.710436959244465,0,1,metanephric tubule morphogenesis,BP,
5113,GO:0072174,1,0.710436959244465,0,1,metanephric tubule formation,BP,
5118,GO:0072182,1,0.710496861605038,0,1,regulation of nephron tubule epithelial cell differentiation,BP,
5133,GO:0072209,1,0.698425417725528,0,1,metanephric mesangial cell differentiation,BP,
5138,GO:0072223,1,0.488571926906169,0,2,metanephric glomerular mesangium development,BP,
5139,GO:0072224,1,0.488571926906169,0,2,metanephric glomerulus development,BP,
5142,GO:0072239,1,0.488571926906169,0,2,metanephric glomerulus vasculature development,BP,
5144,GO:0072254,1,0.698425417725528,0,1,metanephric glomerular mesangial cell differentiation,BP,
5145,GO:0072255,1,0.698425417725528,0,1,metanephric glomerular mesangial cell development,BP,
5146,GO:0072257,1,0.710496861605038,0,1,metanephric nephron tubule epithelial cell differentiation,BP,
5147,GO:0072262,1,0.700771912592825,0,1,metanephric glomerular mesangial cell proliferation involved in metanephros development,BP,
5152,GO:0072298,1,0.700771912592825,0,1,regulation of metanephric glomerulus development,BP,
5153,GO:0072299,1,0.700771912592825,0,1,negative regulation of metanephric glomerulus development,BP,
5154,GO:0072301,1,0.700771912592825,0,1,regulation of metanephric glomerular mesangial cell proliferation,BP,
5155,GO:0072302,1,0.700771912592825,0,1,negative regulation of metanephric glomerular mesangial cell proliferation,BP,
5156,GO:0072307,1,0.710496861605038,0,1,regulation of metanephric nephron tubule epithelial cell differentiation,BP,
5159,GO:0072320,1,0.677010844857903,0,1,volume-sensitive chloride channel activity,MF,
5160,GO:0072329,1,0.493131944016563,0,2,monocarboxylic acid catabolic process,BP,
5161,GO:0072330,1,0.454640015942075,0,2,monocarboxylic acid biosynthetic process,BP,
5167,GO:0072395,1,0.448309892774536,0,2,signal transduction involved in cell cycle checkpoint,BP,
5168,GO:0072401,1,0.448309892774536,0,2,signal transduction involved in DNA integrity checkpoint,BP,
5169,GO:0072413,1,0.448309892774536,0,2,signal transduction involved in mitotic cell cycle checkpoint,BP,
5170,GO:0072422,1,0.448309892774536,0,2,signal transduction involved in DNA damage checkpoint,BP,
5171,GO:0072431,1,0.448309892774536,0,2,signal transduction involved in mitotic G1 DNA damage checkpoint,BP,
5176,GO:0072509,1,0.456241328422273,0,2,divalent inorganic cation transmembrane transporter activity,MF,
5182,GO:0072523,1,0.711421550449818,0,1,purine-containing compound catabolic process,BP,
5185,GO:0072574,1,0.680084082501265,0,1,hepatocyte proliferation,BP,
5186,GO:0072575,1,0.680084082501265,0,1,epithelial cell proliferation involved in liver morphogenesis,BP,
5187,GO:0072576,1,0.680084082501265,0,1,liver morphogenesis,BP,
5188,GO:0072577,1,0.690185661474723,0,1,endothelial cell apoptotic process,BP,
5190,GO:0072584,1,0.663076179385611,0,1,caveolin-mediated endocytosis,BP,
5193,GO:0072595,1,0.698158470740301,0,1,maintenance of protein localization in organelle,BP,
5195,GO:0072604,1,0.690185661474723,0,1,interleukin-6 secretion,BP,
5196,GO:0072606,1,0.711607822536356,0,1,interleukin-8 secretion,BP,
5198,GO:0072656,1,0.698158470740301,0,1,maintenance of protein location in mitochondrion,BP,
5201,GO:0072661,1,0.690185661474723,0,1,protein targeting to plasma membrane,BP,
5202,GO:0072665,1,0.71160768531545,0,1,protein localization to vacuole,BP,
5207,GO:0075733,1,0.711607661943626,0,1,intracellular transport of virus,BP,
5213,GO:0086001,1,0.500046681553418,0,2,cardiac muscle cell action potential,BP,
5214,GO:0086002,1,0.500046681553418,0,2,cardiac muscle cell action potential involved in contraction,BP,
5215,GO:0086003,1,0.354562771984954,0,3,cardiac muscle cell contraction,BP,
5216,GO:0086004,1,0.505426956940186,0,2,regulation of cardiac muscle cell contraction,BP,
5217,GO:0086005,1,0.500046681553418,0,2,ventricular cardiac muscle cell action potential,BP,
5218,GO:0086008,1,0.703878036725278,0,1,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization,MF,
5219,GO:0086009,1,0.488174884959963,0,2,membrane repolarization,BP,
5220,GO:0086010,1,0.703878036725278,0,1,membrane depolarization during action potential,BP,
5221,GO:0086011,1,0.703878036725278,0,1,membrane repolarization during action potential,BP,
5222,GO:0086013,1,0.703878036725278,0,1,membrane repolarization during cardiac muscle cell action potential,BP,
5223,GO:0086019,1,0.694780337175533,0,1,cell-cell signaling involved in cardiac conduction,BP,
5224,GO:0086023,1,0.677890918061584,0,1,adrenergic receptor signaling pathway involved in heart process,BP,
5225,GO:0086029,1,0.694780337175533,0,1,Purkinje myocyte to ventricular cardiac muscle cell signaling,BP,
5226,GO:0086030,1,0.677890918061584,0,1,adrenergic receptor signaling pathway involved in cardiac muscle relaxation,BP,
5227,GO:0086042,1,0.711607693073371,0,1,cardiac muscle cell-cardiac muscle cell adhesion,BP,
5228,GO:0086065,1,0.493558211083218,0,2,cell communication involved in cardiac conduction,BP,
5229,GO:0086068,1,0.694780337175533,0,1,Purkinje myocyte to ventricular cardiac muscle cell communication,BP,
5230,GO:0086069,1,0.711607693073371,0,1,bundle of His cell to Purkinje myocyte communication,BP,
5231,GO:0086073,1,0.711607693073371,0,1,bundle of His cell-Purkinje myocyte adhesion involved in cell communication,BP,
5232,GO:0086080,1,0.711607693073371,0,1,protein binding involved in heterotypic cell-cell adhesion,MF,
5233,GO:0086083,1,0.711607693073371,0,1,cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication,MF,
5234,GO:0086091,1,0.500046681553418,0,2,regulation of heart rate by cardiac conduction,BP,
5235,GO:0086097,1,0.711597574443894,0,1,phospholipase C-activating angiotensin-activated signaling pathway,BP,
5236,GO:0086103,1,0.677890918061584,0,1,G-protein coupled receptor signaling pathway involved in heart process,BP,
5238,GO:0090003,1,0.249051561228408,0,4,regulation of establishment of protein localization to plasma membrane,BP,
5239,GO:0090004,1,0.351751749188214,0,3,positive regulation of establishment of protein localization to plasma membrane,BP,
5240,GO:0090005,1,0.711596825427955,0,1,negative regulation of establishment of protein localization to plasma membrane,BP,
5241,GO:0090009,1,0.711607822536356,0,1,primitive streak formation,BP,
5242,GO:0090022,1,0.480863174141598,0,2,regulation of neutrophil chemotaxis,BP,
5243,GO:0090023,1,0.679378706287525,0,1,positive regulation of neutrophil chemotaxis,BP,
5246,GO:0090032,1,0.488356881126512,0,2,negative regulation of steroid hormone biosynthetic process,BP,
5247,GO:0090036,1,0.711607822536356,0,1,regulation of protein kinase C signaling,BP,
5248,GO:0090037,1,0.711607822536356,0,1,positive regulation of protein kinase C signaling,BP,
5253,GO:0090075,1,0.334622993835038,0,3,relaxation of muscle,BP,
5259,GO:0090102,1,0.711607822536356,0,1,cochlea development,BP,
5260,GO:0090103,1,0.711607822536356,0,1,cochlea morphogenesis,BP,
5261,GO:0090109,1,0.491225090785894,0,2,regulation of cell-substrate junction assembly,BP,
5263,GO:0090131,1,0.664890465759854,0,1,mesenchyme migration,BP,
5267,GO:0090136,1,0.493610409979617,0,2,epithelial cell-cell adhesion,BP,
5268,GO:0090138,1,0.709095041154607,0,1,regulation of actin cytoskeleton organization by cell-cell adhesion,BP,
5270,GO:0090162,1,0.504934176417217,0,2,establishment of epithelial cell polarity,BP,
5273,GO:0090177,1,0.711607822536356,0,1,establishment of planar polarity involved in neural tube closure,BP,
5274,GO:0090178,1,0.711607822536356,0,1,regulation of establishment of planar polarity involved in neural tube closure,BP,
5275,GO:0090179,1,0.711607822536356,0,1,planar cell polarity pathway involved in neural tube closure,BP,
5285,GO:0090193,1,0.698425417725528,0,1,positive regulation of glomerulus development,BP,
5289,GO:0090201,1,0.698158470740301,0,1,negative regulation of release of cytochrome c from mitochondria,BP,
5290,GO:0090202,1,0.704630629043406,0,1,gene looping,BP,
5293,GO:0090218,1,0.698425417725528,0,1,positive regulation of lipid kinase activity,BP,
5294,GO:0090224,1,0.669435136554984,0,1,regulation of spindle organization,BP,
5299,GO:0090279,1,0.484377549970408,0,2,regulation of calcium ion import,BP,
5300,GO:0090280,1,0.698425417725528,0,1,positive regulation of calcium ion import,BP,
5301,GO:0090281,1,0.694780337175533,0,1,negative regulation of calcium ion import,BP,
5315,GO:0090399,1,0.68226354479179,0,1,replicative senescence,BP,
5316,GO:0090400,1,0.68226354479179,0,1,stress-induced premature senescence,BP,
5322,GO:0090526,1,0.707555965307343,0,1,regulation of gluconeogenesis involved in cellular glucose homeostasis,BP,
5323,GO:0090557,1,0.706809127351861,0,1,establishment of endothelial intestinal barrier,BP,
5326,GO:0090579,1,0.704630629043406,0,1,dsDNA loop formation,BP,
5328,GO:0090598,1,0.638176348215889,0,1,male anatomical structure morphogenesis,BP,
5329,GO:0090630,1,0.711607822536356,0,1,activation of GTPase activity,BP,
5331,GO:0090677,1,0.698425417725528,0,1,reversible differentiation,BP,
5332,GO:0090678,1,0.698425417725528,0,1,cell dedifferentiation involved in phenotypic switching,BP,
5334,GO:0097011,1,0.698158470740301,0,1,cellular response to granulocyte macrophage colony-stimulating factor stimulus,BP,
5335,GO:0097012,1,0.698158470740301,0,1,response to granulocyte macrophage colony-stimulating factor,BP,
5336,GO:0097017,1,0.690185661474723,0,1,renal protein absorption,BP,
5337,GO:0097018,1,0.690185661474723,0,1,renal albumin absorption,BP,
5339,GO:0097028,1,0.690185661474723,0,1,dendritic cell differentiation,BP,
5340,GO:0097038,1,0.711607815446889,0,1,perinuclear endoplasmic reticulum,CC,
5341,GO:0097048,1,0.690185661474723,0,1,dendritic cell apoptotic process,BP,
5342,GO:0097058,1,0.670968878396742,0,1,CRLF-CLCF1 complex,CC,
5343,GO:0097059,1,0.670968878396742,0,1,CNTFR-CLCF1 complex,CC,
5346,GO:0097062,1,0.711607657766672,0,1,dendritic spine maintenance,BP,
5347,GO:0097070,1,0.697818647628364,0,1,ductus arteriosus closure,BP,
5349,GO:0097091,1,0.711526480882443,0,1,synaptic vesicle clustering,BP,
5351,GO:0097101,1,0.705560336344585,0,1,blood vessel endothelial cell fate specification,BP,
5352,GO:0097102,1,0.705560336344585,0,1,endothelial tip cell fate specification,BP,
5353,GO:0097104,1,0.711526480882443,0,1,postsynaptic membrane assembly,BP,
5354,GO:0097106,1,0.711526480882443,0,1,postsynaptic density organization,BP,
5355,GO:0097110,1,0.495780105665782,0,2,scaffold protein binding,MF,
5356,GO:0097118,1,0.711526480882443,0,1,neuroligin clustering involved in postsynaptic membrane assembly,BP,
5357,GO:0097119,1,0.711526480882443,0,1,postsynaptic density protein 95 clustering,BP,
5363,GO:0097179,1,0.685229321173304,0,1,protease inhibitor complex,CC,
5364,GO:0097180,1,0.685229321173304,0,1,serine protease inhibitor complex,CC,
5365,GO:0097181,1,0.685229321173304,0,1,protein C inhibitor-coagulation factor V complex,CC,
5366,GO:0097182,1,0.685229321173304,0,1,protein C inhibitor-coagulation factor Xa complex,CC,
5367,GO:0097183,1,0.685229321173304,0,1,protein C inhibitor-coagulation factor XI complex,CC,
5368,GO:0097186,1,0.711607798121381,0,1,amelogenesis,BP,
5373,GO:0097194,1,0.698158470740301,0,1,execution phase of apoptosis,BP,
5375,GO:0097205,1,0.236768429541921,0,4,renal filtration,BP,
5377,GO:0097241,1,0.690185661474723,0,1,hematopoietic stem cell migration to bone marrow,BP,
5378,GO:0097252,1,0.690185661474723,0,1,oligodendrocyte apoptotic process,BP,
5379,GO:0097278,1,0.696889228938764,0,1,complement-dependent cytotoxicity,BP,
5384,GO:0097325,1,0.711607822536356,0,1,melanocyte proliferation,BP,
5385,GO:0097338,1,0.711582810605101,0,1,response to clozapine,BP,
5390,GO:0097421,1,0.706809127351861,0,1,liver regeneration,BP,
5391,GO:0097425,1,0.677010844857903,0,1,smooth endoplasmic reticulum part,CC,
5402,GO:0097531,1,0.677890918061584,0,1,mast cell migration,BP,
5403,GO:0097546,1,0.490299181600157,0,2,ciliary base,CC,
5404,GO:0097553,1,0.694780337175533,0,1,calcium ion transmembrane import into cytosol,BP,
5405,GO:0097581,1,0.669519565619261,0,1,lamellipodium organization,BP,
5406,GO:0097610,1,0.68651492790583,0,1,cell surface furrow,CC,
5407,GO:0097623,1,0.703878036725278,0,1,potassium ion export across plasma membrane,BP,
5412,GO:0097711,1,0.711607652756744,0,1,ciliary basal body docking,BP,
5417,GO:0097734,1,0.481818789959566,0,2,extracellular exosome biogenesis,BP,
5418,GO:0097746,1,0.0296337644744816,0,9,regulation of blood vessel diameter,BP,
5419,GO:0097755,1,0.43952665134987,0,2,positive regulation of blood vessel diameter,BP,
5420,GO:0097756,1,0.0681067835747696,0,7,negative regulation of blood vessel diameter,BP,
5425,GO:0098563,1,0.673712088381978,0,1,intrinsic component of synaptic vesicle membrane,CC,
5429,GO:0098596,1,0.697818647628364,0,1,imitative learning,BP,
5430,GO:0098597,1,0.697818647628364,0,1,observational learning,BP,
5431,GO:0098598,1,0.697818647628364,0,1,learned vocalization behavior or vocal learning,BP,
5434,GO:0098631,1,0.495261051144328,0,2,protein binding involved in cell adhesion,MF,
5435,GO:0098632,1,0.495261051144328,0,2,protein binding involved in cell-cell adhesion,MF,
5436,GO:0098636,1,0.178106728317616,0,5,protein complex involved in cell adhesion,CC,
5437,GO:0098641,1,0.697167990491339,0,1,cadherin binding involved in cell-cell adhesion,MF,
5439,GO:0098656,1,0.471757790553744,0,2,anion transmembrane transport,BP,
5443,GO:0098661,1,0.677010844857903,0,1,inorganic anion transmembrane transport,BP,
5445,GO:0098668,1,0.703878036725278,0,1,potassium ion export from cell,BP,
5447,GO:0098732,1,0.711607679660172,0,1,macromolecule deacylation,BP,
5460,GO:0098801,1,0.159558610271531,0,5,regulation of renal system process,BP,
5465,GO:0098813,1,0.669435136554984,0,1,nuclear chromosome segregation,BP,
5467,GO:0098827,1,0.709685678742096,0,1,endoplasmic reticulum subcompartment,CC,
5470,GO:0098858,1,0.038711598813289,0,9,actin-based cell projection,CC,
5472,GO:0098868,1,0.631393261474434,0,1,bone growth,BP,
5474,GO:0098900,1,0.711607693073371,0,1,regulation of action potential,BP,
5475,GO:0098901,1,0.711607693073371,0,1,regulation of cardiac muscle cell action potential,BP,
5476,GO:0098911,1,0.711607693073371,0,1,regulation of ventricular cardiac muscle cell action potential,BP,
5477,GO:0098915,1,0.703878036725278,0,1,membrane repolarization during ventricular cardiac muscle cell action potential,BP,
5479,GO:0098927,1,0.710730522233721,0,1,vesicle-mediated transport between endosomal compartments,BP,
5482,GO:0099023,1,0.683763673758394,0,1,tethering complex,CC,
5483,GO:0099024,1,0.478864571687703,0,2,plasma membrane invagination,BP,
5488,GO:0099084,1,0.711526480882443,0,1,postsynaptic specialization organization,BP,
5504,GO:0099622,1,0.703878036725278,0,1,cardiac muscle cell membrane repolarization,BP,
5505,GO:0099623,1,0.703878036725278,0,1,regulation of cardiac muscle cell membrane repolarization,BP,
5506,GO:0099625,1,0.703878036725278,0,1,ventricular cardiac muscle cell membrane repolarization,BP,
5508,GO:0100002,1,0.698158470740301,0,1,negative regulation of protein kinase activity by protein phosphorylation,BP,
5509,GO:0101002,1,0.711604649869897,0,1,ficolin-1-rich granule,CC,
5511,GO:0102391,1,0.711607686616218,0,1,decanoate--CoA ligase activity,MF,
5515,GO:1900019,1,0.711607822536356,0,1,regulation of protein kinase C activity,BP,
5516,GO:1900020,1,0.711607822536356,0,1,positive regulation of protein kinase C activity,BP,
5519,GO:1900046,1,0.325816047488212,0,3,regulation of hemostasis,BP,
5520,GO:1900047,1,0.325816047488212,0,3,negative regulation of hemostasis,BP,
5521,GO:1900076,1,0.504859652900128,0,2,regulation of cellular response to insulin stimulus,BP,
5522,GO:1900078,1,0.504859652900128,0,2,positive regulation of cellular response to insulin stimulus,BP,
5523,GO:1900101,1,0.711607815446889,0,1,regulation of endoplasmic reticulum unfolded protein response,BP,
5524,GO:1900103,1,0.711607815446889,0,1,positive regulation of endoplasmic reticulum unfolded protein response,BP,
5527,GO:1900125,1,0.698425417725528,0,1,regulation of hyaluronan biosynthetic process,BP,
5528,GO:1900127,1,0.698425417725528,0,1,positive regulation of hyaluronan biosynthetic process,BP,
5529,GO:1900141,1,0.690185661474723,0,1,regulation of oligodendrocyte apoptotic process,BP,
5530,GO:1900142,1,0.690185661474723,0,1,negative regulation of oligodendrocyte apoptotic process,BP,
5531,GO:1900165,1,0.690185661474723,0,1,negative regulation of interleukin-6 secretion,BP,
5535,GO:1900186,1,0.663076179385611,0,1,negative regulation of clathrin-dependent endocytosis,BP,
5536,GO:1900193,1,0.631393261474434,0,1,regulation of oocyte maturation,BP,
5537,GO:1900194,1,0.631393261474434,0,1,negative regulation of oocyte maturation,BP,
5538,GO:1900238,1,0.698425417725528,0,1,regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
5539,GO:1900239,1,0.698425417725528,0,1,regulation of phenotypic switching,BP,
5540,GO:1900241,1,0.698425417725528,0,1,positive regulation of phenotypic switching,BP,
5541,GO:1900274,1,0.670757822166244,0,1,regulation of phospholipase C activity,BP,
5542,GO:1900371,1,0.303211425893755,0,3,regulation of purine nucleotide biosynthetic process,BP,
5543,GO:1900372,1,0.679378706287525,0,1,negative regulation of purine nucleotide biosynthetic process,BP,
5544,GO:1900373,1,0.448174318882941,0,2,positive regulation of purine nucleotide biosynthetic process,BP,
5545,GO:1900376,1,0.711607822536356,0,1,regulation of secondary metabolite biosynthetic process,BP,
5546,GO:1900377,1,0.711607822536356,0,1,negative regulation of secondary metabolite biosynthetic process,BP,
5548,GO:1900408,1,0.698158470740301,0,1,negative regulation of cellular response to oxidative stress,BP,
5549,GO:1900452,1,0.697657324108981,0,1,regulation of long term synaptic depression,BP,
5550,GO:1900453,1,0.697657324108981,0,1,negative regulation of long term synaptic depression,BP,
5554,GO:1900736,1,0.677890918061584,0,1,regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
5555,GO:1900738,1,0.677890918061584,0,1,positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
5558,GO:1900744,1,0.462126340027252,0,2,regulation of p38MAPK cascade,BP,
5559,GO:1900745,1,0.462126340027252,0,2,positive regulation of p38MAPK cascade,BP,
5560,GO:1900746,1,0.705560336344585,0,1,regulation of vascular endothelial growth factor signaling pathway,BP,
5561,GO:1900750,1,0.670588974535174,0,1,oligopeptide binding,MF,
5562,GO:1901016,1,0.493551163796482,0,2,regulation of potassium ion transmembrane transporter activity,BP,
5563,GO:1901017,1,0.493551163796482,0,2,negative regulation of potassium ion transmembrane transporter activity,BP,
5564,GO:1901018,1,0.711597574443894,0,1,positive regulation of potassium ion transmembrane transporter activity,BP,
5565,GO:1901019,1,0.493428569042605,0,2,regulation of calcium ion transmembrane transporter activity,BP,
5566,GO:1901020,1,0.694780337175533,0,1,negative regulation of calcium ion transmembrane transporter activity,BP,
5570,GO:1901068,1,0.711596825427955,0,1,guanosine-containing compound metabolic process,BP,
5571,GO:1901077,1,0.481387071134835,0,2,regulation of relaxation of muscle,BP,
5572,GO:1901078,1,0.711421550449818,0,1,negative regulation of relaxation of muscle,BP,
5573,GO:1901079,1,0.677890918061584,0,1,positive regulation of relaxation of muscle,BP,
5576,GO:1901136,1,0.491908729761436,0,2,carbohydrate derivative catabolic process,BP,
5579,GO:1901184,1,0.106701931617293,0,6,regulation of ERBB signaling pathway,BP,
5580,GO:1901185,1,0.472544200211835,0,2,negative regulation of ERBB signaling pathway,BP,
5581,GO:1901186,1,0.229280807642413,0,4,positive regulation of ERBB signaling pathway,BP,
5586,GO:1901264,1,0.463809028589789,0,2,carbohydrate derivative transport,BP,
5588,GO:1901292,1,0.711421550449818,0,1,nucleoside phosphate catabolic process,BP,
5590,GO:1901338,1,0.475084646317265,0,2,catecholamine binding,MF,
5597,GO:1901379,1,0.346198368158221,0,3,regulation of potassium ion transmembrane transport,BP,
5598,GO:1901380,1,0.346198368158221,0,3,negative regulation of potassium ion transmembrane transport,BP,
5599,GO:1901381,1,0.5000395424614,0,2,positive regulation of potassium ion transmembrane transport,BP,
5600,GO:1901385,1,0.711421550449818,0,1,regulation of voltage-gated calcium channel activity,BP,
5605,GO:1901550,1,0.676786941682838,0,1,regulation of endothelial cell development,BP,
5606,GO:1901552,1,0.676786941682838,0,1,positive regulation of endothelial cell development,BP,
5610,GO:1901568,1,0.454640015942075,0,2,fatty acid derivative metabolic process,BP,
5611,GO:1901570,1,0.454640015942075,0,2,fatty acid derivative biosynthetic process,BP,
5612,GO:1901571,1,0.679378706287525,0,1,fatty acid derivative transport,BP,
5619,GO:1901620,1,0.711582810605101,0,1,regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
5620,GO:1901621,1,0.711582810605101,0,1,negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
5621,GO:1901623,1,0.711607822536356,0,1,regulation of lymphocyte chemotaxis,BP,
5622,GO:1901626,1,0.711526480882443,0,1,regulation of postsynaptic membrane organization,BP,
5627,GO:1901657,1,0.711596825427955,0,1,glycosyl compound metabolic process,BP,
5628,GO:1901674,1,0.710496861605038,0,1,regulation of histone H3-K27 acetylation,BP,
5629,GO:1901676,1,0.710496861605038,0,1,positive regulation of histone H3-K27 acetylation,BP,
5630,GO:1901678,1,0.709021995543303,0,1,iron coordination entity transport,BP,
5638,GO:1901724,1,0.698425417725528,0,1,positive regulation of cell proliferation involved in kidney development,BP,
5642,GO:1901841,1,0.711421550449818,0,1,regulation of high voltage-gated calcium channel activity,BP,
5648,GO:1901881,1,0.711597574443894,0,1,positive regulation of protein depolymerization,BP,
5649,GO:1901888,1,0.346006729792224,0,3,regulation of cell junction assembly,BP,
5650,GO:1901890,1,0.346006729792224,0,3,positive regulation of cell junction assembly,BP,
5651,GO:1901897,1,0.481387071134835,0,2,regulation of relaxation of cardiac muscle,BP,
5652,GO:1901898,1,0.711421550449818,0,1,negative regulation of relaxation of cardiac muscle,BP,
5653,GO:1901899,1,0.677890918061584,0,1,positive regulation of relaxation of cardiac muscle,BP,
5656,GO:1901976,1,0.698158470740301,0,1,regulation of cell cycle checkpoint,BP,
5658,GO:1901983,1,0.710496861605038,0,1,regulation of protein acetylation,BP,
5659,GO:1901985,1,0.710496861605038,0,1,positive regulation of protein acetylation,BP,
5660,GO:1901987,1,0.13819391106097,0,5,regulation of cell cycle phase transition,BP,
5661,GO:1901988,1,0.314799508098407,0,3,negative regulation of cell cycle phase transition,BP,
5662,GO:1901990,1,0.13819391106097,0,5,regulation of mitotic cell cycle phase transition,BP,
5663,GO:1901991,1,0.314799508098407,0,3,negative regulation of mitotic cell cycle phase transition,BP,
5665,GO:1902001,1,0.698158470740301,0,1,fatty acid transmembrane transport,BP,
5666,GO:1902010,1,0.707555965307343,0,1,negative regulation of translation in response to endoplasmic reticulum stress,BP,
5667,GO:1902033,1,0.711607721708387,0,1,regulation of hematopoietic stem cell proliferation,BP,
5668,GO:1902035,1,0.711607721708387,0,1,positive regulation of hematopoietic stem cell proliferation,BP,
5671,GO:1902074,1,0.679378706287525,0,1,response to salt,BP,
5675,GO:1902107,1,0.347155966550021,0,3,positive regulation of leukocyte differentiation,BP,
5678,GO:1902115,1,0.226122938125544,0,4,regulation of organelle assembly,BP,
5679,GO:1902117,1,0.226122938125544,0,4,positive regulation of organelle assembly,BP,
5682,GO:1902175,1,0.698158470740301,0,1,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
5683,GO:1902176,1,0.698158470740301,0,1,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
5684,GO:1902224,1,0.687664047662032,0,1,ketone body metabolic process,BP,
5689,GO:1902275,1,0.710496861605038,0,1,regulation of chromatin organization,BP,
5690,GO:1902282,1,0.703878036725278,0,1,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,MF,
5692,GO:1902302,1,0.703878036725278,0,1,regulation of potassium ion export,BP,
5693,GO:1902303,1,0.703878036725278,0,1,negative regulation of potassium ion export,BP,
5699,GO:1902379,1,0.711607822536356,0,1,chemoattractant activity involved in axon guidance,MF,
5700,GO:1902400,1,0.448309892774536,0,2,intracellular signal transduction involved in G1 DNA damage checkpoint,BP,
5701,GO:1902402,1,0.448309892774536,0,2,signal transduction involved in mitotic DNA damage checkpoint,BP,
5702,GO:1902403,1,0.448309892774536,0,2,signal transduction involved in mitotic DNA integrity checkpoint,BP,
5706,GO:1902476,1,0.677010844857903,0,1,chloride transmembrane transport,BP,
5712,GO:1902547,1,0.705560336344585,0,1,regulation of cellular response to vascular endothelial growth factor stimulus,BP,
5713,GO:1902554,1,0.336083049583468,0,3,serine/threonine protein kinase complex,CC,
5717,GO:1902581,1,0.711607661943626,0,1,multi-organism cellular localization,BP,
5719,GO:1902583,1,0.711607661943626,0,1,multi-organism intracellular transport,BP,
5722,GO:1902612,1,0.695717016238432,0,1,regulation of anti-Mullerian hormone signaling pathway,BP,
5723,GO:1902613,1,0.695717016238432,0,1,negative regulation of anti-Mullerian hormone signaling pathway,BP,
5724,GO:1902622,1,0.480863174141598,0,2,regulation of neutrophil migration,BP,
5725,GO:1902624,1,0.679378706287525,0,1,positive regulation of neutrophil migration,BP,
5726,GO:1902652,1,0.687664047662032,0,1,secondary alcohol metabolic process,BP,
5727,GO:1902653,1,0.687664047662032,0,1,secondary alcohol biosynthetic process,BP,
5728,GO:1902656,1,0.694780337175533,0,1,calcium ion import into cytosol,BP,
5738,GO:1902749,1,0.70489454545713,0,1,regulation of cell cycle G2/M phase transition,BP,
5739,GO:1902750,1,0.70489454545713,0,1,negative regulation of cell cycle G2/M phase transition,BP,
5740,GO:1902806,1,0.197584562273638,0,4,regulation of cell cycle G1/S phase transition,BP,
5741,GO:1902807,1,0.448309892774536,0,2,negative regulation of cell cycle G1/S phase transition,BP,
5742,GO:1902850,1,0.669435136554984,0,1,microtubule cytoskeleton organization involved in mitosis,BP,
5744,GO:1902883,1,0.698158470740301,0,1,negative regulation of response to oxidative stress,BP,
5745,GO:1902893,1,0.490265752601685,0,2,regulation of pri-miRNA transcription from RNA polymerase II promoter,BP,
5746,GO:1902894,1,0.698425417725528,0,1,negative regulation of pri-miRNA transcription from RNA polymerase II promoter,BP,
5747,GO:1902895,1,0.490265752601685,0,2,positive regulation of pri-miRNA transcription from RNA polymerase II promoter,BP,
5748,GO:1902897,1,0.711526480882443,0,1,regulation of postsynaptic density protein 95 clustering,BP,
5752,GO:1902911,1,0.336083049583468,0,3,protein kinase complex,CC,
5755,GO:1902946,1,0.710730522233721,0,1,protein localization to early endosome,BP,
5756,GO:1902965,1,0.710730522233721,0,1,regulation of protein localization to early endosome,BP,
5757,GO:1902966,1,0.710730522233721,0,1,positive regulation of protein localization to early endosome,BP,
5760,GO:1903018,1,0.686410749449883,0,1,regulation of glycoprotein metabolic process,BP,
5761,GO:1903019,1,0.686410749449883,0,1,negative regulation of glycoprotein metabolic process,BP,
5762,GO:1903025,1,0.710496861605038,0,1,regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
5764,GO:1903035,1,0.230237321358011,0,4,negative regulation of response to wounding,BP,
5769,GO:1903046,1,0.242367556374041,0,4,meiotic cell cycle process,BP,
5774,GO:1903076,1,0.249051561228408,0,4,regulation of protein localization to plasma membrane,BP,
5775,GO:1903077,1,0.711596825427955,0,1,negative regulation of protein localization to plasma membrane,BP,
5776,GO:1903078,1,0.351751749188214,0,3,positive regulation of protein localization to plasma membrane,BP,
5777,GO:1903115,1,0.505426956940186,0,2,regulation of actin filament-based movement,BP,
5779,GO:1903140,1,0.676786941682838,0,1,regulation of establishment of endothelial barrier,BP,
5780,GO:1903142,1,0.676786941682838,0,1,positive regulation of establishment of endothelial barrier,BP,
5782,GO:1903170,1,0.694780337175533,0,1,negative regulation of calcium ion transmembrane transport,BP,
5783,GO:1903201,1,0.698158470740301,0,1,regulation of oxidative stress-induced cell death,BP,
5784,GO:1903202,1,0.698158470740301,0,1,negative regulation of oxidative stress-induced cell death,BP,
5791,GO:1903313,1,0.709721779692915,0,1,positive regulation of mRNA metabolic process,BP,
5792,GO:1903317,1,0.711582810605101,0,1,regulation of protein maturation,BP,
5795,GO:1903348,1,0.706809127351861,0,1,positive regulation of bicellular tight junction assembly,BP,
5798,GO:1903391,1,0.491225090785894,0,2,regulation of adherens junction organization,BP,
5799,GO:1903393,1,0.491225090785894,0,2,positive regulation of adherens junction organization,BP,
5800,GO:1903409,1,0.328693019287204,0,3,reactive oxygen species biosynthetic process,BP,
5801,GO:1903426,1,0.328693019287204,0,3,regulation of reactive oxygen species biosynthetic process,BP,
5802,GO:1903428,1,0.328693019287204,0,3,positive regulation of reactive oxygen species biosynthetic process,BP,
5803,GO:1903429,1,0.631393261474434,0,1,regulation of cell maturation,BP,
5804,GO:1903430,1,0.631393261474434,0,1,negative regulation of cell maturation,BP,
5805,GO:1903432,1,0.707555965307343,0,1,regulation of TORC1 signaling,BP,
5806,GO:1903433,1,0.696889228938764,0,1,regulation of constitutive secretory pathway,BP,
5807,GO:1903435,1,0.696889228938764,0,1,positive regulation of constitutive secretory pathway,BP,
5811,GO:1903509,1,0.711609191793077,0,1,liposaccharide metabolic process,BP,
5812,GO:1903510,1,0.337380714589545,0,3,mucopolysaccharide metabolic process,BP,
5813,GO:1903514,1,0.694780337175533,0,1,calcium ion transport from endoplasmic reticulum to cytosol,BP,
5818,GO:1903524,1,0.146016903318386,0,5,positive regulation of blood circulation,BP,
5823,GO:1903541,1,0.692648698175897,0,1,regulation of exosomal secretion,BP,
5824,GO:1903543,1,0.692648698175897,0,1,positive regulation of exosomal secretion,BP,
5825,GO:1903544,1,0.706809127351861,0,1,response to butyrate,BP,
5826,GO:1903545,1,0.706809127351861,0,1,cellular response to butyrate,BP,
5827,GO:1903551,1,0.692648698175897,0,1,regulation of extracellular exosome assembly,BP,
5828,GO:1903553,1,0.692648698175897,0,1,positive regulation of extracellular exosome assembly,BP,
5829,GO:1903555,1,0.490281503438804,0,2,regulation of tumor necrosis factor superfamily cytokine production,BP,
5830,GO:1903556,1,0.690185661474723,0,1,negative regulation of tumor necrosis factor superfamily cytokine production,BP,
5831,GO:1903557,1,0.711607815446889,0,1,positive regulation of tumor necrosis factor superfamily cytokine production,BP,
5836,GO:1903649,1,0.710730522233721,0,1,regulation of cytoplasmic transport,BP,
5837,GO:1903651,1,0.710730522233721,0,1,positive regulation of cytoplasmic transport,BP,
5840,GO:1903672,1,0.501115340495006,0,2,positive regulation of sprouting angiogenesis,BP,
5845,GO:1903719,1,0.698158470740301,0,1,regulation of I-kappaB phosphorylation,BP,
5846,GO:1903721,1,0.698158470740301,0,1,positive regulation of I-kappaB phosphorylation,BP,
5847,GO:1903725,1,0.351397982948657,0,3,regulation of phospholipid metabolic process,BP,
5848,GO:1903726,1,0.698425417725528,0,1,negative regulation of phospholipid metabolic process,BP,
5849,GO:1903727,1,0.698425417725528,0,1,positive regulation of phospholipid metabolic process,BP,
5850,GO:1903729,1,0.249051561228408,0,4,regulation of plasma membrane organization,BP,
5853,GO:1903779,1,0.310147967337155,0,3,regulation of cardiac conduction,BP,
5854,GO:1903792,1,0.486204882972628,0,2,negative regulation of anion transport,BP,
5855,GO:1903793,1,0.679378706287525,0,1,positive regulation of anion transport,BP,
5858,GO:1903825,1,0.698158470740301,0,1,organic acid transmembrane transport,BP,
5862,GO:1903830,1,0.6624012920059,0,1,magnesium ion transmembrane transport,BP,
5863,GO:1903844,1,0.332451962597946,0,3,regulation of cellular response to transforming growth factor beta stimulus,BP,
5864,GO:1903845,1,0.675230251448907,0,1,negative regulation of cellular response to transforming growth factor beta stimulus,BP,
5870,GO:1903959,1,0.698158470740301,0,1,regulation of anion transmembrane transport,BP,
5871,GO:1903960,1,0.698158470740301,0,1,negative regulation of anion transmembrane transport,BP,
5876,GO:1904029,1,0.0906639759551637,0,6,regulation of cyclin-dependent protein kinase activity,BP,
5877,GO:1904030,1,0.68226354479179,0,1,negative regulation of cyclin-dependent protein kinase activity,BP,
5878,GO:1904031,1,0.139217621773289,0,5,positive regulation of cyclin-dependent protein kinase activity,BP,
5879,GO:1904035,1,0.690185661474723,0,1,regulation of epithelial cell apoptotic process,BP,
5880,GO:1904036,1,0.690185661474723,0,1,negative regulation of epithelial cell apoptotic process,BP,
5882,GO:1904063,1,0.346198368158221,0,3,negative regulation of cation transmembrane transport,BP,
5883,GO:1904064,1,0.5000395424614,0,2,positive regulation of cation transmembrane transport,BP,
5885,GO:1904262,1,0.707555965307343,0,1,negative regulation of TORC1 signaling,BP,
5886,GO:1904375,1,0.249051561228408,0,4,regulation of protein localization to cell periphery,BP,
5887,GO:1904376,1,0.711596825427955,0,1,negative regulation of protein localization to cell periphery,BP,
5888,GO:1904377,1,0.351751749188214,0,3,positive regulation of protein localization to cell periphery,BP,
5889,GO:1904385,1,0.711597574443894,0,1,cellular response to angiotensin,BP,
5890,GO:1904407,1,0.4734145790807,0,2,positive regulation of nitric oxide metabolic process,BP,
5891,GO:1904502,1,0.707555965307343,0,1,regulation of lipophagy,BP,
5892,GO:1904504,1,0.707555965307343,0,1,positive regulation of lipophagy,BP,
5899,GO:1904705,1,0.698425417725528,0,1,regulation of vascular smooth muscle cell proliferation,BP,
5900,GO:1904707,1,0.698425417725528,0,1,positive regulation of vascular smooth muscle cell proliferation,BP,
5901,GO:1904738,1,0.698425417725528,0,1,vascular associated smooth muscle cell migration,BP,
5905,GO:1904752,1,0.698425417725528,0,1,regulation of vascular associated smooth muscle cell migration,BP,
5906,GO:1904754,1,0.698425417725528,0,1,positive regulation of vascular associated smooth muscle cell migration,BP,
5907,GO:1904813,1,0.711604649869897,0,1,ficolin-1-rich granule lumen,CC,
5910,GO:1904862,1,0.711607822536356,0,1,inhibitory synapse assembly,BP,
5918,GO:1904933,1,0.711607822536356,0,1,regulation of cell proliferation in midbrain,BP,
5919,GO:1904934,1,0.711607822536356,0,1,negative regulation of cell proliferation in midbrain,BP,
5920,GO:1904938,1,0.711607822536356,0,1,planar cell polarity pathway involved in axon guidance,BP,
5926,GO:1904955,1,0.711607822536356,0,1,planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation,BP,
5927,GO:1905005,1,0.699990571588227,0,1,regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
5928,GO:1905007,1,0.699990571588227,0,1,positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
5929,GO:1905037,1,0.683763673758394,0,1,autophagosome organization,BP,
5930,GO:1905039,1,0.698158470740301,0,1,carboxylic acid transmembrane transport,BP,
5931,GO:1905063,1,0.698425417725528,0,1,regulation of vascular smooth muscle cell differentiation,BP,
5932,GO:1905064,1,0.698425417725528,0,1,negative regulation of vascular smooth muscle cell differentiation,BP,
5935,GO:1905174,1,0.698425417725528,0,1,regulation of vascular smooth muscle cell dedifferentiation,BP,
5936,GO:1905176,1,0.698425417725528,0,1,positive regulation of vascular smooth muscle cell dedifferentiation,BP,
5940,GO:1905269,1,0.710496861605038,0,1,positive regulation of chromatin organization,BP,
5950,GO:1905438,1,0.711607822536356,0,1,non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
5955,GO:1905476,1,0.711596825427955,0,1,negative regulation of protein localization to membrane,BP,
5959,GO:1905666,1,0.710730522233721,0,1,regulation of protein localization to endosome,BP,
5960,GO:1905668,1,0.710730522233721,0,1,positive regulation of protein localization to endosome,BP,
5962,GO:1905809,1,0.711607822536356,0,1,negative regulation of synapse organization,BP,
5964,GO:1905874,1,0.711526480882443,0,1,regulation of postsynaptic density organization,BP,
5965,GO:1905879,1,0.631393261474434,0,1,regulation of oogenesis,BP,
5966,GO:1905880,1,0.631393261474434,0,1,negative regulation of oogenesis,BP,
5969,GO:1905939,1,0.497008990074133,0,2,regulation of gonad development,BP,
5970,GO:1905940,1,0.497008990074133,0,2,negative regulation of gonad development,BP,
5971,GO:1905941,1,0.700771912592825,0,1,positive regulation of gonad development,BP,
5974,GO:1905953,1,0.698158470740301,0,1,negative regulation of lipid localization,BP,
5976,GO:1990089,1,0.698158470740301,0,1,response to nerve growth factor,BP,
5977,GO:1990090,1,0.698158470740301,0,1,cellular response to nerve growth factor stimulus,BP,
5981,GO:1990172,1,0.711607832986099,0,1,G-protein coupled receptor catabolic process,BP,
5982,GO:1990182,1,0.481818789959566,0,2,exosomal secretion,BP,
5985,GO:1990262,1,0.695717016238432,0,1,anti-Mullerian hormone signaling pathway,BP,
5987,GO:1990316,1,0.707555965307343,0,1,ATG1/ULK1 kinase complex,CC,
5989,GO:1990418,1,0.698158470740301,0,1,response to insulin-like growth factor stimulus,BP,
5990,GO:1990427,1,0.71160840958516,0,1,stereocilia tip-link density,CC,
5991,GO:1990430,1,0.711609191793077,0,1,extracellular matrix protein binding,MF,
5992,GO:1990435,1,0.71160840958516,0,1,upper tip-link density,CC,
5994,GO:1990578,1,0.711607815446889,0,1,perinuclear endoplasmic reticulum membrane,CC,
5998,GO:1990776,1,0.711597574443894,0,1,response to angiotensin,BP,
6000,GO:1990782,1,0.245831361477521,0,4,protein tyrosine kinase binding,MF,
6001,GO:1990785,1,0.70489454545713,0,1,response to water-immersion restraint stress,BP,
6003,GO:1990841,1,0.70489454545713,0,1,promoter-specific chromatin binding,MF,
6004,GO:1990851,1,0.703713205073141,0,1,Wnt-Frizzled-LRP5/6 complex,CC,
6005,GO:1990874,1,0.698425417725528,0,1,vascular smooth muscle cell proliferation,BP,
6008,GO:1990936,1,0.698425417725528,0,1,vascular smooth muscle cell dedifferentiation,BP,
6014,GO:2000008,1,0.711597574443894,0,1,regulation of protein localization to cell surface,BP,
6015,GO:2000009,1,0.711597574443894,0,1,negative regulation of protein localization to cell surface,BP,
6016,GO:2000015,1,0.699990571588227,0,1,regulation of determination of dorsal identity,BP,
6017,GO:2000017,1,0.699990571588227,0,1,positive regulation of determination of dorsal identity,BP,
6018,GO:2000018,1,0.497008990074133,0,2,regulation of male gonad development,BP,
6019,GO:2000019,1,0.710436959244465,0,1,negative regulation of male gonad development,BP,
6020,GO:2000020,1,0.700771912592825,0,1,positive regulation of male gonad development,BP,
6021,GO:2000021,1,0.231687875038078,0,4,regulation of ion homeostasis,BP,
6025,GO:2000045,1,0.197584562273638,0,4,regulation of G1/S transition of mitotic cell cycle,BP,
6026,GO:2000047,1,0.711607822536356,0,1,regulation of cell-cell adhesion mediated by cadherin,BP,
6027,GO:2000049,1,0.711607822536356,0,1,positive regulation of cell-cell adhesion mediated by cadherin,BP,
6028,GO:2000050,1,0.711607822536356,0,1,regulation of non-canonical Wnt signaling pathway,BP,
6029,GO:2000052,1,0.711607822536356,0,1,positive regulation of non-canonical Wnt signaling pathway,BP,
6032,GO:2000064,1,0.345758439334557,0,3,regulation of cortisol biosynthetic process,BP,
6033,GO:2000065,1,0.488356881126512,0,2,negative regulation of cortisol biosynthetic process,BP,
6034,GO:2000066,1,0.710436959244465,0,1,positive regulation of cortisol biosynthetic process,BP,
6035,GO:2000097,1,0.690576730624361,0,1,regulation of smooth muscle cell-matrix adhesion,BP,
6039,GO:2000108,1,0.711607822536356,0,1,positive regulation of leukocyte apoptotic process,BP,
6043,GO:2000117,1,0.480976484752435,0,2,negative regulation of cysteine-type endopeptidase activity,BP,
6045,GO:2000134,1,0.448309892774536,0,2,negative regulation of G1/S transition of mitotic cell cycle,BP,
6053,GO:2000178,1,0.483077648196315,0,2,negative regulation of neural precursor cell proliferation,BP,
6056,GO:2000191,1,0.4734145790807,0,2,regulation of fatty acid transport,BP,
6057,GO:2000192,1,0.698158470740301,0,1,negative regulation of fatty acid transport,BP,
6058,GO:2000193,1,0.679378706287525,0,1,positive regulation of fatty acid transport,BP,
6059,GO:2000194,1,0.700771912592825,0,1,regulation of female gonad development,BP,
6060,GO:2000195,1,0.700771912592825,0,1,negative regulation of female gonad development,BP,
6062,GO:2000224,1,0.710436959244465,0,1,regulation of testosterone biosynthetic process,BP,
6063,GO:2000225,1,0.710436959244465,0,1,negative regulation of testosterone biosynthetic process,BP,
6071,GO:2000272,1,0.694780337175533,0,1,negative regulation of receptor activity,BP,
6072,GO:2000273,1,0.233750798147636,0,4,positive regulation of receptor activity,BP,
6073,GO:2000278,1,0.475615699790726,0,2,regulation of DNA biosynthetic process,BP,
6074,GO:2000345,1,0.680084082501265,0,1,regulation of hepatocyte proliferation,BP,
6075,GO:2000346,1,0.680084082501265,0,1,negative regulation of hepatocyte proliferation,BP,
6076,GO:2000351,1,0.690185661474723,0,1,regulation of endothelial cell apoptotic process,BP,
6077,GO:2000352,1,0.690185661474723,0,1,negative regulation of endothelial cell apoptotic process,BP,
6078,GO:2000369,1,0.663076179385611,0,1,regulation of clathrin-dependent endocytosis,BP,
6080,GO:2000379,1,0.100703517320661,0,6,positive regulation of reactive oxygen species metabolic process,BP,
6087,GO:2000425,1,0.674176169736539,0,1,regulation of apoptotic cell clearance,BP,
6088,GO:2000427,1,0.674176169736539,0,1,positive regulation of apoptotic cell clearance,BP,
6090,GO:2000479,1,0.487512907525191,0,2,regulation of cAMP-dependent protein kinase activity,BP,
6091,GO:2000480,1,0.690234710370884,0,1,negative regulation of cAMP-dependent protein kinase activity,BP,
6092,GO:2000482,1,0.711607822536356,0,1,regulation of interleukin-8 secretion,BP,
6093,GO:2000484,1,0.711607822536356,0,1,positive regulation of interleukin-8 secretion,BP,
6094,GO:2000505,1,0.705560336344585,0,1,regulation of energy homeostasis,BP,
6095,GO:2000508,1,0.690185661474723,0,1,regulation of dendritic cell chemotaxis,BP,
6096,GO:2000510,1,0.690185661474723,0,1,positive regulation of dendritic cell chemotaxis,BP,
6097,GO:2000532,1,0.690185661474723,0,1,regulation of renal albumin absorption,BP,
6098,GO:2000533,1,0.690185661474723,0,1,negative regulation of renal albumin absorption,BP,
6100,GO:2000573,1,0.698425417725528,0,1,positive regulation of DNA biosynthetic process,BP,
6101,GO:2000586,1,0.698425417725528,0,1,regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
6102,GO:2000587,1,0.698425417725528,0,1,negative regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
6103,GO:2000589,1,0.698425417725528,0,1,regulation of metanephric mesenchymal cell migration,BP,
6104,GO:2000591,1,0.698425417725528,0,1,positive regulation of metanephric mesenchymal cell migration,BP,
6108,GO:2000641,1,0.710730522233721,0,1,regulation of early endosome to late endosome transport,BP,
6109,GO:2000643,1,0.710730522233721,0,1,positive regulation of early endosome to late endosome transport,BP,
6112,GO:2000668,1,0.690185661474723,0,1,regulation of dendritic cell apoptotic process,BP,
6113,GO:2000669,1,0.690185661474723,0,1,negative regulation of dendritic cell apoptotic process,BP,
6118,GO:2000705,1,0.677890918061584,0,1,regulation of dense core granule biogenesis,BP,
6119,GO:2000707,1,0.677890918061584,0,1,positive regulation of dense core granule biogenesis,BP,
6125,GO:2000756,1,0.710496861605038,0,1,regulation of peptidyl-lysine acetylation,BP,
6126,GO:2000758,1,0.710496861605038,0,1,positive regulation of peptidyl-lysine acetylation,BP,
6127,GO:2000785,1,0.683763673758394,0,1,regulation of autophagosome assembly,BP,
6128,GO:2000786,1,0.683763673758394,0,1,positive regulation of autophagosome assembly,BP,
6130,GO:2000807,1,0.711526480882443,0,1,regulation of synaptic vesicle clustering,BP,
6131,GO:2000809,1,0.711526480882443,0,1,positive regulation of synaptic vesicle clustering,BP,
6132,GO:2000810,1,0.706809127351861,0,1,regulation of bicellular tight junction assembly,BP,
6153,GO:2001044,1,0.680084082501265,0,1,regulation of integrin-mediated signaling pathway,BP,
6154,GO:2001046,1,0.680084082501265,0,1,positive regulation of integrin-mediated signaling pathway,BP,
6158,GO:2001057,1,0.4734145790807,0,2,reactive nitrogen species metabolic process,BP,
6159,GO:2001074,1,0.700771912592825,0,1,regulation of metanephric ureteric bud development,BP,
6160,GO:2001076,1,0.700771912592825,0,1,positive regulation of metanephric ureteric bud development,BP,
6161,GO:2001135,1,0.711597574443894,0,1,regulation of endocytic recycling,BP,
6162,GO:2001137,1,0.711597574443894,0,1,positive regulation of endocytic recycling,BP,
6176,GO:2001243,1,0.698158470740301,0,1,negative regulation of intrinsic apoptotic signaling pathway,BP,
6178,GO:2001252,1,0.710496861605038,0,1,positive regulation of chromosome organization,BP,
6179,GO:2001257,1,0.349938944114777,0,3,regulation of cation channel activity,BP,
6180,GO:2001258,1,0.694780337175533,0,1,negative regulation of cation channel activity,BP,
6181,GO:2001259,1,0.711597574443894,0,1,positive regulation of cation channel activity,BP,
6182,GO:2001273,1,0.504859652900128,0,2,regulation of glucose import in response to insulin stimulus,BP,
6183,GO:2001275,1,0.504859652900128,0,2,positive regulation of glucose import in response to insulin stimulus,BP,
6184,GO:2001286,1,0.663076179385611,0,1,regulation of caveolin-mediated endocytosis,BP,
6185,GO:2001287,1,0.663076179385611,0,1,negative regulation of caveolin-mediated endocytosis,BP,
